TIF1gamma	B
,	O
a	O
novel	O
member	O
of	O
the	O
transcriptional	B
intermediary	I
factor	I
1	I
family	O
.	O

We	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
member	O
of	O
the	O
Transcriptional	B
Intermediary	I
Factor	I
1	I
(	O
TIF1	B
)	O
gene	O
family	O
,	O
human	O
TIF1gamma	B
.	O

Similar	O
to	O
TIF1alpha	B
and	O
TIF1beta	B
,	O
the	O
structure	O
of	O
TIF1beta	B
is	O
characterized	O
by	O
multiple	O
domains	O
:	O
RING	O
finger	O
,	O
B	O
boxes	O
,	O
Coiled	O
coil	O
,	O
PHD	O
/	O
TTC	O
,	O
and	O
bromodomain	O
.	O

Although	O
structurally	O
related	O
to	O
TIF1alpha	B
and	O
TIF1beta	B
,	O
TIF1gamma	B
presents	O
several	O
functional	O
differences	O
.	O

In	O
contrast	O
to	O
TIF1alpha	B
,	O
but	O
like	O
TIF1beta	B
,	O
TIF1	B
does	O
not	O
interact	O
with	O
nuclear	O
receptors	O
in	O
yeast	O
two	O
-	O
hybrid	O
or	O
GST	O
pull	O
-	O
down	O
assays	O
and	O
does	O
not	O
interfere	O
with	O
retinoic	O
acid	O
response	O
in	O
transfected	O
mammalian	O
cells	O
.	O

Whereas	O
TIF1alpha	B
and	O
TIF1beta	B
were	O
previously	O
found	O
to	O
interact	O
with	O
the	O
KRAB	O
silencing	O
domain	O
of	O
KOX1	B
and	O
with	O
the	O
HP1alpha	B
,	O
MODI	B
(	O
HP1beta	B
)	O
and	O
MOD2	B
(	O
HP1gamma	B
)	O
heterochromatinic	O
proteins	O
,	O
suggesting	O
that	O
they	O
may	O
participate	O
in	O
a	O
complex	O
involved	O
in	O
heterochromatin	O
-	O
induced	O
gene	O
repression	O
,	O
TIF1gamma	B
does	O
not	O
interact	O
with	O
either	O
the	O
KRAB	O
domain	O
of	O
KOX1	B
or	O
the	O
HP1	B
proteins	O
.	O

Nevertheless	O
,	O
TIF1gamma	B
,	O
like	O
TIF1alpha	B
and	O
TIF1beta	B
,	O
exhibits	O
a	O
strong	O
silencing	O
activity	O
when	O
tethered	O
to	O
a	O
promoter	O
.	O

Since	O
deletion	O
of	O
a	O
novel	O
motif	O
unique	O
to	O
the	O
three	O
TIF1	B
proteins	O
,	O
called	O
TIF1	B
signature	O
sequence	O
(	O
TSS	O
)	O
,	O
abrogates	O
transcriptional	O
repression	O
by	O
TIF1gamma	B
,	O
this	O
motif	O
likely	O
participates	O
in	O
TIF1	B
dependent	O
repression	O
.	O

Cloning	O
of	O
a	O
novel	O
gene	O
(	O
ING1L	B
)	O
homologous	O
to	O
ING1	B
,	O
a	O
candidate	O
tumor	O
suppressor	O
.	O

The	O
ING1	B
gene	O
encodes	O
p33	B
(	I
ING1	I
)	I
,	O
a	O
putative	O
tumor	O
suppressor	O
for	O
neuroblastomas	O
and	O
breast	O
cancers	O
,	O
which	O
has	O
been	O
shown	O
to	O
cooperate	O
with	O
p53	B
in	O
controlling	O
cell	O
proliferation	O
.	O

We	O
have	O
isolated	O
a	O
novel	O
human	O
gene	O
,	O
ING1L	B
,	O
that	O
potentially	O
encodes	O
a	O
PHD	O
-	O
type	O
zinc	O
-	O
finger	O
protein	O
highly	O
homologous	O
to	O
p33	B
(	I
ING1	I
)	I
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
and	O
radiation	O
-	O
hybrid	O
analyses	O
assigned	O
ING1L	B
to	O
human	O
chromosome	O
4	O
.	O

Both	O
ING1	B
and	O
ING1L	B
are	O
expressed	O
in	O
a	O
variety	O
of	O
human	O
tissues	O
,	O
but	O
we	O
found	O
ING1L	B
expression	O
to	O
be	O
significantly	O
more	O
pronounced	O
in	O
tumors	O
from	O
several	O
colon	O
-	O
cancer	O
patients	O
than	O
in	O
normal	O
colon	O
tissues	O
excised	O
at	O
the	O
same	O
surgical	O
sites	O
.	O

Although	O
the	O
significance	O
of	O
this	O
observation	O
with	O
respect	O
to	O
carcinogenesis	O
remains	O
to	O
be	O
established	O
,	O
the	O
data	O
suggest	O
that	O
ING1L	B
might	O
be	O
involved	O
in	O
colon	O
cancers	O
through	O
interference	O
with	O
signal	O
(	O
s	O
)	O
transmitted	O
through	O
p53	B
and	O
p33	B
(	I
ING1	I
)	I
.	O

A	O
mutation	O
in	O
OTOF	B
,	O
encoding	O
otoferlin	B
,	O
a	O
FER-1-like	O
protein	O
,	O
causes	O
DFNB9	B
,	O
a	O
nonsyndromic	O
form	O
of	O
deafness	O
.	O

Using	O
a	O
candidate	O
gene	O
approach	O
,	O
we	O
identified	O
a	O
novel	O
human	O
gene	O
,	O
OTOF	B
,	O
underlying	O
an	O
autosomal	O
recessive	O
,	O
nonsyndromic	O
prelingual	O
deafness	O
,	O
DFNB9	B
.	O

The	O
same	O
nonsense	O
mutation	O
was	O
detected	O
in	O
four	O
unrelated	O
affected	O
families	O
of	O
Lebanese	O
origin	O
.	O

OTOF	B
is	O
the	O
second	O
member	O
of	O
a	O
mammalian	O
gene	O
family	O
related	O
to	O
Caenorhabditis	O
elegans	O
fer-1	O
.	O

It	O
encodes	O
a	O
predicted	O
cytosolic	O
protein	O
(	O
of	O
1,230	O
aa	O
)	O
with	O
three	O
C2	O
domains	O
and	O
a	O
single	O
carboxy	O
-	O
terminal	O
transmembrane	O
domain	O
.	O

The	O
sequence	O
homologies	O
and	O
predicted	O
structure	O
of	O
otoferlin	B
,	O
the	O
protein	O
encoded	O
by	O
OTOF	B
,	O
suggest	O
its	O
involvement	O
in	O
vesicle	O
membrane	O
fusion	O
.	O

In	O
the	O
inner	O
ear	O
,	O
the	O
expression	O
of	O
the	O
orthologous	O
mouse	O
gene	O
,	O
mainly	O
in	O
the	O
sensory	O
hair	O
cells	O
,	O
indicates	O
that	O
such	O
a	O
role	O
could	O
apply	O
to	O
synaptic	O
vesicles	O
.	O

Slit2-Mediated	B
chemorepulsion	O
and	O
collapse	O
of	O
developing	O
forebrain	O
axons	O
.	O

Diffusible	O
chemorepellents	O
play	O
a	O
major	O
role	O
in	O
guiding	O
developing	O
axons	O
toward	O
their	O
correct	O
targets	O
by	O
preventing	O
them	O
from	O
entering	O
or	O
steering	O
them	O
away	O
from	O
certain	O
regions	O
.	O

Genetic	O
studies	O
in	O
Drosophila	O
revealed	O
a	O
novel	O
repulsive	O
guidance	O
system	O
that	O
prevents	O
inappropriate	O
axons	O
from	O
crossing	O
the	O
CNS	O
midline	O
;	O
this	O
repulsive	O
system	O
is	O
mediated	O
by	O
the	O
Roundabout	O
(	O
Robo	B
)	O
receptor	O
and	O
its	O
secreted	O
ligand	O
Slit	O
.	O

In	O
rodents	O
,	O
Robo	B
and	O
Slit	O
are	O
expressed	O
in	O
the	O
spinal	O
cord	O
and	O
Slit	O
can	O
repel	O
spinal	O
motor	O
axons	O
in	O
vitro	O
.	O

Here	O
,	O
we	O
extend	O
these	O
findings	O
into	O
higher	O
brain	O
centers	O
by	O
showing	O
that	O
Robo1	B
and	O
Robo2	B
,	O
as	O
well	O
as	O
Slit1	B
and	O
Slit2	B
,	O
are	O
often	O
expressed	O
in	O
complementary	O
patterns	O
in	O
the	O
developing	O
forebrain	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
human	O
Slit2	B
can	O
repel	O
olfactory	O
and	O
hippocampal	O
axons	O
and	O
collapse	O
their	O
growth	O
cones	O
.	O

Human	O
mitochondrial	O
thioredoxin	B
reductase	O
cDNA	O
cloning	O
,	O
expression	O
and	O
genomic	O
organization	O
.	O

We	O
have	O
isolated	O
a	O
1918-bp	O
cDNA	O
from	O
a	O
human	O
adrenal	O
cDNA	O
library	O
which	O
encodes	O
a	O
novel	O
thioredoxin	B
reductase	O
(	O
TrxR2	B
)	O
of	O
521	O
amino	O
acid	O
residues	O
with	O
a	O
calculated	O
molecular	O
mass	O
of	O
56.2	O
kDa	O
.	O

It	O
is	O
highly	O
homologous	O
to	O
the	O
previously	O
described	O
cytosolic	O
enzyme	O
(	O
TrxR1	B
)	O
,	O
including	O
the	O
conserved	O
active	O
site	O
CVNVGC	O
and	O
the	O
FAD	O
-	O
binding	O
and	O
NADPH	O
-	O
binding	O
domains	O
.	O

However	O
,	O
human	O
TrxR2	B
differs	O
from	O
human	O
TrxR1	B
by	O
the	O
presence	O
of	O
a	O
33-amino	O
acid	O
extension	O
at	O
the	O
N	O
-	O
terminus	O
which	O
has	O
properties	O
characteristic	O
of	O
a	O
mitochondrial	O
translocation	O
signal	O
.	O

Northern	O
-	O
blot	O
analysis	O
identified	O
one	O
mRNA	O
species	O
of	O
2.2	O
kb	O
with	O
highest	O
expression	O
in	O
prostate	O
,	O
testis	O
and	O
liver	O
.	O

We	O
expressed	O
human	O
TrxR2	B
as	O
a	O
fusion	O
protein	O
with	O
green	O
fluorescent	O
protein	O
and	O
showed	O
that	O
in	O
vivo	O
it	O
is	O
localized	O
in	O
mitochondria	O
.	O

Removal	O
of	O
the	O
mitochondrial	O
targeting	O
sequence	O
abolishes	O
the	O
mitochondrial	O
translocation	O
.	O

Finally	O
,	O
we	O
determined	O
the	O
genomic	O
organization	O
of	O
the	O
human	O
TrxR2	B
gene	O
,	O
which	O
consists	O
of	O
18	O
exons	O
spanning	O
about	O
67	O
kb	O
,	O
and	O
its	O
chromosomal	O
localization	O
at	O
position	O
22q11.2	O
.	O

Ligand	O
-	O
dependent	O
transcription	O
activation	O
by	O
nuclear	O
receptors	O
requires	O
the	O
DRIP	O
complex	O
.	O

Nuclear	O
receptors	O
modulate	O
the	O
transcription	O
of	O
genes	O
in	O
direct	O
response	O
to	O
small	O
lipophilic	O
ligands	O
.	O

Binding	O
to	O
ligands	O
induces	O
conformational	O
changes	O
in	O
the	O
nuclear	O
receptors	O
that	O
enable	O
the	O
receptors	O
to	O
interact	O
with	O
several	O
types	O
of	O
cofactor	O
that	O
are	O
critical	O
for	O
transcription	O
activation	O
(	O
transactivation	O
)	O
.	O

We	O
previously	O
described	O
a	O
distinct	O
set	O
of	O
ligand	O
-	O
dependent	O
proteins	O
called	O
DRIPs	O
,	O
which	O
interact	O
with	O
the	O
vitamin	B
D	I
receptor	I
(	O
VDR	B
)	O
;	O
together	O
,	O
these	O
proteins	O
constitute	O
a	O
new	O
cofactor	O
complex	O
.	O

DRIPs	O
bind	O
to	O
several	O
nuclear	O
receptors	O
and	O
mediate	O
ligand	O
-	O
dependent	O
enhancement	O
of	O
transcription	O
by	O
VDR	B
and	O
the	O
thyroid	O
-	O
hormone	O
receptor	O
in	O
cell	O
-	O
free	O
transcription	O
assays	O
.	O

Here	O
we	O
report	O
the	O
identities	O
of	O
thirteen	O
DRIPs	O
that	O
constitute	O
this	O
complex	O
,	O
and	O
show	O
that	O
the	O
complex	O
has	O
a	O
central	O
function	O
in	O
hormone	O
-	O
dependent	O
transactivation	O
by	O
VDR	B
on	O
chromatin	O
templates	O
.	O

The	O
DRIPs	O
are	O
almost	O
indistinguishable	O
from	O
components	O
of	O
another	O
new	O
cofactor	O
complex	O
called	O
ARC	O
,	O
which	O
is	O
recruited	O
by	O
other	O
types	O
of	O
transcription	O
activators	O
to	O
mediate	O
transactivation	O
on	O
chromatin	O
-	O
assembled	O
templates	O
.	O

Several	O
DRIP	O
/	O
ARC	O
subunits	O
are	O
also	O
components	O
of	O
other	O
potentially	O
related	O
cofactors	O
,	O
such	O
as	O
CRSP	O
,	O
NAT	B
,	O
SMCC	O
and	O
the	O
mouse	O
Mediator	O
,	O
indicating	O
that	O
unique	O
classes	O
of	O
activators	O
may	O
share	O
common	O
sets	O
or	O
subsets	O
of	O
cofactors	O
.	O

The	O
role	O
of	O
nuclear	O
-	O
receptor	O
ligands	O
may	O
,	O
in	O
part	O
,	O
be	O
to	O
recruit	O
such	O
a	O
cofactor	O
complex	O
to	O
the	O
receptor	O
and	O
,	O
in	O
doing	O
so	O
,	O
to	O
enhance	O
transcription	O
of	O
target	O
genes	O
.	O

Composite	O
co	O
-	O
activator	O
ARC	O
mediates	O
chromatin	O
-	O
directed	O
transcriptional	O
activation	O
.	O

Gene	O
activation	O
in	O
eukaryotes	O
is	O
regulated	O
by	O
complex	O
mechanisms	O
in	O
which	O
the	O
recruitment	O
and	O
assembly	O
of	O
the	O
transcriptional	O
machinery	O
is	O
directed	O
by	O
gene-	O
and	O
cell	O
-	O
type	O
-	O
specific	O
DNA	O
-	O
binding	O
proteins	O
.	O

When	O
DNA	O
is	O
packaged	O
into	O
chromatin	O
,	O
the	O
regulation	O
of	O
gene	O
activation	O
requires	O
new	O
classes	O
of	O
chromatin	O
-	O
targeting	O
activity	O
.	O

In	O
humans	O
,	O
a	O
multisubunit	O
cofactor	O
functions	O
in	O
a	O
chromatin	O
-	O
selective	O
manner	O
to	O
potentiate	O
synergistic	O
gene	O
activation	O
by	O
the	O
transcriptional	O
activators	O
SREBP-1a	B
and	O
Sp1	B
.	O

Here	O
we	O
show	O
that	O
this	O
activator	O
-	O
recruited	O
cofactor	O
(	O
ARC	O
)	O
interacts	O
directly	O
with	O
several	O
different	O
activators	O
,	O
including	O
SREBP-1a	B
,	O
VP16	B
and	O
the	O
p65	B
subunit	I
of	I
NF	I
-	I
kappaB	I
,	O
and	O
strongly	O
enhances	O
transcription	O
directed	O
by	O
these	O
activators	O
in	O
vitro	O
with	O
chromatin	O
-	O
assembled	O
DNA	O
templates	O
.	O

The	O
ARC	O
complex	O
consists	O
of	O
16	O
or	O
more	O
subunits	O
;	O
some	O
of	O
these	O
are	O
novel	O
gene	O
products	O
,	O
whereas	O
others	O
are	O
present	O
in	O
other	O
multisubunit	O
cofactors	O
,	O
such	O
as	O
CRSP	O
,	O
NAT	O
and	O
mammalian	O
Mediator	O
.	O

Detailed	O
analysis	O
indicates	O
that	O
the	O
ARC	O
complex	O
is	O
probably	O
identical	O
to	O
the	O
nuclear	O
hormone	O
-	O
receptor	O
cofactor	O
DRIP	O
.	O

Thus	O
,	O
ARC	O
/	O
DRIP	O
is	O
a	O
large	O
composite	O
co	O
-	O
activator	O
that	O
belongs	O
to	O
a	O
family	O
of	O
related	O
cofactors	O
and	O
is	O
targeted	O
by	O
different	O
classes	O
of	O
activator	O
to	O
mediate	O
transcriptional	O
stimulation	O
.	O

p73	B
and	O
p63	B
are	O
homotetramers	O
capable	O
of	O
weak	O
heterotypic	O
interactions	O
with	O
each	O
other	O
but	O
not	O
with	O
p53	B
.	O

Mutations	O
in	O
the	O
p53	B
tumor	O
suppressor	O
gene	O
are	O
the	O
most	O
frequent	O
genetic	O
alterations	O
found	O
in	O
human	O
cancers	O
.	O

Recent	O
identification	O
of	O
two	O
human	O
homologues	O
of	O
p53	B
has	O
raised	O
the	O
prospect	O
of	O
functional	O
interactions	O
between	O
family	O
members	O
via	O
a	O
conserved	O
oligomerization	O
domain	O
.	O

Here	O
we	O
report	O
in	O
vitro	O
and	O
in	O
vivo	O
analysis	O
of	O
homo-	O
and	O
hetero	O
-	O
oligomerization	O
of	O
p53	B
and	O
its	O
homologues	O
,	O
p63	B
and	O
p73	B
.	O

The	O
oligomerization	O
domains	O
of	O
p63	B
and	O
p73	B
can	O
independently	O
fold	O
into	O
stable	O
homotetramers	O
,	O
as	O
previously	O
observed	O
for	O
p53	B
.	O

However	O
,	O
the	O
oligomerization	O
domain	O
of	O
p53	B
does	O
not	O
associate	O
with	O
that	O
of	O
either	O
p73	B
or	O
p63	B
,	O
even	O
when	O
p53	B
is	O
in	O
15-fold	O
excess	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
oligomerization	O
domains	O
of	O
p63	B
and	O
p73	B
are	O
able	O
to	O
weakly	O
associate	O
with	O
one	O
another	O
in	O
vitro	O
.	O

In	O
vivo	O
co	O
-	O
transfection	O
assays	O
of	O
the	O
ability	O
of	O
p53	B
and	O
its	O
homologues	O
to	O
activate	O
reporter	O
genes	O
showed	O
that	O
a	O
DNA	O
-	O
binding	O
mutant	O
of	O
p53	B
was	O
not	O
able	O
to	O
act	O
in	O
a	O
dominant	O
negative	O
manner	O
over	O
wild	O
-	O
type	O
p73	B
or	O
p63	B
but	O
that	O
a	O
p73	B
mutant	O
could	O
inhibit	O
the	O
activity	O
of	O
wild	O
-	O
type	O
p63	B
.	O

These	O
data	O
suggest	O
that	O
mutant	O
p53	B
in	O
cancer	O
cells	O
will	O
not	O
interact	O
with	O
endogenous	O
or	O
exogenous	O
p63	B
or	O
p73	B
via	O
their	O
respective	O
oligomerization	O
domains	O
.	O

It	O
also	O
establishes	O
that	O
the	O
multiple	O
isoforms	O
of	O
p63	B
as	O
well	O
as	O
those	O
of	O
p73	B
are	O
capable	O
of	O
interacting	O
via	O
their	O
common	O
oligomerization	O
domain	O
.	O

Metaxin	B
1	I
interacts	O
with	O
metaxin	B
2	I
,	O
a	O
novel	O
related	O
protein	O
associated	O
with	O
the	O
mammalian	O
mitochondrial	O
outer	O
membrane	O
.	O

A	O
recently	O
described	O
protein	O
,	O
metaxin	B
1	I
,	O
serves	O
as	O
a	O
component	O
of	O
a	O
preprotein	O
import	O
complex	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
mammalian	O
mitochondrion	O
.	O

A	O
yeast	O
two	O
-	O
hybrid	O
screen	O
with	O
metaxin	B
1	I
as	O
bait	O
has	O
now	O
identified	O
a	O
novel	O
protein	O
,	O
which	O
we	O
have	O
termed	O
metaxin	B
2	I
,	O
as	O
a	O
metaxin	B
1-binding	I
protein	O
.	O

Metaxin	B
2	I
shares	O
29	O
%	O
identity	O
with	O
metaxin	B
1	I
at	O
the	O
amino	O
acid	O
level	O
,	O
but	O
metaxin	B
2	I
,	O
unlike	O
metaxin	B
1	I
,	O
lacks	O
a	O
C	O
-	O
terminal	O
mitochondrial	O
outer	O
membrane	O
signal	O
-	O
anchor	O
domain	O
.	O

Two	O
C.	O
elegans	O
hypothetical	O
proteins	O
,	O
CelZC97.1	O
and	O
CelF39B2.i	O
,	O
share	O
high	O
sequence	O
similarity	O
with	O
metaxin	B
2	I
and	O
metaxin	B
1	I
,	O
respectively	O
,	O
and	O
likely	O
represent	O
the	O
C.	O
elegans	O
orthologs	O
.	O

Affinity	O
-	O
purified	O
antibodies	O
against	O
metaxin	B
2	I
were	O
prepared	O
against	O
the	O
recombinant	O
protein	O
produced	O
in	O
E.	O
coli	O
and	O
were	O
used	O
to	O
analyze	O
the	O
subcellular	O
distribution	O
of	O
metaxin	B
2	I
.	O

In	O
subcellular	O
fractions	O
of	O
mouse	O
liver	O
,	O
a	O
29	O
kD	O
immunoreactive	O
protein	O
,	O
consistent	O
in	O
size	O
with	O
the	O
predicted	O
translation	O
product	O
of	O
metaxin	B
2	I
cDNA	O
,	O
was	O
found	O
solely	O
in	O
mitochondria	O
.	O

Alkali	O
extraction	O
of	O
mitochondria	O
indicated	O
that	O
metaxin	B
2	I
is	O
peripherally	O
associated	O
with	O
mitochondrial	O
membranes	O
.	O

Metaxin	B
2	I
in	O
intact	O
mitochondria	O
was	O
susceptible	O
to	O
digestion	O
with	O
proteinase	O
K	O
,	O
indicating	O
that	O
metaxin	B
2	I
is	O
located	O
on	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
.	O

Finally	O
,	O
baculoviruses	O
encoding	O
a	O
His6-tagged	O
metaxin	B
2	I
and	O
an	O
untagged	O
metaxin	B
1	I
lacking	O
its	O
C	O
-	O
terminal	O
transmembrane	O
domain	O
were	O
produced	O
and	O
used	O
separately	O
or	O
in	O
combination	O
to	O
infect	O
Sf21	O
insect	O
cells	O
.	O

Metaxin	B
1	I
bound	O
to	O
a	O
Ni2	O
+	O
-chelate	O
affinity	O
column	O
only	O
in	O
the	O
presence	O
of	O
metaxin	B
2	I
,	O
indicating	O
that	O
metaxin	B
1	I
and	O
metaxin	B
2	I
interact	O
when	O
overexpressed	O
in	O
insect	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
metaxin	B
2	I
is	O
bound	O
to	O
the	O
cytosolic	O
face	O
of	O
the	O
mitochondrial	O
outer	O
membrane	O
by	O
means	O
of	O
its	O
interaction	O
with	O
membrane	O
-	O
bound	O
metaxin	B
1	I
,	O
and	O
that	O
this	O
complex	O
may	O
play	O
a	O
role	O
in	O
protein	O
import	O
into	O
mammalian	O
mitochondria	O
.	O

Comparative	O
analysis	O
of	O
a	O
novel	O
gene	O
from	O
the	O
Wolf	O
-	O
Hirschhorn	O
/	O
Pitt	O
-	O
Rogers	O
-	O
Danks	O
syndrome	O
critical	O
region	O
.	O

Wolf	O
-	O
Hirschhorn	O
syndrome	O
(	O
WHS	O
)	O
is	O
a	O
multiple	O
malformation	O
syndrome	O
characterized	O
by	O
mental	O
and	O
developmental	O
defects	O
resulting	O
from	O
the	O
absence	O
of	O
a	O
segment	O
of	O
one	O
chromosome	O
4	O
short	O
arm	O
(	O
4p16.3	O
)	O
.	O

Recently	O
,	O
Pitt	O
-	O
Rogers	O
-	O
Danks	O
syndrome	O
(	O
PRDS	O
)	O
,	O
which	O
is	O
also	O
due	O
to	O
a	O
deletion	O
of	O
chromosome	O
4p16.3	O
,	O
has	O
been	O
shown	O
to	O
be	O
allelic	O
to	O
WHS	O
.	O

Due	O
to	O
the	O
complex	O
and	O
variable	O
expression	O
of	O
these	O
disorders	O
,	O
it	O
is	O
thought	O
that	O
WHS	O
/	O
PRDS	O
results	O
from	O
a	O
segmental	O
aneusomy	O
of	O
4p	O
resulting	O
in	O
haploinsufficieny	O
of	O
an	O
undefined	O
number	O
of	O
genes	O
that	O
contribute	O
to	O
the	O
phenotype	O
.	O

In	O
an	O
effort	O
to	O
identify	O
genes	O
that	O
contribute	O
to	O
human	O
development	O
and	O
whose	O
absence	O
may	O
contribute	O
to	O
the	O
phenotype	O
associated	O
with	O
these	O
syndromes	O
,	O
we	O
have	O
generated	O
a	O
transcript	O
map	O
of	O
the	O
165-kb	O
critical	O
region	O
and	O
have	O
identified	O
a	O
number	O
of	O
potential	O
genes	O
.	O

One	O
of	O
these	O
genes	O
,	O
WHSC2	B
,	O
which	O
was	O
identified	O
with	O
the	O
IMAGE	O
cDNA	O
clone	O
53283	O
,	O
has	O
been	O
characterized	O
.	O

Sequence	O
analysis	O
defined	O
an	O
open	O
reading	O
frame	O
of	O
1584	O
bp	O
(	O
528	O
amino	O
acids	O
)	O
,	O
and	O
transcript	O
analysis	O
detected	O
a	O
2.4-kb	O
transcript	O
in	O
all	O
fetal	O
and	O
adult	O
tissues	O
tested	O
.	O

In	O
parallel	O
,	O
the	O
mouse	O
homologue	O
was	O
isolated	O
and	O
characterized	O
.	O

Mouse	O
sequence	O
analysis	O
and	O
the	O
pattern	O
of	O
expression	O
are	O
consistent	O
with	O
the	O
clone	O
being	O
the	O
murine	O
equivalent	O
of	O
the	O
human	O
WHSC2	B
gene	O
(	O
designated	O
Whsc2h	B
)	O
.	O

The	O
data	O
from	O
sequence	O
and	O
transcript	O
analysis	O
of	O
this	O
new	O
human	O
gene	O
in	O
combination	O
with	O
the	O
lack	O
of	O
significant	O
similarity	O
to	O
proteins	O
of	O
known	O
function	O
imply	O
that	O
it	O
represents	O
a	O
novel	O
gene	O
.	O

Most	O
importantly	O
,	O
its	O
location	O
within	O
the	O
WHSCR	O
suggests	O
that	O
this	O
gene	O
may	O
play	O
a	O
role	O
in	O
the	O
phenotype	O
of	O
the	O
Wolf	O
-	O
Hirschhorn	O
/	O
Pitt	O
-	O
Rogers	O
-	O
Danks	O
syndrome	O
.	O

Cloning	O
and	O
mapping	O
of	O
the	O
XRN2	B
gene	O
to	O
human	O
chromosome	O
20p11.1-p11.2	O
.	O

The	O
Dhm1	O
gene	O
is	O
the	O
mouse	O
homologue	O
of	O
the	O
dhp1	O
(	O
+	O
)	O
gene	O
of	O
Schizosaccharomyces	O
pombe	O
,	O
which	O
is	O
involved	O
in	O
homologous	O
recombination	O
and	O
RNA	O
metabolism	O
,	O
such	O
as	O
RNA	O
synthesis	O
and	O
RNA	O
trafficking	O
,	O
in	O
S.	O
pombe	O
.	O

Complementation	O
analysis	O
showed	O
the	O
Dhm1	O
gene	O
on	O
a	O
multicopy	O
plasmid	O
can	O
rescue	O
the	O
temperature	O
-	O
sensitivity	O
mutation	O
of	O
dhp1	O
(	O
ts	O
)	O
and	O
the	O
lethality	O
of	O
the	O
dhp1	O
null	O
mutation	O
.	O

This	O
finding	O
suggests	O
that	O
Dhm1	O
has	O
a	O
function	O
in	O
mouse	O
similar	O
to	O
that	O
of	O
dhp1	O
(	O
+	O
)	O
.	O

The	O
human	O
homologue	O
of	O
this	O
gene	O
,	O
XRN2	B
,	O
has	O
been	O
identified	O
.	O

A	O
3.6-kb	O
transcript	O
of	O
XRN2	B
was	O
detected	O
in	O
16	O
tissues	O
examined	O
and	O
was	O
more	O
abundant	O
in	O
testis	O
.	O

By	O
radiation	O
hybrid	O
panel	O
mapping	O
,	O
the	O
XRN2	B
gene	O
was	O
localized	O
to	O
chromosome	O
20p11.1-p11.2	O
between	O
markers	O
D20S180	O
and	O
D20S871	O
.	O

Rab6	B
is	O
phosphorylated	O
in	O
thrombin	B
-	O
activated	O
platelets	O
by	O
a	O
protein	O
kinase	O
C	O
-	O
dependent	O
mechanism	O
:	O
effects	O
on	O
GTP	O
/	O
GDP	O
binding	O
and	O
cellular	O
distribution	O
.	O

In	O
platelets	O
and	O
other	O
secretory	O
cells	O
,	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
plays	O
a	O
role	O
in	O
exocytosis	O
stimulated	O
by	O
physiological	O
extracellular	O
signals	O
,	O
although	O
its	O
linkage	O
to	O
the	O
secretory	O
machinery	O
is	O
poorly	O
understood	O
.	O

We	O
investigated	O
whether	O
Rab6	B
,	O
a	O
GTP	O
-	O
binding	O
protein	O
that	O
fractionates	O
with	O
platelet	O
alpha	O
-	O
granules	O
,	O
may	O
be	O
involved	O
in	O
linking	O
these	O
processes	O
.	O

We	O
found	O
that	O
Rab6	B
contains	O
two	O
PKC	O
consensus	O
phosphorylation	O
sites	O
that	O
are	O
evolutionarily	O
conserved	O
.	O

In	O
platelets	O
metabolically	O
labelled	O
with	O
[	O
(	O
32	O
)	O
P	O
]	O
P	O
(	O
i	O
)	O
,	O
Rab6	B
phosphorylation	O
was	O
induced	O
by	O
phorbol	O
esters	O
or	O
by	O
thrombin	B
.	O

This	O
phosphorylation	O
was	O
blocked	O
by	O
a	O
specific	O
PKC	O
inhibitor	O
(	O
Ro-31	O
-	O
8220	O
)	O
,	O
but	O
not	O
by	O
a	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
inhibitor	O
(	O
PD-169316	O
)	O
.	O

Physiological	O
stimulation	O
of	O
platelets	O
caused	O
a	O
PKC	O
-	O
dependent	O
translocation	O
of	O
Rab6	B
from	O
platelet	O
particulate	O
fractions	O
,	O
nearly	O
doubling	O
the	O
fraction	O
of	O
Rab6	B
in	O
the	O
cytosol	O
.	O

A	O
human	O
Rab6	B
isoform	O
(	O
Rab6C	B
)	O
that	O
is	O
preferentially	O
expressed	O
in	O
human	O
platelet	O
RNA	O
was	O
cloned	O
and	O
its	O
phosphorylation	O
by	O
PKC	O
was	O
characterized	O
.	O

Rab6C	B
incorporated	O
up	O
to	O
2	O
mol	O
of	O
[	O
(	O
32	O
)	O
P	O
]	O
P	O
(	O
i	O
)	O
per	O
mol	O
of	O
active	O
protein	O
.	O

Rab6C	B
bound	O
GDP	O
and	O
GTP	O
with	O
K	O
(	O
d	O
)	O
values	O
of	O
113+	O
/	O
-12	O
and	O
119+	O
/	O
-27	O
nM	O
respectively	O
,	O
and	O
hydrolysed	O
GTP	O
at	O
a	O
rate	O
of	O
100+	O
/	O
-15	O
micromol	O
of	O
GTP	O
/	O
mol	O
of	O
Rab6C	B
per	O
min	O
.	O

PKC	O
phosphorylation	O
of	O
Rab6C	B
increased	O
the	O
affinity	O
for	O
GTP	O
by	O
3-fold	O
,	O
although	O
it	O
had	O
lesser	O
effects	O
on	O
GDP	O
(	O
1.6-fold	O
)	O
.	O

Phosphorylation	O
did	O
not	O
alter	O
the	O
GTPase	O
activity	O
.	O

In	O
summary	O
,	O
thrombin	B
activation	O
of	O
platelets	O
leads	O
to	O
PKC	O
-	O
dependent	O
phosphorylation	O
of	O
Rab6	B
and	O
a	O
translocation	O
of	O
Rab6	B
to	O
the	O
cytosol	O
.	O

We	O
suggest	O
that	O
PKC	O
phosphorylation	O
may	O
be	O
an	O
important	O
mechanism	O
through	O
which	O
Rab	O
functional	O
interactions	O
in	O
vesicle	O
trafficking	O
and	O
secretion	O
can	O
be	O
altered	O
in	O
response	O
to	O
an	O
external	O
stimulus	O
.	O

A	O
SMAD	B
ubiquitin	O
ligase	O
targets	O
the	O
BMP	B
pathway	O
and	O
affects	O
embryonic	O
pattern	O
formation	O
.	O

The	O
TGF	B
-	I
beta	I
superfamily	O
of	O
proteins	O
regulates	O
many	O
different	O
biological	O
processes	O
,	O
including	O
cell	O
growth	O
,	O
differentiation	O
and	O
embryonic	O
pattern	O
formation	O
.	O

TGF	B
-	I
beta	I
-	O
like	O
factors	O
signal	O
across	O
cell	O
membranes	O
through	O
complexes	O
of	O
transmembrane	O
receptors	O
known	O
as	O
type	O
I	O
and	O
type	O
II	O
serine	O
/	O
threonine	O
-	O
kinase	O
receptors	O
,	O
which	O
in	O
turn	O
activate	O
the	O
SMAD	B
signalling	O
pathway	O
.	O

On	O
the	O
inside	O
of	O
the	O
cell	O
membrane	O
,	O
a	O
receptor	O
-	O
regulated	O
class	O
of	O
SMADs	O
are	O
phosphorylated	O
by	O
the	O
type	O
-	O
I	O
-	O
receptor	O
kinase	O
.	O

In	O
this	O
way	O
,	O
receptors	O
for	O
different	O
factors	O
are	O
able	O
to	O
pass	O
on	O
specific	O
signals	O
along	O
the	O
pathway	O
:	O
for	O
example	O
,	O
receptors	O
for	O
bone	B
morphogenetic	I
protein	I
(	O
BMP	B
)	O
target	O
SMADs	B
1	I
,	I
5	I
and	I
8	I
,	O
whereas	O
receptors	O
for	O
activin	B
and	O
TGF	B
-	I
beta	I
target	O
SMADs	B
2	I
and	I
3	I
.	O

Phosphorylation	O
of	O
receptor	O
-	O
regulated	O
SMADs	O
induces	O
their	O
association	O
with	O
Smad4	B
,	O
the	O
'	O
common	O
-	O
partner	O
'	O
SMAD	B
,	O
and	O
stimulates	O
accumulation	O
of	O
this	O
complex	O
in	O
the	O
nucleus	O
,	O
where	O
it	O
regulates	O
transcriptional	O
responses	O
.	O

Here	O
we	O
describe	O
Smurf1	B
,	O
a	O
new	O
member	O
of	O
the	O
Hect	O
family	O
of	O
E3	O
ubiquitin	O
ligases	O
.	O

Smurf1	B
selectively	O
interacts	O
with	O
receptor	O
-	O
regulated	O
SMADs	O
specific	O
for	O
the	O
BMP	B
pathway	O
in	O
order	O
to	O
trigger	O
their	O
ubiquitination	O
and	O
degradation	O
,	O
and	O
hence	O
their	O
inactivation	O
.	O

In	O
the	O
amphibian	O
Xenopus	O
laevis	O
,	O
Smurf1	B
messenger	O
RNA	O
is	O
localized	O
to	O
the	O
animal	O
pole	O
of	O
the	O
egg	O
;	O
in	O
Xenopus	O
embryos	O
,	O
ectopic	O
Smurf1	B
inhibits	O
the	O
transmission	O
of	O
BMP	B
signals	O
and	O
thereby	O
affects	O
pattern	O
formation	O
.	O

Smurf1	B
also	O
enhances	O
cellular	O
responsiveness	O
to	O
the	O
Smad2	B
(	O
activin	B
/	O
TGF	B
-	I
beta	I
)	O
pathway	O
.	O

Thus	O
,	O
targeted	O
ubiquitination	O
of	O
SMADs	O
may	O
serve	O
to	O
control	O
both	O
embryonic	O
development	O
and	O
a	O
wide	O
variety	O
of	O
cellular	O
responses	O
to	O
TGF	B
-	I
beta	I
signals	O
.	O

Human	O
eukaryotic	O
initiation	O
factor	O
EIF2C1	B
gene	O
:	O
cDNA	O
sequence	O
,	O
genomic	O
organization	O
,	O
localization	O
to	O
chromosomal	O
bands	O
1p34-p35	O
,	O
and	O
expression	O
.	O

We	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
the	O
human	O
eukaryotic	O
protein	O
translation	O
initiation	O
factor	O
EIF2C1	B
gene	O
.	O

The	O
human	O
EIF2C1	B
gene	O
consists	O
of	O
19	O
exons	O
and	O
18	O
introns	O
that	O
span	O
a	O
region	O
of	O
almost	O
50	O
kb	O
.	O

It	O
is	O
located	O
on	O
the	O
short	O
arm	O
of	O
chromosome	O
1	O
in	O
the	O
region	O
1p34-p35	O
.	O

This	O
genomic	O
region	O
is	O
frequently	O
lost	O
in	O
human	O
cancers	O
such	O
as	O
Wilms	O
tumors	O
,	O
neuroblastoma	O
,	O
and	O
carcinomas	O
of	O
the	O
breast	O
,	O
liver	O
,	O
and	O
colon	O
.	O

The	O
human	O
EIF2C1	B
gene	O
is	O
ubiquitously	O
expressed	O
at	O
low	O
to	O
medium	O
levels	O
.	O

Differential	O
polyadenylation	O
and	O
splicing	O
result	O
in	O
a	O
complex	O
transcriptional	O
pattern	O
.	O

The	O
cDNA	O
sequence	O
is	O
7478	O
bp	O
long	O
and	O
contains	O
an	O
extremely	O
large	O
3	O
'	O
untranslated	O
region	O
of	O
4799	O
bp	O
with	O
multiple	O
,	O
short	O
repeated	O
segments	O
composed	O
of	O
mono-	O
,	O
tri-	O
,	O
or	O
quattronucleotides	O
interspersed	O
throughout	O
.	O

The	O
human	O
EIF2C1	B
gene	O
belongs	O
to	O
a	O
multigene	O
family	O
in	O
human	O
.	O

It	O
is	O
highly	O
conserved	O
during	O
evolution	O
,	O
sharing	O
about	O
90	O
%	O
identity	O
with	O
rabbit	O
eIF2C	B
and	O
70	O
%	O
identity	O
with	O
plant	O
AGO1	B
at	O
the	O
amino	O
acid	O
level	O
.	O

These	O
facts	O
suggest	O
that	O
human	O
EIF2C1	B
might	O
play	O
an	O
important	O
physiological	O
role	O
.	O

Characterization	O
of	O
copine	B
VII	I
,	O
a	O
new	O
member	O
of	O
the	O
copine	O
family	O
,	O
and	O
its	O
exclusion	O
as	O
a	O
candidate	O
in	O
sporadic	O
breast	O
cancers	O
with	O
loss	O
of	O
heterozygosity	O
at	O
16q24.3	O
.	O

In	O
a	O
search	O
for	O
candidate	O
tumor	O
suppressor	O
genes	O
within	O
a	O
650-kb	O
common	O
region	O
of	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
at	O
16q24.3	O
in	O
breast	O
cancer	O
tissues	O
,	O
a	O
2.6-kb	O
cDNA	O
,	O
named	O
copine	B
VII	I
(	O
CPNE7	B
)	O
,	O
was	O
characterized	O
.	O

The	O
gene	O
is	O
2654	O
bp	O
and	O
codes	O
for	O
a	O
633-residue	O
protein	O
with	O
high	O
homology	O
to	O
the	O
other	O
members	O
of	O
the	O
copine	O
family	O
,	O
such	O
as	O
copine	B
I	I
,	O
copine	B
III	I
,	O
and	O
N	B
-	I
copine	I
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
contains	O
two	O
copies	O
of	O
a	O
C2	O
domain	O
in	O
the	O
N	O
-	O
terminus	O
.	O

Since	O
these	O
domains	O
have	O
been	O
found	O
in	O
several	O
membrane	O
-	O
binding	O
proteins	O
involved	O
in	O
different	O
intracellular	O
processes	O
,	O
copine	B
VII	I
was	O
viewed	O
as	O
a	O
potential	O
tumor	O
suppressor	O
gene	O
.	O

Mutation	O
analysis	O
was	O
carried	O
out	O
by	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
analysis	O
of	O
18	O
breast	O
tumor	O
tissue	O
samples	O
with	O
ascertained	O
LOH	O
on	O
chromosome	O
16q24.3	O
.	O

Since	O
only	O
two	O
polymorphisms	O
were	O
identified	O
,	O
no	O
evidence	O
was	O
found	O
to	O
indicate	O
that	O
copine	B
VII	I
is	O
the	O
tumor	O
suppressor	O
gene	O
at	O
16q24.3	O
involved	O
in	O
breast	O
cancer	O
.	O

Characterization	O
of	O
the	O
structure	O
and	O
regulation	O
of	O
two	O
novel	O
isoforms	O
of	O
serum-	B
and	I
glucocorticoid	I
-	I
induced	I
protein	I
kinase	I
.	O

The	O
catalytic	O
domain	O
of	O
serum-	B
and	I
glucocorticoid	I
-	I
induced	I
protein	I
kinase	I
(	O
SGK	B
)	O
is	O
54	O
%	O
identical	O
with	O
protein	B
kinase	I
B	O
(	O
PKB	O
)	O
and	O
,	O
like	O
PKB	O
,	O
is	O
activated	O
in	O
vitro	O
by	O
3-phosphoinositide	B
-	I
dependent	I
protein	I
kinase-1	I
(	O
PDK1	B
)	O
and	O
in	O
vivo	O
in	O
response	O
to	O
signals	O
that	O
activate	O
phosphatidylinositol	O
(	O
PI	O
)	O
3-kinase	O
.	O

Here	O
we	O
identify	O
two	O
novel	O
isoforms	O
of	O
SGK	B
,	O
termed	O
SGK2	B
and	O
SGK3	B
,	O
whose	O
catalytic	O
domains	O
share	O
80	O
%	O
amino	O
acid	O
sequence	O
identity	O
with	O
each	O
other	O
and	O
with	O
SGK	B
(	O
renamed	O
SGK1	B
)	O
.	O

Like	O
SGK1	B
,	O
the	O
mRNA	O
encoding	O
SGK3	B
is	O
expressed	O
in	O
all	O
tissues	O
examined	O
,	O
but	O
SGK2	B
mRNA	O
is	O
only	O
present	O
at	O
significant	O
levels	O
in	O
liver	O
,	O
kidney	O
and	O
pancreas	O
and	O
,	O
at	O
lower	O
levels	O
,	O
in	O
the	O
brain	O
.	O

The	O
levels	O
of	O
SGK2	B
mRNA	O
in	O
H4IIE	O
cells	O
and	O
SGK3	B
mRNA	O
in	O
Rat2	O
fibroblasts	O
are	O
not	O
increased	O
by	O
stimulation	O
with	O
serum	O
or	O
dexamethasone	O
,	O
whereas	O
the	O
level	O
of	O
SGK1	B
mRNA	O
is	O
increased	O
greatly	O
.	O

SGK2	B
and	O
SGK3	B
are	O
activated	O
in	O
vitro	O
by	O
PDK1	B
,	O
albeit	O
more	O
slowly	O
than	O
SGK1	B
,	O
and	O
their	O
activation	O
is	O
accompanied	O
by	O
the	O
phosphorylation	O
of	O
Thr	O
(	O
193	O
)	O
and	O
Thr	O
(	O
253	O
)	O
respectively	O
,	O
the	O
residues	O
equivalent	O
to	O
the	O
Thr	O
in	O
the	O
'	O
activation	O
loop	O
'	O
of	O
PKB	O
that	O
is	O
targeted	O
by	O
PDK1	B
.	O

The	O
PDK1-catalysed	B
phosphorylation	O
and	O
activation	O
of	O
SGK2	B
and	O
SGK3	B
,	O
like	O
SGK1	B
,	O
is	O
greatly	O
potentiated	O
by	O
mutating	O
Ser	O
(	O
356	O
)	O
and	O
Ser	O
(	O
419	O
)	O
respectively	O
to	O
Asp	O
,	O
these	O
residues	O
being	O
equivalent	O
to	O
the	O
C	O
-	O
terminal	O
phosphorylation	O
site	O
of	O
PKB	O
.	O

Like	O
SGK1	B
,	O
SGK2	B
and	O
SGK3	B
are	O
activated	O
5-fold	O
via	O
a	O
phosphorylation	O
mechanism	O
when	O
cells	O
are	O
exposed	O
to	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
but	O
,	O
in	O
contrast	O
with	O
SGK1	B
,	O
activation	O
is	O
only	O
suppressed	O
partially	O
by	O
inhibitors	O
of	O
PI	O
3-kinase	O
.	O

SGK2	B
and	O
SGK3	B
are	O
activated	O
to	O
a	O
smaller	O
extent	O
by	O
insulin	B
-	I
like	I
growth	I
factor-1	I
(	O
2-fold	O
)	O
than	O
SGK1	B
(	O
5-fold	O
)	O
.	O

Like	O
PKB	O
and	O
SGK1	B
,	O
SGK2	B
and	O
SGK3	B
preferentially	O
phosphorylate	O
Ser	O
and	O
Thr	O
residues	O
that	O
lie	O
in	O
Arg	O
-	O
Xaa	O
-	O
Arg	O
-	O
Xaa	O
-	O
Xaa	O
-	O
Ser	O
/	O
Thr	O
motifs	O
.	O

Purification	O
,	O
molecular	O
cloning	O
,	O
and	O
genomic	O
organization	O
of	O
human	O
brain	B
long	I
-	I
chain	I
acyl	I
-	I
CoA	I
hydrolase	I
.	O

An	O
acyl	O
-	O
CoA	O
hydrolase	O
,	O
referred	O
to	O
as	O
hBACH	B
,	O
was	O
purified	O
from	O
human	O
brain	O
cytosol	O
.	O

The	O
enzyme	O
had	O
a	O
molecular	O
mass	O
of	O
100	O
kDa	O
and	O
43-kDa	O
subunits	O
,	O
and	O
was	O
highly	O
active	O
with	O
long	O
-	O
chain	O
acyl	O
-	O
CoAs	O
,	O
e.g.	O
a	O
maximal	O
velocity	O
of	O
295	O
micromol	O
/	O
min	O
/	O
mg	O
and	O
K	O
(	O
m	O
)	O
of	O
6.4	O
microM	O
for	O
palmitoyl	O
-	O
CoA.	O
Acyl	O
-	O
CoAs	O
with	O
carbon	O
chain	O
lengths	O
of	O
C	O
(	O
8	O
-	O
18	O
)	O
were	O
also	O
good	O
substrates	O
.	O

In	O
human	O
brain	O
cytosol	O
,	O
85	O
%	O
of	O
palmitoyl	O
-	O
CoA	O
hydrolase	O
activity	O
was	O
titrated	O
by	O
an	O
anti	O
-	O
BACH	B
antibody	O
,	O
which	O
accounted	O
for	O
over	O
75	O
%	O
of	O
the	O
enzyme	O
activity	O
found	O
in	O
the	O
brain	O
tissue	O
.	O

The	O
cDNA	O
isolated	O
for	O
hBACH	B
,	O
when	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
directed	O
the	O
expression	O
of	O
palmitoyl	O
-	O
CoA	O
hydrolase	O
activity	O
and	O
a	O
44-kDa	O
protein	O
immunoreactive	O
to	O
the	O
anti	O
-	O
BACH	B
antibody	O
,	O
which	O
in	O
turn	O
neutralized	O
the	O
hydrolase	O
activity	O
.	O

The	O
hBACH	B
cDNA	O
encoded	O
a	O
338-amino	O
acid	O
sequence	O
which	O
was	O
95	O
%	O
identical	O
to	O
that	O
of	O
a	O
rat	O
homolog	O
.	O

The	O
hBACH	B
gene	O
spanned	O
about	O
130	O
kb	O
and	O
comprised	O
9	O
exons	O
,	O
and	O
was	O
mapped	O
to	O
1p36.2	O
on	O
the	O
cytogenetic	O
ideogram	O
.	O

These	O
findings	O
indicate	O
that	O
the	O
long	O
-	O
chain	O
acyl	O
-	O
CoA	O
hydrolase	O
present	O
in	O
the	O
brain	O
is	O
well	O
conserved	O
between	O
man	O
and	O
the	O
rat	O
,	O
suggesting	O
a	O
conserved	O
role	O
for	O
this	O
enzyme	O
in	O
the	O
mammalian	O
brain	O
,	O
and	O
enabling	O
genetic	O
studies	O
on	O
the	O
functional	O
analysis	O
of	O
acyl	O
-	O
CoA	O
hydrolase	O
.	O

Family	O
of	O
human	O
oxysterol	B
binding	I
protein	I
(	O
OSBP	B
)	O
homologues	O
.	O

A	O
novel	O
member	O
implicated	O
in	O
brain	O
sterol	O
metabolism	O
.	O

Oxysterol	B
binding	I
protein	I
(	O
OSBP	B
)	O
is	O
a	O
cytosolic	O
protein	O
that	O
undergoes	O
ligand	O
-	O
induced	O
binding	O
to	O
the	O
Golgi	O
apparatus	O
and	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
cellular	O
cholesterol	O
metabolism	O
.	O

In	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
an	O
OSBP	B
homologue	O
is	O
involved	O
in	O
membrane	O
trafficking	O
through	O
the	O
Golgi	O
complex	O
.	O

Prompted	O
by	O
the	O
multitude	O
of	O
OSBP	B
-	O
related	O
genes	O
in	O
the	O
yeast	O
genome	O
,	O
we	O
carried	O
out	O
a	O
search	O
for	O
human	O
expressed	O
sequence	O
tags	O
(	O
ESTs	O
)	O
displaying	O
homology	O
to	O
the	O
sterol	O
-	O
binding	O
domain	O
of	O
OSBP	B
.	O

This	O
revealed	O
a	O
minimum	O
of	O
six	O
novel	O
OSBP	B
-	O
related	O
proteins	O
,	O
designated	O
ORP-1	B
to	I
ORP-6	I
.	O

ORP	O
cDNA	O
probes	O
were	O
generated	O
by	O
reverse	O
transcription	O
-	O
PCR	O
from	O
human	O
liver	O
mRNA	O
,	O
and	O
used	O
for	O
Northern	O
blot	O
analysis	O
of	O
human	O
tissue	O
transcript	O
panels	O
.	O

This	O
verified	O
that	O
each	O
of	O
them	O
represents	O
a	O
different	O
gene	O
product	O
and	O
showed	O
that	O
they	O
display	O
distinct	O
tissue	O
-	O
specific	O
expression	O
patterns	O
.	O

The	O
ORP-1	B
and	I
-2	I
mRNA	O
expression	O
levels	O
were	O
similar	O
to	O
or	O
higher	O
than	O
that	O
of	O
OSBP	B
while	O
the	O
ORP-3	B
to	I
-6	I
mRNAs	O
were	O
detected	O
at	O
lower	O
levels	O
in	O
specific	O
tissues	O
.	O

The	O
most	O
abundantly	O
expressed	O
new	O
gene	O
,	O
ORP-1	B
,	O
was	O
transcribed	O
at	O
strikingly	O
high	O
levels	O
in	O
the	O
cortical	O
areas	O
of	O
human	O
brain	O
and	O
displayed	O
sterol	O
-	O
regulated	O
expression	O
in	O
a	O
cultured	O
human	O
neuroblastoma	O
cell	O
line	O
.	O

This	O
indicates	O
that	O
ORP-1	B
may	O
play	O
an	O
important	O
role	O
in	O
maintaining	O
the	O
sterol	O
balance	O
in	O
cells	O
of	O
the	O
central	O
nervous	O
system	O
.	O

Together	O
with	O
OSBP	B
,	O
the	O
identified	O
gene	O
products	O
constitute	O
a	O
novel	O
human	O
protein	O
family	O
that	O
may	O
provide	O
a	O
link	O
between	O
organellar	O
sterol	O
status	O
and	O
membrane	O
dynamics	O
.	O

Myoferlin	B
,	O
a	O
candidate	O
gene	O
and	O
potential	O
modifier	O
of	O
muscular	O
dystrophy	O
.	O

Dysferlin	B
,	O
the	O
gene	O
product	O
of	O
the	O
limb	O
girdle	O
muscular	O
dystrophy	O
(	O
LGMD	O
)	O
2B	O
locus	O
,	O
encodes	O
a	O
membrane	O
-	O
associated	O
protein	O
with	O
homology	O
to	O
Caenorhabditis	O
elegans	O
fer-1	O
.	O

Humans	O
with	O
mutations	O
in	O
dysferlin	B
(	O
DYSF	B
)	O
develop	O
muscle	O
weakness	O
that	O
affects	O
both	O
proximal	O
and	O
distal	O
muscles	O
.	O

Strikingly	O
,	O
the	O
phenotype	O
in	O
LGMD	O
2B	O
patients	O
is	O
highly	O
variable	O
,	O
but	O
the	O
type	O
of	O
mutation	O
in	O
DYSF	B
can	O
not	O
explain	O
this	O
phenotypic	O
variability	O
.	O

Through	O
electronic	O
database	O
searching	O
,	O
we	O
identified	O
a	O
protein	O
highly	O
homologous	O
to	O
dysferlin	B
that	O
we	O
have	O
named	O
myoferlin	B
.	O

Myoferlin	B
mRNA	O
was	O
highly	O
expressed	O
in	O
cardiac	O
muscle	O
and	O
to	O
a	O
lesser	O
degree	O
in	O
skeletal	O
muscle	O
.	O

However	O
,	O
antibodies	O
raised	O
to	O
myoferlin	B
showed	O
abundant	O
expression	O
of	O
myoferlin	B
in	O
both	O
cardiac	O
and	O
skeletal	O
muscle	O
.	O

Within	O
the	O
cell	O
,	O
myoferlin	B
was	O
associated	O
with	O
the	O
plasma	O
membrane	O
but	O
,	O
unlike	O
dysferlin	B
,	O
myoferlin	B
was	O
also	O
associated	O
with	O
the	O
nuclear	O
membrane	O
.	O

Ferlin	O
family	O
members	O
contain	O
C2	O
domains	O
,	O
and	O
these	O
domains	O
play	O
a	O
role	O
in	O
calcium	O
-	O
mediated	O
membrane	O
fusion	O
events	O
.	O

To	O
investigate	O
this	O
,	O
we	O
studied	O
the	O
expression	O
of	O
myoferlin	B
in	O
the	O
mdx	O
mouse	O
,	O
which	O
lacks	O
dystrophin	O
and	O
whose	O
muscles	O
undergo	O
repeated	O
rounds	O
of	O
degeneration	O
and	O
regeneration	O
.	O

We	O
found	O
upregulation	O
of	O
myoferlin	B
at	O
the	O
membrane	O
in	O
mdx	O
skeletal	O
muscle	O
.	O

Thus	O
,	O
myoferlin	B
(	O
MYOF	B
)	O
is	O
a	O
candidate	O
gene	O
for	O
muscular	O
dystrophy	O
and	O
cardiomyopathy	O
,	O
or	O
possibly	O
a	O
modifier	O
of	O
the	O
muscular	O
dystrophy	O
phenotype	O
.	O

A	O
novel	O
human	O
odorant	O
-	O
binding	O
protein	O
gene	O
family	O
resulting	O
from	O
genomic	O
duplicons	O
at	O
9q34	O
:	O
differential	O
expression	O
in	O
the	O
oral	O
and	O
genital	O
spheres	O
.	O

Lipocalins	O
are	O
carrier	O
proteins	O
for	O
hydrophobic	O
molecules	O
in	O
many	O
biological	O
fluids	O
.	O

In	O
the	O
oral	O
sphere	O
(	O
nasal	O
mucus	O
,	O
saliva	O
,	O
tears	O
)	O
,	O
they	O
have	O
an	O
environmental	O
biosensor	O
function	O
and	O
are	O
involved	O
in	O
the	O
detection	O
of	O
odours	O
and	O
pheromones	O
.	O

Herein	O
,	O
we	O
report	O
the	O
first	O
identification	O
of	O
human	O
lipocalins	O
involved	O
in	O
odorant	O
binding	O
.	O

They	O
correspond	O
to	O
a	O
gene	O
family	O
located	O
on	O
human	O
chromosome	O
9q34	O
produced	O
by	O
genomic	O
duplications	O
:	O
two	O
new	O
odorant	O
-	O
binding	O
protein	O
genes	O
(	O
hOBP	B
(	I
IIa	I
)	I
and	O
hOBP	B
(	I
IIb	I
)	I
)	O
,	O
the	O
previously	O
described	O
tear	B
lipocalin	I
LCN1	I
gene	O
and	O
two	O
new	O
LCN1	B
pseudogenes	O
.	O

Although	O
95	O
%	O
similar	O
in	O
sequence	O
,	O
the	O
two	O
hOBP	O
(	O
II	O
)	O
genes	O
were	O
differentially	O
expressed	O
in	O
secretory	O
structures	O
.	O

hOBP	B
(	I
IIa	I
)	I
was	O
strongly	O
expressed	O
in	O
the	O
nasal	O
structures	O
,	O
salivary	O
and	O
lachrymal	O
glands	O
,	O
and	O
lung	O
,	O
therefore	O
having	O
an	O
oral	O
sphere	O
profile	O
.	O

hOBP	B
(	I
IIb	I
)	I
was	O
more	O
strongly	O
expressed	O
in	O
genital	O
sphere	O
organs	O
such	O
as	O
the	O
prostate	O
and	O
mammary	O
glands	O
.	O

Both	O
were	O
expressed	O
in	O
the	O
male	O
deferent	O
ducts	O
and	O
placenta	O
.	O

Surprisingly	O
,	O
alternatively	O
spliced	O
mRNAs	O
resulting	O
in	O
proteins	O
with	O
different	O
C	O
-	O
termini	O
were	O
generated	O
from	O
each	O
of	O
the	O
two	O
genes	O
.	O

The	O
single	O
LCN1	B
gene	O
in	O
humans	O
generated	O
a	O
putative	O
odorant	O
-	O
binding	O
protein	O
in	O
nasal	O
structures	O
.	O

Finally	O
,	O
based	O
on	O
the	O
proposed	O
successive	O
genomic	O
duplication	O
history	O
,	O
we	O
demonstrated	O
the	O
recruitment	O
of	O
exons	O
within	O
intronic	O
DNA	O
generating	O
diversity	O
.	O

This	O
is	O
consistent	O
with	O
a	O
positive	O
selection	O
pressure	O
in	O
vertebrate	O
evolution	O
in	O
the	O
intron	O
-	O
late	O
hypothesis	O
.	O

Isolation	O
and	O
characterization	O
of	O
monoclonal	O
antibodies	O
directed	O
against	O
subunits	O
of	O
human	O
RNA	O
polymerases	O
I	O
,	O
II	O
,	O
and	O
III	O
.	O

Human	O
nuclei	O
contain	O
three	O
different	O
RNA	O
polymerases	O
:	O
polymerases	O
I	O
,	O
II	O
,	O
and	O
III	O
.	O

Each	O
polymerase	O
is	O
a	O
multi	O
-	O
subunit	O
enzyme	O
with	O
12	O
-	O
17	O
subunits	O
.	O

The	O
localization	O
of	O
these	O
subunits	O
is	O
limited	O
by	O
the	O
paucity	O
of	O
antibodies	O
suitable	O
for	O
immunofluorescence	O
.	O

We	O
now	O
describe	O
eight	O
different	O
monoclonal	O
antibodies	O
that	O
react	O
specifically	O
with	O
RPB6	B
(	O
also	O
known	O
as	O
RPA20	B
,	O
RPB14.4	B
,	O
or	O
RPC20	B
)	O
,	O
RPB8	B
(	O
RPA18	B
,	O
RPB17	B
,	O
or	O
RPC18	B
)	O
,	O
RPC32	B
,	O
or	O
RPC39	B
and	O
which	O
are	O
suitable	O
for	O
such	O
studies	O
.	O

Each	O
antibody	O
detects	O
one	O
specific	O
band	O
in	O
immunoblots	O
of	O
nuclear	O
extracts	O
;	O
each	O
also	O
immunoprecipitates	O
large	O
complexes	O
containing	O
many	O
other	O
subunits	O
.	O

When	O
used	O
for	O
immunofluorescence	O
,	O
antibodies	O
against	O
the	O
subunits	O
shared	O
by	O
all	O
three	O
polymerases	O
(	O
i.e.	O
,	O
RPB6	B
,	O
RPB8	B
)	O
gave	O
a	O
few	O
bright	O
foci	O
in	O
nucleoli	O
and	O
nucleoplasm	O
,	O
as	O
well	O
as	O
many	O
fainter	O
nucleoplasmic	O
foci	O
;	O
all	O
the	O
bright	O
foci	O
were	O
generally	O
distinct	O
from	O
speckles	O
containing	O
Sm	O
antigen	O
.	O

Antibodies	O
against	O
the	O
two	O
subunits	O
found	O
only	O
in	O
polymerase	O
III	O
(	O
i.e.	O
,	O
RPC32	B
,	O
RPC39	B
)	O
gave	O
a	O
few	O
bright	O
and	O
many	O
faint	O
nucleoplasmic	O
foci	O
,	O
but	O
no	O
nucleolar	O
foci	O
.	O

Growth	O
in	O
two	O
transcriptional	O
inhibitors-5	O
,	O
6-dichloro-1-beta	O
-	O
d	O
-	O
ribofuranosylbenzimidazole	O
and	O
actinomycin	O
D	O
-	O
led	O
to	O
the	O
redistribution	O
of	O
each	O
subunit	O
in	O
a	O
characteristic	O
manner	O
.	O

Five	O
members	O
of	O
a	O
novel	O
Ca	O
(	O
2+	O
)	O
-binding	O
protein	O
(	O
CABP	B
)	O
subfamily	O
with	O
similarity	O
to	O
calmodulin	O
.	O

Five	O
members	O
of	O
a	O
novel	O
Ca	O
(	O
2+	O
)	O
-binding	O
protein	O
subfamily	O
(	O
CaBP	B
)	O
,	O
with	O
46	O
-	O
58	O
%	O
sequence	O
similarity	O
to	O
calmodulin	O
(	O
CaM	O
)	O
,	O
were	O
identified	O
in	O
the	O
vertebrate	O
retina	O
.	O

Important	O
differences	O
between	O
these	O
Ca	O
(	O
2+	O
)	O
-binding	O
proteins	O
and	O
CaM	O
include	O
alterations	O
within	O
their	O
second	O
EF	O
-	O
hand	O
loop	O
that	O
render	O
these	O
motifs	O
inactive	O
in	O
Ca	O
(	O
2	O
+	O
)	O
coordination	O
and	O
the	O
fact	O
that	O
their	O
central	O
alpha	O
-	O
helixes	O
are	O
extended	O
by	O
one	O
alpha	O
-	O
helical	O
turn	O
.	O

CaBP1	B
and	O
CaBP2	B
contain	O
a	O
consensus	O
sequence	O
for	O
N	O
-	O
terminal	O
myristoylation	O
,	O
similar	O
to	O
members	O
of	O
the	O
recoverin	O
subfamily	O
and	O
are	O
fatty	O
acid	O
acylated	O
in	O
vitro	O
.	O

The	O
patterns	O
of	O
expression	O
differ	O
for	O
each	O
of	O
the	O
various	O
members	O
.	O

Expression	O
of	O
CaBP5	B
,	O
for	O
example	O
,	O
is	O
restricted	O
to	O
retinal	O
rod	O
and	O
cone	O
bipolar	O
cells	O
.	O

In	O
contrast	O
,	O
CaBP1	B
has	O
a	O
more	O
widespread	O
pattern	O
of	O
expression	O
.	O

In	O
the	O
brain	O
,	O
CaBP1	B
is	O
found	O
in	O
the	O
cerebral	O
cortex	O
and	O
hippocampus	O
,	O
and	O
in	O
the	O
retina	O
this	O
protein	O
is	O
found	O
in	O
cone	O
bipolar	O
and	O
amacrine	O
cells	O
.	O

CaBP1	B
and	O
CaBP2	B
are	O
expressed	O
as	O
multiple	O
,	O
alternatively	O
spliced	O
variants	O
,	O
and	O
in	O
heterologous	O
expression	O
systems	O
these	O
forms	O
show	O
different	O
patterns	O
of	O
subcellular	O
localization	O
.	O

In	O
reconstitution	O
assays	O
,	O
CaBPs	O
are	O
able	O
to	O
substitute	O
functionally	O
for	O
CaM.	O
These	O
data	O
suggest	O
that	O
these	O
novel	O
CaBPs	O
are	O
an	O
important	O
component	O
of	O
Ca	O
(	O
2+	O
)	O
-mediated	O
cellular	O
signal	O
transduction	O
in	O
the	O
central	O
nervous	O
system	O
where	O
they	O
may	O
augment	O
or	O
substitute	O
for	O
CaM.	O

Leukolysin	B
/	O
MMP25	B
/	O
MT6-MMP	B
:	O
a	O
novel	O
matrix	O
metalloproteinase	O
specifically	O
expressed	O
in	O
the	O
leukocyte	O
lineage	O
.	O

A	O
novel	O
matrix	O
metalloproteinase	O
(	O
MMP	B
)	O
was	O
identified	O
from	O
leukocytes	O
and	O
found	O
to	O
be	O
specifically	O
expressed	O
by	O
peripheral	O
blood	O
leukocytes	O
among	O
29	O
different	O
tissues	O
examined	O
.	O

Named	O
leukolysin	B
,	O
it	O
encodes	O
for	O
562	O
residues	O
with	O
a	O
conserved	O
MMP	B
structure	O
,	O
i.e.	O
,	O
pre-	O
,	O
pro-	O
,	O
catalytic	O
,	O
hinge-	O
and	O
hemopexin	O
-	O
like	O
domains	O
,	O
but	O
also	O
a	O
RXK	O
/	O
RR	O
motif	O
,	O
known	O
for	O
its	O
role	O
in	O
MMP	B
zymogen	O
activation	O
,	O
and	O
a	O
C	O
-	O
terminal	O
hydrophobic	O
segment	O
.	O

Overall	O
,	O
leukolysin	B
displays	O
the	O
strongest	O
homology	O
to	O
the	O
newly	O
identified	O
MT	O
-	O
MMP	B
subgroup	O
with	O
45	O
%	O
and	O
39	O
%	O
identities	O
to	O
MT4-	B
and	I
MT1-MMPs	I
vs	O
30	O
%	O
and	O
31.5	O
%	O
to	O
MMP1	B
and	I
3	I
respectively	O
.	O

Unlike	O
MT4-MMP	B
whose	O
proteolytic	O
activity	O
remains	O
undefined	O
,	O
a	O
C	O
-	O
terminally	O
truncated	O
leukolysin	B
is	O
expressed	O
as	O
a	O
strong	O
gelatinolytic	O
species	O
at	O
28	O
kDa	O
which	O
is	O
derived	O
from	O
a	O
cell	O
-	O
associated	O
34	O
kDa	O
proenzyme	O
,	O
presumably	O
by	O
furin	B
or	O
proprotein	O
convertase	O
mediated	O
removal	O
of	O
the	O
propeptide	O
(	O
approximately	O
6	O
kDa	O
)	O
.	O

By	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
tagging	O
,	O
the	O
intracellular	O
proenzyme	O
is	O
localized	O
to	O
granules	O
throughout	O
the	O
cell	O
,	O
suggesting	O
that	O
activation	O
occur	O
immediately	O
prior	O
to	O
secretion	O
.	O

Taken	O
together	O
,	O
leukolysin	B
may	O
be	O
part	O
of	O
the	O
proteolytic	O
arsenal	O
deployed	O
by	O
leukocytes	O
during	O
inflammatory	O
responses	O
.	O

Molecular	O
cloning	O
of	O
a	O
novel	O
MMP	B
:	O
MMP:25	B

Chromosome	O
instability	O
and	O
immunodeficiency	O
syndrome	O
caused	O
by	O
mutations	O
in	O
a	O
DNA	O
methyltransferase	O
gene	O
.	O

The	O
recessive	O
autosomal	O
disorder	O
known	O
as	O
ICF	B
syndrome	O
(	O
for	O
immunodeficiency	O
,	O
centromere	O
instability	O
and	O
facial	O
anomalies	O
;	O
Mendelian	O
Inheritance	O
in	O
Man	O
number	O
242860	O
)	O
is	O
characterized	O
by	O
variable	O
reductions	O
in	O
serum	O
immunoglobulin	O
levels	O
which	O
cause	O
most	O
ICF	B
patients	O
to	O
succumb	O
to	O
infectious	O
diseases	O
before	O
adulthood	O
.	O

Mild	O
facial	O
anomalies	O
include	O
hypertelorism	O
,	O
low	O
-	O
set	O
ears	O
,	O
epicanthal	O
folds	O
and	O
macroglossia	O
.	O

The	O
cytogenetic	O
abnormalities	O
in	O
lymphocytes	O
are	O
exuberant	O
:	O
juxtacentromeric	O
heterochromatin	O
is	O
greatly	O
elongated	O
and	O
thread	O
-	O
like	O
in	O
metaphase	O
chromosomes	O
,	O
which	O
is	O
associated	O
with	O
the	O
formation	O
of	O
complex	O
multiradiate	O
chromosomes	O
.	O

The	O
same	O
juxtacentromeric	O
regions	O
are	O
subject	O
to	O
persistent	O
interphase	O
self	O
-	O
associations	O
and	O
are	O
extruded	O
into	O
nuclear	O
blebs	O
or	O
micronuclei	O
.	O

Abnormalities	O
are	O
largely	O
confined	O
to	O
tracts	O
of	O
classical	O
satellites	O
2	O
and	O
3	O
at	O
juxtacentromeric	O
regions	O
of	O
chromosomes	O
1	O
,	O
9	O
and	O
16	O
.	O

Classical	O
satellite	O
DNA	O
is	O
normally	O
heavily	O
methylated	O
at	O
cytosine	O
residues	O
,	O
but	O
in	O
ICF	B
syndrome	O
it	O
is	O
almost	O
completely	O
unmethylated	O
in	O
all	O
tissues	O
.	O

ICF	B
syndrome	O
is	O
the	O
only	O
genetic	O
disorder	O
known	O
to	O
involve	O
constitutive	O
abnormalities	O
of	O
genomic	O
methylation	O
patterns	O
.	O

Here	O
we	O
show	O
that	O
five	O
unrelated	O
ICF	B
patients	O
have	O
mutations	O
in	O
both	O
alleles	O
of	O
the	O
gene	O
that	O
encodes	O
DNA	B
methyltransferase	I
3B	I
(	O
refs	O
5	O
,	O
6	O
)	O
.	O

Cytosine	O
methylation	O
is	O
essential	O
for	O
the	O
organization	O
and	O
stabilization	O
of	O
a	O
specific	O
type	O
of	O
heterochromatin	O
,	O
and	O
this	O
methylation	O
appears	O
to	O
be	O
carried	O
out	O
by	O
an	O
enzyme	O
specialized	O
for	O
the	O
purpose	O
.	O

Cloning	O
and	O
functional	O
characterization	O
of	O
novel	O
large	O
conductance	O
calcium	O
-	O
activated	O
potassium	O
channel	O
beta	O
subunits	O
,	O
hKCNMB3	B
and	O
hKCNMB4	B
.	O

We	O
present	O
the	O
cloning	O
and	O
characterization	O
of	O
two	O
novel	O
calcium	O
-	O
activated	O
potassium	O
channel	O
beta	O
subunits	O
,	O
hKCNMB3	B
and	O
hKCNMB4	B
,	O
that	O
are	O
enriched	O
in	O
the	O
testis	O
and	O
brain	O
,	O
respectively	O
.	O

We	O
compare	O
and	O
contrast	O
the	O
steady	O
state	O
and	O
kinetic	O
properties	O
of	O
these	O
beta	O
subunits	O
with	O
the	O
previously	O
cloned	O
mouse	O
beta1	O
(	O
mKCNMB1	O
)	O
and	O
the	O
human	O
beta2	B
subunit	I
(	O
hKCNMB2	B
)	O
.	O

Once	O
inactivation	O
is	O
removed	O
,	O
we	O
find	O
that	O
hKCNMB2	B
has	O
properties	O
similar	O
to	O
mKCNMB1	O
.	O

hKCNMB2	B
slows	O
Hslo1	O
channel	O
gating	O
and	O
shifts	O
the	O
current	O
-	O
voltage	O
relationship	O
to	O
more	O
negative	O
potentials	O
.	O

hKCNMB3	B
and	O
hKCNMB4	B
have	O
distinct	O
effects	O
on	O
slo	O
currents	O
not	O
observed	O
with	O
mKCNMB1	O
and	O
hKCNMB2	B
.	O

Although	O
we	O
found	O
that	O
hKCNMB3	B
does	O
interact	O
with	O
Hslo	O
channels	O
,	O
its	O
effects	O
on	O
Hslo1	O
channel	O
properties	O
were	O
slight	O
,	O
increasing	O
Hslo1	O
activation	O
rates	O
.	O

In	O
contrast	O
,	O
hKCNMB4	B
slows	O
Hslo1	O
gating	O
kinetics	O
,	O
and	O
modulates	O
the	O
apparent	O
calcium	O
sensitivity	O
of	O
Hslo1	O
.	O

We	O
found	O
that	O
the	O
different	O
effects	O
of	O
the	O
beta	O
subunits	O
on	O
some	O
Hslo1	O
channel	O
properties	O
are	O
calcium	O
-	O
dependent	O
.	O

mKCNMB1	O
and	O
hKCNMB2	B
slow	O
activation	O
at	O
1	O
microM	O
but	O
not	O
at	O
10	O
microM	O
free	O
calcium	O
concentrations	O
.	O

hKCNMB4	B
decreases	O
Hslo1	O
channel	O
openings	O
at	O
low	O
calcium	O
concentrations	O
but	O
increases	O
channel	O
openings	O
at	O
high	O
calcium	O
concentrations	O
.	O

These	O
results	O
suggest	O
that	O
beta	O
subunits	O
in	O
diverse	O
tissue	O
types	O
fine	O
-	O
tune	O
slo	O
channel	O
properties	O
to	O
the	O
needs	O
of	O
a	O
particular	O
cell	O
.	O

Positional	O
cloning	O
of	O
zebrafish	O
ferroportin1	B
identifies	O
a	O
conserved	O
vertebrate	O
iron	O
exporter	O
.	O

Defects	O
in	O
iron	O
absorption	O
and	O
utilization	O
lead	O
to	O
iron	O
deficiency	O
and	O
overload	O
disorders	O
.	O

Adult	O
mammals	O
absorb	O
iron	O
through	O
the	O
duodenum	O
,	O
whereas	O
embryos	O
obtain	O
iron	O
through	O
placental	O
transport	O
.	O

Iron	O
uptake	O
from	O
the	O
intestinal	O
lumen	O
through	O
the	O
apical	O
surface	O
of	O
polarized	O
duodenal	O
enterocytes	O
is	O
mediated	O
by	O
the	O
divalent	O
metal	O
transporter	O
,	O
DMTi	O
.	O

A	O
second	O
transporter	O
has	O
been	O
postulated	O
to	O
export	O
iron	O
across	O
the	O
basolateral	O
surface	O
to	O
the	O
circulation	O
.	O

Here	O
we	O
have	O
used	O
positional	O
cloning	O
to	O
identify	O
the	O
gene	O
responsible	O
for	O
the	O
hypochromic	O
anaemia	O
of	O
the	O
zebrafish	O
mutant	O
weissherbst	O
.	O

The	O
gene	O
,	O
ferroportin1	B
,	O
encodes	O
a	O
multiple	O
-	O
transmembrane	O
domain	O
protein	O
,	O
expressed	O
in	O
the	O
yolk	O
sac	O
,	O
that	O
is	O
a	O
candidate	O
for	O
the	O
elusive	O
iron	O
exporter	O
.	O

Zebrafish	O
ferroportin1	B
is	O
required	O
for	O
the	O
transport	O
of	O
iron	O
from	O
maternally	O
derived	O
yolk	O
stores	O
to	O
the	O
circulation	O
and	O
functions	O
as	O
an	O
iron	O
exporter	O
when	O
expressed	O
in	O
Xenopus	O
oocytes	O
.	O

Human	O
Ferroportin1	B
is	O
found	O
at	O
the	O
basal	O
surface	O
of	O
placental	O
syncytiotrophoblasts	O
,	O
suggesting	O
that	O
it	O
also	O
transports	O
iron	O
from	O
mother	O
to	O
embryo	O
.	O

Mammalian	O
Ferroportin1	B
is	O
expressed	O
at	O
the	O
basolateral	O
surface	O
of	O
duodenal	O
enterocytes	O
and	O
could	O
export	O
cellular	O
iron	O
into	O
the	O
circulation	O
.	O

We	O
propose	O
that	O
Ferroportin1	B
function	O
may	O
be	O
perturbed	O
in	O
mammalian	O
disorders	O
of	O
iron	O
deficiency	O
or	O
overload	O
.	O

Human	O
MT6-matrix	B
metalloproteinase	I
:	O
identification	O
,	O
progelatinase	B
A	I
activation	O
,	O
and	O
expression	O
in	O
brain	O
tumors	O
.	O

The	O
localization	O
of	O
proteolytic	O
enzymes	O
at	O
the	O
cell	O
surface	O
is	O
a	O
widely	O
used	O
strategy	O
for	O
facilitating	O
tumor	O
invasion	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
cloned	O
a	O
new	O
member	O
of	O
the	O
membrane	O
-	O
type	O
subfamily	O
of	O
matrix	O
metalloproteinases	O
(	O
MT	O
-	O
MMPs	O
)	O
,	O
a	O
group	O
of	O
enzymes	O
associated	O
with	O
tumor	O
progression	O
.	O

The	O
cloned	O
cDNA	O
encodes	O
a	O
protein	O
of	O
562	O
amino	O
acids	O
with	O
a	O
domain	O
organization	O
similar	O
to	O
that	O
of	O
other	O
MT	O
-	O
MMPs	O
,	O
including	O
a	O
prodomain	O
with	O
a	O
cysteine	O
switch	O
,	O
a	O
catalytic	O
domain	O
with	O
the	O
zinc	O
-	O
binding	O
site	O
,	O
a	O
hemopexin	O
-	O
like	O
domain	O
,	O
and	O
a	O
COOH	O
-	O
terminal	O
extension	O
rich	O
in	O
hydrophobic	O
residues	O
.	O

The	O
predicted	O
protein	O
sequence	O
also	O
contains	O
a	O
short	O
insertion	O
of	O
basic	O
residues	O
located	O
between	O
the	O
propeptide	O
and	O
the	O
catalytic	O
domain	O
and	O
involved	O
in	O
the	O
proteolytic	O
activation	O
of	O
MT	O
-	O
MMPs	O
by	O
furin	O
-	O
like	O
enzymes	O
.	O

Furthermore	O
,	O
immunofluorescence	O
and	O
Western	O
blot	O
analysis	O
of	O
COS-7	O
cells	O
transfected	O
with	O
the	O
isolated	O
cDNA	O
revealed	O
that	O
the	O
encoded	O
protein	O
is	O
localized	O
at	O
the	O
cell	O
surface	O
.	O

Based	O
on	O
these	O
properties	O
,	O
this	O
novel	O
human	O
matrix	O
metalloproteinase	O
has	O
been	O
called	O
MT6-MMP	B
because	O
it	O
is	O
the	O
sixth	O
identified	O
member	O
of	O
this	O
subfamily	O
of	O
matrix	O
metalloproteinase	O
.	O

Cotransfection	O
of	O
expression	O
plasmids	O
encoding	O
MT6-MMP	B
and	O
progelatinase	B
A	I
resulted	O
in	O
activation	O
of	O
COS-7-secreted	O
progelatinase	B
A	I
,	O
as	O
demonstrated	O
by	O
gelatin	O
zymography	O
.	O

In	O
contrast	O
,	O
transfection	O
of	O
progelatinase	B
A	I
cDNA	O
alone	O
did	O
not	O
lead	O
to	O
the	O
activation	O
of	O
the	O
proenzyme	O
.	O

Northern	O
blot	O
analysis	O
of	O
polyadenylated	O
RNAs	O
isolated	O
from	O
human	O
tissues	O
demonstrated	O
that	O
MT6-MMP	B
is	O
predominantly	O
expressed	O
in	O
leukocytes	O
,	O
lung	O
,	O
and	O
spleen	O
.	O

MT6-MMP	B
was	O
also	O
detected	O
at	O
high	O
levels	O
in	O
SW480	O
colon	O
carcinoma	O
cells	O
as	O
well	O
as	O
in	O
some	O
anaplastic	O
astrocytomas	O
and	O
glioblastomas	O
,	O
but	O
not	O
in	O
normal	O
colon	O
or	O
brain	O
or	O
in	O
meningiomas	O
.	O

On	O
the	O
basis	O
of	O
these	O
results	O
,	O
we	O
propose	O
that	O
MT6-MMP	B
may	O
facilitate	O
tumor	O
progression	O
through	O
its	O
ability	O
to	O
activate	O
progelatinase	B
A	I
at	O
the	O
membrane	O
of	O
cells	O
from	O
colon	O
carcinomas	O
or	O
brain	O
tumors	O
.	O

Large	O
exons	O
encoding	O
multiple	O
ectodomains	O
are	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O

Recent	O
studies	O
revealed	O
a	O
striking	O
difference	O
in	O
the	O
genomic	O
organization	O
of	O
classic	O
cadherin	O
genes	O
and	O
one	O
family	O
of	O
""""	O
nonclassic	O
cadherin	O
""""	O
genes	O
designated	O
protocadherins	O
.	O

Specifically	O
,	O
the	O
DNA	O
sequences	O
encoding	O
the	O
ectodomain	O
repeats	O
of	O
classic	O
cadherins	O
are	O
interrupted	O
by	O
multiple	O
introns	O
.	O

By	O
contrast	O
,	O
all	O
of	O
the	O
encoded	O
ectodomains	O
of	O
each	O
member	O
of	O
the	O
protocadherin	O
gene	O
clusters	O
are	O
present	O
in	O
one	O
large	O
exon	O
.	O

To	O
determine	O
whether	O
large	O
ectodomain	O
exons	O
are	O
a	O
general	O
feature	O
of	O
protocadherin	O
genes	O
we	O
have	O
investigated	O
the	O
genomic	O
organization	O
of	O
several	O
additional	O
human	O
protocadherin	O
genes	O
by	O
using	O
DNA	O
sequence	O
information	O
in	O
GenBank	O
.	O

These	O
genes	O
include	O
protocadherin	B
12	I
(	O
Pcdh12	B
)	O
,	O
an	O
ortholog	O
of	O
the	O
mouse	O
vascular	B
endothelial	I
cadherin-2	I
gene	O
;	O
hFmi1	B
and	O
hFmi2	B
,	O
homologs	O
of	O
the	O
Drosophila	O
planar	O
cell	O
polarity	O
gene	O
,	O
flamingo	O
;	O
hFat2	B
,	O
a	O
homolog	O
of	O
the	O
Drosophila	O
tumor	O
suppressor	O
gene	O
fat	O
;	O
and	O
the	O
Drosophila	O
DN	O
-	O
cadherin	O
and	O
DE	O
-	O
cadherin	O
genes	O
.	O

Each	O
of	O
these	O
genes	O
was	O
found	O
to	O
be	O
a	O
member	O
of	O
the	O
protocadherin	O
subfamily	O
,	O
based	O
on	O
amino	O
acid	O
sequence	O
comparisons	O
of	O
their	O
ectodomains	O
.	O

Remarkably	O
,	O
all	O
of	O
these	O
protocadherin	O
genes	O
share	O
a	O
common	O
feature	O
:	O
most	O
of	O
the	O
genomic	O
DNA	O
sequences	O
encoding	O
their	O
ectodomains	O
are	O
not	O
interrupted	O
by	O
an	O
intron	O
.	O

We	O
conclude	O
that	O
the	O
presence	O
of	O
unusually	O
large	O
exons	O
is	O
a	O
characteristic	O
feature	O
of	O
protocadherin	O
genes	O
.	O

Induction	O
of	O
a	O
novel	O
cellular	O
homolog	O
of	O
interleukin-10	B
,	O
AK155	B
,	O
by	O
transformation	O
of	O
T	O
lymphocytes	O
with	O
herpesvirus	O
saimiri	O
.	O

Although	O
herpesvirus	O
saimiri	O
-	O
transformed	O
T	O
lymphocytes	O
retain	O
multiple	O
normal	O
T	O
-	O
cell	O
functions	O
,	O
only	O
a	O
few	O
changes	O
have	O
been	O
described	O
.	O

By	O
subtractive	O
hybridization	O
,	O
we	O
have	O
isolated	O
a	O
novel	O
cellular	O
gene	O
,	O
ak155	B
,	O
a	O
sequence	O
homolog	O
of	O
the	O
interleukin-10	B
gene	O
.	O

Specifically	O
herpesvirus	O
saimiri	O
-	O
transformed	O
T	O
cells	O
overexpress	O
ak155	B
and	O
secrete	O
the	O
protein	O
into	O
the	O
supernatant	O
.	O

In	O
other	O
T	O
-	O
cell	O
lines	O
and	O
in	O
native	O
peripheral	O
blood	O
cells	O
,	O
but	O
not	O
in	O
B	O
cells	O
,	O
ak155	B
is	O
transcribed	O
at	O
low	O
levels	O
.	O

AK155	B
forms	O
homodimers	O
similarly	O
to	O
interleukin-10	B
.	O

As	O
a	O
lymphokine	O
,	O
AK155	B
may	O
contribute	O
to	O
the	O
transformed	O
phenotype	O
of	O
human	O
T	O
cells	O
after	O
infection	O
by	O
herpesvirus	O
saimiri	O
.	O

A	O
novel	O
mammalian	O
iron	O
-	O
regulated	O
protein	O
involved	O
in	O
intracellular	O
iron	O
metabolism	O
.	O

We	O
have	O
isolated	O
and	O
characterized	O
a	O
novel	O
iron	O
-	O
regulated	O
gene	O
that	O
is	O
homologous	O
to	O
the	O
divalent	O
metal	O
transporter	O
1	O
family	O
of	O
metal	O
transporters	O
.	O

This	O
gene	O
,	O
termed	O
metal	O
transporter	O
protein	O
(	O
mtp1	B
)	O
,	O
is	O
expressed	O
in	O
tissues	O
involved	O
in	O
body	O
iron	O
homeostasis	O
including	O
the	O
developing	O
and	O
mature	O
reticuloendothelial	O
system	O
,	O
the	O
duodenum	O
,	O
and	O
the	O
pregnant	O
uterus	O
.	O

MTP1	B
is	O
also	O
expressed	O
in	O
muscle	O
and	O
central	O
nervous	O
system	O
cells	O
in	O
the	O
embryo	O
.	O

At	O
the	O
subcellular	O
level	O
,	O
MTP1	B
is	O
localized	O
to	O
the	O
basolateral	O
membrane	O
of	O
the	O
duodenal	O
epithelial	O
cell	O
and	O
a	O
cytoplasmic	O
compartment	O
of	O
reticuloendothelial	O
system	O
cells	O
.	O

Overexpression	O
of	O
MTP1	B
in	O
tissue	O
culture	O
cells	O
results	O
in	O
intracellular	O
iron	O
depletion	O
.	O

In	O
the	O
adult	O
mouse	O
,	O
MTP1	B
expression	O
in	O
the	O
liver	O
and	O
duodenum	O
are	O
reciprocally	O
regulated	O
.	O

Iron	O
deficiency	O
induces	O
MTP1	B
expression	O
in	O
the	O
duodenum	O
but	O
down	O
-	O
regulates	O
expression	O
in	O
the	O
liver	O
.	O

These	O
data	O
indicate	O
that	O
MTP1	B
is	O
an	O
iron	O
-	O
regulated	O
membrane	O
-	O
spanning	O
protein	O
that	O
is	O
involved	O
in	O
intracellular	O
iron	O
metabolism	O
.	O

Molecular	O
cloning	O
of	O
globotriaosylceramide	B
/	I
CD77	I
synthase	I
,	O
a	O
glycosyltransferase	O
that	O
initiates	O
the	O
synthesis	O
of	O
globo	O
series	O
glycosphingolipids	O
.	O

The	O
expression	O
cloning	O
of	O
a	O
cDNA	O
for	O
globotriaosylceramide	B
(	I
Gb3	I
)	I
/	I
CD77	I
synthase	I
(	O
alpha1,4-galactosyltransferase	B
)	O
was	O
achieved	O
using	O
an	O
anti	O
-	O
Gb3	O
antibody	O
and	O
mouse	O
L	O
cells	O
as	O
a	O
recipient	O
cell	O
line	O
for	O
the	O
transfection	O
.	O

The	O
isolated	O
cDNA	O
clone	O
designated	O
pVTR1	O
predicted	O
a	O
type	O
II	O
membrane	O
protein	O
with	O
19	O
amino	O
acids	O
of	O
cytoplasmic	O
domain	O
,	O
26	O
amino	O
acids	O
of	O
transmembrane	O
region	O
,	O
and	O
a	O
catalytic	O
domain	O
with	O
308	O
amino	O
acids	O
.	O

Introduction	O
of	O
the	O
cDNA	O
clone	O
into	O
L	O
cells	O
resulted	O
in	O
the	O
neosynthesis	O
of	O
Gb3	O
/	O
CD77	O
,	O
and	O
the	O
extracts	O
of	O
the	O
transfectant	O
cells	O
showed	O
alpha1	O
,	O
4-galactosyltransferase	O
activity	O
only	O
on	O
lactosylceramide	O
and	O
galactosylceramide	O
.	O

In	O
Northern	O
blotting	O
,	O
a	O
2.3-kilobase	O
mRNA	O
was	O
strongly	O
expressed	O
in	O
heart	O
,	O
kidney	O
,	O
spleen	O
,	O
and	O
placenta	O
and	O
weakly	O
in	O
colon	O
,	O
small	O
intestine	O
,	O
and	O
brain	O
.	O

Transfection	O
of	O
the	O
cDNA	O
into	O
L	O
cells	O
resulted	O
in	O
the	O
constitution	O
of	O
sensitivity	O
to	O
the	O
apoptosis	O
with	O
Shiga	O
-	O
like	O
toxins	O
(	O
verotoxins	O
)	O
.	O

Since	O
Gb3	B
/	I
CD77	I
synthase	I
initiates	O
the	O
synthesis	O
of	O
globo	O
series	O
glycolipids	O
,	O
the	O
isolation	O
of	O
this	O
cDNA	O
will	O
make	O
possible	O
further	O
investigations	O
into	O
the	O
function	O
of	O
its	O
important	O
series	O
of	O
glycolipids	O
.	O

LRP	B
-	I
DIT	I
,	O
a	O
putative	O
endocytic	O
receptor	O
gene	O
,	O
is	O
frequently	O
inactivated	O
in	O
non	O
-	O
small	O
cell	O
lung	O
cancer	O
cell	O
lines	O
.	O

A	O
variety	O
of	O
studies	O
suggest	O
that	O
allelic	O
losses	O
at	O
chromosome	O
2q	O
are	O
associated	O
with	O
aggressive	O
behavior	O
of	O
various	O
forms	O
of	O
human	O
neoplasia	O
.	O

Using	O
a	O
probe	O
to	O
detect	O
homozygous	O
deletions	O
on	O
chromosome	O
2q21.2	O
in	O
kidney	O
and	O
bladder	O
cancer	O
cell	O
lines	O
,	O
we	O
identified	O
a	O
new	O
candidate	O
tumor	O
suppressor	O
gene	O
,	O
lipoprotein	B
receptor	I
-	I
related	I
protein	I
-	I
deleted	I
in	I
tumors	I
(	O
LRP	B
-	I
DIT	I
)	O
.	O

The	O
predicted	O
LRP	B
-	I
DIT	I
product	O
of	O
4599	O
amino	O
acids	O
has	O
extensive	O
homology	O
to	O
a	O
gigantic	O
receptor	O
,	O
LRP1	B
,	O
which	O
mediates	O
endocytosis	O
of	O
multiple	O
proteins	O
from	O
the	O
cell	O
surface	O
.	O

Homozygous	O
deletions	O
in	O
LRP	B
-	I
DIT	I
were	O
detected	O
in	O
17	O
%	O
(	O
4	O
of	O
23	O
)	O
of	O
non	O
-	O
small	O
cell	O
lung	O
cancer	O
(	O
NSCLC	O
)	O
cell	O
lines	O
.	O

The	O
expression	O
of	O
only	O
abnormal	O
transcripts	O
missing	O
portions	O
of	O
the	O
LRP	B
-	I
DIT	I
sequence	O
was	O
demonstrated	O
in	O
an	O
additional	O
30	O
%	O
(	O
11	O
of	O
36	O
)	O
of	O
NSCLC	O
lines	O
.	O

Finally	O
,	O
a	O
missense	O
mutation	O
at	O
codon	O
3157	O
was	O
detected	O
in	O
one	O
of	O
four	O
NSCLC	O
lines	O
tested	O
for	O
the	O
large	O
open	O
reading	O
frame	O
.	O

In	O
contrast	O
,	O
no	O
LRP	B
-	I
DIT	I
alterations	O
were	O
identified	O
in	O
a	O
major	O
fraction	O
of	O
SCLC	O
cell	O
lines	O
,	O
indicating	O
that	O
this	O
gene	O
is	O
preferentially	O
inactivated	O
in	O
one	O
histological	O
type	O
of	O
lung	O
cancer	O
.	O

Our	O
data	O
suggest	O
that	O
inactivation	O
of	O
LRP	B
-	I
DIT	I
occurs	O
in	O
at	O
least	O
40	O
%	O
of	O
NSCLC	O
lines	O
and	O
thus	O
may	O
play	O
an	O
important	O
role	O
in	O
tumorigenesis	O
of	O
NSCLCs	O
.	O

Cloning	O
and	O
functional	O
expression	O
of	O
two	O
families	O
of	O
beta	O
-	O
subunits	O
of	O
the	O
large	O
conductance	O
calcium	O
-	O
activated	O
K+	O
channel	O
.	O

We	O
report	O
here	O
a	O
characterization	O
of	O
two	O
families	O
of	O
calcium	B
-	I
activated	I
K	I
(	I
+	I
)	I
channel	I
beta	I
-	I
subunits	I
,	I
beta2	I
and	I
beta3	I
,	O
which	O
are	O
encoded	O
by	O
distinct	O
genes	O
that	O
map	O
to	O
3q26.2	O
-	O
27	O
.	O

A	O
single	O
beta2	B
family	O
member	O
and	O
four	O
alternatively	O
spliced	O
variants	O
of	O
beta3	O
were	O
investigated	O
.	O

These	O
subunits	O
have	O
predicted	O
molecular	O
masses	O
of	O
27	O
.	O
1	O
-	O
31.6	O
kDa	O
,	O
share	O
approximately	O
30	O
-	O
44	O
%	O
amino	O
acid	O
identity	O
with	O
beta1	B
,	O
and	O
exhibit	O
distinct	O
but	O
overlapping	O
expression	O
patterns	O
.	O

Coexpression	O
of	O
the	O
beta2	B
or	O
beta3a	B
-	I
c	I
subunits	O
with	O
a	O
BK	O
alpha	O
-	O
subunit	O
altered	O
the	O
functional	O
properties	O
of	O
the	O
current	O
expressed	O
by	O
the	O
alpha	O
-	O
subunit	O
alone	O
.	O

The	O
beta2	B
subunit	I
rapidly	O
and	O
completely	O
inactivated	O
the	O
current	O
and	O
shifted	O
the	O
voltage	O
dependence	O
for	O
activation	O
to	O
more	O
polarized	O
membrane	O
potentials	O
.	O

In	O
contrast	O
,	O
coexpression	O
of	O
the	O
beta3a	B
-	I
c	I
subunits	O
resulted	O
in	O
only	O
partial	O
inactivation	O
of	O
the	O
current	O
,	O
and	O
the	O
beta3b	O
subunit	O
conferred	O
an	O
apparent	O
inward	O
rectification	O
.	O

Furthermore	O
,	O
unlike	O
the	O
beta1	B
and	O
beta2	B
subunits	O
,	O
none	O
of	O
the	O
beta3	O
subunits	O
increased	O
channel	O
sensitivity	O
to	O
calcium	O
or	O
voltage	O
.	O

The	O
tissue	O
-	O
specific	O
expression	O
of	O
these	O
beta	O
-	O
subunits	O
may	O
allow	O
for	O
the	O
assembly	O
of	O
a	O
large	O
number	O
of	O
distinct	O
BK	O
channels	O
in	O
vivo	O
,	O
contributing	O
to	O
the	O
functional	O
diversity	O
of	O
native	O
BK	O
currents	O
.	O

Cloning	O
of	O
CCRL1	B
,	O
an	O
orphan	O
seven	O
transmembrane	O
receptor	O
related	O
to	O
chemokine	O
receptors	O
,	O
expressed	O
abundantly	O
in	O
the	O
heart	O
.	O

In	O
an	O
attempt	O
to	O
identify	O
novel	O
chemokine	O
receptor	O
genes	O
,	O
cDNA	O
expressed	O
sequence	O
tags	O
(	O
EST	O
)	O
were	O
analyzed	O
for	O
a	O
significant	O
homology	O
with	O
mammalian	O
chemokine	O
receptors	O
.	O

The	O
sequence	O
from	O
one	O
of	O
the	O
selected	O
EST	O
clones	O
was	O
used	O
to	O
generate	O
a	O
full	O
-	O
length	O
cDNA	O
encoding	O
a	O
putative	O
seven	O
transmembrane	O
receptor	O
,	O
CCRL1-CC	B
chemokine	B
receptor	I
like	I
1	I
.	O

The	O
full	O
-	O
length	O
receptor	O
encodes	O
a	O
polypeptide	O
of	O
350	O
amino	O
acids	O
and	O
has	O
about	O
35	O
%	O
homology	O
to	O
the	O
chemokine	O
receptors	O
CCR6	B
and	O
CCR7	B
.	O

Northern	O
blot	O
analysis	O
indicates	O
predominant	O
expression	O
of	O
about	O
5.0	O
,	O
2.0	O
and	O
1.3	O
kb	O
mRNA	O
forms	O
in	O
human	O
heart	O
tissue	O
,	O
while	O
low	O
-	O
level	O
expression	O
of	O
the	O
2.0	O
and	O
1.3	O
kb	O
forms	O
was	O
observed	O
in	O
lung	O
,	O
pancreas	O
and	O
spleen	O
and	O
in	O
fetal	O
tissues	O
.	O

In	O
-	O
situ	O
hybridization	O
confirmed	O
the	O
presence	O
of	O
CCRL1	B
mRNA	O
in	O
cardiac	O
muscle	O
cells	O
.	O

Similar	O
to	O
the	O
chemokine	O
receptor	O
CCR6	B
,	O
CCRL1	B
maps	O
to	O
chromosome	O
6	O
and	O
has	O
one	O
intron	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
.	O

Coupled	O
transcription	O
-	O
translation	O
of	O
CCRL1	B
cDNA	O
yielded	O
a	O
glycosylated	O
polypeptide	O
of	O
about	O
45kDa	O
.	O

Localization	O
and	O
genomic	O
organization	O
of	O
a	O
new	O
hepatocellular	O
organic	O
anion	O
transporting	O
polypeptide	O
.	O

Based	O
on	O
sequence	O
homology	O
to	O
the	O
human	O
organic	B
anion	I
transporting	I
polypeptide	I
2	I
(	O
OATP2	B
;	O
SLC21A6	B
)	O
,	O
we	O
cloned	O
a	O
new	O
member	O
of	O
the	O
SLC21A	O
superfamily	O
of	O
solute	O
carriers	O
,	O
termed	O
OATP8	B
(	O
SLC21A8	B
)	O
.	O

The	O
protein	O
of	O
702	O
amino	O
acids	O
showed	O
an	O
amino	O
acid	O
identity	O
of	O
80	O
%	O
with	O
human	O
OATP2	B
.	O

Based	O
on	O
Northern	O
blotting	O
,	O
the	O
expression	O
of	O
OATP8	B
was	O
restricted	O
to	O
human	O
liver	O
.	O

Cosmid	O
clones	O
containing	O
the	O
genes	O
encoding	O
human	O
OATP1	B
(	O
SLC21A3	B
)	O
,	O
OATP2	B
(	O
SLC21A6	B
)	O
,	O
and	O
OATP8	B
(	O
SLC21A8	B
)	O
served	O
to	O
establish	O
their	O
genomic	O
organization	O
.	O

All	O
three	O
genes	O
contained	O
14	O
exons	O
with	O
13	O
identical	O
splice	O
sites	O
when	O
transferred	O
to	O
the	O
amino	O
acid	O
sequence	O
.	O

An	O
antibody	O
raised	O
against	O
the	O
carboxyl	O
terminus	O
localized	O
OATP8	B
to	O
the	O
basolateral	O
membrane	O
of	O
human	O
hepatocytes	O
and	O
the	O
recombinant	O
glycoprotein	O
,	O
expressed	O
in	O
MDCKII	O
cells	O
,	O
to	O
the	O
lateral	O
membrane	O
.	O

Transport	O
properties	O
of	O
OATP8	B
were	O
studied	O
in	O
stably	O
transfected	O
MDCKII	O
and	O
HEK293	O
cells	O
.	O

Organic	O
anions	O
transported	O
by	O
human	O
OATP8	B
included	O
sulfobromophthalein	O
,	O
with	O
a	O
K	O
(	O
m	O
)	O
of	O
3.3	O
microm	O
,	O
and	O
17beta	O
-	O
glucuronosyl	O
estradiol	O
,	O
with	O
a	O
K	O
(	O
m	O
)	O
of	O
5.4	O
microm	O
.	O

Several	O
bile	O
salts	O
were	O
not	O
substrates	O
.	O

Thus	O
,	O
human	O
OATP8	B
is	O
a	O
new	O
uptake	O
transporter	O
in	O
the	O
basolateral	O
hepatocyte	O
membrane	O
with	O
an	O
overlapping	O
but	O
distinct	O
substrate	O
specificity	O
as	O
compared	O
with	O
OATP2	B
,	O
which	O
is	O
localized	O
to	O
the	O
same	O
membrane	O
domain	O
.	O

Cloning	O
,	O
characterization	O
,	O
and	O
expression	O
of	O
the	O
human	O
TIN	B
-	I
ag	I
-	I
RP	I
gene	O
encoding	O
a	O
novel	O
putative	O
extracellular	O
matrix	O
protein	O
.	O

The	O
human	O
gene	O
encoding	O
a	O
novel	O
tubulointerstitial	B
nephritis	I
antigen	I
(	I
TIN	I
-	I
ag	I
)	I
-related	I
protein	O
(	O
TIN	B
-	I
ag	I
-	I
RP	I
)	O
was	O
isolated	O
,	O
and	O
its	O
genomic	O
organization	O
was	O
determined	O
.	O

BLAST	O
searches	O
revealed	O
the	O
highest	O
degree	O
of	O
homology	O
to	O
several	O
mammalian	O
TIN	B
-	I
ag	I
orthologues	O
,	O
and	O
a	O
weak	O
homology	O
to	O
cathepsin	B
B	I
-	O
like	O
proteases	O
.	O

The	O
12	O
kb	O
gene	O
was	O
mapped	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
to	O
chromosome	O
1p34.2	O
-	O
3	O
,	O
a	O
locus	O
neither	O
related	O
to	O
that	O
of	O
the	O
human	O
TIN	B
-	I
ag	I
(	O
6p11.2	O
-	O
12	O
)	O
nor	O
to	O
that	O
of	O
cathepsin	B
B	I
(	O
8p22	O
-	O
23.1	O
)	O
.	O

The	O
TIN	B
-	I
ag	I
-	I
RP	I
is	O
encoded	O
in	O
ten	O
exons	O
with	O
introns	O
ranging	O
from	O
83	O
bp	O
to	O
4	O
kb	O
.	O

In	O
addition	O
,	O
the	O
gene	O
contained	O
one	O
exon	O
in	O
the	O
5'UTR	O
,	O
but	O
none	O
in	O
the	O
3'UTR	O
.	O

Five	O
of	O
the	O
10	O
splice	O
sites	O
of	O
the	O
TIN	B
-	I
ag	I
-	I
RP	I
gene	O
were	O
fully	O
conserved	O
when	O
compared	O
to	O
a	O
related	O
gene	O
of	O
C.	O
elegans	O
,	O
whereas	O
only	O
one	O
splice	O
site	O
was	O
identical	O
to	O
those	O
found	O
in	O
cathepsin	B
B	I
genes	O
.	O

Furthermore	O
,	O
human	O
TIN	B
-	I
ag	I
-	I
RP	I
tagged	O
with	O
the	O
T7-epitope	O
,	O
was	O
expressed	O
in	O
HeLa	O
cells	O
,	O
and	O
was	O
found	O
to	O
be	O
localized	O
in	O
vesicular	O
compartments	O
as	O
well	O
as	O
secreted	O
into	O
the	O
medium	O
suggesting	O
the	O
involvement	O
of	O
the	O
endosomal	O
trafficking	O
pathway	O
.	O

Based	O
on	O
the	O
high	O
degree	O
of	O
homology	O
of	O
the	O
amino	O
acid	O
sequences	O
and	O
genomic	O
organization	O
between	O
TIN	B
-	I
ag	I
-	I
RP	I
and	O
TIN	B
-	I
ag	I
,	O
we	O
suggest	O
that	O
both	O
molecules	O
may	O
form	O
a	O
distinct	O
group	O
or	O
family	O
of	O
TIN	B
-	I
ag	I
-	O
like	O
proteins	O
.	O

Tollip	B
,	O
a	O
new	O
component	O
of	O
the	O
IL-1RI	B
pathway	O
,	O
links	O
IRAK	B
to	O
the	O
IL-1	B
receptor	O
.	O

Interleukin-1	O
(	O
IL-1	B
)	O
is	O
a	O
proinflammatory	O
cytokine	O
that	O
elicits	O
its	O
pleiotropic	O
effects	O
through	O
activation	O
of	O
the	O
transcription	O
factors	O
NF	O
-	O
kappaB	O
and	O
AP-1	O
.	O

Binding	O
of	O
IL-1	B
to	O
its	O
receptor	O
results	O
in	O
rapid	O
assembly	O
of	O
a	O
membrane	O
-	O
proximal	O
signalling	O
complex	O
that	O
consists	O
of	O
two	O
different	O
receptor	O
chains	O
(	O
IL-1Rs	O
)	O
,	O
IL-1RI	B
and	O
IL-1RAcP	B
,	O
the	O
adaptor	O
protein	O
MyD88	B
,	O
the	O
serine	O
/	O
threonine	O
kinase	O
IRAK	B
and	O
a	O
new	O
protein	O
,	O
which	O
we	O
have	O
named	O
Tollip	B
.	O

Here	O
we	O
show	O
that	O
,	O
before	O
IL-1beta	B
treatment	O
,	O
Tollip	B
is	O
present	O
in	O
a	O
complex	O
with	O
IRAK	B
,	O
and	O
that	O
recruitment	O
of	O
Tollip	B
-	O
IRAK	B
complexes	O
to	O
the	O
activated	O
receptor	O
complex	O
occurs	O
through	O
association	O
of	O
Tollip	B
with	O
IL-1RAcP.	B
Co	O
-	O
recruited	O
MyD88	B
then	O
triggers	O
IRAK	B
autophosphorylation	O
,	O
which	O
in	O
turn	O
leads	O
to	O
rapid	O
dissociation	O
of	O
IRAK	B
from	O
Tollip	B
(	O
and	O
IL-1Rs	O
)	O
.	O

As	O
overexpression	O
of	O
Tollip	B
results	O
in	O
impaired	O
NF	O
-	O
kappaB	O
activation	O
,	O
we	O
conclude	O
that	O
Tollip	B
is	O
an	O
important	O
constituent	O
of	O
the	O
IL-1R	O
signalling	O
pathway	O
.	O

Excessive	O
placental	O
secretion	O
of	O
neurokinin	B
B	I
during	O
the	O
third	O
trimester	O
causes	O
pre	O
-	O
eclampsia	O
.	O

Pre	O
-	O
eclampsia	O
is	O
a	O
principal	O
cause	O
of	O
maternal	O
morbidity	O
and	O
mortality	O
,	O
affecting	O
5	O
-	O
10	O
%	O
of	O
first	O
pregnancies	O
worldwide	O
.	O

Manifestations	O
include	O
increased	O
blood	O
pressure	O
,	O
proteinuria	O
,	O
coagulopathy	O
and	O
peripheral	O
and	O
cerebral	O
oedema	O
.	O

Although	O
the	O
aetiology	O
and	O
pathogenesis	O
remain	O
to	O
be	O
elucidated	O
,	O
the	O
placenta	O
is	O
undoubtedly	O
involved	O
,	O
as	O
termination	O
of	O
pregnancy	O
eradicates	O
the	O
disease	O
.	O

Here	O
we	O
have	O
cloned	O
a	O
complementary	O
DNA	O
from	O
human	O
placental	O
messenger	O
RNA	O
encoding	O
a	O
precursor	O
protein	O
of	O
121	O
amino	O
acids	O
which	O
gives	O
rise	O
to	O
a	O
mature	O
peptide	O
identical	O
to	O
the	O
neuropeptide	O
neurokinin	B
B	I
(	O
NKB	B
)	O
of	O
other	O
mammalian	O
species	O
.	O

In	O
female	O
rats	O
,	O
concentrations	O
of	O
NKB	B
several	O
-	O
fold	O
above	O
that	O
of	O
an	O
animal	O
20	O
days	O
into	O
pregnancy	O
caused	O
substantial	O
pressor	O
activity	O
.	O

In	O
human	O
pregnancy	O
,	O
the	O
expression	O
of	O
NKB	B
was	O
confined	O
to	O
the	O
outer	O
syncytiotrophoblast	O
of	O
the	O
placenta	O
,	O
significant	O
concentrations	O
of	O
NKB	B
could	O
be	O
detected	O
in	O
plasma	O
as	O
early	O
as	O
week	O
9	O
,	O
and	O
plasma	O
concentrations	O
of	O
NKB	B
were	O
grossly	O
elevated	O
in	O
pregnancy	O
-	O
induced	O
hypertension	O
and	O
pre	O
-	O
eclampsia	O
.	O

We	O
conclude	O
that	O
elevated	O
levels	O
of	O
NKB	B
in	O
early	O
pregnancy	O
may	O
be	O
an	O
indicator	O
of	O
hypertension	O
and	O
pre	O
-	O
eclampsia	O
,	O
and	O
that	O
treatment	O
with	O
certain	O
neurokinin	O
receptor	O
antagonists	O
may	O
be	O
useful	O
in	O
alleviating	O
the	O
symptoms	O
.	O

Genomic	O
structure	O
of	O
the	O
human	O
ING1	B
gene	O
and	O
tumor	O
-	O
specific	O
mutations	O
detected	O
in	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinomas	O
.	O

We	O
characterized	O
the	O
genomic	O
structure	O
of	O
the	O
human	O
ING1	B
gene	O
,	O
a	O
candidate	O
tumor	O
suppressor	O
gene	O
,	O
and	O
found	O
that	O
the	O
gene	O
has	O
three	O
exons	O
.	O

We	O
also	O
demonstrated	O
that	O
four	O
mRNA	O
variants	O
were	O
transcribed	O
from	O
three	O
different	O
promoter	O
regions	O
.	O

Of	O
34	O
informative	O
cases	O
of	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
,	O
68	O
%	O
of	O
tumors	O
showed	O
loss	O
of	O
heterozygosity	O
at	O
chromosome	O
13q33	O
-	O
34	O
,	O
where	O
the	O
ING1	B
gene	O
is	O
located	O
.	O

Here	O
we	O
present	O
the	O
first	O
report	O
that	O
three	O
missense	O
mutations	O
and	O
three	O
silent	O
changes	O
were	O
detected	O
in	O
the	O
ING1	B
gene	O
in	O
6	O
of	O
23	O
tumors	O
with	O
allelic	O
loss	O
at	O
the	O
13q33	O
-	O
34	O
region	O
.	O

These	O
missense	O
mutations	O
were	O
found	O
within	O
the	O
PHD	O
finger	O
domain	O
and	O
nuclear	O
localization	O
motif	O
in	O
ING1	B
protein	O
,	O
probably	O
abrogating	O
the	O
normal	O
function	O
.	O

Isolation	O
and	O
characterization	O
of	O
the	O
novel	O
popeye	O
gene	O
family	O
expressed	O
in	O
skeletal	O
muscle	O
and	O
heart	O
.	O

We	O
identified	O
a	O
novel	O
gene	O
family	O
in	O
vertebrates	O
which	O
is	O
preferentially	O
expressed	O
in	O
developing	O
and	O
adult	O
striated	O
muscle	O
.	O

Three	O
genes	O
of	O
the	O
Popeye	O
(	O
POP	O
)	O
family	O
were	O
detected	O
in	O
human	O
and	O
mouse	O
and	O
two	O
in	O
chicken	O
.	O

Chromosomal	O
mapping	O
indicates	O
that	O
Pop1	B
and	O
Pop3	B
genes	O
are	O
clustered	O
on	O
mouse	O
chromosome	O
10	O
,	O
whereas	O
Pop2	B
maps	O
to	O
mouse	O
chromosome	O
16	O
.	O

We	O
found	O
evidence	O
that	O
POP1	B
and	O
POP3	B
in	O
chicken	O
may	O
also	O
be	O
linked	O
and	O
multiple	O
transcript	O
isoforms	O
are	O
generated	O
from	O
this	O
locus	O
.	O

The	O
POP	O
genes	O
encode	O
proteins	O
with	O
three	O
potential	O
transmembrane	O
domains	O
that	O
are	O
conserved	O
in	O
all	O
family	O
members	O
.	O

Individual	O
POP	O
genes	O
exhibit	O
specific	O
expression	O
patterns	O
during	O
development	O
and	O
postnatally	O
.	O

Chicken	O
POP3	B
and	O
mouse	O
Pop1	B
are	O
first	O
preferentially	O
expressed	O
in	O
atrium	O
and	O
later	O
also	O
in	O
the	O
subepicardial	O
compact	O
layer	O
of	O
the	O
ventricles	O
.	O

Chicken	O
POP1	B
and	O
mouse	O
Pop2	B
are	O
expressed	O
in	O
the	O
entire	O
heart	O
except	O
the	O
outflow	O
tract	O
.	O

All	O
three	O
Pop	O
genes	O
are	O
expressed	O
in	O
heart	O
and	O
skeletal	O
muscle	O
of	O
the	O
adult	O
mouse	O
and	O
lower	O
in	O
lung	O
.	O

Pop1	B
and	O
Pop2	B
expression	O
is	O
upregulated	O
in	O
uterus	O
of	O
pregnant	O
mice	O
.	O

Like	O
the	O
mouse	O
genes	O
,	O
human	O
POP	O
genes	O
are	O
predominantly	O
expressed	O
in	O
skeletal	O
and	O
cardiac	O
muscle	O
.	O

The	O
strong	O
conservation	O
of	O
POP	O
genes	O
during	O
evolution	O
and	O
their	O
preferential	O
expression	O
in	O
heart	O
and	O
skeletal	O
muscle	O
suggest	O
that	O
these	O
novel	O
proteins	O
may	O
have	O
an	O
important	O
function	O
in	O
these	O
tissues	O
in	O
vertebrates	O
.	O

Identification	O
,	O
cloning	O
,	O
expression	O
,	O
and	O
biochemical	O
characterization	O
of	O
the	O
testis	B
-	I
specific	I
RNA	I
polymerase	I
II	I
elongation	I
factor	I
ELL3	I
.	O

The	O
human	O
ELL	B
gene	O
,	O
which	O
is	O
a	O
frequent	O
target	O
for	O
translocation	O
in	O
acute	O
myeloid	O
leukemia	O
,	O
was	O
initially	O
isolated	O
from	O
rat	O
liver	O
nuclei	O
and	O
found	O
to	O
be	O
an	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
.	O

Based	O
on	O
homology	O
to	O
ELL	B
,	O
we	O
later	O
cloned	O
ELL2	B
and	O
demonstrated	O
that	O
it	O
can	O
also	O
increase	O
the	O
catalytic	O
rate	O
of	O
transcription	O
elongation	O
by	O
RNA	O
polymerase	O
II	O
.	O

To	O
better	O
understand	O
the	O
role	O
of	O
ELL	B
proteins	O
in	O
the	O
regulation	O
of	O
transcription	O
by	O
RNA	O
polymerase	O
II	O
,	O
we	O
have	O
initiated	O
a	O
search	O
for	O
proteins	O
related	O
to	O
ELLs	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
molecular	O
cloning	O
,	O
expression	O
,	O
and	O
characterization	O
of	O
ELL3	B
,	O
a	O
novel	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
approximately	O
50	O
%	O
similar	O
to	O
both	O
ELL	B
and	O
ELL2	B
.	O

Our	O
transcriptional	O
studies	O
have	O
demonstrated	O
that	O
ELL3	B
can	O
also	O
increase	O
the	O
catalytic	O
rate	O
of	O
transcription	O
elongation	O
by	O
RNA	O
polymerase	O
II	O
.	O

The	O
C	O
-	O
terminal	O
domain	O
of	O
ELL	B
,	O
which	O
we	O
recently	O
demonstrated	O
to	O
be	O
required	O
and	O
sufficient	O
for	O
the	O
immortalization	O
of	O
myeloid	O
progenitor	O
cells	O
,	O
shares	O
strong	O
similarities	O
to	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
ELL3	B
.	O

ELL3	B
was	O
localized	O
by	O
immunofluorescence	O
to	O
the	O
nucleus	O
of	O
cells	O
,	O
and	O
Northern	O
analysis	O
indicated	O
that	O
ELL3	B
is	O
a	O
testis	O
-	O
specific	O
RNA	O
polymerase	O
II	O
elongation	O
factor	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
human	O
FGF-20	B
on	O
chromosome	O
8p21.3-p22	O
.	O

The	O
fibroblast	O
growth	O
factors	O
(	O
FGFs	O
)	O
play	O
important	O
roles	O
in	O
morphogenesis	O
,	O
angiogenesis	O
,	O
tissue	O
remodeling	O
,	O
and	O
carcinogenesis	O
.	O

Human	O
FGF-20	B
has	O
been	O
cloned	O
and	O
characterized	O
in	O
this	O
study	O
.	O

FGF-20	B
encodes	O
a	O
211-amino	O
-	O
acid	O
polypeptide	O
with	O
the	O
FGF	O
-	O
core	O
domain	O
.	O

A	O
strong	O
hydrophobic	O
region	O
was	O
found	O
in	O
the	O
FGF	O
-	O
core	O
domain	O
of	O
FGF-20	B
;	O
however	O
,	O
no	O
typical	O
N	O
-	O
terminal	O
signal	O
sequence	O
was	O
found	O
in	O
FGF-20	B
,	O
just	O
as	O
in	O
FGF-9	B
and	O
FGF-16	B
.	O

Total	O
amino	O
acid	O
identities	O
are	O
as	O
follows	O
:	O
FGF-20	B
vs	O
FGF-9	B
,	O
71.6	O
%	O
;	O
FGF-20	B
vs	O
FGF-16	B
,	O
66.2	O
%	O
;	O
FGF-9	B
vs	O
FGF-16	B
,	O
72.4	O
%	O
.	O

Phylogenic	O
analysis	O
indicated	O
that	O
FGF-20	B
,	O
FGF-9	B
,	O
and	O
FGF-16	B
constitute	O
a	O
subfamily	O
among	O
the	O
FGF	O
family	O
.	O

FGF-20	B
mRNA	O
of	O
2.4	O
kb	O
in	O
size	O
was	O
detected	O
in	O
colon	O
cancer	O
cell	O
line	O
SW480	O
by	O
Northern	O
blot	O
analysis	O
.	O

Lower	O
levels	O
of	O
FGF-20	B
mRNA	O
were	O
detected	O
in	O
human	O
fetal	O
tissues	O
and	O
primary	O
cancers	O
by	O
cDNA	O
-	O
PCR	O
.	O

The	O
nucleotide	O
sequence	O
of	O
FGF-20	B
cDNA	O
is	O
split	O
into	O
three	O
parts	O
in	O
the	O
human	O
genome	O
sequence	O
of	O
the	O
chromosome	O
8p21.3-p22	O
region	O
(	O
Accession	O
No.	O
AB020858	O
)	O
.	O

These	O
results	O
indicate	O
that	O
the	O
FGF-20	B
gene	O
,	O
located	O
on	O
human	O
chromosome	O
8p21.3-p22	O
,	O
consists	O
of	O
three	O
exons	O
.	O

Compared	O
with	O
the	O
nucleotide	O
sequence	O
of	O
FGF-20	B
cDNA	O
determined	O
in	O
this	O
study	O
,	O
one	O
nucleotide	O
deletion	O
and	O
one	O
nucleotide	O
substitution	O
in	O
the	O
putative	O
coding	O
region	O
were	O
identified	O
in	O
human	O
genome	O
sequence	O
AB020858	O
.	O

The	O
cysteine-	O
and	O
glycine	O
-	O
rich	O
LIM	O
domain	O
protein	O
CRP2	B
specifically	O
interacts	O
with	O
a	O
novel	O
human	O
protein	O
(	O
CRP2BP	B
)	O
.	O

We	O
used	O
the	O
interaction	O
trap	O
to	O
isolate	O
a	O
novel	O
human	O
protein	O
that	O
specifically	O
interacts	O
with	O
the	O
double	O
LIM	O
domain	O
protein	O
CRP2	B
.	O

This	O
protein	O
,	O
designated	O
CRP2BP	B
(	O
for	O
CRP2	B
binding	I
partner	I
)	O
,	O
was	O
previously	O
postulated	O
by	O
sequencing	O
contigs	O
of	O
human	O
chromosome	O
20	O
.	O

The	O
observed	O
interaction	O
is	O
mediated	O
via	O
the	O
LIM1	O
domain	O
of	O
CRP2	B
and	O
is	O
of	O
functional	O
relevance	O
in	O
cellular	O
environment	O
.	O

This	O
novel	O
single	O
copy	O
gene	O
spans	O
approximately	O
45-bp	O
and	O
is	O
organized	O
into	O
at	O
least	O
ten	O
exons	O
.	O

CRP2BP	B
is	O
expressed	O
in	O
all	O
human	O
tissues	O
tested	O
,	O
with	O
a	O
major	O
mRNA	O
of	O
4-kb	O
in	O
size	O
and	O
an	O
additional	O
3.2-kb	O
transcript	O
in	O
placenta	O
.	O

Cloning	O
and	O
characterization	O
of	O
human	O
DDX24	B
and	O
mouse	O
Ddx24	B
,	O
two	O
novel	O
putative	O
DEAD	O
-	O
Box	O
proteins	O
,	O
and	O
mapping	O
DDX24	B
to	O
human	O
chromosome	O
14q32	O
.	O

DEAD	O
-	O
box	O
proteins	O
are	O
a	O
large	O
group	O
of	O
putative	O
RNA	O
helicases	O
that	O
exist	O
ubiquitously	O
in	O
organisms	O
ranging	O
from	O
bacteria	O
to	O
humans	O
.	O

They	O
are	O
likely	O
to	O
play	O
important	O
roles	O
in	O
many	O
different	O
RNA	O
metabolic	O
processes	O
.	O

In	O
this	O
paper	O
,	O
we	O
report	O
the	O
cloning	O
of	O
human	O
DDX24	B
,	O
a	O
putative	O
DEAD	O
-	O
box	O
protein	O
,	O
and	O
its	O
ortholog	O
,	O
Ddx24	B
in	O
mouse	O
.	O

The	O
deduced	O
proteins	O
encoded	O
by	O
these	O
two	O
cDNAs	O
share	O
78.7	O
%	O
identity	O
at	O
the	O
amino	O
acid	O
level	O
and	O
possess	O
all	O
the	O
well	O
-	O
conserved	O
motifs	O
of	O
DEAD	O
-	O
box	O
proteins	O
.	O

However	O
,	O
little	O
homology	O
can	O
be	O
found	O
between	O
them	O
and	O
other	O
DEAD	O
-	O
box	O
proteins	O
,	O
even	O
in	O
their	O
core	O
region	O
(	O
identity	O
<	O
40	O
%	O
)	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
a	O
3.0-kb	O
transcript	O
of	O
human	O
DDX24	B
exists	O
ubiquitously	O
in	O
the	O
16	O
human	O
tissues	O
examined	O
and	O
was	O
most	O
abundant	O
in	O
heart	O
and	O
brain	O
,	O
but	O
with	O
lowest	O
levels	O
in	O
thymus	O
and	O
small	O
intestine	O
.	O

The	O
mouse	O
Ddx24	B
,	O
whose	O
transcript	O
is	O
4.0	O
kb	O
,	O
was	O
also	O
expressed	O
widely	O
in	O
10	O
tissues	O
tested	O
with	O
the	O
highest	O
level	O
in	O
heart	O
and	O
testis	O
.	O

By	O
radiation	O
hybrid	O
mapping	O
,	O
the	O
human	O
DDX24	B
gene	O
was	O
localized	O
to	O
human	O
chromosome	O
14q32	O
between	O
the	O
markers	O
D14S81	O
and	O
D14S265	O
.	O

Moreover	O
,	O
the	O
gene	O
structure	O
of	O
DDX24	B
was	O
determined	O
by	O
comparing	O
its	O
cDNA	O
and	O
genomic	O
sequence	O
from	O
BAC	O
R-1089B7	O
,	O
which	O
showed	O
that	O
the	O
gene	O
spanned	O
a	O
30-kb	O
region	O
and	O
consisted	O
of	O
at	O
least	O
nine	O
exons	O
.	O

A	O
human	O
gene	O
coding	O
for	O
a	O
membrane	B
-	I
associated	I
nucleic	I
acid	I
-	I
binding	I
protein	I
.	O

Studies	O
to	O
clone	O
a	O
cell	O
-	O
surface	O
DNA	O
-	O
binding	O
protein	O
involved	O
in	O
the	O
binding	O
and	O
internalization	O
of	O
extracellular	O
DNA	O
have	O
led	O
to	O
the	O
isolation	O
of	O
a	O
gene	O
for	O
a	O
membrane	B
-	I
associated	I
nucleic	I
acid	I
-	I
binding	I
protein	I
(	O
MNAB	B
)	O
.	O

The	O
full	O
-	O
length	O
cDNA	O
is	O
4.3	O
kilobases	O
with	O
an	O
open	O
reading	O
frame	O
of	O
3576	O
base	O
pairs	O
encoding	O
a	O
protein	O
of	O
approximately	O
130	O
kDa	O
(	O
GenBank	O
accession	O
numbers	O
and	O
)	O
.	O

The	O
MNAB	B
gene	O
is	O
on	O
human	O
chromosome	O
9	O
with	O
wide	O
expression	O
in	O
normal	O
tissues	O
and	O
tumor	O
cells	O
.	O

A	O
C3HC4	O
RING	O
finger	O
and	O
a	O
CCCH	O
zinc	O
finger	O
have	O
been	O
identified	O
in	O
the	O
amino	O
-	O
terminal	O
half	O
of	O
the	O
protein	O
.	O

MNAB	B
bound	O
DNA	O
(	O
K	O
(	O
D	O
)	O
approximately	O
4	O
nm	O
)	O
and	O
mutagenesis	O
of	O
a	O
single	O
conserved	O
amino	O
acid	O
in	O
the	O
zinc	O
finger	O
reduced	O
DNA	O
binding	O
by	O
50	O
%	O
.	O

A	O
potential	O
transmembrane	O
domain	O
exists	O
near	O
the	O
carboxyl	O
terminus	O
.	O

Antibodies	O
against	O
the	O
amino	O
-	O
terminal	O
half	O
of	O
the	O
protein	O
immunoprecipitated	O
a	O
protein	O
of	O
molecular	O
mass	O
approximately	O
150	O
kDa	O
and	O
reacted	O
with	O
cell	O
surfaces	O
.	O

The	O
MNAB	B
protein	O
is	O
membrane	O
-	O
associated	O
and	O
primarily	O
localized	O
to	O
the	O
perinuclear	O
space	O
,	O
probably	O
to	O
the	O
endoplasmic	O
reticulum	O
or	O
trans	O
-	O
Golgi	O
network	O
.	O

Characterization	O
of	O
the	O
MNAB	B
protein	O
as	O
a	O
cell	O
-	O
surface	O
DNA	O
-	O
binding	O
protein	O
,	O
critical	O
in	O
binding	O
and	O
internalization	O
of	O
extracellular	O
DNA	O
,	O
awaits	O
confirmation	O
of	O
its	O
localization	O
to	O
cell	O
surfaces	O
.	O

Cloning	O
,	O
genomic	O
organization	O
,	O
and	O
tissue	O
distribution	O
of	O
human	O
Ssf-1	B
.	O

During	O
the	O
screening	O
of	O
a	O
human	O
placenta	O
cDNA	O
library	O
,	O
realized	O
in	O
order	O
to	O
isolate	O
the	O
P2Y	O
(	O
11	O
)	O
coding	O
sequence	O
,	O
an	O
unrelated	O
cDNA	O
was	O
cloned	O
.	O

We	O
identified	O
a	O
1422	O
bp	O
open	O
reading	O
frame	O
encoding	O
a	O
human	O
protein	O
displaying	O
40	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
Saccharomyces	O
cerevisiae	O
Ssf-1	B
,	O
a	O
protein	O
involved	O
in	O
the	O
second	O
step	O
of	O
mRNA	O
splicing	O
.	O

Sequencing	O
of	O
the	O
corresponding	O
genomic	O
DNA	O
showed	O
that	O
the	O
gene	O
encoding	O
human	O
Ssf-1	B
is	O
located	O
upstream	O
to	O
the	O
P2Y	O
(	O
11	O
)	O
gene	O
on	O
chromosome	O
19p31	O
.	O

Comparison	O
of	O
the	O
cDNA	O
and	O
genomic	O
DNA	O
sequences	O
revealed	O
that	O
the	O
human	O
Ssf-1	B
gene	O
is	O
split	O
into	O
12	O
exons	O
.	O

Northern	O
blotting	O
experiments	O
showed	O
that	O
the	O
1.7	O
kb	O
Ssf-1	B
mRNA	O
presents	O
an	O
ubiquitous	O
tissue	O
expression	O
.	O

We	O
also	O
show	O
that	O
,	O
in	O
HL-60	O
human	O
promyelocytic	O
leukemia	O
cells	O
,	O
Ssf-1	B
mRNA	O
is	O
rapidly	O
upregulated	O
following	O
a	O
treatment	O
by	O
granulocyte	B
-	I
colony	I
stimulating	I
factor	I
and	O
dibutyryl	O
-	O
cyclicAMP	O
,	O
two	O
agents	O
known	O
to	O
induce	O
the	O
granulocytic	O
differentiation	O
of	O
these	O
cells	O
.	O

Regulation	O
of	O
chromatin	O
structure	O
by	O
site	O
-	O
specific	O
histone	O
H3	O
methyltransferases	O
.	O

The	O
organization	O
of	O
chromatin	O
into	O
higher	O
-	O
order	O
structures	O
influences	O
chromosome	O
function	O
and	O
epigenetic	O
gene	O
regulation	O
.	O

Higher	O
-	O
order	O
chromatin	O
has	O
been	O
proposed	O
to	O
be	O
nucleated	O
by	O
the	O
covalent	O
modification	O
of	O
histone	O
tails	O
and	O
the	O
subsequent	O
establishment	O
of	O
chromosomal	O
subdomains	O
by	O
non	O
-	O
histone	O
modifier	O
factors	O
.	O

Here	O
we	O
show	O
that	O
human	O
SUV39H1	B
and	O
murine	O
Suv39h1	B
-	O
-mammalian	O
homologues	O
of	O
Drosophila	O
Su	O
(	O
var	O
)	O
3	O
-	O
9	O
and	O
of	O
Schizosaccharomyces	O
pombe	O
clr4	O
-	O
-encode	O
histone	O
H3-specific	O
methyltransferases	O
that	O
selectively	O
methylate	O
lysine	O
9	O
of	O
the	O
amino	O
terminus	O
of	O
histone	O
H3	O
in	O
vitro	O
.	O

We	O
mapped	O
the	O
catalytic	O
motif	O
to	O
the	O
evolutionarily	O
conserved	O
SET	O
domain	O
,	O
which	O
requires	O
adjacent	O
cysteine	O
-	O
rich	O
regions	O
to	O
confer	O
histone	O
methyltransferase	O
activity	O
.	O

Methylation	O
of	O
lysine	O
9	O
interferes	O
with	O
phosphorylation	O
of	O
serine	O
10	O
,	O
but	O
is	O
also	O
influenced	O
by	O
pre	O
-	O
existing	O
modifications	O
in	O
the	O
amino	O
terminus	O
of	O
H3	O
.	O

In	O
vivo	O
,	O
deregulated	O
SUV39H1	B
or	O
disrupted	O
Suv39h	B
activity	O
modulate	O
H3	O
serine	O
10	O
phosphorylation	O
in	O
native	O
chromatin	O
and	O
induce	O
aberrant	O
mitotic	O
divisions	O
.	O

Our	O
data	O
reveal	O
a	O
functional	O
interdependence	O
of	O
site	O
-	O
specific	O
H3	O
tail	O
modifications	O
and	O
suggest	O
a	O
dynamic	O
mechanism	O
for	O
the	O
regulation	O
of	O
higher	O
-	O
order	O
chromatin	O
.	O

Isolation	O
,	O
tissue	O
distribution	O
,	O
and	O
chromosomal	O
localization	O
of	O
the	O
human	O
activation	B
-	I
induced	I
cytidine	I
deaminase	I
(	O
AID	B
)	O
gene	O
.	O

The	O
gene	O
encoding	O
activation	B
-	I
induced	I
cytidine	I
deaminase	I
(	O
AID	B
)	O
,	O
a	O
member	O
of	O
the	O
cytidine	O
deaminase	O
family	O
,	O
was	O
isolated	O
from	O
a	O
murine	O
B	O
cell	O
lymphoma	O
line	O
,	O
CH12F3	O
-	O
2	O
,	O
induced	O
by	O
combined	O
stimulation	O
of	O
TGF	O
-	O
beta	O
,	O
IL-4	B
,	O
and	O
CD40L	B
.	O

We	O
have	O
isolated	O
the	O
human	O
orthologue	O
of	O
mouse	O
AID	B
cDNA	O
,	O
which	O
has	O
an	O
open	O
reading	O
frame	O
of	O
198	O
residues	O
containing	O
a	O
conserved	O
cytidine	O
deaminase	O
motif	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
human	O
AID	B
is	O
92	O
%	O
identical	O
to	O
that	O
of	O
mouse	O
AID	B
.	O

RT	O
-	O
PCR	O
analysis	O
of	O
15	O
human	O
tissues	O
showed	O
that	O
AID	B
mRNA	O
is	O
expressed	O
strongly	O
in	O
lymph	O
nodes	O
and	O
tonsils	O
.	O

The	O
complete	O
human	O
AID	B
gene	O
consisting	O
of	O
five	O
exons	O
was	O
isolated	O
and	O
mapped	O
to	O
chromosome	O
12p13	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O

Human	O
interleukin-10-related	B
T	I
cell	I
-	I
derived	I
inducible	I
factor	I
:	O
molecular	O
cloning	O
and	O
functional	O
characterization	O
as	O
an	O
hepatocyte	O
-	O
stimulating	O
factor	O
.	O

IL-10-related	B
T	O
cell	O
-	O
derived	O
inducible	O
factor	O
(	O
IL	B
-	I
TIF	I
or	O
IL-21	B
)	O
is	O
a	O
new	O
cytokine	O
structurally	O
related	O
to	O
IL-10	B
and	O
originally	O
identified	O
in	O
the	O
mouse	O
as	O
a	O
gene	O
induced	O
by	O
IL-9	B
in	O
T	O
cells	O
and	O
mast	O
cells	O
.	O

Here	O
,	O
we	O
report	O
the	O
cloning	O
of	O
the	O
human	O
IL	B
-	I
TIF	I
cDNA	O
,	O
which	O
shares	O
79	O
%	O
amino	O
acid	O
identity	O
with	O
mouse	O
IL	B
-	I
TIF	I
and	O
25	O
%	O
identity	O
with	O
human	O
IL-10	B
.	O

Recombinant	O
human	O
IL	B
-	I
TIF	I
was	O
found	O
to	O
activate	O
signal	B
transducer	I
and	I
activator	I
of	I
transcription	I
factors-1	I
and	I
-3	I
in	O
several	O
hepatoma	O
cell	O
lines	O
.	O

IL	B
-	I
TIF	I
stimulation	O
of	O
HepG2	O
human	O
hepatoma	O
cells	O
up	O
-	O
regulated	O
the	O
production	O
of	O
acute	O
phase	O
reactants	O
such	O
as	O
serum	O
amyloid	O
A	O
,	O
alpha1-antichymotrypsin	B
,	O
and	O
haptoglobin	B
.	O

Although	O
IL-10	B
and	O
IL	B
-	I
TIF	I
have	O
distinct	O
activities	O
,	O
antibodies	O
directed	O
against	O
the	O
beta	B
chain	I
of	I
the	I
IL-10	I
receptor	I
blocked	O
the	O
induction	O
of	O
acute	O
phase	O
reactants	O
by	O
IL	B
-	I
TIF	I
,	O
indicating	O
that	O
this	O
chain	O
is	O
a	O
common	O
component	O
of	O
the	O
IL-10	B
and	O
IL	B
-	I
TIF	I
receptors	O
.	O

Similar	O
acute	O
phase	O
reactant	O
induction	O
was	O
observed	O
in	O
mouse	O
liver	O
upon	O
IL	B
-	I
TIF	I
injection	O
,	O
and	O
IL	B
-	I
TIF	I
expression	O
was	O
found	O
to	O
be	O
rapidly	O
increased	O
after	O
lipopolysaccharide	O
(	O
LPS	O
)	O
injection	O
,	O
suggesting	O
that	O
this	O
cytokine	O
contributes	O
to	O
the	O
inflammatory	O
response	O
in	O
vivo	O
.	O

Characterization	O
of	O
TCL	B
,	O
a	O
new	O
GTPase	O
of	O
the	O
rho	O
family	O
related	O
to	O
TC10	B
andCcdc42	O
.	O

GTPases	O
of	O
the	O
Rho	O
family	O
control	O
a	O
wide	O
variety	O
of	O
cellular	O
processes	O
such	O
as	O
cell	O
morphology	O
,	O
motility	O
,	O
proliferation	O
,	O
differentiation	O
,	O
and	O
apoptosis	O
.	O

We	O
report	O
here	O
the	O
characterization	O
of	O
a	O
new	O
Rho	O
member	O
,	O
which	O
shares	O
85	O
%	O
and	O
78	O
%	O
amino	O
acid	O
similarity	O
to	O
TC10	B
and	O
Cdc42	B
,	O
respectively	O
.	O

This	O
GTPase	O
,	O
termed	O
as	O
TC10-like	B
(	O
TCL	B
)	O
is	O
encoded	O
by	O
an	O
unexpectedly	O
large	O
locus	O
,	O
made	O
of	O
five	O
exons	O
spanning	O
over	O
85	O
kilobases	O
on	O
human	O
chromosome	O
14	O
.	O

TCL	B
mRNA	O
is	O
2.5	O
kilobases	O
long	O
and	O
is	O
mainly	O
expressed	O
in	O
heart	O
.	O

In	O
vitro	O
,	O
TCL	B
shows	O
rapid	O
GDP	O
/	O
GTP	O
exchange	O
and	O
displays	O
higher	O
GTP	O
dissociation	O
and	O
hydolysis	O
rates	O
than	O
TC10	B
.	O

Using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
and	O
GST	O
pull	O
-	O
down	O
assays	O
,	O
we	O
show	O
that	O
GTP	O
-	O
bound	O
but	O
not	O
GDP	O
-	O
bound	O
TCL	B
protein	O
directly	O
interacts	O
with	O
Cdc42	B
/	O
Rac	B
interacting	O
binding	O
domains	O
,	O
such	O
as	O
those	O
found	O
in	O
PAK	O
and	O
WASP	B
.	O

Despite	O
its	O
overall	O
similarity	O
to	O
TC10	B
and	O
Cdc42	B
,	O
the	O
constitutively	O
active	O
TCL	B
mutant	O
displays	O
distinct	O
morphogenic	O
activity	O
in	O
REF-52	O
fibroblasts	O
,	O
producing	O
large	O
and	O
dynamic	O
F	O
-	O
actin	O
-	O
rich	O
ruffles	O
on	O
the	O
dorsal	O
cell	O
membrane	O
.	O

Interestingly	O
,	O
TCL	B
morphogenic	O
activity	O
is	O
blocked	O
by	O
dominant	O
negative	O
Rac1	B
and	O
Cdc42	B
mutants	O
,	O
suggesting	O
a	O
cross	O
-	O
talk	O
between	O
these	O
three	O
Rho	O
GTPases	O
.	O

Complete	O
nucleotide	O
sequence	O
and	O
genomic	O
structure	O
of	B
the	O
human	O
NRAMP1	B
gene	O
region	O
on	O
chromosome	O
region	O
2q35	O
.	O

Several	O
lines	O
of	B
independent	O
evidence	O
suggest	O
that	O
human	O
Natural	B
Resistance	I
Associated	I
Macrophage	I
Protein	I
1	I
gene	O
(	O
NRAMP1	B
)	O
is	O
an	O
important	O
regulator	O
of	B
susceptibility	O
to	O
infectious	O
diseases	O
caused	O
by	O
certain	O
intracellular	O
pathogens	O
.	O

Here	O
,	O
we	O
report	O
the	O
nucleotide	O
sequence	O
of	B
32198	O
bp	O
of	B
genomic	O
DNA	O
overlapping	O
NRAMP1	B
on	O
chromosomal	O
region	O
2q35	O
.	O

The	O
NRAMP1	B
gene	O
spans	O
13604	O
bp	O
.	O

The	O
gene	O
and	O
its	O
5	O
'	O
genomic	O
region	O
are	O
highly	O
enriched	O
for	O
DNA	O
repeat	O
sequences	O
.	O

A	O
second	O
gene	O
was	O
identified	O
in	O
the	O
immediate	O
vicinity	O
of	B
NRAMP1	B
and	O
was	O
tentatively	O
named	O
Nuclear	B
LIM	I
Interactor	I
-	I
Interacting	I
Factor	I
(	O
NLI	B
-	I
IF	I
)	O
by	O
analogy	O
to	O
its	O
closest	O
ortholog	O
.	O

The	O
human	O
NLI	B
-	I
IF	I
gene	O
begins	O
4721	O
bp	O
downstream	O
of	B
the	O
NRAMP1	B
stop	O
codon	O
and	O
is	O
composed	O
of	B
seven	O
exons	O
varying	O
in	O
size	O
from	O
57	O
bp	O
to	O
1644	O
bp	O
.	O

The	O
gene	O
gives	O
rise	O
to	O
a	O
2655-bp	O
mRNA	O
transcript	O
that	O
contains	O
a	O
783-bp	O
open	O
reading	O
frame	O
.	O

The	O
predicted	O
molecular	O
weight	O
of	B
the	O
261-amino	O
acid	O
NLI	B
-	I
IF	I
protein	O
is	O
29.2	O
kDa	O
.	O

Several	O
putative	O
gene	O
regulatory	O
elements	O
were	O
identified	O
in	O
the	O
5	O
'	O
upstream	O
region	O
of	B
NLI	B
-	I
IF	I
,	O
including	O
consensus	O
binding	O
sequences	O
for	O
Sp1	B
,	O
AP-2	O
,	O
NF	O
-	O
kappa	O
B	O
,	O
and	O
PU	B
1	I
.	O

The	O
NLI	B
-	I
IF	I
amino	O
acid	O
sequence	O
has	O
homology	O
to	O
proteins	O
that	O
have	O
a	O
high	O
degree	O
of	B
homology	O
with	O
the	O
NLI	O
-	O
interacting	O
factor	O
from	O
Gallus	O
gallus	O
and	O
are	O
found	O
in	O
divergent	O
species	O
ranging	O
from	O
yeast	O
to	O
plants	O
.	O

NLI	B
-	I
IF	I
is	O
part	O
of	B
a	O
human	O
gene	O
family	O
encoding	O
four	O
related	O
proteins	O
of	B
unknown	O
function	O
.	O

Northern	O
blot	O
analysis	O
of	B
15	O
different	O
human	O
tissues	O
revealed	O
a	O
2.6-kb	O
NLI	B
-	I
IF	I
mRNA	O
that	O
was	O
ubiquitously	O
expressed	O
,	O
but	O
at	O
varying	O
levels	O
.	O

A	O
second	O
transcript	O
with	O
estimated	O
size	O
of	B
7	O
kb	O
was	O
expressed	O
only	O
in	O
the	O
placenta	O
.	O

Our	O
data	O
provide	O
new	O
sequence	O
information	O
about	O
the	O
NRAMP1	B
gene	O
region	O
that	O
will	O
be	O
useful	O
in	O
the	O
search	O
for	O
genetic	O
variants	O
causally	O
involved	O
in	O
altered	O
susceptibility	O
to	O
infectious	O
diseases	O
.	O

The	O
WFDC1	B
gene	O
encoding	O
ps20	B
localizes	O
to	O
16q24	O
,	O
a	O
region	O
of	O
LOH	O
in	O
multiple	O
cancers	O
.	O

We	O
previously	O
identified	O
ps20	B
protein	O
as	O
a	O
secreted	O
growth	O
inhibitor	O
and	O
purified	O
the	O
protein	O
from	O
fetal	O
rat	O
prostate	O
urogenital	O
sinus	O
mesenchymal	O
cell	O
conditioned	O
medium	O
.	O

The	O
rat	O
cDNA	O
was	O
subsequently	O
cloned	O
,	O
and	O
ps20	B
was	O
found	O
to	O
contain	O
a	O
WAP	O
-	O
type	O
four	O
-	O
disulfide	O
core	O
motif	O
,	O
indicating	O
it	O
may	O
function	O
as	O
a	O
protease	O
inhibitor	O
.	O

We	O
now	O
report	O
cloning	O
and	O
characterization	O
of	O
the	O
mouse	O
ps20	B
gene	O
(	O
designated	O
Wfdc1	B
)	O
,	O
the	O
human	O
homolog	O
cDNA	O
,	O
and	O
the	O
human	O
gene	O
(	O
designated	O
WFDC1	B
)	O
.	O

Both	O
the	O
mouse	O
and	O
human	O
WFDC1	B
genes	O
consist	O
of	O
seven	O
exons	O
and	O
encode	O
respective	O
ps20	B
proteins	O
sharing	O
79.1	O
%	O
identity	O
and	O
nearly	O
identical	O
WAP	O
motifs	O
in	O
exon	O
2	O
.	O

The	O
WFDC1	B
gene	O
was	O
mapped	O
by	O
FISH	O
analysis	O
to	O
human	O
Chromosome	O
(	O
Chr	O
)	O
16q24	O
,	O
an	O
area	O
of	O
frequent	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
previously	O
identified	O
in	O
multiple	O
cancers	O
including	O
prostate	O
,	O
breast	O
,	O
hepatocellular	O
,	O
and	O
Wilms	O
'	O
tumor	O
.	O

Identification	O
and	O
characterization	O
of	O
the	O
WFDC1	B
gene	O
may	O
aid	O
in	O
better	O
understanding	O
the	O
potential	O
role	O
of	O
this	O
gene	O
and	O
ps20	B
in	O
prostate	O
biology	O
and	O
carcinogenesis	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
type	O
of	O
histamine	O
receptor	O
preferentially	O
expressed	O
in	O
leukocytes	O
.	O

Recently	O
cDNA	O
encoding	O
the	O
histamine	B
H3	I
receptor	I
was	O
isolated	O
after	O
15	O
years	O
of	O
considerable	O
research	O
.	O

However	O
,	O
several	O
studies	O
have	O
proposed	O
heterogeneity	O
of	O
the	O
H3	O
receptor	O
.	O

We	O
report	O
here	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
type	O
of	O
histamine	O
receptor	O
.	O

A	O
novel	O
orphan	O
G	O
-	O
protein	O
-	O
coupled	O
receptor	O
named	O
GPRv53	B
was	O
obtained	O
through	O
a	O
search	O
of	O
the	O
human	O
genomic	O
DNA	O
data	O
base	O
and	O
analyzed	O
by	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
(	O
RACE	O
)	O
.	O

GPRv53	B
possessed	O
the	O
features	O
of	O
biologic	O
amine	O
receptors	O
and	O
had	O
the	O
highest	O
homology	O
with	O
H3	O
receptor	O
among	O
known	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
.	O

Mammalian	O
cells	O
expressing	O
GPRv53	B
were	O
demonstrated	O
to	O
bind	O
and	O
respond	O
to	O
histamine	O
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
.	O

In	O
functional	O
assays	O
,	O
not	O
only	O
an	O
H3	O
receptor	O
agonist	O
,	O
R-	O
(	O
alpha	O
)	O
-methylhistamine	O
,	O
but	O
also	O
a	O
H3	O
receptor	O
antagonist	O
,	O
clobenpropit	O
,	O
and	O
a	O
neuroleptic	O
,	O
clozapine	O
,	O
activated	O
GPRv53-expressing	B
cells	O
.	O

Tissue	O
distribution	O
analysis	O
revealed	O
that	O
expression	O
of	O
GPRv53	B
is	O
localized	O
in	O
the	O
peripheral	O
blood	O
leukocytes	O
,	O
spleen	O
,	O
thymus	O
,	O
and	O
colon	O
,	O
which	O
was	O
totally	O
different	O
from	O
the	O
H3	O
receptor	O
,	O
whose	O
expression	O
was	O
restricted	O
to	O
the	O
brain	O
.	O

The	O
discovery	O
of	O
the	O
GPRv53	B
receptor	O
will	O
open	O
a	O
new	O
phase	O
of	O
research	O
on	O
the	O
physiological	O
role	O
of	O
histamine	O
.	O

Brain	O
-	O
specific	O
expression	O
of	O
a	O
novel	O
human	O
UDP	O
-	O
GalNAc	O
:	O
polypeptide	O
N	O
-	O
acetylgalactosaminyltransferase	O
(	O
GalNAc	B
-	I
T9	I
)	O
.	O

We	O
isolated	O
cDNA	O
coding	O
for	O
the	O
ninth	O
of	O
the	O
UDP	O
-	O
GalNAc	O
:	O
polypeptide	O
N	O
-	O
acetylgalactosaminyltransferases	O
(	O
GalNAc	B
-	I
T9	I
)	O
from	O
human	O
brain	O
by	O
the	O
polymerase	O
chain	O
reaction	O
.	O

The	O
polypeptide	O
encoded	O
by	O
GalNAc	B
-	I
T9	I
contained	O
the	O
structural	O
features	O
characteristic	O
of	O
GalNAc	O
transferases	O
,	O
such	O
as	O
a	O
GT1	O
motif	O
,	O
a	O
Gal	O
/	O
GalNAc	O
transferase	O
motif	O
,	O
(	O
QXW	O
)	O
(	O
3	O
)	O
repeats	O
,	O
and	O
conserved	O
His	O
,	O
Cys	O
,	O
and	O
acidic	O
amino	O
acid	O
residues	O
.	O

Northern	O
blot	O
analysis	O
revealed	O
the	O
mRNA	O
expression	O
of	O
the	O
enzyme	O
to	O
be	O
confined	O
to	O
the	O
brain	O
.	O

The	O
brain	O
-	O
specific	O
expression	O
of	O
GalNAc	B
-	I
T9	I
suggested	O
that	O
this	O
isozyme	O
catalyzes	O
O	O
-	O
glycosylation	O
in	O
the	O
brain	O
.	O

The	O
orthologous	O
human	B
and	I
murine	I
semaphorin	I
6A-1	I
proteins	I
(	O
SEMA6A-1	B
/	O
Sema6A-1	B
)	O
bind	O
to	O
the	O
enabled	B
/	I
vasodilator	I
-	I
stimulated	I
phosphoprotein	I
-	I
like	I
protein	I
(	O
EVL	B
)	O
via	B
a	O
novel	O
carboxyl	O
-	O
terminal	O
zyxin	O
-	O
like	O
domain	O
.	O

Neuronal	O
development	O
and	O
apoptosis	O
critically	O
depend	O
on	O
the	O
transformation	O
of	O
extracellular	O
signals	O
to	O
intracellular	O
actions	O
resulting	O
in	O
cytoskeletal	O
rearrangements	O
.	O

Ena	B
/	O
VASP	B
(	O
enabled	O
/	O
vasodilator	B
-	I
stimulated	I
phosphoprotein	I
)	O
proteins	O
play	O
an	O
important	O
role	O
in	O
actin	O
and	O
filament	O
dynamics	O
,	O
whereas	O
members	O
of	O
the	O
semaphorin	O
protein	O
family	O
are	O
guidance	O
signals	O
in	O
embryo-	O
and	O
organogenesis	O
.	O

Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
novel	O
transmembranous	O
human	O
and	O
murine	O
semaphorins	O
,	O
(	B
HSA	I
)	I
SEMA6A-1	I
and	O
(	O
MMU	O
)	O
Sema6A-1	B
.	O

These	O
semaphorin	O
6	O
variants	O
directly	O
link	O
the	O
Ena	B
/	O
VASP	B
and	O
the	O
semaphorin	O
protein	O
family	O
,	O
since	O
SEMA6A-1	B
/	O
Sema6A-1	B
is	O
capable	O
of	O
a	O
selective	O
binding	O
to	O
the	O
protein	O
EVL	B
(	O
Ena	B
/	I
VASP	I
-	I
like	I
protein	I
)	O
.	O

EVL	B
is	O
the	O
third	O
member	O
of	O
the	O
Ena	B
/	O
VASP	B
family	O
of	O
proteins	O
that	O
was	O
identified	O
sharing	O
the	O
same	O
structural	O
features	O
as	O
Mena	B
(	O
mammalian	B
enabled	I
)	O
and	O
VASP	B
,	O
although	O
its	O
functionality	O
seems	O
to	O
be	O
different	O
from	O
that	O
of	O
the	O
other	O
members	O
.	O

Here	O
we	O
demonstrate	O
that	O
SEMA6A-1	B
/	O
Sema6A-1	B
is	O
colocalized	O
with	O
EVL	B
via	B
its	O
zyxin	O
-	O
like	O
carboxyl	O
-	O
terminal	O
domain	O
that	O
contains	O
a	O
modified	O
binding	O
motif	O
,	O
which	O
further	O
stresses	O
the	O
existence	O
of	O
functional	O
differences	O
between	O
EVL	B
and	O
Mena	B
/	O
VASP	B
.	O

In	O
addition	O
these	O
findings	O
suggest	O
a	O
completely	O
new	O
role	O
for	O
transmembranous	O
semaphorins	O
such	O
as	O
SEMA6A-1	B
/	O
Sema6A-1	B
in	O
retrograde	O
signaling	O
.	O

Protein	B
4.1	I
R-135	I
interacts	O
with	O
a	O
novel	O
centrosomal	O
protein	O
(	O
CPAP	B
)	O
which	O
is	O
associated	O
with	O
the	O
gamma	O
-	O
tubulin	O
complex	O
.	O

Using	O
a	O
yeast	O
two	O
-	O
hybrid	O
system	O
,	O
we	O
isolated	O
a	O
novel	O
human	O
centrosomal	O
protein	O
,	O
CPAP	B
(	O
centrosomal	O
P4.1-associated	O
protein	O
)	O
,	O
which	O
specifically	O
interacts	O
with	O
the	O
head	O
domain	O
of	O
the	O
135-kDa	B
protein	I
4.1R	I
isoform	I
(	O
4.1R-135	B
)	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
the	O
carboxyl	O
terminus	O
of	O
CPAP	B
has	O
31.3	O
%	O
amino	O
acid	O
identity	O
with	O
human	O
Tcp-10	B
(	O
a	O
t	O
-	O
complex	O
responder	O
gene	O
product	O
)	O
.	O

Interestingly	O
,	O
most	O
of	O
the	O
sequence	O
identity	O
is	O
restricted	O
to	O
two	O
conserved	O
regions	O
.	O

One	O
carries	O
a	O
leucine	O
zipper	O
,	O
which	O
may	O
form	O
a	O
series	O
of	O
heptad	O
repeats	O
involved	O
in	O
coiled	O
-	O
coil	O
formation	O
;	O
the	O
other	O
contains	O
unusual	O
glycine	O
repeats	O
with	O
unknown	O
function	O
.	O

Immunofluorescence	O
analysis	O
revealed	O
that	O
CPAP	B
and	O
gamma	O
-	O
tubulin	O
are	O
localized	O
within	O
the	O
centrosome	O
throughout	O
the	O
cell	O
cycle	O
.	O

CPAP	B
cosediments	O
with	O
gamma	O
-	O
tubulin	O
in	O
sucrose	O
gradients	O
and	O
coimmunoprecipitates	O
with	O
gamma	O
-	O
tubulin	O
,	O
indicating	O
that	O
CPAP	B
is	O
a	O
part	O
of	O
the	O
gamma	O
-	O
tubulin	O
complex	O
.	O

Furthermore	O
,	O
functional	O
analysis	O
revealed	O
that	O
CPAP	B
is	O
localized	O
within	O
the	O
center	O
of	O
microtubule	O
asters	O
and	O
may	O
participate	O
in	O
microtubule	O
nucleation	O
.	O

The	O
formation	O
of	O
microtubule	O
asters	O
was	O
significantly	O
inhibited	O
by	O
anti	O
-	O
CPAP	B
antibody	O
.	O

Together	O
,	O
these	O
observations	O
indicate	O
that	O
CPAP	B
may	O
play	O
an	O
important	O
role	O
in	O
cell	O
division	O
and	O
centrosome	O
function	O
.	O

Molecular	O
cloning	O
,	O
chromosomal	O
localization	O
,	O
tissue	O
mRNA	O
levels	O
,	O
bacterial	O
expression	O
,	O
and	O
enzymatic	O
properties	O
of	O
human	O
NMN	B
adenylyltransferase	I
.	O

A	O
1329-base	O
pair	O
clone	O
isolated	O
from	O
a	O
human	O
placenta	O
cDNA	O
library	O
contains	O
a	O
full	O
-	O
length	O
837-base	O
pair	O
coding	O
region	O
for	O
a	O
31.9-kDa	O
protein	O
whose	O
deduced	O
primary	O
structure	O
exhibits	O
high	O
homology	O
to	O
consensus	O
sequences	O
found	O
in	O
other	O
NMN	O
adenylyltransferases	O
.	O

Northern	O
blotting	O
detected	O
a	O
major	O
3.1-kilobase	O
mRNA	O
transcript	O
as	O
well	O
as	O
a	O
minor	O
4.1-kilobase	O
transcript	O
in	O
all	O
human	O
tissues	O
examined	O
.	O

In	O
several	O
cancer	O
cell	O
lines	O
,	O
lower	O
levels	O
of	O
mRNA	O
expression	O
were	O
clearly	O
evident	O
.	O

The	O
gene	O
encoding	O
the	O
human	O
enzyme	O
was	O
mapped	O
to	O
chromosome	O
band	O
1p32	O
-	O
35	O
.	O

High	O
efficiency	O
bacterial	O
expression	O
yielded	O
1.5	O
mg	O
of	O
recombinant	O
enzyme	O
/	O
liter	O
of	O
culture	O
medium	O
.	O

The	O
molecular	O
and	O
kinetic	O
properties	O
of	O
recombinant	O
human	O
NMN	B
adenylyltransferase	I
provide	O
new	O
directions	O
for	O
investigating	O
metabolic	O
pathways	O
involving	O
this	O
enzyme	O
.	O

Membrane	B
-	I
type	I
6	I
matrix	I
metalloproteinase	I
(	O
MT6-MMP	B
,	O
MMP-25	B
)	O
is	O
the	O
second	O
glycosyl	O
-	O
phosphatidyl	O
inositol	O
(	O
GPI	O
)	O
-anchored	O
MMP	O
.	O

A	O
recently	O
identified	O
membrane	B
-	I
type	I
6	I
matrix	I
metalloproteinase	I
(	O
MT6-MMP	B
)	O
has	O
a	O
hydrophobic	O
stretch	O
of	O
24	O
amino	O
acids	O
at	O
the	O
C	O
-	O
terminus	O
.	O

This	O
hydrophobicity	O
pattern	O
is	O
similar	O
to	O
glycosyl	O
-	O
phosphatidyl	O
inositol	O
(	O
GPI	O
)	O
-anchored	O
MMP	O
,	O
MT4-MMP	B
,	O
and	O
other	O
GPI	O
-	O
anchored	O
proteins	O
.	O

Thus	O
,	O
we	O
tested	O
the	O
possibility	O
that	O
MT6-MMP	B
was	O
also	O
a	O
GPI	O
-	O
anchored	O
proteinase	O
.	O

Our	O
results	O
showed	O
that	O
MT6-MMP	B
as	O
well	O
as	O
MT4-MMP	B
were	O
labeled	O
with	O
[	O
3H	O
]	O
ethanolamine	O
indicating	O
the	O
presence	O
of	O
a	O
GPI	O
unit	O
with	O
incorporated	O
label	O
.	O

In	O
addition	O
,	O
phosphatidyl	O
inositol	O
-	O
specific	O
phospholipase	O
C	O
treatment	O
released	O
MT6-MMP	B
from	O
the	O
surface	O
of	O
transfected	O
cells	O
.	O

These	O
results	O
strongly	O
indicate	O
that	O
MT6-MMP	B
is	O
a	O
GPI	O
-	O
anchored	O
protein	O
.	O

Since	O
two	O
members	O
of	O
MT	O
-	O
MMPs	O
are	O
now	O
assigned	O
as	O
GPI	O
-	O
anchored	O
proteinase	O
,	O
MT	O
-	O
MMPs	O
can	O
be	O
subgrouped	O
into	O
GPI	O
type	O
and	O
transmembrane	O
type	O
.	O

Cloning	O
,	O
localisation	O
and	O
functional	O
expression	O
of	O
a	O
novel	O
human	O
,	O
cerebellum	O
specific	O
,	O
two	O
pore	O
domain	O
potassium	O
channel	O
.	O

We	O
have	O
isolated	O
,	O
by	O
degenerate	O
PCR	O
,	O
a	O
complementary	O
DNA	O
encoding	O
a	O
novel	O
two	O
pore	O
domain	O
potassium	O
channel	O
.	O

This	O
is	O
the	O
7th	O
functional	O
member	O
of	O
the	O
human	O
tandem	O
pore	O
domain	O
potassium	O
channel	O
family	O
to	O
be	O
reported	O
.	O

It	O
has	O
an	O
open	O
reading	O
frame	O
of	O
1.125	O
kb	O
and	O
encodes	O
a	O
374	O
amino	O
acid	O
protein	O
which	O
shows	O
62	O
%	O
identity	O
to	O
the	O
human	O
TASK-1	B
gene	O
:	O
identity	O
to	O
other	O
human	O
members	O
of	O
the	O
family	O
is	O
31	O
-	O
35	O
%	O
at	O
the	O
amino	O
acid	O
level	O
.	O

We	O
believe	O
this	O
gene	O
to	O
be	O
human	O
TASK-3	B
,	O
the	O
ortholog	O
of	O
the	O
recently	O
reported	O
rat	O
TASK-3	B
gene	O
:	O
amino	O
acid	O
identity	O
between	O
the	O
two	O
is	O
74	O
%	O
.	O
'	O

Taqman	O
'	O
mRNA	O
analysis	O
demonstrated	O
a	O
very	O
specific	O
tissue	O
distribution	O
pattern	O
,	O
showing	O
human	O
TASK-3	B
mRNA	O
to	O
be	O
localised	O
largely	O
in	O
the	O
cerebellum	O
,	O
in	O
contrast	O
rat	O
TASK-3	B
was	O
reported	O
to	O
be	O
widely	O
distributed	O
.	O

We	O
have	O
shown	O
by	O
radiation	O
hybrid	O
mapping	O
that	O
human	O
TASK-3	B
can	O
be	O
assigned	O
to	O
chromosome	O
8q24.3	O
.	O

Human	O
TASK-3	B
was	O
demonstrated	O
to	O
endow	O
Xenopus	O
oocytes	O
with	O
a	O
negative	O
resting	O
membrane	O
potential	O
through	O
the	O
presence	O
of	O
a	O
large	O
K	O
(	O
+	O
)	O
selective	O
conductance	O
.	O

TASK-3	B
is	O
inhibited	O
by	O
extracellular	O
acidosis	O
with	O
a	O
mid	O
-	O
point	O
of	O
inhibition	O
around	O
pH	O
6	O
.	O

5	O
,	O
supporting	O
the	O
predictions	O
from	O
the	O
sequence	O
data	O
that	O
this	O
is	O
a	O
third	B
human	I
TASK	I
(	I
TWIK	I
-	I
related	I
acid	I
sensitive	I
K	I
(	I
+	I
)	I
channel	I
)	I
gene	I
.	O

A	O
novel	O
gene	O
,	O
MEL1	B
,	O
mapped	O
to	O
1p36.3	O
is	O
highly	O
homologous	O
to	O
the	O
MDS1	B
/	O
EVI1	B
gene	O
and	O
is	O
transcriptionally	O
activated	O
in	O
t	O
(	O
1;3	O
)	O
(	O
p36;q21	O
)	O
-positive	O
leukemia	O
cells	O
.	O

The	O
reciprocal	O
translocation	O
t	O
(	O
1;3	O
)	O
(	O
p36;q21	O
)	O
occurs	O
in	O
a	O
subset	O
of	O
myelodysplastic	O
syndrome	O
(	O
MDS	B
)	O
and	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
,	O
which	O
is	O
frequently	O
characterized	O
by	O
trilineage	O
dysplasia	O
,	O
in	O
particular	O
dysmegakaryocytopoiesis	O
,	O
and	O
poor	O
prognosis	O
.	O

Previously	O
,	O
the	O
breakpoint	O
cluster	O
region	O
(	O
BCR	O
)	O
at	O
3q21	O
was	O
identified	O
within	O
a	O
60-kilobase	O
(	O
kb	O
)	O
region	O
centromeric	O
to	O
the	O
BCR	O
of	O
3q21q26	O
syndrome	O
and	O
that	O
at	O
1p36.3	O
within	O
a	O
90-kb	O
region	O
.	O

In	O
this	O
study	O
,	O
genes	O
were	O
searched	O
near	O
the	O
breakpoints	O
at	O
1p36.3	O
,	O
and	O
a	O
novel	O
gene	O
was	O
isolated	O
that	O
encoded	O
a	O
zinc	O
finger	O
protein	O
with	O
a	O
PR	O
domain	O
,	O
which	O
is	O
highly	O
homologous	O
to	O
the	O
MDS1	B
/	O
EVI1	B
gene	O
.	O

The	O
novel	O
gene	O
,	O
designated	O
as	O
MEL1	B
(	O
MDS1	B
/	I
EVI1-like	I
gene	I
1	I
)	O
,	O
with	O
1257	O
amino	O
acid	O
residues	O
is	O
64	O
%	O
similar	O
in	O
nucleotide	O
and	O
63	O
%	O
similar	O
in	O
amino	O
acid	O
sequences	O
to	O
MDS1	B
/	O
EVI1	B
with	O
the	O
same	O
domain	O
structure	O
.	O

The	O
MEL1	B
gene	O
is	O
expressed	O
in	O
leukemia	O
cells	O
with	O
t	O
(	O
1;3	O
)	O
but	O
not	O
in	O
other	O
cell	O
lines	O
or	O
bone	O
marrow	O
,	O
spleen	O
,	O
and	O
fetal	O
liver	O
,	O
suggesting	O
that	O
MEL1	B
is	O
specifically	O
in	O
the	O
t	O
(	O
1;3	O
)	O
(	O
p36;q21	O
)	O
-positive	O
MDS	B
/	O
AML	O
.	O

On	O
the	O
basis	O
of	O
the	O
positional	O
relationship	O
between	O
the	O
EVI1	B
and	O
MEL1	B
genes	O
in	O
each	O
translocation	O
,	O
it	O
was	O
suggested	O
that	O
both	O
genes	O
are	O
transcriptionally	O
activated	O
by	O
the	O
translocation	O
of	O
the	O
3q21	O
region	O
with	O
the	O
Ribophorin	B
I	I
gene	O
.	O

Because	O
of	O
the	O
transcriptional	O
activation	O
of	O
the	O
EVI1	B
family	O
genes	O
in	O
both	O
t	O
(	O
1;3	O
)	O
(	O
p36;q21	O
)	O
-positive	O
MDS	B
/	O
AML	O
and	O
3q21q26	O
syndrome	O
,	O
it	O
is	O
suggested	O
that	O
they	O
share	O
a	O
common	O
molecular	O
mechanism	O
for	O
the	O
leukemogenic	O
transformation	O
of	O
the	O
cells	O
.	O

Bcl	B
-	I
G	I
,	O
a	O
novel	O
pro	O
-	O
apoptotic	O
member	O
of	O
the	O
Bcl-2	O
family	O
.	O

A	O
new	O
member	O
of	O
the	O
Bcl-2	O
family	O
was	O
identified	O
,	O
Bcl	B
-	I
G.	I
The	O
human	O
BCL	B
-	I
G	I
gene	O
consists	O
of	O
6	O
exons	O
,	O
resides	O
on	O
chromosome	O
12p12	O
,	O
and	O
encodes	O
two	O
proteins	O
through	O
alternative	O
mRNA	O
splicing	O
,	O
Bcl	B
-	I
G	I
(	I
L	I
)	I
(	O
long	O
)	O
and	O
Bcl	B
-	I
G	I
(	I
S	I
)	I
(	O
short	O
)	O
consisting	O
of	O
327	O
and	O
252	O
amino	O
acids	O
in	O
length	O
,	O
respectively	O
.	O

Bcl	B
-	I
G	I
(	I
L	I
)	I
and	O
Bcl	B
-	I
G	I
(	I
S	I
)	I
have	O
identical	O
sequences	O
for	O
the	O
first	O
226	O
amino	O
acids	O
but	O
diverge	O
thereafter	O
.	O

Among	O
the	O
Bcl-2	O
homology	O
(	O
BH	O
)	O
domains	O
previously	O
recognized	O
in	O
Bcl-2	O
family	O
proteins	O
,	O
the	O
BH3	O
domain	O
is	O
found	O
in	O
both	O
Bcl	B
-	I
G	I
(	I
L	I
)	I
and	O
Bcl	B
-	I
G	I
(	I
S	I
)	I
,	O
but	O
only	O
the	O
longer	O
Bcl	B
-	I
G	I
(	I
L	I
)	I
protein	O
possesses	O
a	O
BH2	O
domain	O
.	O

Bcl	B
-	I
G	I
(	I
L	I
)	I
mRNA	O
is	O
expressed	O
widely	O
in	O
adult	O
human	O
tissues	O
,	O
whereas	O
Bcl	B
-	I
G	I
(	I
S	I
)	I
mRNA	O
was	O
found	O
only	O
in	O
testis	O
.	O

Overexpression	O
of	O
Bcl	B
-	I
G	I
(	I
L	I
)	I
or	O
Bcl	B
-	I
G	I
(	I
S	I
)	I
in	O
cells	O
induced	O
apoptosis	O
although	O
Bcl	B
-	I
G	I
(	I
S	I
)	I
was	O
far	O
more	O
potent	O
than	O
Bcl	B
-	I
G	I
(	I
L	I
)	I
.	O

Apoptosis	O
induction	O
by	O
Bcl	B
-	I
G	I
(	I
S	I
)	I
depended	O
on	O
the	O
BH3	O
domain	O
and	O
was	O
suppressed	O
by	O
coexpression	O
of	O
anti	O
-	O
apoptotic	O
Bcl	B
-	I
X	I
(	I
L	I
)	I
protein	O
.	O

Bcl	B
-	I
X	I
(	I
L	I
)	I
also	O
coimmunoprecipitated	O
with	O
Bcl	B
-	I
G	I
(	I
S	I
)	I
but	O
not	O
with	O
mutants	O
of	O
Bcl	B
-	I
G	I
(	I
S	I
)	I
in	O
which	O
the	O
BH3	O
domain	O
was	O
deleted	O
or	O
mutated	O
or	O
with	O
Bcl	B
-	I
G	I
(	I
L	I
)	I
.	O

Bcl	B
-	I
G	I
(	I
S	I
)	I
was	O
predominantly	O
localized	O
to	O
cytosolic	O
organelles	O
,	O
whereas	O
Bcl	B
-	I
G	I
(	I
L	I
)	I
was	O
diffusely	O
distributed	O
throughout	O
the	O
cytosol	O
.	O

A	O
mutant	O
of	O
Bcl	B
-	I
G	I
(	I
L	I
)	I
in	O
which	O
the	O
BH2	O
domain	O
was	O
deleted	O
displayed	O
increased	O
apoptotic	O
activity	O
and	O
coimmunoprecipitated	O
with	O
Bcl	B
-	I
X	I
(	I
L	I
)	I
,	O
suggesting	O
that	O
the	O
BH2	O
domain	O
autorepresses	O
Bcl	B
-	I
G	I
(	I
L	I
)	I
.	O

Rab6c	B
,	O
a	O
new	O
member	O
of	O
the	O
rab	O
gene	O
family	O
,	O
is	O
involved	O
in	O
drug	O
resistance	O
in	O
MCF7	O
/	O
AdrR	O
cells	O
.	O

A	O
new	O
Rab6	B
homolog	O
cDNA	O
,	O
Rab6c	B
,	O
was	O
discovered	O
by	O
a	O
hypermethylated	O
DNA	O
fragment	O
probe	O
that	O
was	O
isolated	O
from	O
a	O
human	O
multidrug	O
resistant	O
(	O
MDR	O
)	O
breast	O
cancer	O
cell	O
line	O
,	O
MCF7	O
/	O
AdrR	O
,	O
by	O
the	O
methylation	O
sensitive	O
-	O
representational	O
difference	O
analysis	O
(	O
MS	O
-	O
RDA	O
)	O
technique	O
.	O

Rab6c	B
was	O
found	O
to	O
be	O
under	O
-	O
expressed	O
in	O
MCF7	O
/	O
AdrR	O
and	O
MES	O
-	O
SA	O
/	O
Dx5	O
(	O
a	O
human	O
MDR	O
uterine	O
sarcoma	O
cell	O
line	O
)	O
compared	O
with	O
their	O
non	O
-	O
MDR	O
parental	O
cell	O
lines	O
.	O

MCF7	O
/	O
AdrR	O
cells	O
expressing	O
the	O
exogenous	O
Rab6c	B
exhibited	O
less	O
resistance	O
to	O
several	O
anti	O
-	O
cancer	O
drugs	O
,	O
such	O
as	O
doxorubicin	O
(	O
DOX	O
)	O
,	O
taxol	O
,	O
vinblastine	O
,	O
and	O
vincristine	O
,	O
than	O
the	O
control	O
cells	O
containing	O
the	O
empty	O
vector	O
.	O

Flow	O
cytometry	O
experiments	O
confirmed	O
that	O
the	O
transfectants	O
'	O
diminished	O
resistance	O
to	O
DOX	O
was	O
caused	O
by	O
increased	O
drug	O
accumulation	O
induced	O
by	O
the	O
exogenous	O
Rab6c	B
.	O

These	O
results	O
indicate	O
that	O
Rab6c	B
is	O
involved	O
in	O
drug	O
resistance	O
in	O
MCF7	O
/	O
AdrR	O
cells	O
.	O

Genomic	O
organization	O
of	B
the	O
JEM-1	B
(	O
BLZF1	B
)	O
gene	O
on	O
human	O
chromosome	O
1q24	O
:	O
molecular	O
cloning	O
and	O
analysis	O
of	B
its	O
promoter	O
region	O
.	O

The	O
Jem-1	B
(	O
JEM-1	B
,	O
HGMW	O
-	O
approved	O
symbol	O
BLZF1	B
)	O
gene	O
mapping	O
to	O
human	O
chromosome	O
1q24	O
codes	O
for	O
a	O
ubiquitously	O
expressed	O
3-kb	O
mRNA	O
,	O
translated	O
in	O
a	O
45-kDa	O
nuclear	O
protein	O
.	O

Recent	O
studies	O
have	O
shown	O
a	O
deficient	O
expression	O
of	B
this	O
gene	O
in	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
.	O

However	O
,	O
treatment	O
with	O
retinoids	O
was	O
able	O
to	O
upregulate	O
JEM-1	B
mRNA	O
in	O
maturing	O
NB4	O
leukemia	O
cells	O
.	O

Here	O
,	O
we	O
report	O
the	O
characterization	O
of	B
the	O
structural	O
organization	O
of	B
JEM-1	B
.	O

By	O
hybridization	O
screening	O
of	B
a	O
human	O
genomic	O
library	O
derived	O
from	O
blood	O
mononuclear	O
cells	O
,	O
five	O
overlapping	O
genomic	O
DNA	O
clones	O
were	O
isolated	O
.	O

These	O
clones	O
extend	O
over	O
34	O
kb	O
of	B
the	O
human	O
genome	O
and	O
comprise	O
the	O
complete	O
JEM-1	B
gene	O
and	O
a	O
4-kb	O
5'flanking	O
region	O
.	O

Determination	O
of	B
the	O
exon	O
-	O
intron	O
structure	O
of	B
Jem-1	B
revealed	O
seven	O
exons	O
whose	O
junctions	O
with	O
introns	O
exhibited	O
typical	O
splice	O
sequences	O
.	O

A	O
shorter	O
transcript	O
(	O
Jem-1s	B
,	O
1.3	O
kb	O
)	O
generated	O
by	O
exon	O
3	O
extension	O
and	O
polyadenylation	O
was	O
identified	O
.	O

Its	O
translation	O
generated	O
a	O
23-kDa	O
protein	O
that	O
exhibited	O
a	O
cytoplasmic	O
localization	O
.	O

5'RACE	O
-	O
PCR	O
identified	O
a	O
major	O
transcription	O
start	O
site	O
(	O
TSS	O
)	O
located	O
at	O
403	O
nt	O
upstream	O
of	B
the	O
ATG	O
.	O

Computer	O
analysis	O
of	B
the	O
1	O
.	O

8-kb	O
5'flanking	O
region	O
showed	O
that	O
it	O
lacks	O
a	O
TATA	O
box	O
,	O
Inr	O
motifs	O
or	O
DPE	O
motifs	O
,	O
but	O
it	O
contains	O
a	O
typical	O
CCAAT	O
box	O
located	O
95	O
bp	O
upstream	O
of	B
the	O
TSS	O
.	O

Sequencing	O
also	O
revealed	O
potential	O
cis	O
-	O
acting	O
elements	O
for	O
multiple	O
transcription	O
regulators	O
including	O
Sp1	B
,	O
GATA	O
,	O
C	O
/	O
EBP	O
,	O
AP-1	O
,	O
and	O
Pu1	B
.	O

No	O
retinoic	O
acid	O
receptor	O
elements	O
or	O
retinoic	O
X	O
receptor	O
elements	O
were	O
detected	O
.	O

This	O
1.8-kb	O
DNA	O
sequence	O
showed	O
a	O
strong	O
constitutive	O
promoter	O
activity	O
determined	O
by	O
a	O
luciferase	O
-	O
reporter	O
gene	O
assay	O
in	O
transiently	O
transfected	O
HeLa	O
cells	O
.	O

Retinoids	O
further	O
increased	O
luciferase	O
expression	O
2.7-fold	O
.	O

We	O
demonstrated	O
that	O
the	O
1-kb	O
distal	O
sequence	O
contains	O
yet	O
unidentified	O
elements	O
reducing	O
constitutive	O
transcription	O
.	O

Thus	O
,	O
the	O
maximal	O
constitutive	O
promoter	O
activity	O
was	O
assigned	O
to	O
a	O
-432	O
+	O
101	O
region	O
overlapping	O
the	O
TSS	O
.	O

These	O
data	O
support	O
the	O
idea	O
of	B
a	O
constitutive	O
expression	O
of	B
JEM-1	B
,	O
but	O
a	O
negative	O
regulation	O
in	O
APL	O
released	O
by	O
retinoids	O
.	O

The	O
Fanconi	O
anemia	O
protein	O
FANCF	B
forms	O
a	O
nuclear	O
complex	O
with	O
FANCA	B
,	O
FANCC	B
and	O
FANCG	B
.	O

Fanconi	O
anemia	O
(	O
FA	B
)	O
is	O
a	O
chromosomal	O
instability	O
syndrome	O
associated	O
with	O
a	O
strong	O
predisposition	O
to	O
cancer	O
,	O
particularly	O
acute	O
myeloid	O
leukemia	O
and	O
squamous	O
cell	O
carcinoma	O
.	O

At	O
the	O
cellular	O
level	O
,	O
FA	B
is	O
characterized	O
by	O
spontaneous	O
chromosomal	O
breakage	O
and	O
a	O
unique	O
hypersensitivity	O
to	O
DNA	O
cross	O
-	O
linking	O
agents	O
.	O

Complementation	O
analysis	O
has	O
indicated	O
that	O
at	O
least	O
seven	O
distinct	O
genes	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
FA	B
.	O

Despite	O
the	O
identification	O
of	O
four	O
of	O
these	O
genes	O
(	O
FANCA	B
,	O
FANCC	B
,	O
FANCF	B
and	O
FANCG	B
)	O
,	O
the	O
nature	O
of	O
the	O
'	O
FA	B
pathway	O
'	O
has	O
remained	O
enigmatic	O
,	O
as	O
the	O
FA	B
proteins	O
lack	O
sequence	O
homologies	O
or	O
motifs	O
that	O
could	O
point	O
to	O
a	O
molecular	O
function	O
.	O

To	O
further	O
define	O
this	O
pathway	O
,	O
we	O
studied	O
the	O
subcellular	O
localizations	O
and	O
mutual	O
interactions	O
of	O
the	O
FA	B
proteins	O
,	O
including	O
the	O
recently	O
identified	O
FANCF	B
protein	O
,	O
in	O
human	O
lymphoblasts	O
.	O

FANCF	B
was	O
found	O
predominantly	O
in	O
the	O
nucleus	O
,	O
where	O
it	O
complexes	O
with	O
FANCA	B
,	O
FANCC	B
and	O
FANCG	B
.	O

These	O
interactions	O
were	O
detected	O
in	O
wild	O
-	O
type	O
and	O
FA	B
-	O
D	O
lymphoblasts	O
,	O
but	O
not	O
in	O
lymphoblasts	O
of	O
other	O
FA	B
complementation	O
groups	O
.	O

This	O
implies	O
that	O
each	O
of	O
the	O
FA	B
proteins	O
,	O
except	O
FANCD	O
,	O
is	O
required	O
for	O
these	O
complexes	O
to	O
form	O
.	O

Similarly	O
,	O
we	O
show	O
that	O
the	O
interaction	O
between	O
FANCA	B
and	O
FANCC	B
is	O
restricted	O
to	O
wild	O
-	O
type	O
and	O
FA	B
-	O
D	O
cells	O
.	O

Furthermore	O
,	O
we	O
document	O
the	O
subcellular	O
localization	O
of	O
FANCA	B
and	O
the	O
FANCA	B
/	O
FANCG	B
complex	O
in	O
all	O
FA	B
complementation	O
groups	O
.	O

Our	O
results	O
,	O
along	O
with	O
published	O
data	O
,	O
culminate	O
in	O
a	O
model	O
in	O
which	O
a	O
multi	O
-	O
protein	O
FA	B
complex	O
serves	O
a	O
nuclear	O
function	O
to	O
maintain	O
genomic	O
integrity	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
DEFCAP	B
-	I
L	I
and	I
-S	I
,	O
two	O
isoforms	O
of	O
a	O
novel	O
member	O
of	O
the	O
mammalian	O
Ced-4	O
family	O
of	O
apoptosis	O
proteins	O
.	O

We	O
report	O
the	O
deduced	O
amino	O
acid	O
sequences	O
of	O
two	O
alternately	O
spliced	O
isoforms	O
,	O
designated	O
DEFCAP	B
-	I
L	I
and	I
-S	I
,	O
that	O
differ	O
in	O
44	O
amino	O
acids	O
and	O
encode	O
a	O
novel	O
member	O
of	O
the	O
mammalian	O
Ced-4	O
family	O
of	O
apoptosis	O
proteins	O
.	O

Similar	O
to	O
the	O
other	O
mammalian	O
Ced-4	O
proteins	O
(	O
Apaf-1	B
and	O
Nod1	B
)	O
,	O
DEFCAP	B
contains	O
a	O
caspase	O
recruitment	O
domain	O
(	O
CARD	O
)	O
and	O
a	O
putative	O
nucleotide	O
binding	O
domain	O
,	O
signified	O
by	O
a	O
consensus	O
Walker	O
's	O
A	O
box	O
(	O
P	O
-	O
loop	O
)	O
and	O
B	O
box	O
(	O
Mg	O
(	O
2+	O
)	O
-binding	O
site	O
)	O
.	O

Like	O
Nod1	B
,	O
but	O
different	O
from	O
Apaf-1	B
,	O
DEFCAP	B
contains	O
a	O
putative	O
regulatory	O
domain	O
containing	O
multiple	O
leucine	O
-	O
rich	O
repeats	O
(	O
LRR	O
)	O
.	O

However	O
,	O
a	O
distinguishing	O
feature	O
of	O
the	O
primary	O
sequence	O
of	O
DEFCAP	B
is	O
that	O
DEFCAP	B
contains	O
at	O
its	O
NH	O
(	O
2	O
)	O
terminus	O
a	O
pyrin	O
-	O
like	O
motif	O
and	O
a	O
proline	O
-	O
rich	O
sequence	O
,	O
possibly	O
involved	O
in	O
protein	O
-	O
protein	O
interactions	O
with	O
Src	O
homology	O
domain	O
3-containing	O
proteins	O
.	O

By	O
using	O
in	O
vitro	O
coimmunoprecipitation	O
experiments	O
,	O
both	O
long	O
and	O
short	O
isoforms	O
were	O
capable	O
of	O
strongly	O
interacting	O
with	O
caspase-2	B
and	O
exhibited	O
a	O
weaker	O
interaction	O
with	O
caspase-9	B
.	O

Transient	O
overexpression	O
of	O
full	O
-	O
length	O
DEFCAP	B
-	I
L	I
,	O
but	O
not	O
DEFCAP	B
-	I
S	I
,	O
in	O
breast	O
adenocarcinoma	O
cells	O
MCF7	O
resulted	O
in	O
significant	O
levels	O
of	O
apoptosis	O
.	O

In	O
vitro	O
death	O
assays	O
with	O
transient	O
overexpression	O
of	O
deletion	O
constructs	O
of	O
both	O
isoforms	O
using	O
beta	O
-	O
galactosidase	O
as	O
a	O
reporter	O
gene	O
in	O
MCF7	O
cells	O
suggest	O
the	O
following	O
:	O
1	O
)	O
the	O
nucleotide	O
binding	O
domain	O
may	O
act	O
as	O
a	O
negative	O
regulator	O
of	O
the	O
killing	O
activity	O
of	O
DEFCAP	B
;	O
2	O
)	O
the	O
LRR	O
/	O
CARD	O
represents	O
a	O
putative	O
constitutively	O
active	O
inducer	O
of	O
apoptosis	O
;	O
3	O
)	O
the	O
killing	O
activity	O
of	O
LRR	O
/	O
CARD	O
is	O
inhibitable	O
by	O
benzyloxycarbonyl	O
-	O
Val	O
-	O
Ala	O
-	O
Asp	O
(	O
OMe	O
)	O
-fluoromethyl	O
ketone	O
and	O
to	O
a	O
lesser	O
extent	O
by	O
Asp	O
-	O
Glu	O
-	O
Val	O
-	O
Asp	O
(	O
OMe	O
)	O
-fluoromethyl	O
ketone	O
;	O
and	O
4	O
)	O
the	O
CARD	O
is	O
critical	O
for	O
killing	O
activity	O
of	O
DEFCAP	B
.	O

These	O
results	O
suggest	O
that	O
DEFCAP	B
is	O
a	O
novel	O
member	O
of	O
the	O
mammalian	O
Ced-4	O
family	O
of	O
proteins	O
capable	O
of	O
inducing	O
apoptosis	O
,	O
and	O
understanding	O
its	O
regulation	O
may	O
elucidate	O
the	O
complex	O
nature	O
of	O
the	O
mammalian	O
apoptosis	O
-	O
promoting	O
machinery	O
.	O

Interleukin	B
21	I
and	O
its	O
receptor	O
are	O
involved	O
in	O
NK	O
cell	O
expansion	O
and	O
regulation	O
of	O
lymphocyte	O
function	O
.	O

Cytokines	O
are	O
important	O
in	O
the	O
regulation	O
of	O
haematopoiesis	O
and	O
immune	O
responses	O
,	O
and	O
can	O
influence	O
lymphocyte	O
development	O
.	O

Here	O
we	O
have	O
identified	O
a	O
class	O
I	O
cytokine	O
receptor	O
that	O
is	O
selectively	O
expressed	O
in	O
lymphoid	O
tissues	O
and	O
is	O
capable	O
of	O
signal	O
transduction	O
.	O

The	O
full	O
-	O
length	O
receptor	O
was	O
expressed	O
in	O
BaF3	O
cells	O
,	O
which	O
created	O
a	O
functional	O
assay	O
for	O
ligand	O
detection	O
and	O
cloning	O
.	O

Conditioned	O
media	O
from	O
activated	O
human	O
CD3	O
+	O
T	O
cells	O
supported	O
proliferation	O
of	O
the	O
assay	O
cell	O
line	O
.	O

We	O
constructed	O
a	O
complementary	O
DNA	O
expression	O
library	O
from	O
activated	O
human	O
CD3	O
+	O
T	O
cells	O
,	O
and	O
identified	O
a	O
cytokine	O
with	O
a	O
four	O
-	O
helix	O
-	O
bundle	O
structure	O
using	O
functional	O
cloning	O
.	O

This	O
cytokine	O
is	O
most	O
closely	O
related	O
to	O
IL2	B
and	O
IL15	B
,	O
and	O
has	O
been	O
designated	O
IL21	B
with	O
the	O
receptor	O
designated	O
IL21	B
R.	I
In	O
vitro	O
assays	O
suggest	O
that	O
IL21	B
has	O
a	O
role	O
in	O
the	O
proliferation	O
and	O
maturation	O
of	O
natural	O
killer	O
(	O
NK	O
)	O
cell	O
populations	O
from	O
bone	O
marrow	O
,	O
in	O
the	O
proliferation	O
of	O
mature	O
B	O
-	O
cell	O
populations	O
co	O
-	O
stimulated	O
with	O
anti	O
-	O
CD40	O
,	O
and	O
in	O
the	O
proliferation	O
of	O
T	O
cells	O
co	O
-	O
stimulated	O
with	O
anti	O
-	O
CD3	O
.	O

The	O
novel	O
Rho	B
-	I
family	I
GTPase	I
rif	I
regulates	O
coordinated	O
actin	O
-	O
based	O
membrane	O
rearrangements	O
.	O

Small	O
GTPases	O
of	O
the	O
Rho	O
family	O
have	O
a	O
critical	O
role	O
in	O
controlling	O
cell	O
morphology	O
,	O
motility	O
and	O
adhesion	O
through	O
dynamic	O
regulation	O
of	O
the	O
actin	O
cytoskeleton	O
[	O
1,2	O
]	O
.	O

Individual	O
Rho	O
GTPases	O
have	O
been	O
shown	O
to	O
regulate	O
distinct	O
components	O
of	O
the	O
cytoskeletal	O
architecture	O
;	O
RhoA	B
stimulates	O
the	O
bundling	O
of	O
actin	O
filaments	O
into	O
stress	O
fibres	O
[	O
3	O
]	O
,	O
Rac	O
reorganises	O
actin	O
to	O
produce	O
membrane	O
sheets	O
or	O
lamellipodia	O
[	O
4	O
]	O
and	O
Cdc42	B
causes	O
the	O
formation	O
of	O
thin	O
,	O
actin	O
-	O
rich	O
surface	O
projections	O
called	O
filopodia	O
[	O
5	O
]	O
.	O

We	O
have	O
isolated	O
a	O
new	O
Rho	O
-	O
family	O
GTPase	O
,	O
Rif	B
(	O
Rho	B
in	I
filopodia	I
)	O
,	O
and	O
shown	O
that	O
it	O
represents	O
an	O
alternative	O
signalling	O
route	O
to	O
the	O
generation	O
of	O
filopodial	O
structures	O
.	O

Coordinated	O
regulation	O
of	O
Rho	O
-	O
family	O
GTPases	O
can	O
be	O
used	O
to	O
generate	O
more	O
complicated	O
actin	O
rearrangements	O
,	O
such	O
as	O
those	O
underlying	O
cell	O
migration	O
[	O
6	O
]	O
.	O

In	O
addition	O
to	O
inducing	O
filopodia	O
,	O
Rif	B
functions	O
cooperatively	O
with	O
Cdc42	B
and	O
Rac	O
to	O
generate	O
additional	O
structures	O
,	O
increasing	O
the	O
diversity	O
of	O
actin	O
-	O
based	O
morphology	O
.	O

Mitomycin	O
C	O
resistance	O
induced	O
by	O
TCF-3	B
overexpression	O
in	O
gastric	O
cancer	O
cell	O
line	O
MKN28	O
is	O
associated	O
with	O
DT	B
-	I
diaphorase	I
down	O
-	O
regulation	O
.	O

TCF	O
transcription	O
factors	O
are	O
mediators	O
of	O
the	O
WNT	O
signaling	O
pathway	O
and	O
are	O
antagonized	O
by	O
the	O
transforming	O
growth	O
factor	O
beta	O
signaling	O
pathway	O
.	O

Here	O
human	O
TCF-3	B
has	O
been	O
cloned	O
and	O
characterized	O
.	O

Differential	O
expression	O
analyses	O
of	O
TCF	O
genes	O
in	O
gastric	O
cancer	O
revealed	O
that	O
TCF-1	B
was	O
expressed	O
in	O
most	O
cases	O
of	O
primary	O
gastric	O
cancer	O
at	O
almost	O
the	O
same	O
level	O
as	O
in	O
normal	O
gastric	O
mucosa	O
and	O
that	O
TCF-3	B
was	O
occasionally	O
up	O
-	O
regulated	O
in	O
primary	O
gastric	O
cancer	O
.	O

The	O
TCF-3	B
expression	O
vector	O
was	O
transfected	O
to	O
gastric	O
cancer	O
cell	O
line	O
MKN28	O
to	O
establish	O
stable	O
transformants	O
.	O

Three	O
independent	O
MKN28	O
transformants	O
overexpressing	O
TCF-3	B
showed	O
about	O
8-fold	O
resistance	O
to	O
mitomycin	O
C	O
(	O
MMC	O
;	O
IC50	O
,	O
2.4	O
microg	O
/	O
ml	O
)	O
compared	O
with	O
MKN28	O
vector	O
transfectants	O
(	O
IC50	O
=	O
0.3	O
microg	O
/	O
ml	O
)	O
.	O

Among	O
the	O
10	O
drug	O
resistance	O
-	O
associated	O
genes	O
examined	O
in	O
this	O
study	O
,	O
the	O
DT	B
-	I
diaphorase	I
(	O
DTD	B
)	O
gene	O
was	O
down	O
-	O
regulated	O
in	O
three	O
MKN28	O
transformants	O
overexpressing	O
TCF-3	B
.	O

DTD	B
mRNA	O
was	O
also	O
down	O
-	O
regulated	O
in	O
primary	O
gastric	O
cancer	O
with	O
TCF-3	B
up	O
-	O
regulation	O
.	O

In	O
addition	O
,	O
DTD	B
protein	O
was	O
down	O
-	O
regulated	O
in	O
three	O
MKN28	O
transformants	O
overexpressing	O
TCF-3	B
compared	O
with	O
MKN28	O
vector	O
transfectants	O
.	O

DTD	B
is	O
implicated	O
in	O
the	O
activation	O
of	O
MMC	O
in	O
target	O
cells	O
,	O
and	O
DTD	B
down	O
-	O
regulation	O
explains	O
MMC	O
resistance	O
.	O

MMC	O
resistance	O
induced	O
by	O
TCF-3	B
overexpression	O
is	O
probably	O
due	O
to	O
DTD	B
down	O
-	O
regulation	O
,	O
which	O
might	O
provide	O
a	O
possible	O
target	O
for	O
new	O
therapy	O
of	O
drug	O
-	O
resistant	O
gastric	O
cancer	O
.	O

betaIV	B
spectrin	I
,	O
a	O
new	O
spectrin	O
localized	O
at	O
axon	O
initial	O
segments	O
and	O
nodes	O
of	O
ranvier	O
in	O
the	O
central	O
and	O
peripheral	O
nervous	O
system	O
.	O

We	O
report	O
the	O
identification	O
of	O
betaIV	B
spectrin	I
,	O
a	O
novel	O
spectrin	O
isolated	O
as	O
an	O
interactor	O
of	O
the	O
receptor	B
tyrosine	I
phosphatase	I
-	I
like	I
protein	I
ICA512	I
.	O

The	O
betaIV	B
spectrin	I
gene	O
is	O
located	O
on	O
human	O
and	O
mouse	O
chromosomes	O
19q13.13	O
and	O
7b2	O
,	O
respectively	O
.	O

Alternative	O
splicing	O
of	O
betaIV	B
spectrin	I
generates	O
at	O
least	O
four	O
distinct	O
isoforms	O
,	O
numbered	O
betaIVSigma1-betaIVSigma4	B
spectrin	I
.	O

The	O
longest	O
isoform	O
(	O
betaIVSigma1	B
spectrin	I
)	O
includes	O
an	O
actin	O
-	O
binding	O
domain	O
,	O
followed	O
by	O
17	O
spectrin	O
repeats	O
,	O
a	O
specific	O
domain	O
in	O
which	O
the	O
amino	O
acid	O
sequence	O
ERQES	O
is	O
repeated	O
four	O
times	O
,	O
several	O
putative	O
SH3-binding	O
sites	O
and	O
a	O
pleckstrin	O
homology	O
domain	O
.	O

betaIVSigma2	B
and	I
betaIVSigma3	I
spectrin	I
encompass	O
the	O
NH	O
(	O
2	O
)	O
-	O
and	O
COOH	O
-	O
terminal	O
halves	O
of	O
betaIVSigma1	B
spectrin	I
,	O
respectively	O
,	O
while	O
betaIVSigma4	B
spectrin	I
lacks	O
the	O
ERQES	O
and	O
the	O
pleckstrin	O
homology	O
domain	O
.	O

Northern	O
blots	O
revealed	O
an	O
abundant	O
expression	O
of	O
betaIV	B
spectrin	I
transcripts	O
in	O
brain	O
and	O
pancreatic	O
islets	O
.	O

By	O
immunoblotting	O
,	O
betaIVSigma1	B
spectrin	I
is	O
recognized	O
as	O
a	O
protein	O
of	O
250	O
kD.	O
Anti	O
-	O
betaIV	B
spectrin	I
antibodies	O
also	O
react	O
with	O
two	O
additional	O
isoforms	O
of	O
160	O
and	O
140	O
kD.	O
These	O
isoforms	O
differ	O
from	O
betaIVSigma1	B
spectrin	I
in	O
terms	O
of	O
their	O
distribution	O
on	O
subcellular	O
fractionation	O
,	O
detergent	O
extractability	O
,	O
and	O
phosphorylation	O
.	O

In	O
islets	O
,	O
the	O
immunoreactivity	O
for	O
betaIV	B
spectrin	I
is	O
more	O
prominent	O
in	O
alpha	O
than	O
in	O
beta	O
cells	O
.	O

In	O
brain	O
,	O
betaIV	B
spectrin	I
is	O
enriched	O
in	O
myelinated	O
neurons	O
,	O
where	O
it	O
colocalizes	O
with	O
ankyrin	B
(	I
G	I
)	I
480	I
/	I
270-kD	I
at	O
axon	O
initial	O
segments	O
and	O
nodes	O
of	O
Ranvier	O
.	O

Likewise	O
,	O
betaIV	B
spectrin	I
is	O
concentrated	O
at	O
the	O
nodes	O
of	O
Ranvier	O
in	O
the	O
rat	O
sciatic	O
nerve	O
.	O

In	O
the	O
rat	O
hippocampus	O
,	O
betaIVSigma1	B
spectrin	I
is	O
detectable	O
from	O
embryonic	O
day	O
19	O
,	O
concomitantly	O
with	O
the	O
appearance	O
of	O
immunoreactivity	O
at	O
the	O
initial	O
segments	O
.	O

Thus	O
,	O
we	O
suggest	O
that	O
betaIVSigma1	B
spectrin	I
interacts	O
with	O
ankyrin	B
(	I
G	I
)	I
480	I
/	I
270-kD	I
and	O
participates	O
in	O
the	O
clustering	O
of	O
voltage	O
-	O
gated	O
Na	O
(	O
+	O
)	O
channels	O
and	O
cell	O
-	O
adhesion	O
molecules	O
at	O
initial	O
segments	O
and	O
nodes	O
of	O
Ranvier	O
.	O

Characterization	O
of	O
C14orf4	B
,	O
a	O
novel	O
intronless	O
human	O
gene	O
containing	O
a	O
polyglutamine	O
repeat	O
,	O
mapped	O
to	O
the	O
ARVD1	B
critical	O
region	O
.	O

Within	O
the	O
ARVD1	B
(	O
arrhythmogenic	O
right	O
ventricular	O
dysplasia	O
/	O
cardiomyopathy	O
,	O
type	O
1	O
)	O
critical	O
region	O
,	O
mapped	O
to	O
14q24.3	O
,	O
we	O
detected	O
an	O
intronless	O
gene	O
of	O
4859	O
bp	O
,	O
predominantly	O
expressed	O
in	O
the	O
heart	O
tissue	O
.	O

This	O
gene	O
encodes	O
a	O
796-amino	O
-	O
acid	O
,	O
proline	O
-	O
rich	O
protein	O
showing	O
polyglutamine	O
and	O
polyalanine	O
tracks	O
with	O
variable	O
length	O
at	O
the	O
N	O
-	O
terminus	O
and	O
a	O
C3HC4	O
RING	O
finger	O
domain	O
at	O
the	O
C	O
-	O
terminus	O
.	O

CREB	O
and	O
AP-2	O
binding	O
sites	O
are	O
present	O
in	O
the	O
promoter	O
region	O
.	O

The	O
5	O
'	O
flanking	O
region	O
contains	O
neither	O
a	O
TATA	O
box	O
nor	O
a	O
CAAT	O
box	O
,	O
but	O
it	O
is	O
high	O
in	O
GC	O
content	O
and	O
includes	O
several	O
Sp1	O
binding	O
sites	O
.	O

Protein	O
similarity	O
searches	O
revealed	O
a	O
significant	O
match	O
between	O
the	O
C	O
-	O
terminus	O
and	O
a	O
human	O
hypothetical	O
protein	O
,	O
whose	O
gene	O
is	O
located	O
on	O
the	O
chromosome	O
19	O
long	O
arm	O
.	O

The	O
predicted	O
protein	O
shows	O
PEST	O
sequences	O
,	O
suggesting	O
its	O
rapid	O
degradation	O
.	O

The	O
novel	O
intronless	O
gene	O
,	O
provisionally	O
named	O
C14orf4	B
and	O
probably	O
encoding	O
a	O
nuclear	O
protein	O
,	O
was	O
excluded	O
from	O
being	O
the	O
ARVD1	B
gene	O
.	O

Three	O
novel	O
components	O
of	O
the	O
human	O
exosome	O
.	O

The	O
yeast	O
exosome	O
is	O
a	O
complex	O
of	O
3	O
'	O
--	O
>	O
5	O
'	O
exoribonucleases	O
.	O

Sequence	O
analysis	O
identified	O
putative	O
human	O
homologues	O
for	O
exosome	O
components	O
,	O
although	O
several	O
were	O
found	O
only	O
as	O
expressed	O
sequence	O
tags	O
.	O

Here	O
we	O
report	O
the	O
cloning	O
of	O
full	O
-	O
length	O
cDNAs	O
,	O
which	O
encode	O
putative	O
human	O
homologues	O
of	O
the	O
Rrp40p	B
,	O
Rrp41p	B
,	O
and	O
Rrp46p	B
components	O
of	O
the	O
exosome	O
.	O

Recombinant	O
proteins	O
were	O
expressed	O
and	O
used	O
to	O
raise	O
rabbit	O
antisera	O
.	O

In	O
Western	O
blotting	O
experiments	O
,	O
these	O
decorated	O
HeLa	O
cell	O
proteins	O
of	O
the	O
predicted	O
sizes	O
.	O

All	O
three	O
human	O
proteins	O
were	O
enriched	O
in	O
the	O
HeLa	O
cells	O
nucleus	O
and	O
nucleolus	O
,	O
but	O
were	O
also	O
clearly	O
detected	O
in	O
the	O
cytoplasm	O
.	O

Size	O
exclusion	O
chromatography	O
revealed	O
that	O
hRrp40p	B
,	O
hRrp41p	B
,	O
and	O
hRrp46p	B
were	O
present	O
in	O
a	O
large	O
complex	O
.	O

This	O
cofractionated	O
with	O
the	O
human	O
homologues	O
of	O
other	O
exosome	O
components	O
,	O
hRrp4p	B
and	O
PM	B
/	I
Scl-100	I
.	O

Anti	O
-	O
PM	O
/	O
Scl	O
-	O
positive	O
patient	O
sera	O
coimmunoprecipitated	O
hRrp40p	B
,	O
hRrp41p	B
,	O
and	O
hRrp46p	B
demonstrating	O
their	O
physical	O
association	O
.	O

The	O
immunoprecipitated	O
complex	O
exhibited	O
3	O
'	O
--	O
>	O
5	O
'	O
exoribonuclease	O
activity	O
in	O
vitro	O
.	O

hRrp41p	B
was	O
expressed	O
in	O
yeast	O
and	O
shown	O
to	O
suppress	O
the	O
lethality	O
of	O
genetic	O
depletion	O
of	O
yeast	O
Rrp41p	B
.	O

We	O
conclude	O
that	O
hRrp40p	B
,	O
hRrp41p	B
,	O
and	O
hRrp46p	B
represent	O
novel	O
components	O
of	O
the	O
human	O
exosome	O
complex	O
.	O

The	O
neural	O
cell	O
recognition	O
molecule	O
neurofascin	B
interacts	O
with	O
syntenin-1	B
but	O
not	O
with	O
syntenin-2	B
,	O
both	O
of	O
which	O
reveal	O
self	O
-	O
associating	O
activity	O
.	O

Neurofascin	B
belongs	O
to	O
the	O
L1	O
subgroup	O
of	O
the	O
immunoglobulin	O
superfamily	O
of	O
cell	O
adhesion	O
molecules	O
and	O
is	O
implicated	O
in	O
axonal	O
growth	O
and	O
fasciculation	O
.	O

We	O
used	O
yeast	O
two	O
-	O
hybrid	O
screening	O
to	O
identify	O
proteins	O
that	O
interact	O
with	O
neurofascin	B
intracellularly	O
and	O
therefore	O
might	O
link	O
it	O
to	O
trafficking	O
,	O
spatial	O
targeting	O
,	O
or	O
signaling	O
pathways	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
rat	O
syntenin-1	B
,	O
previously	O
published	O
as	O
syntenin	B
,	O
mda-9	B
,	O
or	O
TACIP18	B
in	O
human	O
,	O
is	O
a	O
neurofascin	B
-	O
binding	O
protein	O
that	O
exhibits	O
a	O
wide	O
-	O
spread	O
tissue	O
expression	O
pattern	O
with	O
a	O
relative	O
maximum	O
in	O
brain	O
.	O

Syntenin-1	B
was	O
found	O
not	O
to	O
interact	O
with	O
other	O
vertebrate	O
members	O
of	O
the	O
L1	O
subgroup	O
such	O
as	O
L1	O
itself	O
or	O
NrCAM	B
.	O

We	O
confirmed	O
the	O
specificity	O
of	O
the	O
neurofascin	B
-	O
syntenin-1	B
interaction	O
by	O
ligand	O
-	O
overlay	O
assay	O
,	O
surface	O
plasmon	O
resonance	O
analysis	O
,	O
and	O
colocalization	O
of	O
both	O
proteins	O
in	O
heterologous	O
cells	O
.	O

The	O
COOH	O
terminus	O
of	O
neurofascin	B
was	O
mapped	O
to	O
interact	O
with	O
the	O
second	O
PDZ	O
domain	O
of	O
syntenin-1	B
.	O

Furthermore	O
,	O
we	O
isolated	O
syntenin-2	B
that	O
may	O
be	O
expressed	O
in	O
two	O
isoforms	O
.	O

Despite	O
their	O
high	O
sequence	O
similarity	O
to	O
syntenin-1	B
,	O
syntenin-2alpha	B
,	O
which	O
interacts	O
with	O
neurexin	B
I	I
,	O
and	O
syntenin-2beta	B
do	O
not	O
bind	O
to	O
neurofascin	B
or	O
several	O
other	O
transmembrane	O
proteins	O
that	O
are	O
binding	O
partners	O
of	O
syntenin-1	B
.	O

Finally	O
,	O
we	O
report	O
that	O
syntenin-1	B
and	O
-2	O
both	O
form	O
homodimers	O
and	O
can	O
interact	O
with	O
each	O
other	O
.	O

Regulation	O
of	O
Smad	B
degradation	O
and	O
activity	O
by	O
Smurf2	B
,	O
an	O
E3	O
ubiquitin	O
ligase	O
.	O

Smad	B
proteins	O
are	O
key	O
intracellular	O
signaling	O
effectors	O
for	O
the	O
transforming	O
growth	O
factor	O
-	O
beta	O
superfamily	O
of	O
peptide	O
growth	O
factors	O
.	O

Following	O
receptor	O
-	O
induced	O
activation	O
,	O
Smads	O
move	O
into	O
the	O
nucleus	O
to	O
activate	O
transcription	O
of	O
a	O
select	O
set	O
of	O
target	O
genes	O
.	O

The	O
activity	O
of	O
Smad	B
proteins	O
must	O
be	O
tightly	O
regulated	O
to	O
exert	O
the	O
biological	O
effects	O
of	O
different	O
ligands	O
in	O
a	O
timely	O
manner	O
.	O

Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
Smurf2	B
,	O
a	O
new	O
member	O
of	O
the	O
Hect	O
family	O
of	O
E3	O
ubiquitin	O
ligases	O
.	O

Smurf2	B
selectively	O
interacts	O
with	O
receptor	O
-	O
regulated	O
Smads	O
and	O
preferentially	O
targets	O
Smad1	B
for	O
ubiquitination	O
and	O
proteasome	O
-	O
mediated	O
degradation	O
.	O

At	O
higher	O
expression	O
levels	O
,	O
Smurf2	B
also	O
decreases	O
the	O
protein	O
levels	O
of	O
Smad2	B
,	O
but	O
not	O
Smad3	B
.	O

In	O
Xenopus	O
embryos	O
,	O
ectopic	O
Smurf2	B
expression	O
specifically	O
inhibits	O
Smad1	B
responses	O
and	O
thereby	O
affects	O
embryonic	O
patterning	O
by	O
bone	O
morphogenetic	O
protein	O
signals	O
.	O

These	O
findings	O
suggest	O
that	O
Smurf2	B
may	O
regulate	O
the	O
competence	O
of	O
a	O
cell	O
to	O
respond	O
to	O
transforming	O
growth	O
factor	O
-	O
beta	O
/	O
bone	O
morphogenetic	O
protein	O
signaling	O
through	O
a	O
distinct	O
degradation	O
pathway	O
that	O
is	O
similar	O
to	O
,	O
yet	O
independent	O
of	O
,	O
Smurf1	B
.	O

Human	O
Upf	O
proteins	O
target	O
an	O
mRNA	O
for	O
nonsense	O
-	O
mediated	O
decay	O
when	O
bound	O
downstream	O
of	O
a	O
termination	O
codon	O
.	O

Nonsense	O
-	O
mediated	O
decay	O
(	O
NMD	O
)	O
rids	O
eukaryotic	O
cells	O
of	O
aberrant	O
mRNAs	O
containing	O
premature	O
termination	O
codons	O
.	O

These	O
are	O
discriminated	O
from	O
true	O
termination	O
codons	O
by	O
downstream	O
cis	O
-	O
elements	O
,	O
such	O
as	O
exon	O
-	O
exon	O
junctions	O
.	O

We	O
describe	O
three	O
novel	O
human	O
proteins	O
involved	O
in	O
NMD	O
,	O
hUpf2	B
,	O
hUpf3a	B
,	O
and	O
hUpf3b	B
.	O

While	O
in	O
HeLa	O
cell	O
extracts	O
these	O
proteins	O
are	O
complexed	O
with	O
hUpf1	B
,	O
in	O
intact	O
cells	O
hUpf3a	B
and	O
hUpf3b	B
are	O
nucleocytoplasmic	O
shuttling	O
proteins	O
,	O
hUpf2	B
is	O
perinuclear	O
,	O
and	O
hUpf1	B
cytoplasmic	O
.	O

hUpf3a	B
and	O
hUpf3b	B
associate	O
selectively	O
with	O
spliced	O
beta	O
-	O
globin	O
mRNA	O
in	O
vivo	O
,	O
and	O
tethering	O
of	O
any	O
hUpf	O
protein	O
to	O
the	O
3'UTR	O
of	O
beta	O
-	O
globin	O
mRNA	O
elicits	O
NMD	O
.	O

These	O
data	O
suggest	O
that	O
assembly	O
of	O
a	O
dynamic	O
hUpf	O
complex	O
initiates	O
in	O
the	O
nucleus	O
at	O
mRNA	O
exon	O
-	O
exon	O
junctions	O
and	O
triggers	O
NMD	O
in	O
the	O
cytoplasm	O
when	O
recognized	O
downstream	O
of	O
a	O
translation	O
termination	O
site	O
.	O

Identification	O
of	O
four	O
novel	O
human	O
G	O
protein	O
-	O
coupled	O
receptors	O
expressed	O
in	O
the	O
brain	O
.	O

We	O
report	O
the	O
discovery	O
and	O
tissue	O
distributions	O
of	O
four	O
novel	O
human	O
genes	O
,	O
GPR61	B
,	O
GPR62	B
,	O
GPR63	B
and	O
GPR77	B
,	O
all	O
of	O
which	O
encode	O
G	O
protein	O
-	O
coupled	O
receptors	O
(	O
GPCRs	O
)	O
.	O

GPR61	B
was	O
discovered	O
in	O
a	O
search	O
of	O
the	O
patent	O
literature	O
which	O
retrieved	O
a	O
rabbit	O
DNA	O
sequence	O
partially	O
encoding	O
a	O
novel	O
GPCR	B
.	O

This	O
sequence	O
was	O
used	O
to	O
obtain	O
a	O
full	O
-	O
length	O
human	O
cDNA	O
encoding	O
GPR61	B
,	O
a	O
receptor	O
of	O
417	O
amino	O
acid	O
length	O
.	O

A	O
search	O
of	O
the	O
GenBank	O
genomic	O
sequence	O
databases	O
revealed	O
three	O
previously	O
unrecognized	O
intronless	O
genes	O
encoding	O
the	O
orphan	O
GPCrs	O
(	O
oGPCRs	O
)	O
GPR62	B
,	O
GPR63	B
and	O
GPR77	B
,	O
with	O
respective	O
amino	O
acid	O
lengths	O
of	O
368	O
,	O
419	O
and	O
337	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
GPR61	B
and	O
GPR62	B
,	O
and	O
a	O
published	O
orphan	O
receptor	O
p47MNR	O
,	O
shared	O
the	O
highest	O
level	O
of	O
identities	O
to	O
each	O
other	O
,	O
ranging	O
from	O
36	O
to	O
45	O
%	O
in	O
the	O
transmembrane	O
(	O
TM	O
)	O
domains	O
.	O

Together	O
,	O
these	O
three	O
oGPCRs	O
appear	O
to	O
comprise	O
a	O
novel	O
subfamily	O
of	O
GPCRs	O
,	O
most	O
closely	O
related	O
to	O
the	O
serotonin	B
5-HT	I
(	I
6	I
)	I
receptor	I
.	O

Sequence	O
analysis	O
of	O
GPR63	B
and	O
GPR77	B
revealed	O
highest	O
sequence	O
identities	O
in	O
the	O
TM	O
regions	O
with	O
the	O
oGPCR	O
PSP24	B
(	O
58	O
%	O
)	O
and	O
the	O
anaphylatoxin	B
C5a	I
receptor	I
(	O
49	O
%	O
)	O
respectively	O
.	O

Tissue	O
distribution	O
analyses	O
detected	O
the	O
expression	O
of	O
all	O
four	O
novel	O
genes	O
in	O
the	O
human	O
brain	O
.	O

GPR61	B
mRNA	O
expression	O
was	O
detected	O
in	O
the	O
caudate	O
,	O
putamen	O
and	O
thalamus	O
of	O
human	O
brain	O
,	O
with	O
a	O
more	O
widespread	O
expression	O
pattern	O
in	O
rat	O
brain	O
,	O
with	O
mRNA	O
signals	O
in	O
areas	O
of	O
the	O
cortex	O
,	O
hippocampus	O
,	O
thalamus	O
,	O
hypothalamus	O
and	O
midbrain	O
.	O

GPR62	B
mRNA	O
expression	O
was	O
detected	O
in	O
the	O
basal	O
forebrain	O
,	O
frontal	O
cortex	O
,	O
caudate	O
,	O
putamen	O
,	O
thalamus	O
and	O
hippocampus	O
.	O

GPR63	B
mRNA	O
expression	O
was	O
detected	O
in	O
the	O
frontal	O
cortex	O
,	O
with	O
lower	O
levels	O
in	O
the	O
thalamus	O
,	O
caudate	O
,	O
hypothalamus	O
and	O
midbrain	O
.	O

Analysis	O
of	O
GPR77	B
mRNA	O
expression	O
revealed	O
signals	O
in	O
the	O
frontal	O
cortex	O
,	O
hippocampus	O
and	O
hypothalamus	O
with	O
high	O
transcript	O
levels	O
in	O
the	O
liver	O
.	O

WBSCR14	B
,	O
a	O
gene	O
mapping	O
to	O
the	O
Williams	O
--	O
Beuren	O
syndrome	O
deleted	O
region	O
,	O
is	O
a	O
new	O
member	O
of	O
the	O
Mlx	B
transcription	O
factor	O
network	O
.	O

Williams	O
-	O
Beuren	O
syndrome	O
(	O
WBS	O
)	O
is	O
a	O
developmental	O
disorder	O
associated	O
with	O
haploinsufficiency	O
of	O
multiple	O
genes	O
at	O
7q11.23	O
.	O

Here	O
,	O
we	O
report	O
the	O
functional	O
characterization	O
of	O
WBS	B
critical	I
region	I
gene	I
14	I
(	O
WBSCR14	B
)	O
,	O
a	O
gene	O
contained	O
in	O
the	O
WBS	O
commonly	O
deleted	O
region	O
.	O

It	O
encodes	O
a	O
basic	O
-	O
helix	O
--	O
loop	O
--	O
helix	O
leucine	O
zipper	O
(	O
bHLHZip	O
)	O
transcription	O
factor	O
of	O
the	O
Myc	O
/	O
Max	B
/	O
Mad	B
superfamily	O
.	O

WBSCR14	B
is	O
expressed	O
in	O
multiple	O
tissues	O
,	O
including	O
regions	O
of	O
the	O
brain	O
and	O
the	O
intestinal	O
tract	O
.	O

WBSCR14	B
forms	O
heterodimers	O
with	O
the	O
bHLHZip	O
protein	O
Mlx	B
to	O
bind	O
the	O
DNA	O
sequence	O
CACGTG	O
.	O

Like	O
Max	B
,	O
Mlx	B
has	O
no	O
intrinsic	O
transcriptional	O
activity	O
,	O
but	O
its	O
association	O
with	O
Mad1	B
,	O
Mad4	B
,	O
Mnt	B
or	O
WBSCR14	B
can	O
repress	O
E	O
-	O
box	O
-	O
dependent	O
transcription	O
.	O

Preliminary	O
results	O
suggest	O
a	O
possible	O
role	O
of	O
WBSCR14	B
in	O
growth	O
control	O
.	O

Our	O
data	O
support	O
the	O
view	O
that	O
the	O
Max	B
-	I
like	I
bHLHZip	I
protein	I
,	O
Mlx	B
,	O
is	O
a	O
key	O
element	O
of	O
a	O
transcription	O
factor	O
network	O
.	O

We	O
thus	O
suggest	O
that	O
WBSCR14	B
may	O
contribute	O
to	O
some	O
aspects	O
of	O
the	O
WBS	O
pathology	O
.	O

Cargo	O
of	O
kinesin	O
identified	O
as	O
JIP	B
scaffolding	O
proteins	O
and	O
associated	O
signaling	O
molecules	O
.	O

The	O
cargo	O
that	O
the	O
molecular	O
motor	O
kinesin	O
moves	O
along	O
microtubules	O
has	O
been	O
elusive	O
.	O

We	O
searched	O
for	O
binding	O
partners	O
of	O
the	O
COOH	O
terminus	O
of	O
kinesin	O
light	O
chain	O
,	O
which	O
contains	O
tetratricopeptide	O
repeat	O
(	O
TPR	O
)	O
motifs	O
.	O

Three	O
proteins	O
were	O
found	O
,	O
the	O
c	O
-	O
jun	O
NH	O
(	O
2	O
)	O
-terminal	O
kinase	O
(	O
JNK	B
)	O
-interacting	O
proteins	O
(	O
JIPs	O
)	O
JIP-1	B
,	O
JIP-2	B
,	O
and	O
JIP-3	B
,	O
which	O
are	O
scaffolding	O
proteins	O
for	O
the	O
JNK	B
signaling	O
pathway	O
.	O

Concentration	O
of	O
JIPs	O
in	O
nerve	O
terminals	O
requires	O
kinesin	O
,	O
as	O
evident	O
from	O
the	O
analysis	O
of	O
JIP	B
COOH	O
-	O
terminal	O
mutants	O
and	O
dominant	O
negative	O
kinesin	O
constructs	O
.	O

Coprecipitation	O
experiments	O
suggest	O
that	O
kinesin	O
carries	O
the	O
JIP	B
scaffolds	O
preloaded	O
with	O
cytoplasmic	O
(	O
dual	O
leucine	B
zipper	I
-	I
bearing	I
kinase	I
)	O
and	O
transmembrane	O
signaling	O
molecules	O
(	O
the	O
Reelin	O
receptor	O
,	O
ApoER2	B
)	O
.	O

These	O
results	O
demonstrate	O
a	O
direct	O
interaction	O
between	O
conventional	O
kinesin	O
and	O
a	O
cargo	O
,	O
indicate	O
that	O
motor	O
proteins	O
are	O
linked	O
to	O
their	O
membranous	O
cargo	O
via	O
scaffolding	O
proteins	O
,	O
and	O
support	O
a	O
role	O
for	O
motor	O
proteins	O
in	O
spatial	O
regulation	O
of	O
signal	O
transduction	O
pathways	O
.	O

Identification	O
of	O
muscle	O
specific	O
ring	O
finger	O
proteins	O
as	O
potential	O
regulators	O
of	O
the	O
titin	B
kinase	O
domain	O
.	O

The	O
giant	O
myofibrillar	O
protein	O
titin	B
contains	O
within	O
its	O
C	O
-	O
terminal	O
region	O
a	O
serine	O
-	O
threonine	O
kinase	O
of	O
unknown	O
function	O
.	O

We	O
have	O
identified	O
a	O
novel	O
muscle	O
specific	O
RING	O
finger	O
protein	O
,	O
referred	O
to	O
as	O
MURF-1	B
,	O
that	O
binds	O
in	O
vitro	O
to	O
the	O
titin	B
repeats	O
A168	O
/	O
A169	O
adjacent	O
to	O
the	O
titin	B
kinase	O
domain	O
.	O

In	O
myofibrils	O
,	O
MURF-1	B
is	O
present	O
within	O
the	O
periphery	O
of	O
the	O
M	O
-	O
line	O
lattice	O
in	O
close	O
proximity	O
to	O
titin	B
's	O
catalytic	O
kinase	O
domain	O
,	O
within	O
the	O
Z	O
-	O
line	O
lattice	O
,	O
and	O
also	O
in	O
soluble	O
form	O
within	O
the	O
cytoplasm	O
.	O

Yeast	O
two	O
-	O
hybrid	O
screens	O
with	O
MURF-1	B
as	O
a	O
bait	O
identified	O
two	O
other	O
highly	O
homologous	O
MURF	B
proteins	O
,	O
MURF-2	B
and	O
MURF-3	B
.	O

MURF-1,2,3	B
proteins	O
are	O
encoded	O
by	O
distinct	O
genes	O
,	O
share	O
highly	O
conserved	O
N	O
-	O
terminal	O
RING	O
domains	O
and	O
in	O
vitro	O
form	O
dimers	O
/	O
heterodimers	O
by	O
shared	O
coiled	O
-	O
coil	O
motifs	O
.	O

Of	O
the	O
MURF	B
family	O
,	O
only	O
MURF-1	B
interacts	O
with	O
titin	B
repeats	O
A168	O
/	O
A169	O
,	O
whereas	O
MURF-3	B
has	O
been	O
reported	O
to	O
affect	O
microtubule	O
stability	O
.	O

Association	O
of	O
MURF-1	B
with	O
M	O
-	O
line	O
titin	B
may	O
potentially	O
modulate	O
titin	B
's	O
kinase	O
activity	O
similar	O
to	O
other	O
known	O
kinase	O
-	O
associated	O
proteins	O
,	O
whereas	O
differential	O
expression	O
and	O
heterodimerization	O
of	O
MURF1	B
,	I
2	I
and	I
3	I
may	O
link	O
together	O
titin	B
kinase	O
and	O
microtubule	O
-	O
dependent	O
signal	O
pathways	O
in	O
striated	O
muscles	O
.	O

MMP-28	B
,	O
a	O
new	O
human	O
matrix	O
metalloproteinase	O
with	O
an	O
unusual	O
cysteine	O
-	O
switch	O
sequence	O
is	O
widely	O
expressed	O
in	O
tumors	O
.	O

We	O
report	O
the	O
discovery	O
,	O
cloning	O
,	O
and	O
characterization	O
of	O
a	O
novel	O
human	O
matrix	O
metalloproteinase	O
(	O
MMP-28	B
)	O
cDNA	O
gene	O
.	O

The	O
deduced	O
520-amino	O
-	O
acid	O
sequence	O
of	O
MMP-28	B
includes	O
a	O
signal	O
peptide	O
,	O
a	O
prodomain	O
with	O
an	O
unusual	O
cysteine	O
-	O
switch	O
PRCGVTD	O
motif	O
followed	O
by	O
the	O
furin	O
cleavage	O
RRKKR	O
site	O
,	O
a	O
catalytic	O
domain	O
,	O
a	O
hinge	O
-	O
region	O
and	O
a	O
hemopexin	O
-	O
like	O
domain	O
.	O

On	O
the	O
basis	O
of	O
their	O
structural	O
characteristics	O
,	O
MMP-28	B
belongs	O
to	O
the	O
MMP-19	O
subfamily	O
.	O

The	O
genomic	O
MMP-28	B
gene	O
uniquely	O
mapped	O
to	O
chromosome	O
17q11.2	O
includes	O
eight	O
exons	O
and	O
seven	O
introns	O
.	O

The	O
broad	O
range	O
of	O
expression	O
in	O
carcinomas	O
as	O
well	O
as	O
normal	O
adult	O
and	O
fetal	O
tissues	O
suggests	O
an	O
important	O
functional	O
role	O
for	O
MMP-28	B
.	O

Human	O
corneal	B
GlcNac	I
6-O	I
-	I
sulfotransferase	I
and	O
mouse	O
intestinal	O
GlcNac	O
6-O	O
-	O
sulfotransferase	O
both	O
produce	O
keratan	O
sulfate	O
.	O

Human	O
corneal	O
N	O
-	O
acetylglucosamine	O
6-O	O
-	O
sulfotransferase	O
(	O
hCGn6ST	B
)	O
has	O
been	O
identified	O
by	O
the	O
positional	O
candidate	O
approach	O
as	O
the	O
gene	O
responsible	O
for	O
macular	O
corneal	O
dystrophy	O
(	O
MCD	O
)	O
.	O

Because	O
of	O
its	O
high	O
homology	O
to	O
carbohydrate	O
sulfotransferases	O
and	O
the	O
presence	O
of	O
mutations	O
of	O
this	O
gene	O
in	O
MCD	O
patients	O
who	O
lack	O
sulfated	O
keratan	O
sulfate	O
in	O
the	O
cornea	O
and	O
serum	O
,	O
hCGn6ST	B
protein	O
is	O
thought	O
to	O
be	O
a	O
sulfotransferase	O
that	O
catalyzes	O
sulfation	O
of	O
GlcNAc	O
in	O
keratan	O
sulfate	O
.	O

In	O
this	O
report	O
,	O
we	O
analyzed	O
the	O
enzymatic	O
activity	O
of	O
hCGn6ST	B
by	O
expressing	O
it	O
in	O
cultured	O
cells	O
.	O

A	O
lysate	O
prepared	O
from	O
HeLa	O
cells	O
transfected	O
with	O
an	O
intact	O
form	O
of	O
hCGn6ST	B
cDNA	O
or	O
culture	O
medium	O
from	O
cells	O
transfected	O
with	O
a	O
secreted	O
form	O
of	O
hCGn6ST	B
cDNA	O
showed	O
an	O
activity	O
of	O
transferring	O
sulfate	O
to	O
C-6	O
of	O
GlcNAc	O
of	O
synthetic	O
oligosaccharide	O
substrates	O
in	O
vitro	O
.	O

When	O
hCGn6ST	B
was	O
expressed	O
together	O
with	O
human	O
keratan	B
sulfate	I
Gal-6-sulfotransferase	I
(	O
hKSG6ST	B
)	O
,	O
HeLa	O
cells	O
produced	O
highly	O
sulfated	O
carbohydrate	O
detected	O
by	O
an	O
anti	O
-	O
keratan	O
sulfate	O
antibody	O
5D4	O
.	O

These	O
results	O
indicate	O
that	O
hCGn6ST	B
transfers	O
sulfate	O
to	O
C-6	O
of	O
GlcNAc	O
in	O
keratan	O
sulfate	O
.	O

Amino	O
acid	O
substitutions	O
in	O
hCGn6ST	B
identical	O
to	O
changes	O
resulting	O
from	O
missense	O
mutations	O
found	O
in	O
MCD	O
patients	O
abolished	O
enzymatic	O
activity	O
.	O

Moreover	O
,	O
mouse	O
intestinal	O
GlcNAc	O
6-O	O
-	O
sulfotransferase	O
had	O
the	O
same	O
activity	O
as	O
hCGn6ST	B
.	O

This	O
observation	O
suggests	O
that	O
mouse	O
intestinal	O
GlcNAc	O
6-O	O
-	O
sulfotransferase	O
is	O
the	O
orthologue	O
of	O
hCGn6ST	B
and	O
functions	O
as	O
a	O
sulfotransferase	O
to	O
produce	O
keratan	O
sulfate	O
in	O
the	O
cornea	O
.	O

Extensive	O
repertoire	O
of	O
membrane	O
-	O
bound	O
and	O
soluble	O
dendritic	B
cell	I
-	I
specific	I
ICAM-3-grabbing	I
nonintegrin	I
1	I
(	O
DC	B
-	I
SIGN1	I
)	O
and	O
DC	B
-	I
SIGN2	I
isoforms	O
.	O

Inter	O
-	O
individual	O
variation	O
in	O
expression	O
of	O
DC	B
-	I
SIGN	I
transcripts	O
.	O

Expression	O
in	O
dendritic	O
cells	O
(	O
DCs	O
)	O
of	O
DC	B
-	I
SIGN	I
,	O
a	O
type	O
II	O
membrane	O
protein	O
with	O
a	O
C	O
-	O
type	O
lectin	O
ectodomain	O
,	O
is	O
thought	O
to	O
play	O
an	O
important	O
role	O
in	O
establishing	O
the	O
initial	O
contact	O
between	O
DCs	O
and	O
resting	O
T	O
cells	O
.	O

DC	B
-	I
SIGN	I
is	O
also	O
a	O
unique	O
type	O
of	O
human	O
immunodeficiency	O
virus-1	O
(	O
HIV-1	O
)	O
attachment	O
factor	O
and	O
promotes	O
efficient	O
infection	O
in	O
trans	O
of	O
cells	O
that	O
express	O
CD4	B
and	O
chemokine	O
receptors	O
.	O

We	O
have	O
identified	O
another	O
gene	O
,	O
designated	O
here	O
as	O
DC	B
-	I
SIGN2	I
,	O
that	O
exhibits	O
high	O
sequence	O
homology	O
with	O
DC	B
-	I
SIGN	I
.	O

Here	O
we	O
demonstrate	O
that	O
alternative	O
splicing	O
of	O
DC	B
-	I
SIGN1	I
(	O
original	O
version	O
)	O
and	O
DC	B
-	I
SIGN2	I
pre	O
-	O
mRNA	O
generates	O
a	O
large	O
repertoire	O
of	O
DC	B
-	I
SIGN	I
-	O
like	O
transcripts	O
that	O
are	O
predicted	O
to	O
encode	O
membrane	O
-	O
associated	O
and	O
soluble	O
isoforms	O
.	O

The	O
range	O
of	O
DC	B
-	I
SIGN1	I
mRNA	O
expression	O
was	O
significantly	O
broader	O
than	O
previously	O
reported	O
and	O
included	O
THP-1	O
monocytic	O
cells	O
,	O
placenta	O
,	O
and	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMCs	O
)	O
,	O
and	O
there	O
was	O
cell	O
maturation	O
/	O
activation	O
-	O
induced	O
differences	O
in	O
mRNA	O
expression	O
levels	O
.	O

Immunostaining	O
of	O
term	O
placenta	O
with	O
a	O
DC	B
-	I
SIGN1-specific	I
antiserum	O
showed	O
that	O
DC	B
-	I
SIGN1	I
is	O
expressed	O
on	O
endothelial	O
cells	O
and	O
CC	B
chemokine	I
receptor	I
5	I
(	O
CCR5	B
)	O
-positive	O
macrophage	O
-	O
like	O
cells	O
in	O
the	O
villi	O
.	O

DC	B
-	I
SIGN2	I
mRNA	O
expression	O
was	O
high	O
in	O
the	O
placenta	O
and	O
not	O
detectable	O
in	O
PBMCs	O
.	O

In	O
DCs	O
,	O
the	O
expression	O
of	O
DC	B
-	I
SIGN2	I
transcripts	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
DC	B
-	I
SIGN1	I
.	O

Notably	O
,	O
there	O
was	O
significant	O
inter	O
-	O
individual	O
heterogeneity	O
in	O
the	O
repertoire	O
of	O
DC	B
-	I
SIGN1	I
and	O
DC	B
-	I
SIGN2	I
transcripts	O
expressed	O
.	O

The	O
genes	O
for	O
DC	B
-	I
SIGN1	I
,	O
DC	B
-	I
SIGN2	I
,	O
and	O
CD23	B
,	O
another	O
Type	O
II	O
lectin	O
,	O
colocalize	O
to	O
an	O
approximately	O
85	O
kilobase	O
pair	O
region	O
on	O
chromosome	O
19p13.3	O
,	O
forming	O
a	O
cluster	O
of	O
related	O
genes	O
that	O
undergo	O
highly	O
complex	O
alternative	O
splicing	O
events	O
.	O

The	O
molecular	O
diversity	O
of	O
DC	B
-	I
SIGN-1	I
and	O
-2	O
is	O
reminiscent	O
of	O
that	O
observed	O
for	O
certain	O
other	O
adhesive	O
cell	O
surface	O
proteins	O
involved	O
in	O
cell	O
-	O
cell	O
connectivity	O
.	O

The	O
generation	O
of	O
this	O
large	O
collection	O
of	O
polymorphic	O
cell	O
surface	O
and	O
soluble	O
variants	O
that	O
exhibit	O
inter	O
-	O
individual	O
variation	O
in	O
expression	O
levels	O
has	O
important	O
implications	O
for	O
the	O
pathogenesis	O
of	O
HIV-1	O
infection	O
,	O
as	O
well	O
as	O
for	O
the	O
molecular	O
code	O
required	O
to	O
establish	O
complex	O
interactions	O
between	O
antigen	O
-	O
presenting	O
cells	O
and	O
T	O
cells	O
,	O
i.e.	O
the	O
immunological	O
synapse	O
.	O

Identification	O
of	O
the	O
human	O
crooked	B
neck	I
gene	O
by	O
comparative	O
gene	O
identification	O
.	O

Drosophila	O
melanogaster	O
serves	O
as	O
a	O
useful	O
model	O
organism	O
for	O
functional	O
genomic	O
studies	O
,	O
and	O
its	O
genome	O
project	O
was	O
recently	O
completed	O
.	O

We	O
previously	O
described	O
a	O
comparative	O
-	O
gene	O
-	O
identification	O
approach	O
to	O
assist	O
human	O
ortholog	O
gene	O
identification	O
that	O
involves	O
applying	O
an	O
entire	O
proteome	O
as	O
an	O
alignment	O
template	O
.	O

Analysis	O
of	O
the	O
available	O
14100	O
Drosophila	O
protein	O
sequences	O
revealed	O
that	O
37	O
%	O
of	O
them	O
(	O
5228	O
sequences	O
)	O
might	O
lead	O
to	O
discoveries	O
of	O
novel	O
human	O
genes	O
.	O

Upon	O
further	O
database	O
interrogations	O
,	O
we	O
found	O
several	O
putative	O
full	O
-	O
length	O
human	O
gene	O
transcripts	O
,	O
including	O
the	O
human	O
crooked	B
neck	I
(	O
crn	B
)	O
gene	O
.	O

Based	O
on	O
sequence	O
gap	O
-	O
closure	O
experiments	O
using	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
as	O
well	O
as	O
bioinformatic	O
analysis	O
,	O
we	O
found	O
that	O
the	O
assembled	O
human	O
cDNA	O
contig	O
of	O
crooked	B
neck	I
gene	O
was	O
at	O
least	O
3903	O
base	O
pairs	O
in	O
length	O
with	O
alternative	O
splicing	O
variations	O
which	O
encoded	O
mainly	O
for	O
a	O
687-amino	O
-	O
acid	O
residue	O
protein	O
.	O

The	O
human	O
crooked	B
neck	I
gene	O
was	O
located	O
on	O
chromosome	O
20	O
with	O
at	O
least	O
15	O
exons	O
.	O

The	O
unique	O
features	O
of	O
the	O
16	O
copies	O
of	O
the	O
tetratrico	O
peptide	O
repeat	O
(	O
TPR	O
)	O
motif	O
were	O
conserved	O
in	O
the	O
yeast	O
,	O
fly	O
and	O
human	O
crooked	B
neck	I
orthologous	O
proteins	O
,	O
which	O
were	O
important	O
for	O
spliceosome	O
assembly	O
in	O
cells	O
.	O

Identification	O
of	O
a	O
novel	O
fibroblast	O
growth	O
factor	O
,	O
FGF-22	B
,	O
preferentially	O
expressed	O
in	O
the	O
inner	O
root	O
sheath	O
of	O
the	O
hair	O
follicle	O
.	O

We	O
isolated	O
cDNA	O
encoding	O
a	O
novel	O
fibroblast	O
growth	O
factor	O
(	O
FGF-22	B
)	O
(	O
170	O
amino	O
acids	O
)	O
from	O
human	O
placenta	O
.	O

Of	O
the	O
FGF	O
family	O
members	O
,	O
FGF-22	B
,	O
which	O
appears	O
to	O
be	O
a	O
secreted	O
protein	O
,	O
is	O
most	O
similar	O
to	O
FGF-10	B
and	O
FGF-7	B
(	O
approximately	O
46	O
%	O
and	O
approximately	O
40	O
%	O
amino	O
acid	O
identities	O
,	O
respectively	O
)	O
.	O

The	O
human	O
FGF-22	B
gene	O
was	O
localized	O
on	O
chromosome	O
19p13.3	O
.	O

We	O
also	O
isolated	O
mouse	O
cDNA	O
encoding	O
FGF-22	B
(	O
162	O
amino	O
acids	O
)	O
from	O
the	O
skin	O
.	O

Mouse	O
FGF-22	B
shows	O
high	O
homology	O
(	O
87	O
%	O
amino	O
acid	O
identity	O
)	O
to	O
human	O
FGF-22	B
.	O

Mouse	O
FGF-22	B
mRNA	O
was	O
found	O
to	O
be	O
preferentially	O
expressed	O
in	O
the	O
skin	O
among	O
the	O
mouse	O
adult	O
tissues	O
examined	O
by	O
Northern	O
blotting	O
analysis	O
.	O

By	O
in	O
situ	O
hybridization	O
,	O
FGF-22	B
mRNA	O
in	O
the	O
skin	O
was	O
found	O
to	O
be	O
preferentially	O
expressed	O
in	O
the	O
inner	O
root	O
sheath	O
of	O
the	O
hair	O
follicle	O
.	O

Therefore	O
,	O
FGF-22	B
is	O
expected	O
to	O
be	O
a	O
unique	O
FGF	O
that	O
plays	O
a	O
role	O
in	O
hair	O
development	O
.	O

Molecular	O
cloning	O
and	O
preliminary	O
functional	O
analysis	O
of	O
two	O
novel	O
human	O
KRAB	O
zinc	O
finger	O
proteins	O
,	O
HKr18	B
and	O
HKr19	B
.	O

cDNA	O
clones	O
encoding	O
two	O
novel	O
human	O
KRAB	O
zinc	O
finger	O
proteins	O
,	O
HKr18	B
and	O
HKr19	B
,	O
were	O
isolated	O
from	O
a	O
human	O
testis	O
cDNA	O
library	O
.	O

Their	O
corresponding	O
genes	O
were	O
later	O
identified	O
in	O
sequences	O
originating	O
from	O
chromosomes	O
19	O
and	O
7	O
,	O
respectively	O
.	O

On	O
the	O
basis	O
of	O
the	O
collected	O
information	O
from	O
gene	O
and	O
cDNA	O
sequences	O
,	O
Hkr18	B
was	O
found	O
to	O
be	O
a	O
protein	O
of	O
94	O
kDa	O
with	O
20	O
zinc	O
finger	O
motifs	O
in	O
its	O
C	O
terminus	O
.	O

The	O
HKr19	B
is	O
a	O
smaller	O
protein	O
,	O
with	O
a	O
molecular	O
weight	O
of	O
56	O
kDa	O
containing	O
11	O
zinc	O
finger	O
motifs	O
.	O

Both	O
HKr18	B
and	O
HKr19	B
contained	O
a	O
KRAB	O
A	O
as	O
well	O
as	O
a	O
KRAB	O
B	O
domain	O
in	O
their	O
N	O
termini	O
.	O

Northern	O
blot	O
analysis	O
showed	O
expression	O
of	O
HKr18	B
in	O
all	O
human	O
tissues	O
tested	O
,	O
indicating	O
a	O
ubiquitous	O
expression	O
pattern	O
.	O

In	O
contrast	O
,	O
HKr19	B
showed	O
a	O
more	O
restricted	O
tissue	O
distribution	O
,	O
with	O
detectable	O
expression	O
primarily	O
in	O
testis	O
and	O
fetal	O
tissues	O
.	O

The	O
HKr19	B
protein	O
is	O
a	O
member	O
of	O
the	O
large	O
ZNF91	O
subfamily	O
of	O
KRAB	O
zinc	O
finger	O
genes	O
.	O

A	O
PCR	O
-	O
based	O
analysis	O
of	O
the	O
expression	O
of	O
HKr19	B
and	O
other	O
closely	O
related	O
genes	O
showed	O
that	O
lymphoid	O
,	O
myeloid	O
,	O
and	O
nonhematopoietic	O
cells	O
expressed	O
different	O
sets	O
of	O
these	O
genes	O
.	O

This	O
latter	O
finding	O
indicates	O
that	O
some	O
members	O
of	O
the	O
ZNF91	O
family	O
may	O
be	O
involved	O
in	O
regulating	O
lineage	O
commitment	O
during	O
hematopoietic	O
development	O
.	O

Transfection	O
of	O
various	O
parts	O
of	O
HKr19	B
into	O
human	O
embryonic	O
kidney	O
cells	O
(	O
HEK	O
293	O
cells	O
)	O
showed	O
that	O
the	O
entire	O
protein	O
and	O
its	O
zinc	O
finger	O
region	O
were	O
toxic	O
to	O
these	O
cells	O
when	O
expressed	O
at	O
high	O
levels	O
.	O

In	O
contrast	O
,	O
the	O
KRAB	O
domain	O
and	O
the	O
linker	O
region	O
seemed	O
to	O
be	O
well	O
tolerated	O
.	O

Negative	O
regulation	O
of	O
protein	O
translation	O
by	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
-	I
interacting	I
kinases	I
1	I
and	I
2	I
.	O

Eukaryotic	B
initiation	I
factor	I
4E	I
(	O
eIF4E	B
)	O
is	O
a	O
key	O
component	O
of	O
the	O
translational	O
machinery	O
and	O
an	O
important	O
modulator	O
of	O
cell	O
growth	O
and	O
proliferation	O
.	O

The	O
activity	O
of	O
eIF4E	B
is	O
thought	O
to	O
be	O
regulated	O
by	O
interaction	O
with	O
inhibitory	O
binding	O
proteins	O
(	O
4E	O
-	O
BPs	O
)	O
and	O
phosphorylation	O
by	O
mitogen	O
-	O
activated	O
protein	O
(	O
MAP	O
)	O
kinase	O
-	O
interacting	O
kinase	O
(	O
MNK	O
)	O
on	O
Ser209	O
in	O
response	O
to	O
mitogens	O
and	O
cellular	O
stress	O
.	O

Here	O
we	O
demonstrate	O
that	O
phosphorylation	O
of	O
eIF4E	B
via	O
MNK1	B
is	O
mediated	O
via	O
the	O
activation	O
of	O
either	O
the	O
Erk	O
or	O
p38	O
pathway	O
.	O

We	O
further	O
show	O
that	O
expression	O
of	O
active	O
mutants	O
of	O
MNK1	B
and	O
MNK2	B
in	O
293	O
cells	O
diminishes	O
cap	O
-	O
dependent	O
translation	O
relative	O
to	O
cap	O
-	O
independent	O
translation	O
in	O
a	O
transient	O
reporter	O
assay	O
.	O

The	O
same	O
effect	O
on	O
cap	O
-	O
dependent	O
translation	O
was	O
observed	O
when	O
MNK1	B
was	O
activated	O
by	O
the	O
Erk	O
or	O
p38	O
pathway	O
.	O

In	O
line	O
with	O
these	O
findings	O
,	O
addition	O
of	O
recombinant	O
active	O
MNK1	B
to	O
rabbit	O
reticulocyte	O
lysate	O
resulted	O
in	O
a	O
reduced	O
protein	O
synthesis	O
in	O
vitro	O
,	O
and	O
overexpression	O
of	O
MNK2	B
caused	O
a	O
decreased	O
rate	O
of	O
protein	O
synthesis	O
in	O
293	O
cells	O
.	O

By	O
using	O
CGP	O
57380	O
,	O
a	O
novel	O
low	O
-	O
molecular	O
-	O
weight	O
kinase	O
inhibitor	O
of	O
MNK1	B
,	O
we	O
demonstrate	O
that	O
eIF4E	B
phosphorylation	O
is	O
not	O
crucial	O
to	O
the	O
formation	O
of	O
the	O
initiation	O
complex	O
,	O
mitogen	O
-	O
stimulated	O
increase	O
in	O
cap	O
-	O
dependent	O
translation	O
,	O
and	O
cell	O
proliferation	O
.	O

Our	O
results	O
imply	O
that	O
activation	O
of	O
MNK	O
by	O
MAP	O
kinase	O
pathways	O
does	O
not	O
constitute	O
a	O
positive	O
regulatory	O
mechanism	O
to	O
cap	O
-	O
dependent	O
translation	O
.	O

Instead	O
,	O
we	O
propose	O
that	O
the	O
kinase	O
activity	O
of	O
MNKs	O
,	O
eventually	O
through	O
phosphorylation	O
of	O
eIF4E	B
,	O
may	O
serve	O
to	O
limit	O
cap	O
-	O
dependent	O
translation	O
under	O
physiological	O
conditions	O
.	O

A	O
soluble	O
class	B
II	I
cytokine	I
receptor	I
,	O
IL-22RA2	B
,	O
is	O
a	O
naturally	O
occurring	O
IL-22	B
antagonist	O
.	O

IL-22	B
is	O
an	O
IL-10	B
homologue	O
that	O
binds	O
to	O
and	O
signals	O
through	O
the	O
class	B
II	I
cytokine	I
receptor	I
heterodimer	O
IL-22RA1	B
/	O
CRF2	B
-	I
4	I
.	O

IL-22	B
is	O
produced	O
by	O
T	O
cells	O
and	O
induces	O
the	O
production	O
of	O
acute	O
-	O
phase	O
reactants	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
suggesting	O
its	O
involvement	O
in	O
inflammation	O
.	O

Here	O
we	O
report	O
the	O
identification	O
of	O
a	O
class	B
II	I
cytokine	I
receptor	I
designated	O
IL-22RA2	B
(	O
IL-22	B
receptor	I
-	I
alpha	I
2	I
)	O
that	O
appears	O
to	O
be	O
a	O
naturally	O
expressed	O
soluble	O
receptor	O
.	O

IL-22RA2	B
shares	O
amino	O
acid	O
sequence	O
homology	O
with	O
IL-22RA1	B
(	O
also	O
known	O
as	O
IL-22R	B
,	O
zcytor11	B
,	O
and	O
CRF2	B
-	I
9	I
)	O
and	O
is	O
physically	O
adjacent	O
to	O
IL-20Ralpha	B
and	O
IFN	B
-	I
gammaR1	I
on	O
chromosome	O
6q23.3	O
-	O
24.2	O
.	O

We	O
demonstrate	O
that	O
IL-22RA2	B
binds	O
specifically	O
to	O
IL-22	B
and	O
neutralizes	O
IL-22-induced	B
proliferation	O
of	O
BaF3	O
cells	O
expressing	O
IL-22	B
receptor	O
subunits	O
.	O

IL-22RA2	B
mRNA	O
is	O
highly	O
expressed	O
in	O
placenta	O
and	O
spleen	O
by	O
Northern	O
blotting	O
.	O

PCR	O
analysis	O
using	O
RNA	O
from	O
various	O
tissues	O
and	O
cell	O
lines	O
showed	O
that	O
IL-22RA2	B
was	O
expressed	O
in	O
a	O
range	O
of	O
tissues	O
,	O
including	O
those	O
in	O
the	O
digestive	O
,	O
female	O
reproductive	O
,	O
and	O
immune	O
systems	O
.	O

In	O
situ	O
hybridization	O
revealed	O
the	O
dominant	O
cell	O
types	O
expressing	O
IL-22RA2	B
were	O
mononuclear	O
cells	O
and	O
epithelium	O
.	O

Because	O
IL-22	B
induces	O
the	O
expression	O
of	O
acute	O
phase	O
reactants	O
,	O
IL-22RA2	B
may	O
play	O
an	O
important	O
role	O
as	O
an	O
IL-22	B
antagonist	O
in	O
the	O
regulation	O
of	O
inflammatory	O
responses	O
.	O

Two	O
closely	O
related	O
human	O
nuclear	O
export	O
factors	O
utilize	O
entirely	O
distinct	O
export	O
pathways	O
.	O

Nuclear	O
mRNA	O
export	O
mediated	O
by	O
the	O
human	O
protein	O
TAP	O
requires	O
a	O
carboxy	O
-	O
terminal	O
domain	O
that	O
directly	O
interacts	O
with	O
components	O
of	O
the	O
nuclear	O
pore	O
complex	O
.	O

Here	O
we	O
demonstrate	O
that	O
NXF3	B
,	O
a	O
human	O
RNA	O
binding	O
protein	O
related	O
to	O
TAP	O
,	O
lacks	O
this	O
domain	O
yet	O
retains	O
the	O
ability	O
to	O
export	O
tethered	O
RNA	O
transcripts	O
and	O
to	O
shuttle	O
between	O
the	O
nucleus	O
and	O
the	O
cytoplasm	O
.	O

NXF3	B
contains	O
a	O
novel	O
Crm1-dependent	B
nuclear	O
export	O
signal	O
that	O
compensates	O
in	O
cis	O
for	O
the	O
loss	O
of	O
the	O
nuclear	O
pore	O
targeting	O
domain	O
.	O

NXF3-dependent	B
RNA	O
export	O
is	O
therefore	O
blocked	O
by	O
Crm1-specific	B
inhibitors	O
that	O
do	O
not	O
affect	O
TAP	O
function	O
.	O

Thus	O
,	O
while	O
the	O
related	O
TAP	O
and	O
NXF3	B
proteins	O
are	O
both	O
capable	O
of	O
mediating	O
nuclear	O
RNA	O
export	O
,	O
they	O
do	O
so	O
via	O
unrelated	O
export	O
pathways	O
.	O

CHMP1	B
functions	O
as	O
a	O
member	O
of	O
a	O
newly	O
defined	O
family	O
of	O
vesicle	O
trafficking	O
proteins	O
.	O

A	O
multivesicular	O
body	O
is	O
a	O
vesicle	O
-	O
filled	O
endosome	O
that	O
targets	O
proteins	O
to	O
the	O
interior	O
of	O
lysosomes	O
.	O

We	O
have	O
identified	O
a	O
conserved	O
eukaryotic	O
protein	O
,	O
human	O
CHMP1	B
,	O
which	O
is	O
strongly	O
implicated	O
in	O
multivesicular	O
body	O
formation	O
.	O

Immunocytochemistry	O
and	O
biochemical	O
fractionation	O
localize	O
CHMP1	B
to	O
early	O
endosomes	O
and	O
CHMP1	B
physically	O
interacts	O
with	O
SKD1	O
/	O
VPS4	O
,	O
a	O
highly	O
conserved	O
protein	O
directly	O
linked	O
to	O
multivesicular	O
body	O
sorting	O
in	O
yeast	O
.	O

Similar	O
to	O
the	O
action	O
of	O
a	O
mutant	O
SKD1	O
protein	O
,	O
overexpression	O
of	O
a	O
fusion	O
derivative	O
of	O
human	O
CHMP1	B
dilates	O
endosomal	O
compartments	O
and	O
disrupts	O
the	O
normal	O
distribution	O
of	O
several	O
endosomal	O
markers	O
.	O

Genetic	O
studies	O
in	O
Saccharomyces	O
cerevisiae	O
further	O
support	O
a	O
conserved	O
role	O
of	O
CHMP1	B
in	O
vesicle	O
trafficking	O
.	O

Deletion	O
of	O
CHM1	O
,	O
the	O
budding	O
yeast	O
homolog	O
of	O
CHMP1	B
,	O
results	O
in	O
defective	O
sorting	O
of	O
carboxypeptidases	O
S	O
and	O
Y	O
and	O
produces	O
abnormal	O
,	O
multi	O
-	O
lamellar	O
prevacuolar	O
compartments	O
.	O

This	O
phenotype	O
classifies	O
CHM1	O
as	O
a	O
member	O
of	O
the	O
class	O
E	O
vacuolar	O
protein	O
sorting	O
genes	O
.	O

Yeast	O
Chm1p	O
belongs	O
to	O
a	O
structurally	O
-	O
related	O
,	O
but	O
rather	O
divergent	O
family	O
of	O
proteins	O
,	O
including	O
Vps24p	O
and	O
Snf7p	O
and	O
three	O
novel	O
proteins	O
,	O
Chm2p	O
,	O
Chm5p	O
and	O
Chm6p	O
,	O
which	O
are	O
all	O
essential	O
for	O
multivesicular	O
body	O
sorting	O
.	O

These	O
observations	O
identify	O
the	O
conserved	O
CHMP	O
/	O
Chmp	O
family	O
as	O
a	O
set	O
of	O
proteins	O
fundamental	O
to	O
understanding	O
multivesicular	O
body	O
sorting	O
in	O
eukaryotic	O
organisms	O
.	O

NXF5	B
,	O
a	O
novel	O
member	O
of	O
the	O
nuclear	O
RNA	O
export	O
factor	O
family	O
,	O
is	O
lost	O
in	O
a	O
male	O
patient	O
with	O
a	O
syndromic	O
form	O
of	O
mental	O
retardation	O
.	O

BACKGROUND	O
:	O
Although	O
X	O
-	O
linked	O
mental	O
retardation	O
(	O
XLMR	O
)	O
affects	O
2%-3	O
%	O
of	O
the	O
human	O
population	O
,	O
little	O
is	O
known	O
about	O
the	O
underlying	O
molecular	O
mechanisms	O
.	O

Recent	O
interest	O
in	O
this	O
topic	O
led	O
to	O
the	O
identification	O
of	O
several	O
genes	O
for	O
which	O
mutations	O
result	O
in	O
the	O
disturbance	O
of	O
cognitive	O
development	O
.	O

RESULTS	O
:	O
We	O
identified	O
a	O
novel	O
gene	O
that	O
is	O
interrupted	O
by	O
an	O
inv	O
(	O
X	O
)	O
(	O
p21.1;q22	O
)	O
in	O
a	O
male	O
patient	O
with	O
a	O
syndromic	O
form	O
of	O
mental	O
retardation	O
.	O

Molecular	O
analysis	O
of	O
both	O
breakpoint	O
regions	O
did	O
not	O
reveal	O
an	O
interrupted	O
gene	O
on	O
Xp	O
,	O
but	O
identified	O
a	O
novel	O
nuclear	O
RNA	O
export	O
factor	O
(	O
NXF	B
)	O
gene	O
cluster	O
,	O
Xcen	O
-	O
NXF5-NXF2-NXF4-NXF3-Xqter	B
,	O
in	O
which	O
NXF5	B
is	O
split	O
by	O
the	O
breakpoint	O
,	O
leading	O
to	O
its	O
functional	O
nullisomy	O
.	O

The	O
predicted	O
NXF5	B
protein	O
shows	O
high	O
similarity	O
with	O
the	O
central	O
part	O
of	O
the	O
presumed	O
mRNA	O
nuclear	O
export	O
factor	O
TAP	B
/	O
NXF1	B
.	O

Functional	O
analysis	O
of	O
NXF5	B
demonstrates	O
binding	O
to	O
RNA	O
as	O
well	O
as	O
to	O
the	O
RNA	O
nuclear	O
export	O
-	O
associated	O
protein	O
p15	B
/	O
NXT	B
.	O

In	O
contrast	O
to	O
TAP	B
/	O
NXF1	B
,	O
overexpression	O
studies	O
localized	O
NXF5	B
in	O
the	O
form	O
of	O
granules	O
in	O
the	O
cell	O
body	O
and	O
neurites	O
of	O
mature	O
hippocampal	O
neurons	O
,	O
suggesting	O
a	O
role	O
in	O
mRNA	O
transport	O
.	O

The	O
two	O
newly	O
identified	O
mouse	O
nxf	B
homologs	O
,	O
nxf	B
-	O
a	O
and	O
nxf	B
-	O
b	O
,	O
which	O
also	O
map	O
on	O
X	O
,	O
show	O
highest	O
mRNA	O
levels	O
in	O
the	O
brain	O
.	O

CONCLUSIONS	O
:	O
A	O
novel	O
member	O
of	O
the	O
nuclear	O
RNA	O
export	O
factor	O
family	O
is	O
absent	O
in	O
a	O
male	O
patient	O
with	O
a	O
syndromic	O
form	O
of	O
mental	O
retardation	O
.	O

Although	O
we	O
did	O
not	O
find	O
direct	O
evidence	O
for	O
the	O
involvement	O
of	O
NXF5	B
in	O
MR	O
,	O
the	O
gene	O
could	O
be	O
involved	O
in	O
development	O
,	O
possibly	O
through	O
a	O
process	O
in	O
mRNA	O
metabolism	O
in	O
neurons	O
.	O

Phylogenetic	O
conservation	O
of	O
the	O
makorin-2	B
gene	O
,	O
encoding	O
a	O
multiple	O
zinc	O
-	O
finger	O
protein	O
,	O
antisense	O
to	O
the	O
RAF1	B
proto	O
-	O
oncogene	O
.	O

Natural	O
endogenous	O
antisense	O
RNAs	O
have	O
been	O
reported	O
in	O
multiple	O
loci	O
,	O
with	O
evidence	O
in	O
some	O
cases	O
supporting	O
a	O
regulatory	O
role	O
for	O
the	O
antisense	O
transcript	O
.	O

Here	O
,	O
we	O
describe	O
a	O
novel	O
gene	O
,	O
makorin	B
RING	I
zinc	I
finger-2	I
(	O
MKRN2	B
)	O
,	O
that	O
overlaps	O
and	O
is	O
antisense	O
to	O
the	O
gene	O
RAF1	B
in	O
mammals	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
RAF1	B
orthologues	O
suggests	O
that	O
this	O
relationship	O
may	O
have	O
existed	O
for	O
up	O
to	O
450	O
million	O
years	O
.	O

We	O
have	O
also	O
identified	O
MKRN2	B
orthologues	O
in	O
two	O
species	O
of	O
fish	O
.	O

This	O
places	O
the	O
gene	O
duplication	O
event	O
that	O
created	O
this	O
locus	O
from	O
an	O
ancestral	O
MKRN1	B
gene	O
early	O
in	O
vertebrate	O
evolution	O
,	O
over	O
450	O
million	O
years	O
ago	O
.	O

Northern	O
blot	O
analyses	O
show	O
that	O
human	O
MKRN2	B
and	O
RAF1	B
are	O
co	O
-	O
expressed	O
in	O
tissues	O
and	O
cell	O
lines	O
,	O
raising	O
the	O
possibility	O
of	O
mRNA	O
duplex	O
formation	O
.	O

The	O
encoded	O
makorin-2	B
protein	O
is	O
likely	O
a	O
ribonucleoprotein	O
of	O
unknown	O
function	O
,	O
but	O
its	O
conservation	O
suggests	O
an	O
important	O
cellular	O
role	O
.	O

The	O
data	O
presented	O
here	O
describe	O
a	O
conserved	O
vertebrate	O
MKRN2	B
gene	O
that	O
is	O
closely	O
associated	O
with	O
the	O
RAF1	B
locus	O
.	O

Functional	O
cloning	O
of	O
Src	B
-	I
like	I
adapter	I
protein-2	I
(	O
SLAP-2	B
)	O
,	O
a	O
novel	O
inhibitor	O
of	O
antigen	O
receptor	O
signaling	O
.	O

In	O
an	O
effort	O
to	O
identify	O
novel	O
therapeutic	O
targets	O
for	O
autoimmunity	O
and	O
transplant	O
rejection	O
,	O
we	O
developed	O
and	O
performed	O
a	O
large	O
-	O
scale	O
retroviral	O
-	O
based	O
functional	O
screen	O
to	O
select	O
for	O
proteins	O
that	O
inhibit	O
antigen	O
receptor	O
-	O
mediated	O
activation	O
of	O
lymphocytes	O
.	O

In	O
addition	O
to	O
known	O
regulators	O
of	O
antigen	O
receptor	O
signaling	O
,	O
we	O
identified	O
a	O
novel	O
adaptor	O
protein	O
,	O
SLAP-2	B
which	O
shares	O
36	O
%	O
sequence	O
similarity	O
with	O
the	O
known	O
Src	B
-	I
like	I
adaptor	I
protein	I
,	O
SLAP	B
.	O

Similar	O
to	O
SLAP	B
,	O
SLAP-2	B
is	O
predominantly	O
expressed	O
in	O
hematopoietic	O
cells	O
.	O

Overexpression	O
of	O
SLAP-2	B
in	O
B	O
and	O
T	O
cell	O
lines	O
specifically	O
impaired	O
antigen	O
receptor	O
-	O
mediated	O
signaling	O
events	O
,	O
including	O
CD69	B
surface	O
marker	O
upregulation	O
,	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
promoter	O
activation	O
and	O
calcium	O
influx	O
.	O

Signaling	O
induced	O
by	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
and	O
ionomycin	O
was	O
not	O
significantly	O
reduced	O
,	O
suggesting	O
SLAP-2	B
functions	O
proximally	O
in	O
the	O
antigen	O
receptor	O
signaling	O
cascade	O
.	O

The	O
SLAP-2	B
protein	O
contains	O
an	O
NH2-terminal	O
myristoylation	O
consensus	O
sequence	O
and	O
SH3	O
and	O
SH2	O
Src	O
homology	O
domains	O
,	O
but	O
lacks	O
a	O
tyrosine	O
kinase	O
domain	O
.	O

In	O
antigen	O
receptor	O
-	O
stimulated	O
cells	O
,	O
SLAP-2	B
associated	O
with	O
several	O
tyrosine	O
phosphorylated	O
proteins	O
,	O
including	O
the	O
ubiquitin	O
ligase	O
Cbl	B
.	O

Deletion	O
of	O
the	O
COOH	O
terminus	O
of	O
SLAP-2	B
blocked	O
function	O
and	O
abrogated	O
its	O
association	O
with	O
Cbl	B
.	O

Mutation	O
of	O
the	O
putative	O
myristoylation	O
site	O
of	O
SLAP-2	B
compromised	O
its	O
inhibitory	O
activity	O
and	O
impaired	O
its	O
localization	O
to	O
the	O
membrane	O
compartment	O
.	O

Our	O
identification	O
of	O
the	O
negative	O
regulator	O
SLAP-2	B
demonstrates	O
that	O
a	O
retroviral	O
-	O
based	O
screening	O
strategy	O
may	O
be	O
an	O
efficient	O
way	O
to	O
identify	O
and	O
characterize	O
the	O
function	O
of	O
key	O
components	O
of	O
many	O
signal	O
transduction	O
systems	O
.	O

Composition	O
of	O
Drosophila	O
melanogaster	O
proteome	O
involved	O
in	O
fucosylated	O
glycan	O
metabolism	O
.	O

The	O
whole	O
genome	O
approach	O
enables	O
the	O
characterization	O
of	O
all	O
components	O
of	O
any	O
given	O
biological	O
pathway	O
.	O

Moreover	O
,	O
it	O
can	O
help	O
to	O
uncover	O
all	O
the	O
metabolic	O
routes	O
for	O
any	O
molecule	O
.	O

Here	O
we	O
have	O
used	O
the	O
genome	O
of	O
Drosophila	O
melanogaster	O
to	O
search	O
for	O
enzymes	O
involved	O
in	O
the	O
metabolism	O
of	O
fucosylated	O
glycans	O
.	O

Our	O
results	O
suggest	O
that	O
in	O
the	O
fruit	O
fly	O
GDP	O
-	O
fucose	O
,	O
the	O
donor	O
for	O
fucosyltransferase	O
reactions	O
,	O
is	O
formed	O
exclusively	O
via	O
the	O
de	O
novo	O
pathway	O
from	O
GDP	O
-	O
mannose	O
through	O
enzymatic	O
reactions	O
catalyzed	O
by	O
GDP	B
-	I
D	I
-	I
mannose	I
4,6-dehydratase	I
(	O
GMD	B
)	O
and	O
GDP-4-keto-6-deoxy	B
-	I
D	I
-	I
mannose	I
3,5-epimerase	I
/	I
4-reductase	I
(	O
GMER	B
,	O
also	O
known	O
as	O
FX	B
in	O
man	O
)	O
.	O

The	O
Drosophila	O
genome	O
does	O
not	O
have	O
orthologs	O
for	O
the	O
salvage	O
pathway	O
enzymes	O
,	O
i.e.	O
fucokinase	B
and	O
GDP	B
-	I
fucose	I
pyrophosphorylase	I
synthesizing	O
GDP	O
-	O
fucose	O
from	O
fucose	O
.	O

In	O
addition	O
we	O
identified	O
two	O
novel	O
fucosyltransferases	O
predicted	O
to	O
catalyze	O
alpha1,3-	O
and	O
alpha1,6-specific	O
linkages	O
to	O
the	O
GlcNAc	O
residues	O
on	O
glycans	O
.	O

No	O
genes	O
with	O
the	O
capacity	O
to	O
encode	O
alpha1,2-specific	O
fucosyltransferases	O
were	O
found	O
.	O

We	O
also	O
identified	O
two	O
novel	O
genes	O
coding	O
for	O
O	O
-	O
fucosyltransferases	O
and	O
a	O
gene	O
responsible	O
for	O
a	O
fucosidase	O
enzyme	O
in	O
the	O
Drosophila	O
genome	O
.	O

Finally	O
,	O
using	O
the	O
Drosophila	O
CG4435	O
gene	O
,	O
we	O
identified	O
two	O
novel	O
human	O
genes	O
putatively	O
coding	O
for	O
fucosyltransferases	O
.	O

This	O
work	O
can	O
serve	O
as	O
a	O
basis	O
for	O
further	O
whole	O
-	O
genome	O
approaches	O
in	O
mapping	O
all	O
possible	O
glycosylation	O
pathways	O
and	O
as	O
a	O
basic	O
analysis	O
leading	O
to	O
subsequent	O
experimental	O
studies	O
to	O
verify	O
the	O
predictions	O
made	O
in	O
this	O
work	O
.	O

Expression	O
pattern	O
in	O
brain	O
of	O
TASK-1	B
,	O
TASK-3	B
,	O
and	O
a	O
tandem	O
pore	O
domain	O
K	O
(	O
+	O
)	O
channel	O
subunit	O
,	O
TASK-5	B
,	O
associated	O
with	O
the	O
central	O
auditory	O
nervous	O
system	O
.	O

TWIK	O
-	O
related	O
acid	O
-	O
sensitive	O
K	O
(	O
+	O
)	O
(	O
TASK	B
)	O
channels	O
contribute	O
to	O
setting	O
the	O
resting	O
potential	O
of	O
mammalian	O
neurons	O
and	O
have	O
recently	O
been	O
defined	O
as	O
molecular	O
targets	O
for	O
extracellular	O
protons	O
and	O
volatile	O
anesthetics	O
.	O

We	O
have	O
isolated	O
a	O
novel	O
member	O
of	O
this	O
subfamily	O
,	O
hTASK-5	B
,	O
from	O
a	O
human	O
genomic	O
library	O
and	O
mapped	O
it	O
to	O
chromosomal	O
region	O
20q12	O
-	O
20q13	O
.	O

hTASK-5	B
did	O
not	O
functionally	O
express	O
in	O
Xenopus	O
oocytes	O
,	O
whereas	O
chimeric	O
TASK-5	B
/	O
TASK-3	B
constructs	O
containing	O
the	O
region	O
between	O
M1	O
and	O
M3	O
of	O
TASK-3	B
produced	O
K	O
(	O
+	O
)	O
selective	O
currents	O
.	O

To	O
better	O
correlate	O
TASK	B
subunits	O
with	O
native	O
K	O
(	O
+	O
)	O
currents	O
in	O
neurons	O
the	O
precise	O
cellular	O
distribution	O
of	O
all	O
TASK	B
family	O
members	O
was	O
elucidated	O
in	O
rat	O
brain	O
.	O

A	O
comprehensive	O
in	O
situ	O
hybridization	O
analysis	O
revealed	O
that	O
both	O
TASK-1	B
and	O
TASK-3	B
transcripts	O
are	O
most	O
strongly	O
expressed	O
in	O
many	O
neurons	O
likely	O
to	O
be	O
cholinergic	O
,	O
serotonergic	O
,	O
or	O
noradrenergic	O
.	O

In	O
contrast	O
,	O
TASK-5	B
expression	O
is	O
found	O
in	O
olfactory	O
bulb	O
mitral	O
cells	O
and	O
Purkinje	O
cells	O
,	O
but	O
predominantly	O
associated	O
with	O
the	O
central	O
auditory	O
pathway	O
.	O

Thus	O
,	O
TASK-5	B
K	O
(	O
+	O
)	O
channels	O
,	O
possibly	O
in	O
conjunction	O
with	O
auxiliary	O
proteins	O
,	O
may	O
play	O
a	O
role	O
in	O
the	O
transmission	O
of	O
temporal	O
information	O
in	O
the	O
auditory	O
system	O
.	O

Identification	O
of	O
two	O
novel	O
human	O
dynein	O
light	O
chain	O
genes	O
,	O
DNLC2A	B
and	O
DNLC2B	B
,	O
and	O
their	O
expression	O
changes	O
in	O
hepatocellular	O
carcinoma	O
tissues	O
from	O
68	O
Chinese	O
patients	O
.	O

Two	O
full	O
-	O
length	O
cDNAs	O
,	O
DNLC2A	B
and	O
DNLC2B	B
,	O
were	O
cloned	O
and	O
characterized	O
.	O

Their	O
open	O
reading	O
frames	O
respectively	O
encode	O
96	O
amino	O
acids	O
which	O
are	O
most	O
closely	O
homologous	O
to	O
roadblock	O
/	O
LC7	O
,	O
one	O
member	O
of	O
an	O
ancient	O
dynein	O
light	O
chain	O
protein	O
family	O
,	O
conserved	O
in	O
nematode	O
,	O
fruit	O
fly	O
,	O
mouse	O
and	O
rat	O
.	O

The	O
DNLC2A	B
was	O
expressed	O
in	O
12	O
of	O
16	O
human	O
tissues	O
examined	O
,	O
with	O
especially	O
strong	O
expression	O
in	O
heart	O
,	O
liver	O
and	O
brain	O
,	O
whereas	O
there	O
was	O
weak	O
expression	O
in	O
lung	O
,	O
prostate	O
,	O
testis	O
,	O
small	O
intestine	O
and	O
colon	O
.	O

The	O
expression	O
of	O
DNLC2B	B
was	O
generally	O
high	O
compared	O
with	O
that	O
of	O
DNLC2A	B
except	O
in	O
liver	O
.	O

Northern	O
blotting	O
and/or	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
analysis	O
examined	O
the	O
expression	O
changes	O
of	O
DNLC2A	B
and	O
DNLC2B	B
in	O
68	O
hepatocellular	O
carcinoma	O
tissue	O
samples	O
.	O

It	O
was	O
revealed	O
that	O
DNLC2A	B
was	O
up	O
-	O
regulated	O
(	O
45	O
out	O
of	O
the	O
68	O
cases	O
)	O
while	O
DNLC2B	B
was	O
down	O
-	O
regulated	O
(	O
44	O
out	O
of	O
68	O
cases	O
)	O
,	O
compared	O
with	O
their	O
adjacent	O
tumor	O
-	O
free	O
liver	O
tissues	O
.	O

Interestingly	O
,	O
among	O
the	O
total	O
68	O
liver	O
cancer	O
samples	O
tested	O
,	O
DNLC2A	B
was	O
up	O
-	O
regulated	O
while	O
DNLC2B	B
was	O
down	O
-	O
regulated	O
in	O
28	O
cases	O
;	O
DNLC2A	B
was	O
up	O
-	O
regulated	O
while	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
DNLC2B	B
in	O
10	O
cases	O
;	O
no	O
obvious	O
change	O
was	O
observed	O
for	O
DNLC2A	B
while	O
DNLC2B	B
was	O
down	O
-	O
regulated	O
in	O
14	O
cases	O
.	O

Although	O
the	O
underlying	O
mechanism	O
is	O
not	O
clear	O
to	O
date	O
,	O
the	O
apparent	O
up	O
-	O
regulation	O
of	O
DNLC2A	B
and	O
down	O
-	O
regulation	O
of	O
DNLC2B	B
suggest	O
that	O
these	O
genes	O
might	O
be	O
involved	O
in	O
tumor	O
progression	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
different	O
expression	O
changes	O
of	O
the	O
two	O
homologous	O
genes	O
indicate	O
that	O
hepatocellular	O
carcinomas	O
are	O
caused	O
by	O
different	O
pathological	O
mechanisms	O
.	O

In	O
addition	O
,	O
DNLC2A	B
was	O
assigned	O
to	O
human	O
chromosome	O
20q12-q13.11	O
near	O
the	O
marker	O
D20S106	O
by	O
radiation	O
hybrid	O
mapping	O
.	O

Identification	O
of	O
ARAP3	B
,	O
a	O
novel	O
PI3	O
K	O
effector	O
regulating	O
both	O
Arf	O
and	O
Rho	O
GTPases	O
,	O
by	O
selective	O
capture	O
on	O
phosphoinositide	O
affinity	O
matrices	O
.	O

We	O
show	O
that	O
matrices	O
carrying	O
the	O
tethered	O
homologs	O
of	O
natural	O
phosphoinositides	O
can	O
be	O
used	O
to	O
capture	O
and	O
display	O
multiple	O
phosphoinositide	O
binding	O
proteins	O
in	O
cell	O
and	O
tissue	O
extracts	O
.	O

We	O
present	O
the	O
mass	O
spectrometric	O
identification	O
of	O
over	O
20	O
proteins	O
isolated	O
by	O
this	O
method	O
,	O
mostly	O
from	O
leukocyte	O
extracts	O
:	O
they	O
include	O
known	O
and	O
novel	O
proteins	O
with	O
established	O
phosphoinositide	O
binding	O
domains	O
and	O
also	O
known	O
proteins	O
with	O
surprising	O
and	O
unusual	O
phosphoinositide	O
binding	O
properties	O
.	O

One	O
of	O
the	O
novel	O
PtdIns	O
(	O
3,4,5	O
)	O
P3	O
binding	O
proteins	O
,	O
ARAP3	B
,	O
has	O
an	O
unusual	O
domain	O
structure	O
,	O
including	O
five	O
predicted	O
PH	O
domains	O
.	O

We	O
show	O
that	O
it	O
is	O
a	O
specific	O
PtdIns	O
(	O
3,4,5	O
)	O
P3	O
/	O
PtdIns	O
(	O
3,4	O
)	O
P2-stimulated	O
Arf6	B
GAP	I
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
both	O
its	O
Arf	O
GAP	O
and	O
Rho	O
GAP	O
domains	O
cooperate	O
in	O
mediating	O
PI3K	O
-	O
dependent	O
rearrangements	O
in	O
the	O
cell	O
cytoskeleton	O
and	O
cell	O
shape	O
.	O

A	O
novel	O
Src	O
homology	O
2	O
domain	O
-	O
containing	O
molecule	O
,	O
Src	B
-	I
like	I
adapter	I
protein-2	I
(	O
SLAP-2	B
)	O
,	O
which	O
negatively	O
regulates	O
T	O
cell	O
receptor	O
signaling	O
.	O

We	O
have	O
cloned	O
a	O
novel	O
adapter	O
protein	O
containing	O
Src	O
homology	O
2	O
and	O
Src	O
homology	O
3	O
domains	O
similar	O
to	O
the	O
Src	O
family	O
of	O
tyrosine	O
kinases	O
.	O

This	O
molecule	O
lacks	O
a	O
catalytic	O
tyrosine	O
kinase	O
domain	O
and	O
is	O
related	O
to	O
a	O
previously	O
identified	O
protein	O
,	O
Src	B
-	I
like	I
adapter	I
protein	I
(	O
SLAP	B
)	O
,	O
and	O
is	O
therefore	O
designated	O
SLAP-2	B
.	O

Northern	O
blot	O
analysis	O
indicates	O
that	O
SLAP-2	B
is	O
predominantly	O
expressed	O
in	O
the	O
immune	O
system	O
.	O

Jurkat	O
T	O
cells	O
express	O
SLAP-2	B
protein	O
and	O
overexpression	O
of	O
SLAP-2	B
in	O
these	O
cells	O
negatively	O
regulates	O
T	O
cell	O
receptor	O
signaling	O
as	O
assessed	O
by	O
interleukin-2	O
promoter	O
or	O
NF	O
-	O
AT	O
promoter	O
reporter	O
constructs	O
.	O

Mutational	O
analysis	O
revealed	O
that	O
an	O
intact	O
SH2	O
domain	O
of	O
SLAP-2	B
is	O
essential	O
for	O
this	O
inhibitory	O
effect	O
,	O
whereas	O
mutation	O
of	O
the	O
SH3	O
domain	O
alone	O
has	O
no	O
effect	O
.	O

This	O
inhibitory	O
effect	O
is	O
upstream	O
of	O
the	O
activation	O
of	O
Ras	O
and	O
increase	O
of	O
intracellular	O
calcium	O
levels	O
,	O
as	O
no	O
inhibition	O
was	O
observed	O
when	O
the	O
cells	O
were	O
activated	O
by	O
phorbol	O
ester	O
plus	O
ionomycin	O
.	O

SLAP-2	B
interacts	O
with	O
Cbl	B
in	O
vivo	O
in	O
a	O
phosphorylation	O
independent	O
manner	O
and	O
with	O
ZAP-70	B
and	O
T	B
cell	I
receptor	I
zeta	I
chain	I
upon	O
T	O
cell	O
receptor	O
activation	O
.	O

Finally	O
,	O
we	O
show	O
that	O
the	O
mutation	O
of	O
a	O
predicted	O
myristoylation	O
site	O
within	O
the	O
NH	O
(	O
2	O
)	O
-terminal	O
of	O
SLAP-2	B
is	O
essential	O
for	O
its	O
inhibitory	O
effect	O
.	O

This	O
report	O
therefore	O
implicates	O
SLAP	B
and	O
SLAP-2	B
as	O
a	O
family	O
of	O
adapter	O
proteins	O
that	O
negatively	O
regulate	O
T	O
cell	O
receptor	O
signaling	O
.	O

Identification	O
of	O
the	O
mitochondrial	B
glutamate	I
transporter	I
.	O

Bacterial	O
expression	O
,	O
reconstitution	O
,	O
functional	O
characterization	O
,	O
and	O
tissue	O
distribution	O
of	O
two	O
human	O
isoforms	O
.	O

The	O
mitochondrial	O
carriers	O
are	O
a	O
family	O
of	O
transport	O
proteins	O
in	O
the	O
inner	O
membranes	O
of	O
mitochondria	O
.	O

They	O
shuttle	O
substrates	O
,	O
metabolites	O
,	O
and	O
cofactors	O
through	O
this	O
membrane	O
and	O
connect	O
cytoplasm	O
functions	O
with	O
others	O
in	O
the	O
matrix	O
.	O

Glutamate	O
is	O
co	O
-	O
transported	O
with	O
H	O
(	O
+	O
)	O
(	O
or	O
exchanged	O
for	O
OH	O
(	O
-	O
)	O
)	O
,	O
but	O
no	O
protein	O
has	O
ever	O
been	O
associated	O
with	O
this	O
activity	O
.	O

Two	O
human	O
expressed	O
sequence	O
tags	O
encode	O
proteins	O
of	O
323	O
and	O
315	O
amino	O
acids	O
with	O
63	O
%	O
identity	O
that	O
are	O
related	O
to	O
the	O
aspartate	O
-	O
glutamate	O
carrier	O
,	O
a	O
member	O
of	O
the	O
carrier	O
family	O
.	O

They	O
have	O
been	O
overexpressed	O
in	O
Escherichia	O
coli	O
and	O
reconstituted	O
into	O
phospholipid	O
vesicles	O
.	O

Their	O
transport	O
properties	O
demonstrate	O
that	O
the	O
two	O
proteins	O
are	O
isoforms	O
of	O
the	O
glutamate	O
/	O
H	O
(	O
+	O
)	O
symporter	O
described	O
in	O
the	O
past	O
in	O
whole	O
mitochondria	O
.	O

Isoform	O
1	O
is	O
expressed	O
at	O
higher	O
levels	O
than	O
isoform	O
2	O
in	O
all	O
the	O
tissues	O
except	O
in	O
brain	O
,	O
where	O
the	O
two	O
isoforms	O
are	O
expressed	O
at	O
comparable	O
levels	O
.	O

The	O
differences	O
in	O
expression	O
levels	O
and	O
kinetic	O
parameters	O
of	O
the	O
two	O
isoforms	O
suggest	O
that	O
isoform	O
2	O
matches	O
the	O
basic	O
requirement	O
of	O
all	O
tissues	O
especially	O
with	O
respect	O
to	O
amino	O
acid	O
degradation	O
,	O
and	O
isoform	O
1	O
becomes	O
operative	O
to	O
accommodate	O
higher	O
demands	O
associated	O
with	O
specific	O
metabolic	O
functions	O
such	O
as	O
ureogenesis	O
.	O

Identification	O
of	O
mammalian	O
Sds3	B
as	O
an	O
integral	O
component	O
of	O
the	O
Sin3	O
/	O
histone	O
deacetylase	O
corepressor	O
complex	O
.	O

Silencing	O
of	O
gene	O
transcription	O
involves	O
local	O
chromatin	O
modification	O
achieved	O
through	O
the	O
local	O
recruitment	O
of	O
large	O
multiprotein	O
complexes	O
containing	O
histone	O
deacetylase	O
(	O
HDAC	B
)	O
activity	O
.	O

The	O
mammalian	O
corepressors	O
mSin3A	B
and	O
mSin3B	B
have	O
been	O
shown	O
to	O
play	O
a	O
key	O
role	O
in	O
this	O
process	O
by	O
tethering	O
HDACs	B
1	I
and	I
2	I
to	O
promoter	O
-	O
bound	O
transcription	O
factors	O
.	O

Similar	O
mechanisms	O
appear	O
to	O
be	O
operative	O
in	O
yeast	O
,	O
in	O
which	O
epistasis	O
experiments	O
have	O
established	O
that	O
the	O
mSin3	O
and	O
HDAC	B
orthologs	O
(	O
SIN3	O
and	O
RPD3	B
)	O
,	O
along	O
with	O
a	O
novel	O
protein	O
,	O
SDS3	B
,	O
function	O
in	O
the	O
same	O
repressor	O
pathway	O
.	O

Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
a	O
component	O
of	O
the	O
mSin3-HDAC	O
complex	O
that	O
bears	O
homology	O
to	O
yeast	O
SDS3	B
,	O
physically	O
associates	O
with	O
mSin3	O
proteins	O
in	O
vivo	O
,	O
represses	O
transcription	O
in	O
a	O
manner	O
that	O
is	O
partially	O
dependent	O
on	O
HDAC	B
activity	O
,	O
and	O
enables	O
HDAC1	B
catalytic	O
activity	O
in	O
vivo	O
.	O

That	O
key	O
physical	O
and	O
functional	O
properties	O
are	O
also	O
shared	O
by	O
yeast	O
SDS3	B
underscores	O
the	O
central	O
role	O
of	O
the	O
Sin3-HDAC	O
-	O
Sds3	B
complex	O
in	O
eukaryotic	O
cell	O
biology	O
,	O
and	O
the	O
discovery	O
of	O
mSds3	O
in	O
mammalian	O
cells	O
provides	O
a	O
new	O
avenue	O
for	O
modulating	O
the	O
activity	O
of	O
this	O
complex	O
in	O
human	O
disease	O
.	O

Mirk	B
protein	I
kinase	I
is	O
activated	O
by	O
MKK3	B
and	O
functions	O
as	O
a	O
transcriptional	O
activator	O
of	O
HNF1alpha	B
.	O

Mirk	B
/	O
Dyrk1B	B
is	O
an	O
arginine	O
-	O
directed	O
serine	O
/	O
threonine	O
protein	O
kinase	O
that	O
is	O
expressed	O
at	O
low	O
levels	O
in	O
most	O
normal	O
tissues	O
but	O
at	O
elevated	O
levels	O
in	O
many	O
tumor	O
cell	O
lines	O
and	O
in	O
normal	O
skeletal	O
muscle	O
.	O

Colon	O
carcinoma	O
cell	O
lines	O
stably	O
overexpressing	O
Mirk	B
proliferated	O
in	O
serum	O
-	O
free	O
medium	O
,	O
but	O
the	O
mechanism	O
of	O
Mirk	B
action	O
is	O
unknown	O
.	O

DCoHm	B
(	O
dimerization	B
cofactor	I
of	I
hepatocyte	I
nuclear	I
factor	I
1alpha	I
(	I
HNF1alpha	I
)	I
from	I
muscle	I
)	O
,	O
a	O
novel	O
gene	O
of	O
the	O
DCoH	B
family	O
with	O
78	O
%	O
amino	O
acid	O
identity	O
to	O
DCoH	B
,	O
was	O
identified	O
as	O
a	O
Mirk	B
-	O
binding	O
protein	O
by	O
yeast	O
two	O
-	O
hybrid	O
analysis	O
and	O
cloned	O
.	O

Mirk	B
co	O
-	O
immunoprecipitated	O
with	O
DCoHm	B
and	O
bound	O
to	O
DCoHm	B
in	O
glutathione	O
S	O
-	O
transferase	O
pull	O
-	O
down	O
assays	O
.	O

DCoH	B
stabilizes	O
HNF1alpha	B
as	O
a	O
dimer	O
and	O
enhances	O
its	O
transcriptional	O
activity	O
on	O
the	O
beta	O
-	O
fibrinogen	O
promoter	O
reporter	O
,	O
and	O
DCoHm	B
had	O
similar	O
activity	O
.	O

Mirk	B
enhanced	O
HNF1alpha	B
transcriptional	O
activity	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
,	O
whereas	O
two	O
kinase	O
-	O
inactive	O
Mirk	B
mutants	O
and	O
a	O
Mirk	B
N	O
-	O
terminal	O
deletion	O
mutant	O
did	O
not	O
.	O

Mirk	B
,	O
DCoHm	B
,	O
and	O
HNF1alpha	B
formed	O
a	O
complex	O
.	O

Mirk	B
bound	O
to	O
a	O
specific	O
region	O
within	O
the	O
CREB	O
-	O
binding	O
protein	O
-	O
binding	O
region	O
of	O
HNF1alpha	B
and	O
phosphorylated	O
HNF1alpha	B
at	O
a	O
site	O
adjacent	O
to	O
the	O
Mirk	B
-	O
binding	O
region	O
.	O

Conversely	O
,	O
the	O
HNF1alpha	B
binding	O
domain	O
was	O
located	O
within	O
the	O
first	O
five	O
conserved	O
kinase	O
subdomains	O
of	O
Mirk	B
.	O

Mirk	B
co	O
-	O
immunoprecipitated	O
with	O
the	O
MAPK	B
kinase	I
MKK3	I
,	O
an	O
upstream	O
activator	O
of	O
p38	B
.	O

MKK3	B
enhanced	O
Mirk	B
kinase	O
activity	O
and	O
the	O
transcriptional	O
activation	O
of	O
HNF1alpha	B
by	O
Mirk	B
,	O
suggesting	O
that	O
Mirk	B
,	O
like	O
p38	B
,	O
is	O
activated	O
by	O
certain	O
environmental	O
stress	O
agents	O
.	O

The	O
Mirk	B
-	O
binding	O
protein	O
DCoH	B
has	O
been	O
shown	O
to	O
be	O
selectively	O
expressed	O
in	O
colon	O
carcinomas	O
but	O
not	O
in	O
normal	O
tissue	O
.	O

Mirk	B
may	O
function	O
as	O
an	O
HNF1alpha	B
transcriptional	O
activator	O
in	O
response	O
to	O
an	O
MKK3-mediated	B
stress	O
signal	O
,	O
and	O
the	O
selective	O
expression	O
of	O
DCoH	B
could	O
restrict	O
the	O
Mirk	B
response	O
to	O
carcinoma	O
cells	O
.	O

Human	O
C1qRp	B
is	O
identical	O
with	O
CD93	B
and	O
the	O
mNI-11	B
antigen	I
but	O
does	O
not	O
bind	O
C1q	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
human	O
C1qRp	B
is	O
a	O
receptor	O
for	O
the	O
complement	O
component	O
C1q	O
;	O
however	O
,	O
there	O
is	O
no	O
direct	O
evidence	O
for	O
an	O
interaction	O
between	O
C1q	O
and	O
C1qRp	B
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
C1q	O
does	O
not	O
show	O
enhanced	O
binding	O
to	O
C1qRp	B
-	O
transfected	O
cells	O
compared	O
with	O
control	O
cells	O
.	O

Furthermore	O
,	O
a	O
soluble	O
recombinant	O
C1qRp	B
-	O
Fc	O
chimera	O
failed	O
to	O
interact	O
with	O
immobilized	O
C1q	O
.	O

The	O
proposed	O
role	O
of	O
C1qRp	B
in	O
the	O
phagocytic	O
response	O
in	O
vivo	O
is	O
also	O
unsupported	O
in	O
that	O
we	O
demonstrate	O
that	O
this	O
molecule	O
is	O
not	O
expressed	O
by	O
macrophages	O
in	O
a	O
variety	O
of	O
human	O
tissues	O
and	O
the	O
predominant	O
site	O
of	O
expression	O
is	O
on	O
endothelial	O
cells	O
.	O

Studies	O
on	O
the	O
rodent	O
homolog	O
of	O
C1qRp	B
,	O
known	O
as	O
AA4	O
,	O
have	O
suggested	O
that	O
this	O
molecule	O
may	O
function	O
as	O
an	O
intercellular	O
adhesion	O
molecule	O
.	O

Here	O
we	O
show	O
that	O
C1qRp	B
is	O
the	O
Ag	O
recognized	O
by	O
several	O
previously	O
described	O
mAbs	O
,	O
mNI-11	O
and	O
two	O
anti	O
-	O
CD93	B
Abs	O
(	O
clones	O
X2	O
and	O
VIMD2b	O
)	O
.	O

Interestingly	O
,	O
mNI-11	O
(	O
Fab	O
'	O
)	O
has	O
been	O
shown	O
to	O
promote	O
monocyte	O
-	O
monocyte	O
and	O
monocyte	O
-	O
endothelial	O
cell	O
adhesive	O
interactions	O
.	O

We	O
produced	O
a	O
recombinant	O
C1qRp	B
-	O
Fc	O
chimera	O
containing	O
the	O
C	O
-	O
type	O
lectin	O
-	O
like	O
domain	O
of	O
C1qRp	B
and	O
found	O
specific	O
binding	O
to	O
vascular	O
endothelial	O
cells	O
in	O
sections	O
of	O
inflamed	O
human	O
tonsil	O
,	O
indicating	O
the	O
presence	O
of	O
a	O
C1qRp	B
ligand	O
at	O
this	O
site	O
.	O

This	O
interaction	O
was	O
Ca	O
(	O
2	O
+	O
)	O
independent	O
and	O
was	O
not	O
blocked	O
by	O
our	O
anti	O
-	O
C1qRp	B
mAb	O
BIIG-4	O
,	O
but	O
was	O
blocked	O
by	O
the	O
proadhesive	O
mAb	O
mNI-11	O
.	O

Collectively	O
,	O
these	O
data	O
indicate	O
that	O
C1qRp	B
is	O
not	O
a	O
receptor	O
for	O
C1q	O
,	O
and	O
they	O
support	O
the	O
emerging	O
role	O
of	O
C1qRp	B
(	O
here	O
renamed	O
CD93	B
)	O
in	O
functions	O
relevant	O
to	O
intercellular	O
adhesion	O
.	O

Human	O
sprouty	B
4	I
,	O
a	O
new	O
ras	O
antagonist	O
on	O
5q31	O
,	O
interacts	O
with	O
the	O
dual	O
specificity	O
kinase	O
TESK1	B
.	O

The	O
Drosophila	O
melanogaster	O
protein	O
sprouty	O
is	O
induced	O
upon	O
fibroblast	O
growth	O
factor	O
(	O
FGF	O
)	O
-	O
and	O
epidermal	B
growth	I
factor	I
(	I
EGF	I
)	I
-receptor	I
tyrosine	O
kinase	O
activation	O
and	O
acts	O
as	O
an	O
inhibitor	O
of	O
the	O
ras	O
/	O
MAP	O
kinase	O
pathway	O
downstream	O
of	O
these	O
receptors	O
.	O

By	O
differential	O
display	O
RT	O
-	O
PCR	O
of	O
activated	O
vs.	O
resting	O
umbilical	O
artery	O
smooth	O
muscle	O
cells	O
(	O
SMCs	O
)	O
we	O
detected	O
a	O
new	O
human	O
sprouty	O
gene	O
,	O
which	O
we	O
designated	O
human	O
sprouty	B
4	I
(	O
hspry4	B
)	O
based	O
on	O
its	O
homology	O
with	O
murine	O
sprouty	B
4	I
.	O

Hspry4	B
is	O
widely	O
expressed	O
and	O
Northern	O
blots	O
indicate	O
that	O
different	O
isoforms	O
of	O
hspry4	B
are	O
induced	O
upon	O
cellular	O
activation	O
.	O

The	O
hspry4	B
gene	O
maps	O
to	O
5q31.3	O
.	O

It	O
encodes	O
a	O
protein	O
of	O
322	O
amino	O
acids	O
,	O
which	O
,	O
in	O
support	O
of	O
a	O
modulating	O
role	O
in	O
signal	O
transduction	O
,	O
contains	O
a	O
prototypic	O
cysteine	O
-	O
rich	O
region	O
,	O
three	O
,	O
potentially	O
Src	O
homology	O
3	O
(	O
SH3	O
)	O
binding	O
,	O
proline	O
-	O
rich	O
regions	O
and	O
a	O
PEST	O
sequence	O
.	O

This	O
new	O
sprouty	O
orthologue	O
can	O
suppress	O
the	O
insulin-	B
and	I
EGF	I
-	I
receptor	I
transduced	O
MAP	O
kinase	O
signaling	O
pathway	O
,	O
but	O
fails	O
to	O
inhibit	O
MAP	O
kinase	O
activation	O
by	O
constitutively	O
active	O
V12	O
ras	O
.	O

Hspry4	B
appears	O
to	O
impair	O
the	O
formation	O
of	O
active	O
GTP	O
-	O
ras	O
and	O
exert	O
its	O
activity	O
at	O
the	O
level	O
of	O
wild	O
-	O
type	O
ras	O
or	O
upstream	O
thereof	O
.	O

In	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
,	O
using	O
hspry4	B
as	O
bait	O
,	O
testicular	B
protein	I
kinase	I
1	I
(	O
TESK1	B
)	O
was	O
identified	O
from	O
a	O
human	O
fetal	O
liver	O
cDNA	O
library	O
as	O
a	O
partner	O
of	O
hspry4	B
.	O

The	O
hspry4-TESK1	B
interaction	O
was	O
confirmed	O
by	O
coimmunoprecipitation	O
experiments	O
and	O
increases	O
by	O
growth	O
factor	O
stimulation	O
.	O

The	O
two	O
proteins	O
colocalize	O
in	O
apparent	O
cytoplasmic	O
vesicles	O
and	O
do	O
not	O
show	O
substantial	O
translocation	O
to	O
the	O
plasma	O
membrane	O
upon	O
receptor	O
tyrosine	O
kinase	O
stimulation	O
.	O

Human	O
aminopeptidase	B
B	I
(	O
rnpep	B
)	O
on	O
chromosome	O
1q32.2	O
:	O
complementary	O
DNA	O
,	O
genomic	O
structure	O
and	O
expression	O
.	O

Aminopeptidase	B
B	I
(	O
APB	B
)	O
is	O
a	O
Zn	O
(	O
2+	O
)	O
-metalloexopeptidase	O
,	O
which	O
selectively	O
removes	O
Arg	O
and/or	O
Lys	O
residues	O
from	O
the	O
N	O
-	O
terminus	O
of	O
several	O
peptide	O
substrates	O
.	O

Several	O
data	O
strongly	O
support	O
the	O
hypothesis	O
that	O
this	O
enzyme	O
could	O
participate	O
in	O
the	O
final	O
stages	O
of	O
precursor	O
processing	O
mechanisms	O
and/or	O
in	O
particular	O
inflammatory	O
processes	O
and	O
tumor	O
developments	O
.	O

Therefore	O
,	O
we	O
have	O
cloned	O
the	O
complementary	O
DNA	O
encoding	O
the	O
human	O
APB	B
,	O
a	O
658-residues	O
protein	O
,	O
containing	O
the	O
canonical	O
""""	O
HEXXH	O
(	O
X	O
(	O
18	O
)	O
)	O
E	O
""""	O
,	O
a	O
signature	O
allowing	O
its	O
classification	O
in	O
the	O
M1	O
family	O
of	O
metallopeptidases	O
.	O

The	O
genomic	O
structure	O
of	O
the	O
human	O
APB	B
gene	O
(	O
rnpep	B
;	O
1q32.1-q32.2	O
)	O
was	O
also	O
determined	O
.	O

rnpep	B
is	O
bracketed	O
by	O
pre	O
-	O
protein	O
translocase	O
of	O
the	O
inner	O
mitochondrial	O
membrane	O
gene	O
and	O
ETS	O
family	O
transcription	O
factor	O
ELF3	B
gene	O
.	O

It	O
spans	O
more	O
than	O
24	O
kbp	O
and	O
contains	O
11	O
exons	O
ranging	O
from	O
109	O
to	O
574	O
bp	O
.	O

Finally	O
,	O
expression	O
of	O
the	O
human	O
APB	B
messenger	O
RNA	O
(	O
mRNA	O
)	O
was	O
investigated	O
using	O
a	O
pre	O
-	O
made	O
dot	O
-	O
blot	O
.	O

This	O
mRNA	O
seems	O
to	O
be	O
ubiquitous	O
although	O
its	O
expression	O
level	O
varies	O
depending	O
of	O
the	O
cells	O
or	O
tissues	O
considered	O
.	O

A	O
coregulatory	O
role	O
for	O
the	O
TRAP	O
-	O
mediator	O
complex	O
in	O
androgen	B
receptor	I
-	O
mediated	O
gene	O
expression	O
.	O

The	O
human	O
thyroid	O
hormone	O
receptor	O
-	O
associated	O
protein	O
(	O
TRAP	O
)	O
-Mediator	O
complex	O
was	O
originally	O
identified	O
as	O
a	O
large	O
multimeric	O
complex	O
that	O
copurifies	O
with	O
the	O
thyroid	O
hormone	O
receptor	O
(	O
TR	O
)	O
from	O
HeLa	O
cells	O
and	O
markedly	O
enhances	O
TR	O
-	O
mediated	O
transcription	O
in	O
vitro	O
.	O

More	O
recent	O
studies	O
have	O
implicated	O
TRAP	O
-	O
Mediator	O
as	O
a	O
coactivator	O
for	O
a	O
broad	O
range	O
of	O
nuclear	O
hormone	O
receptors	O
as	O
well	O
as	O
other	O
classes	O
of	O
transcriptional	O
activators	O
.	O

Here	O
we	O
present	O
evidence	O
that	O
TRAP	O
-	O
Mediator	O
plays	O
a	O
functional	O
role	O
in	O
androgen	B
receptor	I
(	O
AR	B
)	O
-mediated	O
transcription	O
.	O

We	O
show	O
that	O
several	O
subunits	O
of	O
the	O
complex	O
ligand	O
-	O
dependently	O
coimmunoprecipitate	O
with	O
AR	B
from	O
both	O
prostate	O
cancer	O
LNCaP	O
cells	O
and	O
from	O
HeLa	O
cells	O
stably	O
transfected	O
with	O
AR	B
.	O

The	O
220-kDa	O
subunit	O
of	O
the	O
complex	O
(	O
TRAP220	B
)	O
can	O
contact	O
the	O
ligand	O
-	O
binding	O
domain	O
of	O
AR	B
in	O
vitro	O
,	O
possibly	O
implicating	O
TRAP220	B
involvement	O
in	O
targeting	O
AR	B
to	O
the	O
holocomplex	O
.	O

Consistent	O
with	O
a	O
TRAP	O
-	O
Mediator	O
coactivator	O
role	O
,	O
transient	O
overexpression	O
of	O
the	O
TRAP220	B
,	O
TRAP170	B
,	O
and	O
TRAP100	B
subunits	O
enhanced	O
ligand	O
-	O
dependent	O
transcription	O
by	O
AR	B
in	O
cultured	O
cells	O
.	O

Finally	O
,	O
chromatin	O
immunoprecipitation	O
assays	O
show	O
that	O
TRAP220	B
is	O
recruited	O
to	O
the	O
androgen	O
-	O
responsive	O
prostate	O
-	O
specific	O
antigen	O
gene	O
promoter	O
in	O
vivo	O
in	O
ligand	O
-	O
stimulated	O
LNCaP	O
cells	O
.	O

Collectively	O
,	O
these	O
data	O
suggest	O
that	O
TRAP	O
-	O
Mediator	O
may	O
play	O
an	O
important	O
coregulatory	O
role	O
in	O
AR	B
-	O
mediated	O
gene	O
expression	O
.	O

Role	O
of	O
TRAF3	B
and	I
-6	I
in	O
the	O
activation	O
of	O
the	O
NF	O
-	O
kappa	O
B	O
and	O
JNK	B
pathways	O
by	O
X	B
-	I
linked	I
ectodermal	I
dysplasia	I
receptor	I
.	O

X	B
-	I
linked	I
ectodermal	I
dysplasia	I
receptor	I
(	O
XEDAR	B
)	O
is	O
a	O
recently	O
isolated	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
receptor	O
family	O
that	O
has	O
been	O
shown	O
to	O
be	O
highly	O
expressed	O
in	O
ectodermal	O
derivatives	O
during	O
embryonic	O
development	O
and	O
binds	O
to	O
ectodysplasin	B
-	I
A2	I
(	O
EDA	B
-	I
A2	I
)	O
.	O

By	O
using	O
a	O
subclone	O
of	O
293F	O
cells	O
with	O
stable	O
expression	O
of	O
XEDAR	B
,	O
we	O
report	O
that	O
XEDAR	B
activates	O
the	O
NF	O
-	O
kappaB	O
and	O
JNK	B
pathways	O
in	O
an	O
EDA	B
-	I
A2-dependent	I
fashion	O
.	O

Treatment	O
with	O
EDA	B
-	I
A2	I
leads	O
to	O
the	O
recruitment	O
of	O
TRAF3	B
and	I
-6	I
to	O
the	O
aggregated	O
XEDAR	B
complex	O
,	O
suggesting	O
a	O
central	O
role	O
of	O
these	O
adaptors	O
in	O
the	O
proximal	O
aspect	O
of	O
XEDAR	B
signaling	O
.	O

Whereas	O
TRAF3	B
and	I
-6	I
,	O
IKK1	B
/	I
IKKalpha	I
,	O
IKK2	B
/	I
IKKbeta	I
,	O
and	O
NEMO	B
/	I
IKKgamma	I
are	O
involved	O
in	O
XEDAR	B
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
,	O
XEDAR	B
-	O
induced	O
JNK	B
activation	O
seems	O
to	O
be	O
mediated	O
via	O
a	O
pathway	O
dependent	O
on	O
TRAF3	B
,	O
TRAF6	B
,	O
and	O
ASK1	B
.	O

Deletion	O
and	O
point	O
mutagenesis	O
studies	O
delineate	O
two	O
distinct	O
regions	O
in	O
the	O
cytoplasmic	O
domain	O
of	O
XEDAR	B
,	O
which	O
are	O
involved	O
in	O
binding	O
to	O
TRAF3	B
and	I
-6	I
,	O
respectively	O
,	O
and	O
play	O
a	O
major	O
role	O
in	O
the	O
activation	O
of	O
the	O
NF	O
-	O
kappaB	O
and	O
JNK	B
pathways	O
.	O

Taken	O
together	O
,	O
our	O
results	O
establish	O
a	O
major	O
role	O
of	O
TRAF3	B
and	I
-6	I
in	O
XEDAR	B
signaling	O
and	O
in	O
the	O
process	O
of	O
ectodermal	O
differentiation	O
.	O

K+	O
channel	O
activation	O
by	O
all	O
three	O
isoforms	O
of	O
serum-	O
and	O
glucocorticoid	O
-	O
dependent	O
protein	O
kinase	O
SGK	B
.	O

The	O
serum-	O
and	O
glucocorticoid	O
-	O
dependent	O
kinase	O
SGK1	B
was	O
originally	O
identified	O
as	O
a	O
glucocorticoid	O
-	O
sensitive	O
gene	O
.	O

Subsequently	O
,	O
the	O
two	O
homologous	O
kinases	O
SGK2	B
and	O
SGK3	B
have	O
been	O
cloned	O
,	O
being	O
products	O
of	O
distinct	O
genes	O
,	O
which	O
are	O
differentially	O
expressed	O
and	O
share	O
80	O
%	O
identity	O
in	O
amino	O
acid	O
sequence	O
in	O
their	O
catalytic	O
domains	O
.	O

While	O
SGK1	B
has	O
been	O
shown	O
to	O
activate	O
ion	O
channels	O
,	O
including	O
K	O
(	O
+	O
)	O
channels	O
,	O
the	O
functions	O
of	O
SGK2	B
and	O
SGK3	B
have	O
not	O
been	O
examined	O
.	O

The	O
present	O
study	O
was	O
therefore	O
performed	O
to	O
elucidate	O
the	O
effect	O
of	O
SGK1	B
,	O
SGK2	B
,	O
and	O
SGK3	B
on	O
electrical	O
properties	O
of	O
renal	O
epithelial	O
cells	O
.	O

To	O
this	O
end	O
human	O
embryonic	O
kidney	O
(	O
HEK293	O
)	O
cells	O
were	O
transfected	O
with	O
the	O
kinases	O
and	O
ion	O
-	O
channel	O
activity	O
determined	O
using	O
the	O
patch	O
-	O
clamp	O
technique	O
.	O

In	O
non	O
-	O
transfected	O
cells	O
and	O
in	O
cells	O
transfected	O
with	O
the	O
empty	O
GFP	O
construct	O
a	O
voltage	O
-	O
gated	O
K	O
(	O
+	O
)	O
current	O
was	O
observed	O
amounting	O
to	O
303+	O
/	O
-19	O
pA	O
(	O
n=13	O
)	O
and	O
299+	O
/	O
-29	O
pA	O
(	O
n=23	O
)	O
,	O
respectively	O
.	O

Transfection	O
with	O
SGK1	B
,	O
SGK2	B
or	O
SGK3	B
increased	O
the	O
voltage	O
-	O
gated	O
K	O
(	O
+	O
)	O
current	O
to	O
1056+	O
/	O
-152	O
pA	O
(	O
n=17	O
)	O
,	O
555+	O
/	O
-47	O
pA	O
(	O
n=17	O
)	O
,	O
and	O
775+	O
/	O
-98	O
pA	O
(	O
n=16	O
)	O
,	O
respectively	O
.	O

The	O
K	O
(	O
+	O
)	O
current	O
was	O
fully	O
blocked	O
by	O
3	O
mM	O
tetraethylammonium	O
chloride	O
and	O
inhibited	O
45	O
%	O
by	O
the	O
Kv1	O
channel	O
blocker	O
margatoxin	O
(	O
10	O
nM	O
)	O
.	O

In	O
dual	O
electrode	O
voltage	O
-	O
clamp	O
experiments	O
SGK	B
isoforms	O
up	O
-	O
regulated	O
Kv1	O
voltage	O
-	O
gated	O
K	O
(	O
+	O
)	O
channels	O
expressed	O
in	O
Xenopus	O
laevis	O
oocytes	O
.	O

The	O
present	O
observations	O
thus	O
reveal	O
a	O
powerful	O
stimulating	O
effect	O
of	O
all	O
three	O
isoforms	O
of	O
SGK	B
on	O
K	O
(	O
+	O
)	O
channels	O
.	O

Those	O
effects	O
may	O
participate	O
in	O
regulation	O
of	O
epithelial	O
transport	O
,	O
cell	O
proliferation	O
,	O
and	O
neuromuscular	O
excitability	O
.	O

Physical	O
interaction	O
between	O
hepatitis	O
C	O
virus	O
NS4B	O
protein	O
and	O
CREB	B
-	I
RP	I
/	O
ATF6beta	B
.	O

By	O
using	O
a	O
yeast	O
two	O
-	O
hybrid	O
assay	O
,	O
cyclic	B
AMP	I
-	I
response	I
-	I
element	I
-	I
binding	I
protein	I
-	I
related	I
protein	I
(	O
CREB	B
-	I
RP	I
)	O
,	O
also	O
called	O
activating	B
transcription	I
factor	I
6beta	I
(	O
ATF6beta	B
)	O
,	O
was	O
identified	O
as	O
a	O
cellular	O
protein	O
that	O
interacts	O
with	O
the	O
NS4B	O
protein	O
of	O
hepatitis	O
C	O
virus	O
.	O

An	O
N	O
-	O
terminal	O
half	O
of	O
NS4B	O
and	O
a	O
central	O
portion	O
of	O
CREB	B
-	I
RP	I
/	O
ATF6beta	B
containing	O
the	O
basic	O
leucine	O
zipper	O
(	O
bZIP	O
)	O
domain	O
were	O
involved	O
in	O
the	O
interaction	O
.	O

The	O
interaction	O
between	O
NS4B	O
and	O
CREB	B
-	I
RP	I
/	O
ATF6beta	B
was	O
demonstrated	O
also	O
in	O
mammalian	O
cells	O
by	O
co	O
-	O
immunoprecipitation	O
and	O
confocal	O
microscopic	O
analyses	O
using	O
specific	O
antibodies	O
.	O

The	O
bZIP	O
domain	O
of	O
ATF6alpha	B
,	O
which	O
shares	O
high	O
sequence	O
similarity	O
with	O
CREB	B
-	I
RP	I
/	O
ATF6beta	B
,	O
was	O
also	O
shown	O
to	O
interact	O
with	O
NS4B	O
in	O
yeast	O
although	O
the	O
interaction	O
was	O
weaker	O
than	O
that	O
between	O
NS4B	O
and	O
CREB	B
-	I
RP	I
/	O
ATF6beta	B
.	O

CREB	B
-	I
RP	I
/	O
ATF6beta	B
and	O
ATF6alpha	B
are	O
known	O
as	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
-	O
induced	O
transcription	O
factors	O
.	O

Collectively	O
,	O
our	O
results	O
imply	O
the	O
possibility	O
that	O
NS4B	O
modulates	O
certain	O
cellular	O
responses	O
upon	O
ER	O
stress	O
through	O
the	O
physical	O
interaction	O
with	O
CREB	B
-	I
RP	I
/	O
ATF6beta	B
and	O
ATF6alpha	B
.	O

Complex	O
transcriptional	O
effects	O
of	O
p63	B
isoforms	O
:	O
identification	O
of	O
novel	O
activation	O
and	O
repression	O
domains	O
.	O

p63	B
is	O
a	O
transcription	O
factor	O
structurally	O
related	O
to	O
the	O
p53	B
tumor	O
suppressor	O
.	O

The	O
C	O
-	O
terminal	O
region	O
differs	O
from	O
p53	B
's	O
in	O
that	O
it	O
contains	O
a	O
sterile	O
alpha	O
motif	O
(	O
SAM	O
)	O
domain	O
and	O
is	O
subject	O
to	O
multiple	O
alternative	O
splicings	O
.	O

The	O
N	O
-	O
terminal	O
region	O
is	O
present	O
in	O
the	O
transactivation	O
(	O
TA	O
)	O
and	O
DeltaN	O
configurations	O
,	O
with	O
the	O
latter	O
lacking	O
the	O
transcriptional	O
activation	O
domain	O
1	O
.	O

Single	O
amino	O
acid	O
substitutions	O
and	O
frameshift	O
mutations	O
of	O
p63	B
cause	O
the	O
human	O
ankyloblepharon	O
ectodermal	O
dysplasia	O
clefting	O
(	O
AEC	O
)	O
or	O
ectrodactyly	O
ectodermal	O
dysplasia	O
and	O
facial	O
clefting	O
(	O
EEC	O
)	O
syndromes	O
.	O

We	O
have	O
systematically	O
compared	O
the	O
activities	O
of	O
the	O
wild	O
-	O
type	O
p63	B
isoforms	O
and	O
of	O
the	O
natural	O
mutants	O
in	O
activation	O
and	O
repression	O
assays	O
on	O
three	O
promoters	O
modulated	O
by	O
p53	B
.	O

We	O
found	O
that	O
p63	B
proteins	O
with	O
an	O
altered	O
SAM	O
domain	O
or	O
no	O
SAM	O
domain	O
-	O
the	O
beta	O
isoforms	O
,	O
the	O
EEC	O
frameshift	O
mutant	O
,	O
and	O
the	O
missense	O
AEC	O
mutations	O
-	O
all	O
showed	O
a	O
distinctly	O
higher	O
level	O
of	O
activation	O
of	O
the	O
MDM2	B
promoter	O
and	O
decreased	O
repression	O
on	O
the	O
HSP70	O
promoter	O
.	O

Fusion	O
of	O
SAM	O
to	O
the	O
GAL4	B
DNA	O
-	O
binding	O
domain	O
repressed	O
a	O
heterologous	O
promoter	O
.	O

A	O
second	O
activation	O
domain	O
,	O
TA2	O
,	O
corresponding	O
to	O
exons	O
11	O
to	O
12	O
,	O
was	O
uncovered	O
by	O
comparing	O
the	O
activation	O
of	O
DeltaN	O
isoforms	O
on	O
natural	O
promoters	O
and	O
in	O
GAL4	B
fusion	O
systems	O
.	O

In	O
colony	O
formation	O
assays	O
,	O
the	O
AEC	O
mutants	O
,	O
but	O
not	O
the	O
EEC	O
frameshift	O
,	O
were	O
consistently	O
less	O
efficient	O
in	O
suppressing	O
growth	O
,	O
in	O
both	O
the	O
TA	O
version	O
and	O
the	O
DeltaN	O
version	O
,	O
with	O
respect	O
to	O
their	O
p63alpha	B
counterparts	O
.	O

These	O
data	O
highlight	O
the	O
modularity	O
of	O
p63	B
,	O
identifying	O
the	O
SAM	O
domain	O
as	O
a	O
dominant	O
transcriptional	O
repression	O
module	O
and	O
indicating	O
that	O
the	O
AEC	O
and	O
EEC	O
frameshift	O
mutants	O
are	O
characterized	O
by	O
a	O
subversion	O
of	O
the	O
p63	B
transcriptional	O
potential	O
.	O

The	O
human	O
tuftelin	B
gene	O
and	O
the	O
expression	O
of	O
tuftelin	B
in	O
mineralizing	O
and	O
nonmineralizing	O
tissues	O
.	O

Tuftelin	B
has	O
been	O
suggested	O
to	O
play	O
an	O
important	O
role	O
during	O
the	O
development	O
and	O
mineralization	O
of	O
enamel	O
,	O
but	O
its	O
precise	O
function	O
is	O
still	O
unclear	O
.	O

This	O
article	O
reviews	O
major	O
milestones	O
in	O
the	O
discovery	O
,	O
structural	O
characterization	O
,	O
expression	O
,	O
localization	O
,	O
and	O
conservation	O
of	O
tuftelin	B
in	O
different	O
vertebrate	O
species	O
.	O

It	O
focuses	O
on	O
the	O
structure	O
of	O
the	O
human	O
tuftelin	B
gene	O
,	O
which	O
has	O
recently	O
been	O
deciphered	O
[	O
12	O
]	O
.	O

It	O
describes	O
the	O
exon	O
-	O
intron	O
organization	O
,	O
sizes	O
and	O
structure	O
,	O
the	O
promoter	O
structure	O
,	O
and	O
the	O
newly	O
discovered	O
alternatively	O
spliced	O
human	O
tooth	O
-	O
bud	O
tuftelin	B
mRNA	O
transcripts	O
.	O

It	O
also	O
examines	O
information	O
on	O
the	O
structural	O
motifs	O
in	O
the	O
human	O
-	O
derived	O
tuftelin	B
protein	O
and	O
how	O
they	O
relate	O
to	O
tuftelin	B
from	O
other	O
species	O
.	O

It	O
reviews	O
our	O
recent	O
results	O
on	O
the	O
transcription	O
of	O
tuftelin	B
mRNA	O
and	O
protein	O
expression	O
in	O
several	O
nonmineralizing	O
soft	O
tissues	O
,	O
using	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
followed	O
by	O
DNA	O
cloning	O
and	O
sequencing	O
,	O
indirect	O
immunohistochemistry	O
,	O
immunohistochemistry	O
combined	O
with	O
confocal	O
microscopy	O
,	O
and	O
in	O
situ	O
hybridization	O
.	O

These	O
results	O
and	O
earlier	O
Northern	O
blot	O
results	O
show	O
that	O
tuftelin	B
,	O
in	O
addition	O
to	O
being	O
expressed	O
in	O
the	O
developing	O
and	O
mineralizing	O
tooth	O
,	O
is	O
also	O
expressed	O
in	O
several	O
nonmineralizing	O
soft	O
tissues	O
,	O
suggesting	O
that	O
tuftelin	B
has	O
a	O
universal	O
function	O
and/or	O
a	O
multifunctional	O
role	O
.	O

Human	O
IL-21	B
and	O
IL-4	B
bind	O
to	O
partially	O
overlapping	O
epitopes	O
of	O
common	B
gamma	I
-	I
chain	I
.	O

Interleukin	B
21	I
(	O
IL-21	B
)	O
is	O
a	O
recently	O
identified	O
novel	O
cytokine	O
that	O
plays	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
B	O
,	O
T	O
,	O
and	O
NK	O
cell	O
functions	O
.	O

Its	O
effects	O
depend	O
on	O
binding	O
to	O
and	O
signaling	O
through	O
an	O
IL-21	B
receptor	I
complex	O
consisting	O
of	O
the	O
IL-21	B
receptor	I
(	O
IL-21R	B
)	O
and	O
the	O
common	B
gamma	I
-	I
chain	I
(	O
gamma	B
(	I
c	I
)	I
)	O
.	O

In	O
this	O
study	O
using	O
biosensor	O
technique	O
,	O
the	O
ligand	O
-	O
binding	O
properties	O
of	O
IL-21R	B
and	O
gamma	B
(	I
c	I
)	I
,	O
which	O
are	O
presently	O
poorly	O
understood	O
on	O
a	O
molecular	O
level	O
,	O
were	O
analyzed	O
employing	O
recombinant	O
ectodomains	O
of	O
IL-21R	B
and	O
gamma	B
(	I
c	I
)	I
.	O

The	O
formation	O
of	O
a	O
binary	O
complex	O
between	O
IL-21	B
and	O
immobilized	O
IL-21R	B
(	O
K	O
(	O
D	O
)	O
70pM	O
)	O
,	O
gamma	B
(	I
c	I
)	I
and	O
immobilized	O
IL-21	B
(	O
K	O
(	O
D	O
)	O
160	O
microM	O
)	O
and	O
a	O
ternary	O
complex	O
between	O
gamma	B
(	I
c	I
)	I
and	O
IL-21	B
saturated	O
immobilized	O
IL-21R	B
(	O
K	O
(	O
D	O
)	O
160nM	O
)	O
could	O
be	O
analyzed	O
.	O

The	O
gamma	B
(	I
c	I
)	I
residues	O
involved	O
in	O
IL-21	B
binding	O
were	O
defined	O
by	O
alanine	O
-	O
scanning	O
mutational	O
analysis	O
.	O

The	O
epitope	O
comprises	O
gamma	B
(	I
c	I
)	I
residues	O
N44	O
,	O
Y103	O
,	O
N128	O
,	O
L161	O
,	O
E162	O
,	O
and	O
L208	O
.	O

It	O
is	O
not	O
identical	O
but	O
partially	O
overlapping	O
with	O
the	O
previously	O
established	O
gamma	B
(	I
c	I
)	I
epitope	O
for	O
IL-4	B
binding	O
.	O

These	O
results	O
open	O
the	O
way	O
to	O
understand	O
the	O
molecular	O
recognition	O
mechanism	O
in	O
the	O
IL-21	B
receptor	I
system	O
and	O
also	O
the	O
promiscuous	O
binding	O
properties	O
of	O
gamma	B
(	I
c	I
)	I
.	O

Robo1	B
and	O
Robo2	B
are	O
homophilic	O
binding	O
molecules	O
that	O
promote	O
axonal	O
growth	O
.	O

In	O
the	O
present	O
study	O
we	O
show	O
that	O
following	O
transfection	O
in	O
3T3	O
cells	O
,	O
human	O
Robo1	B
and	O
Robo2	B
stimulate	O
neurite	O
outgrowth	O
from	O
Robo	B
-	O
positive	O
neurons	O
(	O
retinal	O
neurons	O
and	O
olfactory	O
neurons	O
)	O
,	O
but	O
have	O
no	O
effect	O
on	O
Robo	B
-	O
negative	O
neurons	O
(	O
cerebellar	O
granule	O
cells	O
)	O
.	O

The	O
neurite	O
outgrowth	O
response	O
was	O
inhibited	O
by	O
an	O
antibody	O
raised	O
against	O
the	O
first	O
Ig	O
domain	O
of	O
Robo1	B
/	I
2	I
or	O
by	O
soluble	O
Robo	B
-	O
Fc	O
chimera	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
the	O
extracellular	O
domains	O
of	O
Robo1	B
and	O
Robo2	B
are	O
homophilic	O
adhesion	O
molecules	O
that	O
can	O
also	O
interact	O
with	O
each	O
other	O
.	O

These	O
data	O
suggest	O
a	O
wider	O
range	O
of	O
functions	O
for	O
the	O
Robo	B
family	O
in	O
the	O
development	O
of	O
the	O
nervous	O
system	O
and	O
provide	O
novel	O
insights	O
into	O
the	O
molecular	O
basis	O
for	O
the	O
phenotypes	O
observed	O
in	O
Robo	B
mutants	O
in	O
Drosophila	O
,	O
C.	O
elegans	O
,	O
and	O
zebrafish	O
.	O

TIRP	B
,	O
a	O
novel	O
Toll	O
/	O
interleukin-1	O
receptor	O
(	O
TIR	O
)	O
domain	O
-	O
containing	O
adapter	O
protein	O
involved	O
in	O
TIR	O
signaling	O
.	O

The	O
Toll	O
/	O
interleukin-1	O
receptor	O
(	O
TIR	O
)	O
family	O
members	O
play	O
important	O
roles	O
in	O
host	O
defense	O
.	O

These	O
receptors	O
signal	O
through	O
TIR	O
domain	O
-	O
containing	O
adapter	O
proteins	O
.	O

In	O
this	O
report	O
,	O
we	O
identified	O
a	O
novel	O
TIR	O
domain	O
-	O
containing	O
adapter	O
protein	O
designated	O
as	O
TIRP	B
.	O

Co	O
-	O
immunoprecipitation	O
experiments	O
suggest	O
that	O
TIRP	B
is	O
associated	O
with	O
IL-1	O
receptors	O
.	O

TIRP	B
also	O
interacts	O
with	O
kinase	O
-	O
inactive	O
mutants	O
of	O
IRAK	B
and	O
IRAK-4	B
,	O
IRAK-2	B
,	O
IRAK	B
-	I
M	I
,	O
and	O
TRAF6	B
.	O

Overexpression	O
of	O
TIRP	B
activates	O
NF	O
-	O
kappaB	O
and	O
potentiates	O
IL-1	O
receptor	O
-	O
mediated	O
NF	O
-	O
kappaB	O
activation	O
.	O

A	O
dominant	O
negative	O
mutant	O
of	O
TIRP	B
inhibits	O
IL-1-	O
but	O
not	O
tumor	O
necrosis	O
factor	O
-	O
triggered	O
NF	O
-	O
kappaB	O
activation	O
.	O

Moreover	O
,	O
TIRP	B
-	O
mediated	O
NF	O
-	O
kappaB	O
activation	O
is	O
inhibited	O
by	O
dominant	O
negative	O
mutants	O
of	O
IRAK	B
,	O
IRAK-2	B
,	O
TRAF6	B
,	O
and	O
IKKbeta	B
.	O

Our	O
findings	O
suggest	O
that	O
TIRP	B
is	O
involved	O
in	O
IL-1-triggered	O
NF	O
-	O
kappaB	O
activation	O
and	O
functions	O
upstream	O
of	O
IRAK	B
,	O
IRAK-2	B
,	O
TRAF6	B
,	O
and	O
IKKbeta	B

Ca2	O
+	O
-dependent	O
potentiation	O
of	O
the	O
nonselective	O
cation	O
channel	O
TRPV4	B
is	O
mediated	O
by	O
a	O
C	O
-	O
terminal	O
calmodulin	O
binding	O
site	O
.	O

Most	O
Ca2	O
+	O
-permeable	O
ion	O
channels	O
are	O
inhibited	O
by	O
increases	O
in	O
the	O
intracellular	O
Ca2	O
+	O
concentration	O
(	O
[	O
Ca2+	O
]	O
i	O
)	O
,	O
thus	O
preventing	O
potentially	O
deleterious	O
rises	O
in	O
[	O
Ca2+	O
]	O
i	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
currents	O
through	O
the	O
osmo-	O
,	O
heat-	O
and	O
phorbol	O
ester	O
-	O
sensitive	O
,	O
Ca2	O
+	O
-permeable	O
nonselective	O
cation	O
channel	O
TRPV4	B
are	O
potentiated	O
by	O
intracellular	O
Ca2	O
+	O
.	O

Spontaneous	O
TRPV4	B
currents	O
and	O
currents	O
stimulated	O
by	O
hypotonic	O
solutions	O
or	O
phorbol	O
esters	O
were	O
reduced	O
strongly	O
at	O
all	O
potentials	O
in	O
the	O
absence	O
of	O
extracellular	O
Ca2	O
+	O
.	O

The	O
other	O
permeant	O
divalent	O
cations	O
Ba2	O
+	O
and	O
Sr2	O
+	O
were	O
less	O
effective	O
than	O
Ca2	O
+	O
in	O
supporting	O
channel	O
activity	O
.	O

An	O
intracellular	O
site	O
of	O
Ca2	O
+	O
action	O
was	O
supported	O
by	O
the	O
parallel	O
decrease	O
in	O
spontaneous	O
currents	O
and	O
[	O
Ca2+	O
]	O
i	O
on	O
removal	O
of	O
extracellular	O
Ca2	O
+	O
and	O
the	O
ability	O
of	O
Ca2	O
+	O
release	O
from	O
intracellular	O
stores	O
to	O
restore	O
TRPV4	B
activity	O
in	O
the	O
absence	O
of	O
extracellular	O
Ca2	O
+	O
.	O

During	O
TRPV4	B
activation	O
by	O
hypotonic	O
solutions	O
or	O
phorbol	O
esters	O
,	O
Ca2	O
+	O
entry	O
through	O
the	O
channel	O
increased	O
the	O
rate	O
and	O
extent	O
of	O
channel	O
activation	O
.	O

Currents	O
were	O
also	O
potentiated	O
by	O
ionomycin	O
in	O
the	O
presence	O
of	O
extracellular	O
Ca2	O
+	O
.	O

Ca2	O
+	O
-dependent	O
potentiation	O
of	O
TRPV4	B
was	O
often	O
followed	O
by	O
inhibition	O
.	O

By	O
mutagenesis	O
,	O
we	O
localized	O
the	O
structural	O
determinant	O
of	O
Ca2	O
+	O
-dependent	O
potentiation	O
to	O
an	O
intracellular	O
,	O
C	O
-	O
terminal	O
calmodulin	O
binding	O
domain	O
.	O

This	O
domain	O
binds	O
calmodulin	O
in	O
a	O
Ca2	O
+	O
-dependent	O
manner	O
.	O

TRPV4	B
mutants	O
that	O
did	O
not	O
bind	O
calmodulin	O
lacked	O
Ca2	O
+	O
-dependent	O
potentiation	O
.	O

We	O
conclude	O
that	O
TRPV4	B
activity	O
is	O
tightly	O
controlled	O
by	O
intracellular	O
Ca2	O
+	O
.	O

Ca2	O
+	O
entry	O
increases	O
both	O
the	O
rate	O
and	O
extent	O
of	O
channel	O
activation	O
by	O
a	O
calmodulin	O
-	O
dependent	O
mechanism	O
.	O

Excessive	O
increases	O
in	O
[	O
Ca2+	O
]	O
i	O
via	O
TRPV4	B
are	O
prevented	O
by	O
a	O
Ca2	O
+	O
-dependent	O
negative	O
feedback	O
mechanism	O
.	O

Antagonistic	O
effects	O
of	O
beta	B
-	I
site	I
amyloid	I
precursor	I
protein	I
-	I
cleaving	I
enzymes	I
1	I
and	I
2	I
on	O
beta	B
-	I
amyloid	I
peptide	I
production	O
in	O
cells	O
.	O

The	O
deposition	O
of	O
extracellular	O
beta	B
-	I
amyloid	I
peptide	I
(	O
A	B
beta	I
)	O
in	O
the	O
brain	O
is	O
a	O
pathologic	O
feature	O
of	O
Alzheimer	B
's	O
disease	O
.	O

The	O
beta	B
-	I
site	I
amyloid	I
precursor	I
protein	I
cleaving	I
enzyme	I
1	I
(	O
BACE1	B
)	O
,	O
an	O
integral	O
membrane	O
aspartyl	O
protease	O
responsible	O
for	O
cleavage	O
of	O
amyloid	B
precursor	I
protein	I
(	O
APP	B
)	O
at	O
the	O
beta	O
-	O
site	O
,	O
promotes	O
A	B
beta	I
production	O
.	O

A	O
second	O
integral	O
membrane	O
aspartyl	O
protease	O
related	O
to	O
BACE1	B
,	O
referred	O
to	O
as	O
beta	B
-	I
site	I
amyloid	I
precursor	I
protein	I
cleaving	I
enzyme	I
2	I
(	O
BACE2	B
)	O
has	O
also	O
been	O
demonstrated	O
to	O
cleave	O
APP	B
at	O
the	O
beta	O
-	O
cleavage	O
site	O
in	O
transfected	O
cells	O
.	O

The	O
role	O
of	O
endogenous	O
BACE2	B
in	O
A	B
beta	I
production	O
remains	O
unresolved	O
.	O

We	O
investigated	O
the	O
role	O
of	O
endogenous	O
BACE2	B
in	O
A	B
beta	I
production	O
in	O
cells	O
by	O
selective	O
inactivation	O
of	O
its	O
transcripts	O
using	O
RNA	O
interference	O
.	O

We	O
are	O
able	O
to	O
reduce	O
steady	O
state	O
levels	O
for	O
mRNA	O
for	O
each	O
enzyme	O
by	O
>	O
85	O
%	O
,	O
and	O
protein	O
amounts	O
by	O
88	O
-	O
94	O
%	O
in	O
cells	O
.	O

Selective	O
inactivation	O
of	O
BACE1	B
by	O
RNA	O
interference	O
results	O
in	O
decreased	O
beta	O
-	O
cleaved	O
secreted	O
APP	B
and	O
A	B
beta	I
peptide	O
secretion	O
from	O
cells	O
,	O
as	O
expected	O
.	O

Selective	O
inactivation	O
of	O
BACE2	B
by	O
RNAi	O
results	O
in	O
increased	O
beta	O
-	O
cleaved	O
secreted	O
APP	B
and	O
A	B
beta	I
peptide	O
secretion	O
from	O
cells	O
.	O

Simultaneous	O
targeting	O
of	O
both	O
enzymes	O
by	O
RNA	O
interference	O
does	O
not	O
have	O
any	O
net	O
effect	O
on	O
A	B
beta	I
released	O
from	O
cells	O
.	O

Our	O
observations	O
of	O
changes	O
in	O
APP	B
metabolism	O
and	O
A	B
beta	I
are	O
consistent	O
with	O
a	O
role	O
of	O
BACE2	B
in	O
suppressing	O
A	B
beta	I
production	O
in	O
cells	O
that	O
co	O
-	O
express	O
both	O
enzymes	O
.	O

Characterization	O
of	O
Pellino2	B
,	O
a	O
substrate	O
of	O
IRAK1	B
and	O
IRAK4	B
.	O

Interleukin-1	O
(	O
IL-1	O
)	O
receptor	O
-	O
associated	O
kinases	O
(	O
IRAKs	O
)	O
are	O
central	O
components	O
of	O
Toll	O
/	O
IL-1	O
receptor	O
(	O
TIR	O
)	O
signaling	O
pathways	O
.	O

In	O
an	O
attempt	O
to	O
discover	O
novel	O
signal	O
transducers	O
in	O
TIR	O
signaling	O
,	O
we	O
identified	O
human	O
Pellino2	B
as	O
an	O
interaction	O
partner	O
of	O
IRAK4	B
.	O

Pellino2	B
interacts	O
with	O
kinase	O
-	O
active	O
as	O
well	O
as	O
kinase	O
-	O
inactive	O
IRAK1	B
and	O
IRAK4	B
.	O

Furthermore	O
,	O
Pellino2	B
is	O
one	O
of	O
the	O
first	O
substrates	O
identified	O
for	O
IRAK1	B
and	O
IRAK4	B
.	O

Functional	O
studies	O
using	O
overexpression	O
or	O
RNAi	O
knock	O
-	O
down	O
of	O
Pellino2	B
suggest	O
a	O
role	O
of	O
Pellino2	B
as	O
a	O
scaffolding	O
protein	O
similar	O
to	O
Pellino1	B
.	O

However	O
,	O
unlike	O
Pellino1	B
,	O
Pellino2	B
does	O
not	O
seem	O
to	O
activate	O
a	O
specific	O
transcription	O
factor	O
,	O
but	O
links	O
TIR	O
signaling	O
to	O
basic	O
cellular	O
processes	O
.	O

Expression	O
and	O
localization	O
of	O
VCX	O
/	O
Y	O
proteins	O
and	O
their	O
possible	O
involvement	O
in	O
regulation	O
of	O
ribosome	O
assembly	O
during	O
spermatogenesis	O
.	O

Variable	O
Charge	O
X	O
/	O
Y	O
(	O
VCX	O
/	O
Y	O
)	O
is	O
a	O
human	O
testis	O
-	O
specific	O
gene	O
family	O
that	O
localized	O
on	O
X	O
and	O
Y	O
chromosomes	O
.	O

In	O
this	O
study	O
,	O
VCY	B
protein	O
was	O
expressed	O
in	O
E.	O
coli	O
in	O
the	O
form	O
of	O
glutathione	O
-	O
S	O
-	O
transferase	O
(	O
GST	O
)	O
fusion	O
protein	O
.	O

With	O
the	O
purified	O
fusion	O
protein	O
as	O
antigen	O
,	O
the	O
anti	O
-	O
GST	O
-	O
VCY	B
antibody	O
was	O
generated	O
and	O
the	O
localization	O
of	O
VCY	B
protein	O
in	O
human	O
testis	O
was	O
determined	O
by	O
immunohistochemistry	O
.	O

In	O
the	O
testis	O
seminiferous	O
epithelium	O
,	O
VCY	B
proteins	O
were	O
highly	O
expressed	O
in	O
nuclei	O
of	O
germ	O
cells	O
.	O

Using	O
propidium	O
iodide	O
staining	O
and	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
tag	O
technologies	O
,	O
VCY	B
and	O
VCX-8r	B
proteins	O
were	O
mainly	O
localized	O
in	O
the	O
nucleoli	O
of	O
COS7	O
cells	O
.	O

In	O
addition	O
,	O
the	O
colocalization	O
for	O
VCY	B
and	O
VCX-8r	B
in	O
COS7	O
cells	O
was	O
also	O
observed	O
.	O

With	O
VCY	B
cDNA	O
as	O
bait	O
,	O
a	O
cDNA	O
fragment	O
of	O
acidic	B
ribosomal	I
protein	I
PO	I
was	O
obtained	O
using	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

All	O
the	O
information	O
above	O
indicates	O
that	O
VCX	O
/	O
Y	O
protein	O
family	O
might	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
ribosome	O
assembly	O
during	O
spermatogenesis	O
.	O

VIPL	B
,	O
a	O
VIP36-like	B
membrane	O
protein	O
with	O
a	O
putative	O
function	O
in	O
the	O
export	O
of	O
glycoproteins	O
from	O
the	O
endoplasmic	O
reticulum	O
.	O

Subsets	O
of	O
glycoproteins	O
are	O
thought	O
to	O
require	O
lectin	O
-	O
like	O
membrane	O
receptors	O
for	O
efficient	O
export	O
out	O
of	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
.	O

To	O
identify	O
new	O
members	O
related	O
to	O
two	O
previously	O
characterized	O
intracellular	O
lectins	O
ERGIC-53	B
/	O
p58	B
and	O
VIP36	B
,	O
we	O
carried	O
out	O
an	O
extensive	O
database	O
search	O
using	O
the	O
conserved	O
carbohydrate	O
recognition	O
domain	O
(	O
CRD	O
)	O
as	O
a	O
search	O
string	O
.	O

A	O
gene	O
,	O
more	O
closely	O
related	O
to	O
VIP36	B
than	O
to	O
ERGIC-53	B
/	O
p58	B
,	O
and	O
hence	O
called	O
VIPL	B
(	O
VIP36-Like	B
)	O
,	O
was	O
identified	O
.	O

VIPL	B
has	O
been	O
conserved	O
through	O
evolution	O
from	O
zebra	O
fish	O
to	O
man	O
.	O

The	O
2.4-kb	O
VIPL	B
mRNA	O
was	O
widely	O
expressed	O
to	O
varying	O
levels	O
in	O
different	O
tissues	O
.	O

Using	O
an	O
antiserum	O
prepared	O
against	O
the	O
CRD	O
,	O
the	O
32-kDa	O
VIPL	B
protein	O
was	O
detected	O
in	O
various	O
cell	O
lines	O
.	O

The	O
single	O
N	O
-	O
linked	O
glycan	O
of	O
VIPL	B
remained	O
endoglycosidase	O
H	O
-	O
sensitive	O
during	O
a	O
2-h	O
pulse	O
-	O
chase	O
,	O
even	O
when	O
the	O
protein	O
was	O
overexpressed	O
or	O
mutated	O
to	O
allow	O
export	O
to	O
the	O
plasma	O
membrane	O
.	O

VIPL	B
localized	O
primarily	O
to	O
the	O
ER	O
and	O
partly	O
to	O
the	O
Golgi	O
complex	O
.	O

Like	O
VIP36	B
,	O
the	O
cytoplasmic	O
tail	O
of	O
VIPL	B
terminates	O
in	O
the	O
sequence	O
KRFY	O
,	O
a	O
motif	O
characteristic	O
for	O
proteins	O
recycling	O
between	O
the	O
ER	O
and	O
ERGIC	O
/	O
cis	O
-	O
Golgi	O
.	O

Mutating	O
the	O
retrograde	O
transport	O
signal	O
KR	O
to	O
AA	O
resulted	O
in	O
transport	O
of	O
VIPL	B
to	O
the	O
cell	O
surface	O
.	O

Finally	O
,	O
knock	O
-	O
down	O
of	O
VIPL	B
mRNA	O
using	O
siRNA	O
significantly	O
slowed	O
down	O
the	O
secretion	O
of	O
two	O
glycoproteins	O
(	O
M	O
(	O
R	O
)	O
35	O
and	O
250	O
kDa	O
)	O
to	O
the	O
medium	O
,	O
suggesting	O
that	O
VIPL	B
may	O
also	O
function	O
as	O
an	O
ER	O
export	O
receptor	O
.	O

Identification	O
of	O
a	O
novel	O
system	O
L	O
amino	O
acid	O
transporter	O
structurally	O
distinct	O
from	O
heterodimeric	O
amino	O
acid	O
transporters	O
.	O

A	O
cDNA	O
that	O
encodes	O
a	O
novel	O
Na+-independent	O
neutral	O
amino	O
acid	O
transporter	O
was	O
isolated	O
from	O
FLC4	O
human	O
hepatocarcinoma	O
cells	O
by	O
expression	O
cloning	O
.	O

When	O
expressed	O
in	O
Xenopus	O
oocytes	O
,	O
the	O
encoded	O
protein	O
designated	O
LAT3	B
(	O
L	B
-	I
type	I
amino	I
acid	I
transporter	I
3	I
)	O
transported	O
neutral	O
amino	O
acids	O
such	O
as	O
l	O
-	O
leucine	O
,	O
l	O
-	O
isoleucine	O
,	O
l	O
-	O
valine	O
,	O
and	O
l	O
-	O
phenylalanine	O
.	O

The	O
LAT3-mediated	B
transport	O
was	O
Na+-independent	O
and	O
inhibited	O
by	O
2-aminobicyclo	O
[	O
2.2.1	O
]	O
heptane-2-carboxylic	O
acid	O
,	O
consistent	O
with	O
the	O
properties	O
of	O
system	O
L.	O
Distinct	O
from	O
already	O
known	O
system	O
L	O
transporters	O
LAT1	B
and	O
LAT2	B
,	O
which	O
form	O
heterodimeric	O
complex	O
with	O
4F2	B
heavy	I
chain	I
,	O
LAT3	B
was	O
functional	O
by	O
itself	O
in	O
Xenopus	O
oocytes	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
LAT3	B
was	O
identical	O
to	O
the	O
gene	O
product	O
of	O
POV1	B
reported	O
as	O
a	O
prostate	O
cancer	O
-	O
up	O
-	O
regulated	O
gene	O
whose	O
function	O
was	O
not	O
determined	O
,	O
whereas	O
it	O
did	O
not	O
exhibit	O
significant	O
similarity	O
to	O
already	O
identified	O
transporters	O
.	O

The	O
Eadie	O
-	O
Hofstee	O
plots	O
of	O
LAT3-mediated	B
transport	O
were	O
curvilinear	O
,	O
whereas	O
the	O
low	O
affinity	O
component	O
is	O
predominant	O
at	O
physiological	O
plasma	O
amino	O
acid	O
concentration	O
.	O

In	O
addition	O
to	O
amino	O
acid	O
substrates	O
,	O
LAT3	B
recognized	O
amino	O
acid	O
alcohols	O
.	O

The	O
transport	O
of	O
l	O
-	O
leucine	O
was	O
electroneutral	O
and	O
mediated	O
by	O
a	O
facilitated	O
diffusion	O
.	O

In	O
contrast	O
,	O
l	O
-	O
leucinol	O
,	O
l	O
-	O
valinol	O
,	O
and	O
l	O
-	O
phenylalaninol	O
,	O
which	O
have	O
a	O
net	O
positive	O
charge	O
induced	O
inward	O
currents	O
under	O
voltage	O
clamp	O
,	O
suggesting	O
these	O
compounds	O
are	O
transported	O
by	O
LAT3	B
.	O

LAT3-mediated	B
transport	O
was	O
inhibited	O
by	O
the	O
pretreatment	O
with	O
N	O
-	O
ethylmaleimide	O
,	O
consistent	O
with	O
the	O
property	O
of	O
system	O
L2	O
originally	O
characterized	O
in	O
hepatocyte	O
primary	O
culture	O
.	O

Based	O
on	O
the	O
substrate	O
selectivity	O
,	O
affinity	O
,	O
and	O
N	O
-	O
ethylmaleimide	O
sensitivity	O
,	O
LAT3	B
is	O
proposed	O
to	O
be	O
a	O
transporter	O
subserving	O
system	O
L2	O
.	O

LAT3	B
should	O
denote	O
a	O
new	O
family	O
of	O
organic	O
solute	O
transporters	O
.	O

DACH1	B
inhibits	O
transforming	O
growth	O
factor	O
-	O
beta	O
signaling	O
through	O
binding	O
Smad4	B
.	O

The	O
vertebrate	O
homologues	O
of	O
Drosophila	O
dachsund	O
,	O
DACH1	B
and	O
DACH2	B
,	O
have	O
been	O
implicated	O
as	O
important	O
regulatory	O
genes	O
in	O
development	O
.	O

DACH1	B
plays	O
a	O
role	O
in	O
retinal	O
and	O
pituitary	O
precursor	O
cell	O
proliferation	O
and	O
DACH2	B
plays	O
a	O
specific	O
role	O
in	O
myogenesis	O
.	O

DACH	B
proteins	O
contain	O
a	O
domain	O
(	O
DS	O
domain	O
)	O
that	O
is	O
conserved	O
with	O
the	O
proto	O
-	O
oncogenes	O
Ski	B
and	O
Sno	B
.	O

Since	O
the	O
Ski	B
/	O
Sno	B
proto	O
-	O
oncogenes	O
repress	O
AP-1	O
and	O
SMAD	O
signaling	O
,	O
we	O
hypothesized	O
that	O
DACH1	B
might	O
play	O
a	O
similar	O
cellular	O
function	O
.	O

Herein	O
,	O
DACH1	B
was	O
found	O
to	O
be	O
expressed	O
in	O
breast	O
cancer	O
cell	O
lines	O
and	O
to	O
inhibit	O
transforming	O
growth	O
factor	O
-	O
beta	O
(	O
TGF	O
-	O
beta	O
)	O
-induced	O
apoptosis	O
.	O

DACH1	B
repressed	O
TGF	O
-	O
beta	O
induction	O
of	O
AP-1	O
and	O
Smad	O
signaling	O
in	O
gene	O
reporter	O
assays	O
and	O
repressed	O
endogenous	O
TGF	O
-	O
beta	O
-	O
responsive	O
genes	O
by	O
microarray	O
analyses	O
.	O

DACH1	B
bound	O
to	O
endogenous	O
NCoR	B
and	O
Smad4	B
in	O
cultured	O
cells	O
and	O
DACH1	B
co	O
-	O
localized	O
with	O
NCoR	B
in	O
nuclear	O
dotlike	O
structures	O
.	O

NCoR	B
enhanced	O
DACH1	B
repression	O
,	O
and	O
the	O
repression	O
of	O
TGF	O
-	O
beta	O
-	O
induced	O
AP-1	O
or	O
Smad	O
signaling	O
by	O
DACH1	B
required	O
the	O
DACH1	B
DS	O
domain	O
.	O

The	O
DS	O
domain	O
of	O
DACH	B
was	O
sufficient	O
for	O
NCoR	B
binding	O
at	O
a	O
Smad4-binding	B
site	O
.	O

Smad4	B
was	O
required	O
for	O
DACH1	B
repression	O
of	O
Smad	O
signaling	O
.	O

In	O
Smad4	B
null	O
HTB-134	O
cells	O
,	O
DACH1	B
inhibited	O
the	O
activation	O
of	O
SBE-4	O
reporter	O
activity	O
induced	O
by	O
Smad2	B
or	O
Smad3	B
only	O
in	O
the	O
presence	O
of	O
Smad4	B
.	O

DACH1	B
participates	O
in	O
the	O
negative	O
regulation	O
of	O
TGF	O
-	O
beta	O
signaling	O
by	O
interacting	O
with	O
NCoR	B
and	O
Smad4	B
.	O

A	O
mammalian	O
homolog	O
of	O
Drosophila	O
melanogaster	O
transcriptional	O
coactivator	O
intersex	O
is	O
a	O
subunit	O
of	O
the	O
mammalian	O
Mediator	O
complex	O
.	O

The	O
multiprotein	O
Mediator	O
complex	O
is	O
a	O
coactivator	O
required	O
for	O
transcriptional	O
activation	O
of	O
RNA	O
polymerase	O
II	O
transcribed	O
genes	O
by	O
DNA	O
binding	O
transcription	O
factors	O
.	O

We	O
previously	O
partially	O
purified	O
a	O
Med8-containing	O
Mediator	O
complex	O
from	O
rat	O
liver	O
nuclei	O
(	O
Brower	O
,	O
C.	O
S.	O
,	O
Sato	O
,	O
S.	O
,	O
Tomomori	O
-	O
Sato	O
,	O
C.	O
,	O
Kamura	O
,	O
T.	O
,	O
Pause	O
,	O
A.	O
,	O
Stearman	O
,	O
R.	O
,	O
Klausner	O
,	O
R.	O
D.	O
,	O
Malik	O
,	O
S.	O
,	O
Lane	O
,	O
W.	O
S.	O
,	O
Sorokina	O
,	O
I.	O
,	O
Roeder	O
,	O
R.	O
G.	O
,	O
Conaway	O
,	O
J.	O
W.	O
,	O
and	O
Conaway	O
,	O
R.	O
C.	O
(	O
2002	O
)	O
Proc	O
.	O

Natl	O
.	O

Acad	O
.	O

Sci	O
.	O

U.	O
S.	O
A.	O
99	O
,	O
10353	O
-	O
10358	O
)	O
.	O

Analysis	O
of	O
proteins	O
present	O
in	O
the	O
most	O
highly	O
enriched	O
Mediator	O
fractions	O
by	O
tandem	O
mass	O
spectrometry	O
led	O
to	O
the	O
identification	O
of	O
several	O
new	O
mammalian	O
Mediator	O
subunits	O
,	O
as	O
well	O
as	O
several	O
potential	O
Mediator	O
subunits	O
.	O

Here	O
we	O
identify	O
one	O
of	O
these	O
proteins	O
,	O
encoded	O
by	O
the	O
previously	O
uncharacterized	O
AK000411	B
open	O
reading	O
frame	O
,	O
as	O
a	O
new	O
subunit	O
of	O
the	O
mammalian	O
Mediator	O
complex	O
.	O

The	O
AK000411	B
protein	O
,	O
which	O
we	O
designate	O
hIntersex	B
(	O
human	B
Intersex	I
)	O
,	O
shares	O
significant	O
sequence	O
similarity	O
with	O
the	O
Drosophila	O
melanogaster	O
intersex	O
protein	O
,	O
which	O
has	O
functional	O
properties	O
expected	O
of	O
a	O
transcriptional	O
coactivator	O
specific	O
for	O
the	O
Drosophila	O
doublesex	O
transactivator	O
.	O

In	O
addition	O
,	O
we	O
show	O
that	O
hIntersex	B
assembles	O
into	O
a	O
subcomplex	O
with	O
Mediator	B
subunits	I
p28b	I
and	I
TRFP	I
.	O

Taken	O
together	O
,	O
our	O
findings	O
identify	O
a	O
new	O
subunit	O
of	O
the	O
mammalian	O
Mediator	O
and	O
shed	O
new	O
light	O
on	O
the	O
architecture	O
of	O
the	O
mammalian	O
Mediator	O
complex	O
.	O

TACC1-chTOG	B
-	O
Aurora	B
A	I
protein	O
complex	O
in	O
breast	O
cancer	O
.	O

The	O
three	O
human	O
TACC	O
(	O
transforming	O
acidic	O
coiled	O
-	O
coil	O
)	O
genes	O
encode	O
a	O
family	O
of	O
proteins	O
with	O
poorly	O
defined	O
functions	O
that	O
are	O
suspected	O
to	O
play	O
a	O
role	O
in	O
oncogenesis	O
.	O

A	O
Xenopus	O
TACC	O
homolog	O
called	O
Maskin	O
is	O
involved	O
in	O
translational	O
control	O
,	O
while	O
Drosophila	O
D	O
-	O
TACC	O
interacts	O
with	O
the	O
microtubule	O
-	O
associated	O
protein	O
MSPS	O
(	O
Mini	O
SPindleS	O
)	O
to	O
ensure	O
proper	O
dynamics	O
of	O
spindle	O
pole	O
microtubules	O
during	O
cell	O
division	O
.	O

We	O
have	O
delineated	O
here	O
the	O
interactions	O
of	O
TACC1	B
with	O
four	O
proteins	O
,	O
namely	O
the	O
microtubule	O
-	O
associated	O
chTOG	B
(	O
colonic	B
and	I
hepatic	I
tumor	I
-	I
overexpressed	I
gene	I
)	O
protein	O
(	O
ortholog	O
of	O
Drosophila	O
MSPS	O
)	O
,	O
the	O
adaptor	O
protein	O
TRAP	B
(	O
tudor	B
repeat	I
associator	I
with	I
PCTAIRE2	I
)	O
,	O
the	O
mitotic	O
serine	O
/	O
threonine	O
kinase	O
Aurora	B
A	I
and	O
the	O
mRNA	O
regulator	O
LSM7	B
(	O
Like	B
-	I
Sm	I
protein	I
7	I
)	O
.	O

To	O
measure	O
the	O
relevance	O
of	O
the	O
TACC1-associated	B
complex	O
in	O
human	O
cancer	O
we	O
have	O
examined	O
the	O
expression	O
of	O
the	O
three	O
TACC	O
,	O
chTOG	B
and	O
Aurora	B
A	I
in	O
breast	O
cancer	O
using	O
immunohistochemistry	O
on	O
tissue	O
microarrays	O
.	O

We	O
show	O
that	O
expressions	O
of	O
TACC1	B
,	O
TACC2	B
,	O
TACC3	B
and	O
Aurora	B
A	I
are	O
significantly	O
correlated	O
and	O
downregulated	O
in	O
a	O
subset	O
of	O
breast	O
tumors	O
.	O

Using	O
siRNAs	O
,	O
we	O
further	O
show	O
that	O
depletion	O
of	O
chTOG	B
and	O
,	O
to	O
a	O
lesser	O
extent	O
of	O
TACC1	B
,	O
perturbates	O
cell	O
division	O
.	O

We	O
propose	O
that	O
TACC	O
proteins	O
,	O
which	O
we	O
also	O
named	O
'	O
Taxins	O
'	O
,	O
control	O
mRNA	O
translation	O
and	O
cell	O
division	O
in	O
conjunction	O
with	O
microtubule	O
organization	O
and	O
in	O
association	O
with	O
chTOG	B
and	O
Aurora	B
A	I
,	O
and	O
that	O
these	O
complexes	O
and	O
cell	O
processes	O
may	O
be	O
affected	O
during	O
mammary	O
gland	O
oncogenesis	O
.	O

Aurora	B
B	I
-TACC1	O
protein	O
complex	O
in	O
cytokinesis	O
.	O

Taxins	O
are	O
a	O
family	O
of	O
centrosomal	O
proteins	O
important	O
for	O
the	O
regulation	O
of	O
mitosis	O
and	O
microtubule	O
dynamics	O
.	O

Cytokinesis	O
,	O
the	O
last	O
step	O
of	O
M	O
phase	O
,	O
is	O
essential	O
for	O
chromosomal	O
integrity	O
and	O
cell	O
division	O
.	O

It	O
is	O
highly	O
regulated	O
and	O
involves	O
a	O
reorganization	O
of	O
microtubules	O
and	O
actin	O
filaments	O
.	O

We	O
show	O
here	O
that	O
TACC1	B
localizes	O
diffusely	O
to	O
the	O
midzone	O
spindle	O
in	O
anaphase	O
and	O
strongly	O
to	O
the	O
midbody	O
during	O
cytokinesis	O
,	O
indicating	O
a	O
possible	O
involvement	O
of	O
this	O
protein	O
in	O
the	O
exit	O
of	O
M	O
phase	O
.	O

TACC1	B
also	O
relocalizes	O
to	O
the	O
nucleolus	O
in	O
interphase	O
.	O

We	O
demonstrate	O
that	O
TACC1	B
and	O
the	O
mitotic	O
kinase	O
Aurora	B
B	I
belong	O
to	O
the	O
same	O
complex	O
during	O
cytokinesis	O
.	O

We	O
further	O
show	O
that	O
Aurora	B
B	I
knocked	O
down	O
by	O
RNA	O
-	O
mediated	O
interference	O
prevents	O
the	O
formation	O
of	O
the	O
midbody	O
-	O
and	O
consequently	O
affects	O
TACC1	B
localization	O
at	O
this	O
site	O
-	O
and	O
leads	O
to	O
abnormal	O
cell	O
division	O
and	O
multinucleated	O
cells	O
.	O

Mutual	O
interactions	O
between	O
subunits	O
of	O
the	O
human	O
RNase	O
MRP	O
ribonucleoprotein	O
complex	O
.	O

The	O
eukaryotic	O
ribonuclease	O
for	O
mitochondrial	O
RNA	O
processing	O
(	O
RNase	O
MRP	O
)	O
is	O
mainly	O
located	O
in	O
the	O
nucleoli	O
and	O
belongs	O
to	O
the	O
small	O
nucleolar	O
ribonucleoprotein	O
(	O
snoRNP	O
)	O
particles	O
.	O

RNase	O
MRP	O
is	O
involved	O
in	O
the	O
processing	O
of	O
pre	O
-	O
rRNA	O
and	O
the	O
generation	O
of	O
RNA	O
primers	O
for	O
mitochondrial	O
DNA	O
replication	O
.	O

A	O
closely	O
related	O
snoRNP	O
,	O
which	O
shares	O
protein	O
subunits	O
with	O
RNase	O
MRP	O
and	O
contains	O
a	O
structurally	O
related	O
RNA	O
subunit	O
,	O
is	O
the	O
pre	O
-	O
tRNA	O
processing	O
factor	O
RNase	O
P.	O
Up	O
to	O
now	O
,	O
10	O
protein	O
subunits	O
of	O
these	O
complexes	O
have	O
been	O
described	O
,	O
designated	O
hPop1	B
,	O
hPop4	B
,	O
hPop5	B
,	O
Rpp14	B
,	O
Rpp20	B
,	O
Rpp21	B
,	O
Rpp25	B
,	O
Rpp30	B
,	O
Rpp38	B
and	O
Rpp40	B
.	O

To	O
get	O
more	O
insight	O
into	O
the	O
assembly	O
of	O
the	O
human	O
RNase	O
MRP	O
complex	O
we	O
studied	O
protein	O
-	O
protein	O
and	O
protein	O
-	O
RNA	O
interactions	O
by	O
means	O
of	O
GST	O
pull	O
-	O
down	O
experiments	O
.	O

A	O
total	O
of	O
19	O
direct	O
protein	O
-	O
protein	O
and	O
six	O
direct	O
protein	O
-	O
RNA	O
interactions	O
were	O
observed	O
.	O

The	O
analysis	O
of	O
mutant	O
RNase	O
MRP	O
RNAs	O
showed	O
that	O
distinct	O
regions	O
are	O
involved	O
in	O
the	O
direct	O
interaction	O
with	O
protein	O
subunits	O
.	O

The	O
results	O
provide	O
insight	O
into	O
the	O
way	O
the	O
protein	O
and	O
RNA	O
subunits	O
assemble	O
into	O
a	O
ribonucleoprotein	O
particle	O
.	O

Based	O
upon	O
these	O
data	O
a	O
new	O
model	O
for	O
the	O
architecture	O
of	O
the	O
human	O
RNase	O
MRP	O
complex	O
was	O
generated	O
.	O

HIPK2	B
neutralizes	O
MDM2	B
inhibition	O
rescuing	O
p53	B
transcriptional	O
activity	O
and	O
apoptotic	O
function	O
.	O

The	O
p53	B
oncosuppressor	O
protein	O
is	O
subject	O
to	O
negative	O
regulation	O
by	O
MDM2	B
,	O
which	O
efficiently	O
inhibits	O
its	O
activity	O
through	O
an	O
autoregulatory	O
loop	O
.	O

In	O
response	O
to	O
stress	O
,	O
however	O
,	O
p53	B
undergoes	O
post	O
-	O
translational	O
modifications	O
that	O
allow	O
the	O
protein	O
to	O
escape	O
MDM2	B
control	O
,	O
accumulate	O
,	O
and	O
become	O
active	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
,	O
following	O
DNA	O
damage	O
,	O
the	O
HIPK2	B
serine	O
/	O
threonine	O
kinase	O
binds	O
and	O
phosphorylates	O
p53	B
,	O
inducing	O
p53	B
transcriptional	O
activity	O
and	O
apoptotic	O
function	O
.	O

Here	O
,	O
we	O
investigated	O
the	O
role	O
of	O
HIPK2	B
in	O
the	O
activation	O
of	O
p53	B
in	O
the	O
presence	O
of	O
MDM2	B
.	O

We	O
found	O
that	O
HIPK2	B
rescues	O
p53	B
transcriptional	O
activity	O
overcoming	O
MDM2	B
inhibition	O
,	O
and	O
that	O
restoration	O
of	O
this	O
p53	B
function	O
induces	O
apoptosis	O
.	O

Recovery	O
of	O
p53-dependent	B
apoptosis	O
is	O
achieved	O
by	O
preventing	O
p53	B
nuclear	O
export	O
and	O
ubiquitination	O
mediated	O
by	O
MDM2	B
in	O
vitro	O
and	O
in	O
vivo	O
following	O
genotoxic	O
stress	O
.	O

These	O
results	O
shed	O
new	O
light	O
on	O
the	O
mechanisms	O
by	O
which	O
the	O
HIPK2	B
/	O
p53	B
pathway	O
promotes	O
apoptosis	O
and	O
suppression	O
of	O
tumorigenesis	O
.	O

Ca2	O
+	O
dependence	O
of	O
the	O
Ca2	O
+	O
-selective	O
TRPV6	B
channel	O
.	O

Microfluorimetry	O
and	O
patch	O
-	O
clamp	O
experiments	O
were	O
performed	O
on	O
TRPV6-expressing	B
HEK	O
cells	O
to	O
determine	O
whether	O
this	O
Ca	O
(	O
2+	O
)	O
-sensing	O
Ca	O
(	O
2	O
+	O
)	O
channel	O
is	O
constitutively	O
active	O
.	O

Intact	O
cells	O
loaded	O
with	O
fura-2	O
had	O
an	O
elevated	O
intracellular	O
free	O
Ca	O
(	O
2	O
+	O
)	O
concentration	O
(	O
[	O
Ca	O
(	O
2+	O
)	O
]	O
(	O
i	O
)	O
)	O
,	O
which	O
decreased	O
to	O
the	O
same	O
level	O
such	O
as	O
in	O
non	O
-	O
transfected	O
cells	O
if	O
external	O
Ca	O
(	O
2	O
+	O
)	O
was	O
chelated	O
by	O
EGTA	O
.	O

Whole	O
cell	O
recordings	O
from	O
non	O
-	O
transfected	O
HEK	O
cells	O
and	O
cells	O
expressing	O
human	O
TRPV6	B
revealed	O
the	O
presence	O
of	O
a	O
basal	O
inward	O
current	O
in	O
both	O
types	O
of	O
cells	O
when	O
the	O
internal	O
solution	O
contained	O
0.1	O
mm	O
EGTA	O
and	O
100	O
nm	O
[	O
Ca	O
(	O
2+	O
)	O
]	O
(	O
i	O
)	O
or	O
if	O
the	O
cytosolic	O
Ca	O
(	O
2	O
+	O
)	O
buffering	O
remained	O
undisturbed	O
in	O
perforated	O
patch	O
-	O
clamp	O
experiments	O
.	O

If	O
recombinantly	O
expressed	O
TRPV6	B
forms	O
open	O
channels	O
,	O
one	O
would	O
expect	O
Ca	O
(	O
2+	O
)	O
-induced	O
current	O
inhibition	O
,	O
because	O
TRPV6	B
is	O
negatively	O
regulated	O
by	O
internal	O
Ca	O
(	O
2	O
+	O
)	O
.	O

However	O
,	O
dialyzing	O
solutions	O
with	O
high	O
[	O
Ca	O
(	O
2	O
+	O
)	O
]	O
such	O
as	O
1	O
microm	O
into	O
TRPV6-expressing	B
cells	O
did	O
not	O
block	O
the	O
basal	O
inward	O
current	O
,	O
which	O
was	O
not	O
different	O
from	O
the	O
recordings	O
from	O
non	O
-	O
transfected	O
cells	O
.	O

In	O
contrast	O
,	O
dialyzing	O
0.5	O
mm	O
EGTA	O
into	O
TRPV6-expressing	B
cells	O
readily	O
activated	O
Ca	O
(	O
2	O
+	O
)	O
inward	O
currents	O
,	O
which	O
were	O
undetectable	O
in	O
non	O
-	O
transfected	O
cells	O
.	O

Interestingly	O
,	O
monovalent	O
cations	O
permeated	O
the	O
TRPV6	B
channels	O
under	O
conditions	O
where	O
no	O
Ca	O
(	O
2	O
+	O
)	O
permeation	O
was	O
detectable	O
,	O
indicating	O
that	O
divalent	O
cations	O
block	O
TRPV6	B
channels	O
from	O
the	O
extracellular	O
side	O
.	O

Like	O
human	O
TRPV6	B
,	O
the	O
truncated	O
human	O
TRPV6	B
(	I
Delta695	I
-	I
725	I
)	I
,	O
which	O
lacks	O
the	O
C	O
-	O
terminal	O
domain	O
required	O
for	O
Ca	O
(	O
2+	O
)	O
-calmodulin	O
binding	O
,	O
does	O
not	O
form	O
constitutive	O
active	O
channels	O
,	O
whereas	O
the	O
human	O
TRPV6	B
(	I
D542A	I
)	I
,	O
carrying	O
a	O
point	O
mutation	O
in	O
the	O
presumed	O
pore	O
region	O
,	O
does	O
not	O
function	O
as	O
a	O
channel	O
.	O

In	O
summary	O
,	O
no	O
constitutive	O
open	O
TRPV6	B
channels	O
were	O
detected	O
in	O
patch	O
-	O
clamp	O
experiments	O
from	O
transfected	O
HEK	O
cells	O
.	O

However	O
,	O
channel	O
activity	O
is	O
highly	O
regulated	O
by	O
intracellular	O
and	O
extracellular	O
divalent	O
cations	O
.	O

Human	O
p32	B
,	O
interacts	O
with	O
B	B
subunit	I
of	I
the	I
CCAAT	I
-	I
binding	I
factor	I
,	I
CBF	I
/	I
NF	I
-	I
Y	I
,	O
and	O
inhibits	O
CBF	O
-	O
mediated	O
transcription	O
activation	O
in	O
vitro	O
.	O

To	O
understand	O
the	O
role	O
of	O
the	O
CCAAT	O
-	O
binding	O
factor	O
,	O
CBF	O
,	O
in	O
transcription	O
,	O
we	O
developed	O
a	O
strategy	O
to	O
purify	O
the	O
heterotrimeric	O
CBF	O
complex	O
from	O
HeLa	O
cell	O
extracts	O
using	O
two	O
successive	O
immunoaffinity	O
chromatography	O
steps	O
.	O

Here	O
we	O
show	O
that	O
the	O
p32	B
protein	O
,	O
previously	O
identified	O
as	O
the	O
ASF	B
/	I
SF2	I
splicing	I
factor	I
-	I
associated	I
protein	I
,	O
copurified	O
with	O
the	O
CBF	O
complex	O
.	O

Studies	O
of	O
protein	O
-	O
protein	O
interaction	O
demonstrated	O
that	O
p32	B
interacts	O
specifically	O
with	O
CBF	B
-	I
B	I
subunit	I
and	O
also	O
associates	O
with	O
CBF	O
-	O
DNA	O
complex	O
.	O

Cellular	O
localization	O
by	O
immunofluorescence	O
staining	O
revealed	O
that	O
p32	B
is	O
present	O
in	O
the	O
cell	O
throughout	O
the	O
cytosol	O
and	O
nucleus	O
,	O
whereas	O
CBF	O
is	O
present	O
primarily	O
in	O
the	O
nucleus	O
.	O

A	O
portion	O
of	O
the	O
p32	B
colocalizes	O
with	O
CBF	B
-	I
B	I
in	O
the	O
nucleus	O
.	O

Interestingly	O
,	O
reconstitution	O
of	O
p32	B
in	O
an	O
in	O
vitro	O
transcription	O
reaction	O
demonstrated	O
that	O
p32	B
specifically	O
inhibits	O
CBF	O
-	O
mediated	O
transcription	O
activation	O
.	O

Altogether	O
,	O
our	O
study	O
identified	O
p32	B
as	O
a	O
novel	O
and	O
specific	O
corepressor	O
of	O
CBF	O
-	O
mediated	O
transcription	O
activation	O
in	O
vitro	O
.	O

WNK1	B
phosphorylates	O
synaptotagmin	B
2	I
and	O
modulates	O
its	O
membrane	O
binding	O
.	O

WNK	B
(	O
with	O
no	O
lysine	O
[	O
K	O
]	O
)	O
protein	O
kinases	O
were	O
named	O
for	O
their	O
unique	O
active	O
site	O
organization	O
.	O

Mutations	O
in	O
WNK1	B
and	O
WNK4	B
cause	O
a	O
familial	O
form	O
of	O
hypertension	O
by	O
undefined	O
mechanisms	O
.	O

Here	O
,	O
we	O
report	O
that	O
WNK1	B
selectively	O
binds	O
to	O
and	O
phosphorylates	O
synaptotagmin	B
2	I
(	O
Syt2	B
)	O
within	O
its	O
calcium	O
binding	O
C2	O
domains	O
.	O

Endogenous	O
WNK1	B
and	O
Syt2	B
coimmunoprecipitate	O
and	O
colocalize	O
on	O
a	O
subset	O
of	O
secretory	O
granules	O
in	O
INS-1	O
cells	O
.	O

Phosphorylation	O
by	O
WNK1	B
increases	O
the	O
amount	O
of	O
Ca2	O
+	O
required	O
for	O
Syt2	B
binding	O
to	O
phospholipid	O
vesicles	O
;	O
mutation	O
of	O
threonine	O
202	O
,	O
a	O
WNK1	B
phosphorylation	O
site	O
,	O
partially	O
prevents	O
this	O
change	O
.	O

These	O
findings	O
suggest	O
that	O
phosphorylation	O
of	O
Syts	O
by	O
WNK1	B
can	O
regulate	O
Ca2	O
+	O
sensing	O
and	O
the	O
subsequent	O
Ca2	O
+	O
-dependent	O
interactions	O
mediated	O
by	O
Syt	O
C2	O
domains	O
.	O

These	O
findings	O
provide	O
a	O
biochemical	O
mechanism	O
that	O
could	O
lead	O
to	O
the	O
retention	O
or	O
insertion	O
of	O
proteins	O
in	O
the	O
plasma	O
membrane	O
.	O

Interruption	O
of	O
this	O
regulatory	O
pathway	O
may	O
disturb	O
membrane	O
events	O
that	O
regulate	O
ion	O
balance	O
.	O

A	O
protein	O
interaction	O
network	O
links	O
GIT1	B
,	O
an	O
enhancer	O
of	O
huntingtin	B
aggregation	O
,	O
to	O
Huntington	O
's	O
disease	O
.	O

Analysis	O
of	O
protein	O
-	O
protein	O
interactions	O
(	O
PPIs	O
)	O
is	O
a	O
valuable	O
approach	O
for	O
characterizing	O
proteins	O
of	O
unknown	O
function	O
.	O

Here	O
,	O
we	O
have	O
developed	O
a	O
strategy	O
combining	O
library	O
and	O
matrix	O
yeast	O
two	O
-	O
hybrid	O
screens	O
to	O
generate	O
a	O
highly	O
connected	O
PPI	O
network	O
for	O
Huntington	O
's	O
disease	O
(	O
HD	B
)	O
.	O

The	O
network	O
contains	O
186	O
PPIs	O
among	O
35	O
bait	O
and	O
51	O
prey	O
proteins	O
.	O

It	O
revealed	O
165	O
new	O
potential	O
interactions	O
,	O
32	O
of	O
which	O
were	O
confirmed	O
by	O
independent	O
binding	O
experiments	O
.	O

The	O
network	O
also	O
permitted	O
the	O
functional	O
annotation	O
of	O
16	O
uncharacterized	O
proteins	O
and	O
facilitated	O
the	O
discovery	O
of	O
GIT1	B
,	O
a	O
G	O
protein	O
-	O
coupled	O
receptor	O
kinase	O
-	O
interacting	O
protein	O
,	O
which	O
enhances	O
huntingtin	B
aggregation	O
by	O
recruitment	O
of	O
the	O
protein	O
into	O
membranous	O
vesicles	O
.	O

Coimmunoprecipitations	O
and	O
immunofluorescence	O
studies	O
revealed	O
that	O
GIT1	B
and	O
huntingtin	B
associate	O
in	O
mammalian	O
cells	O
under	O
physiological	O
conditions	O
.	O

Moreover	O
,	O
GIT1	B
localizes	O
to	O
neuronal	O
inclusions	O
,	O
and	O
is	O
selectively	O
cleaved	O
in	O
HD	B
brains	O
,	O
indicating	O
that	O
its	O
distribution	O
and	O
function	O
is	O
altered	O
during	O
disease	O
pathogenesis	O
.	O

Interleukin-1	B
type	I
II	I
receptor	I
:	O
a	O
decoy	O
target	O
for	O
IL-1	O
that	O
is	O
regulated	O
by	O
IL-4	B
.	O

Interleukin-1	O
(	O
IL-1	O
)	O
interacts	O
with	O
cells	O
through	O
two	O
types	O
of	O
binding	O
molecules	O
,	O
IL-1	B
type	I
I	I
receptor	I
(	O
IL-1R	B
I	I
)	O
and	O
IL-1R	B
II	I
.	O

The	O
function	O
of	O
IL-1R	B
II	I
is	O
unknown	O
.	O

In	O
studies	O
using	O
monoclonal	O
antibodies	O
,	O
IL-1	O
prolonged	O
the	O
in	O
vitro	O
survival	O
of	O
polymorphonuclear	O
cells	O
(	O
PMN	O
)	O
through	O
IL-1R	B
I	I
,	O
and	O
IL-4	B
antagonized	O
the	O
action	O
of	O
IL-1	O
by	O
inducing	O
expression	O
and	O
release	O
of	O
IL-1R	B
II	I
.	O

Dexamethasone	O
also	O
induced	O
expression	O
and	O
release	O
of	O
the	O
IL-1R	B
II	I
in	O
PMN	O
.	O

These	O
results	O
,	O
together	O
with	O
the	O
effect	O
of	O
antibodies	O
to	O
IL-1R	O
on	O
IL-1-induced	O
production	O
of	O
cytokines	O
in	O
monocytes	O
,	O
indicate	O
that	O
IL-1	O
acts	O
on	O
myelomonocytic	O
cells	O
through	O
IL-1R	B
I	I
and	O
that	O
IL-1R	B
II	I
inhibits	O
IL-1	O
activity	O
by	O
acting	O
as	O
a	O
decoy	O
target	O
for	O
IL-1	O
.	O

The	O
existence	O
of	O
multiple	O
pathways	O
of	O
regulation	O
emphasizes	O
the	O
need	O
for	O
tight	O
control	O
of	O
IL-1	O
action	O
.	O

Assignment	O
of	O
the	O
PSST	B
subunit	I
gene	O
of	O
human	O
mitochondrial	O
complex	O
I	O
to	O
chromosome	O
19p13	O
.	O

The	O
cDNA	O
for	O
the	O
PSST	B
subunit	I
of	I
human	I
mitochondrial	I
nicotinamide	I
adenine	I
dinucleotide	I
(	I
NADH	I
)	I
:	O
ubiquinone	O
oxidoreductase	O
[	O
complex	O
I	O
;	O
NADH	O
dehydrogenase	O
(	O
ubiquinone	O
)	O
,	O
Fe	O
-	O
S	O
(	O
20	O
kDa	O
)	O
;	O
EC	O
1.6.5.3	O
]	O
was	O
generated	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
of	O
human	O
cDNA	O
.	O

The	O
sequence	O
of	O
the	O
mature	O
protein	O
deduced	O
from	O
the	O
cDNA	O
codes	O
for	O
a	O
protein	O
that	O
is	O
closely	O
related	O
to	O
the	O
bovine	O
protein	O
(	O
93	O
%	O
homology	O
)	O
.	O

Nine	O
conservative	O
substitutions	O
are	O
found	O
in	O
the	O
mature	O
protein	O
,	O
mainly	O
in	O
the	O
N	O
and	O
C	O
terminal	O
regions	O
.	O

The	O
mature	O
human	O
protein	O
is	O
missing	O
four	O
amino	O
acids	O
(	O
PAAL	O
)	O
close	O
to	O
the	O
N	O
terminus	O
that	O
are	O
present	O
in	O
the	O
bovine	O
protein	O
.	O

The	O
N	O
terminus	O
of	O
the	O
mature	O
protein	O
is	O
preceded	O
by	O
a	O
presequence	O
of	O
38	O
amino	O
acids	O
that	O
,	O
although	O
quite	O
different	O
from	O
its	O
bovine	O
counterpart	O
(	O
52	O
%	O
homology	O
)	O
,	O
has	O
properties	O
that	O
are	O
characteristic	O
of	O
a	O
mitochondrial	O
import	O
sequence	O
.	O

Southern	O
hybridization	O
analysis	O
predicts	O
an	O
estimated	O
gene	O
size	O
of	O
3.8	O
kb	O
.	O

Northern	O
hybridization	O
analysis	O
of	O
mRNA	O
from	O
fibroblasts	O
of	O
complex	O
I	O
-	O
deficient	O
patients	O
revealed	O
no	O
size	O
or	O
transcript	O
level	O
abnormalities	O
.	O

The	O
cDNA	O
of	O
the	O
PSST	B
protein	O
was	O
used	O
to	O
investigate	O
tissue	O
-	O
specific	O
expression	O
and	O
to	O
localize	O
the	O
gene	O
for	O
this	O
subunit	O
to	O
chromosome	O
19p13	O
.	O

JEM-1	B
,	O
a	O
novel	O
gene	O
encoding	O
a	O
leucine	O
-	O
zipper	O
nuclear	O
factor	O
upregulated	O
during	O
retinoid	O
-	O
induced	O
maturation	O
of	O
NB4	O
promyelocytic	O
leukaemia	O
.	O

Retinoid	O
-	O
induced	O
proliferation	O
causing	O
hyperleukocytosis	O
is	O
a	O
severe	O
complication	O
of	O
retinoid	O
therapy	O
in	O
t	O
(	O
15;17	O
)	O
acute	O
promyelocytic	O
leukaemia	O
.	O

The	O
molecular	O
basis	O
of	O
this	O
phenomenon	O
is	O
unknown	O
.	O

It	O
is	O
possible	O
that	O
the	O
transiently	O
enhanced	O
cell	O
proliferation	O
results	O
from	O
RA	O
-	O
induction	O
of	O
growth	O
regulatory	O
genes	O
.	O

Using	O
Differential	O
Display	O
of	O
cDNAs	O
from	O
NB4	O
cells	O
we	O
have	O
identified	O
Jem	O
,	O
a	O
novel	O
gene	O
transcript	O
which	O
is	O
upregulated	O
by	O
retinoids	O
during	O
the	O
early	O
proliferative	O
response	O
in	O
maturating	O
cells	O
but	O
not	O
in	O
resistant	O
cells	O
.	O

A	O
2.7	O
kb	O
cDNA	O
was	O
cloned	O
and	O
sequenced	O
.	O

The	O
open	O
reading	O
frame	O
contains	O
a	O
400	O
amino	O
acid	O
sequence	O
corresponding	O
to	O
a	O
novel	O
45	O
kDa	O
basic	O
protein	O
(	O
pI	O
8.9	O
)	O
.	O

The	O
JEM	O
DNA	O
sequence	O
is	O
detected	O
by	O
FISH	O
on	O
human	O
chromosome	O
1	O
at	O
q24	O
.	O

The	O
Jem	O
peptide	O
sequence	O
shows	O
a	O
'	O
leucine	O
-	O
zipper	O
'	O
dimerisation	O
motif	O
with	O
limited	O
homology	O
to	O
Fos	B
/	O
Jun	B
and	O
ATF	B
/	O
CREB	B
proteins	O
and	O
several	O
putative	O
phosphorylation	O
sites	O
.	O

An	O
atypical	O
basic	O
region	O
may	O
correspond	O
to	O
an	O
unknown	O
DNA	O
-	O
binding	O
domain	O
.	O

The	O
C	O
-	O
terminal	O
end	O
of	O
Jem	O
spans	O
a	O
long	O
stretch	O
featuring	O
a	O
PEST	O
motif	O
.	O

After	O
transfection	O
into	O
COS	O
cells	O
,	O
the	O
Jem	O
protein	O
shows	O
a	O
ponctuated	O
nuclear	O
localisation	O
.	O

We	O
hypothesise	O
that	O
this	O
novel	O
nuclear	O
factor	O
may	O
act	O
as	O
a	O
transcription	O
factor	O
,	O
or	O
a	O
coregulator	O
,	O
involved	O
in	O
either	O
cell	O
growth	O
control	O
and/or	O
maturation	O
.	O

Presenilin	B
1	I
interaction	O
in	O
the	O
brain	O
with	O
a	O
novel	O
member	O
of	O
the	O
Armadillo	O
family	O
.	O

One	O
approach	O
to	O
understanding	O
the	O
function	O
of	O
presenilin	B
1	I
(	O
PS1	B
)	O
,	O
is	O
to	O
discover	O
those	O
proteins	O
with	O
which	O
it	O
interacts	O
.	O

Evidence	O
for	O
a	O
function	O
in	O
developmental	O
patterning	O
came	O
from	O
C.	O
elegans	O
,	O
in	O
which	O
a	O
PS	O
homologue	O
was	O
identified	O
by	O
screening	O
for	O
suppressors	O
of	O
a	O
mutation	O
in	O
Notch	O
/	O
lin-12	O
,	O
a	O
gene	O
which	O
specifies	O
cell	O
fate	O
.	O

However	O
,	O
this	O
genetic	O
experiment	O
can	O
not	O
determine	O
which	O
proteins	O
directly	O
interact	O
with	O
PS1	B
.	O

Therefore	O
,	O
we	O
utilized	O
the	O
two	O
hybrid	O
system	O
and	O
confirmatory	O
co	O
-	O
immunoprecipitations	O
to	O
identify	O
a	O
novel	O
catenin	O
,	O
termed	O
delta	O
-	O
catenin	O
,	O
which	O
interacts	O
with	O
PS1	B
and	O
is	O
principally	O
expressed	O
in	O
brain	O
.	O

The	O
catenins	O
are	O
a	O
gene	O
family	O
related	O
to	O
the	O
Armadillo	O
gene	O
in	O
Drosophila	O
,	O
some	O
of	O
which	O
appear	O
to	O
have	O
dual	O
roles	O
-	O
they	O
are	O
components	O
of	O
cell	O
-	O
cell	O
adherens	O
junctions	O
,	O
and	O
may	O
serve	O
as	O
intermediates	O
in	O
the	O
Wingless	O
(	O
Wg	O
)	O
signaling	O
pathway	O
,	O
which	O
,	O
like	O
Notch	O
/	O
lin-12	O
,	O
is	O
also	O
responsible	O
for	O
a	O
variety	O
of	O
inductive	O
signaling	O
events	O
.	O

In	O
the	O
non	O
-	O
neuronal	O
293	O
cell	O
line	O
,	O
PS1	B
interacted	O
with	O
beta	B
-	I
catenin	I
,	O
the	O
family	O
member	O
with	O
the	O
greatest	O
homology	O
to	O
Armadillo	O
.	O

Wg	O
and	O
Notch	O
interactions	O
are	O
mediated	O
by	O
the	O
Dishevelled	O
gene	O
,	O
which	O
may	O
form	O
a	O
signaling	O
complex	O
with	O
PS1	B
and	O
Wg	O
pathway	O
intermediates	O
to	O
regulate	O
the	O
function	O
of	O
the	O
Notch	O
/	O
lin-12	O
gene	O
.	O

A	O
transcriptional	O
mediator	O
protein	O
that	O
is	O
required	O
for	O
activation	O
of	O
many	O
RNA	O
polymerase	O
II	O
promoters	O
and	O
is	O
conserved	O
from	O
yeast	O
to	O
humans	O
.	O

A	O
temperature	O
-	O
sensitive	O
mutation	O
was	O
obtained	O
in	O
Med6p	O
,	O
a	O
component	O
of	O
the	O
mediator	O
complex	O
from	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
mediator	O
complex	O
has	O
been	O
shown	O
to	O
enable	O
transcriptional	O
activation	O
in	O
vitro	O
.	O

This	O
mutation	O
in	O
Med6p	O
abolished	O
activation	O
of	O
transcription	O
from	O
four	O
of	O
five	O
inducible	O
promoters	O
tested	O
in	O
vivo	O
.	O

There	O
was	O
no	O
effect	O
,	O
however	O
,	O
on	O
uninduced	O
transcription	O
,	O
transcription	O
of	O
constitutively	O
expressed	O
genes	O
,	O
or	O
transcription	O
by	O
RNA	O
polymerases	O
I	O
and	O
III	O
.	O

Mediator	O
-	O
RNA	O
polymerase	O
II	O
complex	O
isolated	O
from	O
the	O
mutant	O
yeast	O
strain	O
was	O
temperature	O
sensitive	O
for	O
transcriptional	O
activation	O
in	O
a	O
reconstituted	O
in	O
vitro	O
system	O
due	O
to	O
a	O
defect	O
in	O
initiation	O
complex	O
formation	O
.	O

A	O
database	O
search	O
revealed	O
the	O
existence	O
of	O
MED6-related	B
genes	O
in	O
humans	O
and	O
Caenorhabditis	O
elegans	O
,	O
suggesting	O
that	O
the	O
role	O
of	O
mediator	O
in	O
transcriptional	O
activation	O
is	O
conserved	O
throughout	O
the	O
evolution	O
.	O

Isolation	O
and	O
functional	O
analysis	O
of	O
a	O
cDNA	O
for	O
human	O
Jagged2	B
,	O
a	O
gene	O
encoding	O
a	O
ligand	O
for	O
the	O
Notch1	B
receptor	O
.	O

Signaling	O
through	O
Notch	O
receptors	O
has	O
been	O
implicated	O
in	O
the	O
control	O
of	O
cellular	O
differentiation	O
in	O
animals	O
ranging	O
from	O
nematodes	O
to	O
humans	O
.	O

Starting	O
from	O
a	O
human	O
expressed	O
sequence	O
tag	O
-	O
containing	O
sequence	O
resembling	O
that	O
of	O
Serrate	O
,	O
the	O
gene	O
for	O
a	O
ligand	O
of	O
Drosophila	O
melanogaster	O
Notch	O
,	O
we	O
assembled	O
a	O
full	O
-	O
length	O
cDNA	O
,	O
now	O
called	O
human	O
Jagged2	B
,	O
from	O
overlapping	O
cDNA	O
clones	O
.	O

The	O
full	O
-	O
length	O
cDNA	O
encodes	O
a	O
polypeptide	O
having	O
extensive	O
sequence	O
homology	O
to	O
Serrate	O
(	O
40.6	O
%	O
identity	O
and	O
58.7	O
%	O
similarity	O
)	O
and	O
even	O
greater	O
homology	O
to	O
several	O
putative	O
mammalian	O
Notch	O
ligands	O
that	O
have	O
subsequently	O
been	O
described	O
.	O

When	O
in	O
situ	O
hybridization	O
was	O
performed	O
,	O
expression	O
of	O
the	O
murine	O
Jagged2	B
homolog	O
was	O
found	O
to	O
be	O
highest	O
in	O
fetal	O
thymus	O
,	O
epidermis	O
,	O
foregut	O
,	O
dorsal	O
root	O
ganglia	O
,	O
and	O
inner	O
ear	O
.	O

In	O
Northern	O
blot	O
analysis	O
of	O
RNA	O
from	O
tissues	O
of	O
2-week	O
-	O
old	O
mice	O
,	O
the	O
5.0-kb	O
Jagged2	B
transcript	O
was	O
most	O
abundant	O
in	O
heart	O
,	O
lung	O
,	O
thymus	O
,	O
skeletal	O
muscle	O
,	O
brain	O
,	O
and	O
testis	O
.	O

Immunohistochemistry	O
revealed	O
coexpression	O
of	O
Jagged2	B
and	O
Notch1	B
within	O
thymus	O
and	O
other	O
fetal	O
murine	O
tissues	O
,	O
consistent	O
with	O
interaction	O
of	O
the	O
two	O
proteins	O
in	O
vivo	O
.	O

Coculture	O
of	O
fibroblasts	O
expressing	O
human	O
Jagged2	B
with	O
murine	O
C2C12	O
myoblasts	O
inhibited	O
myogenic	O
differentiation	O
,	O
accompanied	O
by	O
increased	O
Notch1	B
and	O
the	O
appearance	O
of	O
a	O
novel	O
115-kDa	O
Notch1	B
fragment	O
.	O

Exposure	O
of	O
C2C12	O
cells	O
to	O
Jagged2	B
led	O
to	O
increased	O
amounts	O
of	O
Notch	O
mRNA	O
as	O
well	O
as	O
mRNAs	O
for	O
a	O
second	O
Notch	O
receptor	O
,	O
Notch3	O
,	O
and	O
a	O
second	O
Notch	O
ligand	O
,	O
Jagged1	O
.	O

Constitutively	O
active	O
forms	O
of	O
Notchl	O
in	O
C2C12	O
cells	O
also	O
induced	O
increased	O
levels	O
of	O
the	O
same	O
set	O
of	O
mRNAs	O
,	O
suggesting	O
positive	O
feedback	O
control	O
of	O
these	O
genes	O
initiated	O
by	O
binding	O
of	O
Jagged2	B
to	O
Notch1	B
.	O

This	O
feedback	O
control	O
may	O
function	O
in	O
vivo	O
to	O
coordinate	O
differentiation	O
across	O
certain	O
groups	O
of	O
progenitor	O
cells	O
adopting	O
identical	O
cell	O
fates	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
novel	O
ligand	O
-	O
dependent	O
thyroid	O
hormone	O
receptor	O
-	O
coactivating	O
protein	O
.	O

The	O
thyroid	O
hormone	O
receptor	O
(	O
TR	O
)	O
regulates	O
the	O
expression	O
of	O
target	O
genes	O
upon	O
binding	O
to	O
triiodothyronine	O
(	O
T3	O
)	O
response	O
elements	O
.	O

In	O
the	O
presence	O
of	O
T3	O
,	O
the	O
TR	O
recruits	O
coactivating	O
proteins	O
that	O
both	O
modulate	O
and	O
integrate	O
the	O
ligand	O
response	O
.	O

We	O
report	O
here	O
the	O
cloning	O
of	O
a	O
novel	O
protein	O
using	O
the	O
TR	O
ligand	O
-	O
binding	O
domain	O
as	O
bait	O
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

Analysis	O
of	O
a	O
putative	O
full	O
-	O
length	O
clone	O
demonstrates	O
a	O
cDNA	O
sequence	O
that	O
encodes	O
a	O
protein	O
of	O
920	O
amino	O
acids	O
with	O
a	O
size	O
of	O
120	O
kDa	O
(	O
p120	B
)	O
.	O

Alignment	O
with	O
known	O
sequences	O
shows	O
homology	O
to	O
a	O
previously	O
identified	O
protein	O
of	O
unknown	O
function	O
,	O
termed	O
skeletal	B
muscle	I
abundant	I
protein	I
.	O

Interaction	O
studies	O
demonstrate	O
that	O
p120	B
interacts	O
with	O
the	O
TR	O
AF-2	O
domain	O
in	O
the	O
presence	O
of	O
ligand	O
through	O
a	O
111-amino	O
acid	O
region	O
.	O

Northern	O
analysis	O
demonstrates	O
widespread	O
expression	O
in	O
human	O
tissues	O
.	O

Cotransfection	O
assays	O
in	O
CV-1	O
cells	O
demonstrate	O
that	O
p120	B
enhances	O
TR	O
-	O
mediated	O
transactivation	O
on	O
multiple	O
T3	O
response	O
elements	O
in	O
the	O
presence	O
of	O
T3	O
.	O

In	O
addition	O
,	O
CREB	B
-	I
binding	I
protein	I
synergizes	O
with	O
p120	B
to	O
enhance	O
this	O
effect	O
.	O

When	O
linked	O
to	O
the	O
GAL4	O
DNA	O
-	O
binding	O
domain	O
,	O
p120	B
is	O
an	O
activator	O
of	O
transcription	O
alone	O
.	O

Thus	O
,	O
p120	B
satisfies	O
a	O
number	O
of	O
important	O
criteria	O
as	O
a	O
nuclear	O
receptor	O
coactivator	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
novel	O
human	O
pH	O
-	O
dependent	O
organic	O
cation	O
transporter	O
,	O
OCTN1	B
.	O

cDNA	O
for	O
a	O
novel	O
proton	O
/	O
organic	O
cation	O
transporter	O
,	O
OCTN1	B
,	O
was	O
cloned	O
from	O
human	O
fetal	O
liver	O
and	O
its	O
transport	O
activity	O
was	O
investigated	O
.	O

OCTN1	B
encodes	O
a	O
551-amino	O
acid	O
protein	O
with	O
11	O
transmembrane	O
domains	O
and	O
one	O
nucleotide	O
binding	O
site	O
motif	O
.	O

It	O
is	O
strongly	O
expressed	O
in	O
kidney	O
,	O
trachea	O
,	O
bone	O
marrow	O
and	O
fetal	O
liver	O
and	O
in	O
several	O
human	O
cancer	O
cell	O
lines	O
,	O
but	O
not	O
in	O
adult	O
liver	O
.	O

When	O
expressed	O
in	O
HEK293	O
cells	O
,	O
OCTN1	B
exhibited	O
saturable	O
and	O
pH	O
-	O
dependent	O
[	O
3H	O
]	O
tetraethyl	O
ammonium	O
uptake	O
with	O
higher	O
activity	O
at	O
neutral	O
and	O
alkaline	O
pH	O
than	O
at	O
acidic	O
pH.	O
Furthermore	O
,	O
treatment	O
with	O
metabolic	O
inhibitors	O
reduced	O
the	O
uptake	O
,	O
which	O
is	O
consistent	O
with	O
the	O
presence	O
of	O
the	O
nucleotide	O
binding	O
site	O
sequence	O
motif	O
.	O

Although	O
its	O
subcellular	O
localization	O
and	O
detailed	O
functional	O
characteristics	O
are	O
not	O
clear	O
at	O
present	O
,	O
OCTN1	B
appears	O
to	O
be	O
a	O
novel	O
proton	O
antiporter	O
that	O
functions	O
for	O
active	O
secretion	O
of	O
cationic	O
compounds	O
across	O
the	O
renal	O
epithelial	O
brush	O
-	O
border	O
membrane	O
.	O

It	O
may	O
play	O
a	O
role	O
in	O
the	O
renal	O
excretion	O
of	O
xenobiotics	O
and	O
their	O
metabolites	O
.	O

Cloning	O
and	O
functional	O
expression	O
of	O
the	O
human	O
GlcNAc-1-P	B
transferase	I
,	O
the	O
enzyme	O
for	O
the	O
committed	O
step	O
of	O
the	O
dolichol	O
cycle	O
,	O
by	O
heterologous	O
complementation	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
gene	O
for	O
the	O
human	O
dolichol	O
cycle	O
GlcNAc-1-P	B
transferase	I
(	O
ALG7	B
/	O
GPT	B
)	O
was	O
cloned	O
by	O
screening	O
a	O
human	O
lung	O
fibroblast	O
cDNA	O
library	O
.	O

The	O
library	O
was	O
constructed	O
in	O
a	O
Saccharomyces	O
cerevisiae	O
expression	O
vector	O
,	O
and	O
the	O
positive	O
clone	O
was	O
identified	O
by	O
complementation	O
of	O
the	O
conditional	O
lethal	O
S.cerevisiae	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O

This	O
strain	O
was	O
constructed	O
by	O
replacing	O
the	O
endogenous	O
promoter	O
of	O
the	O
GPT	B
-	O
gene	O
by	O
the	O
stringently	O
regulated	O
GAL1-promoter	O
.	O

This	O
construct	O
allows	O
to	O
specifically	O
suppress	O
the	O
endogenous	O
enzyme	O
activity	O
.	O

The	O
insert	O
of	O
the	O
positive	O
clone	O
displayed	O
an	O
open	O
reading	O
frame	O
of	O
1200	O
nucleotides	O
,	O
coding	O
for	O
a	O
putative	O
protein	O
of	O
400	O
amino	O
acids	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
44.7	O
kDa	O
.	O

The	O
deduced	O
protein	O
sequence	O
shows	O
a	O
homology	O
of	O
over	O
90	O
%	O
when	O
compared	O
with	O
other	O
mammalian	O
GPT	B
sequences	O
,	O
thus	O
resembling	O
the	O
close	O
phylogenetic	O
relationship	O
between	O
mammalian	O
species	O
.	O

This	O
homology	O
however	O
decreases	O
to	O
40	O
-	O
50	O
%	O
when	O
compared	O
to	O
more	O
distantly	O
related	O
organisms	O
such	O
as	O
S.cerevisiae	O
,	O
Schizosaccharomyces	O
pombe	O
,	O
or	O
Leishmania	O
amazonensis	O
.	O

Biochemical	O
characterization	O
of	O
the	O
recombinant	O
protein	O
showed	O
that	O
it	O
is	O
functionally	O
expressed	O
in	O
the	O
S.cerevisiae	O
strain	O
YPH	O
-	O
A7-GAL	O
.	O

GlcNAc-	O
and	O
GlcNAc2-PP	O
-	O
Dolichol	O
biosynthesis	O
could	O
be	O
shown	O
with	O
isolated	O
S.cerevisiae	O
membranes	O
from	O
cells	O
harboring	O
the	O
recombinant	O
plasmid	O
and	O
grown	O
on	O
glucose	O
thus	O
suppressing	O
transcription	O
of	O
the	O
endogenous	O
gene	O
.	O

Synthesis	O
could	O
be	O
stimulated	O
by	O
dolicholphosphate	O
and	O
was	O
inhibited	O
by	O
tunicamycin	O
.	O

These	O
results	O
show	O
that	O
we	O
have	O
cloned	O
the	O
human	O
GlcNAc-1-P	B
transferase	I
by	O
heterologous	O
complementation	O
in	O
S.	O
cerevisiae	O
,	O
a	O
strategy	O
that	O
may	O
be	O
useful	O
for	O
the	O
cloning	O
and	O
characterization	O
of	O
glycosyltransferases	O
from	O
a	O
variety	O
of	O
organisms	O
.	O

Molecular	O
cloning	O
of	O
a	O
T	B
cell	I
-	I
specific	I
adapter	I
protein	I
(	O
TSAd	B
)	O
containing	O
an	O
Src	O
homology	O
(	O
SH	O
)	O
2	O
domain	O
and	O
putative	O
SH3	O
and	O
phosphotyrosine	O
binding	O
sites	O
.	O

Adapter	O
proteins	O
link	O
catalytic	O
signaling	O
proteins	O
to	O
cell	O
surface	O
receptors	O
or	O
downstream	O
effector	O
proteins	O
.	O

In	O
this	O
paper	O
,	O
we	O
present	O
the	O
cDNA	O
sequence	O
F2771	B
,	O
isolated	O
from	O
an	O
activated	O
CD8	O
+	O
T	O
cell	O
cDNA	O
library	O
.	O

The	O
F2771	B
cDNA	O
encodes	O
a	O
novel	O
putative	O
adapter	O
protein	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
includes	O
an	O
SH2	O
domain	O
as	O
well	O
as	O
putative	O
SH3	O
and	O
phosphotyrosine	O
binding	O
interaction	O
motifs	O
,	O
but	O
lacks	O
any	O
known	O
catalytic	O
domains	O
.	O

The	O
expression	O
of	O
the	O
gene	O
is	O
limited	O
to	O
tissues	O
of	O
the	O
immune	O
system	O
and	O
,	O
in	O
particular	O
,	O
activated	O
T	O
cells	O
.	O

The	O
protein	O
expressed	O
by	O
F2771	B
cDNA	O
in	O
transfected	O
COS	O
cells	O
is	O
localized	O
in	O
the	O
cytoplasm	O
.	O

A	O
polyclonal	O
antiserum	O
raised	O
against	O
an	O
F2771-encoded	B
peptide	O
reacts	O
with	O
a	O
tyrosine	O
-	O
phosphorylated	O
52-kDa	O
protein	O
expressed	O
in	O
phytohemagglutinin	O
-	O
stimulated	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O

The	O
gene	O
is	O
localized	O
to	O
chromosome	O
1q21	O
,	O
a	O
region	O
often	O
found	O
to	O
be	O
aberrant	O
in	O
lymphomas	O
.	O

The	O
T	O
cell	O
-	O
specific	O
expression	O
and	O
the	O
rapid	O
induction	O
of	O
mRNA	O
expression	O
upon	O
receptor	O
binding	O
,	O
as	O
well	O
as	O
the	O
lack	O
of	O
catalytic	O
domains	O
in	O
the	O
presence	O
of	O
protein	O
interaction	O
domains	O
,	O
indicate	O
that	O
the	O
F2771	B
gene	O
encodes	O
a	O
novel	O
T	B
cell	I
-	I
specific	I
adapter	I
protein	I
(	O
TSAd	B
)	O
involved	O
in	O
the	O
control	O
of	O
T	O
cell	O
activation	O
.	O

Characterisation	O
of	O
a	O
new	O
human	O
and	O
murine	O
member	O
of	O
the	O
DnaJ	O
family	O
of	O
proteins	O
.	O

We	O
report	O
the	O
characterisation	O
of	O
a	O
human	O
gene	O
,	O
designated	O
MCG18	B
(	O
multiple	B
endocrine	I
neoplasia	I
type	I
1	I
candidate	I
gene	I
18	I
)	O
,	O
that	O
encodes	O
a	O
new	O
member	O
of	O
the	O
DnaJ	O
family	O
of	O
proteins	O
.	O

Database	O
searches	O
indicate	O
that	O
MCG18	B
also	O
has	O
the	O
locus	O
name	O
HSPF2	B
.	O

MCG18	B
lies	O
250bp	O
centromeric	O
of	O
the	O
VRF	B
/	O
VEGFB	B
gene	O
on	O
chromosome	O
11q13	O
.	O

The	O
MCG18	B
cDNA	O
is	O
predicted	O
to	O
encode	O
a	O
241	O
amino	O
acid	O
product	O
that	O
has	O
partial	O
homology	O
to	O
Escherichia	O
coli	O
dnaJ	O
in	O
that	O
it	O
contains	O
the	O
J	O
domain	O
.	O

However	O
,	O
MCG18	B
has	O
greatest	O
similarity	O
to	O
a	O
functionally	O
undefined	O
protein	O
from	O
Caenorhabditis	O
elegans	O
,	O
both	O
of	O
which	O
are	O
predicted	O
to	O
have	O
a	O
membrane	O
-	O
spanning	O
region	O
adjacent	O
to	O
their	O
J	O
domains	O
.	O

The	O
cDNA	O
encoding	O
the	O
murine	O
homolog	O
(	O
Mcg18	B
)	O
was	O
also	O
cloned	O
and	O
sequenced	O
,	O
and	O
the	O
encoded	O
protein	O
shares	O
81	O
%	O
similarity	O
to	O
MCG18	B
.	O

The	O
coding	O
region	O
of	O
MCG18	B
is	O
interrupted	O
by	O
4	O
introns	O
and	O
the	O
mRNA	O
is	O
expressed	O
as	O
a	O
1.4	O
kb	O
message	O
in	O
all	O
tissues	O
examined	O
,	O
including	O
those	O
derived	O
from	O
the	O
breast	O
,	O
ovary	O
,	O
bladder	O
,	O
lung	O
and	O
keratinocytes	O
.	O

The	O
C	O
-	O
terminus	O
of	O
the	O
HTLV-1	O
Tax	O
oncoprotein	O
mediates	O
interaction	O
with	O
the	O
PDZ	O
domain	O
of	O
cellular	O
proteins	O
.	O

Infection	O
by	O
HTLV-1	O
has	O
been	O
correlated	O
with	O
the	O
appearance	O
of	O
various	O
proliferative	O
or	O
degenerative	O
diseases	O
.	O

Some	O
of	O
these	O
disorders	O
have	O
been	O
observed	O
in	O
transgenic	O
mice	O
expressing	O
the	O
Tax	O
protein	O
,	O
which	O
is	O
known	O
to	O
transactivate	O
various	O
viral	O
and	O
cellular	O
promoters	O
through	O
interactions	O
with	O
several	O
transcription	O
factors	O
.	O

In	O
this	O
study	O
we	O
show	O
that	O
the	O
C	O
-	O
terminus	O
of	O
this	O
viral	O
oncoprotein	O
represents	O
a	O
motif	O
permitting	O
binding	O
of	O
Tax	O
to	O
the	O
PDZ	O
domains	O
of	O
several	O
cellular	O
proteins	O
.	O

A	O
two	O
-	O
hybrid	O
screen	O
with	O
Tax	O
as	O
bait	O
indeed	O
yielded	O
complementary	O
DNAs	O
coding	O
for	O
six	O
proteins	O
including	O
PDZ	O
domains	O
.	O

Two	O
of	O
them	O
correspond	O
to	O
truncated	O
forms	O
of	O
the	O
PSD-95	B
and	O
beta1-syntrophin	B
proteins	O
,	O
another	O
clone	O
codes	O
for	O
a	O
protein	B
homologous	I
to	I
the	I
product	I
of	I
the	I
C.	I
elegans	I
gene	I
lin-7	I
.	O

The	O
other	O
three	O
clones	O
code	O
for	O
new	O
human	O
members	O
of	O
the	O
PDZ	O
family	O
of	O
cellular	O
proteins	O
.	O

The	O
interaction	O
of	O
Tax	O
with	O
the	O
products	O
of	O
these	O
clones	O
was	O
confirmed	O
by	O
immunoprecipitation	O
assays	O
in	O
mammalian	O
cells	O
,	O
and	O
analysis	O
of	O
various	O
mutants	O
of	O
Tax	O
established	O
the	O
importance	O
of	O
the	O
C	O
-	O
terminal	O
amino	O
acids	O
for	O
several	O
of	O
these	O
interactions	O
.	O

These	O
data	O
suggest	O
that	O
Tax	O
could	O
perturb	O
the	O
normal	O
function	O
of	O
targeted	O
cellular	O
proteins	O
by	O
strongly	O
interacting	O
with	O
their	O
PDZ	O
domains	O
.	O

Uroplakin	B
II	I
gene	O
is	O
expressed	O
in	O
transitional	O
cell	O
carcinoma	O
but	O
not	O
in	O
bilharzial	O
bladder	O
squamous	O
cell	O
carcinoma	O
:	O
alternative	O
pathways	O
of	O
bladder	O
epithelial	O
differentiation	O
and	O
tumor	O
formation	O
.	O

Uroplakins	O
(	O
UPs	O
)	O
are	O
integral	O
membrane	O
proteins	O
that	O
are	O
synthesized	O
as	O
the	O
major	O
differentiation	O
products	O
of	O
mammalian	O
urothelium	O
.	O

We	O
have	O
cloned	O
the	O
human	O
UP	B
-	I
II	I
gene	O
and	O
localized	O
it	O
on	O
chromosome	O
11q23	O
.	O

A	O
survey	O
of	O
50	O
transitional	O
cell	O
carcinomas	O
(	O
TCCs	O
)	O
revealed	O
a	O
UP	B
-	I
II	I
polymorphism	O
but	O
no	O
tumor	O
-	O
specific	O
mutations	O
.	O

Immunohistochemical	O
staining	O
using	O
rabbit	O
antisera	O
against	O
a	O
synthetic	O
peptide	O
of	O
UP	B
-	I
II	I
and	O
against	O
total	O
UPs	O
showed	O
UP	O
reactivity	O
in	O
39.5	O
%	O
(	O
17	O
of	O
43	O
cases	O
)	O
of	O
conventional	O
TCCs	O
,	O
12.8	O
%	O
(	O
5	O
of	O
39	O
)	O
of	O
bilharzial	O
-	O
related	O
TCCs	O
,	O
and	O
2.7	O
%	O
(	O
1	O
of	O
36	O
)	O
of	O
bilharzial	O
-	O
related	O
squamous	O
cell	O
carcinomas	O
(	O
SCCs	O
)	O
.	O

The	O
finding	O
that	O
fewer	O
bilharzial	O
TCCs	O
express	O
UPs	O
than	O
conventional	O
TCCs	O
(	O
12.8	O
versus	O
40	O
%	O
)	O
raised	O
the	O
possibility	O
that	O
the	O
former	O
are	O
heterogeneous	O
,	O
expressing	O
SCC	O
features	O
to	O
varying	O
degrees	O
.	O

Our	O
data	O
strongly	O
support	O
the	O
hypothesis	O
that	O
urothelium	O
can	O
undergo	O
at	O
least	O
three	O
pathways	O
of	O
differentiation	O
:	O
(	O
a	O
)	O
urothelium	O
-	O
type	O
pathway	O
;	O
(	O
b	O
)	O
epidermis	O
-	O
type	O
pathway	O
;	O
and	O
(	O
c	O
)	O
glandular	O
-	O
type	O
pathway	O
,	O
characterized	O
by	O
the	O
production	O
of	O
UPs	O
,	O
K1	B
/	I
K10	I
keratins	I
,	O
and	O
secreted	O
glycoproteins	O
,	O
respectively	O
.	O

Vitamin	O
A	O
deficiency	O
and	O
mesenchymal	O
factors	O
may	O
play	O
a	O
role	O
in	O
determining	O
the	O
relative	O
contributions	O
of	O
these	O
pathways	O
to	O
urothelial	O
differentiation	O
as	O
well	O
as	O
to	O
the	O
formation	O
of	O
TCC	O
,	O
SCC	O
,	O
and	O
adenocarcinoma	O
,	O
or	O
a	O
mixture	O
thereof	O
.	O

Homology	O
between	O
a	O
human	O
apoptosis	O
specific	O
protein	O
and	O
the	O
product	O
of	O
APG5	B
,	O
a	O
gene	O
involved	O
in	O
autophagy	O
in	O
yeast	O
.	O

Apoptosis	O
specific	O
proteins	O
(	O
ASP	B
)	O
are	O
expressed	O
in	O
the	O
cytoplasm	O
of	O
cultured	O
mammalian	O
cells	O
of	O
various	O
lineages	O
following	O
induction	O
of	O
apoptosis	O
.	O

The	O
cDNA	O
encoding	O
ASP	B
has	O
been	O
cloned	O
from	O
a	O
human	O
expression	O
library	O
and	O
has	O
significant	O
homology	O
to	O
the	O
Saccharomyces	O
cerevisiae	O
APG5	B
gene	O
which	O
is	O
essential	O
for	O
yeast	O
autophagy	O
.	O

The	O
ASP	B
gene	O
,	O
known	O
as	O
hAPG5	B
,	O
can	O
be	O
transcribed	O
to	O
give	O
mRNAs	O
of	O
3.3	O
kbp	O
,	O
2.5	O
kbp	O
and	O
1.8	O
kbp	O
which	O
are	O
present	O
at	O
comparable	O
levels	O
in	O
viable	O
and	O
apoptotic	O
cells	O
,	O
demonstrating	O
that	O
protein	O
expression	O
must	O
be	O
regulated	O
at	O
the	O
translational	O
level	O
.	O

These	O
data	O
indicate	O
a	O
possible	O
relationship	O
between	O
apoptosis	O
and	O
autophagy	O
and	O
suggest	O
evolutionary	O
conservation	O
in	O
mammalian	O
apoptosis	O
of	O
a	O
degradative	O
process	O
present	O
in	O
yeast	O
.	O

A	O
12R	B
-	I
lipoxygenase	I
in	O
human	O
skin	O
:	O
mechanistic	O
evidence	O
,	O
molecular	O
cloning	O
,	O
and	O
expression	O
.	O

A	O
recognized	O
feature	O
of	O
psoriasis	O
and	O
other	O
proliferative	O
dermatoses	O
is	O
accumulation	O
in	O
the	O
skin	O
of	O
the	O
unusual	O
arachidonic	O
acid	O
metabolite	O
,	O
12R	O
-	O
hydroxyeicosatetraenoic	O
acid	O
(	O
12R	O
-	O
HETE	O
)	O
.	O

This	O
hydroxy	O
fatty	O
acid	O
is	O
opposite	O
in	O
chirality	O
to	O
the	O
product	O
of	O
the	O
well	O
-	O
known	O
12S	B
-	I
lipoxygenase	I
and	O
heretofore	O
in	O
mammals	O
is	O
known	O
only	O
as	O
a	O
product	O
of	O
cytochrome	O
P450s	O
.	O

Here	O
we	O
provide	O
mechanistic	O
evidence	O
for	O
a	O
lipoxygenase	O
route	O
to	O
12R	O
-	O
HETE	O
in	O
human	O
psoriatic	O
tissue	O
and	O
describe	O
a	O
12R	B
-	I
lipoxygenase	I
that	O
can	O
account	O
for	O
the	O
biosynthesis	O
.	O

Initially	O
we	O
demonstrated	O
retention	O
of	O
the	O
C-12	O
deuterium	O
of	O
octadeuterated	O
arachidonic	O
acid	O
in	O
its	O
conversion	O
to	O
12R	O
-	O
HETE	O
in	O
incubations	O
of	O
psoriatic	O
scales	O
,	O
indicating	O
the	O
end	O
product	O
is	O
not	O
formed	O
by	O
isomerization	O
from	O
12S	O
-	O
H	O
(	O
P	O
)	O
ETE	O
via	O
the	O
12-keto	O
derivative	O
.	O

Secondly	O
,	O
analysis	O
of	O
product	O
formed	O
from	O
[	O
10R-3H	O
]	O
and	O
[	O
10S-3H	O
]	O
-labeled	O
arachidonic	O
acids	O
revealed	O
that	O
12R	O
-	O
HETE	O
synthesis	O
is	O
associated	O
with	O
stereospecific	O
removal	O
of	O
the	O
pro	O
-	O
R	O
hydrogen	O
from	O
the	O
10-carbon	O
of	O
arachidonate	O
.	O

This	O
result	O
is	O
compatible	O
with	O
12R	B
-	I
lipoxygenase	I
-	O
catalyzed	O
formation	O
of	O
12R	O
-	O
HETE	O
and	O
not	O
with	O
a	O
P450-catalyzed	O
route	O
to	O
12R	O
-	O
HETE	O
in	O
psoriatic	O
scales	O
.	O

We	O
cloned	O
a	O
lipoxygenase	O
from	O
human	O
keratinocytes	O
;	O
the	O
cDNA	O
and	O
deduced	O
amino	O
acid	O
sequences	O
share	O
<	O
/=50	O
%	O
identity	O
to	O
other	O
human	O
lipoxygenases	O
.	O

This	O
enzyme	O
,	O
when	O
expressed	O
in	O
Hela	O
cells	O
,	O
oxygenates	O
arachidonic	O
acid	O
to	O
12-HPETE	O
,	O
>	O
98	O
%	O
12R	O
in	O
configuration	O
.	O

The	O
12R	B
-	I
lipoxygenase	I
cDNA	O
is	O
detectable	O
by	O
PCR	O
in	O
psoriatic	O
scales	O
and	O
as	O
a	O
2.5-kilobase	O
mRNA	O
by	O
Northern	O
analysis	O
of	O
keratinocytes	O
.	O

Identification	O
of	O
this	O
enzyme	O
extends	O
the	O
known	O
distribution	O
of	O
R	O
-	O
lipoxygenases	O
to	O
humans	O
and	O
presents	O
an	O
additional	O
target	O
for	O
potential	O
therapeutic	O
interventions	O
in	O
psoriasis	O
.	O

A	O
novel	O
homeobox	O
gene	O
PITX3	B
is	O
mutated	O
in	O
families	O
with	O
autosomal	O
-	O
dominant	O
cataracts	O
and	O
ASMD	O
.	O

We	O
report	O
here	O
the	O
identification	O
of	O
a	O
new	O
human	O
homeobox	O
gene	O
,	O
PITX3	B
,	O
and	O
its	O
involvement	O
in	O
anterior	O
segment	O
mesenchymal	O
dysgenesis	O
(	O
ASMD	O
)	O
and	O
congenital	O
cataracts	O
in	O
humans	O
.	O

The	O
PITX3	B
gene	O
is	O
the	O
human	O
homologue	O
of	O
the	O
mouse	O
Pitx3	B
gene	O
and	O
is	O
a	O
member	O
of	O
the	O
RIEG	O
/	O
PITX	O
homeobox	O
gene	O
family	O
.	O

The	O
protein	O
encoded	O
by	O
PITX3	B
shows	O
99	O
%	O
amino	O
-	O
acid	O
identity	O
to	O
the	O
mouse	O
protein	O
,	O
with	O
100	O
%	O
identity	O
in	O
the	O
homeodomain	O
and	O
approximately	O
70	O
%	O
overall	O
identity	O
to	O
other	O
members	O
of	O
this	O
family	O
.	O

We	O
mapped	O
the	O
human	O
PITX3	B
gene	O
to	O
10q25	O
using	O
a	O
radiation	O
-	O
hybrid	O
panel	O
.	O

A	O
collection	O
of	O
80	O
DNA	O
samples	O
from	O
individuals	O
with	O
various	O
eye	O
anomalies	O
was	O
screened	O
for	O
mutations	O
in	O
the	O
PITX3	B
gene	O
.	O

We	O
identified	O
two	O
mutations	O
in	O
independent	O
patients	O
.	O

A	O
17-bp	O
insertion	O
in	O
the	O
3'-end	O
of	O
the	O
coding	O
sequence	O
,	O
resulting	O
in	O
a	O
frame	O
shift	O
,	O
occurred	O
in	O
a	O
patient	O
with	O
ASMD	O
and	O
cataracts	O
,	O
and	O
a	O
G-->A	O
substitution	O
,	O
changing	O
a	O
codon	O
for	O
serine	O
into	O
a	O
codon	O
for	O
asparagine	O
,	O
in	O
the	O
5'-end	O
of	O
the	O
gene	O
occurred	O
in	O
a	O
patient	O
with	O
congenital	O
cataracts	O
.	O

Both	O
mutations	O
cosegregate	O
with	O
the	O
disease	O
phenotype	O
in	O
families	O
,	O
and	O
neither	O
were	O
found	O
in	O
up	O
to	O
300	O
control	O
individuals	O
studied	O
.	O

Further	O
expression	O
analysis	O
of	O
Pitx3	B
in	O
the	O
mouse	O
supports	O
a	O
unique	O
role	O
in	O
early	O
ocular	O
development	O
,	O
with	O
later	O
expression	O
extending	O
to	O
the	O
midbrain	O
,	O
tongue	O
,	O
incisors	O
,	O
sternum	O
,	O
vertebrae	O
and	O
limbs	O
.	O

These	O
data	O
strongly	O
suggest	O
a	O
role	O
for	O
PITX3	B
in	O
ASMD	O
and	O
cataracts	O
and	O
provide	O
new	O
evidence	O
of	O
the	O
contribution	O
of	O
the	O
RIEG	O
/	O
PITX	O
gene	O
family	O
to	O
the	O
developmental	O
program	O
underpinning	O
normal	O
eye	O
formation	O
.	O

Human	O
RanBP3	B
,	O
a	O
group	O
of	O
nuclear	O
RanGTP	O
binding	O
proteins	O
.	O

A	O
group	O
of	O
novel	O
human	O
Ran	O
-	O
binding	O
proteins	O
,	O
RanBP3	B
,	O
was	O
identified	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
via	O
Ran	O
-	O
mediated	O
interaction	O
with	O
the	O
nucleotide	O
exchange	O
factor	O
RCC1	B
.	O

Several	O
open	O
reading	O
frames	O
,	O
representing	O
putative	O
alternatively	O
spliced	O
products	O
,	O
were	O
established	O
by	O
cDNA	O
cloning	O
.	O

Two	O
of	O
them	O
,	O
RanBP3-a	B
and	O
RanBP3-b	B
,	O
encode	O
nuclear	O
hydrophilic	O
proteins	O
of	O
499	O
and	O
562	O
amino	O
acid	O
residues	O
.	O

The	O
sequences	O
contain	O
FXFG	O
motifs	O
,	O
characteristic	O
of	O
a	O
subgroup	O
of	O
nucleoporins	O
,	O
and	O
a	O
C	O
-	O
terminal	O
domain	O
showing	O
similarity	O
to	O
the	O
Ran	O
-	O
binding	O
protein	O
RanBP1	B
.	O

These	O
proteins	O
are	O
localized	O
in	O
the	O
nucleus	O
,	O
preferentially	O
bind	O
RanGTP	O
and	O
may	O
be	O
nuclear	O
effectors	O
of	O
the	O
Ran	O
pathway	O
.	O

A	O
stress	O
response	O
pathway	O
from	O
the	O
endoplasmic	O
reticulum	O
to	O
the	O
nucleus	O
requires	O
a	O
novel	O
bifunctional	O
protein	O
kinase	O
/	O
endoribonuclease	O
(	O
Ire1p	B
)	O
in	O
mammalian	O
cells	O
.	O

Eukaryotes	O
respond	O
to	O
the	O
presence	O
of	O
unfolded	O
protein	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
by	O
up	O
-	O
regulating	O
the	O
transcription	O
of	O
genes	O
encoding	O
ER	O
protein	O
chaperones	O
,	O
such	O
as	O
BiP.	B
We	O
have	O
isolated	O
a	O
novel	O
human	O
cDNA	O
encoding	O
a	O
homolog	O
to	O
Saccharomyces	O
cerevisiae	O
Ire1p	B
,	O
a	O
proximal	O
sensor	O
for	O
this	O
signal	O
transduction	O
pathway	O
in	O
yeast	O
.	O

The	O
gene	O
product	O
hIre1p	B
is	O
a	O
type	O
1	O
transmembrane	O
protein	O
containing	O
a	O
cytoplasmic	O
domain	O
that	O
is	O
highly	O
conserved	O
to	O
the	O
yeast	O
counterpart	O
having	O
a	O
Ser	O
/	O
Thr	O
protein	O
kinase	O
domain	O
and	O
a	O
domain	O
homologous	O
to	O
RNase	B
L.	I
However	O
,	O
the	O
luminal	O
domain	O
has	O
extensively	O
diverged	O
from	O
the	O
yeast	O
gene	O
product	O
.	O

hIre1p	B
expressed	O
in	O
mammalian	O
cells	O
displayed	O
intrinsic	O
autophosphorylation	O
activity	O
and	O
an	O
endoribonuclease	O
activity	O
that	O
cleaved	O
the	O
5	O
'	O
splice	O
site	O
of	O
yeast	O
HAC1	O
mRNA	O
,	O
a	O
substrate	O
for	O
the	O
endoribonuclease	O
activity	O
of	O
yeast	O
Ire1p	B
.	O

Overexpressed	O
hIre1p	B
was	O
localized	O
to	O
the	O
ER	O
with	O
particular	O
concentration	O
around	O
the	O
nuclear	O
envelope	O
and	O
some	O
colocalization	O
with	O
the	O
nuclear	O
pore	O
complex	O
.	O

Expression	O
of	O
Ire1p	B
mRNA	O
was	O
autoregulated	O
through	O
a	O
process	O
that	O
required	O
a	O
functional	O
hIre1p	B
kinase	O
activity	O
.	O

Finally	O
,	O
overexpression	O
of	O
wild	O
-	O
type	O
hIre1p	B
constitutively	O
activated	O
a	O
reporter	O
gene	O
under	O
transcriptional	O
control	O
of	O
the	O
rat	O
BiP	B
promoter	O
,	O
whereas	O
expression	O
of	O
a	O
catalytically	O
inactive	O
hIre1p	B
acted	O
in	O
a	O
trans	O
-	O
dominant	O
-	O
negative	O
manner	O
to	O
prevent	O
transcriptional	O
activation	O
of	O
the	O
BiP	B
promoter	O
in	O
response	O
to	O
ER	O
stress	O
induced	O
by	O
inhibition	O
of	O
N	O
-	O
linked	O
glycosylation	O
.	O

These	O
results	O
demonstrate	O
that	O
hIre1p	B
is	O
an	O
essential	O
proximal	O
sensor	O
of	O
the	O
unfolded	O
protein	O
response	O
pathway	O
in	O
mammalian	O
cells	O
.	O

Atrophin-1	B
,	O
the	O
DRPLA	B
gene	O
product	O
,	O
interacts	O
with	O
two	O
families	O
of	O
WW	O
domain	O
-	O
containing	O
proteins	O
.	O

Atrophin-1	B
contains	O
a	O
polyglutamine	O
repeat	O
,	O
expansion	O
of	O
which	O
is	O
responsible	O
for	O
dentatorubral	O
and	O
pallidoluysian	O
atrophy	O
(	O
DRPLA	B
)	O
.	O

The	O
normal	O
function	O
of	O
atrophin-1	B
is	O
unknown	O
.	O

We	O
have	O
identified	O
five	O
atrophin-1	B
interacting	O
proteins	O
(	O
AIPs	O
)	O
which	O
bind	O
to	O
atrophin-1	B
in	O
the	O
vicinity	O
of	O
the	O
polyglutamine	O
tract	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

Four	O
of	O
the	O
interactions	O
were	O
confirmed	O
using	O
in	O
vitro	O
binding	O
assays	O
.	O

All	O
five	O
interactors	O
contained	O
multiple	O
WW	O
domains	O
.	O

Two	O
are	O
novel	O
.	O

The	O
AIPs	O
can	O
be	O
divided	O
into	O
two	O
distinct	O
classes	O
.	O

AIP1	B
and	O
AIP3	B
/	I
WWP3	I
are	O
MAGUK	O
-	O
like	O
multidomain	O
proteins	O
containing	O
a	O
number	O
of	O
protein	O
-	O
protein	O
interaction	O
modules	O
,	O
namely	O
a	O
guanylate	O
kinase	O
-	O
like	O
region	O
,	O
two	O
WW	O
domains	O
,	O
and	O
multiple	O
PDZ	O
domains	O
.	O

AIP2	B
/	I
WWP2	I
,	O
AIP4	B
,	O
and	O
AIP5	B
/	I
WWP1	I
are	O
highly	O
homologous	O
,	O
each	O
having	O
four	O
WW	O
domains	O
and	O
a	O
HECT	O
domain	O
characteristic	O
of	O
ubiquitin	O
ligases	O
.	O

These	O
interactors	O
are	O
similar	O
to	O
recently	O
isolated	O
huntingtin	B
-	O
interacting	O
proteins	O
,	O
suggesting	O
possible	O
commonality	O
of	O
function	O
between	O
two	O
proteins	O
responsible	O
for	O
very	O
similar	O
diseases	O
.	O

cDNA	O
sequence	O
and	O
chromosomal	O
localization	O
of	O
the	O
remaining	O
three	O
human	O
nuclear	O
encoded	O
iron	O
sulphur	O
protein	O
(	O
IP	O
)	O
subunits	O
of	O
complex	O
I	O
:	O
the	O
human	O
IP	O
fraction	O
is	O
completed	O
.	O

NADH	O
:	O
ubiquinone	O
oxidoreductase	O
(	O
complex	O
I	O
)	O
of	O
the	O
mitochondrial	O
respiratory	O
chain	O
can	O
be	O
fragmented	O
in	O
a	O
flavoprotein	O
(	O
FP	O
)	O
,	O
iron	O
-	O
sulfur	O
protein	O
(	O
IP	O
)	O
,	O
and	O
hydrophobic	O
protein	O
(	O
HP	O
)	O
subfraction	O
.	O

The	O
IP	O
subfraction	O
is	O
hypothesized	O
to	O
be	O
significant	O
,	O
since	O
it	O
contains	O
important	O
prosthetic	O
groups	O
highly	O
conserved	O
among	O
species	O
.	O

We	O
cloned	O
the	O
cDNA	O
of	O
three	O
remaining	O
human	O
NADH	O
:	O
ubiquinone	O
oxidoreductase	O
subunits	O
of	O
this	O
IP	O
fraction	O
:	O
the	O
NDUFS2	B
(	O
49	O
kDa	O
)	O
,	O
NDUFS3	B
(	O
30	O
kDa	O
)	O
,	O
and	O
NDUFS6	B
(	O
13	O
kDa	O
)	O
subunits	O
.	O

All	O
presented	O
cDNAs	O
include	O
the	O
complete	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
,	O
which	O
consist	O
of	O
1392	O
,	O
795	O
,	O
and	O
375	O
base	O
pairs	O
,	O
coding	O
for	O
463	O
,	O
264	O
,	O
and	O
124	O
amino	O
acids	O
,	O
respectively	O
.	O

The	O
latter	O
show	O
96	O
,	O
90	O
,	O
and	O
83	O
%	O
homology	O
with	O
the	O
corresponding	O
bovine	O
translation	O
products	O
.	O

The	O
3	O
'	O
untranslated	O
regions	O
(	O
UTR	O
)	O
are	O
complete	O
in	O
all	O
three	O
cDNAs	O
.	O

Polymerase	O
chain	O
reaction	O
performed	O
with	O
DNA	O
isolated	O
from	O
somatic	O
human	O
-	O
rodent	O
cell	O
hybrids	O
containing	O
defined	O
human	O
chromosomes	O
as	O
template	O
gave	O
a	O
human	O
-	O
specific	O
signal	O
which	O
mapped	O
the	O
NDUFS2	B
and	O
NDUFS3	B
subunits	O
to	O
chromosomes	O
1	O
and	O
11	O
,	O
respectively	O
.	O

In	O
the	O
case	O
of	O
the	O
NDUFS6	B
subunit	O
a	O
pseudogene	O
may	O
be	O
present	O
since	O
signals	O
were	O
seen	O
in	O
the	O
lanes	O
containing	O
chromosomes	O
5	O
and	O
6	O
.	O

The	O
NDUFS2	B
contains	O
a	O
highly	O
conserved	O
protein	O
kinase	O
C	O
phosphorylation	O
site	O
and	O
the	O
NDUFS3	B
subunit	O
contains	O
a	O
highly	O
conserved	O
casein	O
kinase	O
II	O
phosphorylation	O
site	O
which	O
make	O
them	O
strong	O
candidates	O
for	O
future	O
mutation	O
detection	O
studies	O
in	O
enzymatic	O
complex	O
I	O
-	O
deficient	O
patients	O
.	O

Isolation	O
and	O
characterization	O
of	O
PAGE-1	B
and	O
GAGE-7	B
.	O

New	O
genes	O
expressed	O
in	O
the	O
LNCaP	O
prostate	O
cancer	O
progression	O
model	O
that	O
share	O
homology	O
with	O
melanoma	O
-	O
associated	O
antigens	O
.	O

The	O
LNCaP	O
progression	O
model	O
of	O
human	O
prostate	O
cancer	O
consists	O
of	O
lineage	O
-	O
related	O
sublines	O
that	O
differ	O
in	O
their	O
androgen	O
sensitivity	O
and	O
metastatic	O
potential	O
.	O

A	O
differential	O
display	O
polymerase	O
chain	O
reaction	O
was	O
employed	O
to	O
evaluate	O
mRNA	O
expression	O
differences	O
between	O
the	O
LNCaP	O
sublines	O
in	O
order	O
to	O
define	O
the	O
differences	O
in	O
gene	O
expression	O
between	O
the	O
androgen	O
-	O
sensitive	O
,	O
nontumorigenic	O
LNCaP	O
cell	O
line	O
and	O
the	O
androgen	O
-	O
insensitive	O
,	O
metastatic	O
LNCaP	O
sublines	O
,	O
C4	O
-	O
2	O
and	O
C4	O
-	O
2B	O
.	O

An	O
amplicon	O
,	O
BG16.21	O
,	O
was	O
isolated	O
that	O
showed	O
increased	O
expression	O
in	O
the	O
androgen	O
-	O
independent	O
and	O
metastatic	O
LNCaP	O
sublines	O
,	O
C4	O
-	O
2	O
and	O
C4	O
-	O
2B	O
.	O

Hybridization	O
screening	O
of	O
a	O
lambda	O
gt11	O
expression	O
library	O
with	O
BG16.21	O
revealed	O
two	O
transcripts	O
,	O
both	O
homologous	O
to	O
BG16.21	O
at	O
the	O
3	O
'	O
end	O
.	O

A	O
GenBankTM	O
data	O
base	O
search	O
using	O
the	O
GCG	O
Wisconsin	O
software	O
package	O
revealed	O
the	O
shorter	O
approximately	O
600-bp	O
transcript	O
(	O
designated	O
GAGE-7	B
)	O
to	O
be	O
a	O
new	O
member	O
of	O
the	O
GAGE	O
family	O
.	O

The	O
second	O
approximately	O
700-bp	O
transcript	O
was	O
a	O
novel	O
gene	O
(	O
designated	O
PAGE-1	B
,	O
""""	O
prostate	B
associated	I
gene	I
""""	O
)	O
with	O
only	O
45	O
%	O
homology	O
to	O
GAGE	O
gene	O
family	O
members	O
.	O

RNA	O
blot	O
analysis	O
demonstrated	O
that	O
GAGE-7	B
mRNA	O
was	O
expressed	O
at	O
equal	O
levels	O
in	O
all	O
lineage	O
related	O
prostate	O
cancer	O
cell	O
sublines	O
,	O
while	O
PAGE-1	B
mRNA	O
levels	O
were	O
elevated	O
5-fold	O
in	O
C4	O
-	O
2	O
and	O
C4	O
-	O
2B	O
as	O
compared	O
with	O
LNCaP	O
cells	O
.	O

Neither	O
GAGE-7	B
nor	O
PAGE-1	B
demonstrated	O
any	O
regulation	O
by	O
androgens	O
in	O
the	O
prostate	O
cancer	O
cell	O
lines	O
used	O
in	O
this	O
study	O
.	O

PAGE-1	B
and	O
GAGE-7	B
expression	O
was	O
found	O
to	O
be	O
restricted	O
to	O
testes	O
(	O
high	O
)	O
and	O
placenta	O
(	O
low	O
)	O
on	O
human	O
multiple	O
tissue	O
Northern	O
blots	O
.	O

As	O
GAGE	O
/	O
MAGE	O
antigens	O
were	O
reported	O
previously	O
to	O
be	O
targets	O
for	O
tumor	O
-	O
specific	O
cytotoxic	O
lymphocytes	O
in	O
melanoma	O
,	O
these	O
results	O
suggest	O
that	O
PAGE-1	B
and	O
GAGE-7	B
may	O
be	O
related	O
to	O
prostate	O
cancer	O
progression	O
and	O
may	O
serve	O
as	O
potential	O
targets	O
for	O
novel	O
therapies	O
.	O

SAP30	B
,	O
a	O
novel	O
protein	O
conserved	O
between	O
human	O
and	O
yeast	O
,	O
is	O
a	O
component	O
of	O
a	O
histone	O
deacetylase	O
complex	O
.	O

Histone	O
acetylation	O
plays	O
a	O
key	O
role	O
in	O
the	O
regulation	O
of	O
eukaryotic	O
gene	O
expression	O
.	O

Recently	O
,	O
histone	O
acetylation	O
and	O
deacetylation	O
were	O
found	O
to	O
be	O
catalyzed	O
by	O
structurally	O
distinct	O
,	O
multisubunit	O
complexes	O
that	O
mediate	O
,	O
respectively	O
,	O
activation	O
and	O
repression	O
of	O
transcription	O
.	O

Here	O
,	O
we	O
identify	O
SAP30	B
as	O
a	O
novel	O
component	O
of	O
the	O
human	O
histone	O
deacetylase	O
complex	O
that	O
includes	O
Sin3	O
,	O
the	O
histone	O
deacetylases	O
HDAC1	B
and	O
HDAC2	B
,	O
histone	O
binding	O
proteins	O
RbAp46	B
and	O
RbAp48	B
,	O
as	O
well	O
as	O
other	O
polypeptides	O
.	O

Moreover	O
,	O
we	O
describe	O
a	O
SAP30	B
homolog	O
in	O
yeast	O
that	O
is	O
functionally	O
related	O
to	O
Sin3	O
and	O
the	O
histone	O
deacetylase	O
Rpd3	B
.	O

The	O
human	O
SAP30	B
complex	O
is	O
active	O
in	O
deacetylating	O
core	O
histone	O
octamers	O
,	O
but	O
inactive	O
in	O
deacetylating	O
nucleosomal	O
histones	O
due	O
to	O
the	O
inability	O
of	O
the	O
histone	O
binding	O
proteins	O
RbAp46	B
and	O
RbAp48	B
to	O
gain	O
access	O
to	O
nucleosomal	O
histones	O
.	O

These	O
results	O
define	O
SAP30	B
as	O
a	O
component	O
of	O
a	O
histone	O
deacetylase	O
complex	O
conserved	O
among	O
eukaryotic	O
organisms	O
.	O

A	O
novel	O
human	O
actin	O
-	O
binding	O
protein	O
homologue	O
that	O
binds	O
to	O
platelet	O
glycoprotein	B
Ibalpha	I
.	O

Glycoprotein	O
(	O
GP	O
)	O
Ib	O
-	O
IX	O
-	O
V	O
is	O
one	O
of	O
the	O
major	O
transmembrane	O
complexes	O
present	O
on	O
the	O
platelet	O
surface	O
.	O

Its	O
extracellular	O
domain	O
binds	O
von	B
Willebrand	I
factor	I
(	O
vWF	B
)	O
and	O
thrombin	B
,	O
while	O
its	O
intracellular	O
domain	O
associates	O
tightly	O
with	O
the	O
cytoskeleton	O
through	O
the	O
actin	B
-	I
binding	I
protein	I
(	I
ABP	I
)	I
-280	I
,	O
also	O
known	O
as	O
filamin	B
.	O

In	O
the	O
present	O
study	O
,	O
a	O
full	O
-	O
length	O
cDNA	O
coding	O
for	O
a	O
human	O
ABP	O
homologue	O
has	O
been	O
cloned	O
and	O
sequenced	O
.	O

This	O
protein	O
was	O
identified	O
by	O
the	O
yeast	O
two	O
-	O
hybrid	O
screening	O
procedure	O
via	O
its	O
interaction	O
with	O
the	O
intracellular	O
domain	O
of	O
GPIbalpha	B
.	O

Initially	O
,	O
a	O
1.3-kb	O
partial	O
cDNA	O
was	O
isolated	O
from	O
a	O
megakaryocyte	O
-	O
like	O
cell	O
line	O
(	O
K562	O
)	O
cDNA	O
library	O
followed	O
by	O
a	O
full	O
-	O
length	O
cDNA	O
of	O
9.4	O
kb	O
that	O
was	O
identified	O
in	O
a	O
human	O
placenta	O
library	O
.	O

The	O
full	O
-	O
length	O
cDNA	O
encoded	O
a	O
protein	O
of	O
2,578	O
amino	O
acids	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
276	O
kD	O
(	O
ABP-276	B
)	O
.	O

The	O
amino	O
terminal	O
248	O
amino	O
acids	O
contained	O
an	O
apparent	O
actin	O
binding	O
domain	O
followed	O
by	O
24	O
tandem	O
repeats	O
each	O
containing	O
about	O
96	O
amino	O
acids	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
the	O
protein	O
shared	O
a	O
high	O
degree	O
of	O
homology	O
with	O
human	O
endothelial	O
ABP-280	B
(	O
70	O
%	O
identity	O
)	O
and	O
chicken	O
filamin	B
(	O
83	O
%	O
identity	O
)	O
.	O

However	O
,	O
the	O
32	O
amino	O
acid	O
Hinge	O
I	O
region	O
in	O
ABP-280	B
that	O
contains	O
a	O
calpain	O
cleavage	O
site	O
conferring	O
flexibility	O
on	O
the	O
molecule	O
,	O
was	O
absent	O
in	O
the	O
homologue	O
.	O

An	O
isoform	O
containing	O
a	O
24	O
amino	O
acid	O
insertion	O
with	O
a	O
unique	O
sequence	O
at	O
the	O
missing	O
Hinge	O
I	O
region	O
was	O
also	O
identified	O
(	O
ABP-278	B
)	O
.	O

This	O
isoform	O
resulted	O
from	O
alternative	O
RNA	O
splicing	O
.	O

ABP-276	B
and/or	O
ABP-278	B
were	O
present	O
in	O
all	O
tissues	O
examined	O
,	O
but	O
the	O
relative	O
amount	O
varied	O
in	O
that	O
some	O
tissue	O
contained	O
both	O
forms	O
,	O
while	O
other	O
tissue	O
contained	O
predominately	O
one	O
or	O
the	O
other	O
.	O

cDNA	O
cloning	O
and	O
chromosomal	O
localization	O
of	O
the	O
human	O
and	O
mouse	O
isoforms	O
of	O
Ksp	B
-	I
cadherin	I
.	O

Ksp	B
-	I
cadherin	I
is	O
a	O
novel	O
kidney	O
-	O
specific	O
member	O
of	O
the	O
cadherin	O
superfamily	O
of	O
cell	O
adhesion	O
molecules	O
.	O

We	O
have	O
determined	O
the	O
complete	O
cDNA	O
coding	O
sequences	O
of	O
both	O
the	O
human	O
and	O
the	O
mouse	O
isoforms	O
of	O
Ksp	B
-	I
cadherin	I
.	O

The	O
inferred	O
amino	O
acid	O
sequences	O
of	O
the	O
human	O
and	O
mouse	O
isoforms	O
are	O
79	O
and	O
75	O
%	O
identical	O
to	O
the	O
originally	O
described	O
rabbit	O
isoform	O
of	O
Ksp	B
-	I
cadherin	I
(	O
Thomson	O
et	O
al.	O
,	O
1995	O
;	O
J.	O
Biol	O
.	O

Chem	O
.	O
270	O
,	O
17594	O
-	O
17601	O
)	O
,	O
respectively	O
.	O

The	O
relative	O
locations	O
of	O
cadherin	O
-	O
specific	O
sequence	O
motifs	O
,	O
putative	O
N	O
-	O
glycosylation	O
sites	O
,	O
and	O
characteristic	O
protein	O
domains	O
are	O
entirely	O
conserved	O
in	O
all	O
three	O
isoforms	O
.	O

Multiple	O
organ	O
Northern	O
analyses	O
indicate	O
that	O
,	O
as	O
in	O
the	O
rabbit	O
,	O
both	O
the	O
human	O
and	O
the	O
mouse	O
Ksp	B
-	I
cadherin	I
transcripts	O
appear	O
to	O
have	O
distinct	O
kidney	O
-	O
specific	O
distributions	O
.	O

The	O
human	O
Ksp	B
-	I
cadherin	I
gene	O
(	O
CDH16	B
)	O
maps	O
to	O
chromosome	O
16q21-proximal	O
16q22	O
.	O

The	O
mouse	O
Ksp	B
-	I
cadherin	I
gene	O
(	O
Cdh16	B
)	O
was	O
localized	O
to	O
a	O
highly	O
syntenic	O
region	O
of	O
distal	O
Chromosome	O
8	O
.	O

Both	O
the	O
human	O
and	O
the	O
mouse	O
Ksp	B
-	I
cadherin	I
genes	O
were	O
localized	O
to	O
previously	O
identified	O
clusters	O
of	O
cadherin	O
gene	O
sequences	O
,	O
consistent	O
with	O
the	O
hypothesis	O
that	O
most	O
cadherin	O
family	O
members	O
arose	O
by	O
gene	O
duplication	O
from	O
a	O
single	O
ancestral	O
gene	O
at	O
a	O
relatively	O
early	O
stage	O
in	O
the	O
evolution	O
of	O
the	O
mammalian	O
genome	O
.	O

ZK1	B
,	O
a	O
novel	O
Krüppel	O
-	O
type	O
zinc	O
finger	O
gene	O
,	O
is	O
induced	O
following	O
exposure	O
to	O
ionizing	O
radiation	O
and	O
enhances	O
apoptotic	O
cell	O
death	O
on	O
hematopoietic	O
cells	O
.	O

To	O
identify	O
and	O
early	O
response	O
factor	O
by	O
exposure	O
to	O
ionizing	O
radiation	O
,	O
we	O
cloned	O
the	O
cDNA	O
of	O
a	O
novel	O
Krüppel	O
-	O
type	O
zinc	O
finger	O
(	O
ZNF	O
)	O
gene	O
,	O
ZK1	O
,	O
from	O
a	O
cDNA	O
library	O
constructed	O
from	O
the	O
human	O
leukemia	O
cell	O
line	O
,	O
CMK86	O
,	O
using	O
degenerate	O
primers	O
.	O

This	O
cDNA	O
encoded	O
a	O
protein	O
of	O
671	O
amino	O
acids	O
with	O
an	O
A	O
box	O
of	O
Krüppel	O
-	O
associated	O
box	O
(	O
KRAB	O
)	O
domain	O
at	O
the	O
N	O
-	O
terminus	O
,	O
followed	O
by	O
15	O
ZNF	O
motifs	O
.	O

The	O
expression	O
level	O
of	O
the	O
ZK1	O
mRNA	O
in	O
human	O
leukemia	O
cells	O
lines	O
,	O
CMK86	O
and	O
U937	O
,	O
was	O
increased	O
after	O
exposure	O
to	O
ionizing	O
radiation	O
.	O

Furthermore	O
,	O
murine	O
myeloid	O
precursor	O
32D	O
cells	O
that	O
were	O
stably	O
transfected	O
with	O
ZK1	O
cDNA	O
had	O
higher	O
sensitivity	O
to	O
ionizing	O
radiation	O
than	O
the	O
32D	O
parent	O
cells	O
.	O

These	O
data	O
suggest	O
that	O
the	O
ZK1	O
gene	O
is	O
one	O
of	O
early	O
response	O
genes	O
by	O
exposure	O
to	O
ionizing	O
radiation	O
,	O
and	O
may	O
have	O
some	O
functions	O
on	O
radiation	O
-	O
induced	O
apoptotic	O
cell	O
death	O
on	O
hematopoietic	O
cells	O
.	O

Homeodomain	O
-	O
interacting	O
protein	O
kinases	O
,	O
a	O
novel	O
family	O
of	O
co	O
-	O
repressors	O
for	O
homeodomain	O
transcription	O
factors	O
.	O

A	O
novel	O
family	O
of	O
cofactors	O
that	O
differentially	O
interact	O
with	O
homeoproteins	O
have	O
been	O
identified	O
via	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
.	O

The	O
proteins	O
contain	O
a	O
conserved	O
protein	O
kinase	O
domain	O
that	O
is	O
separated	O
from	O
a	O
domain	O
that	O
interacts	O
with	O
homeoproteins	O
and	O
hence	O
are	O
termed	O
homeodomain	O
-	O
interacting	O
protein	O
kinases	O
(	O
HIPKs	O
)	O
:	O
HIPK1	B
,	O
HIPK2	B
,	O
and	O
HIPK3	B
.	O

We	O
show	O
that	O
HIPKs	O
are	O
nuclear	O
kinases	O
using	O
GFP	O
-	O
HIPK	B
fusion	O
constructs	O
.	O

The	O
DNA	O
binding	O
activity	O
of	O
the	O
NK-3	B
homeoprotein	O
is	O
greatly	O
enhanced	O
by	O
HIPK2	B
,	O
but	O
this	O
effect	O
is	O
independent	O
of	O
its	O
phosphorylation	O
by	O
HIPK2	B
.	O

In	O
cultured	O
cells	O
,	O
HIPKs	O
localize	O
to	O
nuclear	O
speckles	O
and	O
potentiate	O
the	O
repressor	O
activities	O
of	O
NK	O
homeoproteins	O
.	O

The	O
co	O
-	O
repressor	O
activity	O
of	O
HIPKs	O
depends	O
on	O
both	O
its	O
homeodomain	O
interaction	O
domain	O
and	O
a	O
co	O
-	O
repressor	O
domain	O
that	O
maps	O
to	O
the	O
N	O
terminus	O
.	O

Thus	O
,	O
HIPKs	O
represent	O
a	O
heretofore	O
undescribed	O
family	O
of	O
co	O
-	O
repressors	O
for	O
homeodomain	O
transcription	O
factors	O
.	O

The	O
cytoplasmic	O
zinc	B
finger	I
protein	I
ZPR1	I
accumulates	O
in	O
the	O
nucleolus	O
of	O
proliferating	O
cells	O
.	O

The	O
zinc	B
finger	I
protein	I
ZPR1	I
translocates	O
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
after	O
treatment	O
of	O
cells	O
with	O
mitogens	O
.	O

The	O
function	O
of	O
nuclear	O
ZPR1	B
has	O
not	O
been	O
defined	O
.	O

Here	O
we	O
demonstrate	O
that	O
ZPR1	B
accumulates	O
in	O
the	O
nucleolus	O
of	O
proliferating	O
cells	O
.	O

The	O
role	O
of	O
ZPR1	B
was	O
examined	O
using	O
a	O
gene	O
disruption	O
strategy	O
.	O

Cells	O
lacking	O
ZPR1	B
are	O
not	O
viable	O
.	O

Biochemical	O
analysis	O
demonstrated	O
that	O
the	O
loss	O
of	O
ZPR1	B
caused	O
disruption	O
of	O
nucleolar	O
function	O
,	O
including	O
preribosomal	O
RNA	O
expression	O
.	O

These	O
data	O
establish	O
ZPR1	B
as	O
an	O
essential	O
protein	O
that	O
is	O
required	O
for	O
normal	O
nucleolar	O
function	O
in	O
proliferating	O
cells	O
.	O

Coding	O
sequence	O
and	O
expression	O
patterns	O
of	O
mouse	O
chordin	B
and	O
mapping	O
of	O
the	O
cognate	O
mouse	O
chrd	B
and	O
human	O
CHRD	B
genes	O
.	O

Chordin	B
is	O
a	O
key	O
developmental	O
protein	O
that	O
dorsalizes	O
early	O
vertebrate	O
embryonic	O
tissues	O
by	O
binding	O
to	O
ventralizing	O
TGF	B
-	I
beta	I
-	O
like	O
bone	O
morphogenetic	O
proteins	O
and	O
sequestering	O
them	O
in	O
latent	O
complexes	O
.	O

Here	O
we	O
report	O
the	O
first	O
characterization	O
of	O
mammalian	O
chordin	B
.	O

The	O
full	O
-	O
length	O
cDNA	O
sequence	O
for	O
mouse	O
chordin	B
is	O
given	O
,	O
and	O
RNA	O
blot	O
analysis	O
shows	O
the	O
murine	O
chordin	B
gene	O
Chrd	B
to	O
be	O
expressed	O
at	O
relatively	O
high	O
levels	O
in	O
7-day	O
postcoitum	O
mouse	O
embryos	O
and	O
at	O
much	O
decreased	O
levels	O
at	O
later	O
developmental	O
times	O
and	O
in	O
adult	O
tissues	O
.	O

These	O
results	O
imply	O
a	O
major	O
role	O
for	O
chordin	B
during	O
gastrulation	O
of	O
the	O
mammalian	O
embryo	O
.	O

Nevertheless	O
,	O
both	O
murine	O
and	O
human	O
chordin	B
genes	O
are	O
shown	O
to	O
be	O
expressed	O
at	O
readily	O
detectable	O
levels	O
in	O
several	O
fetal	O
and	O
adult	O
tissues	O
,	O
most	O
notably	O
liver	O
and	O
cerebellum	O
,	O
suggesting	O
additional	O
roles	O
in	O
organogenesis	O
and	O
homeostasis	O
.	O

Chrd	B
was	O
mapped	O
to	O
mouse	O
chromosome	O
16	O
using	O
interspecific	O
crosses	O
,	O
and	O
the	O
cognate	O
human	O
gene	O
CHRD	B
was	O
localized	O
to	O
human	O
chromosome	O
3q27	O
by	O
radiation	O
hybrid	O
mapping	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
novel	O
human	O
hepatocyte	O
transcription	O
factor	O
,	O
hB1F	B
,	O
which	O
binds	O
and	O
activates	O
enhancer	O
II	O
of	O
hepatitis	O
B	O
virus	O
.	O

Enhancer	O
II	O
(	O
ENII	O
)	O
of	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
is	O
one	O
of	O
the	O
essential	O
cis	O
-	O
elements	O
for	O
the	O
transcriptional	O
regulation	O
of	O
HBV	O
gene	O
expression	O
.	O

Its	O
function	O
is	O
highly	O
liver	O
-	O
specific	O
,	O
suggesting	O
that	O
liver	O
-	O
enriched	O
transcriptional	O
factors	O
play	O
critical	O
roles	O
in	O
regulating	O
the	O
activity	O
of	O
ENII	O
.	O

In	O
this	O
report	O
,	O
a	O
novel	O
hepatocyte	O
transcription	O
factor	O
,	O
which	O
binds	O
specifically	O
to	O
the	O
B1	O
region	O
(	O
AACGACCGACCTTGAG	O
)	O
within	O
the	O
major	O
functional	O
unit	O
(	O
B	O
unit	O
)	O
of	O
ENII	O
,	O
has	O
been	O
cloned	O
from	O
a	O
human	O
liver	O
cDNA	O
library	O
by	O
yeast	O
one	O
-	O
hybrid	O
screening	O
,	O
and	O
demonstrated	O
to	O
trans	O
-	O
activate	O
ENII	O
via	O
the	O
B1	O
region	O
.	O

We	O
named	O
this	O
factor	O
hB1F	B
,	O
for	O
human	B
B1-binding	I
factor	I
.	O

Amino	O
acid	O
analysis	O
revealed	O
this	O
factor	O
structurally	O
belongs	O
to	O
nuclear	O
receptor	O
superfamily	O
.	O

Based	O
on	O
the	O
sequence	O
similarities	O
,	O
hB1F	B
is	O
characterized	O
to	O
be	O
a	O
novel	O
human	B
homolog	I
of	I
the	I
orphan	I
receptor	I
fushi	I
tarazu	I
factor	I
I	I
(	O
FTZ	B
-	I
F1	I
)	O
.	O

Using	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
,	O
a	O
splicing	O
isoform	O
of	O
hB1F	B
(	O
hB1F-2	B
)	O
was	O
identified	O
,	O
which	O
has	O
an	O
extra	O
46	O
amino	O
acid	O
residues	O
in	O
the	O
A	O
/	O
B	O
region	O
.	O

Examination	O
of	O
the	O
tissue	O
distribution	O
has	O
revealed	O
an	O
abundant	O
5.2-kilobase	O
transcript	O
of	O
hB1F	B
is	O
present	O
specifically	O
in	O
human	O
pancreas	O
and	O
liver	O
.	O

Interestingly	O
,	O
an	O
additional	O
transcript	O
of	O
3.8	O
kilobases	O
was	O
found	O
to	O
be	O
present	O
in	O
hepatoma	O
cells	O
HepG2	O
.	O

Fluorescent	O
in	O
situ	O
hybridization	O
has	O
mapped	O
the	O
gene	O
locus	O
of	O
hB1F	B
to	O
the	O
region	O
q31	O
-	O
32.1	O
of	O
human	O
chromosome	O
1	O
.	O

Altogether	O
,	O
this	O
study	O
provides	O
the	O
first	O
report	O
that	O
a	O
novel	O
human	O
homolog	O
of	O
FTZ	B
-	I
F1	I
binds	O
and	O
regulates	O
ENII	O
of	O
HBV	O
.	O

The	O
potential	O
roles	O
of	O
this	O
FTZ	B
-	I
F1	I
homolog	I
in	O
tissue	O
-	O
specific	O
gene	O
regulation	O
,	O
in	O
embryonic	O
development	O
,	O
as	O
well	O
as	O
in	O
liver	O
carcinogenesis	O
are	O
discussed	O
.	O

A	O
family	O
of	O
stress	O
-	O
inducible	O
GADD45-like	B
proteins	O
mediate	O
activation	O
of	O
the	O
stress	O
-	O
responsive	O
MTK1	B
/	I
MEKK4	I
MAPKKK	I
.	O

The	O
stress	O
-	O
responsive	O
p38	B
and	O
JNK	B
MAPK	O
pathways	O
regulate	O
cell	O
cycle	O
and	O
apoptosis	O
.	O

A	O
human	O
MAPKKK	O
,	O
MTK1	B
(=	O
MEKK4	B
)	O
,	O
mediates	O
activation	O
of	O
both	O
p38	B
and	O
JNK	B
in	O
response	O
to	O
environmental	O
stresses	O
.	O

Using	O
a	O
yeast	O
two	O
-	O
hybrid	O
method	O
,	O
three	O
related	O
proteins	O
,	O
GADD45alpha	B
(=	O
GADD45	B
)	O
,	O
GADD45	B
,	O
(=	O
MyD118	B
)	O
,	O
and	O
GADD45gamma	B
,	O
were	O
identified	O
that	O
bound	O
to	O
an	O
N	O
-	O
terminal	O
domain	O
of	O
MTK1	B
.	O

These	O
proteins	O
activated	O
MTK1	B
kinase	O
activity	O
,	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

The	O
GADD45-like	B
genes	O
are	O
induced	O
by	O
environmental	O
stresses	O
,	O
including	O
MMS	O
,	O
UV	O
,	O
and	O
gamma	O
irradiation	O
.	O

Expression	O
of	O
the	O
GADD45-like	B
genes	O
induces	O
p38	B
/	O
JNK	B
activation	O
and	O
apoptosis	O
,	O
which	O
can	O
be	O
partially	O
suppressed	O
by	O
coexpression	O
of	O
a	O
dominant	O
inhibitory	O
MTK1	B
mutant	O
protein	O
.	O

We	O
propose	O
that	O
the	O
GADD45-like	B
proteins	O
mediate	O
activation	O
of	O
the	O
p38	B
/	O
JNK	B
pathway	O
,	O
via	O
MTK1	B
/	O
MEKK4	B
,	O
in	O
response	O
to	O
environmental	O
stresses	O
.	O

CIR	B
,	O
a	O
corepressor	O
linking	O
the	O
DNA	O
binding	O
factor	O
CBF1	B
to	O
the	O
histone	O
deacetylase	O
complex	O
.	O

CBF1	B
is	O
a	O
member	O
of	O
the	O
CSL	B
family	O
of	O
DNA	O
binding	O
factors	O
,	O
which	O
mediate	O
either	O
transcriptional	O
repression	O
or	O
transcriptional	O
activation	O
.	O

CSL	B
proteins	O
play	O
a	O
central	O
role	O
in	O
Notch	O
signaling	O
and	O
in	O
Epstein	O
-	O
Barr	O
virus	O
-	O
induced	O
immortalization	O
.	O

Notch	O
is	O
a	O
transmembrane	O
protein	O
involved	O
in	O
cell	O
-	O
fate	O
decisions	O
,	O
and	O
the	O
cytoplasmic	O
domain	O
of	O
Notch	O
(	O
NotchIC	O
)	O
targets	O
CBF1	B
.	O

The	O
Epstein	O
-	O
Barr	O
virus	O
-	O
immortalizing	O
protein	O
EBNA2	O
activates	O
both	O
cellular	O
and	O
viral	O
gene	O
expression	O
by	O
targeting	O
CBF1	B
and	O
mimicking	O
NotchIC	O
.	O

We	O
have	O
examined	O
the	O
mechanism	O
of	O
CBF1-mediated	B
repression	O
and	O
show	O
that	O
CBF1	B
binds	O
to	O
a	O
unique	O
corepressor	O
,	O
CBF1	B
interacting	I
corepressor	I
(	O
CIR	B
)	O
.	O

A	O
CIR	B
homolog	O
is	O
encoded	O
by	O
Caenorhabditis	O
elegans	O
,	O
indicating	O
that	O
CIR	B
is	O
evolutionarily	O
conserved	O
.	O

Two	O
CBF1	B
mutants	O
that	O
were	O
unable	O
to	O
bind	O
CIR	B
did	O
not	O
function	O
as	O
repressors	O
,	O
suggesting	O
that	O
targeting	O
of	O
CIR	B
to	O
CBF1	B
is	O
an	O
important	O
component	O
of	O
repression	O
.	O

When	O
expressed	O
as	O
a	O
Gal4	O
fusion	O
protein	O
,	O
CIR	B
repressed	O
reporter	O
gene	O
expression	O
.	O

CIR	B
binds	O
to	O
histone	O
deacetylase	O
and	O
to	O
SAP30	B
and	O
serves	O
as	O
a	O
linker	O
between	O
CBF1	B
and	O
the	O
histone	O
deacetylase	O
complex	O
.	O

GABA	B
(	I
A	I
)	I
-receptor	I
-	I
associated	I
protein	I
links	O
GABA	O
(	O
A	O
)	O
receptors	O
and	O
the	O
cytoskeleton	O
.	O

Type	O
-	O
A	O
receptors	O
for	O
the	O
neurotransmitter	O
GABA	O
(	O
gamma	O
-	O
aminobutyric	O
acid	O
)	O
are	O
ligand	O
-	O
gated	O
chloride	O
channels	O
that	O
mediate	O
inhibitory	O
neurotransmission	O
.	O

Each	O
subunit	O
of	O
the	O
pentameric	O
receptor	O
protein	O
has	O
ligand	O
-	O
binding	O
sites	O
in	O
the	O
amino	O
-	O
terminal	O
extracellular	O
domain	O
and	O
four	O
membrane	O
-	O
spanning	O
regions	O
,	O
one	O
of	O
which	O
forms	O
a	O
wall	O
of	O
the	O
ion	O
channel	O
.	O

Each	O
subunit	O
also	O
has	O
a	O
large	O
intracellular	O
loop	O
that	O
may	O
be	O
a	O
target	O
for	O
protein	O
kinases	O
and	O
be	O
required	O
for	O
subcellular	O
targeting	O
and	O
membrane	O
clustering	O
of	O
the	O
receptor	O
,	O
perhaps	O
by	O
anchoring	O
the	O
receptor	O
to	O
the	O
cytoskeleton	O
.	O

Neurotransmitter	O
receptors	O
need	O
to	O
be	O
positioned	O
in	O
high	O
density	O
in	O
the	O
cell	O
membrane	O
at	O
sites	O
postsynaptic	O
to	O
nerve	O
terminals	O
releasing	O
that	O
neurotransmitter	O
.	O

Other	O
members	O
of	O
the	O
superfamily	O
of	O
ligand	O
-	O
gated	O
ion	O
-	O
channel	O
receptors	O
associate	O
in	O
postsynaptic	O
-	O
membrane	O
clusters	O
by	O
binding	O
to	O
the	O
proteins	O
rapsyn	B
or	O
gephyrin	B
.	O

Here	O
we	O
identify	O
a	O
new	O
cellular	O
protein	O
,	O
GABA	B
(	I
A	I
)	I
-receptor	I
-	I
associated	I
protein	I
(	O
GABARAP	B
)	O
,	O
which	O
can	O
interact	O
with	O
the	O
gamma2	B
subunit	I
of	I
GABA	I
(	I
A	I
)	I
receptors	I
.	O

GABARAP	B
binds	O
to	O
GABA	O
(	O
A	O
)	O
receptors	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
co	O
-	O
localizes	O
with	O
the	O
punctate	O
staining	O
of	O
GABA	O
(	O
A	O
)	O
receptors	O
on	O
cultured	O
cortical	O
neurons	O
.	O

Sequence	O
analysis	O
shows	O
similarity	O
between	O
GABARAP	B
and	O
light	B
chain-3	I
of	I
microtubule	I
-	I
associated	I
proteins	I
1A	I
and	I
1B	I
.	O

Moreover	O
,	O
the	O
N	O
terminus	O
of	O
GABARAP	B
is	O
highly	O
positively	O
charged	O
and	O
features	O
a	O
putative	O
tubulin	O
-	O
binding	O
motif	O
.	O

The	O
interactions	O
among	O
GABA	O
(	O
A	O
)	O
receptors	O
,	O
GABARAP	B
and	O
tubulin	O
suggest	O
a	O
mechanism	O
for	O
the	O
targeting	O
and	O
clustering	O
of	O
GABA	O
(	O
A	O
)	O
receptors	O
.	O

Cloning	O
,	O
gene	O
structure	O
and	O
genomic	O
localization	O
of	O
an	O
orphan	O
transporter	O
from	O
mouse	O
kidney	O
with	O
six	O
alternatively	O
-	O
spliced	O
isoforms	O
.	O

Two	O
genes	O
were	O
identified	O
and	O
characterized	O
that	O
express	O
cDNAs	O
related	O
to	O
previously	O
identified	O
neurotransmitter	O
and/or	O
osmolyte	O
transporters	O
,	O
but	O
which	O
are	O
expressed	O
specifically	O
in	O
the	O
kidney	O
.	O

RNA	O
transcribed	O
from	O
one	O
of	O
these	O
two	O
genes	O
(	O
XT2	B
)	O
was	O
found	O
to	O
undergo	O
an	O
extensive	O
degree	O
of	O
alternative	O
splicing	O
to	O
generate	O
six	O
distinct	O
isoforms	O
.	O

The	O
intron	O
-	O
exon	O
structure	O
of	O
the	O
XT2	B
gene	O
and	O
the	O
sites	O
of	O
alternative	O
splicing	O
were	O
identified	O
.	O

Expression	O
of	O
the	O
second	O
gene	O
(	O
XT3	B
)	O
was	O
found	O
to	O
be	O
conserved	O
in	O
human	O
kidney	O
,	O
and	O
partial	O
sequence	O
was	O
obtained	O
from	O
a	O
human	O
cDNA	O
library	O
.	O

The	O
expressions	O
of	O
both	O
XT2	B
and	O
XT3	B
RNAs	O
were	O
determined	O
in	O
mouse	O
and	O
human	O
tissues	O
,	O
respectively	O
,	O
and	O
the	O
locations	O
of	O
the	O
two	O
genes	O
within	O
the	O
mouse	O
genome	O
were	O
identified	O
.	O

Screening	O
experiments	O
to	O
identify	O
the	O
substrate	O
(	O
s	O
)	O
of	O
these	O
proteins	O
failed	O
to	O
identify	O
specific	O
uptake	O
with	O
any	O
of	O
the	O
tested	O
compounds	O
;	O
however	O
,	O
immunofluorescent	O
microscopy	O
demonstrated	O
that	O
epitope	O
-	O
tagged	O
variants	O
of	O
the	O
protein	O
products	O
of	O
the	O
XT2	B
and	O
XT3	B
cDNAs	O
were	O
present	O
on	O
the	O
plasma	O
membrane	O
of	O
transfected	O
cells	O
.	O

We	O
have	O
cloned	O
vermilion	B
(	O
v	B
)	O
,	O
one	O
of	O
the	O
genes	O
required	O
for	O
brown	O
eye	O
pigment	O
synthesis	O
in	O
Drosophila	O
,	O
using	O
a	O
mutant	O
(	O
vH2a	O
)	O
""""	O
tagged	O
""""	O
with	O
the	O
transposon	O
P	B
factor	I
.	O

Mutations	O
that	O
disrupt	O
v	B
gene	O
expression	O
are	O
clustered	O
within	O
approximately	O
2	O
kilobases	O
of	O
DNA	O
.	O

A	O
1.4-kilobase	O
transcript	O
,	O
homologous	O
to	O
this	O
same	O
region	O
,	O
is	O
present	O
in	O
v+	B
RNA	O
but	O
absent	O
in	O
RNA	O
from	O
several	O
v	B
mutants	O
.	O

The	O
spontaneous	O
v	B
alleles	O
that	O
are	O
suppressed	O
by	O
the	O
suppressor	B
of	I
sable	I
[	O
su	B
(	I
s	I
)	I
]	O
are	O
apparently	O
identical	O
insertions	O
of	O
412	B
,	O
a	O
copia	B
-	O
like	O
transposable	O
element	O
.	O

Preliminary	O
evidence	O
suggests	O
that	O
su	B
(	I
s	I
)	I
-suppressible	O
alleles	O
at	O
other	O
loci	O
may	O
also	O
be	O
412	B
insertions	O
.	O

Two	O
modifiers	O
of	O
bithorax1	O
phenotypic	O
expression	O
are	O
described	O
.	O

An	O
X	B
-	O
chromosome	O
region	O
is	O
associated	O
with	O
sexual	O
dimorphism	O
in	O
bx1	O
penetrance	O
.	O

It	O
is	O
hypothesized	O
that	O
sexual	O
dimorphism	O
is	O
in	O
part	O
due	O
to	O
a	O
lack	O
of	O
dosage	O
compensation	O
of	O
the	O
modifier	O
,	O
in	O
males	O
.	O

A	O
third	O
chromosome	O
region	O
that	O
segregates	O
with	O
the	O
pink	B
peach	I
allele	O
is	O
implicated	O
in	O
mediating	O
temperature	O
sensitivity	O
.	O

By	O
appropriate	O
combinations	O
of	O
modifiers	O
,	O
both	O
sexual	O
dimorphism	O
and	O
temperature	O
sensitivity	O
can	O
be	O
greatly	O
reduced	O
.	O

Type	O
I	O
and	O
type	O
II	O
DNA	O
-	O
topoisomerases	O
are	O
essential	O
enzymes	O
that	O
mediate	O
replication	O
,	O
transcription	O
,	O
recombination	O
,	O
and	O
mitosis	O
in	O
multicellular	O
eukaryotes	O
but	O
the	O
extent	O
of	O
their	O
interchange	O
for	O
specific	O
reactions	O
in	O
vivo	O
is	O
controversial	O
.	O

Expression	O
patterns	O
for	O
topoisomerase	B
I	I
and	O
topoisomerase	B
II	I
during	O
the	O
embryogenesis	O
of	O
Drosophila	O
melanogaster	O
were	O
compared	O
with	O
patterns	O
of	O
DNA	O
replication	O
and	O
expression	O
of	O
the	O
histone	B
genes	O
.	O

In	O
late	O
oogenesis	O
the	O
maternally	O
supplied	O
top2	B
mRNA	O
was	O
evenly	O
distributed	O
throughout	O
the	O
egg	O
with	O
elevated	O
levels	O
at	O
the	O
posterior	O
tip	O
,	O
a	O
pattern	O
that	O
is	O
maintained	O
in	O
syncytial	O
blastoderm	O
embryos	O
.	O

During	O
gastrulation	O
,	O
top2	B
mRNA	O
became	O
differentially	O
localized	O
only	O
to	O
regions	O
of	O
DNA	O
replication	O
,	O
including	O
new	O
expression	O
in	O
the	O
gonads	O
preceding	O
mitosis	O
/	O
meiosis	O
.	O

Significantly	O
higher	O
levels	O
of	O
top2	B
mRNA	O
were	O
found	O
in	O
mitotic	O
compared	O
to	O
endoreplicating	O
tissues	O
.	O

The	O
total	O
histone	B
mRNA	O
was	O
exclusively	O
associated	O
with	O
DNA	O
replication	O
but	O
,	O
in	O
contrast	O
to	O
top2	B
mRNA	O
,	O
mitotic	O
and	O
endoreplicating	O
cells	O
contained	O
similar	O
expression	O
levels	O
with	O
no	O
expression	O
in	O
the	O
gonads	O
.	O

Striking	O
differences	O
exist	O
between	O
the	O
distribution	O
of	O
the	O
top2	B
mRNA	O
and	O
topoisomerase	B
II	I
protein	O
.	O

The	O
protein	O
localizes	O
to	O
all	O
evolving	O
nuclei	O
where	O
it	O
persists	O
throughout	O
embryogenesis	O
.	O

A	O
high	O
level	O
of	O
top1	B
mRNA	O
transcript	O
was	O
present	O
without	O
differential	O
tissue	O
distribution	O
throughout	O
embryogenesis	O
.	O

Experimental	O
populations	O
of	O
Drosophila	O
simulans	O
were	O
established	O
for	O
the	O
purpose	O
of	O
detecting	O
the	O
presence	O
or	O
absence	O
of	O
selection	O
on	O
a	O
restriction	O
fragment	O
length	O
polymorphism	O
in	O
mitochondrial	B
DNA	I
(	O
mtDNA	B
)	O
.	O

It	O
was	O
then	O
discovered	O
that	O
the	O
founding	O
strains	O
differed	O
with	O
respect	O
to	O
the	O
Rickettsia	O
-	O
mediated	O
incompatibility	O
system	O
in	O
this	O
species	O
,	O
which	O
is	O
maternally	O
transmitted	O
together	O
with	O
the	O
mtDNA	B
differences	O
.	O

A	O
population	O
model	O
was	O
constructed	O
using	O
the	O
known	O
fitness	O
effects	O
of	O
the	O
incompatibility	O
system	O
,	O
with	O
the	O
result	O
that	O
the	O
population	O
trajectories	O
can	O
be	O
completely	O
explained	O
by	O
the	O
effects	O
of	O
the	O
microorganism	O
with	O
no	O
need	O
to	O
invoke	O
selection	O
on	O
mtDNA	B
.	O

The	O
strong	O
conclusion	O
is	O
that	O
in	O
this	O
case	O
we	O
can	O
rule	O
out	O
the	O
strong	O
selection	O
proposed	O
by	O
MacRae	O
and	O
Anderson	O
to	O
explain	O
the	O
""""	O
dramatic	O
mtDNA	B
changes	O
""""	O
in	O
their	O
Drosophila	O
pseudoobscura	O
populations	O
.	O

The	O
population	O
theory	O
used	O
for	O
the	O
experiments	O
is	O
discussed	O
in	O
the	O
context	O
of	O
natural	O
populations	O
.	O

Estimated	O
parameters	O
include	O
the	O
possibility	O
that	O
with	O
two	O
populations	O
,	O
one	O
with	O
the	O
organism	O
and	O
one	O
without	O
it	O
,	O
there	O
may	O
be	O
no	O
bias	O
as	O
to	O
which	O
will	O
invade	O
the	O
other	O
,	O
which	O
in	O
turn	O
suggests	O
no	O
global	O
tendency	O
for	O
the	O
infection	O
to	O
spread	O
or	O
decline	O
.	O

We	O
have	O
studied	O
a	O
40-bp	O
upstream	O
regulatory	O
region	O
of	O
the	O
DOPA	B
decarboxylase	I
gene	O
(	O
Ddc	B
)	O
which	O
is	O
important	O
for	O
cell	O
-	O
specific	O
expression	O
in	O
the	O
Drosophila	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
.	O

This	O
region	O
contains	O
two	O
redundant	O
elements	O
which	O
when	O
simultaneously	O
mutated	O
result	O
in	O
lowered	O
DDC	B
expression	O
in	O
serotonin	O
neurons	O
.	O

We	O
uncovered	O
a	O
protein	O
binding	O
site	O
within	O
one	O
of	O
these	O
elements	O
and	O
have	O
cloned	O
a	O
factor	O
which	O
binds	O
to	O
the	O
site	O
.	O

This	O
factor	O
is	O
the	O
product	O
of	O
the	O
zfh-2	B
gene	O
,	O
a	O
complex	O
homeodomain	O
/	O
zinc	O
finger	O
protein	O
previously	O
identified	O
by	O
binding	O
to	O
an	O
opsin	O
regulatory	O
element	O
.	O

The	O
in	O
vivo	O
profile	O
of	O
ZFH-2	B
in	O
the	O
larval	O
CNS	O
shows	O
intriguing	O
overlap	O
with	O
DDC	B
in	O
specific	O
serotonin	O
and	O
dopamine	O
neurons	O
.	O

We	O
show	O
that	O
ZFH-2	B
is	O
related	O
to	O
a	O
human	O
transcription	O
factor	O
ATBF1	O
.	O

The	O
multiple	O
homeodomain	O
and	O
zinc	O
finger	O
motifs	O
in	O
these	O
two	O
proteins	O
show	O
a	O
similar	O
linear	O
arrangement	O
which	O
implies	O
coordinate	O
action	O
among	O
the	O
motifs	O
.	O

In	O
addition	O
,	O
the	O
homology	O
defines	O
a	O
new	O
homeodomain	O
subtype	O
.	O

Pig-1	B
and	O
Sgs-4	B
are	O
a	O
pair	O
of	O
closely	O
linked	O
and	O
divergently	O
transcribed	O
Drosophila	O
melanogaster	O
genes	O
,	O
which	O
are	O
both	O
expressed	O
in	O
larval	O
salivary	O
glands	O
but	O
at	O
different	O
times	O
during	O
development	O
.	O

While	O
Sgs-4	B
is	O
expressed	O
at	O
high	O
levels	O
only	O
at	O
the	O
end	O
of	O
the	O
third	O
instar	O
,	O
Pig-1	B
exhibits	O
a	O
major	O
peak	O
of	O
expression	O
during	O
late	O
second	O
and	O
early	O
third	O
instar	O
.	O

Thus	O
,	O
Pig-1	B
expression	O
declines	O
as	O
Sgs-4	B
expression	O
is	O
induced	O
.	O

In	O
this	O
paper	O
,	O
we	O
show	O
that	O
three	O
adjacent	O
elements	O
located	O
within	O
the	O
short	O
region	O
between	O
these	O
genes	O
can	O
account	O
for	O
the	O
switch	O
from	O
Pig-1	B
to	O
Sgs-4	B
expression	O
.	O

A	O
170-bp	O
segment	O
acts	O
as	O
an	O
enhancer	O
to	O
direct	O
Sgs-4	B
expression	O
in	O
late	O
-	O
third	O
-	O
instar	O
salivary	O
glands	O
.	O

A	O
64-bp	O
sequence	O
located	O
just	O
upstream	O
from	O
the	O
enhancer	O
can	O
modify	O
its	O
temporal	O
specificity	O
so	O
that	O
it	O
works	O
throughout	O
the	O
third	O
instar	O
.	O

Expression	O
induced	O
at	O
mid	O
-	O
third	O
instar	O
by	O
a	O
combination	O
of	O
these	O
two	O
elements	O
can	O
be	O
repressed	O
by	O
a	O
negative	O
regulatory	O
sequence	O
located	O
still	O
further	O
upstream	O
.	O

We	O
present	O
evidence	O
suggesting	O
that	O
the	O
changing	O
interactions	O
between	O
these	O
regulatory	O
elements	O
and	O
the	O
Sgs-4	B
and	O
Pig-1	B
promoters	O
lead	O
to	O
the	O
correct	O
pattern	O
of	O
expression	O
of	O
the	O
two	O
genes	O
.	O

The	O
polyhomeotic	B
(	O
ph	B
)	O
locus	O
of	O
Drosophila	O
is	O
a	O
complex	O
locus	O
essential	O
for	O
the	O
maintenance	O
of	O
segmental	O
identity	O
.	O

Genetic	O
analysis	O
suggested	O
that	O
two	O
independent	O
units	O
contribute	O
to	O
ph	B
function	O
.	O

Comparison	O
of	O
genomic	O
sequence	O
shows	O
that	O
the	O
ph	B
locus	O
has	O
been	O
duplicated	O
,	O
and	O
that	O
it	O
contains	O
proximal	O
and	O
distal	O
transcription	O
units	O
.	O

The	O
proximal	O
transcription	O
unit	O
encodes	O
two	O
embryonic	O
mRNAs	O
of	O
6.4	O
and	O
6.1	O
kb	O
,	O
and	O
the	O
distal	O
unit	O
encodes	O
a	O
6.4-kb	O
embryonic	O
mRNA	O
.	O

The	O
proximal	O
and	O
distal	O
transcription	O
units	O
are	O
differentially	O
regulated	O
at	O
the	O
mRNA	O
level	O
during	O
development	O
as	O
shown	O
by	O
developmental	O
Northern	O
analysis	O
.	O

The	O
distal	O
protein	O
is	O
very	O
similar	O
to	O
the	O
proximal	O
product	O
,	O
except	O
for	O
the	O
absence	O
of	O
an	O
amino	O
terminal	O
region	O
,	O
and	O
a	O
small	O
region	O
near	O
the	O
carboxy	O
terminus	O
.	O

The	O
long	O
open	O
reading	O
frame	O
in	O
the	O
distal	O
cDNA	O
does	O
not	O
begin	O
with	O
an	O
ATG	O
codon	O
,	O
and	O
an	O
internal	O
ATG	O
is	O
used	O
for	O
a	O
start	O
codon	O
.	O

We	O
show	O
that	O
the	O
proximal	O
protein	O
occurs	O
in	O
two	O
forms	O
that	O
are	O
developmentally	O
regulated	O
,	O
and	O
that	O
probably	O
arise	O
from	O
use	O
of	O
two	O
different	O
initiator	O
methionine	O
codons	O
.	O

We	O
find	O
no	O
evidence	O
for	O
differential	O
binding	O
of	O
proximal	O
and	O
distal	O
products	O
to	O
polytene	O
chromosomes	O
.	O

Nevertheless	O
,	O
we	O
show	O
that	O
mutations	O
in	O
the	O
proximal	O
and	O
distal	O
proteins	O
have	O
differing	O
effects	O
on	O
regulation	O
of	O
a	O
reporter	O
under	O
the	O
control	O
of	O
a	O
regulatory	O
region	O
from	O
bithoraxoid	B
,	O
suggesting	O
that	O
ph	B
proximal	O
and	O
distal	O
proteins	O
have	O
different	O
functions	O
.	O

These	O
results	O
show	O
that	O
the	O
ph	B
locus	O
undergoes	O
complex	O
developmental	O
regulation	O
,	O
and	O
suggest	O
that	O
Polycomb	B
group	O
regulation	O
may	O
be	O
more	O
dynamic	O
than	O
anticipated	O
.	O

The	O
Threonine	O
-	O
Glycine	O
(	O
Thr	O
-	O
Gly	O
)	O
region	O
of	O
the	O
period	B
gene	O
(	O
per	B
)	O
in	O
Drosophila	O
was	O
compared	O
in	O
the	O
eight	O
species	O
of	O
the	O
D.	O
melanogaster	O
subgroup	O
.	O

This	O
region	O
can	O
be	O
divided	O
into	O
a	O
diverged	O
variable	O
-	O
length	O
segment	O
which	O
is	O
flanked	O
by	O
more	O
conserved	O
sequences	O
.	O

The	O
number	O
of	O
amino	O
acids	O
encoded	O
in	O
the	O
variable	O
-	O
length	O
region	O
ranges	O
from	O
40	O
in	O
D.	O
teissieri	O
to	O
69	O
in	O
D.	O
mauritiana	O
.	O

This	O
is	O
similar	O
to	O
the	O
range	O
found	O
within	O
natural	O
populations	O
of	O
D.	O
melanogaster	O
.	O

It	O
was	O
possible	O
to	O
derive	O
a	O
Thr	O
-	O
Gly	O
""""	O
allele	O
""""	O
of	O
one	O
species	O
from	O
that	O
of	O
another	O
by	O
invoking	O
hypothetical	O
Thr	O
-	O
Gly	O
intermediates	O
.	O

A	O
phylogeny	O
based	O
on	O
the	O
more	O
conserved	O
flanking	O
sequences	O
was	O
produced	O
.	O

The	O
results	O
highlighted	O
some	O
of	O
the	O
problems	O
which	O
are	O
encountered	O
when	O
highly	O
polymorphic	O
genes	O
are	O
used	O
to	O
infer	O
phylogenies	O
of	O
closely	O
related	O
species	O
.	O

Alcohol	B
dehydrogenase	I
(	O
EC	O
1.1.1.1	O
)	O
of	O
Drosophila	O
melanogaster	O
is	O
coded	O
by	O
a	O
single	O
structural	O
gene	O
,	O
active	O
in	O
both	O
larvae	O
and	O
adults	O
.	O

The	O
major	O
larval	O
and	O
adult	O
transcripts	O
of	O
Adh	B
differ	O
in	O
their	O
5'-untranslated	O
regions	O
.	O

The	O
major	O
larval	O
mRNA	O
is	O
about	O
1100	O
bases	O
long	O
,	O
some	O
50	O
bases	O
shorter	O
than	O
the	O
major	O
adult	O
transcript	O
.	O

The	O
5	O
'	O
end	O
of	O
the	O
larval	O
mRNA	O
is	O
colinear	O
with	O
the	O
genomic	O
sequence	O
immediately	O
adjacent	O
to	O
the	O
coding	O
region	O
,	O
starting	O
70	O
base	O
pairs	O
(	O
bp	O
)	O
upstream	O
of	O
the	O
initiation	O
codon	O
.	O

By	O
contrast	O
,	O
the	O
adult	O
mRNA	O
shares	O
only	O
36	O
of	O
its	O
123	O
5'-untranslated	O
bases	O
with	O
the	O
larval	O
mRNA	O
;	O
the	O
remaining	O
87	O
are	O
encoded	O
by	O
a	O
sequence	O
654	O
bp	O
upstream	O
.	O

Both	O
initiation	O
sites	O
are	O
preceded	O
by	O
a	O
TATA	O
box	O
some	O
24	O
bp	O
upstream	O
.	O

The	O
developmental	O
specificity	O
of	O
Adh	B
expression	O
is	O
seen	O
,	O
therefore	O
,	O
to	O
have	O
a	O
counterpart	O
in	O
the	O
specificity	O
of	O
transcription	O
initiation	O
at	O
the	O
two	O
separate	O
promoter	O
regions	O
.	O

The	O
effect	O
of	O
temperature	O
on	O
spontaneous	O
mutation	O
frequencies	O
was	O
studied	O
in	O
the	O
Drosophila	O
somatic	O
mutation	O
and	O
recombination	O
test	O
.	O

Transdihybrid	O
mwh	B
+	O
/+	O
flr3	O
larvae	O
were	O
grown	O
at	O
various	O
temperatures	O
(	O
15	O
,	O
18	O
,	O
20	O
,	O
22	O
,	O
25	O
,	O
27	O
,	O
and	O
29	O
degrees	O
C	O
)	O
in	O
the	O
absence	O
of	O
any	O
chemical	O
mutagen	O
.	O

Wings	O
of	O
surviving	O
adults	O
were	O
removed	O
and	O
scored	O
for	O
presence	O
of	O
small	O
single	O
spots	O
,	O
large	O
single	O
spots	O
,	O
and	O
twin	O
spots	O
.	O

No	O
significant	O
effect	O
of	O
temperature	O
was	O
found	O
on	O
mean	O
frequency	O
per	O
wing	O
of	O
twin	O
spots	O
.	O

Similarly	O
,	O
no	O
significant	O
effect	O
of	O
temperature	O
was	O
found	O
for	O
large	O
singles	O
within	O
the	O
temperature	O
range	O
of	O
18	O
-	O
29	O
degrees	O
C	O
;	O
however	O
,	O
at	O
15	O
degrees	O
C	O
,	O
the	O
mean	O
frequency	O
per	O
wing	O
of	O
large	O
spots	O
was	O
significantly	O
elevated	O
.	O

A	O
significant	O
quadratic	O
relationship	O
was	O
found	O
between	O
mean	O
frequency	O
of	O
small	O
spots	O
and	O
temperature	O
.	O

Frequency	O
of	O
small	O
spots	O
per	O
wing	O
was	O
minimized	O
within	O
the	O
temperature	O
range	O
of	O
20	O
-	O
27	O
degrees	O
C	O
and	O
increased	O
at	O
higher	O
and	O
lower	O
temperatures	O
.	O

Maximum	O
frequency	O
of	O
small	O
spots	O
per	O
wing	O
was	O
observed	O
at	O
15	O
degrees	O
C.	O
The	O
qualitative	O
nature	O
of	O
the	O
small	O
single	O
spots	O
induced	O
at	O
high	O
and	O
low	O
temperatures	O
is	O
unclear	O
;	O
they	O
may	O
represent	O
slow	O
-	O
growing	O
segmentally	O
aneuploid	O
(	O
deleted	O
)	O
cells	O
or	O
possibly	O
even	O
monosomic	O
cells	O
.	O

Both	O
heat	O
and	O
cold	O
were	O
found	O
to	O
be	O
mutagenic	O
in	O
the	O
Drosophila	O
wing	O
-	O
spot	O
assay	O
.	O

However	O
,	O
the	O
mutagenic	O
potency	O
associated	O
with	O
temperature	O
was	O
much	O
less	O
than	O
that	O
of	O
most	O
chemical	O
mutagens	O
,	O
and	O
no	O
significant	O
effect	O
of	O
temperature	O
was	O
observed	O
in	O
the	O
range	O
of	O
20	O
-	O
27	O
degrees	O
C.	O

We	O
have	O
isolated	O
the	O
gene	O
coding	O
for	O
the	O
Drosophila	O
type	B
II	I
DNA	I
topoisomerase	I
by	O
immunochemically	O
screening	O
a	O
Drosophila	O
cDNA	O
library	O
constructed	O
with	O
a	O
phage	O
lambda	O
expression	O
vector	O
,	O
lambda	O
gt11	O
.	O

The	O
identity	O
of	O
the	O
cloned	O
gene	O
is	O
confirmed	O
by	O
the	O
analysis	O
of	O
an	O
antigenic	O
fusion	O
protein	O
produced	O
in	O
Escherichia	O
coli	O
and	O
by	O
the	O
in	O
vitro	O
translation	O
of	O
its	O
RNA	O
.	O

The	O
gene	O
is	O
5.1	O
kilobases	O
in	O
length	O
,	O
the	O
expected	O
size	O
for	O
a	O
gene	O
encoding	O
topoisomerase	B
II	I
(	O
Mr	O
170,000	O
)	O
,	O
and	O
it	O
is	O
divided	O
into	O
five	O
exons	O
.	O

By	O
in	O
situ	O
hybridization	O
to	O
the	O
polytene	O
chromosomes	O
from	O
salivary	O
glands	O
,	O
we	O
have	O
mapped	O
it	O
to	O
chromosome	O
2L	O
at	O
37D	O
.	O

During	O
Drosophila	O
embryogenesis	O
,	O
mesodermal	O
cells	O
are	O
recruited	O
to	O
form	O
a	O
complex	O
pattern	O
of	O
larval	O
muscles	O
.	O

The	O
formation	O
of	O
the	O
pattern	O
is	O
initiated	O
by	O
the	O
segregation	O
of	O
a	O
special	O
class	O
of	O
founder	O
myoblasts	O
.	O

Single	O
founders	O
fuse	O
with	O
neighbouring	O
nonfounder	O
myoblasts	O
to	O
form	O
the	O
precursors	O
of	O
individual	O
muscles	O
.	O

Founders	O
and	O
the	O
muscles	O
that	O
they	O
give	O
rise	O
to	O
have	O
specific	O
patterns	O
of	O
gene	O
expression	O
and	O
it	O
has	O
been	O
suggested	O
that	O
it	O
is	O
the	O
expression	O
of	O
these	O
founder	O
cell	O
genes	O
that	O
determines	O
individual	O
muscle	O
attributes	O
such	O
as	O
size	O
,	O
shape	O
,	O
insertion	O
sites	O
and	O
innervation	O
.	O

We	O
find	O
that	O
the	O
segmentation	O
gene	O
Kruppel	B
is	O
expressed	O
in	O
a	O
subset	O
of	O
founders	O
and	O
muscles	O
,	O
regulates	O
specific	O
patterns	O
of	O
gene	O
expression	O
in	O
these	O
cells	O
and	O
is	O
required	O
for	O
the	O
acquisition	O
of	O
proper	O
muscle	O
identity	O
.	O

We	O
show	O
that	O
gain	O
and	O
loss	O
of	O
Kruppel	B
expression	O
in	O
sibling	O
founder	O
cells	O
is	O
sufficient	O
to	O
switch	O
these	O
cells	O
,	O
and	O
the	O
muscles	O
that	O
they	O
give	O
rise	O
to	O
,	O
between	O
alternative	O
cell	O
fates	O
.	O

Almost	O
all	O
epidermal	O
cells	O
on	O
the	O
Drosophila	O
wing	O
produce	O
a	O
single	O
cuticular	O
hair	O
.	O

This	O
is	O
formed	O
in	B
the	O
pupae	O
from	O
a	O
microvillus	O
-	O
like	O
cell	O
projection	O
called	O
the	O
prehair	O
.	O

Previous	O
experiments	O
have	O
shown	O
the	O
existence	O
of	O
two	O
mechanisms	O
that	O
ensure	O
that	O
only	O
a	O
single	O
hair	O
is	O
made	O
.	O

One	O
is	O
the	O
restriction	O
of	O
prehair	O
initiation	O
to	O
a	O
small	O
subregion	O
of	O
the	O
cell	O
by	O
the	O
action	O
of	O
the	O
frizzled	B
tissue	O
polarity	O
pathway	O
.	O

The	O
second	O
is	O
a	O
system	O
that	O
ensures	O
the	O
integrity	O
of	O
the	O
prehair	O
.	O

Mutations	O
and	O
drugs	O
that	O
inhibit	O
the	O
actin	O
cytoskeleton	O
lead	O
to	O
the	O
splitting	O
of	O
a	O
single	O
prehair	O
into	O
multiple	O
smaller	O
hairs	O
.	O

We	O
report	O
that	O
large	O
polyploid	O
cells	O
produce	O
multiple	O
hairs	O
both	O
because	O
they	O
form	O
multiple	O
independent	O
prehair	O
initiation	O
centers	O
and	O
because	O
the	O
larger	O
than	O
normal	O
hairs	O
these	O
cells	O
produce	O
have	O
a	O
tendency	O
to	O
split	O
.	O

We	O
show	O
that	O
reducing	O
cell	O
size	O
by	O
starvation	O
partially	O
suppresses	O
the	O
phenotype	O
seen	O
in	B
polyploid	O
cells	O
and	O
that	O
increasing	O
apical	O
cell	O
surface	O
area	O
by	O
mechanical	O
stretching	O
also	O
results	O
in	B
the	O
formation	O
of	O
multiple	O
prehair	O
initiation	O
centers	O
.	O

We	O
also	O
show	O
that	O
the	O
frizzled	B
tissue	O
polarity	O
pathway	O
is	O
functional	O
in	B
large	O
polyploid	O
cells	O
even	O
if	O
it	O
is	O
unable	O
to	O
restrict	O
prehair	O
initiation	O
to	O
a	O
small	O
region	O
of	O
the	O
cell	O
.	O

We	O
conclude	O
that	O
both	O
of	O
these	O
cellular	O
systems	O
are	O
limited	O
in	B
their	O
ability	O
to	O
scale	O
to	O
accommodate	O
larger	O
cell	O
size	O
.	O

In	O
an	O
earlier	O
publication	O
we	O
described	O
similarities	O
at	O
the	O
primary	O
sequence	O
level	O
between	O
the	O
first	O
probable	O
plant	O
G	O
-	O
protein	O
coupled	O
receptor	O
(	O
GPCR	O
)	O
and	O
three	O
GPCR	O
families	O
(	O
families	O
A	O
,	O
B	O
and	O
F	B
according	O
to	O
Kolakowski	O
's	O
classification	O
)	O
that	O
were	O
previously	O
considered	O
evolutionarily	O
unrelated	O
.	O

Here	O
we	O
analyze	O
further	O
the	O
relatedness	O
among	O
different	O
GPCR	O
families	O
.	O

By	O
using	O
PSI	O
-	O
BLAST	O
,	O
which	O
is	O
a	O
search	O
algorithm	O
that	O
is	O
more	O
potent	O
in	O
detecting	O
weak	O
similarities	O
,	O
one	O
finds	O
additional	O
similarities	O
between	O
GPCR	O
families	O
that	O
have	O
not	O
previously	O
been	O
described	O
.	O

Based	O
on	O
these	O
comparisons	O
,	O
it	O
is	O
possible	O
to	O
divide	O
all	O
the	O
GPCR	O
families	O
into	O
one	O
large	O
clade	O
and	O
two	O
smaller	O
ones	O
.	O

The	O
large	O
clade	O
includes	O
the	O
rhodopsin	O
family	O
(	O
family	O
A	O
)	O
,	O
the	O
glucagon	O
receptor	O
family	O
(	O
family	O
B	O
)	O
,	O
cyclic	O
AMP	O
receptors	O
(	O
family	O
F	B
)	O
,	O
an	O
Arabidopsis	O
thaliana	O
receptor	O
,	O
the	O
Frizzled	B
family	O
and	O
probably	O
also	O
the	O
STE3	O
pheromone	O
receptors	O
(	O
family	O
E	O
)	O
and	O
vomeronasal	O
receptors	O
type	O
1	O
.	O

The	O
smaller	O
clades	O
consist	O
of	O
,	O
in	O
one	O
case	O
,	O
BOSS	B
and	O
the	O
GABA	O
-	O
B	O
family	O
of	O
receptors	O
(	O
family	O
C	O
)	O
,	O
and	O
in	O
the	O
other	O
the	O
STE2	O
pheromone	O
receptors	O
(	O
family	O
D	O
)	O
alone	O
.	O

Although	O
our	O
findings	O
are	O
likely	O
to	O
reflect	O
a	O
common	O
ancestry	O
within	O
each	O
of	O
these	O
clades	O
,	O
whether	O
or	O
not	O
two	O
or	O
all	O
three	O
of	O
the	O
clades	O
also	O
share	O
an	O
even	O
more	O
ancient	O
ancestor	O
between	O
them	O
remains	O
an	O
open	O
question	O
that	O
can	O
not	O
be	O
answered	O
from	O
our	O
present	O
data	O
.	O

We	O
have	O
cloned	O
and	O
determined	O
the	O
structure	O
of	O
the	O
gene	O
encoding	O
the	O
H	O
(	O
+	O
)	O
-ATP	O
synthase	B
beta	I
subunit	I
in	O
two	O
distantly	O
related	O
Drosophila	O
species	O
,	O
D.	O
melanogaster	O
and	O
D.	O
virilis	O
.	O

The	O
gene	O
contains	O
three	O
exons	O
that	O
are	O
extremely	O
well	O
conserved	O
at	O
the	O
amino	O
acid	O
level	O
,	O
not	O
only	O
in	O
the	O
region	O
encoding	O
the	O
mature	O
protein	O
but	O
also	O
in	O
that	O
encoding	O
the	O
leader	O
peptide	O
.	O

Primer	O
extension	O
analysis	O
indicates	O
that	O
the	O
5	O
'	O
untranslated	O
region	O
is	O
extremely	O
short	O
,	O
and	O
reveals	O
the	O
presence	O
of	O
multiple	O
initiation	O
sites	O
of	O
transcription	O
in	O
both	O
Drosophila	O
species	O
.	O

The	O
promoters	O
of	O
D.	O
melanogaster	O
and	O
D.	O
virilis	O
H	O
(	O
+	O
)	O
-ATP	O
synthase	B
beta	I
-	O
subunit	O
genes	O
contain	O
a	O
conserved	O
region	O
surrounding	O
the	O
initiation	O
transcription	O
sites	O
.	O

Nucleotide	O
sequence	O
analysis	O
has	O
revealed	O
the	O
absence	O
of	O
canonical	O
TATA	O
and	O
CCAAT	O
boxes	O
and	O
the	O
presence	O
of	O
several	O
putative	O
regulatory	O
elements	O
in	O
both	O
promoter	O
regions	O
,	O
including	O
GAGA	O
,	O
GATA	O
and	O
Ets	O
binding	O
sites	O
.	O

We	O
have	O
analysed	O
the	O
pattern	O
of	O
gene	O
expression	O
during	O
D.	O
melanogaster	O
development	O
.	O

The	O
mRNA	O
is	O
stored	O
in	O
oocytes	O
,	O
and	O
activation	O
of	O
transcription	O
takes	O
place	O
after	O
10	O
h	O
of	O
development	O
.	O

The	O
expression	O
of	O
the	O
nuclear	O
-	O
encoded	O
H	O
(	O
+	O
)	O
-ATP	O
synthase	B
beta	I
subunit	I
is	O
strictly	O
coordinated	O
with	O
the	O
expression	O
of	O
subunits	O
6	O
and	O
8	O
of	O
the	O
same	O
complex	O
that	O
are	O
encoded	O
in	O
the	O
mitochondrial	O
genome	O
.	O

Grimaldi	O
's	O
recent	O
cladistic	O
classification	O
of	O
genera	O
in	O
the	O
family	O
Drosophilidae	O
,	O
based	O
on	O
adult	O
morphological	O
characters	O
,	O
is	O
evaluated	O
for	O
those	O
taxa	O
for	O
which	O
alcohol	B
dehydrogenase	I
DNA	O
sequences	O
are	O
also	O
available	O
.	O

These	O
data	O
allow	O
us	O
to	O
look	O
at	O
relationships	O
of	O
the	O
Drosophila	O
subgenera	O
Sophophora	O
and	O
Drosophila	O
with	O
the	O
Hawaiian	O
Drosophila	O
(	O
Idiomyia	O
)	O
and	O
with	O
Scaptomyza	O
,	O
when	O
Scaptodrosophila	O
is	O
used	O
as	O
an	O
outgroup	O
.	O

The	O
molecular	O
data	O
give	O
strong	O
support	O
for	O
the	O
broad	O
relationships	O
hypothesized	O
by	O
Throckmorton	O
,	O
who	O
contended	O
that	O
the	O
subgenus	O
Sophophora	O
is	O
a	O
sister	O
group	O
to	O
the	O
remaining	O
ingroup	O
taxa	O
.	O

The	O
Drosophila	O
subgenus	O
Engiscaptomyza	O
,	O
which	O
Throckmorton	O
regarded	O
as	O
intermediate	O
between	O
the	O
Idiomyia	O
(	O
Hawaiian	O
Drosophila	O
)	O
and	O
Scaptomyza	O
,	O
is	O
shown	O
to	O
be	O
much	O
more	O
closely	O
allied	O
with	O
Scaptomyza	O
,	O
in	O
agreement	O
with	O
Grimaldi	O
's	O
results	O
from	O
adult	O
morphology	O
.	O

The	O
Hawaiian	O
taxa	O
,	O
both	O
Idiomyia	O
and	O
Scaptomyza	O
,	O
are	O
firmly	O
located	O
as	O
a	O
sister	O
group	O
to	O
the	O
subgenus	O
Drosophila	O
,	O
and	O
these	O
in	O
turn	O
all	O
form	O
a	O
sister	O
group	O
to	O
the	O
subgenus	O
Sophophora	O
.	O

Grimaldi	O
's	O
classification	O
of	O
these	O
taxa	O
is	O
quite	O
different	O
and	O
places	O
the	O
Hawaiian	O
Drosophila	O
(	O
Idiomyia	O
)	O
as	O
sister	O
group	O
to	O
the	O
remaining	O
ingroup	O
taxa	O
(	O
Scaptomyza	O
and	O
the	O
subgenera	O
Sophophora	O
and	O
Drosophila	O
)	O
.	O

Our	O
results	O
show	O
that	O
Grimaldi	O
's	O
new	O
classification	O
of	O
these	O
taxa	O
results	O
in	O
paraphyletic	O
groups	O
,	O
just	O
as	O
does	O
the	O
traditional	O
classification	O
under	O
Throckmorton	O
's	O
interpretation	O
of	O
relationships	O
.	O

Additional	O
data	O
are	O
required	O
to	O
produce	O
a	O
robust	O
classification	O
of	O
this	O
huge	O
paraphyletic	O
genus	O
.	O

Expression	O
of	O
many	O
mammalian	O
genes	O
is	O
activated	O
by	O
the	O
binding	O
of	O
heterodimers	O
of	O
the	O
Myc	O
and	O
Max	B
proteins	O
to	O
specific	O
DNA	O
sequences	O
called	O
the	O
E	O
-	O
boxes	O
.	O

Transcription	O
of	O
the	O
same	O
genes	O
is	O
repressed	O
upon	O
binding	O
to	O
the	O
same	O
sequences	O
of	O
complexes	O
composed	O
of	O
Max	B
,	O
Mad	B
/	O
Mxi1	O
,	O
the	O
co	O
-	O
repressors	O
Sin3	B
and	O
N	O
-	O
CoR	O
,	O
and	O
the	O
histone	O
deacetylase	O
Rpd3	B
.	O

Max	B
-	O
Mad	B
/	O
Mxi1	O
heterodimers	O
,	O
which	O
bind	O
to	O
E	O
-	O
boxes	O
in	O
absence	O
of	O
co	O
-	O
repressors	O
,	O
do	O
not	O
inhibit	O
gene	O
expression	O
simply	O
by	O
competition	O
with	O
Myc	O
-	O
Max	B
heterodimers	O
,	O
but	O
require	O
Sin3	B
and	O
Rpd3	B
for	O
efficient	O
repression	O
of	O
transcription	O
.	O

We	O
have	O
cloned	O
a	O
Drosophila	O
homolog	O
of	O
Sin3	B
(	O
dSin3	B
)	O
and	O
found	O
it	O
to	O
be	O
ubiquitously	O
expressed	O
during	O
embryonic	O
development	O
.	O

Yeast	O
,	O
mouse	O
and	O
Drosophila	O
proteins	O
share	O
six	O
blocks	O
of	O
strong	O
homologies	O
,	O
including	O
four	O
potential	O
paired	O
amphipathic	O
helix	O
domains	O
.	O

In	O
addition	O
,	O
the	O
domain	O
of	O
binding	O
to	O
the	O
histone	O
deacetylase	O
Rpd3	B
is	O
strongly	O
conserved	O
.	O

Null	O
mutations	O
cause	O
recessive	O
embryonic	O
lethality	O
.	O

Rows	O
of	O
cells	O
that	O
flank	O
the	O
parasegment	O
boundary	O
make	O
up	O
a	O
signaling	O
center	O
within	O
the	O
epidermis	O
of	O
the	O
Drosophila	O
embryo	O
.	O

Signals	O
emanating	O
from	O
these	O
cells	O
,	O
encoded	O
by	O
hedgehog	B
(	O
hh	B
)	O
and	O
wingless	B
(	O
wg	B
)	O
,	O
are	O
shown	O
to	O
be	O
required	O
for	O
all	O
segment	O
pattern	O
dorsally	O
.	O

Wg	B
activity	O
is	O
required	O
for	O
the	O
differentiation	O
of	O
one	O
cell	O
type	O
,	O
constituting	O
half	O
the	O
parasegment	O
.	O

The	O
gene	O
lines	B
appears	O
to	O
act	O
in	B
parallel	O
to	O
the	O
Wg	B
pathway	O
in	B
the	O
elaboration	O
of	O
this	O
cell	O
type	O
.	O

Hh	B
activity	O
is	O
responsible	O
for	O
three	O
other	O
cell	O
types	O
in	B
the	O
parasegment	O
.	O

Some	O
cell	O
types	O
are	O
specified	O
as	O
Hh	B
activity	O
and	O
interfere	O
with	O
the	O
function	O
of	O
patched	B
,	O
analogous	O
to	O
patterning	O
of	O
imaginal	O
discs	O
.	O

However	O
,	O
some	O
pattern	O
is	O
independent	O
of	O
the	O
antagonism	O
of	O
patched	B
by	O
Hh	B
,	O
and	O
relies	O
instead	O
on	O
novel	O
interactions	O
with	O
lines	B
.	O

Lastly	O
,	O
we	O
provide	O
evidence	O
that	O
decapentaplegic	B
does	O
not	O
mediate	O
patterning	O
by	O
Hh	B
in	B
the	O
dorsal	O
epidermis	O
.	O

We	O
have	O
further	O
characterized	O
essential	O
loci	O
within	O
the	O
centric	O
heterochromatin	O
of	O
the	O
left	O
arm	O
of	O
chromosome	O
3	O
(	O
3L	O
)	O
of	O
Drosophila	O
melanogaster	O
,	O
using	O
EMS	O
,	O
radiation	O
and	O
P	B
element	I
mutagenesis	O
.	O

We	O
failed	O
to	O
find	O
any	O
new	O
essential	O
genes	O
,	O
a	O
result	O
that	O
suggests	O
a	O
lower	O
-	O
than	O
-	O
average	O
gene	O
density	O
in	O
this	O
region	O
.	O

Mutations	O
affecting	O
expression	O
of	O
the	O
most	O
proximal	O
gene	O
[	O
lethal	B
1	I
,	O
l1	B
or	O
l	B
(	I
3	I
)	I
80Fj	I
]	O
act	O
as	O
dominant	O
suppressors	O
of	O
Polycomb	B
(	O
Pc	B
)	O
,	O
behavior	O
which	O
is	O
consistent	O
with	O
a	O
putative	O
trithorax	B
group	O
(	O
trx	B
-	O
G	O
)	O
gene	O
.	O

The	O
third	O
gene	O
to	O
the	O
left	O
of	O
the	O
centromere	O
[	O
lethal	B
3	I
,	O
l3	B
or	O
l	B
(	I
3	I
)	I
80Fh	I
]	O
is	O
likely	O
to	O
correspond	O
to	O
verthandi	B
(	O
vtd	B
)	O
,	O
a	O
known	O
trx	B
-	O
G	O
gene	O
that	O
plays	O
a	O
role	O
in	O
the	O
regulation	O
of	O
hedgehog	B
(	O
hh	B
)	O
expression	O
and	O
signalling	O
.	O

The	O
intervening	O
gene	O
[	O
lethal	B
2	I
,	O
l2	B
or	O
l	B
(	I
3	I
)	I
80Fi	I
]	O
is	O
required	O
throughout	O
development	O
,	O
and	O
mutant	O
alleles	O
have	O
interesting	O
phenotypes	O
;	O
in	O
various	O
allelic	O
combinations	O
that	O
survive	O
,	O
we	O
observe	O
fertility	O
,	O
bristle	O
,	O
wing	O
,	O
eye	O
and	O
cuticle	O
defects	O
.	O

In	O
this	O
study	O
,	O
we	O
address	O
the	O
question	O
of	O
whether	O
there	O
exist	O
major	O
genes	O
that	O
cause	O
complete	O
male	O
sterility	O
in	O
the	O
interspecific	O
hybrids	O
of	O
Drosophila	O
and	O
,	O
if	O
they	O
do	O
,	O
how	O
these	O
genes	O
may	O
be	O
characterized	O
at	O
the	O
molecular	O
level	O
.	O

Our	O
approach	O
is	O
to	O
introgress	O
small	O
segments	O
of	O
the	O
X	O
chromosome	O
from	O
Drosophila	O
mauritiana	O
(	O
or	O
Drosophila	O
sechellia	O
)	O
into	O
Drosophila	O
simulans	O
by	O
repeated	O
backcrosses	O
for	O
more	O
than	O
20	O
generations	O
.	O

The	O
introgressions	O
are	O
monitored	O
by	O
both	O
visible	O
mutations	O
and	O
a	O
series	O
of	O
DNA	O
markers	O
.	O

We	O
compare	O
the	O
extent	O
of	O
introgressions	O
that	O
cause	O
male	O
sterility	O
with	O
those	O
that	O
do	O
not	O
.	O

If	O
a	O
major	O
sterility	O
factor	O
exists	O
,	O
there	O
should	O
be	O
a	O
sharp	O
boundary	O
between	O
these	O
two	O
classes	O
of	O
introgressions	O
and	O
their	O
breakpoints	O
should	O
demarcate	O
such	O
a	O
gene	O
.	O

Furthermore	O
,	O
if	O
male	O
sterility	O
is	O
the	O
only	O
major	O
fitness	O
effect	O
associated	O
with	O
the	O
introgression	O
,	O
recombination	O
analysis	O
should	O
yield	O
a	O
pattern	O
predicted	O
by	O
the	O
classical	O
three	O
-	O
point	O
cross	O
.	O

Both	O
the	O
genetic	O
and	O
molecular	O
analyses	O
suggest	O
the	O
presence	O
of	O
a	O
major	O
sterility	O
factor	O
from	O
D.	O
mauritiana	O
,	O
which	O
we	O
named	O
Odysseus	B
(	O
Ods	B
)	O
,	O
in	O
the	O
cytological	O
interval	O
of	O
16D	O
.	O

We	O
thus	O
formalize	O
three	O
criteria	O
for	O
inferring	O
the	O
existence	O
of	O
a	O
major	O
gene	O
within	O
an	O
introgression	O
:	O
(	O
1	O
)	O
complete	O
penetrance	O
of	O
sterility	O
,	O
(	O
2	O
)	O
complementarity	O
in	O
recombination	O
analysis	O
,	O
and	O
(	O
3	O
)	O
physical	O
demarcation	O
.	O

Introgressions	O
of	O
Ods	B
from	O
D.	O
sechellia	O
do	O
not	O
cause	O
sterility	O
.	O

Twenty	O
-	O
two	O
introgressions	O
in	O
our	O
collection	O
have	O
breakpoints	O
in	O
this	O
interval	O
of	O
about	O
500	O
kb	O
,	O
making	O
it	O
possible	O
to	O
delineate	O
Ods	B
more	O
precisely	O
for	O
molecular	O
identification	O
.	O

The	O
recombination	O
analysis	O
also	O
reveals	O
the	O
complexity	O
of	O
the	O
introgressed	O
segments	O
--	O
even	O
relatively	O
short	O
ones	O
may	O
contain	O
a	O
second	O
male	O
sterility	O
factor	O
and	O
partial	O
viability	O
genes	O
and	O
may	O
also	O
interfere	O
with	O
crossovers	O
.	O

The	O
spermatogenic	O
defects	O
associated	O
with	O
Ods	B
and/or	O
a	O
second	O
factor	O
were	O
characterized	O
by	O
phase	O
-	O
contrast	O
microscopy	O
.	O

The	O
sina	B
gene	O
encodes	O
a	O
nuclear	O
protein	O
that	O
is	O
required	O
for	O
the	O
correct	O
development	O
of	O
R7	O
photoreceptor	O
cells	O
in	O
the	O
Drosophila	O
eye	O
.	O

We	O
conducted	O
a	O
genetic	O
screen	O
for	O
mutations	O
that	O
reduce	O
the	O
activity	O
of	O
sina	B
and	O
found	O
mutations	O
that	O
define	O
nine	O
genes	O
whose	O
products	O
may	O
be	O
required	O
for	O
normal	O
sina	B
activity	O
.	O

Three	O
of	O
these	O
genes	O
also	O
appear	O
to	O
be	O
essential	O
for	O
signaling	O
by	O
the	O
Sevenless	B
-	O
Ras	B
pathway	O
in	O
R7	O
cells	O
,	O
of	O
which	O
one	O
gene	O
corresponds	O
to	O
the	O
rolled	B
locus	O
(	O
rl	B
)	O
.	O

The	O
rl	B
gene	O
is	O
known	O
to	O
encode	O
a	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
necessary	O
for	O
signaling	O
by	O
Ras	B
.	O

These	O
results	O
suggest	O
that	O
the	O
products	O
of	O
these	O
three	O
genes	O
may	O
participate	O
in	O
a	O
signaling	O
pathway	O
involving	O
both	O
Ras	B
and	O
Sina	B
,	O
possibly	O
by	O
functionally	O
linking	O
these	O
two	O
proteins	O
.	O

The	O
product	O
of	O
the	O
extra	B
sex	I
combs	I
(	O
esc	B
)	O
gene	O
is	O
required	O
early	O
in	O
embryogenesis	O
to	O
ensure	O
the	O
correct	O
spatial	O
expression	O
of	O
the	O
bithorax	B
and	O
Antennapedia	B
gene	O
complexes	O
during	O
subsequent	O
development	O
.	O

Here	O
we	O
describe	O
the	O
spatial	O
and	O
temporal	O
patterns	O
of	O
transcription	O
of	O
the	O
Ultrabithorax	B
(	O
Ubx	B
)	O
gene	O
in	O
mutant	O
esc	B
embryos	O
.	O

In	O
wild	O
-	O
type	O
embryos	O
,	O
Ubx	B
transcripts	O
are	O
first	O
detected	O
in	O
the	O
blastoderm	O
primorida	O
of	O
particular	O
thoracic	O
and	O
abdominal	O
segments	O
,	O
predominately	O
in	O
a	O
band	O
of	O
cells	O
constituting	O
the	O
progenitor	O
cells	O
of	O
parasegment	O
6	O
:	O
after	O
gastrulation	O
,	O
high	O
levels	O
of	O
transcript	O
accumulate	O
in	O
a	O
sharply	O
restricted	O
region	O
of	O
the	O
germ	O
band	O
comprising	O
parasegments	O
6	O
-	O
12	O
.	O

In	O
esc-	B
embryos	O
,	O
the	O
initial	O
pattern	O
of	O
Ubx	B
transcripts	O
appears	O
indistinguishable	O
from	O
that	O
of	O
wild	O
-	O
type	O
embryos	O
.	O

However	O
,	O
following	O
gastrulation	O
and	O
germ	O
band	O
extension	O
,	O
Ubx	B
transcripts	O
accumulate	O
in	O
most	O
of	O
the	O
ectodermal	O
and	O
mesodermal	O
derivatives	O
of	O
the	O
body	O
,	O
including	O
those	O
of	O
all	O
14	O
parasegments	O
.	O

Then	O
,	O
the	O
abundance	O
of	O
the	O
transcripts	O
declines	O
so	O
that	O
after	O
germ	O
band	O
shortening	O
(	O
12	O
h	O
after	O
fertilization	O
)	O
,	O
only	O
low	O
levels	O
are	O
detected	O
in	O
each	O
parasegment	O
.	O

These	O
results	O
show	O
that	O
the	O
esc	B
gene	O
product	O
is	O
not	O
involved	O
in	O
choosing	O
where	O
the	O
Ubx	B
gene	O
is	O
to	O
be	O
expressed	O
,	O
but	O
rather	O
,	O
that	O
it	O
acts	O
subsequently	O
to	O
ensure	O
that	O
the	O
gene	O
remains	O
off	O
in	O
those	O
primordia	O
in	O
which	O
it	O
is	O
not	O
initially	O
activated	O
.	O

In	O
addition	O
,	O
they	O
suggest	O
the	O
possibility	O
that	O
other	O
homeotic	O
genes	O
may	O
regulate	O
Ubx	B
expression	O
--in	O
this	O
case	O
,	O
the	O
accumulating	O
products	O
of	O
other	O
indiscriminately	O
expressed	O
homeotic	O
genes	O
serving	O
to	O
down	O
-	O
regulate	O
Ubx	B
transcription	O
throughout	O
the	O
body	O
.	O

The	O
seven	O
member	O
,	O
human	O
MORF4	O
related	O
gene	O
(	O
MRG	O
)	O
family	O
was	O
recently	O
identified	O
based	O
on	O
the	O
ability	O
of	O
Mortality	O
factor	O
on	O
chromosome	O
4	O
(	O
MORF4	O
)	O
to	O
induce	O
replicative	O
senescence	O
in	O
immortal	O
cell	O
lines	O
assigned	O
to	O
complementation	O
group	O
B	O
(	O
Bertram	O
et	O
al.	O
,	O
1999	O
.	O

Mol	O
.	O

Cell	O
Biol	O
.	O

19	O
,	O
1479	O
-	O
1485	O
)	O
.	O

Initial	O
computer	O
based	O
similarity	O
searches	O
identified	O
human	O
retinoblastoma	O
binding	O
protein	O
1	O
(	O
RBP-1	O
)	O
,	O
Drosophila	O
melanogaster	O
male	O
specific	O
lethal-3	O
(	O
Msl-3	B
)	O
,	O
S.	O
pombe	O
altered	O
polarity-13	O
(	O
Alp13	O
)	O
and	O
S.	O
cerevisiae	O
Eaf3p	O
,	O
a	O
component	O
of	O
the	O
yeast	O
NuA4	O
HAT	O
complex	O
(	O
Galarneau	O
et	O
al.	O
,	O
2000	O
.	O

Mol	O
.	O

Cell	O
5	O
,	O
927	O
-	O
937	O
)	O
,	O
as	O
having	O
similarity	O
to	O
the	O
human	O
MRG	O
protein	O
family	O
.	O

This	O
suggested	O
that	O
the	O
MRG	O
family	O
might	O
be	O
found	O
in	O
multiple	O
species	O
,	O
and	O
analysis	O
of	O
other	O
homologs	O
would	O
provide	O
functional	O
and	O
evolutionary	O
insights	O
into	O
this	O
gene	O
family	O
.	O

Here	O
,	O
we	O
report	O
that	O
MRG	O
family	O
members	O
are	O
present	O
in	O
twenty	O
-	O
three	O
species	O
based	O
on	O
molecular	O
assays	O
and	O
sequence	O
similarity	O
searches	O
.	O

The	O
new	O
family	O
members	O
were	O
divided	O
into	O
two	O
groups	O
based	O
on	O
similarity	O
to	O
the	O
predominant	O
human	O
MRG	O
family	O
members	O
,	O
MRG15	B
and	O
MRGX	O
.	O

The	O
family	O
members	O
similar	O
to	O
MRG15	B
define	O
a	O
new	O
,	O
highly	O
conserved	O
subsection	O
of	O
the	O
chromo	O
domain	O
superfamily	O
.	O

Additionally	O
,	O
conservation	O
in	O
the	O
C	O
-	O
terminal	O
two	O
thirds	O
of	O
all	O
the	O
MRG	O
family	O
members	O
and	O
the	O
Drosophila	O
and	O
human	O
MSL-3	B
proteins	O
defines	O
a	O
new	O
protein	O
domain	O
,	O
the	O
MRG	O
domain	O
.	O

These	O
results	O
indicate	O
a	O
highly	O
conserved	O
role	O
for	O
the	O
MRG	O
family	O
in	O
transcriptional	O
regulation	O
via	O
chromatin	O
remodeling	O
by	O
histone	O
acetylation	O
.	O

Experiments	O
manipulating	O
the	O
level	O
of	O
the	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
transcription	O
factor	O
Twist	B
in	O
the	O
Drosophila	O
embryo	O
have	O
revealed	O
a	O
novel	O
role	O
for	O
this	O
protein	O
in	O
a	O
'	O
myogenic	O
switch	O
'	O
during	O
early	O
development	O
.	O

A	O
novel	O
Drosophila	O
melanogaster	O
gene	O
UBL3	B
was	O
characterized	O
and	O
shown	O
to	O
be	O
highly	O
conserved	O
in	O
man	O
and	O
Caenorhabditis	O
elegans	O
(	O
C.	O
elegans	O
)	O
.	O

The	O
human	O
and	O
mouse	O
homologues	O
were	O
cloned	O
and	O
sequenced	O
.	O

UBL3	B
is	O
a	O
ubiquitin	O
-	O
like	O
protein	O
of	O
unknown	O
function	O
with	O
no	O
conserved	O
homologues	O
in	O
yeast	O
.	O

Mapping	O
of	O
the	O
human	O
and	O
mouse	O
UBL3	B
genes	O
places	O
them	O
within	O
a	O
region	O
of	O
shared	O
gene	O
order	O
between	O
human	O
and	O
mouse	O
chromosomes	O
on	O
human	O
chromosome	O
13q12	O
-	O
13	O
and	O
telomeric	O
mouse	O
chromosome	O
5	O
(	O
MMU5	O
)	O
.	O

The	O
immunophilin	O
FKBP12	B
is	O
an	O
evolutionarily	O
conserved	O
abundant	O
protein	O
;	O
however	O
,	O
its	O
physiological	O
roles	O
remain	O
poorly	O
defined	O
.	O

Here	O
we	O
report	O
that	O
FKBP12	B
is	O
a	O
common	O
cytoplasmic	O
interactor	O
of	O
TGF	O
beta	O
family	O
type	O
I	O
receptors	O
.	O

FKBP12	B
binds	O
to	O
ligand	O
-	O
free	O
TGF	O
beta	O
type	O
I	O
receptor	O
,	O
from	O
which	O
it	O
is	O
released	O
upon	O
a	O
ligand	O
-	O
induced	O
,	O
type	O
II	O
receptor	O
mediated	O
phosphorylation	O
of	O
the	O
type	O
I	O
receptor	O
.	O

Blocking	O
FKBP12	B
/	O
type	O
I	O
receptor	O
interaction	O
with	O
FK506	O
nonfunctional	O
derivatives	O
enhances	O
the	O
ligand	O
activity	O
,	O
indicating	O
that	O
FKBP12	B
binding	O
is	O
inhibitory	O
to	O
the	O
signaling	O
pathways	O
of	O
the	O
TGF	O
beta	O
family	O
ligands	O
.	O

Overexpression	O
of	O
a	O
myristylated	O
FKBP12	B
in	O
Mv1Lu	O
cell	O
specifically	O
inhibits	O
two	O
separate	O
pathways	O
activated	O
by	O
TGF	O
beta	O
,	O
and	O
two	O
point	O
mutations	O
on	O
FKBP12	B
(	O
G89P	O
,	O
I90	O
K	O
)	O
abolish	O
the	O
inhibitory	O
activity	O
of	O
FKBP12	B
,	O
suggesting	O
that	O
FKBP12	B
may	O
dock	O
a	O
cytoplasmic	O
protein	O
to	O
the	O
type	O
I	O
receptors	O
to	O
inhibit	O
TGF	O
beta	O
family	O
mediated	O
signaling	O
.	O

In	O
Drosophila	O
,	O
the	O
dorsoventral	O
asymmetry	O
of	O
the	O
egg	O
chamber	O
depends	O
on	O
a	O
dorsalizing	O
signal	O
that	O
emanates	O
from	O
the	O
oocyte	O
.	O

This	O
signal	O
is	O
supplied	O
by	O
the	O
TGF	O
alpha	O
-	O
like	O
gurken	B
protein	O
whose	O
RNA	O
is	O
localized	O
to	O
the	O
dorsal	O
-	O
anterior	O
corner	O
of	O
the	O
oocyte	O
,	O
gurken	B
protein	O
is	O
the	O
potential	O
ligand	O
of	O
the	O
Drosophila	O
EGF	B
receptor	I
homolog	O
(	O
torpedo	B
)	O
,	O
which	O
is	O
expressed	O
in	O
the	O
follicular	O
epithelium	O
surrounding	O
the	O
oocyte	O
.	O

Here	O
,	O
we	O
describe	O
how	O
changes	O
in	O
the	O
dorsalizing	O
germ	O
-	O
line	O
signal	O
affect	O
the	O
embryonic	O
dorsoventral	O
pattern	O
.	O

A	O
reduction	O
in	O
strength	O
of	O
the	O
germ	O
-	O
line	O
signal	O
as	O
produced	O
by	O
mutations	O
in	O
gurken	B
or	O
torpedo	B
does	O
not	O
change	O
the	O
slope	O
of	O
the	O
embryonic	O
dorsoventral	O
morphogen	O
gradient	O
,	O
but	O
causes	O
a	O
splitting	O
of	O
the	O
gradient	O
ventrally	O
.	O

This	O
leads	O
to	O
embryos	O
with	O
two	O
partial	O
dorsoventral	O
axes	O
.	O

A	O
change	O
in	O
distribution	O
of	O
the	O
germ	O
-	O
line	O
signal	O
as	O
caused	O
by	O
fs	B
(	I
1	I
)	I
K10	I
,	O
squid	B
and	O
orb	B
mutations	O
leads	O
to	O
a	O
shift	O
in	O
the	O
orientation	O
of	O
the	O
embryonic	O
dorsoventral	O
axis	O
relative	O
to	O
the	O
anterior	O
-	O
posterior	O
axis	O
.	O

In	O
extreme	O
cases	O
,	O
this	O
results	O
in	O
embryos	O
with	O
a	O
dorsoventral	O
axis	O
almost	O
parallel	O
to	O
the	O
anterior	O
-	O
posterior	O
axis	O
.	O

These	O
results	O
imply	O
that	O
gurken	B
,	O
unlike	O
other	O
localized	O
cytoplasmic	O
determinants	O
,	O
is	O
not	O
directly	O
responsible	O
for	O
the	O
establishment	O
of	O
cell	O
fates	O
along	O
a	O
body	O
axis	O
,	O
but	O
that	O
it	O
restricts	O
and	O
orients	O
an	O
active	O
axis	O
-	O
forming	O
process	O
which	O
occurs	O
later	O
in	O
the	O
follicular	O
epithelium	O
or	O
in	O
the	O
early	O
embryo	O
.	O

P	B
transposable	O
elements	O
of	O
Drosophila	O
melanogaster	O
cloned	O
from	O
the	O
strong	O
P	B
strain	O
pi	O
2	O
have	O
been	O
analysed	O
.	O

The	O
structures	O
and	O
chromosomal	O
locations	O
of	O
26	O
of	O
the	O
30	O
-	O
50	O
elements	O
estimated	O
to	O
be	O
present	O
in	O
pi	O
2	O
have	O
been	O
determined	O
.	O

At	O
one	O
location	O
two	O
elements	O
are	O
inserted	O
100	O
base	O
pairs	O
(	O
bp	O
)	O
apart	O
,	O
and	O
in	O
a	O
second	O
location	O
two	O
elements	O
are	O
only	O
separated	O
by	O
the	O
8	O
bp	O
duplicated	O
upon	O
P	B
-	I
element	I
insertion	O
.	O

In	O
addition	O
to	O
2.9	O
kilobase	O
-	O
pair	O
(	O
kbp	O
)	O
elements	O
,	O
elements	O
with	O
14	O
different	O
internal	O
deletions	O
from	O
1.3	O
to	O
2.3	O
kbp	O
in	O
size	O
have	O
been	O
isolated	O
.	O

There	O
are	O
7	O
copies	O
of	O
the	O
2.9	O
kbp	O
element	O
,	O
2	O
copies	O
each	O
of	O
5	O
internally	O
deleted	O
elements	O
and	O
a	O
single	O
copy	O
of	O
9	O
internally	O
deleted	O
elements	O
.	O

One	O
of	O
the	O
elements	O
found	O
twice	O
is	O
the	O
KP	O
element	O
,	O
which	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
hybrid	O
dysgenesis	O
in	O
strains	O
which	O
contain	O
many	O
copies	O
of	O
this	O
element	O
.	O

Apart	O
from	O
internal	O
deletions	O
the	O
elements	O
are	O
extremely	O
homogeneous	O
in	O
DNA	O
sequence	O
,	O
with	O
only	O
2	O
single	O
base	O
polymorphisms	O
detected	O
twice	O
each	O
in	O
over	O
16	O
kbp	O
of	O
P	B
-	I
element	I
sequence	O
.	O

Although	O
transpositions	O
are	O
infrequent	O
in	O
an	O
inbred	O
P	B
cytotype	O
strain	O
such	O
as	O
pi	O
2	O
,	O
the	O
distribution	O
of	O
these	O
cloned	O
elements	O
indicates	O
that	O
when	O
the	O
genomic	O
library	O
was	O
made	O
,	O
the	O
strain	O
was	O
polymorphic	O
with	O
respect	O
to	O
element	O
location	O
.	O

The	O
distribution	O
and	O
structures	O
of	O
the	O
element	O
are	O
discussed	O
with	O
respect	O
to	O
models	O
for	O
regulation	O
of	O
P	B
-	I
element	I
transposition	O
.	O

The	O
Drosophila	O
gene	O
Serrate	B
encodes	O
a	O
membrane	O
spanning	O
protein	O
,	O
which	O
is	O
expressed	O
in	O
a	O
complex	O
pattern	O
during	O
embryogenesis	O
and	O
larval	O
stages	O
.	O

Loss	O
of	O
Serrate	B
function	O
leads	O
to	O
larval	O
lethality	O
,	O
which	O
is	O
associated	O
with	O
several	O
morphogenetic	O
defects	O
,	O
including	O
the	O
failure	O
to	O
develop	O
wings	O
and	O
halteres	O
.	O

Serrate	B
has	O
been	O
suggested	O
to	O
act	O
as	O
a	O
short	O
-	O
range	O
signal	O
during	O
wing	O
development	O
.	O

It	O
is	O
required	O
for	O
the	O
induction	O
of	O
the	O
organising	O
centre	O
at	O
the	O
dorsal	O
/	O
ventral	O
compartment	O
boundary	O
,	O
from	O
which	O
growth	O
and	O
patterning	O
of	O
the	O
wing	O
is	O
controlled	O
.	O

In	O
order	O
to	O
understand	O
the	O
regulatory	O
network	O
required	O
to	O
control	O
the	O
spatially	O
and	O
temporally	O
dynamic	O
expression	O
of	O
Serrate	B
,	O
we	O
analysed	O
its	O
cis	O
-	O
regulatory	O
elements	O
by	O
fusing	O
various	O
genomic	O
fragments	O
upstream	O
of	O
the	O
reporter	O
gene	O
lacZ.	B
Enhancer	O
elements	O
reflecting	O
the	O
expression	O
pattern	O
of	O
endogenous	O
Serrate	B
in	O
embryonic	O
and	O
postembryonic	O
tissues	O
could	O
be	O
confined	O
to	O
26	O
kb	O
of	O
genomic	O
DNA	O
,	O
including	O
9	O
kb	O
of	O
transcribed	O
region	O
.	O

Expression	O
in	O
some	O
embryonic	O
tissues	O
is	O
under	O
the	O
control	O
of	O
multiple	O
enhancers	O
located	O
in	O
the	O
5	O
'	O
region	O
and	O
in	O
intron	O
sequences	O
.	O

The	O
data	O
presented	O
here	O
provide	O
the	O
tools	O
to	O
unravel	O
the	O
genetic	O
network	O
which	O
regulates	O
Serrate	B
during	O
different	O
developmental	O
stages	O
in	O
diverse	O
tissues	O
.	O

To	O
examine	O
the	O
details	O
of	O
insertion	O
for	O
the	O
D.	O
malanogaster	O
transposable	O
element	O
copia	B
,	O
we	O
have	O
isolated	O
three	O
independent	O
pairs	O
of	O
genomic	O
fragments	O
which	O
correspond	O
to	O
occupied	O
and	O
unoccupied	O
target	O
sites	O
for	O
insertion	O
.	O

Restriction	O
endonuclease	O
analysis	O
suggests	O
that	O
sites	O
with	O
and	O
without	O
an	O
element	O
differ	O
by	O
a	O
simple	O
5000	O
bp	O
insertion	O
.	O

Direct	O
DNA	O
sequence	O
analysis	O
demonstrates	O
that	O
a	O
5	O
bp	O
sequence	O
,	O
present	O
once	O
in	O
the	O
target	O
DNA	O
at	O
the	O
site	O
of	O
insertion	O
,	O
is	O
found	O
on	O
both	O
sides	O
of	O
the	O
element	O
after	O
insertion	O
.	O

The	O
5	O
bp	O
sequences	O
which	O
are	O
duplicated	O
are	O
different	O
in	O
each	O
case	O
.	O

Moreover	O
,	O
there	O
does	O
not	O
appear	O
to	O
be	O
any	O
sequence	O
homology	O
among	O
these	O
three	O
independent	O
insertion	O
sites	O

Efficient	O
heat	O
shock	O
induction	O
of	O
Drosophila	O
hsp26	B
gene	O
transcription	O
in	O
vivo	O
requires	O
binding	O
sites	O
for	O
heat	B
shock	I
factor	I
(	O
HSF	B
)	O
and	O
GAGA	B
factor	I
(	O
GAF	B
)	O
close	O
to	O
the	O
TATA	O
box	O
(	O
proximal	O
elements	O
)	O
as	O
well	O
as	O
350	O
bp	O
upstream	O
of	O
the	O
start	O
site	O
of	O
transcription	O
(	O
distal	O
elements	O
)	O
.	O

We	O
have	O
evaluated	O
the	O
contribution	O
of	O
hsp26	B
promoter	O
sequences	O
to	O
transcriptional	O
activity	O
in	O
extracts	O
from	O
either	O
heat	O
shocked	O
or	O
unstressed	O
fly	O
embryos	O
.	O

Efficient	O
transcription	O
in	O
either	O
extract	O
was	O
governed	O
by	O
distinct	O
regulatory	O
principles	O
.	O

Transcription	O
in	O
extracts	O
from	O
unstressed	O
embryos	O
relied	O
solely	O
on	O
GAGA	B
elements	O
which	O
efficiently	O
counteracted	O
repression	O
by	O
abundant	O
non	O
-	O
specific	O
DNA	O
-	O
binding	O
proteins	O
.	O

Transcription	O
in	O
extracts	O
from	O
heat	O
shocked	O
embryos	O
depended	O
only	O
a	O
little	O
on	O
GAGA	B
elements	O
,	O
relying	O
mainly	O
on	O
functional	O
HSEs	O
.	O

Constitutively	O
active	O
recombinant	O
HSF	B
or	O
native	O
factor	O
in	O
an	O
extract	O
from	O
heat	O
shocked	O
embryos	O
was	O
able	O
to	O
truly	O
activate	O
transcription	O
essentially	O
via	O
proximal	O
HSEs	O
,	O
but	O
not	O
when	O
bound	O
to	O
distal	O
sites	O
.	O

These	O
two	O
modes	O
of	O
regulation	O
in	O
vitro	O
may	O
correspond	O
to	O
the	O
two	O
functional	O
states	O
of	O
the	O
promoter	O
before	O
and	O
after	O
heat	O
shock	O
in	O
vivo	O
.	O

To	O
determine	O
whether	O
male-	O
or	O
female	O
-	O
biased	O
mutation	O
rates	O
have	O
affected	O
the	O
molecular	O
evolution	O
of	O
Drosophila	O
melanogaster	O
and	O
D.	O
simulans	O
,	O
we	O
calculated	O
the	O
male	O
-	O
to	O
-	O
female	O
ratio	O
of	O
germline	O
cell	O
divisions	O
(	O
[	O
symbol	O
:	O
see	O
text	O
]	O
)	O
from	O
germline	O
generation	O
data	O
and	O
the	O
male	O
-	O
to	O
-	O
female	O
ratio	O
of	O
mutation	O
rate	O
(	O
[	O
symbol	O
:	O
see	O
text	O
]	O
)	O
by	O
comparing	O
chromosomal	O
levels	O
of	O
nucleotide	O
divergence	O
.	O

We	O
found	O
that	O
the	O
ratio	O
of	O
germline	O
cell	O
divisions	O
changes	O
from	O
indicating	O
a	O
weak	O
female	O
bias	O
to	O
indicating	O
a	O
weak	O
male	O
bias	O
as	O
the	O
age	O
of	O
reproduction	O
increases	O
.	O

The	O
range	O
of	O
[	O
symbol	O
:	O
see	O
text	O
]	O
values	O
that	O
we	O
observed	O
,	O
however	O
,	O
does	O
not	O
lead	O
us	O
to	O
expect	O
much	O
,	O
if	O
any	O
,	O
difference	O
in	O
mutation	O
rate	O
between	O
the	O
sexes	O
.	O

Silent	O
and	O
intron	O
nucleotide	O
divergence	O
were	O
compared	O
between	O
nine	O
loci	O
on	O
the	O
X	B
chromosome	O
and	O
nine	O
loci	O
on	O
the	O
second	O
and	O
third	O
chromosomes	O
.	O

The	O
average	O
levels	O
of	O
nucleotide	O
divergence	O
were	O
not	O
significantly	O
different	O
across	O
the	O
chromosomes	O
,	O
although	O
both	O
silent	O
and	O
intron	O
sites	O
show	O
a	O
trend	O
toward	O
slightly	O
more	O
divergence	O
on	O
the	O
X.	B
These	O
results	O
indicate	O
a	O
lack	O
of	O
sex-	O
or	O
chromosome	O
-	O
biased	O
molecular	O
evolution	O
in	O
D.	O
melanogaster	O
and	O
D.	O
simulans	O
.	O

The	O
pattern	O
of	O
adult	O
sensilla	O
in	O
Drosophila	O
is	O
established	O
by	O
the	O
dosage	O
-	O
sensitive	O
interaction	O
of	O
two	O
antagonistic	O
groups	O
of	O
genes	O
.	O

Sensilla	O
development	O
is	O
promoted	O
by	O
members	O
of	O
the	O
achaete	B
-	I
scute	I
complex	O
and	O
the	O
daughterless	B
gene	O
whereas	O
it	O
is	O
suppressed	O
by	O
whereas	O
extramacrochaete	O
(	O
emc	B
)	O
and	O
hairy	B
.	O

All	O
these	O
genes	O
encode	O
helix	O
-	O
loop	O
-	O
helix	O
proteins	O
.	O

The	O
products	O
of	O
the	O
achaete	B
-	I
scute	I
complex	O
and	O
daughterless	B
interact	O
to	O
form	O
heterodimers	O
able	O
to	O
activate	O
transcription	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
(	O
1	O
)	O
extra	O
-	O
macrochaete	O
forms	O
heterodimers	O
with	O
the	O
achaete	B
,	O
scute	B
,	O
lethal	B
of	I
scute	I
and	O
daughterless	B
products	O
;	O
(	O
2	O
)	O
extramacrochaete	O
inhibits	O
DNA	O
-	O
binding	O
of	O
Achaete	B
,	O
Scute	B
and	O
Lethal	B
of	I
Scute	I
/	O
Daughterless	B
heterodimers	O
and	O
Daughterless	B
homodimers	O
and	O
(	O
3	O
)	O
extramacrochaete	O
inhibits	O
transcription	O
activation	O
by	O
heterodimers	O
in	O
a	O
yeast	O
assay	O
system	O
.	O

In	O
addition	O
,	O
we	O
have	O
studied	O
the	O
expression	O
patterns	O
of	O
scute	B
in	O
wild	O
-	O
type	O
and	O
extramacrochaete	O
mutant	O
imaginal	O
discs	O
.	O

Expression	O
of	O
scute	B
RNA	O
during	O
imaginal	O
development	O
occurs	O
in	O
groups	O
of	O
cells	O
,	O
but	O
high	O
levels	O
of	O
protein	O
accumulate	O
in	O
the	O
nuclei	O
of	O
only	O
a	O
subset	O
of	O
the	O
RNA	O
-	O
expressing	O
cells	O
.	O

The	O
pattern	O
is	O
dynamic	O
and	O
results	O
in	O
a	O
small	O
number	O
of	O
protein	O
-	O
containing	O
cells	O
that	O
correspond	O
to	O
sensillum	O
precursors	O
.	O

extramacrochaete	O
loss	O
-	O
of	O
-	O
function	O
alleles	O
develop	O
extra	O
sensilla	O
and	O
correspondingly	O
display	O
a	O
larger	O
number	O
of	O
cells	O
with	O
scute	B
protein	O
.	O

These	O
cells	O
appear	O
to	O
arise	O
from	O
those	O
that	O
in	O
the	O
wild	O
type	O
already	O
express	O
scute	B
RNA	O
;	O
hence	O
,	O
extramacrochaete	O
is	O
a	O
repressor	O
of	O
scute	B
function	O
whose	O
action	O
may	O
take	O
place	O
post	O
-	O
transcriptionally	O
.	O

beta	B
3	I
tubulin	I
expression	O
accompanies	O
the	O
specification	O
and	O
differentiation	O
of	O
the	O
Drosophila	O
mesoderm	O
.	O

The	O
genetic	O
programs	O
involved	O
in	O
these	O
processes	O
are	O
largely	O
unknown	O
.	O

Our	O
previous	O
studies	O
on	O
the	O
regulation	O
of	O
the	O
beta	B
3	I
tubulin	I
gene	O
have	O
shown	O
that	O
upstream	O
sequences	O
guide	O
the	O
expression	O
in	O
the	O
somatic	O
musculature	O
,	O
while	O
regulatory	O
elements	O
in	O
the	O
first	O
intron	O
are	O
necessary	O
for	O
expression	O
in	O
the	O
visceral	O
musculature	O
.	O

To	O
further	O
analyse	O
this	O
mode	O
of	O
regulation	O
,	O
which	O
reflects	O
an	O
early	O
embryonic	O
specification	O
program	O
,	O
we	O
undertook	O
a	O
more	O
detailed	O
analysis	O
of	O
the	O
regulatory	O
capabilities	O
of	O
the	O
intron	O
.	O

The	O
results	O
reveal	O
not	O
only	O
a	O
certain	O
degree	O
of	O
redundancy	O
in	O
the	O
cis	O
-	O
acting	O
elements	O
,	O
which	O
act	O
at	O
different	O
developmental	O
stages	O
in	O
the	O
same	O
mesodermal	O
derivatives	O
,	O
but	O
they	O
also	O
demonstrate	O
in	O
the	O
visceral	O
mesoderm	O
,	O
which	O
forms	O
a	O
continuous	O
epithelium	O
along	O
the	O
body	O
axis	O
of	O
the	O
embryo	O
,	O
an	O
early	O
action	O
of	O
regulators	O
guiding	O
gene	O
expression	O
along	O
the	O
anterior	O
-	O
posterior	O
axis	O
of	O
the	O
embryo	O
:	O
an	O
enhancer	O
element	O
in	O
the	O
intron	O
leads	O
to	O
expression	O
in	O
a	O
subdomain	O
restricted	O
along	O
the	O
anterior	O
-	O
posterior	O
axis	O
.	O

This	O
pattern	O
is	O
altered	O
in	O
mutants	O
in	O
the	O
homeotic	O
gene	O
Ultrabithorax	B
(	O
Ubx	B
)	O
,	O
whereas	O
ectopic	O
Ubx	B
expression	O
leads	O
to	O
activity	O
of	O
the	O
enhancer	O
in	O
the	O
entire	O
visceral	O
mesoderm	O
.	O

So	O
this	O
element	O
is	O
likely	O
to	O
be	O
a	O
target	O
of	O
homeotic	O
genes	O
,	O
which	O
would	O
define	O
the	O
beta	B
3	I
tubulin	I
gene	O
as	O
a	O
realisator	O
gene	O
under	O
the	O
control	O
of	O
selector	O
genes	O
.	O

A	O
large	O
proportion	O
of	O
spontaneous	O
mutations	O
in	O
Drosophila	O
melanogaster	O
strains	O
of	O
laboratory	O
origin	O
are	O
associated	O
with	O
insertions	O
of	O
mobile	O
DNA	O
elements	O
.	O

As	O
a	O
first	O
step	O
toward	O
determining	O
whether	O
spontaneous	O
laboratory	O
mutations	O
are	O
predictive	O
for	O
mutational	O
events	O
occurring	O
in	O
the	O
wild	O
,	O
recessive	O
brown	B
(	O
bw	B
)	O
eye	O
color	O
mutants	O
were	O
isolated	O
.	O

By	O
inbreeding	O
the	O
progeny	O
of	O
wild	O
-	O
caught	O
Drosophila	O
melanogaster	O
females	O
,	O
bw	B
mutations	O
were	O
isolated	O
from	O
seven	O
separate	O
geographic	O
sites	O
distributed	O
among	O
Japan	O
,	O
California	O
.	O

Siberia	O
and	O
Hungary	O
.	O

Among	O
a	O
total	O
of	O
14	O
mutations	O
studied	O
,	O
no	O
case	O
of	O
transposon	O
mutagenesis	O
was	O
found	O
.	O

At	O
least	O
4	O
mutations	O
are	O
associated	O
with	O
small	O
deletions	O
in	O
the	O
bw	B
gene	O
.	O

The	O
remainder	O
are	O
inseparable	O
from	O
wild	O
-	O
type	O
bw	B
by	O
Southern	O
analysis	O
and	O
are	O
presumed	O
to	O
be	O
basepair	O
changes	O
or	O
very	O
small	O
indels	O
.	O

Although	O
only	O
two	O
spontaneous	O
bw	B
mutants	O
of	O
laboratory	O
origin	O
have	O
been	O
analyzed	O
molecularly	O
,	O
one	O
is	O
a	O
mobile	O
element	O
insertion	O
.	O

Kinesin	B
is	O
a	O
mechanochemical	O
enzyme	O
composed	O
of	O
three	O
distinct	O
domains	O
:	O
a	O
globular	O
head	O
domain	O
,	O
a	O
rodlike	O
stalk	O
domain	O
,	O
and	O
a	O
small	O
globular	O
tail	O
domain	O
.	O

The	O
stalk	O
domain	O
has	O
sequence	O
features	O
characteristic	O
of	O
alpha	B
-	O
helical	O
coiled	O
coils	O
.	O

To	O
gain	O
insight	O
into	O
the	O
structure	O
of	O
the	O
kinesin	B
stalk	O
,	O
we	O
expressed	O
it	O
from	O
a	O
segment	O
of	O
the	O
Drosophila	O
melanogaster	O
kinesin	B
heavy	I
chain	I
gene	O
and	O
purified	O
it	O
from	O
Escherichia	O
coli	O
.	O

When	O
observed	O
by	O
EM	O
,	O
this	O
protein	O
formed	O
a	O
rodlike	O
structure	O
40	O
-	O
55	O
nm	O
long	O
that	O
was	O
occasionally	O
bent	O
at	O
a	O
hingelike	O
region	O
near	O
the	O
middle	O
of	O
the	O
molecule	O
.	O

An	O
additional	O
EM	O
study	O
and	O
a	O
chemical	O
cross	O
-	O
linking	O
study	O
showed	O
that	O
this	O
protein	O
forms	O
a	O
parallel	O
dimer	O
and	O
that	O
the	O
two	O
chains	O
are	O
in	O
register	O
.	O

Finally	O
,	O
using	O
circular	O
dichroism	O
spectroscopy	O
,	O
we	O
showed	O
that	O
this	O
protein	O
is	O
approximately	O
55	O
-	O
60	O
%	O
alpha	B
-	O
helical	O
in	O
physiological	O
aqueous	O
solution	O
at	O
25	O
degrees	O
C	O
,	O
and	O
approximately	O
85	O
-	O
90	O
%	O
alpha	B
-	O
helical	O
at	O
4	O
degrees	O
C.	O
From	O
these	O
results	O
,	O
we	O
conclude	O
that	O
the	O
stalk	O
of	O
kinesin	B
heavy	I
chain	I
forms	O
an	O
alpha	B
-	O
helical	O
coiled	O
coil	O
structure	O
.	O

The	O
temperature	O
dependence	O
of	O
the	O
circular	O
dichroism	O
signal	O
has	O
two	O
major	O
transitions	O
,	O
at	O
25	O
-	O
30	O
degrees	O
C	O
and	O
at	O
45	O
-	O
50	O
degrees	O
C	O
,	O
which	O
suggests	O
that	O
a	O
portion	O
of	O
the	O
alpha	B
-	O
helical	O
structure	O
in	O
the	O
stalk	O
is	O
less	O
stable	O
than	O
the	O
rest	O
.	O

By	O
producing	O
the	O
amino	O
-	O
terminal	O
(	O
coil	O
1	O
)	O
and	O
carboxy	O
-	O
terminal	O
(	O
coil	O
2	O
)	O
halves	O
of	O
the	O
stalk	O
separately	O
in	O
E.	O
coli	O
,	O
we	O
showed	O
that	O
the	O
region	O
that	O
melts	O
below	O
30	O
degrees	O
C	O
lies	O
within	O
coil	O
1	O
,	O
while	O
the	O
majority	O
of	O
coil	O
2	O
melts	O
above	O
45	O
degrees	O
C.	O
We	O
suggest	O
that	O
this	O
difference	O
in	O
stability	O
may	O
play	O
a	O
role	O
in	O
the	O
force	O
-	O
generating	O
mechanism	O
or	O
regulation	O
of	O
kinesin	B
.	O

In	O
the	O
Drosophila	O
eye	O
imaginal	O
disc	O
the	O
photoreceptor	O
cells	O
(	O
R	O
cells	O
)	O
differentiate	O
according	O
to	O
a	O
precise	O
spatial	O
and	O
temporal	O
order	O
.	O

The	O
sidekick	B
(	O
sdk	B
)	O
gene	O
is	O
necessary	O
to	O
prevent	O
extra	O
R	O
cells	O
from	O
differentiating	O
during	O
eye	O
disc	O
development	O
.	O

The	O
extra	O
cell	O
appears	O
between	O
R3	O
and	O
R4	O
early	O
in	O
R	O
cell	O
clusters	O
and	O
is	O
most	O
likely	O
the	O
result	O
of	O
the	O
mystery	O
cell	O
inappropriately	O
differentiating	O
as	O
an	O
R	O
cell	O
.	O

Mosaic	O
analysis	O
shows	O
that	O
sdk	B
is	O
required	O
neither	O
in	O
the	O
R	O
cells	O
nor	O
in	O
the	O
extra	O
cell	O
,	O
suggesting	O
that	O
sdk	B
is	O
necessary	O
in	O
the	O
surrounding	O
undifferentiated	O
cells	O
.	O

The	O
sdk	B
gene	O
codes	O
for	O
a	O
protein	O
that	O
is	O
a	O
member	O
of	O
the	O
immunoglobulin	O
superfamily	O
,	O
having	O
six	O
immunoglobulin	O
domains	O
,	O
thirteen	O
fibronectin	O
repeats	O
and	O
a	O
transmembrane	O
domain	O
.	O

The	O
protein	O
structure	O
is	O
consistent	O
with	O
its	O
participation	O
in	O
cell	O
-	O
cell	O
interaction	O
during	O
eye	O
development	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
Drosophila	O
DNA	O
topoisomerase	B
I	I
gene	O
(	O
top1	B
)	O
has	O
been	O
determined	O
.	O

Structurally	O
,	O
top1	B
consists	O
of	O
eight	O
exons	O
and	O
seven	O
introns	O
.	O

The	O
top1	B
coding	O
region	O
contains	O
a	O
new	O
class	O
of	O
opa	B
repeats	O
,	O
encoding	O
clusters	O
of	O
serine	O
residues	O
instead	O
of	O
glutamine	O
repeats	O
usually	O
seen	O
in	O
Drosophila	O
genes	O
of	O
the	O
neurogenic	O
loci	O
.	O

A	O
unique	O
feature	O
of	O
top1	B
is	O
the	O
developmental	O
switch	O
of	O
its	O
transcripts	O
:	O
a	O
heterogeneous	O
population	O
of	O
transcripts	O
ranging	O
from	O
3.8	O
to	O
4.2	O
kb	O
seen	O
maximally	O
at	O
0	O
-	O
2h	O
of	O
embryogenesis	O
and	O
a	O
5.2-kb	O
transcript	O
maximal	O
at	O
6	O
-	O
12h	O
of	O
embryonic	O
development	O
.	O

The	O
transcripts	O
expressed	O
in	O
the	O
0	O
-	O
2-h	O
embryo	O
have	O
been	O
shown	O
as	O
maternal	O
storage	O
products	O
specific	O
to	O
ovarian	O
tissues	O
.	O

RACE	O
analysis	O
shows	O
that	O
whereas	O
the	O
6	O
-	O
12-h	O
transcripts	O
have	O
a	O
single	O
site	O
for	O
polyadenylation	O
,	O
there	O
are	O
at	O
least	O
12	O
different	O
sites	O
for	O
poly	O
(	O
A	O
)	O
addition	O
to	O
the	O
0	O
-	O
2-h	O
transcripts	O
.	O

An	O
additional	O
intron	O
specific	O
for	O
the	O
maternal	O
storage	O
transcripts	O
appears	O
in	O
some	O
of	O
the	O
0	O
-	O
2-h	O
transcripts	O
.	O

No	O
significant	O
heterogeneity	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
top1	B
transcripts	O
is	O
seen	O
.	O

Sequence	O
searches	O
have	O
revealed	O
a	O
number	O
of	O
regulatory	O
sequences	O
for	O
potential	O
translational	O
control	O
in	O
the	O
3	O
'	O
untranslated	O
region	O
.	O

Females	O
homozygous	O
for	O
the	O
otu7	O
allele	O
produce	O
ovarian	O
tumours	O
,	O
as	O
well	O
as	O
egg	O
chambers	O
that	O
reach	O
a	O
relatively	O
late	O
stage	O
of	O
development	O
.	O

Mutant	O
ovarian	O
nurse	O
cells	O
contain	O
giant	O
polytene	O
chromosomes	O
.	O

These	O
are	O
transcriptionally	O
active	O
,	O
and	O
RNA	O
is	O
transported	O
to	O
the	O
oocyte	O
through	O
ring	O
canals	O
,	O
although	O
at	O
reduced	O
rate	O
.	O

Vitellogenic	O
oocytes	O
are	O
endocytotically	O
active	O
.	O

Protein	O
(	O
alpha	O
yolk	O
)	O
spheres	O
are	O
formed	O
,	O
but	O
glycogen	O
(	O
beta	O
yolk	O
)	O
spheres	O
were	O
never	O
seen	O
in	O
the	O
ooplasm	O
.	O

Follicle	O
cells	O
migrate	O
normally	O
and	O
secrete	O
more	O
vitelline	O
membrane	O
and	O
chorion	O
than	O
is	O
required	O
to	O
cover	O
the	O
slowly	O
growing	O
oocyte	O
.	O

Specialized	O
follicle	O
cells	O
also	O
secrete	O
relatively	O
normal	O
dorsal	O
appendages	O
.	O

The	O
micropylar	O
cone	O
is	O
secreted	O
by	O
another	O
cluster	O
of	O
specialized	O
follicle	O
cells	O
called	O
border	O
cells	O
.	O

These	O
are	O
out	O
of	O
phase	O
with	O
the	O
oocyte	O
,	O
and	O
the	O
forming	O
micropylar	O
cone	O
prevents	O
the	O
nurse	O
cells	O
from	O
passing	O
the	O
remainder	O
of	O
their	O
cytoplasm	O
to	O
the	O
oocyte	O
.	O

The	O
result	O
is	O
a	O
morphologically	O
abnormal	O
chamber	O
blocked	O
at	O
the	O
p-12	O
stage	O
.	O

Sections	O
through	O
the	O
micropylar	O
cone	O
of	O
a	O
p-12	O
chamber	O
demonstrated	O
that	O
one	O
of	O
the	O
border	O
cells	O
formed	O
a	O
projection	O
containing	O
a	O
bundle	O
of	O
microtubules	O
.	O

Secretions	O
of	O
the	O
border	O
cells	O
were	O
deposited	O
against	O
this	O
tube	O
,	O
which	O
later	O
degenerates	O
or	O
is	O
withdrawn	O
.	O

Normally	O
this	O
results	O
in	O
a	O
canal	O
,	O
the	O
micropyle	O
,	O
through	O
which	O
the	O
sperm	O
enters	O
the	O
egg	O
.	O

The	O
slowed	O
growth	O
of	O
the	O
mutant	O
oocyte	O
presumably	O
results	O
from	O
a	O
defect	O
in	O
the	O
transport	O
of	O
fluids	O
or	O
charged	O
molecules	O
to	O
it	O
,	O
and	O
the	O
otu+	B
gene	O
is	O
therefore	O
believed	O
to	O
play	O
a	O
vital	O
role	O
in	O
this	O
process	O
.	O

The	O
Hedgehog	B
(	O
Hh	B
)	O
signal	O
has	O
an	O
inductive	O
role	O
during	O
Drosophila	O
development	O
.	O

Patched	B
is	O
part	O
of	O
the	O
Hedgehog	B
-	O
receptor	O
complex	O
and	O
shows	O
a	O
repressive	O
function	O
on	O
the	O
signaling	O
cascade	O
,	O
which	O
is	O
alleviated	O
in	O
the	O
presence	O
of	O
Hh	B
.	O

Herein	O
,	O
we	O
identify	O
the	O
first	O
dominant	O
gain	O
-	O
of	O
-	O
function	O
allele	O
of	O
patched	B
,	O
Confused	B
(	O
patched	B
(	I
Con	I
)	I
)	O
.	O

Analysis	O
of	O
the	O
patched	B
(	I
Con	I
)	I
allele	O
led	O
us	O
to	O
uncover	O
novel	O
features	O
of	O
the	O
reception	O
and	O
function	O
of	O
the	O
Hh	B
signal	O
.	O

At	O
least	O
three	O
different	O
regions	O
of	O
gene	O
expression	O
were	O
identified	O
and	O
a	O
gradient	O
of	O
cell	B
affinities	O
was	O
established	O
in	O
response	O
to	O
Hh	B
.	O

A	O
new	O
state	O
of	O
Cubitus	B
interruptus	I
activity	O
responsible	O
for	O
the	O
activation	O
of	O
araucan	B
and	O
caupolican	B
genes	O
of	O
the	O
iroquois	B
complex	I
,	O
independent	O
of	O
Fused	B
kinase	O
function	O
,	O
was	O
shown	O
.	O

In	O
the	O
disc	O
,	O
patched	B
(	I
Con	I
)	I
behaved	O
like	O
fused	B
mutants	O
and	O
was	O
rescued	O
by	O
Suppressor	B
of	I
fused	I
mutations	O
.	O

However	O
,	O
fused	B
mutants	O
are	O
embryonic	O
lethal	O
while	O
patched	B
(	I
Con	I
)	I
is	O
not	O
,	O
suggesting	O
that	O
Patched	B
could	O
interpret	O
Hedgehog	B
signaling	O
differently	O
in	O
the	O
embryo	O
and	O
in	O
the	O
adult	O
.	O

Here	O
,	O
we	O
show	O
that	O
BarH1	B
and	O
BarH2	B
,	O
a	O
pair	O
of	O
Bar	B
homeobox	O
genes	O
,	O
play	O
essential	O
roles	O
in	O
the	O
formation	O
and	O
specification	O
of	O
the	O
distal	O
leg	O
segments	O
of	O
Drosophila	O
.	O

In	O
early	O
third	O
instar	O
,	O
juxtaposition	O
of	O
Bar	B
-	O
positive	O
and	O
Bar	B
-	O
negative	O
tissues	O
causes	O
central	O
folding	O
that	O
may	O
separate	O
future	O
tarsal	O
segments	O
2	O
from	O
3	O
,	O
while	O
juxtaposition	O
of	O
tissues	O
differentially	O
expressing	O
Bar	B
homeobox	O
genes	O
at	O
later	O
stages	O
gives	O
rise	O
to	O
segmental	O
boundaries	O
of	O
distal	O
tarsi	O
including	O
the	O
tarsus	O
/	O
pretarsus	O
boundary	O
.	O

Tarsus	O
/	O
pretarsus	O
boundary	O
formation	O
requires	O
at	O
least	O
two	O
different	O
Bar	B
functions	O
,	O
early	O
antagonistic	O
interactions	O
with	O
a	O
pretarsus	O
-	O
specific	O
homeobox	O
gene	O
,	O
aristaless	B
,	O
and	O
the	O
subsequent	O
induction	O
of	O
Fas	B
II	I
expression	O
in	O
pretarsus	O
cells	O
abutting	O
tarsal	O
segment	O
5	O
.	O

Bar	B
homeobox	O
genes	O
are	O
also	O
required	O
for	O
specification	O
of	O
distal	O
tarsi	O
.	O

Bar	B
expression	O
requires	O
Distal	B
-	I
less	I
but	O
not	O
dachshund	B
,	O
while	O
early	O
circular	O
dachshund	B
expression	O
is	O
delimited	O
interiorly	O
by	O
BarH1	B
and	O
BarH2	B
.	O

The	O
mouse	O
genome	O
has	O
a	O
number	O
of	O
homeobox	O
genes	O
that	O
are	O
structurally	O
similar	O
to	O
the	O
Drosophila	O
Antenapedia	O
(	O
Antp	B
)	O
gene	O
.	O

We	O
find	O
that	O
one	O
of	O
the	O
mouse	O
Antp	B
-	O
like	O
genes	O
,	O
Hox-2.2	O
,	O
when	O
expressed	O
in	O
developing	O
Drosophila	O
cells	O
under	O
control	O
of	O
a	O
heat	O
shock	O
promoter	O
,	O
can	O
induce	O
homeotic	O
transformations	O
that	O
are	O
nearly	O
identical	O
to	O
those	O
caused	O
by	O
ectopic	O
expression	O
of	O
Antp	B
.	O

In	O
larvae	O
,	O
the	O
Hox-2.2-induced	O
transformations	O
include	O
thoracic	O
denticle	O
belts	O
in	O
place	O
of	O
head	O
structures	O
;	O
in	O
adults	O
,	O
the	O
Hox-2.2	O
transformations	O
include	O
thoracic	O
legs	O
in	O
place	O
of	O
antennae	O
.	O

The	O
phenotypic	O
effects	O
of	O
Hox-2.2	O
do	O
not	O
depend	O
on	O
the	O
endogenous	O
Antp	B
gene	O
,	O
whose	O
spatial	O
limits	O
of	O
expression	O
are	O
unaffected	O
by	O
Hox-2.2	O
expression	O
.	O

Thus	O
,	O
in	O
the	O
Drosophila	O
embryo	O
,	O
Hox-2.2	O
can	O
substitute	O
for	O
some	O
of	O
the	O
segmental	O
identity	O
functions	O
of	O
Antp	B
,	O
presumably	O
by	O
regulating	O
the	O
same	O
set	O
of	O
downstream	O
genes	O
.	O

The	O
roles	O
of	O
different	O
K+	O
currents	O
in	O
regulating	O
the	O
generation	O
and	O
waveform	O
of	O
action	O
potentials	O
in	O
Drosophila	O
dorsal	O
longitudinal	O
flight	O
muscles	O
(	O
DLMs	O
)	O
were	O
examined	O
in	O
current	O
-	O
clamp	O
experiments	O
.	O

In	O
response	O
to	O
depolarizing	O
current	O
,	O
DLMs	O
displayed	O
an	O
initial	O
transient	O
rectification	O
of	O
the	O
electronic	O
potential	O
lasting	O
for	O
up	O
to	O
hundreds	O
of	O
milliseconds	O
.	O

This	O
delay	O
in	O
excitation	O
was	O
followed	O
by	O
oscillations	O
or	O
graded	O
spikes	O
that	O
finally	O
gave	O
way	O
to	O
sharply	O
rising	O
spikes	O
.	O

Previous	O
voltage	O
-	O
clamp	O
studies	O
of	O
DLMs	O
have	O
revealed	O
an	O
inward	O
Ca2	O
+	O
current	O
and	O
at	O
least	O
three	O
K+	O
currents	O
:	O
IA	O
and	O
IK	O
,	O
which	O
are	O
voltage	O
-	O
dependent	O
,	O
and	O
IC	O
,	O
which	O
is	O
Ca2	O
+	O
dependent	O
.	O

IA	O
and	O
IC	O
are	O
early	O
inactivating	O
currents	O
,	O
while	O
IK	O
is	O
a	O
slow	O
,	O
noninactivating	O
current	O
.	O

In	O
mature	O
adults	O
,	O
selective	O
elimination	O
of	O
IA	O
either	O
with	O
Shaker	B
(	O
Sh	B
)	O
mutations	O
or	O
with	O
4-aminopyridine	O
(	O
4-AP	O
)	O
,	O
had	O
no	O
effect	O
on	O
spike	O
duration	O
or	O
on	O
the	O
delay	O
in	O
excitation	O
.	O

In	O
contrast	O
,	O
when	O
IC	O
was	O
specifically	O
eliminated	O
with	O
the	O
slowpoke	B
(	O
slo	B
)	O
mutation	O
,	O
there	O
was	O
no	O
delay	O
before	O
excitation	O
,	O
the	O
amplitude	O
of	O
the	O
spikes	O
was	O
significantly	O
increased	O
,	O
and	O
the	O
spike	O
duration	O
was	O
increased	O
by	O
10-fold	O
.	O

Similar	O
results	O
were	O
obtained	O
by	O
reducing	O
IC	O
in	O
normal	O
muscle	O
by	O
intracellular	O
injections	O
of	O
EGTA	O
or	O
by	O
use	O
of	O
low	O
Ca2	O
+	O
saline	O
.	O

Furthermore	O
,	O
DLM	O
spikes	O
evoked	O
in	O
slo	B
by	O
stimulation	O
of	O
the	O
motorneuron	O
were	O
also	O
broadened	O
,	O
suggesting	O
that	O
IC	O
functions	O
in	O
a	O
similar	O
manner	O
during	O
normal	O
flight	O
as	O
in	O
current	O
-	O
clamped	O
muscles	O
.	O

Elimination	O
of	O
IK	O
along	O
with	O
IA	O
and	O
IC	O
in	O
saline	O
containing	O
tetraethylammonium	O
or	O
Ba2	O
+	O
resulted	O
in	O
further	O
prolongation	O
of	O
the	O
DLM	O
spike	O
.	O

In	O
Ba2	O
+	O
saline	O
,	O
there	O
was	O
an	O
additional	O
increase	O
in	O
spike	O
amplitude	O
as	O
well	O
.	O

We	O
conclude	O
that	O
in	O
mature	O
adults	O
,	O
IC	O
,	O
rather	O
than	O
IA	O
,	O
plays	O
the	O
major	O
role	O
in	O
repolarization	O
of	O
DLM	O
spikes	O
and	O
in	O
the	O
delay	O
before	O
excitation.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Light	O
absorption	O
by	O
rhodopsin	B
generates	O
metarhodopsin	O
,	O
which	O
activates	O
heterotrimeric	O
guanine	O
nucleotide	O
-	O
binding	O
proteins	O
(	O
G	O
proteins	O
)	O
in	O
photoreceptor	O
cells	O
of	O
vertebrates	O
and	O
invertebrates	O
.	O

In	O
contrast	O
to	O
vertebrate	O
metarhodopsins	O
,	O
most	O
invertebrate	O
metarhodopsins	O
are	O
thermally	O
stable	O
and	O
regenerate	O
rhodopsin	B
by	O
absorption	O
of	O
a	O
second	O
photon	O
.	O

In	O
experiments	O
with	O
Rh1	B
Drosophila	O
rhodopsin	B
,	O
the	O
thermal	O
stability	O
of	O
metarhodopsin	O
was	O
found	O
not	O
to	O
be	O
an	O
intrinsic	O
property	O
of	O
the	O
visual	O
pigment	O
but	O
a	O
consequence	O
of	O
its	O
interaction	O
with	O
arrestin	B
(	O
49	O
kilodaltons	O
)	O
.	O

The	O
stabilization	O
of	O
metarhodopsin	O
resulted	O
in	O
a	O
large	O
decrease	O
in	O
the	O
efficiency	O
of	O
G	O
protein	O
activation	O
.	O

Light	O
absorption	O
by	O
thermally	O
stable	O
metarhodopsin	O
initially	O
regenerated	O
an	O
inactive	O
rhodopsin	B
-	O
like	O
intermediate	O
,	O
which	O
was	O
subsequently	O
converted	O
in	O
the	O
dark	O
to	O
active	O
rhodopsin	B
.	O

The	O
accumulation	O
of	O
inactive	O
rhodopsin	B
at	O
higher	O
light	O
levels	O
may	O
represent	O
a	O
mechanism	O
for	O
gain	O
regulation	O
in	O
the	O
insect	O
visual	O
cycle	O
.	O

Graf	O
et	O
al.	O
(	O
U.	O
Graf	O
,	O
F.E.	O
Wurgler	O
,	O
A.J.	O
Katz	O
,	O
H.	O
Frei	O
,	O
H.	O
Juon	O
,	O
C.B.	O
Hall	O
,	O
P.G.	O
Kale	O
,	O
Somatic	O
mutation	O
and	O
recombination	O
test	O
in	O
Drosophila	O
,	O
Environment	O
Mutagen	O
.	O

6	O
(	O
1984	O
)	O
153	O
-	O
188	O
.	O
)	O
described	O
the	O
overall	O
results	O
of	O
assays	O
of	O
a	O
series	O
of	O
compounds	O
in	O
the	O
Drosophila	O
wing	O
spot	O
test	O
as	O
indicating	O
that	O
single	O
mwh	B
spots	O
appeared	O
most	O
frequently	O
,	O
followed	O
by	O
less	O
frequent	O
twin	O
spots	O
with	O
both	O
mwh	B
and	O
flr	B
cells	O
and	O
lastly	O
the	O
'	O
quite	O
rare	O
'	O
single	O
flr	B
spots	O
.	O

Data	O
are	O
presented	O
below	O
demonstrating	O
that	O
some	O
compounds	O
behave	O
in	O
a	O
manner	O
consistent	O
with	O
the	O
above	O
description	O
,	O
whereas	O
others	O
do	O
not	O
in	O
that	O
the	O
frequency	O
of	O
single	O
flr	B
spots	O
is	O
equal	O
to	O
or	O
exceeds	O
that	O
of	O
twin	O
spots	O
and	O
can	O
not	O
be	O
described	O
as	O
occurring	O
'	O
rarely	O
'	O
.	O

It	O
is	O
suggested	O
that	O
(	O
large	O
)	O
flr	B
singles	O
be	O
used	O
as	O
a	O
measure	O
of	O
mutations	O
/	O
deletions	O
directly	O
from	O
treated	O
transheterozygotes	O
.	O

An	O
argument	O
is	O
presented	O
questioning	O
the	O
use	O
of	O
treated	O
mwh	B
+	O
/+	O
TM3	O
individuals	O
as	O
an	O
assay	O
of	O
mutations	O
/	O
deletions	O
at	O
the	O
mwh+	B
locus	O
.	O

We	O
have	O
developed	O
a	O
system	O
for	O
temperature	O
-	O
inducible	O
killing	O
of	O
specific	O
cells	O
in	O
the	O
fruitfly	O
Drosophila	O
melanogaster	O
.	O

The	O
system	O
overcomes	O
many	O
of	O
the	O
limitations	O
of	O
existing	O
cell	O
ablation	O
methods	O
and	O
is	O
in	O
principle	O
applicable	O
to	O
any	O
non	O
-	O
homeothermic	O
eukaryote	O
.	O

Temperature	O
-	O
sensitive	O
and	O
cold	O
-	O
sensitive	O
mutations	O
in	O
the	O
ricin	B
toxin	I
A	I
chain	I
(	O
RTA	B
)	O
of	O
castor	O
bean	O
were	O
generated	O
in	O
yeast	O
.	O

One	O
cold	O
-	O
sensitive	O
mutation	O
,	O
RAcs2	O
,	O
produced	O
temperature	O
-	O
dependent	O
ablation	O
of	O
eye	O
cells	O
in	O
Drosophila	O
when	O
expressed	O
under	O
control	O
of	O
the	O
eye	O
-	O
specific	O
sev	B
enhancer	O
.	O

At	O
29	O
degrees	O
C	O
,	O
cell	O
death	O
was	O
observed	O
within	O
7	O
hours	O
in	O
the	O
developing	O
eye	O
and	O
no	O
obvious	O
toxic	O
effects	O
were	O
observed	O
elsewhere	O
;	O
at	O
18	O
degrees	O
C	O
,	O
extremely	O
low	O
toxicity	O
was	O
observed	O
.	O

DNA	O
sequencing	O
of	O
RAcs2	O
revealed	O
a	O
single	O
amino	O
acid	O
substitution	O
in	O
the	O
RTA	B
active	O
site	O
cleft	O
.	O

We	B
have	O
developed	O
a	O
'	O
directed	O
mosaic	O
'	O
system	O
in	O
Drosophila	O
by	O
using	O
the	O
GAL4	B
system	O
to	O
control	O
the	O
expression	O
of	O
the	O
yeast	O
recombinase	O
,	O
FLP	B
,	O
in	O
a	O
spatial	O
and	O
temporal	O
fashion	O
.	O

By	O
directing	O
FLP	B
expression	O
,	O
we	O
show	O
that	O
it	O
is	O
possible	O
to	O
efficiently	O
and	O
specifically	O
target	O
loss	O
-	O
of	O
-	O
function	O
studies	O
for	O
vital	O
loci	O
to	O
the	O
developmental	O
pathway	O
of	O
interest	O
.	O

A	O
simple	O
F1	O
adult	O
phenotypic	O
screen	O
demonstrated	O
that	O
most	O
adult	O
tissues	O
can	O
be	O
analyzed	O
with	O
this	O
approach	O
.	O

Using	O
GAL4	B
lines	O
expressed	O
during	O
oogenesis	O
,	O
we	O
have	O
refined	O
the	O
system	O
to	O
examine	O
the	O
roles	O
of	O
vital	O
loci	O
in	O
the	O
development	O
of	O
the	O
follicular	O
epithelium	O
.	O

We	O
have	O
identified	O
essential	O
genes	O
involved	O
in	O
egg	O
chamber	O
organization	O
,	O
cell	O
migration	O
and	O
cell	O
shape	O
.	O

Further	O
,	O
we	O
have	O
used	O
this	O
technique	O
to	O
gain	O
insights	O
into	O
the	O
role	O
of	O
the	O
Drosophila	O
EGF	O
receptor	O
pathway	O
in	O
establishing	O
the	O
egg	O
axes	O
.	O

Finally	O
,	O
using	O
different	O
UAS	O
-	O
FLP	B
,	O
GAL4	B
and	O
existing	O
FRT	O
lines	O
,	O
we	O
have	O
built	O
stocks	O
that	O
permit	O
the	O
analysis	O
of	O
approximately	O
95	O
%	O
of	O
the	O
genome	O
in	O
follicular	O
mosaics	O
.	O

As	O
mitochondria	O
are	O
inherited	O
in	O
a	O
matrilinear	O
way	O
,	O
an	O
animal	O
hybrid	O
contains	O
the	O
mitochondrial	B
DNA	I
of	O
its	O
'	O
mother	O
species	O
'	O
.	O

Of	O
80	O
studies	O
that	O
analysed	O
the	O
mitochondrial	B
DNA	I
of	O
at	O
least	O
five	O
hybrid	O
individuals	O
,	O
50	O
showed	O
that	O
all	O
hybrids	O
contained	O
the	O
mitochondrial	B
DNA	I
of	O
only	O
one	O
of	O
the	O
two	O
parental	O
species	O
,	O
indicating	O
either	O
mating	O
of	O
females	O
of	O
species	O
A	O
with	O
males	O
of	O
species	O
B	O
but	O
not	O
vice	O
versa	O
(	O
unidirectional	O
hybridization	O
)	O
or	O
the	O
disappearance	O
of	O
one	O
of	O
the	O
two	O
parental	O
mtDNA	B
types	O
after	O
reciprocal	O
hybridization	O
.	O

I	O
review	O
and	O
discuss	O
factors	O
promoting	O
unidirectional	O
or	O
reciprocal	O
hybridization	O
and	O
present	O
a	O
sexual	O
selection	O
hypothesis	O
for	O
unidirectional	O
hybridization	O
.	O

The	O
inequality	O
of	O
the	O
sexes	O
in	O
parental	O
investment	O
leads	O
to	O
the	O
sex	O
that	O
invests	O
more	O
being	O
the	O
more	O
discriminating	O
one	O
.	O

In	O
the	O
presence	O
of	O
conspecific	O
males	O
,	O
females	O
reject	O
allospecific	O
males	O
and	O
,	O
consequently	O
,	O
a	O
male	O
in	O
an	O
environment	O
of	O
both	O
allospecific	O
sexes	O
is	O
unlikely	O
to	O
mate	O
,	O
while	O
in	O
the	O
absence	O
of	O
conspecific	O
males	O
,	O
females	O
sometimes	O
accept	O
fertilizations	O
by	O
males	O
of	O
other	O
species	O
.	O

Thus	O
,	O
hybrid	O
matings	O
are	O
usually	O
between	O
the	O
females	O
of	O
a	O
rare	O
species	O
and	O
the	O
males	O
of	O
a	O
common	O
species	O
,	O
but	O
not	O
vice	O
versa	O
.	O

Copyright	O
1999	O

The	O
Association	O
for	O
the	O
Study	O
of	O
Animal	O
Behaviour	O
.	O

We	O
have	O
cloned	O
embryonic	O
Drosophila	O
DNA	O
using	O
the	O
poly	O
(	O
dA	O
-	O
DT	O
)	O
connector	O
method	O
(	O
Lobban	O
and	O
Kaiser	O
,	O
1973	O
)	O
and	O
the	O
ampicillin	O
-	O
resistant	O
plasmid	O
pSF2124	O
(	O
So	O
,	O
Gill	O
and	O
Falkow	O
,	O
1975	O
)	O
as	O
a	O
cloning	O
vehicle	O
.	O

Two	O
clones	O
,	O
containing	O
hybrid	O
plasmids	O
with	O
sequences	O
complementary	O
to	O
a	O
5S	B
RNA	O
probe	O
isolated	O
from	O
Drosophila	O
tissue	O
culture	O
cells	O
,	O
were	O
identified	O
by	O
the	O
Grunstein	O
and	O
Hogness	O
(	O
1975	O
)	O
colony	O
hybridization	O
procedure	O
.	O

One	O
hybrid	O
plasmid	O
has	O
a	O
Drosophila	O
insert	O
which	O
is	O
comprised	O
solely	O
of	O
tandem	O
repeats	O
of	O
the	O
5S	B
gene	O
plus	O
spacer	O
sequences	O
.	O

The	O
other	O
plasmid	O
contains	O
an	O
insert	O
which	O
has	O
about	O
20	O
tandem	O
5S	B
repeat	O
units	O
plus	O
an	O
additional	O
4	O
kilobases	O
of	O
adjacent	O
sequences	O
.	O

The	O
size	O
of	O
the	O
5S	B
repeat	O
unit	O
was	O
determined	O
by	O
gel	O
electrophoresis	O
and	O
was	O
found	O
to	O
be	O
approximately	O
375	O
base	O
pairs	O
.	O

We	O
present	O
a	O
restriction	O
map	O
of	O
both	O
plasmids	O
,	O
and	O
a	O
detailed	O
map	O
of	O
of	O
the5S	O
repeat	O
unit	O
.	O

The	O
5S	B
repat	O
unit	O
shows	O
slight	O
length	O
and	O
sequence	O
heterogeneity	O
.	O

We	O
present	O
evidence	O
suggesting	O
that	O
the	O
5S	B
genes	O
in	O
Drosophila	O
melanogaster	O
may	O
be	O
arranged	O
in	O
a	O
single	O
continuous	O
cluster	O
.	O

Axons	O
in	O
the	O
bilateral	O
brain	O
of	O
Drosophila	O
decide	O
whether	O
or	O
not	O
to	O
cross	O
the	O
midline	O
before	O
following	O
their	O
specific	O
subsequent	O
pathways	O
.	O

In	O
commissureless	B
mutants	O
,	O
the	O
RP3	O
and	O
V	B
motoneuron	O
axons	O
often	O
fail	O
to	O
cross	O
the	O
midline	O
but	O
subsequently	O
follow	O
the	O
mirror	O
-	O
image	O
pathways	O
and	O
innervate	O
corresponding	O
muscle	O
targets	O
on	O
the	O
ipsilateral	O
side	O
.	O

Conversely	O
,	O
in	O
roundabout	B
mutants	O
,	O
the	O
RP2	O
and	O
aCC	O
motoneuron	O
axons	O
sometimes	O
cross	O
the	O
midline	O
abnormally	O
but	O
their	O
subsequent	O
pathways	O
and	O
synaptic	O
targeting	O
are	O
the	O
perfect	O
mirror	O
images	O
of	O
those	O
seen	O
in	O
wild	O
type	O
.	O

Furthermore	O
,	O
within	O
a	O
single	O
segment	O
of	O
these	O
mutants	O
,	O
bilateral	O
pairs	O
of	O
motoneuron	O
axons	O
can	O
make	O
their	O
midline	O
decisions	O
independently	O
of	O
each	O
other	O
.	O

Thus	O
,	O
neither	O
the	O
growth	O
cones	O
'	O
particular	O
molecular	O
experience	O
nor	O
the	O
decision	O
at	O
the	O
midline	O
caused	O
by	O
these	O
mutations	O
affects	O
their	O
ability	O
to	O
respond	O
normally	O
to	O
subsequently	O
presented	O
cues	O
.	O

In	O
the	O
absence	O
of	O
the	O
Drosophila	O
abl	B
protein	O
-	O
tyrosine	O
kinase	O
(	O
PTK	O
)	O
,	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
in	O
either	O
disabled	B
or	O
prospero	B
have	O
dominant	O
phenotypic	O
effects	O
on	O
embryonic	O
development	O
.	O

Molecular	O
and	O
genetic	O
characterizations	O
indicate	O
that	O
the	O
products	O
of	O
these	O
genes	O
interact	O
with	O
the	O
abl	B
PTK	O
by	O
different	O
mechanisms	O
.	O

The	O
interaction	O
between	O
abl	B
and	O
prospero	B
,	O
which	O
encodes	O
a	O
nuclear	O
protein	O
required	O
for	O
correct	O
axonal	O
outgrowth	O
,	O
is	O
likely	O
to	O
be	O
indirect	O
.	O

In	O
contrast	O
,	O
the	O
product	O
of	O
disabled	B
may	O
be	O
a	O
substrate	O
for	O
the	O
abl	B
PTK	O
.	O

The	O
disabled	B
protein	O
is	O
colocalized	O
with	O
abl	B
in	O
axons	O
,	O
its	O
predicted	O
amino	O
acid	O
sequence	O
contains	O
10	O
motifs	O
similar	O
to	O
the	O
major	O
autophosphorylation	O
site	O
of	O
abl	B
,	O
and	O
the	O
protein	O
is	O
recognized	O
by	O
antibodies	O
to	O
phosphotyrosine	O
.	O

The	O
5	O
'	O
flanking	O
regions	O
of	O
the	O
four	O
small	O
heat	O
shock	O
genes	O
of	O
Drosophila	O
melanogaster	O
from	O
cytological	O
locus	O
67B	O
have	O
been	O
characterized	O
.	O

Approximately	O
500	O
bp	O
of	O
the	O
primary	O
sequence	O
upstream	O
from	O
the	O
proposed	O
site	O
of	O
initiation	O
of	O
translation	O
has	O
been	O
determined	O
and	O
the	O
5	O
'	O
end	O
of	O
the	O
messenger	O
RNAs	O
have	O
been	O
localized	O
for	O
each	O
gene	O
.	O

Each	O
of	O
the	O
four	O
genes	O
contains	O
an	O
A	O
-	O
T	O
rich	O
sequence	O
,	O
either	O
TATAAATA	O
or	O
TATAAAAG	O
,	O
which	O
is	O
flanked	O
by	O
a	O
G	O
-	O
C	O
rich	O
region	O
.	O

This	O
A	O
-	O
T	O
rich	O
sequence	O
,	O
which	O
ends	O
about	O
23	B
bp	O
upstream	O
from	O
the	O
proposed	O
site	O
of	O
initiation	O
of	O
transcription	O
,	O
is	O
similar	O
to	O
those	O
found	O
in	O
most	O
eukaryotic	O
genes	O
.	O

Novel	O
features	O
of	O
these	O
four	O
genes	O
include	O
a	O
region	O
of	O
homology	O
beginning	O
near	O
the	O
proposed	O
site	O
of	O
initiation	O
of	O
transcription	O
and	O
extending	O
about	O
20	O
bp	O
into	O
the	O
5	O
'	O
noncoding	O
region	O
of	O
the	O
genes	O
.	O

This	O
sequence	O
is	O
also	O
found	O
in	O
the	O
gene	O
for	O
the	O
major	O
heat	O
shock	O
protein	O
,	O
hsp	B
70	I
.	O

The	O
leaders	O
of	O
these	O
five	O
heat	O
shock	O
genes	O
are	O
long	O
,	O
from	O
111	O
to	O
253	O
bases	O
in	O
length	O
,	O
as	O
well	O
as	O
unusually	O
A	O
rich	O
,	O
from	O
46	O
%	O
to	O
51	O
%	O
A.	O
In	O
addition	O
,	O
each	O
of	O
the	O
four	O
small	O
genes	O
contains	O
the	O
sequence	O
ACTTTNA	O
,	O
195	O
+	O
/-	O

12	O
bp	O
from	O
the	O
proposed	O
site	O
of	O
initiation	O
of	O
transcription	O
.	O

Maintenance	O
of	O
the	O
""""	O
on	O
-	O
off	O
""""	O
state	O
of	O
Drosophila	O
homeotic	O
genes	O
in	O
Antennapedia	B
and	O
bithorax	B
complexes	O
requires	O
activities	O
of	O
the	O
trithorax	B
and	O
Polycomb	B
groups	O
of	O
genes	O
.	O

To	O
identify	O
cis	O
-	O
acting	O
sequences	O
for	O
functional	O
reconstruction	O
of	O
regulation	O
by	O
both	O
trithorax	B
and	O
Polycomb	B
,	O
we	O
examined	O
the	O
expression	O
patterns	O
of	O
several	O
Ubx	B
-	O
lacZ	B
transgenes	O
that	O
carry	O
upstream	O
fragments	O
corresponding	O
to	O
a	O
region	O
of	O
approximately	O
50	O
kb	O
.	O

A	O
14.5-kb	O
fragment	O
from	O
the	O
postbithorax	B
/	O
bithoraxoid	B
region	O
of	O
Ultrabithorax	B
exhibited	O
proper	O
regulation	O
by	O
both	O
trithorax	B
and	O
Polycomb	B
in	O
the	O
embryonic	O
central	O
nervous	O
system	O
.	O

Using	O
a	O
Drosophila	O
haploid	O
cell	O
line	O
for	O
transient	O
expression	O
,	O
we	O
found	O
that	O
trithorax	B
or	O
Polycomb	B
can	O
function	O
independently	O
through	O
this	O
upstream	O
fragment	O
to	O
activate	O
or	O
repress	O
the	O
Ultrabithorax	B
promoter	O
,	O
respectively	O
.	O

Studies	O
of	O
deletion	O
mutants	O
of	O
trithorax	B
and	O
Polycomb	B
demonstrated	O
that	O
trithorax	B
-	O
dependent	O
activation	O
requires	O
the	O
central	O
zinc	O
-	O
binding	O
domain	O
,	O
while	O
Polycomb	B
-	O
dependent	O
repression	O
requires	O
the	O
intact	O
chromodomain	O
.	O

In	O
addition	O
,	O
trithorax	B
-	O
dependent	O
activity	O
can	O
be	O
abrogated	O
by	O
increasing	O
the	O
amount	O
of	O
Polycomb	B
,	O
suggesting	O
a	O
competitive	O
interaction	O
between	O
the	O
products	O
of	O
trithorax	B
and	O
Polycomb	B
.	O

Deletion	O
analysis	O
of	O
this	O
fragment	O
demonstrated	O
that	O
a	O
440-bp	O
fragment	O
contains	O
response	O
elements	O
for	O
both	O
trithorax	B
and	O
Polycomb	B
.	O

Furthermore	O
,	O
we	O
showed	O
that	O
the	O
integrity	O
of	O
the	O
proximal	O
promoter	O
region	O
is	O
essential	O
for	O
trithorax	B
-	O
dependent	O
activation	O
,	O
implicating	O
a	O
long	O
-	O
range	O
interaction	O
for	O
promoter	O
activation	O
.	O

'	O
In	O
-	O
out	O
'	O
gene	O
targeting	O
using	O
a	O
hypoxanthine	O
phosphoribosyltransferase	O
(	O
HPRT	B
)	O
minigene	O
was	O
applied	O
to	O
generate	O
two	O
new	O
alleles	O
in	O
the	O
gene	O
(	O
Apob	B
)	O
coding	O
for	O
apolipoprotein	B
B	I
(	O
apo	O
B	O
)	O
in	O
murine	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
.	O

Homologous	O
integration	O
of	O
the	O
targeting	O
vector	O
during	O
the	O
'	O
in	O
step	O
'	O
disrupted	O
the	O
Apob	B
gene	O
leading	O
to	O
an	O
allele	O
encoding	O
apo	O
B81	O
,	O
having	O
a	O
19	O
%	O
carboxyl	O
-	O
terminal	O
truncation	O
.	O

All	O
six	O
targeted	O
cells	O
obtained	O
had	O
more	O
than	O
one	O
insert	O
at	O
the	O
locus	O
,	O
and	O
the	O
chromosomal	O
target	O
sequence	O
in	O
four	O
of	O
them	O
was	O
changed	O
during	O
the	O
recombination	O
.	O

These	O
results	O
suggest	O
that	O
concatenation	O
of	O
the	O
targeting	O
vector	O
prior	O
to	O
insertion	O
was	O
needed	O
to	O
generate	O
sufficient	O
gene	O
product	O
to	O
yield	O
the	O
HPRT+	B
phenotype	O
,	O
and	O
that	O
recombination	O
between	O
the	O
concatenated	O
DNA	O
and	O
endogenous	O
DNA	O
was	O
a	O
gene	O
replacement	O
more	O
frequently	O
than	O
a	O
simple	O
insertion	O
.	O

The	O
'	O
out	O
step	O
'	O
recombination	O
event	O
which	O
occurs	O
between	O
sequences	O
duplicated	O
in	O
the	O
'	O
in	O
step	O
'	O
,	O
was	O
planned	O
to	O
replace	O
the	O
sequences	O
encoding	O
the	O
putative	O
LDL	O
receptor	O
-	O
binding	O
domains	O
of	O
apo	O
B100	O
with	O
sequences	O
encoding	O
human	O
beta	O
-	O
globin	O
peptides	O
(	O
designated	O
apo	O
B100-beta	O
)	O
.	O

6-Thioguanine	O
(	O
6-TG	O
)	O
resistant	O
colonies	O
were	O
obtained	O
from	O
all	O
the	O
'	O
in	O
-	O
step	O
'	O
cell	O
lines	O
tested	O
at	O
frequencies	O
of	O
10	O
(	O
-5	O
)	O
to	O
10	O
(	O
-4	O
)	O
,	O
but	O
the	O
frequency	O
of	O
physical	O
loss	O
of	O
the	O
HPRT	B
sequences	O
accompanied	O
by	O
retention	O
of	O
the	O
modified	O
Apob	B
sequence	O
was	O
variable	O
,	O
indicating	O
that	O
mechanisms	O
other	O
than	O
a	O
simple	O
excision	O
are	O
responsible	O
for	O
the	O
generation	O
of	O
6-TG	O
resistance	O
.	O

Mice	O
from	O
the	O
'	O
in	O
-	O
step	O
'	O
produce	O
apo	O
B81	O
and	O
display	O
characteristics	O
of	O
familial	O
hypobetalipoproteinemia	O
;	O
some	O
homozygotes	O
develop	O
hydrocephaly	O
or	O
exencephaly	O
.	O

Mice	O
from	O
the	O
'	O
out	O
-	O
step	O
'	O
produce	O
apo	O
B100-beta	O
and	O
secrete	O
lipoprotein	O
particles	O
containing	O
the	O
modified	O
protein	O
;	O
their	O
phenotypic	O
changes	O
are	O
subtle	O
,	O
suggesting	O
the	O
lack	O
of	O
the	O
putative	O
LDL	O
receptor	O
-	O
binding	O
domains	O
is	O
not	O
sufficient	O
to	O
increase	O
the	O
steady	O
-	O
state	O
level	O
of	O
apo	O
B100-beta	O
particles	O
above	O
that	O
of	O
apo	O
B100	O
particles	O
in	O
control	O
mice	O
.	O

Some	O
cases	O
of	O
Alzheimer	O
's	O
disease	O
are	O
inherited	O
as	O
an	O
autosomal	O
dominant	O
trait	O
.	O

Genetic	O
linkage	O
studies	O
have	O
mapped	O
a	O
locus	O
(	O
AD3	O
)	O
associated	O
with	O
susceptibility	O
to	O
a	O
very	O
aggressive	O
form	O
of	O
Alzheimer	O
's	O
disease	O
to	O
chromosome	O
14q24.3	O
.	O

We	O
have	O
defined	O
a	O
minimal	O
cosegregating	O
region	O
containing	O
the	O
AD3	O
gene	O
,	O
and	O
isolated	O
at	O
least	O
19	O
different	O
transcripts	O
encoded	O
within	O
this	O
region	O
.	O

One	O
of	O
these	O
transcripts	O
(	O
S182	B
)	O
corresponds	O
to	O
a	O
novel	O
gene	O
whose	O
product	O
is	O
predicted	O
to	O
contain	O
multiple	O
transmembrane	O
domains	O
and	O
resembles	O
an	O
integral	O
membrane	O
protein	O
.	O

Five	O
different	O
missense	O
mutations	O
have	O
been	O
found	O
that	O
cosegregate	O
with	O
early	O
-	O
onset	O
familial	O
Alzheimer	O
's	O
disease	O
.	O

Because	O
these	O
changes	O
occurred	O
in	O
conserved	O
domains	O
of	O
this	O
gene	O
,	O
and	O
are	O
not	O
present	O
in	O
normal	O
controls	O
,	O
they	O
are	O
likely	O
to	O
be	O
causative	O
of	O
AD3	O
.	O

The	O
murine	O
major	O
histocompatibility	O
complex	O
I	O
region	O
encodes	O
two	O
class	O
II	O
antigens	O
,	O
I	O
-	O
A	O
and	O
I	O
-	O
E.	O
From	O
a	O
mouse	O
spleen	O
DNA	O
cosmid	O
library	O
of	O
the	O
b	O
haplotype	O
,	O
we	O
isolated	O
a	O
clone	O
containing	O
the	O
entire	O
I	O
-	O
A	B
beta	I
gene	O
and	O
a	O
separate	O
exon	O
encoding	O
a	B
beta	I
-	O
chain	O
second	O
domain	O
(	O
A	B
beta	I
2	O
)	O
.	O

The	O
A	B
beta	I
gene	O
,	O
encompassing	O
more	O
than	O
6	O
kb	O
,	O
is	O
encoded	O
by	O
six	O
exons	O
corresponding	O
to	O
the	O
different	O
domains	O
of	O
the	O
A	B
beta	I
polypeptide	O
.	O

The	O
translated	O
A	B
beta	I
amino	O
acid	O
sequence	O
displays	O
73	O
%	O
homology	O
to	O
human	O
DC	O
beta	O
chains	O
;	O
homologies	O
to	O
other	O
subsets	O
of	O
human	O
beta	O
chains	O
are	O
lower	O
,	O
establishing	O
that	O
I	O
-	O
A	O
corresponds	O
structurally	O
to	O
DC	O
.	O

The	O
A	B
beta	I
2	O
exon	O
is	O
about	O
20	O
kb	O
centromeric	O
to	O
the	O
A	B
beta	I
gene	O
.	O

Its	O
translated	O
amino	O
acid	O
sequence	O
includes	O
all	O
the	O
conserved	O
amino	O
acids	O
of	O
other	O
class	O
II	O
beta	O
-	O
chain	O
second	O
domains	O
.	O

It	O
shows	O
about	O
60	O
%	O
homology	O
to	O
each	O
of	O
three	O
subsets	O
of	O
human	O
beta	O
chains	O
available	O
for	O
comparison	O
,	O
and	O
to	O
the	O
A	B
beta	I
chain	O
.	O

No	O
A	B
beta	I
2	O
first	O
domain	O
exon	O
has	O
been	O
detected	O
with	O
A	B
beta	I
or	O
DC	O
beta	O
probes	O
.	O

A	O
locus	O
for	O
mouse	O
pulmonary	O
adenoma	O
susceptibility	O
,	O
Pas-1	B
,	O
has	O
been	O
mapped	O
on	O
distal	O
chromosome	O
6	O
,	O
where	O
the	O
K	B
-	I
ras	I
gene	O
is	O
located	O
.	O

Allele	O
-	O
specific	O
activation	O
and	O
expression	O
of	O
the	O
K	B
-	I
ras	I
allele	O
from	O
the	O
susceptible	O
parent	O
has	O
been	O
observed	O
in	O
lung	O
tumors	O
from	O
F1	O
hybrid	O
mice	O
.	O

We	O
report	O
here	O
genetic	O
mapping	O
of	O
lung	O
tumor	O
susceptibility	O
genes	O
in	O
urethane	O
-	O
treated	O
A	O
x	B
B	O
and	O
B	O
x	B
A	O
recombinant	O
inbred	O
(	O
RI	O
)	O
mice	O
using	O
microsatellite	O
markers	O
to	O
seek	O
further	O
evidence	O
for	O
the	O
K	B
-	I
ras	I
gene	O
as	O
candidate	O
for	O
Pas-1	B
.	O

The	O
K	B
-	I
ras	I
genotype	O
differs	O
between	O
the	O
A	O
/	O
J	O
and	O
C57BL	O
/	O
6J	O
progenitors	O
of	O
the	O
RI	O
strains	O
,	O
and	O
distal	O
chromosome	O
6	O
contained	O
a	O
major	O
lung	O
tumor	O
susceptibility	O
determinant	O
in	O
the	O
RI	O
mice	O
.	O

Additional	O
evidence	O
that	O
Pas-1	B
is	O
K	B
-	I
ras	I
involved	O
linkage	O
analysis	O
of	O
(	O
A	O
/	O
JOLaHsd	O
x	B
BALB	O
/	O
cOLaHsd	O
)	O
F2	O
intercross	O
mice	O
whose	O
parents	O
shared	O
the	O
same	O
K	B
-	I
ras	I
genotype	O
.	O

In	O
contrast	O
to	O
the	O
results	O
with	O
the	O
A	O
x	B
B	O
and	O
B	O
x	B
A	O
RI	O
strains	O
,	O
no	O
distal	O
chromosome	O
6	O
site	O
was	O
significantly	O
associated	O
with	O
tumor	O
development	O
in	O
these	O
F2	O
mice	O
.	O

In	O
addition	O
to	O
this	O
major	O
locus	O
,	O
linkage	O
analysis	O
of	O
the	O
RI	O
mice	O
revealed	O
additional	O
quantitative	O
trait	O
loci	O
for	O
susceptibility	O
on	O
chromosomes	O
10	O
,	O
17	O
,	O
and	O
19	O
.	O

These	O
loci	O
may	O
serve	O
as	O
modifiers	O
of	O
Pas-1	B
.	O

The	O
relationship	O
between	O
the	O
K	B
-	I
ras	I
genotype	O
and	O
the	O
frequency	O
of	O
K	B
-	I
ras	I
mutations	O
in	O
urethane	O
-	O
induced	O
lung	O
tumors	O
from	O
the	O
RI	O
mice	O
was	O
also	O
explored	O
.	O

All	O
18	O
tumor	O
DNAs	O
from	O
RI	O
mice	O
with	O
high	O
susceptibility	O
contained	O
an	O
AT-->TA	O
transversion	O
at	O
the	O
second	O
base	O
of	O
K	B
-	I
ras	I
codon	O
61	O
.	O

This	O
was	O
also	O
true	O
for	O
DNAs	O
from	O
27	O
of	O
27	O
(	O
100	O
%	O
)	O
tumors	O
in	O
mice	O
with	O
high	O
intermediate	O
susceptibility	O
.	O

In	O
RI	O
strains	O
with	O
a	O
low	O
intermediate	O
susceptibility	O
,	O
the	O
DNA	O
from	O
39	O
of	O
47	O
(	O
83	O
%	O
)	O
tumors	O
contained	O
an	O
AT-->TA	O
transversion	O
at	O
codon	O
61	O
,	O
and	O
only	O
13	O
of	O
21	O
(	O
62	O
%	O
)	O
tumors	O
had	O
this	O
mutation	O
in	O
the	O
most	O
resistant	O
group	O
.	O

This	O
reflects	O
a	O
positive	O
correlation	O
between	O
the	O
frequency	O
of	O
K	B
-	I
ras	I
mutations	O
in	O
lung	O
tumors	O
of	O
A	O
x	B
B	O
or	O
B	O
x	B
A	O
RI	O
strains	O
and	O
their	O
susceptibility	O
to	O
lung	O
carcinogenesis	O
.	O

Since	O
K	B
-	I
ras	I
appears	O
to	O
be	O
Pas-1	B
,	O
these	O
results	O
suggest	O
that	O
some	O
RI	O
mice	O
that	O
have	O
the	O
resistant	O
K	B
-	I
ras	I
or	O
Pas-1	B
allele	O
undergo	O
tumor	O
development	O
by	O
a	O
K	B
-	I
ras	I
-	O
independent	O
route	O
.	O

Growth	B
hormone	I
(	O
GH	B
)	O
is	O
important	O
for	O
skeletal	O
growth	O
as	O
well	O
as	O
for	O
a	O
normal	O
bone	O
metabolism	O
in	O
adults	O
.	O

The	O
skeletal	O
growth	O
and	O
adult	O
bone	O
metabolism	O
was	O
studied	O
in	O
mice	O
with	O
an	O
inactivated	O
growth	B
hormone	I
receptor	I
(	O
GHR	B
)	O
gene	O
.	O

The	O
lengths	O
of	O
femur	O
,	O
tibia	O
,	O
and	O
crown	O
-	O
rump	O
were	O
,	O
as	O
expected	O
,	O
decreased	O
in	O
GHR-	B
/	O
-	O
mice	O
.	O

Unexpectedly	O
,	O
GHR-	B
/	O
-	O
mice	O
displayed	O
disproportional	O
skeletal	O
growth	O
reflected	O
by	O
decreased	O
femur	O
/	O
crown	O
-	O
rump	O
and	O
femur	O
/	O
tibia	O
ratios	O
.	O

GHR-	B
/	O
-	O
mice	O
demonstrated	O
decreased	O
width	O
of	O
the	O
growth	O
plates	O
in	O
the	O
long	O
bones	O
and	O
disturbed	O
ossification	O
of	O
the	O
proximal	O
tibial	O
epiphysis	O
.	O

Furthermore	O
,	O
the	O
area	O
bone	O
mineral	O
density	O
(	O
BMD	O
)	O
as	O
well	O
as	O
the	O
bone	O
mineral	O
content	O
(	O
BMC	O
)	O
/	O
body	O
weight	O
were	O
markedly	O
decreased	O
in	O
GHR-	B
/	O
-	O
mice	O
.	O

The	O
decrease	O
in	O
BMC	O
in	O
GHR-	B
/	O
-	O
mice	O
was	O
not	O
due	O
to	O
decreased	O
trabecular	O
volumetric	O
BMD	O
but	O
to	O
a	O
decreased	O
cross	O
-	O
sectional	O
cortical	O
bone	O
area	O
In	O
conclusion	O
,	O
GHR-	B
/	O
-	O
mice	O
demonstrate	O
disproportional	O
skeletal	O
growth	O
and	O
markedly	O
decreased	O
bone	O
mineral	O
content	O
.	O

The	O
common	B
cytokine	I
receptor	I
gamma	I
chain	I
(	O
gamma	B
(	I
c	I
)	I
)	O
is	O
an	O
indispensable	O
subunit	O
for	O
the	O
formation	O
of	O
lymphoid	O
-	O
related	O
cytokine	O
receptors	O
,	O
including	O
IL-7	O
and	O
IL-15	O
receptors	O
,	O
that	O
mediate	O
nonredundant	O
or	O
critical	O
signals	O
for	O
the	O
differentiation	O
of	O
T	O
and	O
B	O
cells	O
and	O
natural	O
killer	O
(	O
NK	O
)	O
cells	O
,	O
respectively	O
.	O

We	O
introduced	O
the	O
bcl-2	B
transgene	O
driven	O
by	O
E	O
mu	O
or	O
H-2	O
K	O
promoters	O
into	O
gamma	B
(	I
c	I
)	I
-deficient	O
mice	O
that	O
lack	O
all	O
three	O
lymphoid	O
subclasses	O
.	O

The	O
forced	O
expression	O
of	O
Bcl-2	B
restored	O
all	O
stages	O
of	O
T	O
lymphopoiesis	O
,	O
but	O
not	O
B	O
or	O
NK	O
cell	O
development	O
,	O
indicating	O
that	O
a	O
primary	O
function	O
of	O
gamma	B
(	I
c	I
)	I
-mediated	O
signals	O
in	O
the	O
T	O
lineage	O
might	O
be	O
to	O
maintain	O
cell	O
survival	O
.	O

Therefore	O
,	O
the	O
development	O
of	O
T	O
,	O
B	O
,	O
and	O
NK	O
cells	O
may	O
be	O
influenced	O
by	O
distinct	O
intracytoplasmic	O
signaling	O
cascades	O
that	O
are	O
activated	O
by	O
coupling	O
of	O
gamma	B
(	I
c	I
)	I
-related	O
receptors	O
.	O

Retroviral	O
insertional	O
mutagenesis	O
has	O
been	O
proposed	O
as	O
an	O
efficient	O
mechanism	O
to	O
turn	O
on	O
or	O
to	O
increase	O
the	O
expression	O
of	O
oncogenes	O
in	O
several	O
avian	O
or	O
mammal	O
models	O
.	O

Integration	O
site	O
studies	O
of	O
avian	O
leukosis	O
virus	O
,	O
murine	O
leukaemia	O
and	O
murine	O
mammary	O
tumour	O
viruses	O
led	O
to	O
the	O
coleutification	O
of	O
highly	O
conserved	O
genes	O
whose	O
expression	O
is	O
induced	O
or	O
increased	O
during	O
leukaemogenesis	O
,	O
probably	O
through	O
enhancer	O
elements	O
present	O
in	O
the	O
retroviral	O
long	O
terminal	O
repeats	O
.	O

This	O
is	O
reminiscent	O
of	O
the	O
activation	O
of	O
cellular	O
proto	O
-	O
oncogenes	O
or	O
putative	O
oncogenes	O
in	O
numerous	O
human	O
tumours	O
and	O
leukaemias	O
as	O
a	O
result	O
of	O
chromosomal	O
translocations	O
or	O
DNA	O
rearrangements	O
.	O

Here	O
we	O
report	O
the	O
characterization	O
of	O
a	O
new	O
putative	O
oncogene	O
isolated	O
from	O
a	O
murine	O
erythroleukaemia	O
induced	O
by	O
the	O
acute	O
leukaemogenic	O
retrovirus	O
spleen	O
focus	O
forming	O
virus	O
(	O
SFFV	O
)	O
.	O

An	O
important	O
and	O
unusual	O
feature	O
of	O
this	O
genomic	O
locus	O
Spi-1	B
(	O
for	O
SFFV	O
proviral	O
integration	O
)	O
is	O
that	O
rearrangements	O
due	O
to	O
SFFV	O
integration	O
were	O
found	O
in	O
95	O
%	O
of	O
the	O
erythroid	O
tumours	O
studied	O
.	O

A	O
4.0-kilobase	O
messenger	O
RNA	O
was	O
detected	O
in	O
rearranged	O
tumours	O
.	O

No	O
Spi-1	B
rearrangement	O
was	O
detected	O
in	O
other	O
virally	O
induced	O
myeloid	O
,	O
lymphoid	O
or	O
erythroid	O
tumours	O
tested	O
.	O

Embryonic	O
mice	O
lacking	O
functional	O
Sox4	B
transcription	O
factor	O
die	O
from	O
cardiac	O
failure	O
at	O
embryonic	O
day	O
(	O
ED	O
)	O
14	O
.	O

Heart	O
morphogenesis	O
in	O
these	O
embryos	O
was	O
analyzed	O
in	O
hematoxylin	O
-	O
azophlochsin	O
or	O
immunohistochemically	O
stained	O
,	O
3-dimensionally	O
reconstructed	O
serial	O
sections	O
between	O
ED12	O
and	O
ED14	O
.	O

Although	O
Sox4	B
is	O
expressed	O
in	O
the	O
endocardially	O
derived	O
tissue	O
of	O
both	O
the	O
outflow	O
tract	O
and	O
atrioventricular	O
canal	O
,	O
Sox4-deficient	B
hearts	O
only	O
suffer	O
from	O
defective	O
transformation	O
of	O
the	O
endocardial	O
ridges	O
into	O
semilunar	O
valves	O
and	O
from	O
lack	O
of	O
fusion	O
of	O
these	O
ridges	O
,	O
usually	O
resulting	O
in	O
common	O
trunk	O
,	O
although	O
the	O
least	O
affected	O
hearts	O
should	O
be	O
classified	O
as	O
having	O
a	O
large	O
infundibular	O
septal	O
defect	O
.	O

The	O
more	O
serious	O
cases	O
are	O
,	O
in	O
addition	O
,	O
characterized	O
by	O
an	O
abnormal	O
number	O
and	O
position	O
of	O
the	O
semilunar	O
valve	O
-	O
leaflet	O
anlagen	O
,	O
a	O
configuration	O
of	O
the	O
ridges	O
typical	O
for	O
transposition	O
of	O
the	O
great	O
arteries	O
(	O
with	O
linear	O
rather	O
than	O
spiral	O
course	O
of	O
both	O
ridges	O
and	O
posterior	O
position	O
of	O
the	O
pulmonary	O
trunk	O
at	O
the	O
level	O
of	O
the	O
valve	O
)	O
,	O
and	O
variable	O
size	O
of	O
the	O
aorta	O
relative	O
to	O
the	O
pulmonary	O
trunk	O
.	O

The	O
coronary	O
arteries	O
always	O
originated	O
from	O
the	O
aorta	O
,	O
irrespective	O
of	O
its	O
position	O
relative	O
to	O
the	O
pulmonary	O
trunk	O
.	O

The	O
restriction	O
of	O
the	O
malformations	O
to	O
the	O
arterial	O
pole	O
implies	O
that	O
the	O
interaction	O
between	O
the	O
endocardially	O
derived	O
tissue	O
of	O
the	O
outflow	O
tract	O
and	O
the	O
neural	O
crest	O
-	O
derived	O
myofibroblasts	O
determines	O
proper	O
development	O
of	O
the	O
arterial	O
pole	O
.	O

Atherosclerosis	O
is	O
a	O
complex	O
disease	O
resulting	O
from	O
the	O
interaction	O
of	O
multiple	O
genes	O
.	O

We	O
have	O
used	O
the	O
Ldlr	B
knockout	O
mouse	O
model	O
in	O
an	O
interspecific	O
genetic	O
cross	O
to	O
map	O
atherosclerosis	O
susceptibility	O
loci	O
.	O

A	O
total	O
of	O
174	O
(	O
MOLF	O
/	O
Ei	O
x	O
B6.129S7-Ldlr	O
(	B
tm1Her	I
)	I
)	O
x	O
C57BL	O
/	O
6J	O
-	O
Ldlr	B
(	I
tm1Her	I
)	I
backcross	O
mice	O
,	O
homozygous	O
for	O
the	O
Ldlr	B
null	O
allele	O
,	O
were	O
fed	O
a	O
Western	O
-	O
type	O
diet	O
for	O
3	O
months	O
and	O
then	O
killed	O
for	O
quantification	O
of	O
aortic	O
lesions	O
.	O

A	O
genome	O
scan	O
was	O
carried	O
out	O
by	O
using	O
DNA	O
pools	O
and	O
microsatellite	O
markers	O
spaced	O
at	O
approximately	O
18-centimorgan	O
intervals	O
.	O

Quantitative	O
trait	O
locus	O
analysis	O
of	O
individual	O
backcross	O
mice	O
confirmed	O
linkages	O
to	O
chromosomes	O
4	O
(	O
Athsq1	B
,	O
logarithm	O
of	O
odds	O
=	O
6.2	O
)	O
and	O
6	O
(	O
Athsq2	B
,	O
logarithm	O
of	O
odds	O
=	O
6.7	O
)	O
.	O

Athsq1	B
affected	O
lesions	O
in	O
females	O
only	O
whereas	O
Athsq2	B
affected	O
both	O
sexes	O
.	O

Among	O
females	O
,	O
the	O
loci	O
accounted	O
for	O
approximately	O
50	O
%	O
of	O
the	O
total	O
variance	O
of	O
lesion	O
area	O
.	O

The	O
susceptible	O
allele	O
at	O
Athsq1	B
was	O
derived	O
from	O
the	O
MOLF	O
/	O
Ei	O
genome	O
whereas	O
the	O
susceptible	O
allele	O
at	O
Athsq2	B
was	O
derived	O
from	O
C57BL	O
/	O
6J	O
.	O

Inheritance	O
of	O
susceptible	O
alleles	O
at	O
both	O
loci	O
conferred	O
a	O
2-fold	O
difference	O
in	O
lesion	O
area	O
,	O
suggesting	O
an	O
additive	O
effect	O
of	O
Athsq1	B
and	O
Athsq2	B
.	O

No	O
associations	O
were	O
observed	O
between	O
the	O
quantitative	O
trait	O
loci	O
and	O
levels	O
of	O
plasma	O
total	O
cholesterol	O
,	O
high	O
density	O
lipoprotein	O
cholesterol	O
,	O
non	O
-	O
high	O
density	O
lipoprotein	O
cholesterol	O
,	O
insulin	O
,	O
or	O
body	O
weight	O
.	O

We	O
provide	O
strong	O
evidence	O
for	O
complex	O
inheritance	O
of	O
atherosclerosis	O
in	O
mice	O
with	O
elevated	O
plasma	O
low	O
density	O
lipoprotein	O
cholesterol	O
and	O
show	O
a	O
major	O
influence	O
of	O
nonlipoprotein	O
-	O
related	O
factors	O
on	O
disease	O
susceptibility	O
.	O

Athsq1	B
and	O
Athsq2	B
represent	O
candidate	O
susceptibility	O
loci	O
for	O
human	O
atherosclerosis	O
,	O
most	O
likely	O
residing	O
on	O
chromosomes	O
1p36	O
-	O
-32	O
and	O
12p13	O
-	O
-12	O
,	O
respectively	O
.	O

The	O
organization	O
of	O
chromatin	O
into	O
higher	O
-	O
order	O
structures	O
influences	O
chromosome	O
function	O
and	O
epigenetic	O
gene	O
regulation	O
.	O

Higher	O
-	O
order	O
chromatin	O
has	O
been	O
proposed	O
to	O
be	O
nucleated	O
by	O
the	O
covalent	O
modification	O
of	O
histone	O
tails	O
and	O
the	O
subsequent	O
establishment	O
of	O
chromosomal	O
subdomains	O
by	O
non	O
-	O
histone	O
modifier	O
factors	O
.	O

Here	O
we	O
show	O
that	O
human	O
SUV39H1	B
and	O
murine	O
Suv39h1	B
-	O
-mammalian	O
homologues	O
of	O
Drosophila	O
Su	O
(	O
var	O
)	O
3	O
-	O
9	O
and	O
of	O
Schizosaccharomyces	O
pombe	O
clr4	O
-	O
-encode	O
histone	O
H3-specific	O
methyltransferases	O
that	O
selectively	O
methylate	O
lysine	O
9	O
of	O
the	O
amino	O
terminus	O
of	O
histone	O
H3	O
in	O
vitro	O
.	O

We	O
mapped	O
the	O
catalytic	O
motif	O
to	O
the	O
evolutionarily	O
conserved	O
SET	O
domain	O
,	O
which	O
requires	O
adjacent	O
cysteine	O
-	O
rich	O
regions	O
to	O
confer	O
histone	O
methyltransferase	O
activity	O
.	O

Methylation	O
of	O
lysine	O
9	O
interferes	O
with	O
phosphorylation	O
of	O
serine	O
10	O
,	O
but	O
is	O
also	O
influenced	O
by	O
pre	O
-	O
existing	O
modifications	O
in	O
the	O
amino	O
terminus	O
of	O
H3	O
.	O

In	O
vivo	O
,	O
deregulated	O
SUV39H1	B
or	O
disrupted	O
Suv39h	O
activity	O
modulate	O
H3	O
serine	O
10	O
phosphorylation	O
in	O
native	O
chromatin	O
and	O
induce	O
aberrant	O
mitotic	O
divisions	O
.	O

Our	O
data	O
reveal	O
a	O
functional	O
interdependence	O
of	O
site	O
-	O
specific	O
H3	O
tail	O
modifications	O
and	O
suggest	O
a	O
dynamic	O
mechanism	O
for	O
the	O
regulation	O
of	O
higher	O
-	O
order	O
chromatin	O
.	O

Potassium	O
channels	O
play	O
important	O
roles	O
in	O
shaping	O
the	O
electrical	O
properties	O
of	O
excitable	O
cells	O
.	O

Toward	O
understanding	O
the	O
transcriptional	O
regulation	O
of	O
a	O
member	O
of	O
the	O
inwardly	O
rectifying	O
potassium	O
channel	O
family	O
,	O
we	O
have	O
characterized	O
the	O
genomic	O
structure	O
and	O
5'-proximal	O
promoter	O
of	O
the	O
murine	O
Kcnj2	B
gene	O
(	O
also	O
referred	O
to	O
as	O
IRK1	B
and	O
Kir2.1	B
)	O
.	O

The	O
Kcnj2	B
transcription	O
unit	O
is	O
composed	O
of	O
two	O
exons	O
separated	O
by	O
a	O
5.5-kilobase	O
pair	O
intron	O
.	O

Deletion	O
analysis	O
of	O
5'-flanking	O
sequences	O
identified	O
a	O
promiscuously	O
active	O
172-base	O
pair	O
minimal	O
promoter	O
,	O
whereas	O
expression	O
from	O
a	O
construct	O
containing	O
additional	O
upstream	O
sequences	O
was	O
cell	O
type	O
-	O
restricted	O
.	O

The	O
minimal	O
promoter	O
contained	O
an	O
E	O
box	O
,	O
a	O
Y	B
box	O
,	O
and	O
three	O
GC	O
box	O
consensus	O
elements	O
but	O
lacked	O
both	O
TATA	O
and	O
CCAAT	O
box	O
elements	O
.	O

The	O
activity	O
of	O
the	O
minimal	O
promoter	O
was	O
found	O
to	O
be	O
controlled	O
by	O
a	O
combination	O
of	O
the	O
activities	O
of	O
the	O
transcription	O
factors	O
Sp1	B
,	O
Sp3	B
,	O
and	O
NF	O
-	O
Y.	B
The	O
interplay	O
between	O
Sp1	B
,	O
Sp3	B
,	O
and	O
NF	O
-	O
Y	B
within	O
the	O
architecture	O
of	O
the	O
Kcnj2	B
promoter	O
,	O
the	O
ubiquitous	O
nature	O
of	O
these	O
trans	O
-	O
acting	O
factors	O
,	O
and	O
the	O
action	O
of	O
tissue	O
-	O
selective	O
repressor	O
element	O
(	O
s	O
)	O
may	O
combine	O
to	O
enable	O
a	O
wide	O
variety	O
of	O
cell	O
types	O
to	O
differentially	O
regulate	O
Kcnj2	B
expression	O
through	O
transcriptional	O
control	O
.	O

Introduction	O
of	O
the	O
normal	O
retinoblastoma	O
gene	O
(	O
RB	B
)	O
into	O
different	O
tumor	O
cells	O
possessing	O
inactivated	O
RB	B
genes	O
suppresses	O
their	O
tumorigenicity	O
in	O
nude	O
mice	O
.	O

These	O
results	O
suggest	O
that	O
RB	B
replacement	O
is	O
a	O
potential	O
strategy	O
for	O
developing	O
future	O
clinical	O
treatments	O
of	O
cancer	O
.	O

In	O
a	O
transgenic	O
mouse	O
model	O
,	O
we	O
found	O
that	O
the	O
quantity	O
of	O
RB	B
protein	O
in	O
a	O
given	O
cell	O
may	O
play	O
an	O
important	O
role	O
in	O
dictating	O
its	O
effect	O
.	O

Four	O
founder	O
mice	O
containing	O
1	O
-	O
7	O
copies	O
of	O
a	O
human	O
RB	B
cDNA	O
transgene	O
under	O
the	O
transcriptional	O
control	O
of	O
the	O
human	O
RB	B
promoter	O
were	O
generated	O
.	O

Most	O
of	O
the	O
transgenic	O
mice	O
were	O
smaller	O
than	O
nontransgenic	O
littermates	O
.	O

This	O
effect	O
was	O
found	O
as	O
early	O
as	O
embryonic	O
day	O
15	O
.	O

The	O
degree	O
of	O
dwarfism	O
correlated	O
roughly	O
with	O
the	O
copy	O
number	O
of	O
the	O
transgene	O
and	O
the	O
corresponding	O
level	O
of	O
RB	B
protein	O
.	O

The	O
expression	O
pattern	O
of	O
the	O
transgene	O
products	O
was	O
similar	O
to	O
that	O
of	O
the	O
endogenous	O
mouse	O
RB	B
gene	O
with	O
regard	O
to	O
tissue	O
and	O
temporal	O
distribution	O
.	O

Transferring	O
the	O
transgene	O
to	O
RB	B
deficient	O
mice	O
,	O
which	O
are	O
nonviable	O
,	O
resulted	O
in	O
the	O
development	O
of	O
normal	O
,	O
healthy	O
mice	O
,	O
indicating	O
that	O
the	O
human	O
RB	B
gene	O
can	O
functionally	O
complement	O
the	O
mouse	O
homolog	O
.	O

These	O
studies	O
demonstrate	O
that	O
the	O
effect	O
of	O
RB	B
on	O
overall	O
mouse	O
development	O
is	O
closely	O
dependent	O
upon	O
its	O
dosage	O
.	O

An	O
N	O
-	O
ethyl	O
-	O
N	O
-	O
nitrosourea	O
(	O
ENU	O
)	O
-induced	O
mutation	O
in	O
the	O
Hbb	B
-	I
b1	I
gene	O
of	O
the	O
mouse	O
hemoglobin	O
-	O
beta	O
complex	O
(	O
Hbb	B
)	O
has	O
been	O
shown	O
to	O
result	O
in	O
a	O
high	O
-	O
oxygen	O
affinity	O
hemoglobin	O
,	O
homologous	O
with	O
hemoglobin	O
Rainier	O
in	O
man	O
(	O
Peters	O
,	O
J.	O
,	O
et	O
al.	O
,	O
Genetics	O
110:709	O
,	O
1985	O
)	O
.	O

Substitution	O
of	O
beta	O
145	O
tyrosine	O
by	O
cysteine	O
had	O
occurred	O
in	O
both	O
human	O
and	O
mouse	O
forms	O
,	O
probably	O
as	O
the	O
result	O
of	O
a	O
point	O
mutation	O
.	O

Provided	O
that	O
sufficient	O
sequence	O
information	O
is	O
available	O
,	O
point	O
mutations	O
can	O
be	O
directly	O
and	O
rapidly	O
analyzed	O
by	O
allele	O
-	O
specific	O
amplification	O
(	O
ASA	O
)	O
,	O
as	O
this	O
technique	O
is	O
sensitive	O
enough	O
to	O
detect	O
single	O
nucleotide	O
differences	O
.	O

We	O
report	O
the	O
use	O
of	O
ASA	O
to	O
detect	O
and	O
characterize	O
the	O
mutation	O
in	O
the	O
murine	O
beta	O
-	O
globin	O
gene	O
,	O
Hbb	B
-	O
b1d	O
-	O
m1	O
,	O
and	O
find	O
that	O
the	O
codon	O
for	O
beta	O
145	O
tyrosine	O
(	O
TAC	O
)	O
has	O
been	O
replaced	O
by	O
the	O
codon	O
for	O
cysteine	O
(	O
TGC	O
)	O
.	O

Therefore	O
,	O
ENU	O
induced	O
an	O
A	O
:	O
T----G	O
:	O
C	O
transition	O
.	O

SUMMARY	O
:	O
Decay	O
-	O
accelerating	O
factor	O
(	O
DAF	O
or	O
CD55	B
)	O
is	O
one	O
of	O
a	O
set	O
of	O
regulators	O
that	O
function	O
to	O
protect	O
self	O
cells	O
from	O
deposition	O
of	O
autologous	O
C3b	O
on	O
their	O
surfaces	O
.	O

Its	O
relative	O
importance	O
in	O
vivo	O
,	O
however	O
,	O
is	O
incompletely	O
understood	O
.	O

As	O
one	O
approach	O
to	O
address	O
this	O
issue	O
,	O
we	O
induced	O
nephrotoxic	O
serum	O
(	O
NTS	O
)	O
nephritis	O
in	O
wild	O
-	O
type	O
mice	O
and	O
Daf1	B
gene	O
-	O
floxed	O
mice	O
devoid	O
of	O
renal	O
DAF	O
expression	O
.	O

For	O
these	O
experiments	O
NTS	O
IgG	O
was	O
administered	O
at	O
a	O
dose	O
(	O
0.5	O
mg	O
iv	O
)	O
that	O
requires	O
complement	O
for	O
glomerular	O
injury	O
.	O

After	O
18	O
hours	O
,	O
renal	O
injury	O
was	O
assessed	O
by	O
proteinuria	O
and	O
by	O
histologic	O
,	O
immunohistochemical	O
,	O
and	O
electron	O
microscopic	O
analyses	O
of	O
kidneys	O
.	O

Fifteen	O
normal	O
and	O
15	O
DAF	O
-	O
deficient	O
mice	O
were	O
studied	O
.	O

Baseline	O
albuminuria	O
in	O
the	O
Daf1	B
(	I
-	I
/	I
-	I
)	I
mice	O
was	O
115.9	O
+	O
/-	O

41.4	O
microg	O
/	O
mg	O
creatinine	O
as	O
compared	O
with	O
85.7	O
+	O
/-	O

32.3	O
microg	O
/	O
mg	O
creatinine	O
in	O
their	O
Daf1	B
(	I
+	I
/	I
+	I
)	I
littermates	O
(	O
p	O
=	O
0.075	O
)	O
.	O

After	O
administration	O
of	O
NTS	O
IgG	O
,	O
albuminuria	O
increased	O
to	O
2001.7	O
+	O
/-	O

688.7	O
microg	O
/	O
mg	O
creatinine	O
as	O
compared	O
with	O
799.7	O
+	O
/-	O

340.5	O
microg	O
/	O
mg	O
creatinine	O
in	O
the	O
controls	O
(	O
p	O
=	O
0.0003	O
)	O
.	O

Glomerular	O
histology	O
was	O
similar	O
in	O
Daf1	B
(	I
-	I
/	I
-	I
)	I
and	O
Daf1	B
(	I
+	I
/	I
+	I
)	I
mice	O
,	O
with	O
essentially	O
no	O
infiltrating	O
leukocytes	O
.	O

In	O
contrast	O
,	O
electron	O
microscopy	O
revealed	O
severe	O
podocyte	O
fusion	O
in	O
the	O
Daf1	B
(	I
-	I
/	I
-	I
)	I
mice	O
but	O
only	O
mild	O
focal	O
changes	O
in	O
the	O
controls	O
.	O

Immunohistochemical	O
staining	O
showed	O
equivalent	O
deposition	O
of	O
the	O
administered	O
(	O
sheep	O
)	O
NTS	O
IgG	O
in	O
the	O
Daf1	B
(	I
-	I
/	I
-	I
)	I
and	O
Daf1	B
(	I
+	I
/	I
+	I
)	I
animals	O
.	O

This	O
contrasted	O
with	O
marked	O
deposition	O
of	O
autologous	O
murine	O
C3	O
in	O
the	O
former	O
and	O
minimal	O
deposition	O
in	O
the	O
latter	O
.	O

The	O
results	O
show	O
that	O
DAF	O
is	O
essential	O
physiologically	O
for	O
protecting	O
glomeruli	O
against	O
autologous	O
complement	O
attack	O
initiated	O
by	O
the	O
classical	O
pathway	O
.	O

A	O
mouse	O
homologue	O
of	O
the	O
Saccharomyces	O
cerevisiae	O
Pcd1p	O
coenzyme	O
A	O
diphosphatase	O
,	O
NUDT7alpha	O
,	O
has	O
been	O
expressed	O
as	O
a	O
thioredoxin	O
fusion	O
protein	O
in	O
Escherichia	O
coli	O
.	O

NUDT7alpha	O
is	O
also	O
a	O
CoA	O
diphosphatase	O
of	O
the	O
nudix	O
hydrolase	O
family	O
,	O
and	O
hydrolyses	O
CoA	O
,	O
CoA	O
esters	O
and	O
oxidized	O
CoA	O
with	O
similar	O
efficiences	O
,	O
yielding	O
3',5'-ADP	O
and	O
the	O
corresponding	O
4'-phosphopantetheine	O
derivative	O
as	O
products	O
.	O

K	O
(	O
m	O
)	O
and	O
k	O
(	O
cat	O
)	O
values	O
with	O
CoA	O
were	O
240	O
microM	O
and	O
3.8	O
s	O
(	O
-1	O
)	O
.	O

Activity	O
was	O
optimal	O
at	O
pH	O
8.0	O
with	O
5	O
mM	O
Mg	O
(	O
2	O
+	O
)	O
or	O
Mn	O
(	O
2	O
+	O
)	O
ions	O
,	O
while	O
fluoride	O
was	O
inhibitory	O
with	O
an	O
IC	O
(	O
50	O
)	O
value	O
of	O
20	O
microM.	O
Expression	O
of	O
the	O
Nudt7	B
gene	O
was	O
highest	O
in	O
liver	O
,	O
intermediate	O
in	O
lung	O
and	O
kidney	O
,	O
and	O
lowest	O
in	O
brain	O
and	O
heart	O
,	O
producing	O
a	O
1.5	O
kb	O
transcript	O
.	O

A	O
similar	O
pattern	O
of	O
expression	O
was	O
found	O
for	O
the	O
human	O
orthologue	O
,	O
NUDT7	B
.	O

An	O
enzymically	O
inactive	O
splice	O
variant	O
,	O
NUDT7beta	O
,	O
which	O
lacks	O
20	O
amino	O
acids	O
downstream	O
of	O
the	O
nudix	O
motif	O
,	O
was	O
also	O
found	O
to	O
be	O
expressed	O
in	O
mouse	O
tissues	O
.	O

Transfection	O
of	O
HeLa	O
cells	O
with	O
a	O
vector	O
expressing	O
the	O
Nudt7alpha	O
gene	O
fused	O
to	O
the	O
C	O
-	O
terminus	O
of	O
red	O
fluorescent	O
protein	O
showed	O
that	O
NUDT7alpha	O
,	O
like	O
Pcd1p	O
,	O
was	O
a	O
peroxisomal	O
enzyme	O
.	O

The	O
function	O
of	O
the	O
NUDT7	B
enzyme	O
may	O
be	O
the	O
elimination	O
of	O
oxidized	O
CoA	O
from	O
peroxisomes	O
,	O
or	O
the	O
regulation	O
of	O
CoA	O
and	O
acyl	O
-	O
CoA	O
levels	O
in	O
this	O
organelle	O
in	O
response	O
to	O
metabolic	O
demand	O
.	O

By	O
analysis	O
of	O
cDNA	O
clones	O
that	O
cross	O
-	O
hybridized	O
with	O
a	O
portion	O
of	O
the	O
cDNA	O
encoding	O
the	O
recently	O
described	O
rat	O
protein	O
hepatocyte	O
nuclear	O
factor	O
3	O
alpha	O
(	O
HNF-3	O
alpha	O
,	O
previously	O
called	O
HNF-3A	B
)	O
,	O
we	O
now	O
describe	O
two	O
additional	O
members	O
,	O
HNF-3	O
beta	O
and	O
HNF-3	O
gamma	O
,	O
of	O
this	O
gene	O
family	O
.	O

A	O
110-amino	O
-	O
acid	O
region	O
in	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
this	O
family	O
is	O
not	O
only	O
very	O
highly	O
conserved	O
in	O
rodents	O
(	O
HNF-3	O
alpha	O
,	O
-3	O
beta	O
,	O
and	O
-3	O
gamma	O
are	O
identical	O
in	O
93	O
of	O
110	O
amino	O
acids	O
in	O
this	O
region	O
)	O
but	O
also	O
in	O
Drosophila	O
where	O
the	O
homeotic	O
gene	O
fork	O
head	O
has	O
88	O
of	O
the	O
93	O
residues	O
that	O
are	O
identical	O
in	O
the	O
three	O
rat	O
genes	O
.	O

The	O
HNF-3	O
family	O
in	O
rodents	O
is	O
expressed	O
in	O
cells	O
that	O
derive	O
from	O
the	O
lining	O
of	O
the	O
primitive	O
gut	O
;	O
some	O
of	O
the	O
embryonic	O
Drosophila	O
cells	O
in	O
which	O
fork	O
head	O
is	O
expressed	O
also	O
give	O
rise	O
to	O
gut	O
and	O
salivary	O
glands	O
.	O

Thus	O
,	O
it	O
appears	O
that	O
this	O
gene	O
family	O
,	O
the	O
DNA	O
-	O
binding	O
portion	O
of	O
which	O
is	O
unlike	O
that	O
of	O
any	O
previously	O
recognized	O
DNA	O
-	O
binding	O
proteins	O
,	O
may	O
contribute	O
to	O
differentiation	O
of	O
cells	O
in	O
internal	O
organs	O
in	O
both	O
vertebrates	O
and	O
invertebrates	O
.	O

As	O
in	O
other	O
infectious	O
diseases	O
,	O
the	O
outcome	O
of	O
a	O
Leishmania	O
major	O
infection	O
is	O
closely	O
tied	O
to	O
the	O
T	O
helper	O
cell	O
response	O
type	O
;	O
progressive	O
disease	O
is	O
associated	O
with	O
a	O
predominant	O
Th2	O
lymphocyte	O
response	O
,	O
healing	O
with	O
a	O
Th1	O
response	O
.	O

In	O
mice	O
,	O
susceptibility	O
is	O
genetically	O
con	O
trolled	O
,	O
with	O
BALB	O
/	O
c	O
(	O
C	O
)	O
mice	O
being	O
susceptible	O
and	O
C57BL	O
/	O
6	O
(	O
B	O
)	O
mice	O
being	O
resistant	O
.	O

Using	O
a	O
genome	O
-	O
wide	O
scan	O
on	O
two	O
large	O
populations	O
of	O
F2	O
mice	O
created	O
from	O
these	O
strains	O
,	O
we	O
have	O
shown	O
previously	O
that	O
susceptibility	O
to	O
infection	O
with	O
L.	O
major	O
is	O
controlled	O
by	O
two	O
autosomal	O
loci	O
:	O
lmr1	B
at	O
the	O
H2	B
locus	O
,	O
and	O
lmr2	B
on	O
chromosome	O
9	O
.	O

Employing	O
a	O
strategy	O
to	O
identify	O
loci	O
that	O
interact	O
,	O
we	O
show	O
here	O
that	O
lmr1	B
and	O
lmr2	B
interact	O
synergistically	O
,	O
and	O
we	O
describe	O
a	O
new	O
locus	O
lmr3	B
,	O
lying	O
on	O
the	O
X	B
chromosome	O
,	O
whose	O
effect	O
depends	O
on	O
a	O
specific	O
lmr1	B
haplotype	O
.	O

Cellular	O
stress	O
,	O
particularly	O
in	O
response	O
to	O
toxic	O
and	O
metabolic	O
insults	O
that	O
perturb	O
function	O
of	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
stress	O
)	O
,	O
is	O
a	O
powerful	O
inducer	O
of	O
the	O
transcription	O
factor	O
CHOP	B
.	O

The	O
role	O
of	O
CHOP	B
in	O
the	O
response	O
of	O
cells	O
to	O
injury	O
associated	O
with	O
ER	O
stress	O
was	O
examined	O
in	O
a	O
murine	O
deficiency	O
model	O
obtained	O
by	O
homologous	O
recombination	O
at	O
the	O
chop	B
gene	O
.	O

Compared	O
with	O
the	O
wild	O
type	O
,	O
mouse	O
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
derived	O
from	O
chop	B
-	O
/	O
-	O
animals	O
exhibited	O
significantly	O
less	O
programmed	O
cell	O
death	O
when	O
challenged	O
with	O
agents	O
that	O
perturb	O
ER	O
function	O
.	O

A	O
similar	O
deficit	O
in	O
programmed	O
cells	O
death	O
in	O
response	O
to	O
ER	O
stress	O
was	O
also	O
observed	O
in	O
MEFs	O
that	O
lack	O
CHOP	B
's	O
major	O
dimerization	O
partner	O
,	O
C	O
/	O
EBPbeta	O
,	O
implicating	O
the	O
CHOP	B
-	O
C	O
/	O
EBP	O
pathway	O
in	O
programmed	O
cell	O
death	O
.	O

An	O
animal	O
model	O
for	O
studying	O
the	O
effects	O
of	O
chop	B
on	O
the	O
response	O
to	O
ER	O
stress	O
was	O
developed	O
.	O

It	O
entailed	O
exposing	O
mice	O
with	O
defined	O
chop	B
genotypes	O
to	O
a	O
single	O
sublethal	O
intraperitoneal	O
injection	O
of	O
tunicamycin	O
and	O
resulted	O
in	O
a	O
severe	O
illness	O
characterized	O
by	O
transient	O
renal	O
insufficiency	O
.	O

In	O
chop	B
+	O
/+	O
and	O
chop	B
+	O
/-	O

mice	O
this	O
was	O
associated	O
with	O
the	O
early	O
expression	O
of	O
CHOP	B
in	O
the	O
proximal	O
tubules	O
followed	O
by	O
the	O
development	O
of	O
a	O
histological	O
picture	O
similar	O
to	O
the	O
human	O
condition	O
known	O
as	O
acute	O
tubular	O
necrosis	O
,	O
a	O
process	O
that	O
resolved	O
by	O
cellular	O
regeneration	O
.	O

In	O
the	O
chop	B
-	O
/	O
-	O
animals	O
,	O
in	O
spite	O
of	O
the	O
severe	O
impairment	O
in	O
renal	O
function	O
,	O
evidence	O
of	O
cellular	O
death	O
in	O
the	O
kidney	O
was	O
reduced	O
compared	O
with	O
the	O
wild	O
type	O
.	O

The	O
proximal	O
tubule	O
epithelium	O
of	O
chop	B
-	O
/	O
-	O
animals	O
exhibited	O
fourfold	O
lower	O
levels	O
of	O
TUNEL	O
-	O
positive	O
cells	O
(	O
a	O
marker	O
for	O
programmed	O
cell	O
death	O
)	O
,	O
and	O
significantly	O
less	O
evidence	O
for	O
subsequent	O
regeneration	O
.	O

CHOP	B
therefore	O
has	O
a	O
role	O
in	O
the	O
induction	O
of	O
cell	O
death	O
under	O
conditions	O
associated	O
with	O
malfunction	O
of	O
the	O
ER	O
and	O
may	O
also	O
have	O
a	O
role	O
in	O
cellular	O
regeneration	O
under	O
such	O
circumstances	O
.	O

The	O
granulomatous	O
inflammation	O
in	O
infection	O
with	O
the	O
helminth	O
Schistosoma	O
mansoni	O
represents	O
a	O
cellular	O
hypersensitivity	O
reaction	O
mediated	O
by	O
,	O
and	O
dependent	O
upon	O
,	O
MHC	O
class	O
II	O
-	O
restricted	O
CD4	O
+	O
Th	O
cells	O
sensitized	O
to	O
parasite	O
egg	O
Ags	O
.	O

The	O
current	O
work	O
examines	O
the	O
role	O
and	O
significance	O
of	O
the	O
B7	O
:	O
CD28	O
/	O
CTLA-4	O
pathway	O
in	O
providing	O
the	O
costimulation	O
necessary	O
for	O
the	O
activation	O
of	O
these	O
pathogenic	O
T	O
cells	O
.	O

In	O
vitro	O
T	O
cell	O
responses	O
in	O
B7	B
-	I
1-	I
/	O
-	O
mice	O
,	O
7	O
-	O
8	O
wk	O
postinfection	O
,	O
were	O
no	O
different	O
from	O
wild	O
-	O
type	O
controls	O
,	O
but	O
the	O
absence	O
of	O
B7	B
-	I
2	I
molecules	O
resulted	O
in	O
a	O
decrease	O
in	O
egg	O
Ag	O
-	O
induced	O
proliferation	O
with	O
increased	O
IFN	B
-	I
gamma	I
production	O
.	O

Both	O
B7	B
-	I
1-	I
/	O
-	O
and	O
B7	B
-	I
2-	I
/	O
-	O
mice	O
exhibited	O
intact	O
granuloma	O
formation	O
.	O

In	O
contrast	O
,	O
CD4	O
+	O
Th	O
cells	O
from	O
B7	B
-	I
1	I
/	O
2	O
double	O
-	O
deficient	O
mice	O
displayed	O
a	O
dramatic	O
loss	O
of	O
proliferative	O
capacity	O
upon	O
stimulation	O
with	O
egg	O
Ag	O
.	O

Most	O
strikingly	O
,	O
these	O
T	O
cells	O
secreted	O
only	O
IFN	B
-	I
gamma	I
,	O
but	O
not	O
IL-4	B
and	O
IL-10	B
,	O
a	O
pattern	O
entirely	O
opposite	O
to	O
that	O
displayed	O
by	O
wild	O
-	O
type	O
controls	O
.	O

Despite	O
these	O
major	O
differences	O
in	O
T	O
cell	O
reactivity	O
,	O
B7	B
-	I
1	I
/	O
2-	O
/	O
-	O
mice	O
had	O
only	O
a	O
limited	O
reduction	O
of	O
granuloma	O
size	O
and	O
fibrosis	O
,	O
without	O
appreciable	O
difference	O
in	O
cellular	O
composition	O
.	O

These	O
results	O
show	O
that	O
substantial	O
granuloma	O
formation	O
can	O
occur	O
under	O
conditions	O
of	O
limited	O
T	O
cell	O
expansion	O
and	O
restricted	O
Th1-type	O
cytokine	O
production	O
.	O

They	O
also	O
support	O
the	O
notion	O
that	O
the	O
combined	O
effect	O
of	O
B7	O
signaling	O
is	O
not	O
as	O
critical	O
for	O
Th1	O
cell	O
activation	O
as	O
it	O
is	O
for	O
the	O
development	O
of	O
the	O
Th2	O
dominant	O
environment	O
characteristic	O
of	O
the	O
evolving	O
schistosome	O
infection	O
in	O
H-2b	O
mice	O
.	O

Activation	O
of	O
the	O
high	O
affinity	O
IgE	O
receptor	O
(	O
Fc	O
epsilon	O
RI	O
)	O
of	O
mast	O
cells	O
,	O
a	O
member	O
of	O
the	O
antigen	O
receptor	O
family	O
,	O
leads	O
to	O
the	O
release	O
of	O
allergic	O
mediators	O
,	O
a	O
critical	O
event	O
in	O
the	O
onset	O
of	O
immediate	O
hypersensitivity	O
.	O

Stimulation	O
of	O
Fc	O
epsilon	O
RI	O
results	O
in	O
the	O
rapid	O
association	O
and	O
activation	O
of	O
the	O
Syk	B
tyrosine	O
kinase	O
.	O

Using	O
Syk	B
-	O
deficient	O
mast	O
cells	O
we	O
show	O
that	O
they	O
fail	O
to	O
degranulate	O
,	O
synthesize	O
leukotrienes	O
and	O
secrete	O
cytokines	O
when	O
stimulated	O
through	O
Fc	O
epsilon	O
RI	O
,	O
conclusively	O
demonstrating	O
an	O
essential	O
role	O
for	O
Syk	B
in	O
Fc	O
epsilon	O
RI	O
signalling	O
.	O

Furthermore	O
,	O
our	O
data	O
strongly	O
supports	O
a	O
model	O
of	O
Fc	O
epsilon	O
RI	O
engagement	O
leading	O
to	O
the	O
sequential	O
activation	O
of	O
the	O
tyrosine	O
kinases	O
Lyn	O
and	O
then	O
Syk	B
.	O

A	O
similar	O
mechanism	O
is	O
likely	O
to	O
apply	O
to	O
signal	O
transduction	O
through	O
all	O
members	O
of	O
the	O
antigen	O
receptor	O
family	O
.	O

Exogenous	O
regulation	O
of	O
protein	O
expression	O
creates	O
the	O
potential	O
to	O
examine	O
the	O
consequences	O
of	O
homeostatic	O
Dysregulation	O
in	O
many	O
physiological	O
systems	O
and	O
,	O
when	O
used	O
in	O
transgenic	O
mice	O
,	O
provides	O
the	O
capability	O
of	O
restoring	O
a	O
gene	O
product	O
to	O
its	O
knockout	O
background	O
without	O
antigenicity	O
issues	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
a	O
mifeprisone	O
-	O
inducible	O
system	O
(	O
the	O
GeneSwitch	O
system	O
)	O
to	O
regulate	O
the	O
expression	O
of	O
inhibin	O
A	O
from	O
the	O
liver	O
of	O
mice	O
.	O

Inhibin	O
is	O
a	O
heterodimeric	O
protein	O
(	O
alpha	O
/	O
beta	O
)	O
wherein	O
one	O
of	O
its	O
subunits	O
(	O
beta	O
)	O
is	O
capable	O
of	O
homodimerizing	O
to	O
form	O
its	O
physiological	O
antagonist	O
,	O
activin	B
(	O
beta	O
/	O
beta	O
)	O
.	O

Inhibin	O
is	O
also	O
expressed	O
in	O
two	O
forms	O
,	O
A	O
and	O
B	O
,	O
as	O
determined	O
by	O
the	O
subtype	O
of	O
beta	O
-	O
subunit	O
that	O
dimerizes	O
with	O
the	O
alpha	O
-	O
subunit	O
(	O
alpha	O
/	O
betaA	O
or	O
alpha	O
/	O
betaB	O
)	O
.	O

To	O
utilize	O
the	O
GeneSwitch	O
system	O
,	O
transgenic	O
transactivator	O
mice	O
with	O
liver	O
-	O
specific	O
expression	O
of	O
a	O
mifepristone	O
-	O
activated	O
chimeric	O
nuclear	O
receptor	O
(	O
GLVP	O
)	O
were	O
crossed	O
with	O
transgenic	O
target	O
mice	O
containing	O
a	O
GVLP	O
-	O
responsive	O
promoter	O
upstream	O
of	O
polio	O
-	O
virus	O
IRES	O
(	O
internal	O
ribosome	O
entry	O
site	O
)	O
-linked	O
sequences	O
coding	O
for	O
the	O
alpha-	O
and	O
beta	O
-	O
subunits	O
of	O
inhibin	O
A.	O
This	O
intercross	O
produced	O
""""	O
bigenic	O
""""	O
mice	O
capable	O
of	O
regulable	O
expression	O
of	O
inhibin	O
A	O
from	O
the	O
liver	O
.	O

Overexpression	O
of	O
inhibin	O
A	O
in	O
wild	O
-	O
type	O
mice	O
produced	O
a	O
phenotype	O
wherein	O
males	O
had	O
decreased	O
testis	O
size	O
and	O
females	O
had	O
a	O
block	O
in	O
folliculogenesis	O
at	O
the	O
early	O
antral	O
stage	O
,	O
findings	O
similar	O
to	O
activin	B
type	O
IIA	O
receptor	O
(	O
ActRIIA	B
)	O
null	O
mice	O
.	O

These	O
phenotypes	O
were	O
most	O
likely	O
due	O
to	O
suppressed	O
serum	O
FSH	O
,	O
confirming	O
that	O
the	O
liver	O
-	O
derived	O
inhibin	O
A	O
was	O
secreted	O
into	O
the	O
serum	O
to	O
down	O
-	O
regulate	O
pituitary	O
FSH	O
levels	O
.	O

Furthermore	O
,	O
the	O
generation	O
of	O
bigenic	O
mice	O
in	O
the	O
inhibin	B
alpha	I
null	O
background	O
allowed	O
for	O
the	O
induction	O
of	O
inhibin	O
A	O
in	O
inhibin	B
alpha	I
null	O
male	O
mice	O
with	O
subsequent	O
rescue	O
of	O
these	O
mice	O
from	O
their	O
gonadal	O
tumor	O
-	O
induced	O
lethal	O
phenotype	O
.	O

This	O
work	O
demonstrates	O
the	O
in	O
vivo	O
production	O
of	O
a	O
heterodimeric	O
hormone	O
from	O
a	O
single	O
inducible	O
promoter	O
to	O
study	O
its	O
therapeutic	O
and	O
physiological	O
effects	O
.	O

In	O
addition	O
,	O
these	O
studies	O
are	O
the	O
first	O
example	O
of	O
an	O
inducible	O
system	O
being	O
used	O
to	O
prevent	O
a	O
lethal	O
knockout	O
phenotype	O
in	O
an	O
animal	O
model	O
.	O

An	O
enzyme	O
,	O
8-oxo-7,8-dihydrodeoxyguanosine	O
triphosphatase	O
(	O
8-oxo	O
-	O
dGTPase	O
)	O
,	O
is	O
present	O
in	O
various	O
organisms	O
and	O
plays	O
an	O
important	O
role	O
in	O
the	O
control	O
of	O
spontaneous	O
mutagenesis	O
.	O

The	O
enzyme	O
hydrolyzes	O
8-oxo	O
-	O
dGTP	O
,	O
an	O
oxidized	O
form	O
of	O
dGTP	O
,	O
to	O
8-oxo	O
-	O
dGMP	O
,	O
thereby	O
preventing	O
the	O
occurrence	O
of	O
A	O
:	O
T	O
to	O
C	O
:	O
G	O
transversion	O
,	O
caused	O
by	O
misincorporation	O
.	O

We	O
isolated	O
the	O
mouse	O
genomic	O
sequence	O
encoding	O
the	O
enzyme	O
and	O
elucidated	O
its	O
structure	O
.	O

The	O
gene	O
,	O
named	O
MTH1	B
for	O
mutT	O
homologue	O
1	O
,	O
is	O
composed	O
of	O
at	O
least	O
five	O
exons	O
and	O
spans	O
approximately	O
9	O
kilobase	O
pairs	O
.	O

A	O
genomic	O
region	O
containing	O
the	O
pseudogene	O
was	O
also	O
isolated	O
.	O

The	O
promoter	O
region	O
for	O
the	O
gene	O
is	O
GC	O
-	O
rich	O
,	O
contains	O
many	O
AP-1	O
and	O
AP-2	O
recognition	O
sequences	O
,	O
and	O
lacks	O
a	O
typical	O
TATA	O
box	O
.	O

Primer	O
extension	O
and	O
S1	O
mapping	O
analyses	O
revealed	O
the	O
existence	O
of	O
multiple	O
transcription	O
initiation	O
sites	O
,	O
among	O
which	O
a	O
major	O
site	O
was	O
defined	O
as	O
+	O
1	O
.	O

The	O
putative	O
promoter	O
region	O
was	O
placed	O
upstream	O
of	O
the	O
chloramphenicol	O
acetyltransferase	O
reporter	O
gene	O
,	O
and	O
control	O
of	O
expression	O
of	O
the	O
gene	O
was	O
examined	O
by	O
introducing	O
the	O
construct	O
into	O
mouse	O
NIH	O
3T3	O
cells	O
.	O

Deletion	O
analysis	O
indicated	O
that	O
a	O
sequence	O
from	O
-321	O
to	O
+	O
9	O
carries	O
the	O
basic	O
promoter	O
activity	O
while	O
an	O
adjacent	O
region	O
,	O
spanning	O
from	O
+	O
352	O
to	O
+	O
525	O
stimulates	O
the	O
frequency	O
of	O
transcription	O
.	O

A	O
number	O
of	O
properties	O
of	O
the	O
cancer	O
-	O
related	O
genes	O
c	B
-	I
myc	I
and	O
p53	B
suggest	O
that	O
they	O
might	O
collaborate	O
to	O
induce	O
tumorigenesis	O
.	O

To	O
test	O
this	O
notion	O
,	O
we	O
produced	O
doubly	O
heterozygotic	O
mice	O
bearing	O
disrupted	O
p53	B
alleles	O
and	O
a	O
fusion	O
transgene	O
consisting	O
of	O
the	O
mouse	O
mammary	O
tumor	O
virus	O
(	O
MMTV	O
)	O
LTR	O
and	O
the	O
oncogene	O
c	B
-	I
myc	I
.	O

Mice	O
bearing	O
both	O
the	O
MMT	O
/	O
c	B
-	I
myc	I
transgene	O
and	O
a	O
single	O
p53-	B
allele	O
develop	O
very	O
aggressive	O
pre	O
-	O
T-	O
and	O
T	O
-	O
cell	O
lymphomas	O
with	O
a	O
significantly	O
shorter	O
latency	O
than	O
mice	O
carrying	O
either	O
the	O
p53-	B
allele	O
or	O
the	O
c	B
-	I
myc	I
transgene	O
alone	O
.	O

Moreover	O
,	O
every	O
lymphoma	O
occurring	O
in	O
these	O
animals	O
has	O
lost	O
or	O
suffers	O
an	O
inactivation	O
of	O
its	O
wild	O
type	O
p53	B
allele	O
indicating	O
that	O
loss	O
of	O
p53	B
activity	O
is	O
necessary	O
for	O
this	O
c	B
-	I
myc	I
-	O
accelerated	O
lymphomagenesis	O
.	O

Nonetheless	O
,	O
p53	B
inactivation	O
and	O
expression	O
of	O
the	O
MMTV	O
/	O
c	B
-	I
myc	I
transgene	O
are	O
not	O
sufficient	O
for	O
lymphoid	O
transformation	O
.	O

Tumors	O
that	O
arise	O
in	O
homozygous	O
p53-	B
mice	O
carrying	O
the	O
c	B
-	I
myc	I
transgene	O
are	O
monoclonal	O
,	O
suggesting	O
that	O
at	O
least	O
one	O
additional	O
event	O
is	O
necessary	O
for	O
their	O
transformation	O
.	O

Moreover	O
,	O
since	O
mice	O
bearing	O
only	O
the	O
MMTV	O
/	O
c	B
-	I
myc	I
transgene	O
predominantly	O
develop	O
mammary	O
carcinomas	O
,	O
it	O
was	O
surprising	O
that	O
the	O
p53-	B
allele	O
failed	O
to	O
accelerate	O
the	O
incidence	O
of	O
mammary	O
carcinomas	O
.	O

Further	O
,	O
in	O
contrast	O
to	O
the	O
lymphomas	O
,	O
only	O
one	O
in	O
four	O
mammary	O
tumors	O
that	O
arose	O
in	O
the	O
double	O
heterozygotic	O
mice	O
had	O
lost	O
its	O
wild	O
type	O
p53	B
allele	O
.	O

Apparently	O
cell	O
context	O
influences	O
the	O
ability	O
of	O
c	B
-	I
myc	I
and	O
p53-	B
to	O
cooperate	O
in	O
inducing	O
oncogenesis	O
.	O

N	O
-	O
Linked	O
glycosylation	O
is	O
a	O
post	O
-	O
translational	O
modification	O
occurring	O
in	O
many	O
eukaryotic	O
secreted	O
and	O
surface	O
-	O
bound	O
proteins	O
and	O
has	O
impact	O
on	O
diverse	O
physiological	O
and	O
pathological	O
processes	O
.	O

Similarly	O
important	O
is	O
the	O
generation	O
of	O
glycosylphosphatidylinositol	O
linkers	O
,	O
which	O
anchor	O
membrane	O
proteins	O
to	O
the	O
cell	O
.	O

Both	O
protein	O
modifications	O
depend	O
on	O
the	O
central	O
nucleotide	O
sugar	O
UDP	O
-	O
N	O
-	O
acetylglucosamine	O
(	O
UDP	O
-	O
GlcNAc	O
)	O
.	O

The	O
enzymatic	O
reactions	O
leading	O
to	O
generation	O
of	O
nucleotide	O
sugars	O
are	O
established	O
,	O
yet	O
most	O
of	O
the	O
respective	O
genes	O
still	O
await	O
cloning	O
.	O

We	O
describe	O
the	O
characterization	O
of	O
such	O
a	O
gene	O
,	O
EMeg32	B
,	O
which	O
we	O
identified	O
based	O
on	O
its	O
differential	O
expression	O
in	O
murine	O
hematopoietic	O
precursor	O
cells	O
.	O

We	O
further	O
demonstrate	O
regulated	O
expression	O
during	O
embryogenesis	O
.	O

EMeg32	B
codes	O
for	O
a	O
184-amino	O
acid	O
protein	O
exhibiting	O
glucosamine-6-phosphate	O
acetyltransferase	O
activity	O
.	O

It	O
thereby	O
holds	O
a	O
key	O
position	O
in	O
the	O
pathway	O
toward	O
de	O
novo	O
UDP	O
-	O
GlcNAc	O
synthesis	O
.	O

Surprisingly	O
,	O
the	O
protein	O
associates	O
with	O
the	O
cytoplasmic	O
side	O
of	O
various	O
intracellular	O
membranes	O
,	O
accumulates	O
prior	O
to	O
mitosis	O
,	O
and	O
copurifies	O
with	O
the	O
cdc48	B
homolog	O
p97	B
/	O
valosin	O
-	O
containing	O
protein	O
.	O

BACKGROUND	O
:	O
The	O
human	O
maspin	B
gene	O
encodes	O
a	O
protein	O
in	O
the	O
serine	O
proteinase	O
inhibitor	O
(	O
serpin	O
)	O
family	O
with	O
tumor	O
-	O
suppressing	O
functions	O
in	O
cell	O
culture	O
and	O
in	O
nude	O
mice	O
.	O

In	O
order	O
to	O
examine	O
the	O
role	O
of	O
maspin	B
in	O
an	O
intact	O
mammal	O
,	O
we	O
cloned	O
and	O
sequenced	O
the	O
cDNA	O
of	O
mouse	O
maspin	B
.	O

The	O
recombinant	O
protein	O
was	O
produced	O
and	O
its	O
activity	O
in	O
cell	O
culture	O
was	O
assessed	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
Mouse	O
maspin	B
(	O
mMaspin	O
)	O
was	O
cloned	O
by	O
screening	O
a	O
mouse	O
mammary	O
gland	O
cDNA	O
library	O
with	O
the	O
human	O
maspin	B
cDNA	O
probe	O
.	O

Northern	O
blot	O
analysis	O
was	O
used	O
to	O
examine	O
the	O
expression	O
patterns	O
in	O
mouse	O
tissues	O
,	O
mammary	O
epithelial	O
cells	O
,	O
and	O
carcinomas	O
.	O

Recombinant	O
mMaspin	O
protein	O
was	O
produced	O
in	O
E.	O
coli	O
.	O

Invasion	O
and	O
motility	O
assays	O
were	O
used	O
to	O
assess	O
the	O
biological	O
function	O
of	O
mMaspin	O
.	O

RESULTS	O
:	O
mMaspin	O
is	O
89	O
%	O
homologous	O
with	O
human	O
maspin	B
at	O
the	O
amino	O
acid	O
level	O
.	O

Like	O
its	O
human	O
homolog	O
,	O
mMaspin	O
is	O
expressed	O
in	O
normal	O
mouse	O
mammary	O
epithelial	O
cells	O
and	O
down	O
-	O
regulated	O
in	O
mouse	O
breast	O
tumor	O
cell	O
lines	O
.	O

The	O
expression	O
is	O
altered	O
at	O
different	O
developmental	O
stages	O
in	O
mammary	O
gland	O
.	O

Addition	O
of	O
the	O
recombinant	O
mMaspin	O
protein	O
to	O
mouse	O
tumor	O
cells	O
was	O
shown	O
to	O
inhibit	O
invasion	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

As	O
with	O
the	O
human	O
protein	O
,	O
recombinant	O
mMaspin	O
protein	O
also	O
inhibited	O
mouse	O
mammary	O
tumor	O
motility	O
.	O

Deletion	O
in	O
the	O
putative	O
mMaspin	O
reactive	O
site	O
loop	O
(	O
RSL	O
)	O
region	O
resulted	O
in	O
the	O
loss	O
of	O
its	O
inhibitory	O
functions	O
.	O

CONCLUSIONS	O
:	O
mMaspin	O
is	O
the	O
mouse	O
homolog	O
of	O
a	O
human	O
tumor	O
suppressor	O
gene	O
.	O

The	O
expression	O
of	O
mMaspin	O
is	O
down	O
-	O
regulated	O
in	O
tumor	O
cells	O
and	O
is	O
altered	O
at	O
different	O
developmental	O
stages	O
of	O
mammary	O
gland	O
.	O

mMaspin	O
has	O
inhibitory	O
properties	O
similar	O
to	O
those	O
of	O
human	O
maspin	B
in	O
cell	O
culture	O
,	O
suggesting	O
that	O
the	O
homologous	O
proteins	O
play	O
similar	O
physiological	O
roles	O
in	O
vivo	O
.	O

The	O
3	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
the	O
mouse	O
catalase	B
gene	O
(	O
Cas-1	B
)	O
is	O
demonstrated	O
to	O
be	O
an	O
active	O
site	O
for	O
specific	O
protein	O
interactions	O
.	O

We	O
have	O
identified	O
two	O
regions	O
of	O
the	O
Cas-1	B
3	O
'	O
UTR	O
mRNA	O
that	O
bind	O
to	O
distinct	O
cytoplasmic	O
proteins	O
:	O
one	O
containing	O
a	O
(	O
CA	O
)	O
31	O
repeat	O
with	O
UA	O
octomer	O
(	O
RNA	O
5	O
)	O
and	O
another	O
with	O
a	O
(	O
U	O
)	O
15	O
tract	O
(	O
RNA	O
6	O
)	O
.	O

RNA	O
5	O
interacts	O
with	O
one	O
set	O
of	O
protein	O
complexes	O
(	O
a	O
,	O
b	O
,	O
and	O
c	O
)	O
whereas	O
RNA	O
6	O
interacts	O
with	O
another	O
(	O
x	O
,	O
y	O
,	O
and	O
z	O
)	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
.	O

These	O
RNA	O
-	O
protein	O
complexes	O
are	O
development-	O
,	O
tissue-	O
,	O
and	O
genotype	O
-	O
specific	O
.	O

The	O
proteins	O
involved	O
in	O
the	O
two	O
sets	O
of	O
complexes	O
are	O
different	O
.	O

Further	O
characterization	O
of	O
the	O
proteins	O
involved	O
in	O
these	O
interactions	O
has	O
revealed	O
the	O
presence	O
of	O
a	O
single	O
protein	O
of	O
approximately	O
70	O
kD	O
that	O
binds	O
RNA	O
5	O
,	O
and	O
two	O
proteins	O
approximately	O
38	O
kD	O
and	O
approximately	O
47	O
kD	O
that	O
bind	O
to	O
RNA	O
6	O
.	O

The	O
approximately	O
70-k	O
D	O
and	O
approximately	O
38-kD	O
proteins	O
are	O
also	O
associated	O
with	O
the	O
polysomal	O
fractions	O
and	O
may	O
play	O
a	O
role	O
in	O
the	O
post	O
-	O
transcriptional	O
regulation	O
of	O
Cas-1	B
.	O

Although	O
the	O
observed	O
3	O
'	O
UTR	O
RNA	O
-	O
protein	O
interactions	O
are	O
hypothesized	O
to	O
be	O
important	O
in	O
post	O
-	O
transcriptional	O
regulation	O
of	O
this	O
gene	O
in	O
rodents	O
,	O
specific	O
RNA	O
sequences	O
and	O
their	O
associated	O
proteins	O
identified	O
in	O
this	O
report	O
would	O
now	O
permit	O
the	O
elucidation	O
of	O
the	O
mechanisms	O
of	O
their	O
action	O
at	O
the	O
molecular	O
level	O
.	O

The	O
neurotrophins	O
brain	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	B
)	O
and	O
neurotrophin-4	B
/	O
5	O
(	O
NT4	B
)	O
act	O
via	O
the	O
TrkB	B
receptor	O
and	O
support	O
survival	O
of	O
primary	O
somatic	O
and	O
visceral	O
sensory	O
neurons	O
.	O

The	O
major	O
visceral	O
sensory	O
population	O
,	O
the	O
nodose	O
-	O
petrosal	O
ganglion	O
complex	O
(	O
NPG	O
)	O
,	O
requires	O
BDNF	B
and	O
NT4	B
for	O
survival	O
of	O
a	O
full	O
complement	O
of	O
neurons	O
,	O
providing	O
a	O
unique	O
opportunity	O
to	O
compare	O
gene	O
dosage	O
effects	O
between	O
the	O
two	O
TrkB	B
ligands	O
and	O
to	O
explore	O
the	O
possibility	O
that	O
one	O
ligand	O
can	O
compensate	O
for	O
loss	O
of	O
the	O
other	O
.	O

Analysis	O
of	O
newborn	O
transgenic	O
mice	O
lacking	O
BDNF	B
or	O
NT4	B
,	O
or	O
BDNF	B
and	O
NT4	B
,	O
revealed	O
that	O
survival	O
of	O
many	O
NPG	O
afferents	O
is	O
proportional	O
to	O
the	O
number	O
of	O
functional	O
BDNF	B
alleles	O
,	O
whereas	O
only	O
one	O
functional	O
NT4	B
allele	O
is	O
required	O
to	O
support	O
survival	O
of	O
all	O
NT4-dependent	B
neurons	O
.	O

In	O
addition	O
,	O
subpopulation	O
analysis	O
revealed	O
that	O
BDNF	B
and	O
NT4	B
can	O
compensate	O
for	O
the	O
loss	O
of	O
the	O
other	O
to	O
support	O
a	O
subset	O
of	O
dopaminergic	O
ganglion	O
cells	O
.	O

Together	O
,	O
these	O
data	O
demonstrate	O
that	O
the	O
pattern	O
of	O
neuronal	O
dependencies	O
on	O
BDNF	B
and	O
NT4	B
in	O
vivo	O
is	O
far	O
more	O
heterogeneous	O
than	O
predicted	O
from	O
previous	O
studies	O
in	O
culture	O
.	O

Moreover	O
,	O
BDNF	B
knockout	O
animals	O
lack	O
a	O
subset	O
of	O
afferents	O
involved	O
in	O
ventilatory	O
control	O
and	O
exhibit	O
severe	O
respiratory	O
abnormalities	O
characterized	O
by	O
depressed	O
and	O
irregular	O
breathing	O
and	O
reduced	O
chemosensory	O
drive	O
.	O

BDNF	B
is	O
therefore	O
required	O
for	O
expression	O
of	O
normal	O
respiratory	O
behavior	O
in	O
newborn	O
animals	O
.	O

We	O
previously	O
reported	O
that	O
KIF3A	B
and	O
KIF3B	B
form	O
a	O
heterodimer	O
that	O
functions	O
as	O
a	O
microtubule	O
-	O
based	O
fast	O
anterograde	O
translocator	O
of	O
membranous	O
organelles	O
.	O

We	O
have	O
also	O
shown	O
that	O
this	O
KIF3A	B
/	O
3B	O
forms	O
a	O
complex	O
with	O
other	O
associated	O
polypeptides	O
,	O
named	O
kinesin	O
superfamily	O
-	O
associated	O
protein	O
3	O
(	O
KAP3	B
)	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
purified	O
KAP3	B
protein	O
by	O
immunoprecipitation	O
using	O
anti	O
-	O
KIF3B	B
antibody	O
from	O
mouse	O
testis	O
.	O

Microsequencing	O
was	O
carried	O
out	O
,	O
and	O
we	O
cloned	O
the	O
full	O
-	O
length	O
KAP3	B
cDNA	O
from	O
a	O
mouse	O
brain	O
cDNA	O
library	O
.	O

Two	O
isoforms	O
of	O
KAP3	B
exist	O
[	O
KAP3A	O
(	O
793	O
aa	O
)	O
and	O
KAP3B	O
(	O
772	O
aa	O
)	O
]	O
,	O
generated	O
by	O
alternative	O
splicing	O
in	O
the	O
carboxyl	O
terminus	O
region	O
.	O

Their	O
amino	O
acid	O
sequences	O
have	O
no	O
homology	O
with	O
those	O
of	O
any	O
other	O
known	O
proteins	O
,	O
and	O
prediction	O
of	O
their	O
secondary	O
structure	O
indicated	O
that	O
almost	O
the	O
entire	O
KAP3	B
molecule	O
is	O
alpha	O
-	O
helical	O
.	O

We	O
produced	O
recombinant	O
KAP3	B
and	O
KIF3A	B
/	O
3B	O
using	O
a	O
baculovirus	O
-	O
Sf9	O
expression	O
system	O
.	O

A	O
reconstruction	O
study	O
in	O
Sf9	O
cells	O
revealed	O
that	O
KAP3	B
is	O
a	O
globular	O
protein	O
that	O
binds	O
to	O
the	O
tail	O
domain	O
of	O
KIF3A	B
/	O
3B	O
.	O

The	O
immunolocalization	O
pattern	O
of	O
KAP3	B
was	O
similar	O
to	O
that	O
of	O
KIF3A	B
/	O
3B	O
in	O
nerve	O
cells	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
KAP3	B
does	O
not	O
affect	O
the	O
motor	O
activity	O
of	O
KIF3A	B
/	O
3B	O
.	O

KAP3	B
was	O
associated	O
with	O
a	O
membrane	O
-	O
bound	O
form	O
of	O
KIF3A	B
/	O
3B	O
in	O
a	O
fractional	O
immunoprecipitation	O
experiment	O
,	O
and	O
since	O
the	O
KIF3	B
complex	O
was	O
found	O
to	O
bind	O
to	O
membranous	O
organelles	O
in	O
an	O
EM	O
study	O
,	O
KAP3	B
may	O
regulate	O
membrane	O
binding	O
of	O
the	O
KIF3	B
complex	O
.	O

The	O
Surfeit	O
locus	O
contains	O
the	O
tightest	O
cluster	O
of	O
mammalian	O
genes	O
so	O
far	O
described	O
.	O

The	O
five	O
Surfeit	O
genes	O
(	O
Surf-1	B
to	O
-5	O
)	O
that	O
have	O
been	O
previously	O
isolated	O
and	O
characterized	O
do	O
not	O
share	O
any	O
DNA	O
or	O
amino	O
acid	O
sequence	O
homology	O
.	O

These	O
Surfeit	O
genes	O
appear	O
to	O
be	O
housekeeping	O
genes	O
,	O
with	O
the	O
Surf-3	B
gene	O
encoding	O
the	O
1.7a	O
ribosomal	O
protein	O
and	O
the	O
Surf-4	B
gene	O
encoding	O
an	O
integral	O
membrane	O
protein	O
most	O
likely	O
associated	O
with	O
the	O
endoplasmic	O
reticulum	O
.	O

In	O
this	O
work	O
,	O
we	O
have	O
isolated	O
the	O
Surf-6	B
gene	O
,	O
a	O
sixth	O
member	O
of	O
the	O
Surfeit	O
locus	O
.	O

The	O
Surf-6	B
gene	O
contains	O
four	O
exons	O
spanning	O
a	O
genomic	O
region	O
of	O
14	O
kb	O
and	O
specifies	O
a	O
mRNA	O
of	O
2,571	O
bases	O
.	O

Surf-6	B
has	O
features	O
common	O
to	O
housekeeping	O
genes	O
because	O
its	O
transcript	O
is	O
present	O
in	O
every	O
tissue	O
tested	O
,	O
its	O
5	O
'	O
end	O
is	O
associated	O
with	O
a	O
CpG	O
-	O
rich	O
island	O
,	O
and	O
its	O
promoter	O
does	O
not	O
contain	O
a	O
canonical	O
TATA	O
box	O
.	O

The	O
Surf-6	B
long	O
open	O
reading	O
frame	O
encodes	O
a	O
novel	O
highly	O
basic	O
polypeptide	O
of	O
355	O
amino	O
acids	O
(	O
28	O
%	O
Arg	O
and	O
Lys	O
)	O
.	O

By	O
immunofluorescence	O
and	O
immunoblot	O
analyses	O
,	O
the	O
Surf-6	B
protein	O
has	O
been	O
found	O
to	O
be	O
located	O
in	O
the	O
nucleolus	O
and	O
by	O
immunocytochemical	O
microscopy	O
to	O
be	O
localized	O
predominantly	O
in	O
the	O
nucleolar	O
granular	O
component	O
,	O
a	O
structure	O
that	O
is	O
involved	O
in	O
ribosome	O
maturation	O
.	O

These	O
results	O
indicate	O
that	O
the	O
novel	O
Surf-6	B
gene	O
is	O
involved	O
in	O
a	O
nucleolar	O
function	O
.	O

Interleukin-6	O
(	O
IL-6	B
)	O
administration	O
to	O
human	O
subjects	O
or	O
experimental	O
animals	O
induces	O
changes	O
in	O
thyroid	O
hormone	O
metabolism	O
resembling	O
those	O
in	O
the	O
sick	O
euthyroid	O
syndrome	O
.	O

Furthermore	O
,	O
the	O
decrease	O
in	O
serum	O
T3	O
during	O
illness	O
is	O
significantly	O
related	O
to	O
serum	O
IL-6	B
concentrations	O
.	O

These	O
findings	O
suggest	O
,	O
but	O
do	O
not	O
prove	O
,	O
a	O
causal	O
role	O
for	O
IL-6	B
in	O
the	O
development	O
of	O
the	O
low	O
T3	O
syndrome	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
role	O
of	O
IL-6	B
in	O
the	O
development	O
of	O
the	O
sick	O
euthyroid	O
syndrome	O
in	O
IL-6	B
knock	O
-	O
out	O
(	O
IL-6	B
(	O
-	O
/	O
-	O
)	O
)	O
mice	O
compared	O
to	O
that	O
in	O
wild	O
-	O
type	O
mice	O
(	O
IL-6	B
(	O
+	O
/	O
+	O
)	O
)	O
.	O

Illness	O
was	O
induced	O
in	O
IL-6	B
(	O
-	O
/	O
-	O
)	O
and	O
IL-6	B
(	O
+	O
/	O
+	O
)	O
mice	O
by	O
1	O
)	O
administration	O
of	O
bacterial	O
endotoxin	O
(	O
LPS	O
)	O
,	O
2	O
)	O
infection	O
with	O
Listeria	O
monocytogenes	O
,	O
and	O
3	O
)	O
turpentine	O
injection	O
in	O
both	O
hind	O
limbs	O
.	O

Food	O
intake	O
was	O
kept	O
similar	O
in	O
both	O
groups	O
in	O
all	O
three	O
experiments	O
.	O

Serial	O
measurements	O
were	O
made	O
of	O
serum	O
IL-6	B
,	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
,	O
T3	O
,	O
T4	O
,	O
corticosterone	O
,	O
and	O
liver	O
5'-deiodinase	O
(	O
5'-DI	O
)	O
messenger	O
RNA	O
(	O
mRNA	O
)	O
for	O
24	O
h	O
(	O
LPS	O
)	O
,	O
96	O
h	O
(	O
L.	O
monocytogenes	O
)	O
,	O
and	O
48	O
h	O
(	O
turpentine	O
)	O
.	O

Serum	O
IL-6	B
increased	O
in	O
response	O
to	O
all	O
stimuli	O
in	O
IL-6	B
(	O
+	O
/	O
+	O
)	O
mice	O
,	O
but	O
not	O
in	O
IL-6	B
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

Serum	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
was	O
induced	O
by	O
LPS	O
in	O
both	O
groups	O
to	O
a	O
similar	O
extent	O
,	O
but	O
did	O
not	O
rise	O
after	O
L.	O
monocytogenes	O
or	O
turpentine	O
administration	O
.	O

Serum	O
T3	O
and	O
T4	O
decreased	O
after	O
all	O
three	O
stimuli	O
.	O

The	O
decrease	O
in	O
serum	O
T4	O
in	O
IL-6	B
(	O
-	O
/	O
-	O
)	O
was	O
similar	O
to	O
that	O
in	O
IL-6	B
(	O
+	O
/	O
+	O
)	O
mice	O
.	O

The	O
decrease	O
in	O
serum	O
T3	O
,	O
however	O
,	O
was	O
smaller	O
in	O
the	O
IL-6	B
(	O
-	O
/	O
-	O
)	O
mice	O
than	O
in	O
the	O
IL-6	B
(	O
+	O
/	O
+	O
)	O
mice	O
;	O
T3	O
levels	O
were	O
1.56	O
+	O
/-	O

0.29	O
and	O
0.99	O
+	O
/-	O

0.15	O
nmol	O
/	O
liter	O
,	O
respectively	O
,	O
24	O
h	O
after	O
LPS	O
treatment	O
(	O
P	O
<	O
0.01	O
)	O
,	O
2.39	O
+	O
/-	O

0.17	O
and	O
1.75	O
+	O
/-	O

0.24	O
nmol	O
/	O
liter	O
96	O
h	O
after	O
L.	O
monocytogenes	O
treatment	O
(	O
P	O
<	O
0.01	O
)	O
,	O
and	O
1.46	O
+	O
/-	O

0.18	O
and	O
1.10	O
+	O
/-	O

0.25	O
nmol	O
/	O
liter	O
48	O
h	O
after	O
turpentine	O
treatment	O
(	O
P	O
<	O
0.05	O
)	O
.	O

The	O
smaller	O
fall	O
in	O
serum	O
T3	O
in	O
IL-6	B
(	O
-	O
/	O
-	O
)	O
mice	O
could	O
not	O
be	O
attributed	O
to	O
differences	O
in	O
the	O
severity	O
of	O
the	O
induced	O
illness	O
,	O
food	O
intake	O
,	O
or	O
corticosterone	O
response	O
,	O
which	O
were	O
all	O
similar	O
in	O
IL-6	B
(	O
-	O
/	O
-	O
)	O
mice	O
and	O
IL-6	B
(	O
+	O
/	O
+	O
)	O
mice	O
.	O

Liver	O
5'-deiodinase	O
mRNA	O
decreased	O
after	O
all	O
three	O
stimuli	O
;	O
the	O
decrease	O
after	O
LPS	O
and	O
L.	O
monocytogenes	O
infection	O
was	O
smaller	O
in	O
the	O
IL-6	B
(	O
-	O
/	O
-	O
)	O
mice	O
,	O
but	O
the	O
difference	O
in	O
IL-6	B
(	O
+	O
/	O
+	O
)	O
mice	O
just	O
failed	O
to	O
reached	O
statistical	O
significance	O
.	O

Liver	O
5'-deiodinase	O
activity	O
after	O
turpentine	O
injection	O
administration	O
decreased	O
in	O
the	O
wild	O
-	O
type	O
animals	O
by	O
36	O
%	O
,	O
but	O
did	O
not	O
change	O
in	O
the	O
knock	O
-	O
out	O
mice	O
.	O

In	O
conclusion	O
,	O
acutely	O
induced	O
illness	O
generates	O
the	O
low	O
T3	O
syndrome	O
,	O
which	O
is	O
less	O
marked	O
in	O
IL-6	B
knock	O
-	O
out	O
mice	O
than	O
in	O
wild	O
-	O
type	O
mice	O
.	O

The	O
data	O
suggest	O
a	O
causal	O
role	O
of	O
IL-6	B
in	O
the	O
development	O
of	O
the	O
low	O
T3	O
syndrome	O
.	O

The	O
spontaneous	O
development	O
of	O
autoimmune	O
disease	O
in	O
MRL	O
-	O
lpr	O
mice	O
induces	O
behavioral	O
and	O
endocrine	O
changes	O
that	O
resemble	O
effects	O
of	O
chronic	O
stressors	O
.	O

To	O
further	O
examine	O
the	O
correspondence	O
between	O
autoimmune	O
disease	O
and	O
chronic	O
stress	O
,	O
we	O
asked	O
whether	O
the	O
brains	O
of	O
autoimmune	O
mice	O
show	O
a	O
shift	O
in	O
the	O
corticotropin	O
-	O
releasing	O
factor	O
(	O
CRF	B
)	O
to	O
vasopressin	O
(	O
AVP	B
)	O
ratio	O
.	O

Using	O
in	O
situ	O
hybridization	O
histochemistry	O
with	O
35S	O
-	O
labelled	O
mouse	O
riboprobes	O
,	O
the	O
levels	O
of	O
mRNA	O
transcripts	O
encoding	O
CRF	B
and	O
AVP	B
were	O
compared	O
between	O
autoimmune	O
MRL	O
-	O
lpr	O
and	O
control	O
MRL	O
+	O
/+	O
brains	O
.	O

CRF	B
transcript	O
levels	O
were	O
lower	O
in	O
the	O
hypothalamic	O
paraventricular	O
nucleus	O
and	O
in	O
the	O
central	O
nucleus	O
of	O
the	O
amygdala	O
in	O
MRL	O
-	O
lpr	O
mice	O
.	O

AVP	B
transcript	O
levels	O
were	O
higher	O
in	O
the	O
paraventricular	O
and	O
the	O
supraoptic	O
nuclei	O
in	O
MRL	O
-	O
lpr	O
mice	O
compared	O
to	O
controls	O
.	O

CRF	B
mRNA	O
levels	O
were	O
inversely	O
related	O
to	O
performance	O
in	O
stress	O
-	O
sensitive	O
tasks	O
and	O
to	O
measures	O
of	O
autoimmunity	O
.	O

As	O
found	O
previously	O
for	O
behavioral	O
performance	O
,	O
immunosuppressive	O
treatment	O
with	O
cyclophosphamide	O
abolished	O
the	O
group	O
difference	O
in	O
neuropeptide	O
gene	O
expression	O
.	O

These	O
results	O
indicate	O
that	O
an	O
autoimmune	O
disease	O
process	O
is	O
necessary	O
for	O
the	O
shift	O
in	O
the	O
brain	O
CRF	B
:	I
AVP	I
ratio	O
.	O

Furthermore	O
,	O
they	O
support	O
the	O
parallel	O
between	O
chronic	O
stress	O
and	O
chronic	O
autoimmunity	O
/	O
inflammation	O
,	O
and	O
suggest	O
common	O
central	O
mechanisms	O
relevant	O
to	O
endocrine	O
function	O
and	O
behavior	O
.	O

The	O
Pax	O
gene	O
family	O
encodes	O
transcription	O
factors	O
essential	O
for	O
organ	O
and	O
tissue	O
development	O
in	O
higher	O
eukaryotes	O
.	O

Pax	O
proteins	O
are	O
modular	O
with	O
an	O
N	O
-	O
terminal	O
DNA	O
binding	O
domain	O
,	O
a	O
C	O
-	O
terminal	O
transcription	O
activation	O
domain	O
,	O
and	O
a	O
transcription	O
repression	O
domain	O
called	O
the	O
octapeptide	O
.	O

How	O
these	O
domains	O
interact	O
with	O
the	O
cellular	O
machinery	O
remains	O
unclear	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
isolation	O
and	O
characterization	O
of	O
a	O
novel	O
gene	O
and	O
its	O
encoded	O
protein	O
,	O
PTIP	B
,	O
which	O
binds	O
to	O
the	O
activation	O
domain	O
of	O
Pax2	B
and	O
other	O
Pax	O
proteins	O
.	O

PTIP	B
binds	O
to	O
Pax2	B
in	O
vitro	O
,	O
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
assay	O
and	O
in	O
tissue	O
culture	O
cells	O
.	O

The	O
binding	O
of	O
PTIP	B
to	O
Pax2	B
is	O
inhibited	O
by	O
the	O
octapeptide	O
repression	O
domain	O
.	O

The	O
PTIP	B
protein	O
contains	O
five	O
BRCT	O
domains	O
,	O
first	O
identified	O
in	O
BRCA1	O
and	O
other	O
nuclear	O
proteins	O
involved	O
in	O
DNA	O
repair	O
/	O
recombination	O
or	O
cell	O
cycle	O
control	O
.	O

Pax2	B
and	O
PTIP	B
co	O
-	O
localize	O
in	O
the	O
cell	O
nucleus	O
to	O
actively	O
expressed	O
chromatin	O
and	O
the	O
nuclear	O
matrix	O
fraction	O
.	O

For	O
the	O
first	O
time	O
,	O
these	O
results	O
point	O
to	O
a	O
link	O
between	O
Pax	O
transcription	O
factors	O
and	O
active	O
chromatin	O
.	O

Inhibins	O
and	O
activins	O
are	O
members	O
of	O
the	O
transforming	O
growth	O
factor	O
beta	O
(	O
TGFbeta	O
)	O
family	O
.	O

Female	O
mice	O
in	O
which	O
both	O
alleles	O
encoding	O
the	O
inhibin	O
betaB	O
subunit	O
have	O
been	O
deleted	O
are	O
unable	O
to	O
nurse	O
their	O
pups	O
.	O

We	O
have	O
now	O
identified	O
a	O
cause	O
of	O
lactation	O
failure	O
in	O
these	O
mice	O
.	O

Ductal	O
elongation	O
and	O
alveolar	O
morphogenesis	O
are	O
retarded	O
.	O

During	O
puberty	O
and	O
pregnancy	O
,	O
ductal	O
outgrowth	O
and	O
alveolar	O
development	O
are	O
limited	O
and	O
morphologically	O
abnormal	O
endbuds	O
persist	O
in	O
the	O
glands	O
of	O
postpartum	O
females	O
.	O

The	O
alveolar	O
lumina	O
fail	O
to	O
expand	O
at	O
parturition	O
due	O
to	O
the	O
absence	O
of	O
secreted	O
milk	O
.	O

Transplantation	O
experiments	O
have	O
been	O
performed	O
to	O
determine	O
whether	O
the	O
absence	O
of	O
systemic-	O
or	O
mammary	O
-	O
derived	O
betaB	O
subunits	O
are	O
the	O
cause	O
for	O
the	O
incomplete	O
and	O
aberrant	O
development	O
.	O

While	O
transplanted	O
intact	O
glands	O
from	O
wild	O
-	O
type	O
mice	O
grew	O
normally	O
in	O
betaB	O
-	O
deficient	O
hosts	O
,	O
betaB	O
-	O
deficient	O
glands	O
remained	O
underdeveloped	O
in	O
wild	O
-	O
type	O
hosts	O
.	O

However	O
,	O
betaB	O
-	O
deficient	O
epithelium	O
developed	O
normally	O
when	O
transplanted	O
into	O
the	O
fat	O
pad	O
of	O
wild	O
-	O
type	O
hosts	O
.	O

This	O
demonstrates	O
that	O
ductal	O
elongation	O
and	O
epithelial	O
cell	O
differentiation	O
during	O
puberty	O
and	O
pregnancy	O
require	O
activin	B
/	O
inhibin	O
signalling	O
from	O
the	O
stroma	O
.	O

The	O
results	O
further	O
show	O
that	O
distinct	O
,	O
though	O
related	O
,	O
activins	O
and	O
inhibins	O
perform	O
unique	O
functions	O
and	O
are	O
not	O
able	O
to	O
compensate	O
for	O
the	O
absence	O
of	O
activin	B
B	O
and	O
AB	O
and	O
inhibin	O
B	O
in	O
the	O
process	O
of	O
mammogenesis	O
.	O

The	O
betaB	O
-	O
deficient	O
mice	O
provide	O
the	O
first	O
genetic	O
evidence	O
for	O
stromal	O
signalling	O
in	O
the	O
adult	O
mammary	O
gland	O
in	O
vivo	O
.	O

Mice	O
with	O
a	O
targeted	O
mutation	O
of	O
the	O
gastric	O
inhibitory	O
polypeptide	O
(	O
GIP	O
)	O
receptor	O
gene	O
(	O
GIPR	B
)	O
were	O
generated	O
to	O
determine	O
the	O
role	O
of	O
GIP	O
as	O
a	O
mediator	O
of	O
signals	O
from	O
the	O
gut	O
to	O
pancreatic	O
beta	O
cells	O
.	O

GIPR-	B
/	O
-	O
mice	O
have	O
higher	O
blood	O
glucose	O
levels	O
with	O
impaired	O
initial	O
insulin	O
response	O
after	O
oral	O
glucose	O
load	O
.	O

Although	O
blood	O
glucose	O
levels	O
after	O
meal	O
ingestion	O
are	O
not	O
increased	O
by	O
high	O
-	O
fat	O
diet	O
in	O
GIPR+	B
/	O
+	O
mice	O
because	O
of	O
compensatory	O
higher	O
insulin	O
secretion	O
,	O
they	O
are	O
significantly	O
increased	O
in	O
GIPR-	B
/	O
-	O
mice	O
because	O
of	O
the	O
lack	O
of	O
such	O
enhancement	O
.	O

Accordingly	O
,	O
early	O
insulin	O
secretion	O
mediated	O
by	O
GIP	O
determines	O
glucose	O
tolerance	O
after	O
oral	O
glucose	O
load	O
in	O
vivo	O
,	O
and	O
because	O
GIP	O
plays	O
an	O
important	O
role	O
in	O
the	O
compensatory	O
enhancement	O
of	O
insulin	O
secretion	O
produced	O
by	O
a	O
high	O
insulin	O
demand	O
,	O
a	O
defect	O
in	O
this	O
entero	O
-	O
insular	O
axis	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
diabetes	O
.	O

MyoD1	B
alleles	O
distinguish	O
between	O
the	O
Mm	O
musculus	O
and	O
Mm	O
domesticus	O
subspecies	O
of	O
Mus	O
musculus	O
.	O

SJL	O
/	O
J	O
mice	O
,	O
which	O
belong	O
to	O
the	O
Mm	O
musculus	O
subspecies	O
,	O
are	O
able	O
to	O
regenerate	O
skeletal	O
muscle	O
more	O
efficiently	O
than	O
BALB	O
/	O
c	O
mice	O
which	O
possess	O
the	O
Mm	O
domesticus	O
MyoD1	B
allele	O
.	O

Hence	O
the	O
possibility	O
that	O
regeneration	O
responses	O
are	O
due	O
to	O
species	O
-	O
specific	O
genetic	O
differences	O
including	O
MyoD1	B
was	O
investigated	O
in	O
this	O
study	O
.	O

Quantitative	O
morphometric	O
analysis	O
following	O
muscle	O
crush	O
injury	O
of	O
2	O
Mm	O
musculus	O
strains	O
,	O
MBK	O
and	O
MGL	O
,	O
has	O
indicated	O
that	O
regeneration	O
phenotype	O
is	O
not	O
species	O
-	O
specific	O
and	O
may	O
not	O
be	O
directly	O
related	O
to	O
MyoD1	B
alleles	O
.	O

These	O
results	O
contrast	O
with	O
prior	O
investigations	O
conducted	O
in	O
SJL	O
/	O
J	O
and	O
BALB	O
/	O
c	O
mice	O
,	O
and	O
indicate	O
that	O
other	O
genes	O
may	O
have	O
a	O
direct	O
influence	O
on	O
skeletal	O
muscle	O
regeneration	O
.	O

Histone	B
deacetylase	I
2	I
(	O
HDAC2	B
)	O
is	O
a	O
member	O
of	O
a	O
large	O
family	O
of	O
enzymes	O
that	O
alter	O
gene	O
expression	O
by	O
catalyzing	O
the	O
removal	O
of	O
acetyl	O
groups	O
from	O
core	O
histones	O
.	O

Originally	O
isolated	O
as	O
a	O
transcriptional	O
co	O
-	O
repressor	O
,	O
HDAC2	B
possesses	O
extensive	O
amino	O
acid	O
sequence	O
homology	O
to	O
HDAC1	B
(	O
the	O
founding	O
member	O
and	O
most	O
extensively	O
studied	O
HDAC	O
enzyme	O
)	O
.	O

Because	O
of	O
this	O
high	O
degree	O
of	O
sequence	O
similarity	O
between	O
HDAC1	B
and	O
HDAC2	B
,	O
coupled	O
with	O
the	O
fact	O
that	O
the	O
two	O
always	O
co	O
-	O
exist	O
in	O
the	O
same	O
complexes	O
,	O
it	O
is	O
difficult	O
to	O
assess	O
whether	O
different	O
properties	O
exist	O
between	O
these	O
two	O
proteins	O
.	O

We	O
report	O
here	O
that	O
HDAC2	B
is	O
a	O
phosphoprotein	O
similar	O
to	O
HDAC1	B
.	O

In	O
addition	O
,	O
like	O
HDAC1	B
,	O
the	O
phospho	O
-	O
acceptor	O
sites	O
in	O
HDAC2	B
are	O
located	O
in	O
the	O
C	O
-	O
terminal	O
portion	O
of	O
the	O
protein	O
.	O

However	O
,	O
unlike	O
HDAC1	B
,	O
which	O
can	O
be	O
phosphorylated	O
by	O
protein	O
kinase	O
CK2	B
,	O
cAMP	O
-	O
dependent	O
protein	O
kinase	O
,	O
and	O
protein	O
kinase	O
G	O
,	O
HDAC2	B
is	O
phosphorylated	O
uniquely	O
by	O
protein	O
kinase	O
CK2	B
in	O
vitro	O
.	O

Studies	O
using	O
unfractionated	O
cell	O
extracts	O
with	O
CK2	B
inhibitors	O
suggest	O
that	O
protein	O
kinase	O
CK2	B
is	O
the	O
major	O
source	O
of	O
HDAC2	B
kinase	O
.	O

Finally	O
,	O
and	O
perhaps	O
most	O
interesting	O
,	O
HDAC2	B
phosphorylation	O
promotes	O
enzymatic	O
activity	O
,	O
selectively	O
regulates	O
complex	O
formation	O
,	O
but	O
has	O
no	O
effect	O
on	O
transcriptional	O
repression	O
.	O

Together	O
,	O
our	O
data	O
indicate	O
that	O
like	O
many	O
HDACs	O
,	O
HDAC2	B
is	O
regulated	O
by	O
post	O
-	O
translational	O
modification	O
,	O
particularly	O
phosphorylation	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
there	O
are	O
similarities	O
and	O
differences	O
in	O
the	O
regulation	O
of	O
HDAC1	B
and	O
HDAC2	B
by	O
phosphorylation	O
.	O

The	O
paralogous	O
genes	O
Pax1	B
and	O
Pax9	B
constitute	O
one	O
group	O
within	O
the	O
vertebrate	O
Pax	O
gene	O
family	O
.	O

They	O
encode	O
closely	O
related	O
transcription	O
factors	O
and	O
are	O
expressed	O
in	O
similar	O
patterns	O
during	O
mouse	O
embryogenesis	O
,	O
suggesting	O
that	O
Pax1	B
and	O
Pax9	B
act	O
in	O
similar	O
developmental	O
pathways	O
.	O

We	O
have	O
recently	O
shown	O
that	O
mice	O
homozygous	O
for	O
a	O
defined	O
Pax1	B
null	O
allele	O
exhibit	O
morphological	O
abnormalities	O
of	O
the	O
axial	O
skeleton	O
,	O
which	O
is	O
not	O
affected	O
in	O
homozygous	O
Pax9	B
mutants	O
.	O

To	O
investigate	O
a	O
potential	O
interaction	O
of	O
the	O
two	O
genes	O
,	O
we	O
analysed	O
Pax1	B
/	O
Pax9	B
double	O
mutant	O
mice	O
.	O

These	O
mutants	O
completely	O
lack	O
the	O
medial	O
derivatives	O
of	O
the	O
sclerotomes	O
,	O
the	O
vertebral	O
bodies	O
,	O
intervertebral	O
discs	O
and	O
the	O
proximal	O
parts	O
of	O
the	O
ribs	O
.	O

This	O
phenotype	O
is	O
much	O
more	O
severe	O
than	O
that	O
of	O
Pax1	B
single	O
homozygous	O
mutants	O
.	O

In	O
contrast	O
,	O
the	O
neural	O
arches	O
,	O
which	O
are	O
derived	O
from	O
the	O
lateral	O
regions	O
of	O
the	O
sclerotomes	O
,	O
are	O
formed	O
.	O

The	O
analysis	O
of	O
Pax9	B
expression	O
in	O
compound	O
mutants	O
indicates	O
that	O
both	O
spatial	O
expansion	O
and	O
upregulation	O
of	O
Pax9	B
expression	O
account	O
for	O
its	O
compensatory	O
function	O
during	O
sclerotome	O
development	O
in	O
the	O
absence	O
of	O
Pax1	B
.	O

In	O
Pax1	B
/	O
Pax9	B
double	O
homozygous	O
mutants	O
,	O
formation	O
and	O
anteroposterior	O
polarity	O
of	O
sclerotomes	O
,	O
as	O
well	O
as	O
induction	O
of	O
a	O
chondrocyte	O
-	O
specific	O
cell	O
lineage	O
,	O
appear	O
normal	O
.	O

However	O
,	O
instead	O
of	O
a	O
segmental	O
arrangement	O
of	O
vertebrae	O
and	O
intervertebral	O
disc	O
anlagen	O
,	O
a	O
loose	O
mesenchyme	O
surrounding	O
the	O
notochord	O
is	O
formed	O
.	O

The	O
gradual	O
loss	O
of	O
Sox9	B
and	O
Collagen	O
II	O
expression	O
in	O
this	O
mesenchyme	O
indicates	O
that	O
the	O
sclerotomes	O
are	O
prevented	O
from	O
undergoing	O
chondrogenesis	O
.	O

The	O
first	O
detectable	O
defect	O
is	O
a	O
low	O
rate	O
of	O
cell	O
proliferation	O
in	O
the	O
ventromedial	O
regions	O
of	O
the	O
sclerotomes	O
after	O
sclerotome	O
formation	O
but	O
before	O
mesenchymal	O
condensation	O
normally	O
occurs	O
.	O

At	O
later	O
stages	O
,	O
an	O
increased	O
number	O
of	O
cells	O
undergoing	O
apoptosis	O
further	O
reduces	O
the	O
area	O
normally	O
forming	O
vertebrae	O
and	O
intervertebral	O
discs	O
.	O

Our	O
results	O
reveal	O
functional	O
redundancy	O
between	O
Pax1	B
and	O
Pax9	B
during	O
vertebral	O
column	O
development	O
and	O
identify	O
an	O
early	O
role	O
of	O
Pax1	B
and	O
Pax9	B
in	O
the	O
control	O
of	O
cell	O
proliferation	O
during	O
early	O
sclerotome	O
development	O
.	O

In	O
addition	O
,	O
our	O
data	O
indicate	O
that	O
the	O
development	O
of	O
medial	O
and	O
lateral	O
elements	O
of	O
vertebrae	O
is	O
regulated	O
by	O
distinct	O
genetic	O
pathways	O
.	O

Ciliary	B
neurotrophic	I
factor	I
(	O
CNTF	B
)	O
is	O
an	O
abundant	O
cytosolic	O
molecule	O
in	O
myelinating	O
Schwann	O
cells	O
of	O
adult	O
rodents	O
.	O

In	O
newborn	O
animals	O
in	O
which	O
CNTF	B
is	O
not	O
yet	O
expressed	O
,	O
exogenous	O
CNTF	B
that	O
is	O
locally	O
administered	O
very	O
effectively	O
protects	O
motoneurons	O
from	O
degeneration	O
by	O
axotomy	O
.	O

To	O
evaluate	O
whether	O
endogenous	O
CNTF	B
,	O
released	O
after	O
nerve	O
injury	O
from	O
the	O
cytosol	O
of	O
Schwann	O
cells	O
,	O
supports	O
motoneuron	O
survival	O
,	O
we	O
transected	O
the	O
facial	O
nerve	O
in	O
4-week	O
-	O
old	O
pmn	B
mice	O
.	O

In	O
this	O
mouse	O
mutant	O
a	O
rapidly	O
progressing	O
degenerative	O
disease	O
of	O
motoneurons	O
starts	O
by	O
the	O
third	O
postnatal	O
week	O
at	O
the	O
hindlimbs	O
and	O
progresses	O
to	O
the	O
anterior	O
parts	O
of	O
the	O
body	O
,	O
leading	O
to	O
death	O
by	O
the	O
seventh	O
to	O
eighth	O
week	O
.	O

Apoptotic	O
death	O
of	O
motoneurons	O
can	O
be	O
observed	O
during	O
this	O
period	O
,	O
as	O
revealed	O
by	O
TUNEL	O
staining	O
.	O

In	O
6-week	O
-	O
old	O
unlesioned	O
pmn	B
mice	O
approximately	O
40	O
%	O
of	O
facial	O
motoneurons	O
have	O
degenerated	O
.	O

Facial	O
nerve	O
lesion	O
dramatically	O
increased	O
the	O
number	O
of	O
surviving	O
motoneurons	O
in	O
pmn	B
mice	O
.	O

This	O
protective	O
effect	O
was	O
absent	O
in	O
pmn	B
mice	O
lacking	O
endogenous	O
CNTF	B
.	O

Quantitative	O
analysis	O
of	O
leukemia	B
inhibitory	I
factor	I
(	O
LIF	B
)	O
mRNA	O
expression	O
revealed	O
that	O
the	O
dramatic	O
upregulation	O
seen	O
in	O
wild	O
-	O
type	O
mice	O
after	O
peripheral	O
nerve	O
lesion	O
did	O
not	O
occur	O
in	O
pmn	B
mice	O
.	O

Therefore	O
,	O
endogenous	O
LIF	B
can	O
not	O
compensate	O
for	O
the	O
lack	O
of	O
CNTF	B
in	O
pmn	B
crossbred	O
with	O
CNTF	B
knock	O
-	O
out	O
mice	O
.	O

Thus	O
,	O
endogenous	O
CNTF	B
released	O
from	O
lesioned	O
Schwann	O
cells	O
supports	O
the	O
survival	O
of	O
axotomized	O
motoneurons	O
under	O
conditions	O
in	O
which	O
motoneurons	O
are	O
in	O
the	O
process	O
of	O
rapid	O
degeneration	O
.	O

Altered	O
axon	O
-	O
Schwann	O
cell	O
interactions	O
in	O
PNS	O
myelin	O
-	O
deficient	O
Trembler	O
mice	O
result	O
in	O
changed	O
axonal	O
transport	O
rates	O
,	O
neurofilament	O
and	O
microtubule	O
-	O
associated	O
protein	O
phosphorylation	O
,	O
neurofilament	O
density	O
,	O
and	O
microtubule	O
stability	O
.	O

To	O
determine	O
whether	O
PNS	O
and	O
CNS	O
myelination	O
have	O
equivalent	O
effects	O
on	O
axons	O
,	O
neurofilaments	O
,	O
and	O
microtubules	O
in	O
CNS	O
,	O
myelin	O
-	O
deficient	O
shiverer	B
axons	O
were	O
examined	O
.	O

The	O
genetic	O
defect	O
in	O
shiverer	B
is	O
a	O
deletion	O
in	O
the	O
myelin	B
basic	I
protein	I
(	O
MBP	B
)	O
gene	O
,	O
an	O
essential	O
component	O
of	O
CNS	O
myelin	O
.	O

As	O
a	O
result	O
,	O
shiverer	B
mice	O
have	O
little	O
or	O
no	O
compact	O
CNS	O
myelin	O
.	O

Slow	O
axonal	O
transport	O
rates	O
in	O
shiverer	B
CNS	O
axons	O
were	O
significantly	O
increased	O
,	O
in	O
contrast	O
to	O
the	O
slowing	O
in	O
demyelinated	O
PNS	O
nerves	O
.	O

Even	O
more	O
striking	O
were	O
substantial	O
changes	O
in	O
the	O
composition	O
and	O
properties	O
of	O
microtubules	O
in	O
shiverer	B
CNS	O
axons	O
.	O

The	O
density	O
of	O
axonal	O
microtubules	O
is	O
increased	O
,	O
reflecting	O
increased	O
expression	O
of	O
tubulin	O
in	O
shiverer	B
,	O
and	O
the	O
stability	O
of	O
microtubules	O
is	O
drastically	O
reduced	O
in	O
shiverer	B
axons	O
.	O

Shiverer	B
transgenic	O
mice	O
with	O
two	O
copies	O
of	O
a	O
wild	O
-	O
type	O
myelin	B
basic	I
protein	I
transgene	O
have	O
an	O
intermediate	O
level	O
of	O
compact	O
myelin	O
,	O
making	O
it	O
possible	O
to	O
determine	O
whether	O
the	O
actual	O
level	O
of	O
compact	O
myelin	O
is	O
an	O
important	O
regulator	O
of	O
axonal	O
microtubules	O
.	O

Both	O
increased	O
microtubule	O
density	O
and	O
reduced	O
microtubule	O
stability	O
were	O
still	O
observed	O
in	O
transgenic	O
mouse	O
nerves	O
,	O
indicating	O
that	O
signals	O
beyond	O
synaptogenesis	O
and	O
the	O
mere	O
presence	O
of	O
compact	O
myelin	O
are	O
required	O
for	O
normal	O
regulation	O
of	O
the	O
axonal	O
microtubule	O
cytoskeleton	O
.	O

Csk	B
is	O
a	O
non	O
-	O
receptor	O
protein	O
-	O
tyrosine	O
kinase	O
that	O
acts	O
as	O
a	O
negative	O
regulator	O
of	O
Src	O
family	O
tyrosine	O
kinases	O
.	O

Csk	B
-	O
deficient	O
mouse	O
embryos	O
exhibited	O
developmental	O
defects	O
including	O
inability	O
to	O
turn	O
and	O
impaired	O
formation	O
of	O
neural	O
tube	O
.	O

In	O
these	O
embryos	O
,	O
an	O
accumulation	O
of	O
tyrosine	O
phosphorylated	O
proteins	O
was	O
observed	O
as	O
a	O
consequence	O
of	O
constitutive	O
activation	O
of	O
Src	O
family	O
kinases	O
.	O

In	O
order	O
to	O
identify	O
those	O
tyrosine	O
phosphorylated	O
proteins	O
,	O
we	O
established	O
a	O
Csk	B
-	O
deficient	O
cell	O
line	O
from	O
embryos	O
lacking	O
both	O
Csk	B
and	O
the	O
anti	O
-	O
oncogene	O
product	O
p53	O
.	O

On	O
surveying	O
several	O
proteins	O
known	O
as	O
Src	O
substrates	O
,	O
we	O
found	O
that	O
phosphorylation	O
level	O
of	O
p80	O
/	O
85	O
(	O
cortactin	B
)	O
was	O
markedly	O
elevated	O
in	O
the	O
Csk	B
-	O
deficient	O
cells	O
.	O

Enhancement	O
of	O
cortactin	B
phosphorylation	O
was	O
also	O
seen	O
in	O
Csk	B
-	O
deficient	O
embryos	O
.	O

Furthermore	O
,	O
immunoprecipitated	O
Src	O
was	O
able	O
to	O
directly	O
phosphorylate	O
cortactin	B
in	O
vitro	O
.	O

Thus	O
,	O
we	O
suggest	O
that	O
cortactin	B
is	O
a	O
good	O
substrate	O
of	O
activated	O
Src	O
family	O
kinases	O
in	O
vivo	O
and	O
may	O
play	O
important	O
roles	O
in	O
signaling	O
pathways	O
mediated	O
by	O
Src	O
family	O
kinases	O
.	O

Fibroblast	O
growth	O
factors	O
(	O
FGFs	O
)	O
are	O
believed	O
to	O
be	O
vital	O
for	O
limb	O
outgrowth	O
and	O
patterning	O
during	O
embryonic	O
development	O
.	O

Although	O
the	O
effect	O
of	O
FGFs	O
on	O
the	O
formation	O
of	O
the	O
skeletal	O
elements	O
has	O
been	O
studied	O
in	O
detail	O
,	O
their	O
effect	O
on	O
the	O
development	O
of	O
the	O
limb	O
musculature	O
is	O
still	O
uncertain	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
Blindwell	O
chemotactic	O
chambers	O
to	O
examine	O
the	O
effect	O
of	O
FGF-2	B
and	O
FGF-4	B
on	O
the	O
motility	O
of	O
myogenic	O
cells	O
obtained	O
from	O
the	O
proximal	O
region	O
of	O
the	O
day	O
11.5	O
mouse	O
forelimbs	O
.	O

The	O
limb	O
myogenic	O
cells	O
were	O
found	O
to	O
be	O
chemotactically	O
attracted	O
to	O
FGF-2	B
and	O
FGF-4	B
at	O
10	O
-	O
50	O
ng	O
/	O
ml	O
.	O

Both	O
FGFs	O
increased	O
myogenic	O
cell	O
migration	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
,	O
with	O
maximal	O
responses	O
attained	O
at	O
1	O
-	O
50	O
ng	O
/	O
ml	O
for	O
FGF-2	B
and	O
at	O
10	O
ng	O
/	O
ml	O
for	O
FGF-4	B
;	O
however	O
,	O
FGF-2	B
was	O
found	O
to	O
be	O
a	O
more	O
potent	O
chemoattractant	O
than	O
FGF-4	B
.	O

It	O
was	O
possible	O
to	O
inhibit	O
the	O
myogenic	O
cells	O
'	O
response	O
to	O
FGF-2	B
and	O
FGF-4	B
by	O
the	O
addition	O
of	O
the	O
appropriate	O
neutralizing	O
antibody	O
.	O

The	O
effects	O
of	O
FGF-2	B
on	O
cell	O
migration	O
were	O
further	O
investigated	O
by	O
loading	O
this	O
cytokine	O
into	O
Affi	O
-	O
Gel	O
blue	O
beads	O
and	O
transplanting	O
them	O
into	O
day	O
11.5	O
forelimb	O
buds	O
.	O

The	O
results	O
showed	O
that	O
FGF-2	B
attracted	O
DiI	O
-	O
labelled	O
proximal	O
cells	O
to	O
migrate	O
toward	O
the	O
implanted	O
beads	O
and	O
that	O
the	O
migration	O
was	O
more	O
extensive	O
than	O
that	O
observed	O
in	O
the	O
absence	O
of	O
FGF-2	B
.	O

A	O
checkerboard	O
assay	O
was	O
performed	O
in	O
which	O
various	O
concentrations	O
of	O
FGF-2	B
and	O
FGF-4	B
were	O
introduced	O
to	O
both	O
the	O
upper	O
and	O
lower	O
wells	O
of	O
the	O
Blindwell	O
chambers	O
.	O

The	O
results	O
indicated	O
that	O
both	O
FGF	O
isoforms	O
can	O
stimulate	O
chemokinesis	O
as	O
well	O
as	O
chemotaxis	O
in	O
myogenic	O
cells	O
.	O

In	O
addition	O
,	O
the	O
effect	O
of	O
FGF-2	B
at	O
0.1	O
-	O
10	O
ng	O
/	O
ml	O
stimulated	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
myocytes	O
expressing	O
sarcomeric	O
myosin	O
on	O
examination	O
after	O
48	O
hr	O
in	O
culture	O
,	O
but	O
the	O
effect	O
of	O
FGF-4	B
was	O
negligible	O
at	O
all	O
concentrations	O
analyzed	O
;	O
however	O
,	O
both	O
FGF-2	B
and	O
FGF-4	B
inhibited	O
myocyte	O
fusion	O
compared	O
with	O
the	O
spontaneous	O
fusion	O
observed	O
in	O
control	O
cultures	O
.	O

Finally	O
,	O
we	O
used	O
in	O
situ	O
hybridization	O
and	O
immunohistochemical	O
techniques	O
to	O
determine	O
the	O
distribution	O
of	O
myogenic	O
cells	O
and	O
FGF-2	B
protein	O
in	O
the	O
day	O
11.5	O
mouse	O
forelimbs	O
.	O

We	O
isolated	O
an	O
abundant	O
novel	O
cDNA	O
SSEC-8	B
from	O
a	O
subtraction	O
cDNA	O
library	O
enriched	O
for	O
maternal	O
transcripts	O
that	O
are	O
still	O
present	O
in	O
the	O
mouse	O
2	O
cell	O
stage	O
embryo	O
.	O

This	O
gene	O
is	O
evolutionarily	O
conserved	O
and	O
maps	O
to	O
the	O
distal	O
region	O
of	O
mouse	O
chromosome	O
2	O
.	O

The	O
deduced	O
polypeptide	O
sequence	O
of	O
the	O
encoded	O
protein	O
contains	O
a	O
conserved	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
HLH	O
)	O
motif	O
without	O
a	O
basic	O
DNA	O
binding	O
domain	O
,	O
suggesting	O
that	O
it	O
functions	O
as	O
a	O
negative	O
regulator	O
of	O
basic	O
(	O
b	O
)	O
HLH	O
transcription	O
factors	O
.	O

Gel	O
mobility	O
shift	O
assays	O
show	O
that	O
in	O
vitro	O
translated	O
protein	O
prevents	O
the	O
E12	B
/	O
MyoD	B
bHLH	O
dimer	O
from	O
binding	O
to	O
DNA	O
.	O

Also	O
,	O
transient	O
overexpression	O
of	O
this	O
protein	O
in	O
C2C12	O
cells	O
reduced	O
the	O
transcription	O
of	O
a	O
CAT	O
-	O
reporter	O
regulated	O
by	O
an	O
E12	B
/	O
MyoD	B
driven	O
enhancer	O
.	O

The	O
3'-UTR	O
contains	O
consensus	O
sequences	O
of	O
cytoplasmic	O
polyadenylation	O
elements	O
(	O
CPE	O
's	O
)	O
,	O
and	O
the	O
length	O
of	O
its	O
poly	O
(	O
A	O
)	O
tail	O
changes	O
during	O
oocyte	O
maturation	O
,	O
indicating	O
that	O
its	O
expression	O
is	O
controlled	O
by	O
timely	O
activation	O
of	O
translation	O
.	O

This	O
new	O
gene	O
,	O
Maid	B
,	O
models	O
the	O
translational	O
and	O
transcriptional	O
regulation	O
of	O
gene	O
expression	O
during	O
the	O
transition	O
from	O
gamete	O
to	O
embryo	O
.	O

Mouse	O
Foxc1	B
(	O
previously	O
Mf1	B
)	O
is	O
a	O
member	O
of	O
the	O
conserved	O
forkhead	O
/	O
winged	O
helix	O
transcription	O
factor	O
gene	O
family	O
.	O

It	O
is	O
expressed	O
in	O
many	O
mesodermal	O
tissues	O
including	O
paraxial	O
mesoderm	O
of	O
the	O
trunk	O
and	O
head	O
,	O
prechondrogenic	O
mesenchyme	O
,	O
branchial	O
arches	O
and	O
developing	O
kidney	O
.	O

Homozygous	O
mutants	O
die	O
perinatally	O
with	O
hydrocephalus	O
and	O
skeletal	O
,	O
cardiovascular	O
,	O
ocular	O
and	O
genitourinary	O
defects	O
.	O

Here	O
,	O
we	O
report	O
the	O
cloning	O
and	O
expression	O
of	O
two	O
zebrafish	O
foxc1	B
homologues	O
,	O
foxc1a	O
and	O
foxc1b	O
.	O

During	O
gastrulation	O
and	O
somitogenesis	O
both	O
genes	O
have	O
similar	O
expression	O
patterns	O
in	O
the	O
hypoblast	O
,	O
paraxial	O
and	O
presomitic	O
mesoderm	O
,	O
somites	O
and	O
trunk	O
adaxial	O
cells	O
.	O

Expression	O
in	O
the	O
somites	O
is	O
downregulated	O
as	O
they	O
differentiate	O
,	O
but	O
is	O
maintained	O
in	O
the	O
sclerotome	O
.	O

Later	O
,	O
some	O
differences	O
in	O
expression	O
pattern	O
emerge	O
.	O

For	O
example	O
,	O
only	O
foxc1a	O
transcripts	O
are	O
detected	O
in	O
the	O
pronephros	O
primodia	O
and	O
in	O
the	O
head	O
mesoderm	O
around	O
the	O
eyes	O
,	O
while	O
only	O
foxc1b	O
is	O
expressed	O
in	O
the	O
pharyngeal	O
arches	O
and	O
pectoral	O
fins	O
.	O

Early	O
expression	O
of	O
foxc1a	O
in	O
the	O
paraxial	O
mesoderm	O
is	O
modified	O
in	O
chordino	O
,	O
swirl	O
,	O
somitabun	O
,	O
and	O
spadetail	O
mutants	O
.	O

Sequencing	O
of	O
rat	O
and	O
human	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	B
)	O
cDNA	O
clones	O
has	O
previously	O
identified	O
a	O
3	O
'	O
untranslated	O
region	O
of	O
approximately	O
1.9	O
kb	O
,	O
although	O
the	O
apparent	O
site	O
of	O
polyadenylation	O
differed	O
in	O
the	O
two	O
species	O
,	O
despite	O
a	O
high	O
degree	O
of	O
sequence	O
conservation	O
in	O
the	O
region	O
.	O

Neither	O
site	O
is	O
preceded	O
by	O
a	O
canonical	O
AAUAAA	O
polyadenylation	O
signal	O
,	O
a	O
situation	O
frequently	O
found	O
in	O
genes	O
that	O
are	O
subject	O
to	O
alternative	O
polyadenylation	O
.	O

We	O
have	O
sequenced	O
2.25	O
kb	O
of	O
the	O
3	O
'	O
region	O
of	O
the	O
mouse	O
VEGF	B
gene	O
and	O
mapped	O
the	O
usage	O
of	O
potential	O
polyadenylation	O
sites	O
in	O
fibroblasts	O
cultured	O
under	O
both	O
normoxic	O
and	O
hypoxic	O
conditions	O
.	O

We	O
find	O
that	O
two	O
sites	O
for	O
polyadenylation	O
are	O
present	O
in	O
the	O
mouse	O
VEGF	B
gene	O
but	O
the	O
majority	O
of	O
transcripts	O
contain	O
the	O
longer	O
form	O
of	O
the	O
3'UTR	O
and	O
that	O
their	O
usage	O
is	O
not	O
effected	O
by	O
environmental	O
oxygen	O
tension	O
.	O

To	O
compare	O
the	O
signal	O
transduction	O
pathways	O
used	O
by	O
erythropoietin	B
(	O
Epo	B
)	O
and	O
interleukin-6	O
(	O
IL-6	B
)	O
,	O
the	O
cDNA	O
for	O
the	O
murine	O
Epo	B
receptor	O
(	O
Epo	B
-	O
R	O
)	O
was	O
introduced	O
into	O
an	O
IL-6-responsive	B
plasmacytoma	O
cell	O
line	O
(	O
TEPC-2027	O
)	O
by	O
retrovirally	O
mediated	O
gene	O
transfer	O
.	O

G418-resistant	O
clones	O
were	O
amplified	O
in	O
IL-6	B
and	O
studied	O
for	O
their	O
ability	O
to	O
grow	O
and	O
differentiate	O
in	O
response	O
to	O
Epo	B
.	O

Epo	B
-	O
R	O
synthesized	O
from	O
the	O
viral	O
gene	O
showed	O
the	O
same	O
affinity	O
for	O
Epo	B
as	O
did	O
the	O
receptor	O
on	O
erythroid	O
cells	O
;	O
however	O
,	O
the	O
numbers	O
of	O
Epo	B
receptors	O
expressed	O
on	O
the	O
cell	O
membrane	O
varied	O
among	O
clones	O
.	O

After	O
a	O
delay	O
of	O
3	O
to	O
5	O
days	O
in	O
the	O
presence	O
of	O
Epo	B
,	O
all	O
the	O
clones	O
studied	O
proliferated	O
as	O
well	O
in	O
response	O
to	O
Epo	B
as	O
in	O
response	O
to	O
IL-6	B
.	O

In	O
response	O
to	O
IL-6	B
,	O
Stat3	B
was	O
activated	O
and	O
JunB	B
mRNA	O
was	O
accumulated	O
,	O
whereas	O
in	O
response	O
to	O
Epo	B
,	O
Jak2	B
and	O
Stat5	O
were	O
activated	O
and	O
JunB	B
mRNA	O
was	O
not	O
accumulated	O
in	O
Epo	B
-	O
R	O
-	O
expressing	O
TEPC	O
(	O
Epo	B
-	O
R	O
/	O
TEPC	O
)	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
Epo	B
and	O
IL-6	B
transduced	O
their	O
proliferative	O
signals	O
through	O
different	O
pathways	O
.	O

Further	O
studies	O
showed	O
that	O
,	O
in	O
Epo	B
-	O
R	O
/	O
TEPC	O
cells	O
,	O
Epo	B
neither	O
induces	O
the	O
synthesis	O
of	O
erythroid	O
-	O
specific	O
mRNA	O
nor	O
modifies	O
the	O
synthesis	O
of	O
gamma	O
1	O
lg	O
heavy	O
chain	O
,	O
suggesting	O
that	O
ectopic	O
expression	O
of	O
the	O
Epo	B
-	O
R	O
in	O
plasmacytoma	O
cells	O
does	O
not	O
modify	O
their	O
differentiative	O
potential	O
.	O

The	O
data	O
show	O
that	O
Epo	B
induces	O
a	O
proliferative	O
response	O
without	O
differentiation	O
providing	O
a	O
new	O
cellular	O
model	O
for	O
evaluating	O
molecular	O
events	O
specific	O
for	O
proliferation	O
.	O

Protamines	O
are	O
the	O
major	O
DNA	O
-	O
binding	O
proteins	O
in	O
the	O
nucleus	O
of	O
sperm	O
in	O
most	O
vertebrates	O
and	O
package	O
the	O
DNA	O
in	O
a	O
volume	O
less	O
than	O
5	O
%	O
of	O
a	O
somatic	O
cell	O
nucleus	O
.	O

Many	O
mammals	O
have	O
one	O
protamine	O
,	O
but	O
a	O
few	O
species	O
,	O
including	O
humans	O
and	O
mice	O
,	O
have	O
two	O
.	O

Here	O
we	O
use	O
gene	O
targeting	O
to	O
determine	O
if	O
the	O
second	O
protamine	O
provides	O
redundancy	O
to	O
an	O
essential	O
process	O
,	O
or	O
if	O
both	O
protamines	O
are	O
necessary	O
.	O

We	O
disrupted	O
the	O
coding	O
sequence	O
of	O
one	O
allele	O
of	O
either	O
Prm1	B
or	O
Prm2	B
in	O
embryonic	O
stem	O
(	O
ES	O
)	O
cells	O
derived	O
from	O
129-strain	O
mice	O
,	O
and	O
injected	O
them	O
into	O
blastocysts	O
from	O
C57BL	O
/	O
6-strain	O
mice	O
.	O

Male	O
chimeras	O
produced	O
129-genotype	O
sperm	O
with	O
disrupted	O
Prm1	B
or	O
Prm2	B
alleles	O
,	O
but	O
failed	O
to	O
sire	O
offspring	O
carrying	O
the	O
129	O
genome	O
.	O

We	O
also	O
found	O
that	O
a	O
decrease	O
in	O
the	O
amount	O
of	O
either	O
protamine	O
disrupts	O
nuclear	O
formation	O
,	O
processing	O
of	O
protamine-2	O
and	O
normal	O
sperm	O
function	O
.	O

Our	O
studies	O
show	O
that	O
both	O
protamines	O
are	O
essential	O
and	O
that	O
haploinsufficiency	O
caused	O
by	O
a	O
mutation	O
in	O
one	O
allele	O
of	O
Prm1	B
or	O
Prm2	B
prevents	O
genetic	O
transmission	O
of	O
both	O
mutant	O
and	O
wild	O
-	O
type	O
alleles	O
.	O

Lim1	B
is	O
a	O
homeobox	O
gene	O
expressed	O
in	O
the	O
extraembryonic	O
anterior	O
visceral	O
endoderm	O
and	O
in	O
primitive	O
streak	O
-	O
derived	O
tissues	O
of	O
early	O
mouse	O
embryos	O
.	O

Mice	O
homozygous	O
for	O
a	O
targeted	O
mutation	O
of	O
Lim1	B
lack	O
head	O
structures	O
anterior	O
to	O
rhombomere	O
3	O
in	O
the	O
hindbrain	O
.	O

To	O
determine	O
in	O
which	O
tissues	O
Lim1	B
is	O
required	O
for	O
head	O
formation	O
and	O
its	O
mode	O
of	O
action	O
,	O
we	O
have	O
generated	O
chimeric	O
mouse	O
embryos	O
and	O
performed	O
tissue	O
layer	O
recombination	O
explant	O
assays	O
.	O

In	O
chimeric	O
embryos	O
in	O
which	O
the	O
visceral	O
endoderm	O
was	O
composed	O
of	O
predominantly	O
wild	O
-	O
type	O
cells	O
,	O
we	O
found	O
that	O
Lim1	B
(	I
-	I
)	I
(	O
/	O
)	O
(	O
-	O
)	O
cells	O
were	O
able	O
to	O
contribute	O
to	O
the	O
anterior	O
mesendoderm	O
of	O
embryonic	O
day	O
7.5	O
chimeric	O
embryos	O
but	O
that	O
embryonic	O
day	O
9.5	O
chimeric	O
embryos	O
displayed	O
a	O
range	O
of	O
head	O
defects	O
.	O

In	O
addition	O
,	O
early	O
somite	O
stage	O
chimeras	O
generated	O
by	O
injecting	O
Lim1	B
(	I
-	I
)	I
(	O
/	O
)	O
(	O
-	O
)	O
embryonic	O
stem	O
cells	O
into	O
wild	O
-	O
type	O
tetraploid	O
blastocysts	O
lacked	O
forebrain	O
and	O
midbrain	O
neural	O
tissue	O
.	O

Furthermore	O
,	O
in	O
explant	O
recombination	O
assays	O
,	O
anterior	O
mesendoderm	O
from	O
Lim1	B
(	I
-	I
)	I
(	O
/	O
)	O
(	O
-	O
)	O
embryos	O
was	O
unable	O
to	O
maintain	O
the	O
expression	O
of	O
the	O
anterior	O
neural	O
marker	O
gene	O
Otx2	B
in	O
wild	O
-	O
type	O
ectoderm	O
.	O

In	O
complementary	O
experiments	O
,	O
embryonic	O
day	O
9.5	O
chimeric	O
embryos	O
in	O
which	O
the	O
visceral	O
endoderm	O
was	O
composed	O
of	O
predominantly	O
Lim1	B
(	I
-	I
)	I
(	O
/	O
)	O
(	O
-	O
)	O
cells	O
and	O
the	O
embryo	O
proper	O
of	O
largely	O
wild	O
-	O
type	O
cells	O
,	O
also	O
phenocopied	O
the	O
Lim1	B
(	I
-	I
)	I
(	O
/	O
)	O
(	O
-	O
)	O
headless	O
phenotype	O
.	O

These	O
results	O
indicate	O
that	O
Lim1	B
is	O
required	O
in	O
both	O
primitive	O
streak	O
-	O
derived	O
tissues	O
and	O
visceral	O
endoderm	O
for	O
head	O
formation	O
and	O
that	O
its	O
inactivation	O
in	O
these	O
tissues	O
produces	O
cell	O
non	O
-	O
autonomous	O
defects	O
.	O

We	O
discuss	O
a	O
double	O
assurance	O
model	O
in	O
which	O
Lim1	B
regulates	O
sequential	O
signaling	O
events	O
required	O
for	O
head	O
formation	O
in	O
the	O
mouse	O
.	O

Tumor	B
necrosis	I
factor	I
(	O
TNF	B
)	O
-alpha	O
and	O
transforming	O
growth	O
factor	O
(	O
TGF	O
)	O
-beta	O
produced	O
by	O
glial	O
cells	O
have	O
been	O
proposed	O
bo	O
play	O
a	O
role	O
in	O
various	O
neurodenegerative	O
diseases	O
.	O

The	O
interaction	O
of	O
these	O
two	O
cytokines	O
,	O
however	O
,	O
is	O
unknown	O
.	O

We	O
tested	O
the	O
hypothesis	O
that	O
the	O
TNF	B
-	I
alpha	I
released	O
from	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-treated	O
murine	O
microglial	O
cells	O
would	O
stimulate	O
the	O
release	O
of	O
TGF	O
-	O
beta	O
,	O
which	O
in	O
turn	O
would	O
control	O
TNF	B
-	I
alpha	I
production	O
.	O

Treatment	O
of	O
murine	O
microglial	O
cell	O
cultures	O
with	O
LPS	O
resulted	O
in	O
an	O
acute	O
release	O
of	O
TNF	B
-	I
alpha	I
(	O
peak	O
by	O
8	O
hr	O
)	O
followed	O
by	O
delayed	O
release	O
of	O
bioactive	O
TGF	O
-	O
beta	O
(	O
peak	O
by	O
48	O
hr	O
)	O
.	O

Anti	O
-	O
TNF	B
-	I
alpha	I
antibody	O
significantly	O
inhibited	O
LPS	O
-	O
stimulated	O
TGF	O
-	O
beta	O
production	O
,	O
suggesting	O
the	O
involvement	O
of	O
TNF	B
-	I
alpha	I
in	O
TGF	O
-	O
beta	O
production	O
.	O

Also	O
,	O
exogenous	O
TNF	B
-	I
alpha	I
induced	O
in	O
a	O
dose	O
-	O
dependent	O
fashion	O
microglial	O
cell	O
expression	O
of	O
TGF	B
-	I
beta	I
1	I
mRNA	O
and	O
release	O
of	O
TGF	O
-	O
beta	O
.	O

Exogenous	O
TGF	O
-	O
beta	O
,	O
on	O
the	O
other	O
hand	O
,	O
suppressed	O
LPS	O
-	O
stimulated	O
TNF	B
-	I
alpha	I
release	O
.	O

These	O
findings	O
suggest	O
an	O
autoregulation	O
of	O
microglial	O
cell	O
TNF	B
-	I
alpha	I
production	O
by	O
TGF	O
-	O
beta	O
which	O
may	O
limit	O
inflammation	O
-	O
associated	O
brain	O
injury	O
.	O

Differentially	O
methylated	O
sequences	O
associated	O
with	O
imprinted	O
genes	O
are	O
proposed	O
to	O
control	O
genomic	O
imprinting	O
.	O

A	O
2-kb	O
region	O
located	O
5	O
'	O
to	O
the	O
imprinted	O
mouse	O
H19	B
gene	O
is	O
hypermethylated	O
on	O
the	O
inactive	O
paternal	O
allele	O
throughout	O
development	O
.	O

To	O
determine	O
whether	O
this	O
differentially	O
methylated	O
domain	O
(	O
DMD	O
)	O
is	O
required	O
for	O
imprinted	O
expression	O
at	O
the	O
endogenous	O
locus	O
,	O
we	O
have	O
generated	O
mice	O
harboring	O
a	O
1.6-kb	O
targeted	O
deletion	O
of	O
the	O
DMD	O
and	O
assayed	O
for	O
allelic	O
expression	O
of	O
H19	B
and	O
the	O
linked	O
,	O
oppositely	O
imprinted	O
Igf2	B
gene	O
.	O

H19	B
is	O
activated	O
and	O
Igf2	B
expression	O
is	O
reduced	O
when	O
the	O
DMD	O
deletion	O
is	O
paternally	O
inherited	O
;	O
conversely	O
,	O
upon	O
maternal	O
transmission	O
of	O
the	O
mutation	O
,	O
H19	B
expression	O
is	O
reduced	O
and	O
Igf2	B
is	O
activated	O
.	O

Consistent	O
with	O
the	O
DMD	O
's	O
hypothesized	O
role	O
of	O
setting	O
up	O
the	O
methylation	O
imprint	O
,	O
the	O
mutation	O
also	O
perturbs	O
allele	O
-	O
specific	O
methylation	O
of	O
the	O
remaining	O
H19	B
sequences	O
.	O

In	O
conclusion	O
,	O
these	O
experiments	O
show	O
that	O
the	O
H19	B
hypermethylated	O
5	O
'	O
flanking	O
sequences	O
are	O
required	O
to	O
silence	O
paternally	O
derived	O
H19	B
.	O

Additionally	O
,	O
these	O
experiments	O
demonstrate	O
a	O
novel	O
role	O
for	O
the	O
DMD	O
on	O
the	O
maternal	O
chromosome	O
where	O
it	O
is	O
required	O
for	O
the	O
maximal	O
expression	O
of	O
H19	B
and	O
the	O
silencing	O
of	O
Igf2	B
.	O

Thus	O
,	O
the	O
H19	B
differentially	O
methylated	O
sequences	O
are	O
required	O
for	O
both	O
H19	B
and	O
Igf2	B
imprinting	O
.	O

The	O
brain	O
5-HT1A	B
receptor	I
system	O
in	O
male	O
wild	O
house	O
mice	O
selected	O
for	O
high	O
and	O
low	O
offensive	O
aggression	O
was	O
investigated	O
by	O
autoradiographic	O
analysis	O
of	O
in	O
situ	O
hybridization	O
and	O
radioligand	O
binding	O
.	O

In	O
high	O
-	O
aggressive	O
mice	O
,	O
characterized	O
by	O
a	O
short	O
attack	O
latency	O
,	O
the	O
rise	O
in	O
plasma	O
corticosterone	O
concentration	O
during	O
the	O
early	O
dark	O
phase	O
was	O
reduced	O
.	O

At	O
that	O
time	O
the	O
level	O
of	O
5-HT1A	O
mRNA	O
in	O
the	O
dorsal	O
hippocampus	O
(	O
dentate	O
gyrus	O
and	O
CA1	O
)	O
was	O
twice	O
the	O
amount	O
measured	O
in	O
low	O
-	O
aggressive	O
mice	O
that	O
had	O
long	O
attack	O
latency	O
and	O
high	O
plasma	O
corticosterone	O
level	O
.	O

Increased	O
postsynaptic	O
5-HT1A	B
receptor	I
radioligand	O
binding	O
was	O
found	O
in	O
dentate	O
gyrus	O
,	O
CA1	O
,	O
lateral	O
septum	O
,	O
and	O
frontal	O
cortex	O
.	O

No	O
difference	O
in	O
ligand	O
binding	O
was	O
found	O
for	O
the	O
5-HT1A	O
autoreceptor	O
on	O
cell	O
bodies	O
in	O
the	O
dorsal	O
raphe	O
nucleus	O
.	O

In	O
conclusion	O
,	O
genetic	O
selection	O
for	O
high	O
offensive	O
aggression	O
co	O
-	O
selects	O
for	O
reduced	O
(	O
circadian	O
peak	O
)	O
level	O
in	O
plasma	O
corticosterone	O
and	O
increased	O
postsynaptic	O
5-HT1A	B
receptor	I
number	O
in	O
limbic	O
and	O
cortical	O
regions	O
.	O

Leukotrienes	O
are	O
potent	O
inflammatory	O
mediators	O
synthesized	O
from	O
arachidonic	O
acid	O
(	O
AA	O
)	O
predominately	O
by	O
cells	O
of	O
myeloid	O
origin	O
.	O

The	O
synthesis	O
of	O
these	O
lipids	O
is	O
believed	O
to	O
be	O
dependent	O
not	O
only	O
on	O
the	O
expression	O
of	O
the	O
enzyme	O
5-lipoxygenase	O
(	O
5-LO	O
)	O
,	O
which	O
catalyzes	O
the	O
first	O
steps	O
in	O
the	O
synthesis	O
of	O
leukotrienes	O
,	O
but	O
also	O
on	O
expression	O
of	O
a	O
nuclear	O
membrane	O
protein	O
termed	O
the	O
5-LO	O
-	O
activating	O
protein	O
(	O
FLAP	B
)	O
.	O

To	O
study	O
the	O
relationship	O
of	O
these	O
two	O
proteins	O
in	O
mediating	O
the	O
production	O
of	O
leukotrienes	O
in	O
vivo	O
and	O
to	O
determine	O
whether	O
the	O
membrane	O
protein	O
FLAP	B
has	O
additional	O
functions	O
in	O
various	O
inflammatory	O
processes	O
,	O
we	O
have	O
generated	O
a	O
mouse	O
line	O
deficient	O
in	O
this	O
protein	O
.	O

FLAP	B
-	O
deficient	O
mice	O
develop	O
normally	O
and	O
are	O
healthy	O
.	O

However	O
,	O
an	O
array	O
of	O
assays	O
comparing	O
inflammatory	O
reactions	O
in	O
FLAP	B
-	O
deficient	O
mice	O
and	O
in	O
normal	O
controls	O
revealed	O
that	O
FLAP	B
plays	O
a	O
role	O
in	O
a	O
subset	O
of	O
these	O
reactions	O
.	O

Although	O
examination	O
of	O
DTH	O
and	O
IgE	O
-	O
mediated	O
passive	O
anaphylaxis	O
showed	O
no	O
difference	O
between	O
wild	O
-	O
type	O
and	O
FLAP	B
-	O
deficient	O
animals	O
,	O
mice	O
without	O
FLAP	B
possessed	O
a	O
blunted	O
inflammatory	O
response	O
to	O
topical	O
AA	O
and	O
had	O
increased	O
resistance	O
to	O
platelet	O
-	O
activating	O
factor	O
-	O
induced	O
shock	O
compared	O
to	O
controls	O
.	O

Also	O
,	O
edema	O
associated	O
with	O
Zymosan	O
A	O
-	O
induced	O
peritonitis	O
was	O
markedly	O
reduced	O
in	O
animals	O
lacking	O
FLAP	B
.	O

To	O
determine	O
whether	O
these	O
differences	O
relate	O
solely	O
to	O
a	O
deficit	O
in	O
leukotriene	O
production	O
,	O
or	O
whether	O
they	O
reflect	O
an	O
additional	O
role	O
for	O
FLAP	B
in	O
inflammation	O
,	O
we	O
compared	O
the	O
FLAP	B
-	O
deficient	O
mice	O
to	O
5-LO	O
-	O
deficient	O
animals	O
.	O

Evaluation	O
of	O
mice	O
lacking	O
FLAP	B
and	O
5-LO	O
indicated	O
that	O
production	O
of	O
leukotrienes	O
during	O
inflammatory	O
responses	O
is	O
dependent	O
upon	O
the	O
availability	O
of	O
FLAP	B
and	O
did	O
not	O
support	O
additional	O
functions	O
for	O
FLAP	B
beyond	O
its	O
role	O
in	O
leukotriene	O
production	O
.	O

Combining	O
congenic	O
mapping	O
with	O
microarray	O
expression	O
profiling	O
offers	O
an	O
opportunity	O
to	O
establish	O
functional	O
links	O
between	O
genotype	O
and	O
phenotype	O
for	O
complex	O
traits	O
such	O
as	O
type	O
1	O
diabetes	O
(	O
T1D	O
)	O
.	O

We	O
used	O
high	O
-	O
density	O
oligonucleotide	O
arrays	O
to	O
measure	O
the	O
relative	O
expression	O
levels	O
of	O
>	O
39,000	O
genes	O
and	O
ESTs	O
in	O
the	O
NOD	O
mouse	O
(	O
a	O
murine	O
model	O
of	O
T1D	O
and	O
other	O
autoimmune	O
conditions	O
)	O
,	O
four	O
NOD	O
-	O
derived	O
diabetes	O
-	O
resistant	O
congenic	O
strains	O
,	O
and	O
two	O
nondiabetic	O
control	O
strains	O
.	O

We	O
developed	O
a	O
simple	O
,	O
yet	O
general	O
,	O
method	O
for	O
measuring	O
differential	O
expression	O
that	O
provides	O
an	O
objective	O
assessment	O
of	O
significance	O
and	O
used	O
it	O
to	O
identify	O
>	O
400	O
gene	O
expression	O
differences	O
and	O
eight	O
new	O
candidates	O
for	O
the	O
Idd9.1	B
locus	O
.	O

We	O
also	O
discovered	O
a	O
potential	O
early	O
biomarker	O
for	O
autoimmune	O
hemolytic	O
anemia	O
that	O
is	O
based	O
on	O
different	O
levels	O
of	O
erythrocyte	O
-	O
specific	O
transcripts	O
in	O
the	O
spleen	O
.	O

Overall	O
,	O
however	O
,	O
our	O
results	O
suggest	O
that	O
the	O
dramatic	O
disease	O
protection	O
conferred	O
by	O
six	O
Idd	O
loci	O
(	O
Idd3	B
,	O
Idd5.1	B
,	O
Idd5.2	B
,	O
Idd9.1	B
,	O
Idd9.2	B
,	O
and	O
Idd9.3	B
)	O
can	O
not	O
be	O
rationalized	O
in	O
terms	O
of	O
global	O
effects	O
on	O
the	O
noninduced	O
immune	O
system	O
.	O

They	O
also	O
illustrate	O
the	O
degree	O
to	O
which	O
regulatory	O
systems	O
appear	O
to	O
be	O
robust	O
to	O
genetic	O
variation	O
.	O

These	O
observations	O
have	O
important	O
implications	O
for	O
the	O
design	O
of	O
future	O
microarray	O
-	O
based	O
studies	O
in	O
T1D	O
and	O
,	O
more	O
generally	O
,	O
for	O
studies	O
that	O
aim	O
to	O
combine	O
genome	O
-	O
wide	O
expression	O
profiling	O
and	O
congenic	O
mapping	O
.	O

Cripto	B
protein	O
is	O
a	O
member	O
of	O
the	O
""""	O
EGF	O
family	O
""""	O
of	O
growth	O
factors	O
present	O
in	O
colon	O
tumors	O
and	O
in	O
human	O
and	O
mouse	O
undifferentiated	O
teratocarcinoma	O
cells	O
.	O

During	O
gastrulation	O
in	O
the	O
mouse	O
,	O
cripto	B
-	O
encoding	O
transcripts	O
are	O
expressed	O
in	O
the	O
forming	O
mesoderm	O
and	O
later	O
in	O
the	O
truncus	O
arteriosus	O
of	O
the	O
developing	O
heart	O
.	O

As	O
a	O
necessary	O
step	O
prior	O
to	O
investigating	O
the	O
in	O
vivo	O
role	O
of	O
cripto	B
through	O
gene	O
disruption	O
,	O
we	O
have	O
isolated	O
all	O
the	O
genomic	O
cripto	B
-	O
related	O
sequences	O
in	O
the	O
mouse	O
.	O

One	O
gene	O
(	O
Tdgf1	B
)	O
and	O
two	O
pseudogenes	O
(	O
Tdgf2	B
and	O
Tdgf3	B
)	O
have	O
been	O
isolated	O
and	O
characterized	O
.	O

The	O
mouse	O
Tdgf1	B
(	O
coding	O
for	O
cripto	B
)	O
,	O
like	O
the	O
human	O
gene	O
,	O
is	O
divided	O
into	O
six	O
exons	O
.	O

Comparison	O
of	O
the	O
human	O
and	O
mouse	O
genomic	O
sequences	O
reveals	O
that	O
mouse	O
exons	O
1	O
and	O
3	O
are	O
shorter	O
than	O
the	O
corresponding	O
human	O
exons	O
.	O

The	O
pseudogene	O
Tdgf2	B
corresponds	O
to	O
about	O
1	O
kb	O
of	O
the	O
mRNA	O
and	O
contains	O
five	O
base	O
substitutions	O
in	O
the	O
coding	O
region	O
that	O
represent	O
both	O
silent	O
and	O
replacement	O
substitutions	O
.	O

The	O
pseudogene	O
Tdgf3	B
corresponds	O
only	O
to	O
the	O
coding	O
portion	O
of	O
Tdgf	O
.	O

Many	O
mutations	O
have	O
been	O
introduced	O
in	O
this	O
pseudogene	O
,	O
suggesting	O
its	O
early	O
origin	O
.	O

Alignments	O
of	O
the	O
Tdgf3	B
,	O
human	O
and	O
mouse	O
mRNA	O
sequences	O
,	O
shows	O
that	O
this	O
pseudogene	O
has	O
retained	O
the	O
33	O
nucleotides	O
of	O
the	O
human	O
exon	O
3	O
that	O
are	O
missed	O
in	O
the	O
Tdgf1	B
gene	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
Tdgf3	B
is	O
derived	O
from	O
an	O
ancestral	O
gene	O
and	O
that	O
the	O
human	O
and	O
mouse	O
genes	O
are	O
probably	O
evolving	O
separately	O
.	O

Certain	O
mouse	O
strains	O
(	O
e.g.	O
,	O
DBA	O
/	O
2	O
)	O
contain	O
two	O
renin	O
genes	O
(	O
termed	O
Ren-1	B
and	O
Ren-2	B
)	O
and	O
express	O
higher	O
renin	O
levels	O
in	O
nonkidney	O
tissues	O
than	O
strains	O
with	O
a	O
single	O
renin	O
gene	O
.	O

The	O
5'-flanking	O
regions	O
of	O
the	O
Ren-1	B
and	O
Ren-2	B
genes	O
contain	O
several	O
TATA	O
boxes	O
preceding	O
putative	O
transcriptional	O
start	O
sites	O
.	O

These	O
initiators	O
are	O
termed	O
P1a	O
,	O
P1	O
,	O
P2	O
(	O
from	O
5	O
'	O
to	O
3	O
'	O
)	O
,	O
and	O
their	O
function	O
(	O
with	O
the	O
exception	O
of	O
P2	O
)	O
is	O
largely	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
mapped	O
the	O
renin	O
transcriptional	O
start	O
sites	O
in	O
renal	O
and	O
extrarenal	O
tissues	O
[	O
adrenal	O
,	O
brain	O
,	O
testis	O
,	O
heart	O
,	O
and	O
submandibular	O
gland	O
(	O
SMG	O
)	O
]	O
and	O
examined	O
the	O
effect	O
of	O
adenosine	O
3',5'-cyclic	O
monophosphate	O
(	O
cAMP	O
)	O
on	O
tissue	O
specific	O
promoter	O
usage	O
.	O

Our	O
results	O
showed	O
that	O
,	O
in	O
the	O
unstimulated	O
state	O
,	O
P2	O
(	O
the	O
predicted	O
initiator	O
)	O
is	O
active	O
in	O
all	O
DBA	O
/	O
2	O
mouse	O
tissues	O
.	O

Additional	O
transcriptional	O
start	O
sites	O
were	O
detected	O
in	O
the	O
adrenal	O
and	O
testis	O
(	O
originated	O
by	O
P1a	O
and	O
P2	O
)	O
and	O
the	O
SMG	O
(	O
originated	O
by	O
P1a	O
,	O
P1	O
,	O
and	O
P2	O
)	O
.	O

The	O
administration	O
of	O
8-bromoadenosine	O
3',5'-cyclic	O
monophosphate	O
led	O
to	O
selective	O
stimulation	O
of	O
P1a	O
in	O
the	O
adrenal	O
but	O
did	O
not	O
affect	O
the	O
selective	O
usage	O
of	O
initiation	O
sites	O
in	O
other	O
organs	O
.	O

A	O
locus	O
-	O
specific	O
ddNTP	O
primer	O
extension	O
assay	O
was	O
used	O
to	O
verify	O
which	O
renin	O
gene	O
is	O
induced	O
by	O
cAMP	O
.	O

Results	O
indicated	O
that	O
both	O
Ren-1	B
and	O
Ren-2	B
responded	O
to	O
cAMP	O
treatment	O
in	O
identical	O
fashion	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
more	O
than	O
one	O
form	O
of	O
renin	O
transcript	O
is	O
present	O
in	O
several	O
mouse	O
tissues	O
.	O

There	O
is	O
tissue	O
specificity	O
in	O
promoter	O
usage	O
in	O
the	O
unstimulated	O
state	O
and	O
in	O
response	O
to	O
cAMP	O
.	O

The	O
injection	O
of	O
Schistosoma	O
mansoni	O
eggs	O
into	O
the	O
footpads	O
of	O
mice	O
results	O
in	O
a	O
localized	O
Th2	O
cytokine	O
response	O
and	O
tissue	O
eosinophilia	O
.	O

We	O
examined	O
whether	O
treatment	O
with	O
CD40-activating	O
Abs	O
would	O
block	O
the	O
development	O
of	O
Th2	O
cytokine	O
responses	O
and	O
eosinophilic	O
tissue	O
pathology	O
in	O
this	O
model	O
.	O

Seven	O
days	O
after	O
C57BL	O
/	O
6	O
mice	O
were	O
injected	O
with	O
eggs	O
and	O
the	O
FGK45	O
anti	O
-	O
CD40	O
Ab	O
,	O
Ag	O
-	O
specific	O
synthesis	O
of	O
IL-4	B
,	O
IL-5	B
,	O
and	O
IL-13	B
in	O
lymph	O
node	O
culture	O
was	O
reduced	O
(	O
>	O
10-fold	O
)	O
relative	O
to	O
control	O
mice	O
treated	O
with	O
eggs	O
and	O
rat	O
IgG.	O
In	O
contrast	O
,	O
IFN	B
-	I
gamma	I
and	O
IL-12	O
were	O
increased	O
in	O
both	O
culture	O
supernatants	O
and	O
in	O
the	O
serum	O
.	O

Similar	O
changes	O
in	O
lymph	O
node	O
cytokine	O
mRNA	O
were	O
observed	O
in	O
vivo	O
,	O
and	O
tissue	O
eosinophilia	O
was	O
reduced	O
nearly	O
20-fold	O
.	O

Th2	O
cytokine	O
responses	O
in	O
anti	O
-	O
CD40-treated	O
IFN	B
-	I
gamma-	I
/	O
-	O
and	O
IL-12	B
p40-	I
/	O
-	O
C57BL	O
/	O
6	O
mice	O
were	O
unaffected	O
,	O
although	O
anti	O
-	O
CD40	O
induced	O
high	O
levels	O
of	O
systemic	O
and	O
local	O
IFN	B
-	I
gamma	I
production	O
in	O
both	O
wild	O
-	O
type	O
and	O
IL-12	B
p40-	I
/	O
-	O
mice	O
.	O

We	O
conclude	O
that	O
CD40-activating	O
treatments	O
strongly	O
reverse	O
the	O
immune	O
phenotype	O
generated	O
in	O
response	O
to	O
a	O
classic	O
,	O
Th2-biasing	O
stimulus	O
and	O
stimulate	O
IFN	B
-	I
gamma	I
through	O
a	O
novel	O
IL-12-independent	O
pathway	O
.	O

This	O
model	O
for	O
Th1-deviating	O
immune	O
therapy	O
may	O
have	O
relevance	O
to	O
the	O
treatment	O
of	O
Th2-dependent	O
diseases	O
in	O
general	O
.	O

The	O
genetic	O
linkage	O
map	O
of	O
sheep	O
Chromosome	O
(	O
Chr	O
)	O
6	O
has	O
been	O
extended	O
to	O
include	O
35	O
loci	O
with	O
the	O
addition	O
of	O
11	O
RFLP	O
and	O
12	O
microsatellite	O
loci	O
.	O

The	O
sex	O
-	O
averaged	O
linkage	O
map	O
now	O
spans	O
154	O
cM	O
from	O
phosphodiesterase	O
cyclic	O
GMP	O
beta	O
polypeptide	O
(	O
PDE6B	O
)	O
to	O
OarCP125	O
,	O
an	O
anonymous	O
sheep	O
microsatellite	O
.	O

The	O
male	O
and	O
female	O
map	O
lengths	O
,	O
at	O
180	O
cM	O
and	O
132	O
cM	O
respectively	O
,	O
did	O
not	O
differ	O
significantly	O
.	O

The	O
physical	O
assignment	O
of	O
PDE6B	O
to	O
Chr	O
6q33-qter	O
orientates	O
the	O
linkage	O
map	O
on	O
sheep	O
Chr	O
6	O
with	O
PDE6B	O
near	O
the	O
telomere	O
and	O
OarCP125	O
towards	O
the	O
centromere	O
.	O

The	O
order	O
and	O
genetic	O
distances	O
between	O
loci	O
are	O
similar	O
for	O
the	O
sheep	O
Chr	O
6	O
and	O
cattle	O
Chr	O
6	O
maps	O
,	O
except	O
for	O
the	O
position	O
of	O
the	O
casein	O
genes	O
.	O

The	O
sheep	O
Chr	O
6	O
linkage	O
map	O
is	O
also	O
comparable	O
to	O
portions	O
of	O
human	O
Chr	O
4	O
,	O
mouse	O
Chrs	O
5	O
and	O
3	O
,	O
and	O
pig	O
Chr	O
8	O
.	O

The	O
synteny	O
between	O
sheep	O
Chr	O
6	O
and	O
human	O
Chr	O
4	O
has	O
been	O
extended	O
from	O
PDE6B	O
(	O
4p16.3	O
)	O
to	O
epidermal	B
growth	I
factor	I
(	O
EGF	B
,	O
4q25-q27	O
)	O
.	O

However	O
,	O
a	O
region	O
from	O
platelet	O
-	O
derived	O
growth	O
factor	O
receptor	O
alpha	O
polypeptide	O
(	O
PDGFRA	B
)	O
to	O
bone	B
morphogenetic	I
protein	I
3	I
(	O
BMP3	B
)	O
,	O
which	O
spans	O
19	O
cM	O
on	O
sheep	O
Chr	O
6	O
,	O
appears	O
to	O
be	O
inverted	O
with	O
respect	O
to	O
the	O
human	O
and	O
mouse	O
loci	O
.	O

Other	O
differences	O
in	O
the	O
gene	O
order	O
between	O
sheep	O
,	O
pig	O
,	O
and	O
mouse	O
suggest	O
more	O
complex	O
rearrangements	O
.	O

Cutaneous	O
malignant	O
melanoma	O
(	O
CMM	O
)	O
,	O
already	O
known	O
for	O
its	O
highly	O
aggressive	O
behavior	O
and	O
resistance	O
to	O
conventional	O
therapy	O
,	O
has	O
evolved	O
into	O
a	O
health	O
crisis	O
by	O
virtue	O
of	O
a	O
dramatic	O
elevation	O
in	O
incidence	O
.	O

The	O
underlying	O
genetic	O
basis	O
for	O
CMM	O
,	O
as	O
well	O
as	O
the	O
fundamental	O
role	O
for	O
UV	O
radiation	O
in	O
its	O
etiology	O
,	O
is	O
now	O
widely	O
accepted	O
.	O

However	O
,	O
the	O
only	O
bona	O
fide	O
genetic	O
locus	O
to	O
emerge	O
from	O
extensive	O
analysis	O
of	O
CMM	O
suppressor	O
candidates	O
is	O
INK4a	O
/	O
ARF	B
at	O
9p21	O
,	O
which	O
is	O
lost	O
frequently	O
in	O
familial	O
and	O
occasionally	O
in	O
somatic	O
CMM	O
.	O

The	O
functional	O
relationship	O
between	O
INK4a	O
/	O
ARF	B
and	O
UV	O
radiation	O
in	O
the	O
pathogenesis	O
of	O
CMM	O
is	O
largely	O
unknown	O
.	O

Recently	O
,	O
we	O
reported	O
that	O
hepatocyte	B
growth	I
factor	I
/	O
scatter	B
factor	I
(	O
HGF	B
/	I
SF	I
)	O
-transgenic	O
mice	O
develop	O
melanomas	O
after	O
a	O
single	O
erythemal	O
dose	O
of	O
neonatal	O
UV	O
radiation	O
,	O
supporting	O
epidemiological	O
data	O
implicating	O
childhood	O
sunburn	O
in	O
CMM	O
.	O

Here	O
we	O
show	O
that	O
neonatal	O
UV	O
irradiation	O
induces	O
a	O
full	O
spectrum	O
of	O
melanocyte	O
pathology	O
from	O
early	O
premalignant	O
lesions	O
through	O
distant	O
metastases	O
.	O

Cutaneous	O
melanomas	O
arise	O
with	O
histopathological	O
and	O
molecular	O
pathogenetic	O
features	O
remarkably	O
similar	O
to	O
CMM	O
,	O
including	O
loss	O
of	O
ink4a	O
/	O
arf	B
.	O

A	O
role	O
for	O
ink4a	O
/	O
arf	B
in	O
UV	O
-	O
induced	O
melanomagenesis	O
was	O
directly	O
assessed	O
by	O
placing	O
the	O
HGF	B
/	I
SF	I
transgene	O
on	O
a	O
genetic	O
background	O
devoid	O
of	O
ink4a	O
/	O
arf	B
.	O

Median	O
time	O
to	O
melanoma	O
development	O
induced	O
by	O
UV	O
radiation	O
was	O
only	O
50	O
days	O
in	O
HGF	B
/	I
SF	I
ink4a	O
/	O
arf	B
(	I
-	I
/	I
-	I
)	I
mice	O
,	O
compared	O
with	O
152	O
and	O
238	O
days	O
in	O
HGF	B
/	I
SF	I
ink4a	O
/	O
arf	B
(	I
+	I
/	I
-	I
)	I
and	O
HGF	B
/	I
SF	I
ink4a	O
/	O
arf	B
(	I
+	I
/	I
+	I
)	I
mice	O
,	O
respectively	O
.	O

These	O
studies	O
provide	O
experimental	O
evidence	O
that	O
ink4a	O
/	O
arf	B
plays	O
a	O
critical	O
role	O
in	O
UV	O
-	O
induced	O
melanomagenesis	O
and	O
strongly	O
suggest	O
that	O
sunburn	O
is	O
a	O
highly	O
significant	O
risk	O
factor	O
,	O
particularly	O
in	O
families	O
harboring	O
germ	O
-	O
line	O
mutations	O
in	O
INK4a	O
/	O
ARF	B
.	O

Reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
have	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
many	O
clinical	O
disorders	O
such	O
as	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
ischemia	O
-	O
reperfusion	O
injury	O
,	O
atherosclerosis	O
,	O
neurodegenerative	O
diseases	O
,	O
and	O
cancer	O
.	O

Genetically	O
engineered	O
animal	O
models	O
have	O
been	O
used	O
as	O
a	O
tool	O
for	O
understanding	O
the	O
function	O
of	O
various	O
antioxidant	O
enzymes	O
in	O
cellular	O
defense	O
mechanisms	O
against	O
various	O
types	O
of	O
oxidant	O
tissue	O
injury	O
.	O

Transgenic	O
mice	O
overexpressing	O
three	O
isoforms	O
of	O
superoxide	O
dismutase	O
,	O
catalase	B
,	O
and	O
the	O
cellular	O
glutathione	O
peroxidase	O
(	O
GSHPx-1	B
)	O
in	O
various	O
tissues	O
show	O
an	O
increased	O
tolerance	O
to	O
ischemia	O
-	O
reperfusion	O
heart	O
and	O
brain	O
injury	O
,	O
hyperoxia	O
,	O
cold	O
-	O
induced	O
brain	O
edema	O
,	O
adriamycin	O
,	O
and	O
paraquat	O
toxicity	O
.	O

These	O
results	O
have	O
provided	O
for	O
the	O
first	O
time	O
direct	O
evidence	O
demonstrating	O
the	O
importance	O
of	O
each	O
of	O
these	O
antioxidant	O
enzymes	O
in	O
protecting	O
the	O
animals	O
against	O
the	O
injury	O
resulting	O
from	O
these	O
insults	O
,	O
as	O
well	O
as	O
the	O
effect	O
of	O
an	O
enhanced	O
level	O
of	O
antioxidant	O
in	O
ameliorating	O
the	O
oxidant	O
tissue	O
injury	O
.	O

To	O
evaluate	O
further	O
the	O
nature	O
of	O
these	O
enzymes	O
in	O
antioxidant	O
defense	O
,	O
gene	O
knockout	O
mice	O
deficient	O
in	O
copper	O
-	O
zinc	O
superoxide	O
dismutase	O
(	O
CuZnSOD	B
)	O
and	O
GSHPx-1	B
have	O
also	O
been	O
generated	O
in	O
our	O
laboratory	O
.	O

These	O
mice	O
developed	O
normally	O
and	O
showed	O
no	O
marked	O
pathologic	O
changes	O
under	O
normal	O
physiologic	O
conditions	O
.	O

In	O
addition	O
,	O
a	O
deficiency	O
in	O
these	O
genes	O
had	O
no	O
effects	O
on	O
animal	O
survival	O
under	O
hyperoxida	O
.	O

However	O
,	O
these	O
knockout	O
mice	O
exhibited	O
a	O
pronounced	O
susceptibility	O
to	O
paraquat	O
toxicity	O
and	O
myocardial	O
ischemia	O
-	O
reperfusion	O
injury	O
.	O

Furthermore	O
,	O
female	O
mice	O
lacking	O
CuZnSOD	B
also	O
displayed	O
a	O
marked	O
increase	O
in	O
postimplantation	O
embryonic	O
lethality	O
.	O

These	O
animals	O
should	O
provide	O
a	O
useful	O
model	O
for	O
uncovering	O
the	O
identity	O
of	O
ROS	O
that	O
participate	O
in	O
the	O
pathogenesis	O
of	O
various	O
clinical	O
disorders	O
and	O
for	O
defining	O
the	O
role	O
of	O
each	O
antioxidant	O
enzyme	O
in	O
cellular	O
defense	O
against	O
oxidant	O
-	O
mediated	O
tissue	O
injury	O
.	O

Morphometric	O
analysis	O
of	O
cerebellar	O
foliation	O
patterns	O
at	O
the	O
midsagittal	O
plane	O
was	O
done	O
in	O
the	O
inbred	O
strains	O
BALB	O
/	O
cByJ	O
,	O
C57BL	O
/	O
6ByJ	O
and	O
their	O
7	O
recombinant	O
inbred	O
strains	O
in	O
order	O
to	O
assess	O
possible	O
major	O
gene	O
influences	O
.	O

The	O
cerebellum	O
was	O
dissected	O
away	O
from	O
the	O
brainstem	O
and	O
weighed	O
prior	O
to	O
histology	O
so	O
that	O
measures	O
of	O
the	O
depth	O
of	O
fissures	O
and	O
sulci	O
could	O
be	O
related	O
to	O
overall	O
size	O
of	O
the	O
brain	O
and	O
cerebellum	O
.	O

Results	O
for	O
177	O
mice	O
revealed	O
that	O
many	O
brains	O
had	O
extra	O
sulci	O
present	O
within	O
the	O
central	O
lobe	O
,	O
the	O
culmen	O
,	O
the	O
declive	O
and	O
the	O
uvula	O
,	O
and	O
that	O
patterns	O
within	O
a	O
genetically	O
uniform	O
inbred	O
strain	O
were	O
highly	O
variable	O
.	O

The	O
measure	O
of	O
sulcus	O
depth	O
was	O
continuous	O
,	O
showing	O
no	O
evidence	O
of	O
a	O
normal	O
versus	O
abnormal	O
dichotomy	O
.	O

Furthermore	O
,	O
the	O
frequency	O
and	O
depth	O
of	O
extra	O
sulci	O
were	O
greater	O
in	O
mice	O
with	O
larger	O
cerebella	O
.	O

Strain	O
differences	O
in	O
size	O
of	O
the	O
whole	O
brain	O
and	O
cerebellum	O
clearly	O
resulted	O
from	O
several	O
genetic	O
loci	O
.	O

This	O
was	O
also	O
true	O
of	O
the	O
extra	O
sulci	O
,	O
except	O
for	O
the	O
declival	O
sulcus	O
which	O
revealed	O
a	O
single	O
gene	O
influence	O
.	O

The	O
gene	O
symbol	O
'	O
declival	B
sulcus	I
of	I
cerebellum	I
'	O
(	O
dsc	B
)	O
is	O
proposed	O
.	O

Hypoxia	O
stimulates	O
angiogenesis	O
through	O
the	O
binding	O
of	O
hypoxia	O
-	O
inducible	O
factors	O
to	O
the	O
hypoxia	O
-	O
response	O
element	O
in	O
the	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
Vegf	B
)	O
promotor	O
.	O

Here	O
,	O
we	O
report	O
that	O
deletion	O
of	O
the	O
hypoxia	O
-	O
response	O
element	O
in	O
the	O
Vegf	B
promotor	O
reduced	O
hypoxic	O
Vegf	B
expression	O
in	O
the	O
spinal	O
cord	O
and	O
caused	O
adult	O
-	O
onset	O
progressive	O
motor	O
neuron	O
degeneration	O
,	O
reminiscent	O
of	O
amyotrophic	O
lateral	O
sclerosis	O
.	O

The	O
neurodegeneration	O
seemed	O
to	O
be	O
due	O
to	O
reduced	O
neural	O
vascular	O
perfusion	O
.	O

In	O
addition	O
,	O
Vegf165	O
promoted	O
survival	O
of	O
motor	O
neurons	O
during	O
hypoxia	O
through	O
binding	O
to	O
Vegf	B
receptor	O
2	O
and	O
neuropilin	B
1	O
.	O

Acute	O
ischemia	O
is	O
known	O
to	O
cause	O
nonselective	O
neuronal	O
death	O
.	O

Our	O
results	O
indicate	O
that	O
chronic	O
vascular	O
insufficiency	O
and	O
,	O
possibly	O
,	O
insufficient	O
Vegf	B
-	O
dependent	O
neuroprotection	O
lead	O
to	O
the	O
select	O
degeneration	O
of	O
motor	O
neurons	O
.	O

We	O
recently	O
reported	O
that	O
an	O
8-kilobase	O
(	O
kb	O
)	O
region	O
,	O
spanning	O
from	O
-54	O
to	O
-62	O
kb	O
5	O
'	O
of	O
the	O
human	O
apolipoprotein	B
B	I
(	O
apoB	B
)	O
gene	O
,	O
contains	O
intestine	O
-	O
specific	O
regulatory	O
elements	O
that	O
control	O
apoB	B
expression	O
in	O
the	O
intestines	O
of	O
transgenic	O
mice	O
.	O

In	O
this	O
study	O
,	O
we	O
further	O
localized	O
the	O
apoB	B
intestinal	O
control	O
region	O
to	O
a	O
3-kb	O
segment	O
(	O
-54	O
to	O
-57	O
kb	O
)	O
.	O

DNaseI	B
hypersensitivity	O
studies	O
uncovered	O
a	O
prominent	O
DNaseI	B
hypersensitivity	O
site	O
,	O
located	O
within	O
a	O
315-base	O
pair	O
(	O
bp	O
)	O
fragment	O
at	O
the	O
5'-end	O
of	O
the	O
3-kb	O
segment	O
,	O
in	O
transcriptionally	O
active	O
CaCo-2	O
cells	O
but	O
not	O
in	O
transcriptionally	O
inactive	O
HeLa	O
cells	O
.	O

Transient	O
transfection	O
experiments	O
with	O
CaCo-2	O
and	O
HepG2	O
cells	O
indicated	O
that	O
the	O
315-bp	O
fragment	O
contained	O
an	O
intestine	O
-	O
specific	O
enhancer	O
,	O
and	O
analysis	O
of	O
the	O
DNA	O
sequence	O
revealed	O
putative	O
binding	O
sites	O
for	O
the	O
tissue	O
-	O
specific	O
transcription	O
factors	O
hepatocyte	O
nuclear	O
factor	O
3beta	O
,	O
hepatocyte	O
nuclear	O
factor	O
4	O
,	O
and	O
CAAT	O
enhancer	O
-	O
binding	O
protein	O
beta	O
.	O

Binding	O
of	O
these	O
factors	O
to	O
the	O
315-bp	O
enhancer	O
was	O
demonstrated	O
in	O
gel	O
retardation	O
experiments	O
.	O

Transfection	O
of	O
deletion	O
mutants	O
of	O
the	O
315-bp	O
enhancer	O
revealed	O
the	O
relative	O
contributions	O
of	O
these	O
transcription	O
factors	O
in	O
the	O
activity	O
of	O
the	O
apoB	B
intestinal	O
enhancer	O
.	O

The	O
corresponding	O
segment	O
of	O
the	O
mouse	O
apoB	B
gene	O
(	O
located	O
-40	O
to	O
-83	O
kb	O
5	O
'	O
of	O
the	O
structural	O
gene	O
)	O
exhibited	O
a	O
high	O
degree	O
of	O
sequence	O
conservation	O
in	O
the	O
binding	O
sites	O
for	O
the	O
key	O
transcriptional	O
activators	O
and	O
also	O
exhibited	O
enhancer	O
activity	O
in	O
transient	O
transfection	O
assays	O
with	O
CaCo-2	O
cells	O
.	O

In	O
transgenic	O
mouse	O
expression	O
studies	O
,	O
the	O
315-bp	O
enhancer	O
conferred	O
intestinal	O
expression	O
to	O
human	O
apoB	B
transgenes	O
.	O

The	O
retinoblastoma	B
1	I
gene	O
was	O
assigned	O
to	O
mouse	O
chromosome	O
14	O
at	O
band	O
D3	O
and	O
rat	O
chromosome	O
15	O
at	O
band	O
q12	O
,	O
respectively	O
,	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
.	O

These	O
results	O
suggest	O
the	O
syntenic	O
association	O
between	O
human	O
13q14	O
,	O
mouse	O
14D3	O
and	O
rat	O
15q12	O
.	O

DEAD	O
-	O
box	O
proteins	O
are	O
a	O
large	O
group	O
of	O
putative	O
RNA	O
helicases	O
that	O
exist	O
ubiquitously	O
in	O
organisms	O
ranging	O
from	O
bacteria	O
to	O
humans	O
.	O

They	O
are	O
likely	O
to	O
play	O
important	O
roles	O
in	O
many	O
different	O
RNA	O
metabolic	O
processes	O
.	O

In	O
this	O
paper	O
,	O
we	O
report	O
the	O
cloning	O
of	O
human	O
DDX24	B
,	O
a	O
putative	O
DEAD	O
-	O
box	O
protein	O
,	O
and	O
its	O
ortholog	O
,	O
Ddx24	B
in	O
mouse	O
.	O

The	O
deduced	O
proteins	O
encoded	O
by	O
these	O
two	O
cDNAs	O
share	O
78.7	O
%	O
identity	O
at	O
the	O
amino	O
acid	O
level	O
and	O
possess	O
all	O
the	O
well	O
-	O
conserved	O
motifs	O
of	O
DEAD	O
-	O
box	O
proteins	O
.	O

However	O
,	O
little	O
homology	O
can	O
be	O
found	O
between	O
them	O
and	O
other	O
DEAD	O
-	O
box	O
proteins	O
,	O
even	O
in	O
their	O
core	O
region	O
(	O
identity	O
<	O
40	O
%	O
)	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
a	O
3.0-kb	O
transcript	O
of	O
human	O
DDX24	B
exists	O
ubiquitously	O
in	O
the	O
16	O
human	O
tissues	O
examined	O
and	O
was	O
most	O
abundant	O
in	O
heart	O
and	O
brain	O
,	O
but	O
with	O
lowest	O
levels	O
in	O
thymus	O
and	O
small	O
intestine	O
.	O

The	O
mouse	O
Ddx24	B
,	O
whose	O
transcript	O
is	O
4.0	O
kb	O
,	O
was	O
also	O
expressed	O
widely	O
in	O
10	O
tissues	O
tested	O
with	O
the	O
highest	O
level	O
in	O
heart	O
and	O
testis	O
.	O

By	O
radiation	O
hybrid	O
mapping	O
,	O
the	O
human	O
DDX24	B
gene	O
was	O
localized	O
to	O
human	O
chromosome	O
14q32	O
between	O
the	O
markers	O
D14S81	O
and	O
D14S265	O
.	O

Moreover	O
,	O
the	O
gene	O
structure	O
of	O
DDX24	B
was	O
determined	O
by	O
comparing	O
its	O
cDNA	O
and	O
genomic	O
sequence	O
from	O
BAC	O
R-1089B7	O
,	O
which	O
showed	O
that	O
the	O
gene	O
spanned	O
a	O
30-kb	O
region	O
and	O
consisted	O
of	O
at	O
least	O
nine	O
exons	O
.	O

Activation	O
of	O
the	O
transcription	O
factor	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappaB	O
)	O
is	O
regulated	O
by	O
phosphorylation	O
,	O
ubiquitination	O
,	O
and	O
degradation	O
of	O
its	O
inhibitory	O
factor	O
IkappaB.	O
Very	O
recently	O
,	O
two	O
closely	O
related	O
serine	O
/	O
threonine	O
kinases	O
have	O
been	O
identified	O
as	O
IkappaB	O
kinases	O
which	O
are	O
essential	O
for	O
IkappaB	O
phosphorylation	O
and	O
NF	O
-	O
kappaB	O
activation	O
.	O

Here	O
,	O
we	O
isolated	O
the	O
full	O
-	O
length	O
human	O
cDNA	O
clones	O
encoding	O
these	O
two	O
IkappaB	O
kinases	O
,	O
IKK	B
-	I
alpha	I
and	O
IKK	B
-	I
beta	I
.	O

Both	O
polypeptides	O
contain	O
a	O
conserved	O
amino	O
-	O
terminal	O
kinase	O
domain	O
,	O
a	O
leucine	O
zipper	O
motif	O
and	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
domain	O
at	O
their	O
carboxyl	O
terminus	O
.	O

We	O
showed	O
that	O
IKK	B
-	I
alpha	I
and	O
IKK	B
-	I
beta	I
were	O
coexpressed	O
in	O
most	O
human	O
adult	O
tissues	O
as	O
well	O
as	O
in	O
different	O
developmental	O
stages	O
of	O
mouse	O
embryos	O
,	O
suggesting	O
that	O
they	O
may	O
cooperate	O
in	O
the	O
cells	O
.	O

The	O
IKK	B
-	I
alpha	I
and	O
IKK	B
-	I
beta	I
genes	O
are	O
distinct	O
but	O
evolutionarily	O
conserved	O
.	O

Moreover	O
,	O
the	O
IKK	B
-	I
alpha	I
gene	O
locus	O
was	O
mapped	O
to	O
human	O
chromosome	O
10q24	O
,	O
whereas	O
the	O
IKK	B
-	I
beta	I
gene	O
locus	O
was	O
localized	O
to	O
human	O
chromosome	O
8p11.2	O
.	O

These	O
results	O
indicated	O
that	O
both	O
genes	O
are	O
not	O
clustered	O
on	O
the	O
same	O
chromosome	O
;	O
nevertheless	O
,	O
both	O
genes	O
may	O
be	O
still	O
regulated	O
similarly	O
during	O
development	O
and	O
in	O
adult	O
tissues	O
.	O

To	O
determine	O
the	O
function	O
of	O
the	O
pS2	B
trefoil	O
protein	O
,	O
which	O
is	O
normally	O
expressed	O
in	O
the	O
gastric	O
mucosa	O
,	O
the	O
mouse	O
pS2	B
(	O
mpS2	O
)	O
gene	O
was	O
inactivated	O
.	O

The	O
antral	O
and	O
pyloric	O
gastric	O
mucosa	O
of	O
mpS2-null	O
mice	O
was	O
dysfunctional	O
and	O
exhibited	O
severe	O
hyperplasia	O
and	O
dysplasia	O
.	O

All	O
homozygous	O
mutant	O
mice	O
developed	O
antropyloric	O
adenoma	O
,	O
and	O
30	O
percent	O
developed	O
multifocal	O
intraepithelial	O
or	O
intramucosal	O
carcinomas	O
.	O

The	O
small	O
intestine	O
was	O
characterized	O
by	O
enlarged	O
villi	O
and	O
an	O
abnormal	O
infiltrate	O
of	O
lymphoid	O
cells	O
.	O

These	O
results	O
indicate	O
that	O
mpS2	O
is	O
essential	O
for	O
normal	O
differentiation	O
of	O
the	O
antral	O
and	O
pyloric	O
gastric	O
mucosa	O
and	O
may	O
function	O
as	O
a	O
gastric	O
-	O
specific	O
tumor	O
suppressor	O
gene	O
.	O

Igf2	B
and	O
H19	B
exhibit	O
parent	O
-	O
of	O
-	O
origin	O
-	O
specific	O
monoallelic	O
expression	O
.	O

H19	B
is	O
expressed	O
from	O
the	O
maternal	O
chromosome	O
and	O
Igf2	B
from	O
the	O
paternal	O
.	O

The	O
two	O
genes	O
share	O
enhancer	O
elements	O
and	O
monoallelic	O
expression	O
of	O
both	O
genes	O
is	O
dependent	O
on	O
cis	O
-	O
acting	O
sequences	O
upstream	O
of	O
the	O
H19	B
promoter	O
.	O

In	O
this	O
work	O
we	O
examine	O
the	O
mechanisms	O
by	O
which	O
this	O
region	O
silences	O
the	O
maternal	O
Igf2	B
allele	O
and	O
we	O
demonstrate	O
that	O
deletion	O
of	O
this	O
region	O
can	O
result	O
in	O
high	O
levels	O
of	O
activation	O
of	O
both	O
H19	B
and	O
Igf2	B
from	O
a	O
single	O
chromosome	O
.	O

Moreover	O
,	O
by	O
inserting	O
this	O
cis	O
element	O
between	O
a	O
promoter	O
and	O
its	O
enhancer	O
at	O
a	O
heterologous	O
position	O
,	O
we	O
demonstrate	O
that	O
the	O
sequences	O
carry	O
both	O
insulator	O
activity	O
and	O
the	O
ability	O
to	O
be	O
stably	O
imprinted	O
.	O

We	O
also	O
characterize	O
the	O
insulator	O
in	O
vitro	O
and	O
show	O
that	O
it	O
is	O
neither	O
enhancer	O
nor	O
promoter	O
specific	O
.	O

We	O
have	O
shown	O
in	O
earlier	O
studies	O
,	O
using	O
a	O
mouse	O
model	O
,	O
that	O
the	O
expression	O
of	O
the	O
glutathione	B
peroxidase	I
5	I
protein	O
(	O
GPX5	B
)	O
is	O
restricted	O
to	O
the	O
epididymis	O
and	O
that	O
the	O
accumulation	O
of	O
its	O
corresponding	O
mRNA	O
is	O
hormonally	O
,	O
spatially	O
and	O
temporally	O
regulated	O
throughout	O
postnatal	O
development	O
.	O

We	O
report	O
here	O
,	O
using	O
run	O
-	O
on	O
assays	O
,	O
transient	O
expression	O
experiments	O
as	O
well	O
as	O
gel	O
-	O
shift	O
and	O
footprinting	O
analyses	O
on	O
the	O
findings	O
that	O
at	O
least	O
part	O
of	O
the	O
androgenic	O
control	O
of	O
the	O
GPX5	B
expression	O
is	O
exerted	O
at	O
the	O
transcriptional	O
level	O
via	O
an	O
androgen	O
response	O
element	O
localized	O
in	O
the	O
distal	O
promoter	O
region	O
of	O
the	O
GPX5	B
gene	O
.	O

The	O
gpx5	B
androgen	O
response	O
element	O
(	O
ARE	O
)	O
is	O
found	O
to	O
be	O
consistent	O
with	O
the	O
consensus	O
palindromic	O
steroid	O
-	O
receptor	O
target	O
sequence	O
5'-AGWACWnnnTGTYCT-3	O
'	O
but	O
exhibits	O
a	O
quite	O
weak	O
conservation	O
in	O
the	O
left	O
half	O
site	O
.	O

The	O
data	O
presented	O
here	O
further	O
expand	O
the	O
diversity	O
of	O
sequence	O
able	O
to	O
confer	O
androgen	O
responsiveness	O
.	O

The	O
mechanisms	O
that	O
maintain	O
the	O
epithelial	O
integrity	O
of	O
the	O
gastrointestinal	O
tract	O
remain	O
largely	O
undefined	O
.	O

The	O
gene	O
encoding	O
intestinal	O
trefoil	O
factor	O
(	O
ITF	B
)	O
,	O
a	O
protein	O
secreted	O
throughout	O
the	O
small	O
intestine	O
and	O
colon	O
,	O
was	O
rendered	O
nonfunctional	O
in	O
mice	O
by	O
targeted	O
disruption	O
.	O

Mice	O
lacking	O
ITF	B
had	O
impaired	O
mucosal	O
healing	O
and	O
died	O
from	O
extensive	O
colitis	O
after	O
oral	O
administration	O
of	O
dextran	O
sulfate	O
sodium	O
,	O
an	O
agent	O
that	O
causes	O
mild	O
epithelial	O
injury	O
in	O
wild	O
-	O
type	O
mice	O
.	O

ITF	B
-	O
deficient	O
mice	O
manifested	O
poor	O
epithelial	O
regeneration	O
after	O
injury	O
.	O

These	O
findings	O
reveal	O
a	O
central	O
role	O
for	O
ITF	B
in	O
the	O
maintenance	O
and	O
repair	O
of	O
the	O
intestinal	O
mucosa	O
.	O

Neurofibromatosis	O
type	O
2	O
(	O
NF2	B
)	O
is	O
a	O
complex	O
nervous	O
system	O
disorder	O
characterized	O
by	O
the	O
development	O
of	O
schwannomas	O
(	O
especially	O
vestibular	O
)	O
,	O
meningiomas	O
,	O
ependymomas	O
and	O
juvenile	O
lens	O
opacities	O
.	O

Mutation	O
in	O
the	O
NF2	B
gene	O
,	O
which	O
encodes	O
for	O
the	O
schwannomin	B
protein	O
(	O
SCH	O
)	O
,	O
a	O
member	O
of	O
the	O
band	O
4.1	O
superfamily	O
of	O
genes	O
,	O
predisposes	O
carriers	O
to	O
these	O
central	O
nervous	O
system	O
tumors	O
.	O

We	O
have	O
isolated	O
a	O
mouse	O
cDNA	O
from	O
a	O
brain	O
library	O
which	O
contains	O
the	O
complete	O
open	O
reading	O
frame	O
of	O
the	O
mouse	O
homologue	O
of	O
the	O
NF2	B
gene	O
.	O

This	O
cDNA	O
encodes	O
for	O
a	O
596	O
amino	O
acid	O
protein	O
with	O
98	O
%	O
identity	O
to	O
the	O
human	O
SCH	O
.	O

Cross	O
species	O
hybridization	O
experiments	O
predict	O
that	O
the	O
NF2	B
gene	O
is	O
highly	O
conserved	O
in	O
other	O
vertebrates	O
.	O

Northern	O
analysis	O
detects	O
a	O
4.5	O
kb	O
transcript	O
in	O
mouse	O
brain	O
,	O
kidney	O
,	O
cardiac	O
muscle	O
,	O
skin	O
and	O
lung	O
suggesting	O
ubiquitous	O
expression	O
.	O

The	O
predicted	O
secondary	O
structure	O
of	O
SCH	O
,	O
which	O
is	O
shared	O
by	O
all	O
members	O
of	O
the	O
band	O
4.1	O
superfamily	O
,	O
includes	O
a	O
highly	O
conserved	O
amino	O
-	O
terminal	O
domain	O
which	O
is	O
believed	O
to	O
bind	O
to	O
proteins	O
in	O
the	O
plasma	O
membrane	O
and	O
a	O
large	O
highly	O
charged	O
alpha	O
-	O
helix	O
domain	O
proposed	O
to	O
associate	O
with	O
the	O
cytoskeleton	O
.	O

The	O
NF2	B
gene	O
is	O
the	O
first	O
example	O
of	O
a	O
tumor	O
suppressor	O
gene	O
whose	O
protein	O
product	O
appears	O
to	O
act	O
as	O
a	O
membrane	O
cytoskeleton	O
-	O
linker	O
.	O

These	O
results	O
show	O
that	O
the	O
NF2	B
gene	O
is	O
highly	O
conserved	O
and	O
suggests	O
that	O
the	O
analysis	O
of	O
the	O
mouse	O
NF2	B
gene	O
might	O
yield	O
insights	O
into	O
the	O
function	O
of	O
the	O
human	O
gene	O
.	O

The	O
Eph	O
/	O
Eck	B
subfamily	O
of	O
receptor	O
protein	O
tyrosine	O
kinases	O
is	O
currently	O
the	O
largest	O
subfamily	O
of	O
receptor	O
protein	O
tyrosine	O
kinases	O
with	O
a	O
dozen	O
members	O
(	O
Van	O
der	O
Geer	O
,	O
P.	O
,	O
Hunter	O
,	O
T.	O
,	O
and	O
Lindberg	O
,	O
R.	O
A.	O
(	O
1994	O
)	O
Annu	O
.	O

Rev.	O
Cell	O
Biol	O
.	O

10	O
,	O
251	O
-	O
337	O
)	O
.	O

Using	O
the	O
cytoplasmic	O
domain	O
of	O
Eck	B
as	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
of	O
mouse	O
embryonic	O
and	O
T	O
-	O
cell	O
cDNA	O
libraries	O
,	O
it	O
was	O
discovered	O
that	O
the	O
p85	O
subunit	O
of	O
phosphatidylinositol	O
3-kinase	O
bound	O
Eck	B
.	O

Further	O
,	O
using	O
glutathione	O
S	O
-	O
transferase	O
fusion	O
proteins	O
,	O
it	O
was	O
found	O
that	O
the	O
C	O
-	O
terminal	O
src	O
homology	O
2	O
domain	O
of	O
the	O
p85	O
subunit	O
specifically	O
interacted	O
with	O
Eck	B
.	O

Additionally	O
,	O
Eck	B
coimmunoprecipitated	O
with	O
p85	O
in	O
ligand	O
activated	O
cells	O
confirming	O
their	O
interaction	O
in	O
vivo	O
.	O

In	O
keeping	O
with	O
the	O
above	O
observations	O
,	O
activation	O
of	O
Eck	B
by	O
its	O
ligand	O
,	O
B61	B
,	O
increased	O
phosphatidylinositol	O
3-kinase	O
activity	O
.	O

This	O
is	O
the	O
first	O
description	O
of	O
a	O
signal	O
transduction	O
pathway	O
initiated	O
by	O
any	O
member	O
of	O
the	O
Eph	O
/	O
Eck	B
family	O
.	O

Induction	O
of	O
phase	O
2	O
enzymes	O
,	O
which	O
neutralize	O
reactive	O
electrophiles	O
and	O
act	O
as	O
indirect	O
antioxidants	O
,	O
appears	O
to	O
be	O
an	O
effective	O
means	O
for	O
achieving	O
protection	O
against	O
a	O
variety	O
of	O
carcinogens	O
in	O
animals	O
and	O
humans	O
.	O

Transcriptional	O
control	O
of	O
the	O
expression	O
of	O
these	O
enzymes	O
is	O
mediated	O
,	O
at	O
least	O
in	O
part	O
,	O
through	O
the	O
antioxidant	O
response	O
element	O
(	O
ARE	O
)	O
found	O
in	O
the	O
regulatory	O
regions	O
of	O
their	O
genes	O
.	O

The	O
transcription	O
factor	O
Nrf2	B
,	O
which	O
binds	O
to	O
the	O
ARE	O
,	O
appears	O
to	O
be	O
essential	O
for	O
the	O
induction	O
of	O
prototypical	O
phase	O
2	O
enzymes	O
such	O
as	O
glutathione	O
S	O
-	O
transferases	O
(	O
GSTs	O
)	O
and	O
NAD	O
(	O
P	O
)	O
H	O
:	O
quinone	O
oxidoreductase	O
(	O
NQO1	O
)	O
.	O

Constitutive	O
hepatic	O
and	O
gastric	O
activities	O
of	O
GST	O
and	O
NQO1	O
were	O
reduced	O
by	O
50	O
-	O
80	O
%	O
in	O
nrf2-deficient	B
mice	O
compared	O
with	O
wild	O
-	O
type	O
mice	O
.	O

Moreover	O
,	O
the	O
2-	O
to	O
5-fold	O
induction	O
of	O
these	O
enzymes	O
in	O
wild	O
-	O
type	O
mice	O
by	O
the	O
chemoprotective	O
agent	O
oltipraz	O
,	O
which	O
is	O
currently	O
in	O
clinical	O
trials	O
,	O
was	O
almost	O
completely	O
abrogated	O
in	O
the	O
nrf2-deficient	B
mice	O
.	O

In	O
parallel	O
with	O
the	O
enzymatic	O
changes	O
,	O
nrf2-deficient	B
mice	O
had	O
a	O
significantly	O
higher	O
burden	O
of	O
gastric	O
neoplasia	O
after	O
treatment	O
with	O
benzo	O
[	O
a	O
]	O
pyrene	O
than	O
did	O
wild	O
-	O
type	O
mice	O
.	O

Oltipraz	O
significantly	O
reduced	O
multiplicity	O
of	O
gastric	O
neoplasia	O
in	O
wild	O
-	O
type	O
mice	O
by	O
55	O
%	O
,	O
but	O
had	O
no	O
effect	O
on	O
tumor	O
burden	O
in	O
nrf2-deficient	B
mice	O
.	O

Thus	O
,	O
Nrf2	B
plays	O
a	O
central	O
role	O
in	O
the	O
regulation	O
of	O
constitutive	O
and	O
inducible	O
expression	O
of	O
phase	O
2	O
enzymes	O
in	O
vivo	O
and	O
dramatically	O
influences	O
susceptibility	O
to	O
carcinogenesis	O
.	O

Moreover	O
,	O
the	O
total	O
loss	O
of	O
anticarcinogenic	O
efficacy	O
of	O
oltipraz	O
in	O
the	O
nrf2-disrupted	B
mice	O
highlights	O
the	O
prime	O
importance	O
of	O
elevated	O
phase	O
2	O
gene	O
expression	O
in	O
chemoprotection	O
by	O
this	O
and	O
similar	O
enzyme	O
inducers	O
.	O

c	B
-	I
myc	I
is	O
a	O
member	O
of	O
the	O
helix	O
-	O
loop	O
-	O
helix	O
/	O
leucine	O
zipper	O
family	O
of	O
proteins	O
that	O
modulate	O
the	O
transcriptional	O
activity	O
of	O
specific	O
target	O
genes	O
.	O

Although	O
aberrant	O
c	B
-	I
myc	I
expression	O
has	O
been	O
reported	O
to	O
play	O
a	O
role	O
in	O
multistage	O
carcinogenesis	O
in	O
astrocytic	O
gliomas	O
,	O
little	O
is	O
known	O
about	O
the	O
effects	O
of	O
the	O
expression	O
of	O
c	B
-	I
myc	I
on	O
oligodendrocytes	O
.	O

Using	O
transgenic	O
animals	O
expressing	O
a	O
human	O
c	B
-	I
myc	I
oncogene	O
under	O
transcriptional	O
control	O
of	O
the	O
myelin	B
basic	I
protein	I
gene	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
overexpression	O
of	O
this	O
oncogene	O
in	O
oligodendrocytes	O
.	O

The	O
MBP	B
/	O
c	B
-	I
myc	I
transgenic	O
mice	O
developed	O
severe	O
neurological	O
disturbances	O
characterized	O
by	O
action	O
tremors	O
and	O
recurrent	O
seizures	O
,	O
and	O
premature	O
death	O
during	O
postnatal	O
weeks	O
three	O
to	O
five	O
.	O

Affected	O
transgenic	O
mice	O
of	O
various	O
strains	O
had	O
severely	O
hypomyelinated	O
central	O
nervous	O
systems	O
and	O
expressed	O
low	O
levels	O
of	O
c	B
-	I
myc	I
,	O
myelin	B
basic	I
protein	I
(	O
MBP	B
)	O
and	O
proteolipid	O
protein	O
(	O
PLP	B
)	O
mRNAs	O
in	O
the	O
brain	O
.	O

These	O
c	B
-	I
myc	I
transgenic	O
mice	O
also	O
exhibited	O
an	O
increased	O
number	O
of	O
TUNEL	O
positive	O
nuclei	O
,	O
which	O
in	O
most	O
cases	O
were	O
located	O
in	O
cells	O
that	O
expressed	O
c	B
-	I
myc	I
,	O
as	O
judged	O
by	O
double	O
immunohistochemistry	O
.	O

There	O
was	O
no	O
evidence	O
of	O
brain	O
tumors	O
in	O
the	O
c	B
-	I
myc	I
transgenic	O
mice	O
,	O
including	O
heterozygous	O
mice	O
from	O
two	O
strains	O
that	O
had	O
normal	O
lifespans	O
.	O

These	O
observations	O
indicate	O
that	O
the	O
myelin	O
deficiency	O
observed	O
in	O
the	O
MBP	B
/	O
c	B
-	I
myc	I
transgenic	O
animals	O
results	O
from	O
a	O
cytotoxic	O
effect	O
of	O
the	O
c	B
-	I
myc	I
transgene	O
.	O

PURPOSE	O
:	O
In	O
contrast	O
to	O
wild	O
-	O
type	O
mice	O
,	O
genetically	O
engineered	O
Mucin1	O
(	O
Muc1	B
)	O
null	O
animals	O
display	O
a	O
marked	O
propensity	O
for	O
development	O
of	O
blepharitis	O
and	O
conjunctivitis	O
.	O

Molecular	O
approaches	O
confirmed	O
the	O
presence	O
of	O
Muc1	B
mRNA	O
and	O
protein	O
in	O
the	O
conjunctival	O
tissue	O
of	O
wild	O
-	O
type	O
mice	O
and	O
identified	O
the	O
bacterial	O
species	O
in	O
Muc1	B
null	O
symptomatic	O
mice	O
.	O

METHODS	O
:	O
Muc1	B
null	O
animals	O
housed	O
in	O
a	O
conventional	O
facility	O
were	O
examined	O
for	O
visually	O
apparent	O
inflammation	O
of	O
the	O
eye	O
and	O
surrounding	O
tissue	O
.	O

Blood	O
taken	O
from	O
overtly	O
affected	O
animals	O
was	O
assayed	O
for	O
antibodies	O
to	O
common	O
murine	O
viral	O
agents	O
.	O

Swabs	O
of	O
infected	O
eyes	O
and	O
whole	O
eye	O
preparations	O
were	O
used	O
to	O
detect	O
and	O
speciate	O
bacterial	O
pathogens	O
.	O

Frozen	O
sections	O
of	O
whole	O
eye	O
,	O
lid	O
margin	O
,	O
and	O
Harderian	O
gland	O
were	O
immunostained	O
with	O
antibodies	O
to	O
Muc1	B
and	O
cytokeratin	O
14	O
,	O
both	O
epithelial	O
cell	O
markers	O
.	O

Northern	O
blot	O
analysis	O
and	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
were	O
performed	O
on	O
RNA	O
isolated	O
from	O
conjunctiva	O
and	O
Harderian	O
gland	O
of	O
wild	O
-	O
type	O
mice	O
to	O
compare	O
relative	O
levels	O
of	O
transcript	O
.	O

RESULTS	O
:	O
Student	O
's	O
unpaired	O
t	O
-	O
test	O
performed	O
on	O
the	O
eye	O
inflammation	O
frequency	O
of	O
Muc1	B
null	O
mice	O
confirmed	O
a	O
statistical	O
significance	O
(	O
P	O
<	O
0.01	O
)	O
when	O
compared	O
to	O
wild	O
-	O
type	O
background	O
animals	O
housed	O
in	O
the	O
same	O
room	O
.	O

Analysis	O
of	O
blood	O
samples	O
from	O
affected	O
Muc1	B
null	O
animals	O
detected	O
no	O
common	O
murine	O
viral	O
pathogens	O
.	O

Bacterial	O
analysis	O
of	O
conjunctival	O
swabs	O
and	O
whole	O
eye	O
preparations	O
demonstrated	O
the	O
presence	O
of	O
coagulase	O
-	O
negative	O
Staphylococcus	O
,	O
Streptococcus	O
type	O
alpha	O
,	O
and	O
Corynebacterium	O
group	O
G2	O
.	O

Muc1	B
antibody	O
staining	O
of	O
wild	O
-	O
type	O
sections	O
revealed	O
the	O
presence	O
of	O
Muc1	B
on	O
conjunctival	O
goblet	O
and	O
non	O
-	O
goblet	O
cells	O
and	O
on	O
the	O
epithelium	O
of	O
the	O
Harderian	O
gland	O
.	O

Serial	O
sections	O
stained	O
with	O
cytokeratin	O
14	O
antibody	O
confirmed	O
the	O
epithelial	O
nature	O
of	O
cells	O
expressing	O
the	O
Muc1	B
protein	O
.	O

RNA	O
from	O
conjunctiva	O
and	O
Harderian	O
gland	O
subjected	O
to	O
RT	O
-	O
PCR	O
and	O
northern	O
blot	O
analysis	O
showed	O
an	O
abundance	O
of	O
Muc1	B
transcript	O
in	O
these	O
tissues	O
.	O

CONCLUSIONS	O
:	O
Muc1	B
mRNA	O
and	O
protein	O
are	O
present	O
in	O
murine	O
conjunctival	O
and	O
Harderian	O
gland	O
epithelia	O
.	O

Animals	O
lacking	O
Muc1	B
mRNA	O
and	O
protein	O
are	O
predisposed	O
to	O
developing	O
eye	O
inflammation	O
when	O
compared	O
to	O
wild	O
-	O
type	O
animals	O
with	O
an	O
intact	O
Muc1	B
gene	O
.	O

Muc1	B
appears	O
to	O
play	O
a	O
critical	O
protective	O
role	O
at	O
the	O
ocular	O
surface	O
,	O
presumably	O
by	O
acting	O
as	O
a	O
barrier	O
to	O
infection	O
by	O
certain	O
bacterial	O
strains	O
.	O

Apolipoprotein	B
E	I
(	O
Apo	O
-	O
E	O
)	O
is	O
linked	O
to	O
the	O
pathogenesis	O
of	O
Alzheimer	O
's	O
disease	O
.	O

Apo	O
-	O
E	O
deficient	O
mice	O
have	O
increased	O
lipid	O
peroxidation	O
in	O
plasma	O
.	O

In	O
the	O
present	O
study	O
we	O
examined	O
two	O
markers	O
of	O
oxidative	O
stress	O
in	O
brains	O
of	O
Apo	O
-	O
E	O
deficient	O
mice	O
.	O

The	O
ratios	O
of	O
2,3	O
and	O
2,5	O
dihydroxybenzoic	O
acid	O
(	O
DHBA	O
)	O
/	O
salicylate	O
,	O
an	O
index	O
of	O
hydroxyl	O
radical	O
generation	O
,	O
were	O
unchanged	O
except	O
for	O
an	O
increase	O
in	O
2.5-DHBA	O
/	O
salicylate	O
in	O
the	O
cerebellum	O
.	O

3-Nitroxyrosine	O
is	O
a	O
marker	O
for	O
nitration	O
of	O
proteins	O
produced	O
by	O
peroxynitrite	O
.	O

Concentrations	O
of	O
3-nitrotyrosine	O
were	O
significantly	O
increased	O
in	O
the	O
cerebral	O
cortex	O
,	O
hippocampus	O
,	O
brainstem	O
and	O
cerebellum	O
of	O
Apo	O
-	O
E	O
deficient	O
mice	O
.	O

These	O
results	O
suggest	O
the	O
Apo	O
-	O
E	O
may	O
modulate	O
oxidative	O
stress	O
produced	O
by	O
peroxynitrite	O
.	O

The	O
recent	O
characterization	O
of	O
plasticity	O
in	O
the	O
mouse	O
visual	O
cortex	O
permits	O
the	O
use	O
of	O
mutant	O
mice	O
to	O
investigate	O
the	O
cellular	O
mechanisms	O
underlying	O
activity	O
-	O
dependent	O
development	O
.	O

As	O
calcium	O
-	O
dependent	O
signaling	O
pathways	O
have	O
been	O
implicated	O
in	O
neuronal	O
plasticity	O
,	O
we	O
examined	O
visual	O
cortical	O
plasticity	O
in	O
mice	O
lacking	O
the	O
alpha	O
-	O
isoform	O
of	O
calcium	O
/	O
calmodulin	O
-	O
dependent	O
protein	O
kinase	O
II	O
(	O
alpha	O
CaMKII	B
)	O
.	O

In	O
wild	O
-	O
type	O
mice	O
,	O
brief	O
occlusion	O
of	O
vision	O
in	O
one	O
eye	O
during	O
a	O
critical	O
period	O
reduces	O
responses	O
in	O
the	O
visual	O
cortex	O
.	O

In	O
half	O
of	O
the	O
alpha	O
CaMKII	B
-	O
deficient	O
mice	O
,	O
visual	O
cortical	O
responses	O
developed	O
normally	O
,	O
but	O
visual	O
cortical	O
plasticity	O
was	O
greatly	O
diminished	O
.	O

After	O
intensive	O
training	O
,	O
spatial	O
learning	O
in	O
the	O
Morris	O
water	O
maze	O
was	O
severely	O
impaired	O
in	O
a	O
similar	O
fraction	O
of	O
mutant	O
animals	O
.	O

These	O
data	O
indicate	O
that	O
loss	O
of	O
alpha	O
CaMKII	B
results	O
in	O
a	O
severe	O
but	O
variable	O
defect	O
in	O
neuronal	O
plasticity	O
.	O

Zinc	O
-	O
fingers	O
and	O
homeoboxes	O
1	O
(	O
ZHX1	B
)	O
is	O
a	O
protein	O
which	O
interacts	O
with	O
the	O
activation	O
domain	O
of	O
the	O
A	O
subunit	O
of	O
nuclear	O
factor	O
-	O
Y.	O
To	O
analyze	O
the	O
physiological	O
role	O
(	O
s	O
)	O
of	O
ZHX1	B
,	O
we	O
searched	O
ZHX1-interacting	B
protein	O
(	O
s	O
)	O
using	O
a	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

The	O
rat	O
counterpart	O
of	O
ZHX1	B
cDNAs	O
was	O
cloned	O
from	O
an	O
ovarian	O
granulosa	O
cell	O
complementary	O
DNA	O
(	O
cDNA	O
)	O
library	O
,	O
indicating	O
that	O
ZHX1	B
is	O
able	O
to	O
form	O
a	O
homodimer	O
.	O

An	O
analysis	O
of	O
the	O
nucleotide	O
sequence	O
and	O
its	O
deduced	O
amino	O
acid	O
sequence	O
show	O
that	O
rat	O
ZHX1	B
consists	O
of	O
873	O
amino	O
acid	O
residues	O
.	O

Northern	O
blot	O
analysis	O
shows	O
that	O
ZHX1	B
messenger	O
RNA	O
is	O
expressed	O
ubiquitously	O
and	O
that	O
the	O
level	O
in	O
the	O
ovary	O
are	O
not	O
regulated	O
by	O
gonadotropins	O
.	O

Furthermore	O
,	O
transfection	O
experiments	O
with	O
green	O
fluorescence	O
protein	O
(	O
GFP	O
)	O
expression	O
vectors	O
into	O
human	O
embryonic	O
kidney	O
HEK293	O
cells	O
reveal	O
that	O
full	O
-	O
length	O
ZHX1	B
fused	O
to	O
the	O
GFP	O
is	O
localized	O
in	O
the	O
nuclei	O
.	O

Thus	O
,	O
we	O
report	O
on	O
the	O
molecular	O
cloning	O
,	O
expression	O
and	O
characterization	O
of	O
full	O
-	O
length	O
rat	O
ZHX1	B
cDNA	O
.	O

p53	B
plays	O
an	O
essential	O
pro	O
-	O
apoptotic	O
role	O
,	O
a	O
function	O
thought	O
to	O
be	O
shared	O
with	O
its	O
family	O
members	O
p73	B
and	O
p63	B
.	O

Here	O
,	O
we	O
show	O
that	O
p73	B
is	O
primarily	O
present	O
in	O
developing	O
neurons	O
as	O
a	O
truncated	O
isoform	O
whose	O
levels	O
are	O
dramatically	O
decreased	O
when	O
sympathetic	O
neurons	O
apoptose	O
after	O
nerve	O
growth	O
factor	O
(	O
NGF	O
)	O
withdrawal	O
.	O

Increased	O
expression	O
of	O
truncated	O
p73	B
rescues	O
these	O
neurons	O
from	O
apoptosis	O
induced	O
by	O
NGF	O
withdrawal	O
or	O
p53	B
overexpression	O
.	O

In	O
p73-	B
/	O
-	O
mice	O
,	O
all	O
isoforms	O
of	O
p73	B
are	O
deleted	O
and	O
the	O
apoptosis	O
of	O
developing	O
sympathetic	O
neurons	O
is	O
greatly	O
enhanced	O
.	O

Thus	O
,	O
truncated	O
p73	B
is	O
an	O
essential	O
anti	O
-	O
apoptotic	O
protein	O
in	O
neurons	O
,	O
serving	O
to	O
counteract	O
the	O
pro	O
-	O
apoptotic	O
function	O
of	O
p53	B
.	O

A	O
novel	O
gene	O
,	O
isolated	O
because	O
of	O
structural	O
similarities	O
to	O
fibrillin	O
,	O
was	O
called	O
LTBP2	B
when	O
its	O
4.6-kb	O
transcript	O
was	O
found	O
to	O
encode	O
a	O
protein	O
sequence	O
related	O
to	O
the	O
latent	O
TGF	O
-	O
beta	O
binding	O
protein	O
(	O
LTBP1	B
)	O
,	O
which	O
is	O
encoded	O
on	O
human	O
chromosome	O
(	O
Chr	O
)	O
2	O
,	O
region	O
p12-q22	O
.	O

We	O
have	O
assigned	O
the	O
human	O
and	O
murine	O
LTBP2	B
loci	O
to	O
regions	O
of	O
conserved	O
synteny	O
on	O
human	O
Chr	O
11	O
and	O
mouse	O
Chr	O
19	O
.	O

By	O
PCR	O
analysis	O
of	O
somatic	O
cell	O
hybrid	O
DNA	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
LTBP2	B
was	O
mapped	O
to	O
human	O
Chr	O
band	O
11q12	O
and	O
Ltbp2	B
to	O
mouse	O
Chr	O
band	O
19B	O
.	O

Differences	O
between	O
inbred	O
strains	O
were	O
discovered	O
by	O
single	O
-	O
strand	O
conformation	O
analysis	O
of	O
PCR	O
products	O
from	O
the	O
3	O
'	O
untranslated	O
region	O
.	O

Analysis	O
of	O
BXD	O
and	O
AKXL	O
recombinant	O
inbred	O
strains	O
have	O
placed	O
Ltbp2	B
between	O
D19Rp19	B
and	O
Ly10	O
on	O
proximal	O
mouse	O
Chr	O
19	O
.	O

B	O
cells	O
possess	O
a	O
variety	O
of	O
immune	O
functions	O
that	O
are	O
involved	O
in	O
normal	O
and	O
abnormal	O
immune	O
responses	O
,	O
including	O
autoimmune	O
disorders	O
.	O

Through	O
murine	O
models	O
of	O
intestinal	O
inflammation	O
,	O
we	O
here	O
demonstrate	O
a	O
B	O
cell	O
subset	O
that	O
is	O
induced	O
in	O
gut	O
-	O
associated	O
lymphoid	O
tissues	O
and	O
is	O
characterized	O
by	O
CD1d	O
upregulation	O
.	O

This	O
B	O
cell	O
subset	O
appears	O
under	O
a	O
chronic	O
inflammatory	O
environment	O
,	O
produces	O
IL-10	B
,	O
and	O
suppresses	O
progression	O
of	O
intestinal	O
inflammation	O
by	O
downregulating	O
inflammatory	O
cascades	O
associated	O
with	O
IL-1	B
upregulation	O
and	O
STAT3	B
activation	O
rather	O
than	O
by	O
altering	O
polarized	O
T	O
helper	O
responses	O
.	O

This	O
study	O
indicates	O
that	O
B	O
cells	O
,	O
by	O
producing	O
cytokines	O
such	O
as	O
IL-10	B
,	O
can	O
act	O
as	O
regulatory	O
cells	O
in	O
immunologically	O
mediated	O
inflammatory	O
reactions	O
.	O

The	O
embryonal	O
carcinoma	O
cell	O
line	O
P19	O
responds	O
to	O
treatment	O
with	O
retinoid	O
acid	O
by	O
differentiation	O
into	O
neuronal	O
cell	O
types	O
[	O
2	O
]	O
.	O

Using	O
radioactively	O
labeled	O
cDNA	O
derived	O
from	O
differentiating	O
P19	O
cells	O
we	O
screened	O
an	O
adult	O
mouse	O
brain	O
cDNA	O
library	O
and	O
isolated	O
a	O
gene	O
named	O
shyc	B
for	O
selective	B
hybridizing	I
clone	I
.	O

The	O
encoded	O
protein	O
did	O
not	O
reveal	O
homology	O
to	O
any	O
known	O
protein	O
.	O

We	O
used	O
in	O
situ	O
hybridization	O
on	O
mouse	O
embryonic	O
and	O
adult	O
brain	O
sections	O
to	O
study	O
shyc	B
expression	O
.	O

The	O
developing	O
and	O
embryonic	O
nervous	O
system	O
showed	O
the	O
most	O
prominent	O
hybridization	O
signals	O
.	O

In	O
the	O
adult	O
brain	O
the	O
olfactory	O
pathway	O
was	O
marked	O
by	O
shyc	B
expression	O
.	O

Members	O
of	O
the	O
three	O
-	O
zinc	O
-	O
finger	O
family	O
of	O
transcription	O
factors	O
play	O
an	O
important	O
role	O
in	O
determining	O
basal	O
transcription	O
.	O

We	O
have	O
cloned	O
mouse	O
BTEB3	O
(	O
mBTEB3	O
)	O
,	O
a	O
new	O
member	O
of	O
the	O
basic	O
transcription	O
element	O
binding	O
protein	O
(	O
BTEB	O
)	O
family	O
,	O
which	O
is	O
expressed	O
in	O
a	O
wide	O
variety	O
of	O
tissues	O
.	O

mBTEB3	O
activates	O
transcription	O
of	O
the	O
simian	O
virus	O
40	O
early	O
promoter	O
(	O
4-fold	O
)	O
and	O
of	O
the	O
tissue	O
-	O
specific	O
SM22alpha	O
promoter	O
(	O
100-fold	O
)	O
,	O
suggesting	O
that	O
,	O
like	O
BTEB1	O
and	O
Sp1	B
,	O
mBTEB3	O
is	O
a	O
basal	O
transcription	O
factor	O
.	O

Mice	O
carrying	O
the	O
Tight	B
skin	I
(	O
Tsk	B
)	O
mutation	O
have	O
thickened	O
skin	O
and	O
visceral	O
fibrosis	O
resulting	O
from	O
an	O
accumulation	O
of	O
extracellular	O
matrix	O
molecules	O
.	O

These	O
and	O
other	O
connective	O
tissue	O
abnormalities	O
have	O
made	O
Tskl	O
+	O
mice	O
models	O
for	O
scleroderma	O
,	O
hereditary	O
emphysema	O
,	O
and	O
myocardial	O
hypertrophy	O
.	O

Previously	O
we	O
localized	O
Tsk	B
to	O
mouse	O
chromosome	O
2	O
in	O
a	O
region	O
syntenic	O
with	O
human	O
chromosome	O
15	O
.	O

The	O
microfibrillar	O
glycoprotein	O
gene	O
,	O
fibrillin	B
1	I
(	O
FBN1	B
)	O
,	O
on	O
human	O
chromosome	O
15q	O
,	O
provided	O
a	O
candidate	O
for	O
the	O
Tsk	B
mutation	O
.	O

We	O
now	O
demonstrate	O
that	O
the	O
Tsk	B
chromosome	O
harbors	O
a	O
30-	O
to	O
40-kb	O
genomic	O
duplication	O
within	O
the	O
Fbn1	B
gene	O
that	O
results	O
in	O
a	O
larger	O
than	O
normal	O
in	O
-	O
frame	O
Fbn1	B
transcript	O
.	O

These	O
findings	O
provide	O
hypotheses	O
to	O
explain	O
some	O
of	O
the	O
phenotypic	O
characteristics	O
of	O
Tskl	O
+	O
mice	O
and	O
the	O
lethality	O
of	O
Tsk	B
/	O
Tsk	B
embryos	O
.	O

A	B
gene	O
controlling	O
the	O
expression	O
of	O
a	B
polymorphic	O
92,000-dalton	O
glycoprotein	O
of	O
mouse	O
macrophages	O
and	O
granulocytes	O
has	O
been	O
identified	O
.	O

This	O
glycoprotein	O
was	O
previously	O
shown	O
to	O
be	O
the	O
major	O
iodinated	O
,	O
trypsin	O
-	O
sensitive	O
component	O
of	O
the	O
murine	O
phagocyte	O
cell	O
surface	O
.	O

The	O
gene	O
has	O
been	O
provisionally	O
designated	O
Pgp-1	B
for	O
phagocyte	O
glycoprotein	O
1	O
.	O

Expression	O
of	O
the	O
glycoprotein	O
was	O
measured	O
by	O
monoclonal	O
antibody	O
binding	O
to	O
a	B
polymorphic	O
antigenic	O
determinant	O
.	O

Antibody	O
binding	O
to	O
cells	O
of	O
positive	O
strains	O
of	O
mice	O
was	O
proportional	O
to	O
cell	O
number	O
,	O
whereas	O
binding	O
to	O
cells	O
of	O
negative	O
strains	O
was	O
insignificant	O
.	O

The	O
concentration	O
of	O
the	O
antigen	O
in	O
cells	O
of	O
heterozygous	O
mice	O
was	O
approximately	O
50	O
%	O
of	O
that	O
in	O
homozygous	O
mice	O
.	O

Thirteen	O
of	O
33	O
recombinant	O
inbred	O
strains	O
of	O
mice	O
were	O
positive	O
,	O
with	O
binding	O
values	O
100-fold	O
over	O
background	O
,	O
suggesting	O
that	O
a	B
single	O
gene	O
controlled	O
expression	O
of	O
the	O
antigen	O
.	O

Segregation	O
of	O
the	O
antigen	O
correlated	O
with	O
markers	O
on	O
chromosome	O
2	O
.	O

The	O
segregation	O
of	O
Pgp-1	B
,	O
with	O
nonagouti	B
coat	O
color	O
(	O
a	B
)	O
and	O
hemolytic	B
complement	I
(	O
Hc	B
)	O
activity	O
among	O
progeny	O
of	O
(	O
C3H	O
/	O
HeJ	O
x	B
DBA	O
/	O
2J	O
)	O
F1	O
x	B
DBA	O
/	O
2J	O
mice	O
confirmed	O
the	O
single	O
gene	O
control	O
and	O
the	O
chromosomal	O
assignment	O
.	O

Another	O
gene	O
on	O
chromosome	O
2	O
,	O
Ly	B
-	I
m11	I
,	O
was	O
also	O
typed	O
by	O
using	O
(	O
BALB	O
/	O
cJ	O
x	B
C57BL	O
/	O
6J	O
)	O
F1	O
x	B
C57BL	O
/	O
6J	O
mice	O
.	O

The	O
data	O
from	O
both	O
of	O
these	O
crosses	O
indicated	O
the	O
following	O
gene	O
order	O
:	O
Hc	B
--	O
Pgp-1	B
-	O
-Ly	O
-	B
m11	I
-	O
-a	O
.	O

Human	O
cyclin	B
G2	I
together	O
with	O
its	O
closest	O
homolog	O
cyclin	O
G1	O
defines	O
a	O
novel	O
family	O
of	O
cyclins	O
(	O
Horne	O
,	O
M.	O
C.	O
,	O
Goolsby	O
,	O
G.	O
L.	O
,	O
Donaldson	O
,	O
K.	O
L.	O
,	O
Tran	O
,	O
D.	O
,	O
Neubauer	O
,	O
M.	O
,	O
and	O
Wahl	O
,	O
A.	O
F.	O
(	O
1996	O
)	O
J.	O
Biol	O
.	O

Chem	O
.	O

271	O
,	O
6050	O
-	O
6061	O
)	O
.	O

Cyclin	B
G2	I
is	O
highly	O
expressed	O
in	O
the	O
immune	O
system	O
where	O
immunologic	O
tolerance	O
subjects	O
self	O
-	O
reactive	O
lymphocytes	O
to	O
negative	O
selection	O
and	O
clonal	O
deletion	O
via	O
apoptosis	O
.	O

Here	O
we	O
investigated	O
the	O
effect	O
of	O
growth	O
inhibitory	O
signals	O
on	O
cyclin	B
G2	I
mRNA	O
abundance	O
in	O
different	O
maturation	O
stage	O
-	O
specific	O
murine	O
B	O
cell	O
lines	O
.	O

Upon	O
treatment	O
of	O
wild	O
-	O
type	O
and	O
p53	B
null	O
B	O
cell	O
lines	O
with	O
the	O
negative	O
growth	O
factor	O
,	O
transforming	O
growth	O
factor	O
beta1	O
,	O
or	O
the	O
growth	O
inhibitory	O
corticosteroid	O
dexamethasone	O
,	O
cyclin	B
G2	I
mRNA	O
levels	O
were	O
increased	O
in	O
a	O
time	O
-	O
dependent	O
manner	O
5	O
-	O
14-fold	O
over	O
control	O
cell	O
levels	O
.	O

Unstimulated	O
immature	O
B	O
cell	O
lines	O
(	O
WEHI-231	O
and	O
CH31	O
)	O
and	O
unstimulated	O
or	O
IgM	B
B	O
cell	O
receptor	O
(	O
BCR	O
)	O
-stimulated	O
mature	O
B	O
cell	O
lines	O
(	O
BAL-17	O
and	O
CH12	O
)	O
rapidly	O
proliferate	O
and	O
express	O
low	O
levels	O
of	O
cyclin	B
G2	I
mRNA	O
.	O

In	O
contrast	O
,	O
BCR	O
-	O
stimulated	O
immature	O
B	O
cell	O
lines	O
undergo	O
growth	O
arrest	O
and	O
coincidentally	O
exhibit	O
an	O
approximately	O
10-fold	O
increase	O
in	O
cyclin	B
G2	I
transcripts	O
and	O
a	O
decrease	O
in	O
cyclin	O
D2	O
message	O
.	O

Costimulation	O
of	O
WEHI-231	O
and	O
CH31	O
cells	O
with	O
calcium	O
ionophores	O
and	O
protein	O
kinase	O
C	O
agonists	O
partially	O
mimics	O
anti	O
-	O
IgM	B
stimulation	O
and	O
elicits	O
a	O
strong	O
up	O
-	O
regulation	O
of	O
cyclin	B
G2	I
mRNA	O
and	O
down	O
-	O
regulation	O
of	O
cyclin	O
D2	O
mRNA	O
.	O

Signaling	O
mutants	O
of	O
WEHI-231	O
that	O
are	O
deficient	O
in	O
the	O
phosphoinositide	O
signaling	O
pathway	O
and	O
consequently	O
resistant	O
to	O
the	O
BCR	O
stimulus	O
-	O
induced	O
growth	O
arrest	O
did	O
not	O
display	O
a	O
significant	O
increase	O
in	O
cyclin	B
G2	I
or	O
decrease	O
in	O
cyclin	O
D2	O
mRNAs	O
when	O
challenged	O
with	O
anti	O
-	O
IgM	B
antibodies	O
.	O

The	O
two	O
polyclonal	O
activators	O
lipopolysaccharide	O
and	O
soluble	O
gp39	B
,	O
which	O
inhibit	O
the	O
growth	O
arrest	O
response	O
of	O
immature	O
B	O
cells	O
,	O
suppressed	O
cyclin	B
G2	I
mRNA	O
expression	O
induced	O
by	O
BCR	O
stimulation	O
.	O

These	O
results	O
suggest	O
that	O
in	O
murine	O
B	O
cells	O
responding	O
to	O
growth	O
inhibitory	O
stimuli	O
cyclin	B
G2	I
may	O
be	O
a	O
key	O
negative	O
regulator	O
of	O
cell	O
cycle	O
progression	O
.	O

The	O
Raf	O
kinases	O
play	O
a	O
key	O
role	O
in	O
relaying	O
signals	O
elicited	O
by	O
mitogens	O
or	O
oncogenes	O
.	O

Here	O
,	O
we	O
report	O
that	O
c	B
-	I
raf-1	I
(	O
-	O
/	O
-	O
)	O
embryos	O
are	O
growth	O
retarded	O
and	O
die	O
at	O
midgestation	O
with	O
anomalies	O
in	O
the	O
placenta	O
and	O
in	O
the	O
fetal	O
liver	O
.	O

Although	O
hepatoblast	O
proliferation	O
does	O
not	O
appear	O
to	O
be	O
impaired	O
,	O
c	B
-	I
raf-1	I
(	O
-	O
/	O
-	O
)	O
fetal	O
livers	O
are	O
hypocellular	O
and	O
contain	O
numerous	O
apoptotic	O
cells	O
.	O

Similarly	O
,	O
the	O
poor	O
proliferation	O
of	O
Raf-1	B
(	O
-	O
/	O
-	O
)	O
fibroblasts	O
and	O
hematopoietic	O
cells	O
cultivated	O
in	O
vitro	O
is	O
due	O
to	O
an	O
increase	O
in	O
the	O
apoptotic	O
index	O
of	O
these	O
cultures	O
rather	O
than	O
to	O
a	O
cell	O
cycle	O
defect	O
.	O

Furthermore	O
,	O
Raf-1-	B
deficient	O
fibroblasts	O
are	O
more	O
sensitive	O
than	O
wild-	O
type	O
cells	O
to	O
specific	O
apoptotic	O
stimuli	O
,	O
such	O
as	O
actinomycin	O
D	O
or	O
Fas	B
activation	O
,	O
but	O
not	O
to	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
.	O

MEK	O
/	O
ERK	B
activation	O
is	O
normal	O
in	O
Raf-1-deficient	B
cells	O
and	O
embryos	O
,	O
and	O
is	O
probably	O
mediated	O
by	O
B	O
-	O
RAF	O
.	O

These	O
results	O
indicate	O
that	O
the	O
essential	O
function	O
of	O
Raf-1	B
is	O
to	O
counteract	O
apoptosis	O
rather	O
than	O
to	O
promote	O
proliferation	O
,	O
and	O
that	O
effectors	O
distinct	O
from	O
the	O
MEK	O
/	O
ERK	B
cascade	O
must	O
mediate	O
the	O
anti	O
-	O
apoptotic	O
function	O
of	O
Raf-1	B
.	O

We	O
have	O
developed	O
a	O
genetic	O
approach	O
to	O
isolate	O
cloned	O
cDNA	O
sequences	O
that	O
determine	O
expression	O
of	O
cell	O
surface	O
oligosaccharide	O
structures	O
and	O
their	O
cognate	O
glycosyltransferases	O
.	O

A	O
cDNA	O
library	O
was	O
constructed	O
in	O
a	O
mammalian	O
expression	O
vector	O
by	O
using	O
mRNA	O
from	O
a	O
murine	O
cell	O
line	O
known	O
to	O
express	O
a	O
UDPgalactose	O
:	O
beta	O
-	O
D	O
-	O
galactosyl-1,4-N	O
-	O
acetyl	O
-	O
D	O
-	O
glucosaminide	O
alpha-1,3-galactosyltransferase	O
[	O
(	O
alpha	O
1	O
-	O
3	O
)	O
GT	O
;	O
EC	O
2.4.1.151	O
]	O
.	O

This	O
library	O
was	O
transfected	O
into	O
COS-1	O
cells	O
,	O
which	O
lack	O
expression	O
of	O
(	O
alpha	O
1	O
-	O
3	O
)	O
GT	O
.	O

Transfected	O
cells	O
containing	O
functional	O
(	O
alpha	O
1	O
-	O
3	O
)	O
GT	O
cDNAs	O
were	O
detected	O
and	O
isolated	O
with	O
a	O
lectin	O
that	O
recognizes	O
the	O
surface	O
-	O
expressed	O
glycoconjugate	O
product	O
of	O
the	O
(	O
alpha	O
1	O
-	O
3	O
)	O
GT	O
enzyme	O
.	O

One	O
cloned	O
(	O
alpha	O
1	O
-	O
3	O
)	O
GT	O
cDNA	O
was	O
rescued	O
from	O
lectin	O
-	O
positive	O
transfected	O
cells	O
.	O

This	O
cDNA	O
contains	O
a	O
single	O
long	O
open	O
reading	O
frame	O
that	O
predicts	O
a	O
394-amino	O
-	O
acid	O
protein	O
.	O

No	O
significant	O
primary	O
structure	O
similarities	O
were	O
identified	O
between	O
this	O
protein	O
and	O
other	O
known	O
sequences	O
.	O

However	O
,	O
the	O
protein	O
predicts	O
a	O
type	O
II	O
transmembrane	O
topology	O
similar	O
to	O
two	O
other	O
mammalian	O
glycosyltransferases	O
.	O

This	O
topology	O
places	O
the	O
large	O
COOH	O
-	O
terminal	O
domain	O
within	O
the	O
Golgi	O
lumen	O
;	O
this	O
domain	O
was	O
shown	O
to	O
be	O
catalytically	O
active	O
when	O
expressed	O
in	O
COS-1	O
cells	O
as	O
a	O
portion	O
of	O
a	O
secreted	O
protein	O
A	O
fusion	O
peptide	O
.	O

Biochemical	O
analysis	O
confirmed	O
that	O
this	O
enzyme	O
catalyzes	O
a	O
transglycosylation	O
reaction	O
between	O
UDP	O
-	O
Gal	B
and	O
Gal	B
(	O
beta	O
1	O
-	O
4	O
)	O
GlcNAc	O
to	O
form	O
Gal	B
(	O
alpha	O
1	O
-	O
3	O
)	O
Gal	B
(	O
beta	O
1	O
-	O
4	O
)	O
GlcNAc	O
.	O

This	O
cloning	O
approach	O
may	O
be	O
generally	O
applicable	O
to	O
the	O
isolation	O
of	O
cDNAs	O
encoding	O
other	O
mammalian	O
glycosyltransferases	O
.	O

Vitamin	O
A	O
and	O
other	O
fat	O
-	O
soluble	O
hormones	O
and	O
vitamins	O
have	O
important	O
roles	O
as	O
modulators	O
of	O
essential	O
biological	O
processes	O
such	O
as	O
homeostasis	O
,	O
development	O
,	O
differentiation	O
,	O
and	O
oncogenesis	O
and	O
also	O
as	O
regulators	O
of	O
the	O
immune	O
system	O
.	O

The	O
active	O
form	O
of	O
vitamin	O
A	O
,	O
retinoic	O
acid	O
,	O
as	O
well	O
as	O
vitamin	O
D3	O
and	O
thyroid	O
hormones	O
exert	O
their	O
actions	O
by	O
binding	O
to	O
specific	O
nuclear	O
receptors	O
that	O
represent	O
one	O
subfamily	O
of	O
the	O
steroid	O
/	O
thyroid	O
hormone	O
receptor	O
superfamily	O
.	O

To	O
identify	O
new	O
members	O
of	O
the	O
retinoid	O
/	O
thyroid	O
hormone	O
receptor	O
subfamily	O
that	O
could	O
play	O
a	O
role	O
in	O
the	O
immune	O
system	O
,	O
a	O
screening	O
of	O
a	O
T	O
cell	O
cDNA	O
library	O
was	O
performed	O
using	O
a	O
retinoid	O
X	B
receptor	O
probe	O
.	O

A	O
clone	O
was	O
isolated	O
encoding	O
a	O
novel	O
nuclear	O
receptor	O
expressed	O
mainly	O
in	O
the	O
thymus	O
and	O
T	O
cell	O
line	O
inverted	O
question	O
marks	O
.	O

This	O
new	O
receptor	O
,	O
TOR	B
(	O
thymus	B
orphan	I
receptor	I
)	O
,	O
is	O
most	O
closely	O
related	O
in	O
both	O
its	O
DNA	O
-	O
binding	O
domain	O
and	O
ligand	O
-	O
binding	O
domain	O
,	O
90	O
%	O
and	O
53	O
%	O
,	O
respectively	O
,	O
to	O
ROR	O
alpha	O
/	O
RZR	O
alpha	O
and	O
clusters	O
with	O
these	O
two	O
receptors	O
and	O
RZR	O
beta	O
in	O
a	O
phylogenetic	O
tree	O
,	O
when	O
both	O
the	O
DNA	O
-	O
binding	O
domain	O
and	O
the	O
ligand	O
-	O
binding	O
domain	O
sequences	O
of	O
nuclear	O
receptors	O
are	O
compared	O
.	O

Thus	O
,	O
TOR	B
is	O
part	O
of	O
a	O
subgroup	O
of	O
receptors	O
,	O
one	O
of	O
which	O
has	O
recently	O
been	O
reported	O
to	O
be	O
activated	O
by	O
melatonin	O
.	O

TOR	B
binds	O
specifically	O
to	O
a	O
direct	O
repeat	O
of	O
the	O
half	O
-	O
site	O
sequence	O
5'-AGGTCA-3	O
'	O
with	O
a	O
four-	O
or	O
five	O
-	O
nucleotide	O
spacer	O
,	O
DNA	O
sequences	O
that	O
also	O
serve	O
as	O
binding	O
sites	O
for	O
thyroid	O
hormone	O
(	O
TR	O
)	O
,	O
and	O
retinoic	O
acid	O
receptors	O
(	O
RAR	B
)	O
.	O

In	O
transient	O
transfection	O
experiments	O
TOR	B
does	O
not	O
activate	O
a	O
reporter	O
gene	O
carrying	O
these	O
sequences	O
in	O
the	O
absence	O
or	O
the	O
presence	O
of	O
any	O
known	O
nuclear	O
receptor	O
ligands	O
.	O

TOR	B
,	O
however	O
,	O
is	O
able	O
to	O
repress	O
TR	O
and	O
RAR	B
activity	O
on	O
DR-4-TREs	O
or	O
DR-5-RAREs	O
,	O
respectively	O
.	O

Therefore	O
,	O
our	O
data	O
suggest	O
that	O
TOR	B
,	O
similar	O
to	O
COUP	O
-	O
TF	O
,	O
can	O
negatively	O
regulate	O
retinoic	O
acid	O
and	O
thyroid	O
hormone	O
signals	O
.	O

However	O
,	O
the	O
response	O
elements	O
recognized	O
by	O
TOR	B
and	O
COUP	O
-	O
TF	O
differ	O
as	O
do	O
the	O
expression	O
patterns	O
of	O
these	O
receptors	O
.	O

Thus	O
,	O
one	O
important	O
role	O
of	O
TOR	B
could	O
be	O
to	O
modulate	O
retinoid	O
and	O
thyroid	O
hormone	O
signals	O
in	O
the	O
thymus	O
.	O

Protein	O
L	O
-	O
isoaspartyl	O
methyltransferase	O
(	O
PIMT	B
)	O
is	O
suggested	O
to	O
play	O
a	O
role	O
in	O
the	O
repair	O
of	O
aged	O
protein	O
spontaneously	O
incorporated	O
with	O
isoaspartyl	O
residues	O
.	O

We	O
generated	O
PIMT	B
-	O
deficient	O
mice	O
by	O
targeted	O
disruption	O
of	O
the	O
PIMT	B
gene	O
to	O
elucidate	O
the	O
biological	O
role	O
of	O
the	O
gene	O
in	O
vivo	O
.	O

PIMT	B
-	O
deficient	O
mice	O
died	O
from	O
progressive	O
epileptic	O
seizures	O
with	O
grand	O
mal	O
and	O
myoclonus	O
between	O
4	O
and	O
12	O
weeks	O
of	O
age	O
.	O

An	O
anticonvulsive	O
drug	O
,	O
dipropylacetic	O
acid	O
(	O
DPA	O
)	O
,	O
improved	O
their	O
survival	O
but	O
failed	O
to	O
cure	O
the	O
fatal	O
outcome	O
.	O

L	O
-	O
Isoaspartatate	O
,	O
the	O
putative	O
substrate	O
for	O
PIMT	B
,	O
was	O
increased	O
ninefold	O
in	O
the	O
brains	O
of	O
PIMT	B
-	O
deficient	O
mice	O
.	O

The	O
brains	O
of	O
PIMT	B
-	O
deficient	O
mice	O
started	O
to	O
enlarge	O
after	O
4	O
weeks	O
of	O
age	O
when	O
the	O
apical	O
dendrites	O
of	O
pyramidal	O
neurons	O
in	O
cerebral	O
cortices	O
showed	O
aberrant	O
arborizations	O
with	O
disorganized	O
microtubules	O
.	O

We	O
conclude	O
that	O
methylation	O
of	O
modified	O
proteins	O
with	O
isoaspartyl	O
residues	O
is	O
essential	O
for	O
the	O
maintenance	O
of	O
a	O
mature	O
CNS	O
and	O
that	O
a	O
deficiency	O
in	O
PIMT	B
results	O
in	O
fatal	O
progressive	O
epilepsy	O
in	O
mice	O
.	O

Purkinje	B
cell	I
degeneration	I
(	O
pcd	B
)	O
is	O
an	O
autosomal	O
recessive	O
mutation	O
which	O
maps	O
to	O
chromosome	O
13	O
in	O
the	O
mouse	O
.	O

The	O
pcd	B
mutation	O
causes	O
loss	O
of	O
cerebellar	O
Purkinje	O
cells	O
,	O
retinal	O
photoreceptor	O
cells	O
,	O
and	O
olfactory	O
bulb	O
mitral	O
cells	O
,	O
as	O
well	O
as	O
abnormalities	O
of	O
spermatogenesis	O
.	O

pcd	B
is	O
among	O
a	O
number	O
of	O
autosomal	O
recessive	O
mutations	O
in	O
mice	O
and	O
humans	O
that	O
affect	O
neurologic	O
function	O
and	O
male	O
fertility	O
.	O

The	O
cloning	O
of	O
one	O
or	O
more	O
of	O
these	O
loci	O
would	O
contribute	O
significantly	O
to	O
our	O
understanding	O
of	O
the	O
genetic	O
control	O
of	O
development	O
and	O
maintenance	O
of	O
affected	O
cell	O
types	O
.	O

We	O
report	O
here	O
identification	O
of	O
a	O
transgenic	O
mouse	O
line	O
with	O
an	O
insertional	O
mutation	O
that	O
is	O
allelic	O
with	O
pcd	B
and	O
manifests	O
histopathologic	O
features	O
indistinguishable	O
from	O
those	O
of	O
the	O
spontaneous	O
mutation	O
.	O

The	O
creation	O
of	O
an	O
allele	O
of	O
pcd	B
by	O
transgene	O
insertion	O
should	O
make	O
possible	O
the	O
cloning	O
of	O
the	O
pcd	B
locus	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
characterized	O
the	O
phenotype	O
of	O
cells	O
in	O
the	O
osteoclast	O
lineage	O
by	O
in	O
situ	O
hybridization	O
,	O
using	O
antisense	O
complementary	O
RNA	O
probes	O
that	O
encode	O
three	O
genes	O
typically	O
expressed	O
by	O
osteoclasts	O
,	O
tartrate	O
-	O
resistant	O
acid	O
phosphatase	O
(	O
TRAP	B
)	O
,	O
type	O
IV	O
collagenase	O
(	O
matrix	O
metalloproteinase-9	O
)	O
,	O
and	O
c	O
-	O
fms	B
,	O
the	O
receptor	O
for	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
.	O

By	O
using	O
complementary	O
RNA	O
probes	O
labeled	O
with	O
35S	O
,	O
digoxygenin	O
,	O
or	O
a	O
combination	O
of	O
the	O
two	O
labeling	O
methods	O
(	O
dual	O
labeling	O
in	O
situ	O
hybridization	O
)	O
,	O
we	O
found	O
that	O
each	O
of	O
these	O
genes	O
exhibited	O
a	O
distinct	O
expression	O
pattern	O
during	O
early	O
stages	O
of	O
endochondral	O
bone	O
development	O
[	O
embryonic	O
day	O
15	O
(	O
ED15	O
)	O
to	O
ED17	O
]	O
in	O
fetal	O
mouse	O
hind	O
limbs	O
.	O

Type	O
IV	O
collagenase	O
messenger	O
RNA	O
(	O
mRNA	O
)	O
was	O
first	O
expressed	O
in	O
or	O
just	O
outside	O
of	O
the	O
cellular	O
layers	O
that	O
define	O
perichondrium	O
/	O
periosteum	O
,	O
earlier	O
than	O
transcripts	O
for	O
TRAP	B
or	O
c	O
-	O
fms	B
appeared	O
at	O
the	O
same	O
sites	O
(	O
ED15	O
)	O
.	O

Although	O
transcripts	O
for	O
TRAP	B
and	O
c	O
-	O
fms	B
colocalized	O
within	O
the	O
skeleton	O
,	O
c	O
-	O
fms	B
was	O
also	O
found	O
in	O
surrounding	O
soft	O
tissue	O
,	O
whereas	O
TRAP	B
mRNA	O
was	O
never	O
detected	O
outside	O
the	O
skeleton	O
(	O
ED16	O
)	O
.	O

Type	O
IV	O
collagenase	O
mRNA	O
was	O
uniquely	O
distributed	O
at	O
the	O
chondro	O
-	O
osseous	O
border	O
,	O
being	O
distinct	O
from	O
the	O
distribution	O
of	O
TRAP	B
or	O
c	O
-	O
fms	B
(	O
ED17	O
)	O
.	O

At	O
later	O
stages	O
of	O
skeletal	O
development	O
(	O
ED18	O
to	O
15-day	O
-	O
old	O
postnatal	O
bone	O
)	O
,	O
however	O
,	O
there	O
was	O
more	O
overlap	O
among	O
TRAP	B
,	O
type	O
IV	O
collagenase	O
,	O
and	O
c	O
-	O
fms	B
mRNAs	O
in	O
cells	O
throughout	O
bone	O
,	O
except	O
at	O
the	O
chondro	O
-	O
osseous	O
junction	O
,	O
where	O
type	O
IV	O
collagenase	O
continued	O
to	O
be	O
uniquely	O
localized	O
to	O
some	O
cells	O
at	O
all	O
developmental	O
stages	O
.	O

Whereas	O
the	O
levels	O
of	O
type	O
IV	O
collagenase	O
mRNA	O
expression	O
was	O
most	O
intense	O
at	O
the	O
chondro	O
-	O
osseous	O
margin	O
,	O
the	O
levels	O
of	O
c	O
-	O
fms	B
and	O
TRAP	B
mRNA	O
expression	O
appeared	O
to	O
be	O
more	O
uniform	O
throughout	O
the	O
developing	O
bone	O
.	O

The	O
results	O
indicate	O
that	O
there	O
is	O
considerable	O
heterogeneity	O
among	O
cells	O
expressing	O
osteoclast	O
-	O
associated	O
genes	O
,	O
particularly	O
during	O
early	O
stages	O
of	O
endochondral	O
bone	O
development	O
,	O
but	O
that	O
this	O
difference	O
becomes	O
less	O
pronounced	O
later	O
in	O
the	O
more	O
mature	O
skeleton	O
.	O

Distinct	O
expression	O
patterns	O
of	O
these	O
markers	O
may	O
represent	O
different	O
stages	O
of	O
osteoclastogenesis	O
.	O

Alternatively	O
,	O
type	O
IV	O
collagenase	O
-	O
positive	O
and	O
TRAP	B
/	O
c	O
-	O
fms	B
-	O
positive	O
cells	O
may	O
represent	O
distinct	O
subpopulations	O
of	O
cells	O
of	O
the	O
osteoclast	O
lineage	O
.	O

The	B
mouse	O
Brachyury	B
(	O
T	B
)	O
gene	O
is	O
required	O
for	O
normal	O
development	O
of	O
axial	O
structures	O
.	O

Embryos	O
homozygous	O
for	O
the	O
T	B
mutation	O
show	O
severe	O
deficiencies	O
in	O
mesoderm	O
formation	O
.	O

They	O
lack	O
the	O
notochord	O
and	O
allantois	O
,	O
have	O
abnormal	O
somites	O
,	O
and	O
die	O
at	O
approximately	O
10	O
days	O
postcoitum	O
probably	O
as	O
a	O
result	O
of	O
the	O
allantois	O
defect	O
.	O

Mice	O
heterozygous	O
for	O
the	O
T	B
mutation	O
exhibit	O
a	O
variable	O
short	O
-	O
tailed	O
phenotype	O
.	O

The	O
T	B
gene	O
has	O
been	O
cloned	O
and	O
shown	O
to	O
be	O
expressed	O
in	O
the	O
tissues	O
most	O
strongly	O
affected	O
by	O
the	O
mutation	O
.	O

In	O
this	O
paper	O
,	O
we	O
show	O
that	O
a	O
single	O
-	O
copy	O
transgene	O
representing	O
the	O
wild	O
-	O
type	O
T	B
allele	O
is	O
able	O
to	O
rescue	O
the	O
T	B
-	O
associated	O
tail	O
phenotype	O
.	O

In	O
addition	O
,	O
we	O
show	O
that	O
increasing	O
dosage	O
of	O
the	O
T	B
gene	O
in	O
Tc	O
/	O
+	O
mice	O
causes	O
an	O
increased	O
extension	O
of	O
the	O
axis	O
.	O

These	O
data	O
show	O
the	O
correlation	O
of	O
the	O
level	O
of	O
T	B
product	O
with	O
the	O
extension	O
of	O
the	O
anteroposterior	O
axis	O
,	O
directly	O
demonstrating	O
the	O
involvement	O
of	O
the	O
T	B
product	O
in	O
this	O
process	O
.	O

We	O
have	O
isolated	O
and	O
characterized	O
genomic	O
DNA	O
clones	O
for	O
the	O
human	O
and	O
chicken	O
homologues	O
of	O
the	O
mouse	O
En-1	B
and	O
En-2	B
genes	O
and	O
determined	O
the	O
genomic	O
structure	O
and	O
predicted	O
protein	O
sequences	O
of	O
both	O
En	O
genes	O
in	O
all	O
three	O
species	O
.	O

Comparison	O
of	O
these	O
vertebrate	O
En	O
sequences	O
with	O
the	O
Xenopus	O
En-2	B
[	O
Hemmati	O
-	O
Brivanlou	O
et	O
al.	O
,	O
1991	O
)	O
and	O
invertebrate	O
engrailed	O
-	O
like	O
genes	O
showed	O
that	O
the	O
two	O
previously	O
identified	O
highly	O
conserved	O
regions	O
within	O
the	O
En	O
protein	O
]	O
reviewed	O
in	O
Joyner	O
and	O
Hanks	O
,	O
1991	O
]	O
can	O
be	O
divided	O
into	O
five	O
distinct	O
subregions	O
,	O
designated	O
EH1	O
to	O
EH5	O
.	O

Sequences	O
5	O
'	O
and	O
3	O
'	O
to	O
the	O
predicted	O
coding	O
regions	O
of	O
the	O
vertebrate	O
En	O
genes	O
were	O
also	O
analyzed	O
in	O
an	O
attempt	O
to	O
identify	O
cis	O
-	O
acting	O
DNA	O
sequences	O
important	O
for	O
the	O
regulation	O
of	O
En	O
gene	O
expression	O
.	O

Considerable	O
sequence	O
similarity	O
was	O
found	O
between	O
the	O
mouse	O
and	O
human	O
homologues	O
both	O
within	O
the	O
putative	O
5	O
'	O
and	O
3	O
'	O
untranslated	O
as	O
well	O
as	O
5	O
'	O
flanking	O
regions	O
.	O

Between	O
the	O
mouse	O
and	O
Xenopus	O
En-2	B
genes	O
,	O
shorter	O
stretches	O
of	O
sequence	O
similarity	O
were	O
found	O
within	O
the	O
3	O
'	O
untranslated	O
region	O
.	O

The	O
5	O
'	O
untranslated	O
regions	O
of	O
the	O
mouse	O
,	O
chicken	O
and	O
Xenopus	O
En-2	B
genes	O
,	O
however	O
,	O
showed	O
no	O
similarly	O
conserved	O
stretches	O
.	O

In	O
a	O
preliminary	O
analysis	O
of	O
the	O
expression	O
pattern	O
of	O
the	O
human	O
En	O
genes	O
,	O
En-2	B
protein	O
and	O
RNA	O
were	O
detected	O
in	O
the	O
embryonic	O
and	O
adult	O
cerebellum	O
respectively	O
and	O
not	O
in	O
other	O
tissues	O
tested	O
.	O

These	O
patterns	O
are	O
analogous	O
to	O
those	O
seen	O
in	O
other	O
vertebrates	O
.	O

Taken	O
together	O
these	O
results	O
further	O
strengthen	O
the	O
suggestion	O
that	O
En	O
gene	O
function	O
and	O
regulation	O
has	O
been	O
conserved	O
throughout	O
vertebrate	O
evolution	O
and	O
,	O
along	O
with	O
the	O
five	O
highly	O
conserved	O
regions	O
within	O
the	O
En	O
protein	O
,	O
raise	O
an	O
interesting	O
question	O
about	O
the	O
presence	O
of	O
conserved	O
genetic	O
pathways	O
.	O

The	O
adipocyte	O
-	O
derived	O
hormone	O
adiponectin	B
has	O
been	O
proposed	O
to	O
play	O
important	O
roles	O
in	O
the	O
regulation	O
of	O
energy	O
homeostasis	O
and	O
insulin	O
sensitivity	O
,	O
and	O
it	O
has	O
been	O
reported	O
to	O
exhibit	O
putative	O
antiatherogenic	O
properties	O
in	O
vitro	O
.	O

In	O
this	O
study	O
we	O
generated	O
adiponectin	B
-	O
deficient	O
mice	O
to	O
directly	O
investigate	O
whether	O
adiponectin	B
has	O
a	O
physiological	O
protective	O
role	O
against	O
diabetes	O
and	O
atherosclerosis	O
in	O
vivo	O
.	O

Heterozygous	O
adiponectin	B
-	O
deficient	O
(	O
adipo	B
(	I
+	I
/	I
-	I
)	I
)	O
mice	O
showed	O
mild	O
insulin	O
resistance	O
,	O
while	O
homozygous	O
adiponectin	B
-	O
deficient	O
(	O
adipo	B
(	I
-	I
/	I
-	I
)	I
)	O
mice	O
showed	O
moderate	O
insulin	O
resistance	O
with	O
glucose	O
intolerance	O
despite	O
body	O
weight	O
gain	O
similar	O
to	O
that	O
of	O
wild	O
-	O
type	O
mice	O
.	O

Moreover	O
,	O
adipo	B
(	I
-	I
/	I
-	I
)	I
mice	O
showed	O
2-fold	O
more	O
neointimal	O
formation	O
in	O
response	O
to	O
external	O
vascular	O
cuff	O
injury	O
than	O
wild	O
-	O
type	O
mice	O
(	O
p	O
=	O
0.01	O
)	O
.	O

This	O
study	O
provides	O
the	O
first	O
direct	O
evidence	O
that	O
adiponectin	B
plays	O
a	O
protective	O
role	O
against	O
insulin	O
resistance	O
and	O
atherosclerosis	O
in	O
vivo	O
.	O

The	O
oncogene	O
(	O
v	O
-	O
myb	B
)	O
of	O
avian	O
myeloblastosis	O
virus	O
and	O
a	O
large	O
portion	O
of	O
its	O
cellular	O
homolog	O
(	O
c	B
-	I
myb	I
)	O
have	O
been	O
molecularly	O
cloned	O
and	O
sequenced	O
.	O

The	O
portion	O
of	O
c	B
-	I
myb	I
we	O
analyzed	O
contains	O
seven	O
interspersed	O
segments	O
(	O
or	O
exons	O
)	O
.	O

Fusion	O
of	O
these	O
exons	O
creates	O
a	O
continuous	O
nucleotide	O
sequence	O
that	O
is	O
remarkably	O
similar	O
to	O
the	O
sequence	O
of	O
v	O
-	O
myb	B
and	O
that	O
potentially	O
encodes	O
a	O
protein	O
very	O
similar	O
to	O
that	O
specified	O
by	O
v	O
-	O
myb	B
.	O

Comparisons	O
between	O
the	O
sequences	O
of	O
v	O
-	O
myb	B
and	O
c	B
-	I
myb	I
indicate	O
that	O
transduction	O
of	O
c	B
-	I
myb	I
to	O
form	O
v	O
-	O
myb	B
probably	O
resulted	O
from	O
an	O
initial	O
DNA	O
rearrangement	O
and	O
the	O
subsequent	O
use	O
of	O
a	O
spliced	O
RNA	O
as	O
an	O
intermediate	O
.	O

Mutations	O
at	O
the	O
nude	B
locus	O
disrupt	O
the	O
homing	O
process	O
of	O
T	O
cell	O
progenitor	O
cells	O
to	O
the	O
thymic	O
rudiment	O
,	O
a	O
key	O
aspect	O
of	O
T	O
cell	O
differentiation	O
.	O

Here	O
,	O
we	O
map	O
the	O
nude	B
locus	O
to	O
a	O
set	O
of	O
overlapping	O
yeast	O
artificial	O
chromosomes	O
(	O
YAC	O
)	O
clones	O
covering	O
a	O
genetic	O
interval	O
of	O
about	O
0.5	O
centi	O
Morgan	O
on	O
mouse	O
chromosome	O
11	O
.	O

These	O
results	O
provide	O
a	O
suitable	O
starting	O
point	O
to	O
molecularly	O
clone	O
the	O
nude	B
gene	O
.	O

The	O
fine	O
immunogenetics	O
of	O
the	O
chromosome	O
7	O
mouse	O
minor	O
histocompatibility	O
(	O
H	O
)	O
locus	O
H-4	B
was	O
investigated	O
.	O

Both	O
class	O
I	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
-restricted	O
cytotoxic	O
T	O
lymphocytes	O
(	O
CTL	O
)	O
and	O
class	O
II	O
MHC	O
-	O
restricted	O
""""	O
helper	O
""""	O
T	O
cells	O
(	O
TH	O
)	O
specifically	O
reactive	O
with	O
H-4	B
antigens	O
were	O
isolated	O
as	O
clones	O
and	O
were	O
used	O
as	O
genetic	O
probes	O
for	O
classical	O
backcross	O
segregation	O
analysis	O
.	O

Results	O
of	O
a	O
four	O
point	O
cross	O
indicated	O
that	O
the	O
H-4	B
locus	O
was	O
actually	O
comprised	O
of	O
two	O
genes	O
,	O
that	O
have	O
been	O
designated	O
H-46	B
and	O
H-47	B
.	O

The	O
former	O
encodes	O
antigens	O
recognized	O
by	O
the	O
TH	O
and	O
the	O
latter	O
encodes	O
antigens	O
recognized	O
by	O
the	O
CTL	O
.	O

Moreover	O
,	O
these	O
two	O
genes	O
could	O
be	O
separated	O
from	O
the	O
gene	O
pink	B
-	I
eyed	I
dilution	I
(	O
p	B
)	O
which	O
was	O
found	O
to	O
be	O
""""	O
sandwiched	O
""""	O
between	O
them	O
.	O

The	O
functional	O
significance	O
of	O
a	O
minor	O
H	O
congenic	O
strain	O
differing	O
by	O
both	O
TH	O
-	O
defined	O
H-46	B
and	O
CTL	O
-	O
defined	O
H-47	B
was	O
addressed	O
using	O
F1	O
complementation	O
tests	O
.	O

Such	O
studies	O
indicated	O
that	O
immune	O
responses	O
against	O
H-46	B
antigens	O
was	O
required	O
for	O
generation	O
of	O
H-47-specific	B
CTL	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
selective	O
presentation	O
of	O
different	O
minor	O
H	O
gene	O
products	O
by	O
class	O
I	O
or	O
class	O
II	O
MHC	O
proteins	O
and	O
that	O
the	O
minor	O
H	O
""""	O
locus	O
""""	O
H-4	B
may	O
have	O
necessarily	O
included	O
both	O
TH	O
and	O
CTL	O
-	O
defined	O
genes	O
because	O
of	O
requisite	O
TH	O
-	O
CTL	O
collaboration	O
.	O

To	O
obtain	O
insight	O
into	O
the	O
site	O
and	O
stage	O
specificity	O
of	O
nerve	O
growth	O
factor	O
(	O
NGF	O
)	O
,	O
brain	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	B
)	O
,	O
and	O
neurotrophin-3	O
(	O
NT-3	B
)	O
action	O
in	O
vivo	O
,	O
we	O
compared	O
the	O
expression	O
patterns	O
of	O
the	O
genes	O
for	O
these	O
three	O
related	O
neurotrophic	O
factors	O
as	O
well	O
as	O
for	O
the	O
NGF	O
receptor	O
in	O
developing	O
and	O
adult	O
rats	O
.	O

Initial	O
embryonic	O
expression	O
of	O
these	O
related	O
neurotrophic	O
factors	O
approximately	O
coincides	O
with	O
the	O
onset	O
of	O
neurogenesis	O
.	O

However	O
,	O
the	O
levels	O
at	O
which	O
the	O
three	O
factors	O
are	O
expressed	O
at	O
this	O
time	O
and	O
throughout	O
the	O
developing	O
nervous	O
system	O
are	O
dramatically	O
different	O
.	O

NT-3	B
is	O
by	O
far	O
the	O
most	O
highly	O
expressed	O
in	O
immature	O
regions	O
of	O
the	O
CNS	O
in	O
which	O
proliferation	O
,	O
migration	O
,	O
and	O
differentiation	O
of	O
neuronal	O
precursors	O
is	O
ongoing	O
.	O

NT-3	B
expression	O
dramatically	O
decreases	O
with	O
maturation	O
of	O
these	O
regions	O
.	O

By	O
contrast	O
,	O
BDNF	B
expression	O
is	O
low	O
in	O
developing	O
regions	O
of	O
the	O
CNS	O
and	O
increases	O
as	O
these	O
regions	O
mature	O
.	O

NGF	O
expression	O
varies	O
during	O
the	O
development	O
of	O
discrete	O
CNS	O
regions	O
,	O
but	O
not	O
in	O
any	O
consistent	O
manner	O
compared	O
with	O
NT-3	B
and	O
BDNF	B
.	O

Despite	O
the	O
dramatic	O
variations	O
,	O
NT-3	B
,	O
BDNF	B
,	O
and	O
NGF	O
do	O
share	O
one	O
striking	O
similarity	O
--	O
high	O
level	O
expression	O
in	O
the	O
adult	O
hippocampus	O
.	O

Our	O
observations	O
are	O
consistent	O
with	O
the	O
idea	O
that	O
NT-3	B
,	O
BDNF	B
,	O
and	O
NGF	O
have	O
paralleled	O
as	O
well	O
as	O
reciprocal	O
roles	O
in	O
vivo	O
.	O

Mammalian	O
homologues	O
of	O
the	O
Drosophila	O
cut	O
homeobox	O
gene	O
encode	O
transcriptional	O
repressors	O
that	O
are	O
involved	O
in	O
tissue	O
-	O
specific	O
and	O
developmental	O
gene	O
regulation	O
.	O

We	O
examined	O
the	O
expression	O
of	O
a	O
murine	O
cut	O
homologue	O
(	O
Cux-1	B
)	O
in	O
the	O
adult	O
mouse	O
.	O

In	O
many	O
somatic	O
tissues	O
,	O
Cux-1	B
was	O
expressed	O
as	O
a	O
13-kb	O
transcript	O
.	O

However	O
,	O
the	O
highest	O
expression	O
of	O
Cux-1	B
was	O
in	O
the	O
testis	O
,	O
where	O
a	O
unique	O
2.4-kb	O
splice	O
variant	O
was	O
identified	O
.	O

Less	O
abundant	O
transcripts	O
of	O
5	O
kb	O
,	O
6.5	O
kb	O
,	O
and	O
8.5	O
kb	O
were	O
also	O
detected	O
only	O
in	O
the	O
testis	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
2.4-kb	O
Cux-1	B
transcript	O
was	O
identical	O
to	O
the	O
13-kb	O
transcript	O
in	O
the	O
region	O
of	O
overlap	O
,	O
but	O
the	O
testis	O
-	O
specific	O
transcript	O
encoded	O
a	O
truncated	O
protein	O
that	O
contained	O
only	O
one	O
Cut	O
repeat	O
in	O
addition	O
to	O
the	O
Cut	O
-	O
related	O
homeodomain	O
.	O

Studies	O
of	O
mice	O
homozygous	O
for	O
the	O
atrichosis	B
(	O
at	B
/	O
at	B
)	O
mutation	O
suggested	O
that	O
the	O
2.4-kb	O
transcript	O
was	O
expressed	O
in	O
germ	O
cells	O
in	O
the	O
testis	O
.	O

In	O
situ	O
hybridization	O
verified	O
that	O
Cux-1	B
was	O
transiently	O
expressed	O
in	O
post	O
-	O
meiotic	O
germ	O
cells	O
at	B
the	O
round	O
spermatid	O
stage	O
.	O

Immunoblot	O
analysis	O
of	O
nuclear	O
extracts	O
showed	O
that	O
the	O
testis	O
-	O
specific	O
Cux-1	B
transcripts	O
encoded	O
a	O
55-kDa	O
protein	O
.	O

These	O
results	O
demonstrate	O
that	O
multiple	O
products	O
of	O
a	O
cut	O
-	O
related	O
homeobox	O
gene	O
are	O
expressed	O
in	O
the	O
testis	O
.	O

The	O
highly	O
restricted	O
pattern	O
of	O
expression	O
of	O
Cux-1	B
in	O
the	O
testis	O
suggests	O
that	O
it	O
may	O
be	O
involved	O
in	O
regulation	O
of	O
postmeiotic	O
gene	O
expression	O
.	O

Activation	O
of	O
the	O
Ras	O
/	O
MAPK	O
signaling	O
cascade	O
is	O
essential	O
for	O
growth	O
factor	O
-	O
induced	O
cell	O
proliferation	O
and	O
differentiation	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
purification	O
,	O
cloning	O
,	O
and	O
characterization	O
of	O
a	O
novel	O
protein	O
,	O
designated	O
FRS2	B
,	O
that	O
is	O
tyrosine	O
phosphorylated	O
and	O
binds	O
to	O
Grb2	B
/	O
Sos	O
in	O
response	O
to	O
FGF	O
or	O
NGF	O
stimulation	O
.	O

We	O
find	O
that	O
FRS2	B
is	O
myristylated	O
and	O
that	O
this	O
modification	O
is	O
essential	O
for	O
membrane	O
localization	O
,	O
tyrosine	O
phosphorylation	O
,	O
Grb2	B
/	O
Sos	O
recruitment	O
,	O
and	O
MAPK	O
activation	O
.	O

FRS2	B
functions	O
as	O
a	O
lipid	O
-	O
anchored	O
docking	O
protein	O
that	O
targets	O
signaling	O
molecules	O
to	O
the	O
plasma	O
membrane	O
in	O
response	O
to	O
FGF	O
stimulation	O
to	O
link	O
receptor	O
activation	O
with	O
the	O
MAPK	O
and	O
other	O
signaling	O
pathways	O
essential	O
for	O
cell	O
growth	O
and	O
differentiation	O
.	O

Finally	O
,	O
we	O
demonstrate	O
that	O
FRS2	B
is	O
closely	O
related	O
and	O
probably	O
indentical	O
to	O
SNT	O
,	O
the	O
long	O
-	O
sought	O
target	O
of	O
FGF	O
and	O
NGF	O
receptors	O
.	O

Comparative	O
mapping	O
studies	O
in	O
human	O
and	O
mouse	O
have	O
shown	O
that	O
,	O
to	O
date	O
,	O
human	O
Chromosome	O
(	O
Chr	O
)	O
20	O
is	O
completely	O
syntenic	O
with	O
distal	O
mouse	O
Chr	O
2	O
.	O

The	O
structural	O
locus	O
for	O
S	O
-	O
adenosyl	O
-	O
L	O
-	O
homocysteine	O
hydrolase	O
(	O
EC	O
3.3.1.1	O
)	O
in	O
human	O
,	O
AHCY	B
,	O
maps	O
to	O
20	O
qter-->q13.1	O
,	O
and	O
we	O
report	O
here	O
that	O
the	O
homologous	O
locus	O
in	O
the	O
mouse	O
,	O
Ahcy	B
,	O
maps	O
to	O
distal	O
mouse	O
Chr	O
2	O
with	O
gene	O
order	O
Pcna	B
-	O
Ahcy	B
-	O
Ada	B
.	O

Analysis	O
of	O
123	O
progeny	O
of	O
an	O
interspecific	O
backcross	O
between	O
a	B
laboratory	O
stock	O
,	O
AN	O
,	O
and	O
Mus	O
spretus	O
using	O
a	B
rat	O
cDNA	O
probe	O
revealed	O
the	O
presence	O
of	O
at	O
least	O
two	O
other	O
Ahcy	B
-	O
related	O
sequences	O
segregating	O
independently	O
in	O
the	O
mouse	O
genome	O
.	O

One	O
,	O
Ahcy	B
-	I
rs1	I
,	O
was	O
mapped	O
to	O
Chr	O
8	O
in	O
the	O
BXH	O
recombinant	O
inbred	O
strains	O
,	O
and	O
the	O
other	O
,	O
Ahcy	B
-	I
rs2	I
,	O
shows	O
a	B
pattern	O
of	O
inheritance	O
consistent	O
with	O
X	B
-	O
linkage	O
.	O

In	O
the	O
previous	O
study	O
,	O
we	O
reported	O
increased	O
NOS	O
expression	O
in	O
the	O
astrocytes	O
in	O
the	O
spinal	O
cord	O
of	O
the	O
transgenic	O
mice	O
that	O
are	O
used	O
as	O
ALS	O
animal	O
model	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
performed	O
immunocytochemical	O
studies	O
to	O
investigate	O
the	O
changes	O
of	O
nitrotyrosine	O
-	O
immunoreactivity	O
in	O
the	O
brains	O
of	O
the	O
transgenic	O
mice	O
,	O
and	O
demonstrated	O
in	O
vivo	O
evidence	O
of	O
peroxynitrite	O
-	O
mediated	O
oxidative	O
damage	O
in	O
the	O
pathogenesis	O
of	O
ALS	O
.	O

In	O
the	O
spinal	O
cord	O
of	O
the	O
transgenic	O
mice	O
,	O
immunocytochemistry	O
showed	O
intensely	O
stained	O
nitrotyrosine	O
-	O
IR	O
glial	O
cells	O
with	O
the	O
appearance	O
of	O
astrocytes	O
,	O
but	O
no	O
nitrotyrosine	O
-	O
IR	O
glial	O
cells	O
were	O
observed	O
in	O
the	O
spinal	O
cord	O
of	O
the	O
control	O
mice	O
.	O

In	O
the	O
transgenic	O
mice	O
,	O
nitrotyrosine	O
-	O
IR	O
neurons	O
were	O
observed	O
in	O
the	O
hypoglossal	O
nucleus	O
,	O
lateral	O
reticular	O
nucleus	O
,	O
medullary	O
reticular	O
formation	O
and	O
cerebellar	O
nuclei	O
.	O

Interestingly	O
,	O
nitrotyrosine	O
-	O
IR	O
neurons	O
were	O
observed	O
in	O
the	O
hippocampal	O
formation	O
and	O
septal	O
area	O
of	O
the	O
transgenic	O
mice	O
.	O

In	O
the	O
hippocampus	O
,	O
nitrotyrosine	O
-	O
IR	O
neurons	O
in	O
the	O
CA1	O
region	O
showed	O
intense	O
staining	O
,	O
and	O
the	O
immunoreactivity	O
was	O
localized	O
mainly	O
in	O
the	O
pyramidal	O
cell	O
layer	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
antioxidants	O
and	O
selective	O
neuronal	O
NOS	O
inhibitor	O
increase	O
survival	O
in	O
the	O
SOD1	B
transgenic	O
mouse	O
model	O
of	O
FALS	O
.	O

It	O
is	O
possible	O
that	O
therapy	O
with	O
these	O
agents	O
may	O
slow	O
the	O
neurodegenerative	O
process	O
in	O
human	O
ALS	O
,	O
perhaps	O
through	O
reduction	O
of	O
nitrotyrosine	O
formation	O
.	O

To	O
test	O
the	O
role	O
of	O
the	O
CD44	B
gene	O
in	O
tumorigenesis	O
,	O
mice	O
with	O
the	O
min	O
mutation	O
of	O
the	O
APC	O
gene	O
or	O
with	O
the	O
tm1	O
mutation	O
of	O
the	O
p53	B
gene	O
were	O
crossed	O
with	O
CD44	B
knockout	O
mice	O
.	O

The	O
absence	O
of	O
CD44	B
gene	O
products	O
did	O
not	O
affect	O
tumor	O
incidence	O
or	O
survival	O
;	O
however	O
,	O
mice	O
with	O
disruption	O
of	O
the	O
CD44	B
gene	O
showed	O
virtually	O
aborted	O
metastasis	O
formation	O
of	O
osteosarcomas	O
.	O

This	O
is	O
in	O
agreement	O
with	O
the	O
role	O
attributed	O
to	O
CD44	B
variants	O
in	O
the	O
spread	O
of	O
cancer	O
.	O

Therefore	O
,	O
CD44	B
gene	O
products	O
are	O
not	O
essential	O
for	O
tumor	O
incidence	O
and	O
growth	O
but	O
are	O
important	O
in	O
regulating	O
metastasis	O
formation	O
.	O

We	O
analysed	O
p53	B
expression	O
during	O
proliferation	O
of	O
serum	O
stimulated	O
Swiss	O
mouse	O
3T3	O
cells	O
and	O
of	O
concanavalin	O
A	O
stimulated	O
mouse	O
spleen	O
lymphocytes	O
and	O
correlated	O
it	O
to	O
rate	O
of	O
DNA	O
synthesis	O
and	O
to	O
expression	O
of	O
PCNA	O
.	O

We	O
also	O
analysed	O
mdm2	B
gene	O
expression	O
,	O
as	O
rising	O
p53	B
levels	O
during	O
proliferation	O
might	O
require	O
MDM2	B
protein	O
expression	O
to	O
functionally	O
antagonize	O
p53	B
mediated	O
growth	O
inhibition	O
.	O

p53	B
protein	O
synthesis	O
closely	O
paralleled	O
DNA	O
synthesis	O
and	O
PCNA	O
expression	O
,	O
suggesting	O
a	O
direct	O
involvement	O
of	O
p53	B
in	O
cellular	O
DNA	O
synthesis	O
.	O

mdm2	B
expression	O
in	O
3T3	O
cells	O
could	O
not	O
be	O
correlated	O
with	O
p53	B
expression	O
and	O
DNA	O
synthesis	O
and	O
was	O
not	O
detected	O
at	O
all	O
in	O
stimulated	O
lymphocytes	O
.	O

We	O
conclude	O
that	O
p53	B
and	O
mdm2	B
expression	O
during	O
proliferation	O
are	O
not	O
functionally	O
related	O
and	O
that	O
mdm2	B
expression	O
is	O
not	O
required	O
for	O
proliferation	O
.	O

The	O
expression	O
of	O
the	O
homologue	O
of	O
the	O
Menkes	O
disease	O
gene	O
(	O
Mnk	B
)	O
in	O
mice	O
was	O
studied	O
using	O
RNA	O
blots	O
.	O

The	O
highest	O
level	O
of	O
expression	O
of	O
the	O
8.0	O
kb	O
mRNA	O
was	O
found	O
in	O
placenta	O
,	O
substantial	O
expression	O
was	O
noted	O
in	O
lung	O
,	O
heart	O
,	O
brain	O
,	O
testis	O
and	O
kidney	O
and	O
gut	O
mucosa	O
,	O
but	O
very	O
low	O
levels	O
were	O
found	O
in	O
spleen	O
and	O
adult	O
liver	O
.	O

In	O
fetal	O
liver	O
,	O
the	O
amount	O
of	O
Mnk	B
mRNA	O
is	O
similar	O
to	O
that	O
found	O
in	O
kidney	O
,	O
however	O
,	O
it	O
declines	O
soon	O
after	O
birth	O
.	O

Results	O
with	O
copper	O
-	O
loaded	O
normal	O
mice	O
and	O
mutant	O
mice	O
with	O
genetic	O
defects	O
in	O
copper	O
transport	O
suggested	O
that	O
Mnk	B
mRNA	O
levels	O
are	O
not	O
regulated	O
by	O
tissue	O
copper	O
concentrations	O
.	O

The	O
mutant	O
mouse	O
strain	O
HPH2	B
(	O
hyperphenylalaninemia	O
)	O
was	O
isolated	O
after	O
N	O
-	O
ethyl	O
-	O
N	O
-	O
nitrosourea	O
(	O
ENU	O
)	O
mutagenesis	O
on	O
the	O
basis	O
of	O
delayed	O
plasma	O
clearance	O
of	O
an	O
injected	O
load	O
of	O
phenylalanine	O
.	O

Animals	O
homozygous	O
for	O
the	O
recessive	O
hph2	B
mutation	O
excrete	O
elevated	O
concentrations	O
of	O
many	O
of	O
the	O
neutral	O
amino	O
acids	O
in	O
the	O
urine	O
,	O
while	O
plasma	O
concentrations	O
of	O
these	O
amino	O
acids	O
are	O
normal	O
.	O

In	O
contrast	O
,	O
mutant	O
homozygotes	O
excrete	O
normal	O
levels	O
of	O
glucose	O
and	O
phosphorus	O
.	O

These	O
data	O
suggest	O
an	O
amino	O
acid	O
transport	O
defect	O
in	O
the	O
mutant	O
,	O
confirmed	O
in	O
a	O
small	O
reduction	O
in	O
normalized	O
values	O
of	O
14C	O
-	O
labeled	O
glutamine	O
uptake	O
by	O
kidney	O
cortex	O
brush	O
border	O
membrane	O
vesicles	O
(	O
BBMV	O
)	O
.	O

The	O
hyperaminoaciduria	O
pattern	O
is	O
very	O
similar	O
to	O
that	O
of	O
Hartnup	O
Disorder	O
cases	O
also	O
show	O
niacin	O
deficiency	O
symptoms	O
,	O
of	O
Hartnup	O
Disorder	O
cases	O
also	O
show	O
niacin	O
deficiency	O
symptoms	O
,	O
which	O
are	O
thought	O
to	O
be	O
multifactorially	O
determined	O
.	O

Similarly	O
,	O
the	O
HPH2	B
mouse	O
exhibits	O
a	O
niacin	O
-	O
reversible	O
syndrome	O
that	O
is	O
modified	O
by	O
diet	O
and	O
by	O
genetic	O
background	O
.	O

Thus	O
,	O
HPH2	B
provides	O
a	O
candidate	O
mouse	O
model	O
for	O
the	O
study	O
of	O
Hartnup	O
Disorder	O
,	O
an	O
amino	O
acid	O
transport	O
deficiency	O
and	O
a	O
multifactorial	O
disease	O
in	O
the	O
human	O
.	O

Neurofilaments	O
are	O
central	O
determinants	O
of	O
the	O
diameter	O
of	O
myelinated	O
axons	O
.	O

It	O
is	O
less	O
clear	O
whether	O
neurofilaments	O
serve	O
other	O
functional	O
roles	O
such	O
as	O
maintaining	O
the	O
structural	O
integrity	O
of	O
axons	O
over	O
time	O
.	O

Here	O
we	O
show	O
that	O
an	O
age	O
-	O
dependent	O
axonal	O
atrophy	O
develops	O
in	O
the	O
lumbar	O
ventral	O
roots	O
of	O
mice	O
with	O
a	O
null	O
mutation	O
in	O
the	O
mid	O
-	O
sized	O
neurofilament	O
subunit	O
(	O
NF	B
-	I
M	I
)	O
but	O
not	O
in	O
animals	O
with	O
a	O
null	O
mutation	O
in	O
the	O
heavy	O
neurofilament	O
subunit	O
(	O
NF	B
-	I
H	I
)	O
.	O

Mice	O
with	O
null	O
mutations	O
in	O
both	O
genes	O
develop	O
atrophy	O
in	O
ventral	O
and	O
dorsal	O
roots	O
as	O
well	O
as	O
a	O
hind	O
limb	O
paralysis	O
with	O
aging	O
.	O

The	O
atrophic	O
process	O
is	O
not	O
accompanied	O
by	O
significant	O
axonal	O
loss	O
or	O
anterior	O
horn	O
cell	O
pathology	O
.	O

In	O
the	O
NF	B
-	I
M	I
-	O
null	O
mutant	O
atrophic	O
ventral	O
root	O
,	O
axons	O
show	O
an	O
age	O
-	O
related	O
depletion	O
of	O
neurofilaments	O
and	O
an	O
increased	O
ratio	O
of	O
microtubules	O
/	O
neurofilaments	O
.	O

By	O
contrast	O
,	O
the	O
preserved	O
dorsal	O
root	O
axons	O
of	O
NF	B
-	I
M	I
-	O
null	O
mutant	O
animals	O
do	O
not	O
show	O
a	O
similar	O
depletion	O
of	O
neurofilaments	O
.	O

Thus	O
,	O
the	O
lack	O
of	O
an	O
NF	B
-	I
M	I
subunit	O
renders	O
some	O
axons	O
selectively	O
vulnerable	O
to	O
an	O
age	O
-	O
dependent	O
atrophic	O
process	O
.	O

These	O
studies	O
argue	O
that	O
neurofilaments	O
are	O
necessary	O
for	O
the	O
structural	O
maintenance	O
of	O
some	O
populations	O
of	O
axons	O
during	O
aging	O
and	O
that	O
the	O
NF	B
-	I
M	I
subunit	O
is	O
especially	O
critical	O
.	O

Muscarinic	O
cholinergic	O
signaling	O
plays	O
an	O
essential	O
role	O
in	O
the	O
control	O
of	O
the	O
normal	O
airway	O
functions	O
and	O
in	O
the	O
development	O
of	O
pulmonary	O
pathologies	O
including	O
asthma	O
.	O

In	O
this	O
paper	O
we	O
demonstrate	O
that	O
the	O
airways	O
of	O
mice	O
deficient	O
in	O
a	O
cAMP	O
-	O
specific	O
phosphodiesterase	O
(	O
PDE4D	B
)	O
are	O
no	O
longer	O
responsive	O
to	O
cholinergic	O
stimulation	O
.	O

Airway	O
hyperreactivity	O
that	O
follows	O
exposure	O
to	O
antigen	O
was	O
also	O
abolished	O
in	O
PDE4D	B
(	I
-	I
/	I
-	I
)	I
mice	O
,	O
despite	O
an	O
apparently	O
normal	O
lung	O
inflammatory	O
infiltration	O
.	O

The	O
loss	O
of	O
cholinergic	O
responsiveness	O
was	O
specific	O
to	O
the	O
airway	O
,	O
not	O
observed	O
in	O
the	O
heart	O
,	O
and	O
was	O
associated	O
with	O
a	O
loss	O
of	O
signaling	O
through	O
muscarinic	O
receptors	O
with	O
an	O
inability	O
to	O
decrease	O
cAMP	O
accumulation	O
.	O

These	O
findings	O
demonstrate	O
that	O
the	O
PDE4D	B
gene	O
plays	O
an	O
essential	O
role	O
in	O
cAMP	O
homeostasis	O
and	O
cholinergic	O
stimulation	O
of	O
the	O
airway	O
,	O
and	O
in	O
the	O
development	O
of	O
hyperreactivity	O
.	O

In	O
view	O
of	O
the	O
therapeutic	O
potentials	O
of	O
PDE4	O
inhibitors	O
,	O
our	O
findings	O
provide	O
the	O
rationale	O
for	O
novel	O
strategies	O
that	O
target	O
a	O
single	O
PDE	O
isoenzyme	O
.	O

We	O
previously	O
demonstrated	O
that	O
a	O
member	O
of	O
the	O
Hedgehog	O
gene	O
family	O
,	O
Indian	B
hedgehog	I
(	O
Ihh	B
)	O
,	O
is	O
expressed	O
in	O
the	O
visceral	O
endoderm	O
of	O
EC	O
and	O
ES	O
cell	O
embryoid	O
bodies	O
and	O
mouse	O
embryos	O
.	O

Overexpression	O
studies	O
suggested	O
that	O
Ihh	B
was	O
involved	O
in	O
visceral	O
endoderm	O
differentiation	O
.	O

We	O
now	O
provide	O
evidence	O
for	O
a	O
Hh	O
response	O
in	O
the	O
embryoid	O
body	O
core	O
and	O
in	O
the	O
mesothelial	O
layer	O
of	O
the	O
visceral	O
yolk	O
sac	O
.	O

We	O
also	O
demonstrate	O
that	O
treatment	O
of	O
ES	O
embryoid	O
bodies	O
with	O
the	O
Hh	O
antagonists	O
cAMP	O
and	O
forskolin	O
results	O
in	O
downregulation	O
of	O
the	O
Hh	O
response	O
and	O
altered	O
embryoid	O
body	O
differentiation	O
.	O

The	O
outer	O
endoderm	O
layer	O
undergoes	O
a	O
transition	O
to	O
parietal	O
endoderm	O
while	O
formation	O
of	O
an	O
embryonic	O
ectoderm	O
layer	O
surrounding	O
a	O
cavity	O
is	O
inhibited	O
.	O

These	O
treatments	O
also	O
result	O
in	O
a	O
decrease	O
in	O
the	O
expression	O
of	O
markers	O
for	O
the	O
mesoderm	O
derivatives	O
,	O
blood	O
and	O
endothelial	O
cells	O
.	O

We	O
present	O
a	O
model	O
to	O
explain	O
how	O
Ihh	B
and	O
BMP	O
signaling	O
may	O
regulate	O
extraembryonic	O
endoderm	O
and	O
embryonic	O
ectoderm	O
differentiation	O
.	O

To	O
study	O
the	O
transcriptional	O
mechanisms	O
by	O
which	O
expression	O
of	O
the	O
dopamine	O
receptor	O
regulating	O
factor	O
(	O
DRRF	B
)	O
gene	O
is	O
regulated	O
,	O
a	O
murine	O
genomic	O
clone	O
was	O
isolated	O
using	O
a	O
DRRF	B
cDNA	O
as	O
probe	O
.	O

A	O
24	O
kb	O
genomic	O
fragment	O
which	O
comprises	O
13	O
kb	O
upstream	O
of	O
the	O
transcription	O
initiation	O
site	O
was	O
sequenced	O
.	O

The	O
promoter	O
region	O
lacks	O
a	O
TATA	O
box	O
and	O
CAAT	O
box	O
,	O
is	O
rich	O
in	O
G+C	O
content	O
,	O
and	O
has	O
multiple	O
putative	O
binding	O
sites	O
for	O
the	O
transcription	O
factor	O
Sp1	O
.	O

The	O
DRRF	B
gene	O
also	O
has	O
consensus	O
sequences	O
for	O
AP1	O
and	O
AP2	O
binding	O
sites	O
.	O

The	O
transcriptional	O
activity	O
of	O
five	O
deletion	O
mutants	O
of	O
a	O
1.5	O
kb	O
fragment	O
was	O
analyzed	O
by	O
modulating	O
transcription	O
of	O
the	O
heterologous	O
chloramphenicol	O
acetyltransferase	O
(	O
CAT	O
)	O
gene	O
in	O
the	O
promoterless	O
plasmid	O
pCAT	O
-	O
Basic	O
.	O

All	O
mutants	O
showed	O
significant	O
transcriptional	O
activity	O
in	O
the	O
murine	O
neuroblastoma	O
cell	O
line	O
NB41A3	O
,	O
except	O
the	O
construct	O
stretching	O
from	O
-901	O
to	O
+	O
17	O
.	O

These	O
transient	O
expression	O
assays	O
suggested	O
the	O
presence	O
of	O
positive	O
regulators	O
between	O
-1153	O
and	O
-901	O
and	O
between	O
-118	O
and	O
-93	O
while	O
a	O
negative	O
regulator	O
was	O
found	O
in	O
the	O
region	O
between	O
-901	O
and	O
-118	O
.	O

Comparison	O
among	O
cell	O
types	O
revealed	O
strong	O
transcriptional	O
activity	O
of	O
the	O
DRRF	B
promoter	O
in	O
neuronal	O
NB41A3	O
cells	O
and	O
moderate	O
activity	O
in	O
hepatic	O
HepG2	O
and	O
renal	O
OK	O
cells	O
,	O
but	O
none	O
in	O
skeletal	O
muscle	O
C2C12	O
or	O
glial	O
C6	O
cells	O
.	O

These	O
findings	O
confirm	O
the	O
tissue	O
-	O
specific	O
activity	O
of	O
the	O
DRRF	B
promoter	O
and	O
suggest	O
that	O
this	O
gene	O
shares	O
structural	O
and	O
functional	O
similarities	O
with	O
the	O
dopamine	O
receptor	O
genes	O
that	O
it	O
regulates	O
.	O

The	O
Meis	O
and	O
Pbx	O
genes	O
encode	O
for	O
homeodomain	O
proteins	O
of	O
the	O
TALE	O
class	O
and	O
have	O
been	O
shown	O
to	O
act	O
as	O
co	O
-	O
factors	O
for	O
other	O
homeodomain	O
transcription	O
factors	O
(	O
Mann	O
and	O
Affolter	O
,	O
1998	O
.	O

Curr	O
.	O

Opin	O
.	O

Genet	O
.	O

Dev	O
.	O
8	O
,	O
423	O
-	O
429	O
)	O
.	O

We	O
have	O
studied	O
the	O
expression	O
of	O
these	O
genes	O
in	O
the	O
mouse	O
telencephalon	O
and	O
found	O
that	O
Meis1	B
and	O
Meis2	B
display	O
region	O
-	O
specific	O
patterns	O
of	O
expression	O
from	O
embryonic	O
day	O
(	O
E	O
)	O
10.5	O
until	O
birth	O
,	O
defining	O
distinct	O
subterritories	O
in	O
the	O
developing	O
telencephalon	O
.	O

The	O
expression	O
of	O
the	O
Meis	O
genes	O
and	O
their	O
proteins	O
is	O
highest	O
in	O
the	O
subventricular	O
zone	O
(	O
SVZ	O
)	O
and	O
mantle	O
regions	O
of	O
the	O
ventral	O
telencephalon	O
.	O

Compared	O
to	O
the	O
Meis	O
genes	O
,	O
Pbx	O
genes	O
show	O
a	O
broader	O
expression	O
within	O
the	O
telencephalon	O
.	O

However	O
,	O
as	O
is	O
the	O
case	O
in	O
Drosophila	O
(	O
Rieckhof	O
et	O
al.	O
,	O
1997	O
.	O

Cell	O
91	O
,	O
171	O
-	O
183	O
;	O
Kurrant	O
et	O
al.	O
,	O
1998	O
.	O

Development	O
125	O
,	O
1037	O
-	O
1048	O
;	O
Pai	O
et	O
al.	O
,	O
1998	O
.	O

Genes	O
Dev	O
.	O
12	O
,	O
435	O
-	O
446	O
)	O
,	O
nuclear	O
localized	O
PBX	O
proteins	O
were	O
found	O
to	O
correlate	O
highly	O
with	O
Meis	O
expression	O
.	O

In	O
addition	O
,	O
DLX	O
proteins	O
co	O
-	O
localize	O
with	O
nuclear	O
PBX	O
in	O
distinct	O
regions	O
of	O
the	O
ventral	O
telencephalon	O
.	O

Insulin	B
-	I
like	I
growth	I
factor	I
1	I
(	O
IGF1	B
)	O
has	O
emerged	O
as	O
an	O
essential	O
factor	O
in	O
the	O
follicular	O
cell	O
growth	O
response	O
in	O
vitro	O
to	O
TSH	O
,	O
although	O
its	O
source	O
within	O
the	O
thyroid	O
in	O
vivo	O
is	O
not	O
clear	O
.	O

We	O
have	O
studied	O
the	O
localisation	O
of	O
IGF1	B
mRNA	O
by	O
in	O
situ	O
hybridization	O
using	O
digoxigenin	O
labelled	O
oligoprobes	O
in	O
tissue	O
sections	O
of	O
mouse	O
thyroid	O
.	O

Our	O
results	O
show	O
that	O
in	O
the	O
thyroid	O
IGF1	B
mRNA	O
is	O
predominantly	O
present	O
in	O
follicular	O
cells	O
and	O
C	O
cells	O
rather	O
than	O
the	O
stroma	O
.	O

Follicular	O
cell	O
levels	O
are	O
higher	O
during	O
postnatal	O
thyroid	O
growth	O
and	O
during	O
the	O
growth	O
response	O
to	O
goitrogen	O
administration	O
,	O
but	O
decrease	O
in	O
the	O
mature	O
animal	O
.	O

This	O
decrease	O
in	O
production	O
is	O
limited	O
to	O
the	O
follicular	O
cells	O
,	O
as	O
IGF1	B
mRNA	O
is	O
still	O
easily	O
demonstrable	O
in	O
C	O
cells	O
and	O
in	O
the	O
parathyroid	O
.	O

Immunocytochemistry	O
for	O
IGF1	B
peptide	O
shows	O
a	O
weak	O
and	O
variable	O
follicular	O
cell	O
content	O
in	O
both	O
juvenile	O
and	O
mature	O
mice	O
,	O
but	O
a	O
more	O
uniform	O
distribution	O
during	O
growth	O
in	O
response	O
to	O
a	O
goitrogenic	O
stimulus	O
.	O

These	O
studies	O
show	O
that	O
the	O
follicular	O
cells	O
are	O
the	O
main	O
source	O
of	O
IGF1	B
in	O
the	O
thyroid	O
,	O
and	O
suggest	O
that	O
the	O
role	O
of	O
IGF1	B
in	O
follicular	O
cell	O
growth	O
is	O
as	O
an	O
autocrine	O
factor	O
.	O

Specific	O
chromosomal	O
abnormalities	O
are	O
regularly	O
associated	O
with	O
many	O
murine	O
and	O
human	O
malignancies	O
.	O

In	O
particular	O
,	O
the	O
majority	O
of	O
murine	O
plasmacytomas	O
and	O
human	O
Burkitt	O
's	O
lymphomas	O
contain	O
a	O
characteristic	O
translocation	O
which	O
results	O
in	O
the	O
juxtaposition	O
of	O
a	O
cellular	O
oncogene	O
,	O
c	B
-	I
myc	I
,	O
with	O
the	O
immunoglobulin	O
heavy	O
-	O
chain	O
gene	O
locus	O
,	O
and	O
this	O
rearranged	O
c	B
-	I
myc	I
directs	O
the	O
synthesis	O
of	O
qualitatively	O
and	O
quantitatively	O
abnormal	O
transcripts	O
which	O
may	O
have	O
an	O
aetiological	O
role	O
in	O
the	O
development	O
of	O
the	O
transformed	O
state	O
in	O
lymphoid	O
malignancies	O
.	O

Similarly	O
,	O
rearrangement	O
and	O
abnormal	O
expression	O
of	O
c	B
-	I
myb	I
(	O
ref	O
.	O
10	O
)	O
and	O
c	O
-	O
mos	O
(	O
ref	O
.	O
11	O
)	O
has	O
been	O
reported	O
in	O
other	O
murine	O
lymphoid	O
tumours	O
.	O

Here	O
we	O
describe	O
a	O
novel	O
6:10	O
chromosomal	O
translocation	O
in	O
the	O
murine	O
plasmacytoma	O
cell	O
line	O
NS-1	O
which	O
juxtaposes	O
the	O
immunoglobulin	O
Ck	O
gene	O
with	O
a	O
single	O
-	O
copy	O
sequence	O
of	O
unknown	O
function	O
.	O

The	O
NS-1	O
plasmacytoma	O
is	O
a	O
frequently	O
used	O
fusion	O
partner	O
in	O
hybridoma	O
production	O
and	O
is	O
known	O
to	O
contain	O
a	O
rearranged	O
c	B
-	I
myc	I
gene	O
and	O
a	O
genetic	O
element	O
which	O
transforms	O
normal	O
mouse	O
fibroblasts	O
in	O
DNA	O
-	O
mediated	O
transfection	O
assays	O
.	O

We	O
conclude	O
that	O
individual	O
B	O
-	O
cell	O
tumours	O
may	O
contain	O
multiple	O
chromosomal	O
translocations	O
perhaps	O
relevant	O
to	O
oncogenesis	O
.	O

During	O
mouse	O
preimplantation	O
development	O
,	O
the	O
components	O
of	O
the	O
E	O
-	O
cadherin	O
-	O
catenin	O
complex	O
are	O
derived	O
from	O
both	O
maternal	O
and	O
zygotic	O
gene	O
activity	O
and	O
the	O
adhesion	O
complex	O
is	O
increasingly	O
accumulated	O
and	O
stored	O
in	O
a	O
nonfunctional	O
form	O
,	O
ready	O
to	O
be	O
used	O
for	O
compaction	O
and	O
the	O
formation	O
of	O
the	O
trophectoderm	O
cell	O
layer	O
(	O
Ohsugi	O
et	O
al.	O
,	O
Dev	O
.	O

Dyn	O
.	O

206:391	O
-	O
402	O
,	O
1996	O
)	O
.	O

Here	O
,	O
we	O
show	O
that	O
beta	B
-	I
catenin	I
is	O
a	O
major	O
tyrosine	O
-	O
phosphorylated	O
protein	O
in	O
oocytes	O
and	O
early	O
cleavage	O
-	O
stage	O
embryos	O
and	O
that	O
the	O
relative	O
amount	O
of	O
phosphorylated	O
beta	B
-	I
catenin	I
is	O
greatly	O
reduced	O
during	O
the	O
morula	O
-	O
blastocyst	O
transition	O
.	O

Peptide	O
-	O
specific	O
antibodies	O
indicate	O
that	O
beta	B
-	I
catenin	I
undergoes	O
conformational	O
changes	O
and/or	O
that	O
the	O
carboxy	O
-	O
terminal	O
region	O
of	O
beta	B
-	I
catenin	I
is	O
blocked	O
during	O
preimplantation	O
development	O
.	O

Moreover	O
,	O
the	O
availability	O
of	O
a	O
carboxy	O
-	O
terminal	O
epitope	O
seems	O
to	O
depend	O
on	O
the	O
tyrosine	O
phosphorylation	O
state	O
of	O
beta	B
-	I
catenin	I
and	O
becomes	O
unmasked	O
when	O
oocytes	O
are	O
treated	O
with	O
the	O
tyrosine	O
kinase	O
inhibitor	O
genistein	O
.	O

Our	O
results	O
suggest	O
that	O
tyrosine	O
phosphorylation	O
of	O
beta	B
-	I
catenin	I
represents	O
a	O
molecular	O
mechanism	O
to	O
keep	O
the	O
accumulating	O
E	O
-	O
cadherin	O
adhesion	O
complex	O
in	O
a	O
nonfunctional	O
form	O
.	O

Dev	O
Dyn	O
1999;216:168	O
-	O
176	O
.	O

Cholecystokinin	B
(	O
CCK	B
)	O
is	O
a	O
regulatory	O
peptide	O
that	O
is	O
primarily	O
expressed	O
in	O
two	O
adult	O
cell	O
types	O
:	O
endocrine	O
cells	O
of	O
the	O
intestine	O
and	O
neurons	O
of	O
the	O
central	O
nervous	O
system	O
.	O

To	O
determine	O
the	O
ontogeny	O
of	O
CCK	B
expression	O
during	O
intestinal	O
organogenesis	O
,	O
we	O
created	O
a	O
mouse	O
strain	O
in	O
which	O
the	O
CCK	B
gene	O
was	O
replaced	O
by	O
a	O
lacZ	O
reporter	O
cassette	O
using	O
homologous	O
recombination	O
in	O
embryonic	O
stem	O
cells	O
.	O

Initially	O
,	O
CCK	B
expression	O
in	O
the	O
developing	O
intestine	O
was	O
limited	O
to	O
the	O
myenteric	O
plexus	O
of	O
the	O
enteric	O
nervous	O
system	O
.	O

This	O
expression	O
pattern	O
was	O
widespread	O
,	O
extending	O
from	O
the	O
proximal	O
stomach	O
into	O
the	O
colon	O
,	O
yet	O
transient	O
,	O
being	O
detected	O
soon	O
after	O
gut	O
tube	O
closure	O
[	O
embryonic	O
day	O
10.5	O
(	O
E10.5	O
)	O
]	O
through	O
E15.5	O
.	O

Since	O
enteric	O
neurons	O
are	O
derived	O
from	O
the	O
neural	O
crest	O
,	O
we	O
examined	O
earlier	O
(	O
E8.5	O
-	O
9.5	O
)	O
embryos	O
and	O
concluded	O
that	O
lacZ	O
was	O
expressed	O
in	O
subpopulations	O
of	O
neural	O
tube	O
and	O
neural	O
crest	O
cells	O
.	O

Endocrine	O
cell	O
expression	O
in	O
the	O
intestinal	O
epithelium	O
occurred	O
later	O
,	O
beginning	O
at	O
E15.5	O
as	O
enteric	O
neuronal	O
expression	O
was	O
dwindling	O
.	O

This	O
expression	O
persisted	O
to	O
yield	O
the	O
adult	O
pattern	O
of	O
scattered	O
single	O
endocrine	O
cells	O
in	O
the	O
upper	O
small	O
intestine	O
.	O

The	O
data	O
show	O
that	O
CCK	B
is	O
a	O
very	O
early	O
marker	O
of	O
both	O
neuronal	O
and	O
endocrine	O
cell	O
lineages	O
in	O
the	O
developing	O
gastrointestinal	O
tract	O
.	O

Furthermore	O
,	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
analysis	O
showed	O
that	O
CCK	B
receptor	O
transcripts	O
were	O
detected	O
in	O
embryos	O
as	O
early	O
as	O
E10.5	O
,	O
suggesting	O
that	O
CCK	B
signaling	O
is	O
established	O
early	O
in	O
mouse	O
development	O
.	O

Dev	O
Dyn	O
1999;216:190	O
-	O
200	O
.	O

The	O
X	O
-	O
linked	O
hypophosphatemic	O
mouse	O
(	O
Hyp	B
)	O
has	O
been	O
proposed	O
as	O
a	O
model	O
for	O
the	O
human	O
familial	O
hypophosphatemia	B
(	O
the	O
most	O
common	O
form	O
of	O
vitamin	O
D	O
-	O
resistant	O
rickets	O
)	O
.	O

An	O
osteosarcoma	O
-	O
derived	O
bone	O
-	O
inducing	O
substance	O
was	O
subcutaneously	O
implanted	O
into	O
the	O
Hyp	B
mouse	O
.	O

The	O
implant	O
was	O
consistently	O
replaced	O
by	O
cartilage	O
tissue	O
at	O
2	O
weeks	O
after	O
implantation	O
.	O

The	O
cartilage	O
matrix	O
seemed	O
to	O
be	O
normal	O
,	O
according	O
to	O
the	O
histological	O
examination	O
,	O
and	O
35sulphur	O
(	O
35S	O
)	O
uptake	O
was	O
also	O
normal	O
.	O

Up	O
to	O
4	O
weeks	O
after	O
implantation	O
the	O
cartilage	O
matrix	O
was	O
completely	O
replaced	O
by	O
unmineralized	O
bone	O
matrix	O
and	O
hematopoietic	O
bone	O
marrow	O
.	O

Osteoid	O
tissue	O
arising	O
from	O
the	O
implantation	O
of	O
bone	O
inducing	O
substance	O
in	O
the	O
Hyp	B
mouse	O
showed	O
no	O
radiologic	O
or	O
histologic	O
sign	O
of	O
calcification	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
abnormalities	O
of	O
endochondral	O
ossification	O
in	O
the	O
Hyp	B
mouse	O
might	O
be	O
characterized	O
by	O
the	O
failure	O
of	O
mineralization	O
in	O
cartilage	O
and	O
bone	O
matrix	O
.	O

Analysis	O
of	O
the	O
effects	O
of	O
bone	O
-	O
inducing	O
substance	O
on	O
the	O
Hyp	B
mouse	O
may	O
help	O
to	O
give	O
greater	O
insight	O
into	O
the	O
mechanism	O
and	O
treatment	O
of	O
human	O
familial	O
hypophosphatemia	B
.	O

Antibodies	O
to	O
the	O
gap	O
junction	O
protein	O
connexin45	O
(	O
Cx45	B
)	O
were	O
obtained	O
by	O
immunizing	O
rabbits	O
with	O
fusion	O
protein	O
consisting	O
of	O
glutathione	O
S	O
-	O
transferase	O
and	O
138	O
carboxy	O
-	O
terminal	O
amino	O
acids	O
of	O
mouse	O
Cx45	B
.	O

As	O
shown	O
by	O
immunoblotting	O
and	O
immunofluorescence	O
,	O
the	O
affinity	O
-	O
purified	O
antibodies	O
recognized	O
Cx45	B
protein	O
in	O
transfected	O
human	O
HeLa	O
cells	O
as	O
well	O
as	O
in	O
the	O
kidney	O
-	O
derived	O
human	O
and	O
hamster	O
cell	O
lines	O
293	O
and	O
BHK21	O
,	O
respectively	O
.	O

In	O
Cx45-transfected	B
HeLa	O
cells	O
,	O
this	O
protein	O
is	O
phosphorylated	O
as	O
demonstrated	O
by	O
immunoprecipitation	O
after	O
metabolic	O
labeling	O
.	O

The	O
phosphate	O
label	O
could	O
be	O
removed	O
by	O
treatment	O
with	O
alkaline	O
phosphatase	O
.	O

A	O
weak	O
phosphorylation	O
of	O
Cx45	B
protein	O
was	O
also	O
detected	O
in	O
the	O
cell	O
lines	O
293	O
and	O
BHK21	O
.	O

Treatment	O
with	O
dibutyryl	O
cyclic	O
adenosine-	O
or	O
guanosine	O
monophosphate	O
(	O
cAMP	O
,	O
cGMP	O
)	O
did	O
not	O
alter	O
the	O
level	O
of	O
Cx45	B
phosphorylation	O
,	O
in	O
either	O
Cx45	B
transfectants	O
or	O
in	O
293	O
or	O
BHK21	O
cells	O
.	O

The	O
addition	O
of	O
the	O
tumor	O
-	O
promoting	O
agent	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
TPA	O
)	O
led	O
to	O
an	O
increased	O
32P	O
phosphate	O
incorporation	O
into	O
the	O
Cx45	B
protein	O
in	O
transfected	O
cells	O
.	O

The	O
Cx45	B
protein	O
was	O
found	O
in	O
homogenates	O
of	O
embryonic	O
brain	O
,	O
kidney	O
,	O
and	O
skin	O
,	O
as	O
well	O
as	O
of	O
adult	O
lung	O
.	O

In	O
kidney	O
of	O
four	O
-	O
day	O
-	O
old	O
mice	O
,	O
Cx45	B
was	O
detected	O
in	O
glomeruli	O
and	O
distal	O
tubules	O
,	O
whereas	O
connexin32	O
and	O
-26	O
were	O
coexpressed	O
in	O
proximal	O
tubules	O
.	O

No	O
connexin43	O
protein	O
was	O
detected	O
in	O
proximal	O
tubules	O
.	O

No	O
connexin43	O
protein	O
was	O
detected	O
in	O
renal	O
tubules	O
and	O
glomeruli	O
at	O
this	O
stage	O
of	O
development	O
.	O

Our	O
results	O
suggest	O
that	O
cells	O
in	O
proximal	O
and	O
distal	O
tubules	O
are	O
interconnected	O
by	O
gap	O
junction	O
channels	O
made	O
of	O
different	O
connexin	O
proteins	O
.	O

The	O
Cx45	B
antibodies	O
characterized	O
in	O
this	O
paper	O
should	O
be	O
useful	O
for	O
investigations	O
of	O
Cx45	B
in	O
renal	O
gap	O
junctional	O
communication	O
.	O

The	O
differentiation	O
of	O
somatotrophs	O
and	O
mammotrophs	O
in	O
the	O
pars	O
distalis	O
of	O
dwarf	B
(	O
dw	B
/	O
dw	B
)	O
and	O
normal	O
(	O
+	O
/+	O
;	O
dw	B
/	O
+	O
)	O
litter	O
mates	O
was	O
studied	O
by	O
means	O
of	O
electron	O
microscopy	O
from	O
the	O
day	O
of	O
birth	O
to	O
24	O
days	O
,	O
as	O
well	O
as	O
in	O
adults	O
at	O
3	O
-	O
4	O
months	O
of	O
age	O
.	O

On	O
the	O
basis	O
of	O
a	O
combination	O
of	O
growth	O
measurements	O
,	O
including	O
weight	O
,	O
total	O
body	O
length	O
,	O
and	O
tail	O
length	O
,	O
dwarfs	O
were	O
identifiable	O
with	O
certainty	O
as	O
early	O
as	O
5	O
days	O
in	O
litters	O
from	O
heterozygous	O
matings	O
(	O
dw	B
/	O
+	O
x	O
dw	B
/	O
+	O
)	O
.	O

Newborn	O
dwarfs	O
were	O
obtained	O
from	O
homozygous	O
matings	O
(	O
dw	B
/	O
dw	B
x	O
dw	B
/	O
dw	B
)	O
of	O
adult	O
dwarfs	O
which	O
had	O
been	O
brought	O
to	O
sexual	O
maturity	O
by	O
hormone	O
supplementation	O
.	O

The	O
results	O
indicate	O
that	O
the	O
dwarf	B
pituitary	O
is	O
already	O
abnormal	O
at	O
birth	O
.	O

In	O
contrast	O
to	O
the	O
pars	O
distalis	O
in	O
the	O
normal	O
newborn	O
mouse	O
,	O
somatotrophs	O
and	O
mammotrophs	O
can	O
not	O
be	O
distinguished	O
from	O
one	O
another	O
nor	O
can	O
they	O
be	O
distinguished	O
as	O
a	O
group	O
from	O
other	O
cell	O
types	O
in	O
the	O
dwarf	B
.	O

However	O
,	O
as	O
development	O
progresses	O
,	O
the	O
dwarfs	O
show	O
a	O
large	O
population	O
of	O
an	O
ambiguous	O
somatotroph	O
-	O
mammotroph	O
-	O
like	O
cell	O
with	O
fine	O
structural	O
characteristics	O
of	O
both	O
somatotrophs	O
and	O
mammotrophs	O
;	O
these	O
ambiguous	O
cells	O
also	O
occur	O
in	O
the	O
3	O
-	O
4	O
months	O
old	O
adult	O
.	O

Interleukin-2	O
(	O
IL-2	B
)	O
-deficient	O
(	O
IL-2-	B
/	O
-	O
)	O
mice	O
develop	O
anemia	O
and	O
colonic	O
inflammatory	O
bowel	O
disease	O
.	O

To	O
elucidate	O
the	O
mechanism	O
of	O
this	O
disease	O
,	O
we	O
have	O
bred	O
IL-2-	B
/	O
-	O
mice	O
to	O
two	O
strains	O
of	O
immunodeficient	O
mice	O
,	O
RAG-2-deficient	B
(	O
RAG-2-	B
/	O
-	O
,	O
lacking	O
B	O
and	O
T	O
cells	O
)	O
and	O
JH	O
-	O
deficient	O
mice	O
(	O
JH-	O
/	O
-	O
,	O
lacking	O
B	O
cells	O
)	O
.	O

IL-2-	B
/	O
-	O
,	O
RAG-2-	B
/	O
-	O
double	O
-	O
mutant	O
mice	O
are	O
disease	O
free	O
,	O
while	O
IL-2-	B
/	O
-	O
,	O
JH-	O
/	O
-	O
double	O
-	O
mutant	O
mice	O
succumb	O
to	O
bowel	O
disease	O
at	O
the	O
same	O
rate	O
as	O
IL-2-	B
/	O
-	O
littermates	O
.	O

IL-2-	B
/	O
-	O
,	O
JH-	O
/	O
-	O
mice	O
do	O
not	O
,	O
however	O
,	O
succumb	O
to	O
anemia	O
.	O

Thus	O
,	O
spontaneous	O
intestinal	O
inflammation	O
in	O
IL-2-	B
/	O
-	O
mice	O
requires	O
mature	O
T	O
cells	O
,	O
not	O
B	O
cells	O
,	O
while	O
anemia	O
is	O
dependent	O
on	O
B	O
cells	O
.	O

In	O
Saccharomyces	O
cerevisiae	O
,	O
the	O
genes	O
encoding	O
the	O
HO	B
endonuclease	O
,	O
G1-specific	O
cyclins	O
CLN1	B
and	O
CLN2	B
,	O
as	O
well	O
as	O
most	O
proteins	O
involved	O
in	O
DNA	O
synthesis	O
,	O
are	O
periodically	O
transcribed	O
with	O
maximal	O
levels	O
reached	O
in	O
late	O
G1	O
.	O

For	O
HO	B
and	O
the	O
DNA	O
replication	O
genes	O
,	O
cell	O
cycle	O
stage	O
-	O
specific	O
expression	O
has	O
been	O
shown	O
to	O
be	O
dependent	O
on	O
the	O
Cdc28	B
kinase	O
and	O
passage	O
through	O
START	O
.	O

Here	O
,	O
we	O
show	O
that	O
cells	O
released	O
from	O
cdc28ts	O
arrest	O
in	O
the	O
presence	O
of	O
cycloheximide	O
show	O
wild	O
-	O
type	O
levels	O
of	O
induction	O
for	O
HO	B
,	O
CLN1	B
,	O
and	O
CDC9	B
(	O
DNA	O
ligase	O
)	O
.	O

Induction	O
is	O
gradual	O
with	O
a	O
significant	O
lag	O
not	O
seen	O
in	O
untreated	O
cells	O
where	O
transcript	O
levels	O
fluctuate	O
coordinately	O
with	O
the	O
cell	O
cycle	O
.	O

This	O
lag	O
may	O
be	O
due	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
association	O
of	O
the	O
Cdc28	B
peptide	O
with	O
G1	O
cyclins	O
to	O
form	O
an	O
active	O
kinase	O
complex	O
because	O
overexpression	O
of	O
CLN2	B
prior	O
to	O
release	O
in	O
cycloheximide	O
increases	O
the	O
rate	O
of	O
induction	O
for	O
CDC9	B
and	O
HO	B
.	O

Consistent	O
with	O
this	O
,	O
release	O
from	O
pheromone	O
arrest	O
(	O
where	O
CLN1	B
and	O
CLN2	B
are	O
not	O
expressed	O
)	O
in	O
cycloheximide	O
shows	O
no	O
induction	O
at	O
all	O
.	O

Transcriptional	O
activation	O
of	O
CDC9	B
is	O
likely	O
to	O
be	O
mediated	O
through	O
a	O
conserved	O
promoter	O
element	O
also	O
present	O
in	O
genes	O
for	O
other	O
DNA	O
synthesis	O
enzymes	O
similarly	O
cell	O
cycle	O
regulated	O
.	O

The	O
element	O
contains	O
an	O
intact	O
MluI	O
restriction	O
enzyme	O
recognition	O
site	O
(	O
consensus	O
approximately	O
5'-A	O
/	O
TPuACGCGTNA	O
/	O
T-3	O
'	O
)	O
.	O

Insertion	O
of	O
a	O
20-bp	O
fragment	O
from	O
the	O
CDC9	B
promoter	O
(	O
containing	O
a	O
MluI	O
element	O
)	O
upstream	O
of	O
LacZ	O
confers	O
both	O
periodic	O
expression	O
and	O
transcriptional	O
induction	O
in	O
cycloheximide	O
following	O
release	O
from	O
cdc28ts	O
arrest	O
.	O

High	O
levels	O
of	O
induction	O
depended	O
on	O
both	O
the	O
MluI	O
element	O
and	O
CDC28	B
.	O

These	O
results	O
suggest	O
that	O
the	O
activity	O
of	O
trans	O
-	O
acting	O
factors	O
that	O
operate	O
through	O
the	O
MluI	O
element	O
may	O
be	O
governed	O
by	O
phosphorylation	O
by	O
the	O
Cdc28	B
kinase	O
.	O

The	O
regulation	O
of	O
the	O
Saccharomyces	O
cerevisiae	O
DPP1-encoded	B
diacylglycerol	O
pyrophosphate	O
(	O
DGPP	O
)	O
phosphatase	O
by	O
inositol	O
supplementation	O
and	O
growth	O
phase	O
was	O
examined	O
.	O

Addition	O
of	O
inositol	O
to	O
the	O
growth	O
medium	O
resulted	O
in	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
the	O
level	O
of	O
DGPP	O
phosphatase	O
activity	O
in	O
both	O
exponential	O
and	O
stationary	O
phase	O
cells	O
.	O

Activity	O
was	O
greater	O
in	O
stationary	O
phase	O
cells	O
when	O
compared	O
with	O
exponential	O
phase	O
cells	O
,	O
and	O
the	O
inositol-	O
and	O
growth	O
phase	O
-	O
dependent	O
regulations	O
of	O
DGPP	O
phosphatase	O
were	O
additive	O
.	O

Analyses	O
of	O
DGPP	O
phosphatase	O
mRNA	O
and	O
protein	O
levels	O
,	O
and	O
expression	O
of	O
beta	O
-	O
galactosidase	O
activity	O
driven	O
by	O
a	O
P	B
(	I
DPP1	I
)	I
-lacZ	O
reporter	O
gene	O
,	O
indicated	O
that	O
a	O
transcriptional	O
mechanism	O
was	O
responsible	O
for	O
this	O
regulation	O
.	O

Regulation	O
of	O
DGPP	O
phosphatase	O
by	O
inositol	O
and	O
growth	O
phase	O
occurred	O
in	O
a	O
manner	O
that	O
was	O
opposite	O
that	O
of	O
many	O
phospholipid	O
biosynthetic	O
enzymes	O
.	O

Regulation	O
of	O
DGPP	O
phosphatase	O
expression	O
by	O
inositol	O
supplementation	O
,	O
but	O
not	O
growth	O
phase	O
,	O
was	O
altered	O
in	O
opi1Delta	O
,	O
ino2Delta	O
,	O
and	O
ino4Delta	O
phospholipid	O
synthesis	O
regulatory	O
mutants	O
.	O

CDP	O
-	O
diacylglycerol	O
,	O
a	O
phospholipid	O
pathway	O
intermediate	O
used	O
for	O
the	O
synthesis	O
of	O
phosphatidylserine	O
and	O
phosphatidylinositol	O
,	O
inhibited	O
DGPP	O
phosphatase	O
activity	O
by	O
a	O
mixed	O
mechanism	O
that	O
caused	O
an	O
increase	O
in	O
K	O
(	O
m	O
)	O
and	O
a	O
decrease	O
in	O
V	O
(	O
max	O
)	O
.	O

DGPP	O
stimulated	O
the	O
activity	O
of	O
pure	O
phosphatidylserine	O
synthase	O
by	O
a	O
mechanism	O
that	O
increased	O
the	O
affinity	O
of	O
the	O
enzyme	O
for	O
its	O
substrate	O
CDP	O
-	O
diacylglycerol	O
.	O

Phospholipid	O
composition	O
analysis	O
of	O
a	O
dpp1Delta	O
mutant	O
showed	O
that	O
DGPP	O
phosphatase	O
played	O
a	O
role	O
in	O
the	O
regulation	O
of	O
phospholipid	O
metabolism	O
by	O
inositol	O
,	O
as	O
well	O
as	O
regulating	O
the	O
cellular	O
levels	O
of	O
phosphatidylinositol	O
.	O

The	O
NAD	O
(	O
+	O
)	O
-dependent	O
glutamate	O
dehydrogenase	O
(	O
NAD	O
-	O
GDH	O
)	O
from	O
Pseudomonas	O
aeruginosa	O
PAO1	O
was	O
purified	O
,	O
and	O
its	O
amino	O
-	O
terminal	O
amino	O
acid	O
sequence	O
was	O
determined	O
.	O

This	O
sequence	O
information	O
was	O
used	O
in	O
identifying	O
and	O
cloning	O
the	O
encoding	O
gdhB	B
gene	O
and	O
its	O
flanking	O
regions	O
.	O

The	O
molecular	O
mass	O
predicted	O
from	O
the	O
derived	O
sequence	O
for	O
the	O
encoded	O
NAD	O
-	O
GDH	O
was	O
182.6	O
kDa	O
,	O
in	O
close	O
agreement	O
with	O
that	O
determined	O
from	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
of	O
the	O
purified	O
enzyme	O
(	O
180	O
kDa	O
)	O
.	O

Cross	O
-	O
linking	O
studies	O
established	O
that	O
the	O
native	O
NAD	O
-	O
GDH	O
is	O
a	O
tetramer	O
of	O
equal	O
subunits	O
.	O

Comparison	O
of	O
the	O
derived	O
amino	O
acid	O
sequence	O
of	O
NAD	O
-	O
GDH	O
from	O
P.	O
aeruginosa	O
with	O
the	O
GenBank	O
database	O
showed	O
the	O
highest	O
homology	O
with	O
hypothetical	O
polypeptides	O
from	O
Pseudomonas	O
putida	O
,	O
Mycobacterium	O
tuberculosis	O
,	O
Rickettsia	O
prowazakii	O
,	O
Legionella	O
pneumophila	O
,	O
Vibrio	O
cholerae	O
,	O
Shewanella	O
putrefaciens	O
,	O
Sinorhizobium	O
meliloti	O
,	O
and	O
Caulobacter	O
crescentus	O
.	O

A	O
moderate	O
degree	O
of	O
homology	O
,	O
primarily	O
in	O
the	O
central	O
domain	O
,	O
was	O
observed	O
with	O
the	O
smaller	O
tetrameric	O
NAD	O
-	O
GDH	O
(	O
protomeric	O
mass	O
of	O
110	O
kDa	O
)	O
from	O
Saccharomyces	O
cerevisiae	O
or	O
Neurospora	O
crassa	O
.	O

Comparison	O
with	O
the	O
yet	O
smaller	O
hexameric	O
GDH	O
(	O
protomeric	O
mass	O
of	O
48	O
to	O
55	O
kDa	O
)	O
of	O
other	O
prokaryotes	O
yielded	O
a	O
low	O
degree	O
of	O
homology	O
that	O
was	O
limited	O
to	O
residues	O
important	O
for	O
binding	O
of	O
substrates	O
and	O
for	O
catalytic	O
function	O
.	O

NAD	O
-	O
GDH	O
was	O
induced	O
27-fold	O
by	O
exogenous	O
arginine	O
and	O
only	O
3-fold	O
by	O
exogenous	O
glutamate	O
.	O

Primer	O
extension	O
experiments	O
established	O
that	O
transcription	O
of	O
gdhB	B
is	O
initiated	O
from	O
an	O
arginine	O
-	O
inducible	O
promoter	O
and	O
that	O
this	O
induction	O
is	O
dependent	O
on	O
the	O
arginine	O
regulatory	O
protein	O
,	O
ArgR	O
,	O
a	O
member	O
of	O
the	O
AraC	O
/	O
XyIS	O
family	O
of	O
regulatory	O
proteins	O
.	O

NAD	O
-	O
GDH	O
was	O
purified	O
to	O
homogeneity	O
from	O
a	O
recombinant	O
strain	O
of	O
P.	O
aeruginosa	O
and	O
characterized	O
.	O

The	O
glutamate	O
saturation	O
curve	O
was	O
sigmoid	O
,	O
indicating	O
positive	O
cooperativity	O
in	O
the	O
binding	O
of	O
glutamate	O
.	O

NAD	O
-	O
GDH	O
activity	O
was	O
subject	O
to	O
allosteric	O
control	O
by	O
arginine	O
and	O
citrate	O
,	O
which	O
function	O
as	O
positive	O
and	O
negative	O
effectors	O
,	O
respectively	O
.	O

Both	O
effectors	O
act	O
by	O
influencing	O
the	O
affinity	O
of	O
the	O
enzyme	O
for	O
glutamate	O
.	O

NAD	O
-	O
GDH	O
from	O
this	O
organism	O
differs	O
from	O
previously	O
characterized	O
enzymes	O
with	O
respect	O
to	O
structure	O
,	O
protomer	O
mass	O
,	O
and	O
allosteric	O
properties	O
indicate	O
that	O
this	O
enzyme	O
represents	O
a	O
novel	O
class	O
of	O
microbial	O
glutamate	O
dehydrogenases	O
.	O

A	O
highly	O
conserved	O
48	O
bp	O
DNA	O
element	O
was	O
identified	O
present	O
at	O
26	O
chromosome	O
ends	O
of	O
Saccharomyces	O
cerevisiae	O
.	O

Each	O
element	O
harbours	O
an	O
ideal	O
or	O
a	O
mutated	O
ATF	O
/	O
CREB	O
site	O
,	O
which	O
is	O
a	O
well	O
-	O
known	O
target	O
sequence	O
for	O
bZip	O
transcription	O
factors	O
.	O

In	O
all	O
cases	O
,	O
the	O
sub	O
-	O
telomeric	O
ATF	O
/	O
CREB	O
site	O
element	O
(	O
SACE	O
)	O
is	O
a	O
direct	O
extension	O
of	O
the	O
respective	O
sub	O
-	O
telomeric	O
coreX	O
element	O
.	O

Eight	O
SACEs	O
are	O
part	O
of	O
very	O
long	O
quasi	O
-	O
identical	O
regions	O
of	O
several	O
kilobases	O
,	O
including	O
a	O
sub	O
-	O
telomeric	O
COS	O
open	O
reading	O
frame	O
.	O

Three	O
of	O
these	O
eight	O
SACEs	O
harbour	O
an	O
ideal	O
ATF	O
/	O
CREB	O
site	O
,	O
four	O
a	O
triple	O
-	O
exchange	O
variant	O
(	O
5'-ATGGTATCAT-3	O
'	O
;	O
GTA	O
variant	O
)	O
,	O
and	O
one	O
a	O
single	O
exchange	O
variant	O
with	O
a	O
C	O
to	O
G	O
exchange	O
at	O
the	O
left	O
side	O
of	O
the	O
center	O
of	O
symmetry	O
.	O

We	O
analyzed	O
the	O
function	O
of	O
the	O
SACE	O
of	O
the	O
left	O
arm	O
of	O
chromosome	O
VIII	O
in	O
vivo	O
and	O
found	O
its	O
ATF	O
/	O
CREB	O
site	O
to	O
act	O
as	O
UAS	O
/	O
URS	O
of	O
the	O
COS8	B
promoter	O
,	O
effected	O
by	O
the	O
yeast	O
bZip	O
proteins	O
Sko1p	O
,	O
Aca1p	O
,	O
and	O
Aca2p	O
.	O

Cos8	B
protein	O
was	O
found	O
in	O
proximity	O
to	O
the	O
nuclear	O
membrane	O
,	O
where	O
it	O
accumulated	O
,	O
especially	O
during	O
cell	O
division	O
.	O

When	O
the	O
ATF	O
/	O
CREB	O
site	O
of	O
the	O
COS8	B
promoter	O
was	O
exchanged	O
with	O
the	O
GTA	O
variant	O
,	O
the	O
regulation	O
was	O
changed	O
.	O

COS8	B
was	O
then	O
regulated	O
by	O
Hac1p	O
,	O
a	O
bZip	O
protein	O
known	O
to	O
be	O
involved	O
in	O
the	O
unfolded	O
protein	O
response	O
of	O
S.	O
cerevisiae	O
,	O
indicating	O
,	O
for	O
the	O
first	O
time	O
,	O
a	O
possible	O
functional	O
category	O
for	O
the	O
Cos	O
proteins	O
of	O
S.	O
cerevisiae	O
.	O

The	O
RAD27	B
/	O
RTH1	B
gene	O
of	O
Saccharomyces	O
cerevisiae	O
encodes	O
a	O
structural	O
and	O
functional	O
homolog	O
of	O
the	O
5'-3	O
'	O
exonuclease	O
function	O
of	O
Escherichia	O
coli	O
DNA	O
polymerase	O
I.	O
Four	O
alleles	O
of	O
RAD27	B
were	O
recovered	O
in	O
a	O
screen	O
for	O
hyper	O
-	O
recombination	O
,	O
a	O
phenotype	O
also	O
displayed	O
by	O
polA	O
mutants	O
of	O
E.coli	O
.	O

All	O
four	O
rad27	B
mutants	O
showed	O
similar	O
high	O
levels	O
of	O
mitotic	O
recombination	O
,	O
but	O
varied	O
in	O
their	O
growth	O
rate	O
at	O
various	O
temperatures	O
,	O
and	O
sensitivity	O
to	O
the	O
DNA	O
damaging	O
agent	O
methyl	O
methane	O
sulfonate	O
.	O

Dependence	O
of	O
viability	O
of	O
rad27	B
strains	O
on	O
recombination	O
was	O
determined	O
by	O
crossing	O
a	O
strain	O
containing	O
a	O
null	O
allele	O
of	O
RAD27	B
to	O
strains	O
containing	O
a	O
mutation	O
in	O
either	O
the	O
RAD1	B
,	O
RAD50	B
,	O
RAD51	B
,	O
RAD52	B
,	O
RAD54	B
,	O
RAD55	B
,	O
RAD57	B
,	O
MRE11	B
,	O
XRS2	B
or	O
RAD59	B
gene	O
.	O

In	O
no	O
case	O
were	O
viable	O
spore	O
products	O
recovered	O
that	O
contained	O
both	O
mutations	O
.	O

Elimination	O
of	O
the	O
non	O
-	O
homologous	O
end	O
-	O
joining	O
pathway	O
did	O
not	O
affect	O
the	O
viability	O
of	O
a	O
rad27	B
strain	O
.	O

This	O
suggests	O
that	O
lesions	O
generated	O
in	O
the	O
absence	O
of	O
RAD27	B
must	O
be	O
processed	O
by	O
homologous	O
recombination	O
.	O

In	O
Saccharomyces	O
cerevisiae	O
the	O
GCN4	B
gene	O
encodes	O
the	O
transcriptional	O
activator	O
of	O
the	O
""""	O
general	O
control	O
""""	O
system	O
of	O
amino	O
acid	O
bioynthesis	O
,	O
a	O
network	O
of	O
at	O
least	O
12	O
different	O
biosynthetic	O
pathways	O
.	O

We	O
characterized	O
the	O
consequences	O
of	O
the	O
general	O
control	O
response	O
upon	O
the	O
signal	O
""""	O
amino	O
acid	O
starvation	O
""""	O
induced	O
by	O
the	O
histidine	O
analogue	O
3-aminotriazole	O
with	O
respect	O
to	O
Gcn4p	O
levels	O
in	O
more	O
detail	O
.	O

Therefore	O
,	O
we	O
established	O
test	O
systems	O
to	O
monitor	O
the	O
time	O
course	O
of	O
different	O
parameters	O
,	O
including	O
GCN4	B
mRNA	O
,	O
Gcn4	B
protein	O
,	O
Gcn4p	O
DNA	O
binding	O
activity	O
,	O
as	O
well	O
as	O
Gcn4p	O
transactivation	O
ability	O
.	O

We	O
observed	O
a	O
biphasic	O
response	O
of	O
Gcn4p	O
activity	O
in	O
the	O
cell	O
.	O

At	O
first	O
,	O
translation	O
of	O
GCN4	B
mRNA	O
is	O
induced	O
within	O
20	O
min	O
after	O
switch	O
to	O
starvation	O
conditions	O
.	O

However	O
,	O
an	O
additional	O
increase	O
in	O
GCN4	B
transcript	O
steady	O
state	O
level	O
was	O
observed	O
,	O
leading	O
to	O
an	O
additional	O
second	O
phase	O
of	O
GCN4	B
expression	O
after	O
3	O
-	O
4	O
h	O
of	O
starvation	O
.	O

The	O
DNA	O
binding	O
activity	O
of	O
Gcn4p	O
,	O
as	O
well	O
as	O
the	O
ability	O
to	O
activate	O
transcription	O
of	O
target	O
genes	O
,	O
correlate	O
with	O
the	O
amount	O
of	O
Gcn4	B
protein	O
in	O
the	O
cell	O
,	O
suggesting	O
that	O
under	O
the	O
tested	O
conditions	O
there	O
is	O
no	O
additional	O
regulation	O
of	O
DNA	O
binding	O
or	O
transactivation	O
ability	O
of	O
Gcn4p	O
,	O
respectively	O
.	O

Glucose	O
is	O
well	O
known	O
to	O
cause	O
a	O
rapid	O
,	O
reversible	O
activation	O
of	O
the	O
yeast	O
plasma	O
membrane	O
H	O
(	O
+	O
)	O
-ATPase	O
,	O
very	O
likely	O
mediated	O
by	O
phosphorylation	O
of	O
two	O
or	O
more	O
Ser	O
/	O
Thr	O
residues	O
near	O
the	O
C	O
terminus	O
.	O

Recent	O
mutagenesis	O
studies	O
have	O
shown	O
that	O
glucose	O
-	O
dependent	O
activation	O
can	O
be	O
mimicked	O
constitutively	O
by	O
amino	O
acid	O
substitutions	O
in	O
stalk	O
segment	O
5	O
(	O
S5	O
)	O
,	O
an	O
alpha	O
-	O
helical	O
stretch	O
connecting	O
the	O
catalytic	O
part	O
of	O
the	O
ATPase	O
with	O
transmembrane	O
segment	O
5	O
(	O
Miranda	O
,	O
M.	O
,	O
Allen	O
,	O
K.	O
E.	O
,	O
Pardo	O
,	O
J.	O
P.	O
,	O
and	O
Slayman	O
,	O
C.	O
W.	O
(	O
2001	O
)	O
J.	O
Biol	O
.	O

Chem	O
.	O
276	O
,	O
22485	O
-	O
22490	O
)	O
.	O

In	O
the	O
present	O
work	O
,	O
the	O
fluorescent	O
maleimide	O
Alexa-488	O
has	O
served	O
as	O
a	O
probe	O
for	O
glucose	O
-	O
dependent	O
changes	O
in	O
the	O
conformation	O
of	O
S5	O
.	O

Experiments	O
were	O
carried	O
out	O
in	O
a	O
""""	O
3C	O
""""	O
version	O
of	O
the	O
ATPase	O
,	O
from	O
which	O
six	O
of	O
nine	O
native	O
cysteines	O
had	O
been	O
removed	O
by	O
site	O
-	O
directed	O
mutagenesis	O
to	O
eliminate	O
background	O
labeling	O
by	O
Alexa-488	O
.	O

In	O
this	O
construct	O
,	O
three	O
of	O
twelve	O
cysteines	O
introduced	O
at	O
various	O
positions	O
along	O
S5	O
(	O
A668C	O
,	O
S672C	O
,	O
and	O
D676C	O
)	O
reacted	O
with	O
the	O
Alexa	O
dye	O
in	O
a	O
glucose	O
-	O
independent	O
manner	O
,	O
as	O
shown	O
by	O
fluorescent	O
labeling	O
of	O
the	O
100	O
kDa	O
Pma1	B
polypeptide	O
and	O
by	O
isolation	O
and	O
identification	O
of	O
the	O
corresponding	O
tryptic	O
peptides	O
.	O

Especially	O
significant	O
was	O
the	O
fact	O
that	O
three	O
additional	O
cysteines	O
reacted	O
with	O
Alexa-488	O
more	O
rapidly	O
(	O
Y689C	O
)	O
or	O
only	O
(	O
V665C	O
and	O
L678C	O
)	O
in	O
plasma	O
membranes	O
from	O
glucose	O
-	O
metabolizing	O
cells	O
.	O

The	O
results	O
support	O
a	O
model	O
in	O
which	O
the	O
S5	O
alpha	O
-	O
helix	O
undergoes	O
a	O
significant	O
change	O
in	O
conformation	O
to	O
expose	O
positions	O
665	O
,	O
678	O
,	O
and	O
689	O
during	O
glucose	O
-	O
dependent	O
activation	O
of	O
the	O
ATPase	O
.	O

Gene	O
expression	O
is	O
in	O
part	O
controlled	O
by	O
chromatin	O
remodeling	O
factors	O
and	O
the	O
acetylation	O
state	O
of	O
nucleosomal	O
histones	O
.	O

The	O
latter	O
process	O
is	O
regulated	O
by	O
histone	O
acetyltransferases	O
and	O
histone	O
deacetylases	O
(	O
HDACs	O
)	O
.	O

Previously	O
,	O
three	O
human	O
and	O
five	O
yeast	O
HDAC	O
enzymes	O
had	O
been	O
identified	O
.	O

These	O
can	O
be	O
categorized	O
into	O
two	O
classes	O
:	O
the	O
first	O
class	O
represented	O
by	O
yeast	O
Rpd3-like	B
proteins	O
and	O
the	O
second	O
by	O
yeast	O
Hda1-like	B
proteins	O
.	O

Human	O
HDAC1	O
,	O
HDAC2	O
,	O
and	O
HDAC3	O
proteins	O
are	O
members	O
of	O
the	O
first	O
class	O
,	O
whereas	O
no	O
class	O
II	O
human	O
HDAC	O
proteins	O
had	O
been	O
identified	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
Hda1p	O
was	O
used	O
to	O
search	O
the	O
GenBank	O
/	O
expressed	O
sequence	O
tag	O
databases	O
to	O
identify	O
partial	O
sequences	O
from	O
three	O
putative	O
class	O
II	O
human	O
HDAC	O
proteins	O
.	O

The	O
corresponding	O
full	O
-	O
length	O
cDNAs	O
were	O
cloned	O
and	O
defined	O
as	O
HDAC4	O
,	O
HDAC5	O
,	O
and	O
HDAC6	O
.	O

These	O
proteins	O
possess	O
certain	O
features	O
present	O
in	O
the	O
conserved	O
catalytic	O
domains	O
of	O
class	O
I	O
human	O
HDACs	O
,	O
but	O
also	O
contain	O
additional	O
sequence	O
domains	O
.	O

Interestingly	O
,	O
HDAC6	O
contains	O
an	O
internal	O
duplication	O
of	O
two	O
catalytic	O
domains	O
,	O
which	O
appear	O
to	O
function	O
independently	O
of	O
each	O
other	O
.	O

These	O
class	O
II	O
HDAC	O
proteins	O
have	O
differential	O
mRNA	O
expression	O
in	O
human	O
tissues	O
and	O
possess	O
in	O
vitro	O
HDAC	O
activity	O
that	O
is	O
inhibited	O
by	O
trichostatin	O
A.	O
Coimmunoprecipitation	O
experiments	O
indicate	O
that	O
these	O
HDAC	O
proteins	O
are	O
not	O
components	O
of	O
the	O
previously	O
identified	O
HDAC1	O
and	O
HDAC2	O
NRD	O
and	O
mSin3A	O
complexes	O
.	O

However	O
,	O
HDAC4	O
and	O
HDAC5	O
associate	O
with	O
HDAC3	O
in	O
vivo	O
.	O

This	O
finding	O
suggests	O
that	O
the	O
human	O
class	O
II	O
HDAC	O
enzymes	O
may	O
function	O
in	O
cellular	O
processes	O
distinct	O
from	O
those	O
of	O
HDAC1	O
and	O
HDAC2	O
.	O

In	O
Saccharomyces	O
cerevisiae	O
,	O
expression	O
of	O
functional	O
F1-ATPase	O
requires	O
two	O
proteins	O
encoded	O
by	O
the	O
ATP11	B
and	O
ATP12	B
genes	O
.	O

Mutations	O
in	O
either	O
gene	O
block	O
some	O
crucial	O
late	O
step	O
in	O
assembly	O
of	O
F1	O
,	O
causing	O
the	O
alpha	O
and	O
beta	O
subunits	O
to	O
accumulate	O
in	O
mitochondria	O
as	O
inactive	O
aggregates	O
(	O
Ackerman	O
,	O
S.	O
H.	O
,	O
and	O
Tzagoloff	O
,	O
A.	O
(	O
1991	O
)	O
Proc	O
.	O

Natl	O
.	O

Acad	O
.	O

Sci	O
.	O

U.S.A.	O
87	O
,	O
4986	O
-	O
4990	O
)	O
.	O

In	O
the	O
present	O
study	O
we	O
have	O
cloned	O
and	O
determined	O
the	O
sequence	O
of	O
ATP11	B
.	O

The	O
encoded	O
product	O
is	O
protein	O
of	O
37	O
kDa	O
with	O
no	O
obvious	O
homology	O
to	O
any	O
known	O
protein	O
.	O

In	O
vitro	O
import	O
assays	O
of	O
ATP11	B
precursor	O
and	O
immunochemical	O
evidence	O
indicate	O
that	O
the	O
protein	O
is	O
located	O
in	O
mitochondria	O
.	O

A	O
fusion	O
was	O
made	O
between	O
ATP11	B
and	O
a	O
short	O
sequence	O
coding	O
for	O
78	O
amino	O
acids	O
with	O
the	O
biotination	O
signal	O
of	O
bacterial	O
transcarboxylase	O
.	O

The	O
protein	O
expressed	O
from	O
this	O
construct	O
complements	O
atp11	B
mutants	O
,	O
indicating	O
that	O
the	O
addition	O
of	O
the	O
extra	O
78	O
amino	O
acids	O
at	O
the	O
carboxyl	O
terminus	O
of	O
the	O
ATP11	B
protein	O
does	O
not	O
compromise	O
its	O
function	O
.	O

The	O
hybrid	O
protein	O
is	O
detected	O
in	O
mitochondria	O
with	O
antibodies	O
and	O
with	O
peroxidase	O
-	O
conjugated	O
avidin	O
.	O

Biotinated	O
ATP11	B
protein	O
can	O
be	O
partially	O
purified	O
by	O
affinity	O
chromatography	O
on	O
monomeric	O
or	O
tetrameric	O
avidin	O
coupled	O
to	O
Sepharose	O
.	O

A	O
fraction	O
eluted	O
from	O
the	O
avidin	O
column	O
and	O
enriched	O
for	O
the	O
biotinated	O
ATP11	B
protein	O
also	O
contains	O
the	O
alpha	O
and	O
beta	O
subunits	O
of	O
F1-ATPase	O
.	O

Hsp90	B
is	O
an	O
abundant	O
molecular	O
chaperone	O
essential	O
to	O
the	O
establishment	O
of	O
many	O
cellular	O
regulation	O
and	O
signal	O
transduction	O
systems	O
,	O
but	O
remains	O
one	O
of	O
the	O
least	O
well	O
described	O
chaperones	O
.	O

The	O
biochemical	O
mechanism	O
of	O
protein	O
folding	O
by	O
Hsp90	B
is	O
poorly	O
understood	O
,	O
and	O
the	O
direct	O
involvement	O
of	O
ATP	O
has	O
been	O
particularly	O
contentious	O
.	O

Here	O
we	O
demonstrate	O
in	O
vitro	O
an	O
inherent	O
ATPase	O
activity	O
in	O
both	O
yeast	O
Hsp90	B
and	O
the	O
Escherichia	O
coli	O
homologue	O
HtpG	O
,	O
which	O
is	O
sensitive	O
to	O
inhibition	O
by	O
the	O
Hsp90-specific	B
antibiotic	O
geldanamycin	O
.	O

Mutations	O
of	O
residues	O
implicated	O
in	O
ATP	O
binding	O
and	O
hydrolysis	O
by	O
structural	O
studies	O
abolish	O
this	O
ATPase	O
activity	O
in	O
vitro	O
and	O
disrupt	O
Hsp90	B
function	O
in	O
vivo	O
.	O

These	O
results	O
show	O
that	O
Hsp90	B
is	O
directly	O
ATP	O
dependent	O
in	O
vivo	O
,	O
and	O
suggest	O
an	O
ATP	O
-	O
coupled	O
chaperone	O
cycle	O
for	O
Hsp90-mediated	B
protein	O
folding	O
.	O

The	O
attenuated	O
GTP	O
regulation	O
adenylyl	O
cyclase	O
(	O
CDC35	B
)	O
lysates	O
or	O
membranes	O
prepared	O
from	O
cells	O
of	O
a	O
cdc25ts	O
strain	O
is	O
enhanced	O
2.5-	O
to	O
6-fold	O
by	O
mixing	O
these	O
lysates	O
or	O
membranes	O
with	O
lysates	O
or	O
membranes	O
from	O
a	O
cdc35ts	O
strain	O
harboring	O
wild	O
-	O
type	O
CDC25	B
.	O

The	O
kinetics	O
of	O
activation	O
of	O
the	O
Saccharomyces	O
cerevisiae	O
adenylyl	O
cyclase	O
in	O
vitro	O
is	O
first	O
order	O
,	O
as	O
is	O
the	O
activation	O
of	O
mammalian	O
adenylyl	O
cyclase	O
.	O

The	O
rate	O
of	O
enzyme	O
activation	O
in	O
the	O
presence	O
of	O
non	O
-	O
hydrolysable	O
analogs	O
of	O
GTP	O
increases	O
with	O
the	O
number	O
of	O
CDC25	B
gene	O
copies	O
present	O
in	O
the	O
cell	O
.	O

When	O
GppNHp	O
was	O
used	O
the	O
rate	O
of	O
activation	O
of	O
the	O
cyclase	O
in	O
a	O
strain	O
harboring	O
a	O
multicopy	O
plasmid	O
of	O
CDC25	B
was	O
7.0-fold	O
higher	O
than	O
the	O
rate	O
in	O
an	O
isogenic	O
strain	O
with	O
the	O
cdc25	B
-	I
2	I
mutation	O
.	O

The	O
rate	O
of	O
adenylyl	O
cyclase	O
activation	O
from	O
a	O
strain	O
with	O
a	O
disrupted	O
CDC25	B
gene	O
is	O
14.7-fold	O
lower	O
than	O
the	O
rate	O
in	O
an	O
isogenic	O
strain	O
containing	O
the	O
CDC25	B
gene	O
on	O
a	O
multicopy	O
plasmid	O
.	O

The	O
reconstitution	O
experiments	O
described	O
provide	O
direct	O
biochemical	O
evidence	O
for	O
the	O
role	O
of	O
the	O
CDC25	B
protein	O
in	O
regulating	O
the	O
RAS	O
dependent	O
adenylyl	O
cyclase	O
in	O
S.cerevisiae	O
.	O

The	O
reconstitution	O
experiments	O
and	O
the	O
kinetic	O
experiments	O
may	O
also	O
provide	O
a	O
biochemical	O
assay	O
for	O
the	O
CDC25	B
protein	O
and	O
can	O
form	O
the	O
basis	O
for	O
its	O
characterization	O
.	O

In	O
this	O
study	O
we	O
also	O
show	O
that	O
adenylyl	O
cyclase	O
activity	O
in	O
ras1ras2byc1	O
cells	O
is	O
found	O
in	O
the	O
soluble	O
fraction	O
,	O
whereas	O
in	O
wild	O
-	O
type	O
strain	O
it	O
is	O
found	O
in	O
the	O
membrane	O
fraction	O
.	O

Overexpression	O
of	O
the	O
gene	O
CDC25	B
in	O
the	O
ras1ras2bcy1	O
strain	O
relocalizes	O
adenylyl	O
cyclase	O
activity	O
to	O
the	O
membrane	O
fraction	O
.	O

This	O
finding	O
suggests	O
a	O
biochemical	O
link	O
between	O
CDC25	B
and	O
CDC35	B
in	O
the	O
absence	O
of	O
RAS	O
,	O
in	O
addition	O
to	O
its	O
role	O
in	O
regulating	O
RAS	O
dependent	O
adenylyl	O
cyclase	O
.	O

The	O
RUB1	B
/	O
NEDD-8	O
family	O
of	O
ubiquitin	O
-	O
related	O
genes	O
is	O
widely	O
represented	O
among	O
eukaryotes	O
.	O

Here	O
we	O
report	O
that	O
Cdc53p	O
in	O
Saccharomyces	O
cerevisiae	O
,	O
a	O
member	O
of	O
the	O
Cullin	O
family	O
of	O
proteins	O
,	O
is	O
stably	O
modified	O
by	O
the	O
covalent	O
attachment	O
of	O
a	O
single	O
Rub1p	O
molecule	O
.	O

Two	O
genes	O
have	O
been	O
identified	O
that	O
are	O
required	O
for	O
Rub1p	O
conjugation	O
to	O
Cdc53p	O
.	O

The	O
first	O
gene	O
,	O
designated	O
ENR2	B
,	O
encodes	O
a	O
protein	O
with	O
sequence	O
similarity	O
to	O
the	O
amino	O
-	O
terminal	O
half	O
of	O
the	O
ubiquitin	O
-	O
activating	O
enzyme	O
.	O

By	O
analogy	O
with	O
Aos1p	O
,	O
we	O
infer	O
that	O
Enr2p	O
functions	O
in	O
a	O
bipartite	O
Rub1p	O
-	O
activating	O
enzyme	O
.	O

The	O
second	O
gene	O
is	O
SKP1	B
,	O
shown	O
previously	O
to	O
be	O
required	O
for	O
some	O
ubiquitin	O
-	O
conjugation	O
events	O
.	O

A	O
deletion	O
allele	O
of	O
ENR2	B
is	O
lethal	O
with	O
temperature	O
-	O
sensitive	O
alleles	O
of	O
cdc34	B
and	O
enhances	O
the	O
phenotypes	O
of	O
cdc4	B
,	O
cdc53	B
,	O
and	O
skp1	B
,	O
strongly	O
implying	O
that	O
Rub1p	O
conjugation	O
to	O
Cdc53p	O
is	O
required	O
for	O
optimal	O
assembly	O
or	O
function	O
of	O
the	O
E3	O
complex	O
SCFCdc4	O
.	O

Consistent	O
with	O
this	O
model	O
,	O
both	O
enr2delta	O
and	O
an	O
allele	O
of	O
Cdc53p	O
that	O
is	O
not	O
Rub1p	O
modified	O
,	O
render	O
cells	O
sensitive	O
to	O
alterations	O
in	O
the	O
levels	O
of	O
Cdc4p	O
,	O
Cdc34p	O
,	O
and	O
Cdc53p	O
.	O

Oligosaccharyltransferase	O
mediates	O
the	O
transfer	O
of	O
a	O
preassembled	O
high	O
mannose	O
oligosaccharide	O
from	O
a	O
lipid	O
-	O
linked	O
oligosaccharide	O
donor	O
to	O
consensus	O
glycosylation	O
acceptor	O
sites	O
in	O
newly	O
synthesized	O
proteins	O
in	O
the	O
lumen	O
of	O
the	O
rough	O
endoplasmic	O
reticulum	O
.	O

The	O
Saccharomyces	O
cerevisiae	O
oligosaccharyltransferase	O
is	O
an	O
oligomeric	O
complex	O
composed	O
of	O
six	O
nonidentical	O
subunits	O
(	O
alpha	O
-	O
zeta	O
)	O
,	O
two	O
of	O
which	O
are	O
glycoproteins	O
(	O
alpha	O
and	O
beta	O
)	O
.	O

The	O
beta	O
and	O
delta	O
subunits	O
of	O
the	O
oligosaccharyltransferase	O
are	O
encoded	O
by	O
the	O
WBP1	B
and	O
SWP1	B
genes	O
.	O

Here	O
we	O
describe	O
the	O
functional	O
characterization	O
of	O
the	O
OST1	B
gene	O
that	O
encodes	O
the	O
alpha	O
subunit	O
of	O
the	O
oligosaccharyltransferase	O
.	O

Protein	O
sequence	O
analysis	O
revealed	O
a	O
significant	O
sequence	O
identity	O
between	O
the	O
Saccharomyces	O
cerevisiae	O
Ost1	B
protein	O
and	O
ribophorin	O
I	O
,	O
a	O
previously	O
identified	O
subunit	O
of	O
the	O
mammalian	O
oligosaccharyltransferase	O
.	O

A	O
disruption	O
of	O
the	O
OST1	B
locus	O
was	O
not	O
tolerated	O
in	O
haploid	O
yeast	O
showing	O
that	O
expression	O
of	O
the	O
Ost1	B
protein	O
is	O
essential	O
for	O
vegetative	O
growth	O
of	O
yeast	O
.	O

An	O
analysis	O
of	O
a	O
series	O
of	O
conditional	O
ost1	B
mutants	O
demonstrated	O
that	O
defects	O
in	O
the	O
Ost1	B
protein	O
cause	O
pleiotropic	O
underglycosylation	O
of	O
soluble	O
and	O
membrane	O
-	O
bound	O
glycoproteins	O
at	O
both	O
the	O
permissive	O
and	O
restrictive	O
growth	O
temperatures	O
.	O

Microsomal	O
membranes	O
isolated	O
from	O
ost1	B
mutant	O
yeast	O
showed	O
marked	O
reductions	O
in	O
the	O
in	O
vitro	O
transfer	O
of	O
high	O
mannose	O
oligosaccharide	O
from	O
exogenous	O
lipid	O
-	O
linked	O
oligosaccharide	O
to	O
a	O
glycosylation	O
site	O
acceptor	O
tripeptide	O
.	O

Microsomal	O
membranes	O
isolated	O
from	O
the	O
ost1	B
mutants	O
contained	O
elevated	O
amounts	O
of	O
the	O
Kar2	B
stress	O
-	O
response	O
protein	O
.	O

BACKGROUND	O
:	O
In	O
the	O
rRNA	O
gene	O
cluster	O
on	O
the	O
Saccharomyces	O
cerevisiae	O
chromosome	O
XII	O
,	O
a	O
unique	O
site	O
that	O
blocks	O
progression	O
of	O
the	O
replication	O
fork	O
exists	O
in	O
a	O
single	O
unit	O
of	O
the	O
repeats	O
.	O

The	O
site	O
RFB	O
(	O
replication	O
fork	O
blocking	O
)	O
is	O
located	O
within	O
one	O
of	O
two	O
cis	O
-	O
elements	O
present	O
in	O
a	O
nontranscribed	O
region	O
of	O
each	O
repeated	O
unit	O
,	O
which	O
are	O
required	O
for	O
obtaining	O
maximal	O
activity	O
of	O
a	O
hotspot	O
(	O
HOT1	O
)	O
dependent	O
recombination	O
.	O

RESULTS	O
:	O
To	O
investigate	O
the	O
correlation	O
between	O
replication	O
fork	O
blocking	O
at	O
RFB	O
and	O
homologous	O
recombination	O
at	O
HOT1	O
,	O
we	O
have	O
isolated	O
Hot1-defective	O
mutants	O
and	O
examined	O
their	O
ability	O
for	O
fork	O
blocking	O
at	O
RFB	O
.	O

Amongst	O
23	O
isolated	O
mutants	O
,	O
four	O
were	O
found	O
to	O
be	O
defective	O
in	O
both	O
abilities	O
.	O

Genetic	O
analysis	O
of	O
the	O
mutants	O
reveals	O
that	O
a	O
single	O
mutation	O
,	O
named	O
fob1	B
(	O
fork	O
blocking	O
less	O
)	O
,	O
is	O
responsible	O
for	O
the	O
defects	O
in	O
both	O
abilities	O
.	O

The	O
FOB1	B
gene	O
is	O
located	O
on	O
chromosome	O
IV	O
and	O
has	O
no	O
homology	O
with	O
any	O
other	O
genes	O
listed	O
in	O
DNA	O
data	O
banks	O
.	O

CONCLUSION	O
:	O
The	O
pleiotropic	O
effect	O
of	O
the	O
fob1	B
mutation	O
suggests	O
that	O
homologous	O
recombination	O
at	O
HOT1	O
is	O
closely	O
linked	O
with	O
DNA	O
replication	O
fork	O
blocking	O
event	O
at	O
RFB	O
.	O

Using	O
a	O
Saccharomyces	O
cerevisiae	O
strain	O
containing	O
an	O
integrated	O
copy	O
of	O
an	O
H2A	O
-	O
lacZ	O
fusion	O
gene	O
,	O
we	O
screened	O
for	O
mutants	O
which	O
overexpressed	O
beta	O
-	O
galactosidase	O
as	O
a	O
way	O
to	O
identify	O
genes	O
which	O
regulate	O
transcription	O
of	O
the	O
histone	O
genes	O
.	O

Five	O
recessive	O
mutants	O
with	O
this	O
phenotype	O
were	O
shown	O
to	O
contain	O
altered	O
regulatory	O
genes	O
because	O
they	O
had	O
lost	O
repression	O
of	O
HTA1	B
transcription	O
which	O
occurs	O
upon	O
inhibition	O
of	O
chromosome	O
replication	O
(	O
D.	O
E.	O
Lycan	O
,	O
M.	O
A.	O
Osley	O
,	O
and	O
L.	O
Hereford	O
,	O
Mol	O
.	O

Cell	O
.	O

Biol	O
.	O

7:614	O
-	O
621	O
,	O
1987	O
)	O
.	O

Periodic	O
transcription	O
was	O
affected	O
in	O
the	O
mutants	O
as	O
well	O
,	O
since	O
the	O
HTA1	B
gene	O
was	O
transcribed	O
during	O
the	O
G1	O
and	O
G2	O
phases	O
of	O
the	O
cell	O
cycle	O
,	O
periods	O
in	O
the	O
cell	O
cycle	O
when	O
this	O
gene	O
is	O
normally	O
not	O
expressed	O
.	O

A	O
similar	O
loss	O
of	O
cell	O
cycle	O
-	O
dependent	O
transcription	O
was	O
noted	O
for	O
two	O
of	O
the	O
three	O
remaining	O
histone	O
loci	O
,	O
while	O
the	O
HO	O
and	O
CDC9	B
genes	O
continued	O
to	O
be	O
expressed	O
periodically	O
.	O

Using	O
isolated	O
promoter	O
elements	O
inserted	O
into	O
a	O
heterologous	O
cycl	O
-	O
lacZ	O
fusion	O
gene	O
,	O
we	O
demonstrated	O
that	O
the	O
mutations	O
fell	O
in	O
genes	O
which	O
acted	O
through	O
a	O
negative	O
site	O
in	O
the	O
TRT1	O
H2A	O
-	O
H2B	O
promoter	O
.	O

A	O
novel	O
yeast	O
gene	O
,	O
ELP2	B
,	O
is	O
shown	O
to	O
encode	O
the	O
90-kDa	O
subunit	O
of	O
the	O
Elongator	O
complex	O
and	O
elongating	O
RNA	O
polymerase	O
II	O
holoenzyme	O
.	O

ELP2	B
encodes	O
a	O
protein	O
with	O
eight	O
WD40	O
repeats	O
,	O
and	O
cells	O
lacking	O
the	O
gene	O
display	O
typical	O
elp	O
phenotypes	O
,	O
such	O
as	O
temperature	O
and	O
salt	O
sensitivity	O
.	O

Generally	O
,	O
different	O
combinations	O
of	O
double	O
and	O
triple	O
ELP	O
gene	O
deletions	O
cause	O
the	O
same	O
phenotypes	O
as	O
single	O
ELP1	B
,	O
ELP2	B
,	O
or	O
ELP3	B
deletion	O
,	O
providing	O
genetic	O
evidence	O
that	O
the	O
ELP	O
gene	O
products	O
work	O
together	O
in	O
a	O
complex	O
.	O

The	O
yeast	O
poly	O
(	O
A	O
)	O
binding	O
protein	O
Pab1p	O
mediates	O
the	O
interactions	O
between	O
the	O
5	O
'	O
cap	O
structure	O
and	O
the	O
3	O
'	O
poly	O
(	O
A	O
)	O
tail	O
of	O
mRNA	O
,	O
whose	O
structures	O
synergistically	O
activate	O
translation	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

We	O
found	O
that	O
deletion	O
of	O
the	O
PAT1	B
(	O
YCR077c	B
)	O
gene	O
suppresses	O
a	O
PAB1	B
gene	O
deletion	O
and	O
that	O
Pat1p	O
is	O
required	O
for	O
the	O
normal	O
initiation	O
of	O
translation	O
.	O

A	O
fraction	O
of	O
Pat1p	O
cosediments	O
with	O
free	O
40S	O
ribosomal	O
subunits	O
on	O
sucrose	O
gradients	O
.	O

The	O
PAT1	B
gene	O
is	O
not	O
essential	O
for	O
viability	O
,	O
although	O
disruption	O
of	O
the	O
gene	O
severely	O
impairs	O
translation	O
initiation	O
in	O
vivo	O
,	O
resulting	O
in	O
the	O
accumulation	O
of	O
80S	O
ribosomes	O
and	O
in	O
a	O
large	O
decrease	O
in	O
the	O
amounts	O
of	O
heavier	O
polysomes	O
.	O

Pat1p	O
contributes	O
to	O
the	O
efficiency	O
of	O
translation	O
in	O
a	O
yeast	O
cell	O
-	O
free	O
system	O
.	O

However	O
,	O
the	O
synergy	O
between	O
the	O
cap	O
structure	O
and	O
the	O
poly	O
(	O
A	O
)	O
tail	O
is	O
maintained	O
in	O
vitro	O
in	O
the	O
absence	O
of	O
Pat1p	O
.	O

Analysis	O
of	O
translation	O
initiation	O
intermediates	O
on	O
gradients	O
indicates	O
that	O
Pat1p	O
acts	O
at	O
a	O
step	O
before	O
or	O
during	O
the	O
recruitment	O
of	O
the	O
40S	O
ribosomal	O
subunit	O
by	O
the	O
mRNA	O
,	O
a	O
step	O
which	O
may	O
be	O
independent	O
of	O
that	O
involving	O
Pab1p	O
.	O

We	O
conclude	O
that	O
Pat1p	O
is	O
a	O
new	O
factor	O
involved	O
in	O
protein	O
synthesis	O
and	O
that	O
Pat1p	O
might	O
be	O
required	O
for	O
promoting	O
the	O
formation	O
or	O
the	O
stabilization	O
of	O
the	O
preinitiation	O
translation	O
complexes	O
.	O

The	O
Bcl-2-related	O
protein	O
Bax	O
is	O
toxic	O
when	O
expressed	O
either	O
in	O
yeast	O
or	O
in	O
mammalian	O
cells	O
.	O

Although	O
the	O
mechanism	O
of	O
this	O
toxicity	O
is	O
unknown	O
,	O
it	O
appears	O
to	O
be	O
similar	O
in	O
both	O
cell	O
types	O
and	O
dependent	O
on	O
the	O
localization	O
of	O
Bax	O
to	O
the	O
outer	O
mitochondrial	O
membrane	O
.	O

To	O
investigate	O
the	O
role	O
of	O
mitochondrial	O
respiration	O
in	O
Bax	O
-	O
mediated	O
toxicity	O
,	O
a	O
series	O
of	O
yeast	O
mutant	O
strains	O
was	O
created	O
,	O
each	O
carrying	O
a	O
disruption	O
in	O
either	O
a	O
component	O
of	O
the	O
mitochondrial	O
electron	O
transport	O
chain	O
,	O
a	O
component	O
of	O
the	O
mitochondrial	O
ATP	O
synthesis	O
machinery	O
,	O
or	O
a	O
protein	O
involved	O
in	O
mitochondrial	O
adenine	O
nucleotide	O
exchange	O
.	O

Bax	O
toxicity	O
was	O
reduced	O
in	O
strains	O
lacking	O
the	O
ability	O
to	O
perform	O
oxidative	O
phosphorylation	O
.	O

In	O
contrast	O
,	O
a	O
respiratory	O
-	O
competent	O
strain	O
that	O
lacked	O
the	O
outer	O
mitochondrial	O
membrane	O
Por1	B
protein	O
showed	O
increased	O
sensitivity	O
to	O
Bax	O
expression	O
.	O

Deficiencies	O
in	O
other	O
mitochondrial	O
proteins	O
did	O
not	O
affect	O
Bax	O
toxicity	O
as	O
long	O
as	O
the	O
ability	O
to	O
perform	O
oxidative	O
phosphorylation	O
was	O
maintained	O
.	O

Characterization	O
of	O
Bax	O
-	O
induced	O
toxicity	O
in	O
wild	O
-	O
type	O
yeast	O
demonstrated	O
a	O
growth	O
inhibition	O
that	O
preceded	O
cell	O
death	O
.	O

This	O
growth	O
inhibition	O
was	O
associated	O
with	O
a	O
decreased	O
ability	O
to	O
carry	O
out	O
oxidative	O
phosphorylation	O
following	O
Bax	O
induction	O
.	O

Furthermore	O
,	O
cells	O
recovered	O
following	O
Bax	O
-	O
induced	O
growth	O
arrest	O
were	O
enriched	O
for	O
a	O
petite	O
phenotype	O
and	O
were	O
no	O
longer	O
able	O
to	O
grow	O
on	O
a	O
nonfermentable	O
carbon	O
source	O
.	O

These	O
results	O
suggest	O
that	O
Bax	O
expression	O
leads	O
to	O
an	O
impairment	O
of	O
mitochondrial	O
respiration	O
,	O
inducing	O
toxicity	O
in	O
cells	O
dependent	O
on	O
oxidative	O
phosphorylation	O
for	O
survival	O
.	O

Furthermore	O
,	O
Bax	O
toxicity	O
is	O
enhanced	O
in	O
yeast	O
deficient	O
in	O
the	O
ability	O
to	O
exchange	O
metabolites	O
across	O
the	O
outer	O
mitochondrial	O
membrane	O
.	O

Mitochondrial	O
DNAs	O
(	O
mtDNA	O
)	O
from	O
four	O
stable	O
revertant	O
strains	O
generated	O
from	O
high	O
frequency	O
petite	O
forming	O
strains	O
of	O
Saccharomyces	O
cerevisiae	O
have	O
been	O
shown	O
to	O
contain	O
deletions	O
which	O
have	O
eliminated	O
intergenic	O
sequences	O
encompassing	O
ori1	B
,	O
ori2	B
and	O
ori7	B
.	O

The	O
deleted	O
sequences	O
are	O
dispensable	O
for	O
expression	O
of	O
the	O
respiratory	O
phenotype	O
and	O
mutant	O
strains	O
exhibit	O
the	O
same	O
relative	O
amount	O
of	O
mtDNA	O
per	O
cell	O
as	O
the	O
wild	O
-	O
type	O
(	O
wt	O
)	O
parental	O
strain	O
.	O

These	O
deletion	O
mutants	O
were	O
also	O
used	O
to	O
study	O
the	O
influence	O
of	O
particular	O
intergenic	O
sequences	O
on	O
the	O
transmission	O
of	O
closely	O
linked	O
mitochondrial	O
loci	O
.	O

When	O
the	O
mutant	O
strains	O
were	O
crossed	O
with	O
the	O
parental	O
wt	O
strains	O
,	O
there	O
was	O
a	O
strong	O
bias	O
towards	O
the	O
transmission	O
into	O
the	O
progeny	O
of	O
mitochondrial	O
genomes	O
lacking	O
the	O
intergenic	O
deletions	O
.	O

The	O
deficiency	O
in	O
the	O
transmission	O
of	O
the	O
mutant	O
regions	O
was	O
not	O
a	O
simple	O
function	O
of	O
deletion	O
length	O
and	O
varied	O
between	O
different	O
loci	O
.	O

In	O
crosses	O
between	O
mutant	O
strains	O
which	O
had	O
non	O
-	O
overlapping	O
deletions	O
,	O
wt	O
mtDNA	O
molecules	O
were	O
formed	O
by	O
recombination	O
.	O

The	O
wt	O
recombinants	O
were	O
present	O
at	O
high	O
frequencies	O
among	O
the	O
progeny	O
of	O
such	O
crosses	O
,	O
but	O
recombinants	O
containing	O
both	O
deletions	O
were	O
not	O
detected	O
at	O
all	O
.	O

The	O
results	O
indicate	O
that	O
mitochondrial	O
genomes	O
can	O
be	O
selectively	O
transmitted	O
to	O
progeny	O
and	O
that	O
two	O
particular	O
intergenic	O
regions	O
positively	O
influence	O
transmission	O
.	O

Within	O
these	O
regions	O
other	O
sequences	O
in	O
addition	O
to	O
ori	O
/	O
rep	O
affect	O
transmission	O
.	O

In	O
order	O
to	O
identify	O
proteins	O
that	O
interact	O
with	O
plant	O
transcriptional	O
complexes	O
,	O
we	O
performed	O
a	O
two	O
-	O
hybrid	O
screen	O
in	O
yeast	O
using	O
a	O
cDNA	O
library	O
from	O
embryogenic	O
rice	O
suspension	O
cultures	O
and	O
the	O
plant	O
transcriptional	O
activator	O
viviparous-1	O
(	O
vp1	O
)	O
as	O
'	O
bait	O
'	O
.	O

In	O
this	O
screen	O
,	O
we	O
detected	O
an	O
interaction	O
between	O
VP1	O
and	O
a	O
rice	O
homologue	O
of	O
the	O
Saccharomyces	O
cerevisiae	O
RAD23	B
gene	O
(	O
osRAD23	O
)	O
.	O

The	O
RAD23	B
protein	O
is	O
associated	O
with	O
the	O
general	O
transcriptional	O
machinery	O
in	O
yeast	O
,	O
and	O
is	O
believed	O
to	O
play	O
a	O
role	O
in	O
the	O
processes	O
of	O
nucleotide	O
excision	O
repair	O
in	O
yeast	O
and	O
mammalian	O
cells	O
.	O

This	O
report	O
is	O
the	O
first	O
identification	O
of	O
a	O
RAD23	B
homolog	O
in	O
plants	O
.	O

The	O
osRAD23	O
amino	O
acid	O
sequence	O
shares	O
50	O
-	O
60	O
%	O
similarity	O
throughout	O
its	O
length	O
with	O
RAD23	B
sequences	O
from	O
yeast	O
,	O
mice	O
,	O
and	O
man	O
.	O

osRAD23	O
contains	O
a	O
characteristic	O
ubiquitin	O
-	O
like	O
domain	O
at	O
its	O
N	O
-	O
terminus	O
,	O
which	O
is	O
similar	O
to	O
other	O
RAD23	B
genes	O
.	O

Analysis	O
of	O
the	O
expressed	O
sequence	O
tag	O
database	O
identifies	O
two	O
different	O
classes	O
of	O
RAD23	B
genes	O
in	O
both	O
Arabidopsis	O
and	O
rice	O
.	O

Southern	O
analysis	O
of	O
rice	O
genomic	O
DNA	O
indicated	O
the	O
presence	O
of	O
at	O
least	O
two	O
RAD23-like	B
genes	O
.	O

A	O
single	O
transcript	O
(	O
1.5	O
kb	O
)	O
of	O
osRAD23	O
was	O
detected	O
in	O
total	O
RNA	O
from	O
rice	O
embryonic	O
tissue	O
,	O
while	O
three	O
transcripts	O
(	O
1.8	O
,	O
1.5	O
and	O
1.0	O
kb	O
)	O
were	O
observed	O
in	O
total	O
RNA	O
from	O
vegetative	O
tissues	O
of	O
rice	O
.	O

The	O
repair	O
of	O
DNA	O
double	O
-	O
strand	O
breaks	O
in	O
Saccharomyces	O
cerevisiae	O
requires	O
genes	O
of	O
the	O
RAD52	B
epistasis	O
group	O
,	O
of	O
which	O
RAD55	B
and	O
RAD57	B
are	O
members	O
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
x	O
-	O
ray	O
sensitivity	O
of	O
rad55	B
and	O
rad57	B
mutant	O
strains	O
is	O
suppressible	O
by	O
overexpression	O
of	O
RAD51	B
or	O
RAD52	B
.	O

Virtually	O
complete	O
suppression	O
is	O
provided	O
by	O
the	O
simultaneous	O
overexpression	O
of	O
RAD51	B
and	O
RAD52	B
.	O

This	O
suppression	O
occurs	O
at	O
23	O
degrees	O
C	O
,	O
where	O
these	O
mutants	O
are	O
more	O
sensitive	O
to	O
x	O
-	O
rays	O
,	O
as	O
well	O
as	O
at	O
30	O
degrees	O
C	O
and	O
36	O
degrees	O
C.	O
In	O
addition	O
,	O
a	O
recombination	O
defect	O
of	O
rad55	B
and	O
rad57	B
mutants	O
is	O
similarly	O
suppressed	O
.	O

Direct	O
in	O
vivo	O
interactions	O
between	O
the	O
Rad51	B
and	O
Rad55	B
proteins	O
,	O
and	O
between	O
Rad55	B
and	O
Rad57	B
,	O
have	O
also	O
been	O
identified	O
by	O
using	O
the	O
two	O
-	O
hybrid	O
system	O
.	O

These	O
results	O
indicate	O
that	O
these	O
four	O
proteins	O
constitute	O
part	O
of	O
a	O
complex	O
,	O
a	O
""""	O
recombinosome	O
,	O
""""	O
to	O
effect	O
the	O
recombinational	O
repair	O
of	O
double	O
-	O
strand	O
breaks	O
.	O

A	O
forward	O
mutation	O
system	O
has	O
been	O
developed	O
to	O
obtain	O
rapidly	O
clonable	O
mutants	O
at	O
the	O
URA3	B
locus	O
in	O
yeast	O
by	O
means	O
of	O
selection	O
for	O
5-fluoroorotic	O
acid	O
resistance	O
.	O

We	O
have	O
used	O
this	O
system	O
to	O
determine	O
base	O
changes	O
in	O
35	O
spontaneous	O
and	O
34	O
ultraviolet	O
radiation	O
-	O
induced	O
ura3	B
base	O
substitution	O
mutants	O
.	O

Other	O
mutants	O
(	O
frameshift	O
,	O
deletion	O
,	O
duplication	O
,	O
replacement	O
)	O
were	O
detected	O
as	O
well	O
.	O

Evidence	O
is	O
reported	O
which	O
suggests	O
cyclobutane	O
dimers	O
are	O
the	O
principal	O
mutagenic	O
lesions	O
induced	O
by	O
UV	O
radiation	O
in	O
stationary	O
phase	O
cells	O
of	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

Since	O
most	O
of	O
the	O
induced	O
lesions	O
are	O
at	O
5'-TT-3	O
'	O
sites	O
,	O
the	O
results	O
suggest	O
that	O
the	O
""""	O
A	O
-	O
rule	O
""""	O
,	O
preferential	O
insertion	O
of	O
adenine	O
residues	O
opposite	O
poorly	O
pairing	O
sites	O
in	O
DNA	O
,	O
does	O
not	O
apply	O
for	O
yeast	O
cells	O
irradiated	O
in	O
stationary	O
phase	O
,	O
whereas	O
the	O
spontaneous	O
mutation	O
data	O
indicate	O
that	O
the	O
A	O
-	O
rule	O
applies	O
for	O
cells	O
in	O
logarithmic	O
phase	O
.	O

Most	O
of	O
the	O
spontaneous	O
mutations	O
are	O
transversions	O
.	O

UV	O
-	O
induced	O
transitions	O
and	O
transversions	O
occur	O
at	O
approximately	O
equal	O
frequencies	O
.	O

Yeast	B
calmodulin	O
(	O
CaM	O
)	O
is	O
required	O
for	O
the	O
progression	O
of	O
nuclear	O
division	O
(	O
Ohya	O
,	O
Y.	B
and	O
Y.	B
Anraku	O
.	O
1989	O
.	O

Curr	O
.	O

Genet	O
.	O

15:113	O
-	O
120	O
)	O
,	O
although	O
the	O
precise	O
mechanism	O
and	O
physiological	O
role	O
of	O
CaM	O
in	O
this	O
process	O
are	O
unclear	O
.	O

In	O
this	O
paper	O
we	O
have	O
characterized	O
the	O
phenotype	O
caused	O
by	O
a	O
temperature	O
-	O
sensitive	O
lethal	O
mutation	O
(	O
cmdl-101	O
)	O
in	O
the	O
yeast	O
CaM.	O
The	O
cmdl-101	O
mutation	O
expresses	O
a	O
carboxyl	O
-	O
terminal	O
half	O
of	O
the	O
yeast	O
CaM	O
(	O
Met72-Cys147	O
)	O
under	O
the	O
control	O
of	O
an	O
inducible	O
GAL1	B
promoter	O
.	O

Incubation	O
of	O
the	O
cmdl-101	O
cells	O
at	O
a	O
nonpermissive	O
temperature	O
causes	O
a	O
severe	O
defect	O
in	O
chromosome	O
segregation	O
.	O

The	O
rate	O
of	O
chromosome	O
loss	O
in	O
the	O
cmdl-101	O
mutant	O
is	O
higher	O
than	O
wild	O
-	O
type	O
cell	O
even	O
at	O
permissive	O
temperature	O
.	O

The	O
primary	O
visible	O
defect	O
observed	O
by	O
immunofluorescence	O
and	O
electron	O
microscopic	O
analyses	O
is	O
that	O
the	O
organization	O
of	O
spindle	O
microtubules	O
is	O
abnormal	O
in	O
the	O
cmdl-101	O
cells	O
grown	O
at	O
nonpermissive	O
temperature	O
.	O

Majority	O
of	O
budded	O
cells	O
arrested	O
at	O
the	O
high	O
temperature	O
contain	O
only	O
one	O
spindle	O
pole	O
body	O
(	O
SPB	O
)	O
,	O
which	O
forms	O
monopolar	O
spindle	O
,	O
whereas	O
the	O
budded	O
cells	O
of	O
the	O
same	O
strain	O
incubated	O
at	O
permissive	O
temperature	O
all	O
contain	O
two	O
SPBs	O
.	O

Using	O
the	O
freeze	O
-	O
substituted	O
fixation	O
method	O
,	O
we	O
found	O
that	O
the	O
integrity	O
of	O
the	O
nuclear	O
morphology	O
of	O
the	O
cmdl-101	O
mutant	O
cell	O
is	O
significantly	O
disturbed	O
.	O

The	O
nucleus	O
in	O
wild	O
-	O
type	O
cells	O
is	O
round	O
with	O
smooth	O
contours	O
of	O
nuclear	O
envelope	O
.	O

However	O
,	O
the	O
nuclear	O
envelope	O
in	O
the	O
mutant	O
cells	O
appears	O
to	O
be	O
very	O
flexible	O
and	O
forms	O
irregular	O
projections	O
and	O
invaginations	O
that	O
are	O
never	O
seen	O
in	O
wild	O
-	O
type	O
cells	O
.	O

The	O
deformation	O
of	O
the	O
nuclear	O
becomes	O
much	O
more	O
severe	O
as	O
the	O
incubation	O
at	O
nonpermissive	O
temperature	O
continues	O
.	O

The	O
single	O
SPB	O
frequently	O
localizes	O
on	O
the	O
projections	O
or	O
the	O
invaginations	O
of	O
the	O
nuclear	O
envelope	O
.	O

These	O
observations	O
suggest	O
that	O
CaM	O
is	O
required	O
for	O
the	O
functions	O
of	O
SPB	O
and	O
spindle	O
,	O
and	O
the	O
integrity	O
of	O
nucleus	O
.	O

The	O
SEC4	B
gene	O
product	O
is	O
a	O
major	O
component	O
of	O
the	O
protein	O
secretion	O
machinery	O
.	O

More	O
specifically	O
,	O
it	O
is	O
believed	O
to	O
play	O
a	O
pivotal	O
role	O
in	O
targeting	O
and	O
fusion	O
of	O
secretory	O
vesicles	O
to	O
the	O
plasma	O
membrane	O
.	O

Its	O
recently	O
described	O
implication	O
with	O
the	O
Saccharomyces	O
cerevisiae	O
Rho3p	O
,	O
which	O
is	O
required	O
for	O
directing	O
growing	O
points	O
during	O
bud	O
formation	O
,	O
has	O
prompted	O
us	O
to	O
investigate	O
the	O
role	O
and	O
function	O
of	O
Sec4p	O
in	O
the	O
morphological	O
changes	O
of	O
the	O
yeast	O
pathogen	O
Candida	O
albicans	O
.	O

We	O
have	O
therefore	O
cloned	O
the	O
C.	O
albicans	O
SEC4	B
gene	O
.	O

It	O
encodes	O
a	O
210	O
amino	O
acids	O
long	O
protein	O
sharing	O
up	O
to	O
75	O
%	O
homology	O
to	O
the	O
S.	O
cerevisiae	O
homolog	O
,	O
when	O
conserved	O
changes	O
are	O
allowed	O
.	O

Its	O
RNA	O
is	O
constitutively	O
expressed	O
in	O
C.	O
albicans	O
grown	O
under	O
various	O
physiological	O
conditions	O
.	O

We	O
also	O
show	O
that	O
it	O
can	O
functionally	O
complement	O
a	O
S.	O
cerevisiae	O
sec4	B
thermosensitive	O
mutant	O
.	O

The	O
biosynthesis	O
of	O
ubiquinone	O
(	O
Q	O
)	O
and	O
the	O
functional	O
consequences	O
of	O
Q	O
-	O
deficiency	O
was	O
studied	O
in	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

Lipid	O
extracts	O
were	O
prepared	O
from	O
various	O
respiratory	O
deficient	O
mutants	O
grown	O
in	O
the	O
presence	O
of	O
p-	O
[	O
U-14C	O
]	O
hydroxybenzoic	O
acid	O
.	O

Q	O
mutant	O
strains	O
harboring	O
mutations	O
in	O
the	O
coq3	B
,	O
coq4	B
,	O
coq5	B
,	O
coq6	B
,	O
coq7	B
,	O
or	O
coq8	O
genes	O
were	O
unable	O
to	O
produce	O
Q	O
and	O
accumulated	O
an	O
early	O
intermediated	O
that	O
corresponded	O
to	O
3-hexaprenyl-4-hydroxybenzoic	O
acid	O
.	O

Several	O
respiratory	O
deficient	O
yeast	O
including	O
both	O
nuclear	O
and	O
mitochondrial	O
petite	O
mutant	O
strains	O
,	O
retain	O
the	O
ability	O
to	O
produce	O
Q.	O
Thus	O
,	O
the	O
inability	O
to	O
produce	O
Q	O
is	O
a	O
specific	O
phenotype	O
manifested	O
in	O
the	O
class	O
of	O
mutants	O
termed	O
'	O
coq	O
'	O
.	O

Previous	O
studies	O
described	O
the	O
enhanced	O
sensitivity	O
of	O
the	O
Q	O
-	O
deficient	O
yeast	O
strain	O
containing	O
a	O
deletion	O
in	O
the	O
COQ3	B
gene	O
to	O
the	O
products	O
of	O
autoxidized	O
polyunsaturated	O
fatty	O
acids	O
(	O
Do	O
et	O
al.	O
,	O
1996	O
,	O
Proceeding	O
of	O
the	O
National	O
Academy	O
of	O
Science	O
USA	O
,	O
93	O
,	O
7534	O
-	O
7539	O
)	O
.	O

The	O
results	O
presented	O
here	O
show	O
this	O
to	O
be	O
a	O
general	O
phenotype	O
resulting	O
from	O
Q	O
-	O
deficiency	O
,	O
as	O
all	O
of	O
the	O
coq	O
mutant	O
yeast	O
strains	O
tested	O
exhibit	O
hypersensitivity	O
to	O
polyunsaturated	O
fatty	O
acid	O
treatment	O
.	O

p53	O
binding	O
protein	O
1	O
(	O
53BP1	O
)	O
,	O
a	O
protein	O
proposed	O
to	O
function	O
as	O
a	O
transcriptional	O
coactivator	O
of	O
the	O
p53	O
tumor	O
suppressor	O
,	O
has	O
BRCT	O
domains	O
with	O
high	O
homology	O
to	O
the	O
Saccharomyces	O
cerevisiae	O
Rad9p	O
DNA	O
damage	O
checkpoint	O
protein	O
.	O

To	O
examine	O
whether	O
53BP1	O
has	O
a	O
role	O
in	O
the	O
cellular	O
response	O
to	O
DNA	O
damage	O
,	O
we	O
probed	O
its	O
intracellular	O
localization	O
by	O
immunofluorescence	O
.	O

In	O
untreated	O
primary	O
cells	O
and	O
U2OS	O
osteosarcoma	O
cells	O
,	O
53BP1	O
exhibited	O
diffuse	O
nuclear	O
staining	O
;	O
whereas	O
,	O
within	O
5	O
-	O
15	O
min	O
after	O
exposure	O
to	O
ionizing	O
radiation	O
(	O
IR	O
)	O
,	O
53BP1	O
localized	O
at	O
discreet	O
nuclear	O
foci	O
.	O

We	O
propose	O
that	O
these	O
foci	O
represent	O
sites	O
of	O
processing	O
of	O
DNA	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
,	O
because	O
they	O
were	O
induced	O
by	O
IR	O
and	O
chemicals	O
that	O
cause	O
DSBs	O
,	O
but	O
not	O
by	O
ultraviolet	O
light	O
;	O
their	O
peak	O
number	O
approximated	O
the	O
number	O
of	O
DSBs	O
induced	O
by	O
IR	O
and	O
decreased	O
over	O
time	O
with	O
kinetics	O
that	O
parallel	O
the	O
rate	O
of	O
DNA	O
repair	O
;	O
and	O
they	O
colocalized	O
with	O
IR	O
-	O
induced	O
Mre11	B
/	O
NBS	O
and	O
gamma	O
-	O
H2AX	O
foci	O
,	O
which	O
have	O
been	O
previously	O
shown	O
to	O
localize	O
at	O
sites	O
of	O
DSBs	O
.	O

Formation	O
of	O
53BP1	O
foci	O
after	O
irradiation	O
was	O
not	O
dependent	O
on	O
ataxia	O
-	O
telangiectasia	O
mutated	O
(	O
ATM	O
)	O
,	O
Nijmegen	O
breakage	O
syndrome	O
(	O
NBS1	O
)	O
,	O
or	O
wild	O
-	O
type	O
p53	O
.	O

Thus	O
,	O
the	O
fast	O
kinetics	O
of	O
53BP1	O
focus	O
formation	O
after	O
irradiation	O
and	O
the	O
lack	O
of	O
dependency	O
on	O
ATM	O
and	O
NBS1	O
suggest	O
that	O
53BP1	O
functions	O
early	O
in	O
the	O
cellular	O
response	O
to	O
DNA	O
DSBs	O
.	O

DNA	O
methylating	O
agents	O
such	O
as	O
N	O
-	O
methyl	O
-	O
N'-nitro	O
-	O
N	O
-	O
nitrosoguanidine	O
(	O
MNNG	O
)	O
are	O
potent	O
carcinogens	O
;	O
their	O
carcinogenic	O
effect	O
is	O
mainly	O
due	O
to	O
the	O
effect	O
of	O
production	O
of	O
O6-methylguanine	O
(	O
O6	O
MeG	O
)	O
on	O
DNA	O
.	O

O6	O
MeG	O
is	O
not	O
only	O
mutagenic	O
but	O
also	O
toxic	O
to	O
the	O
cell	O
because	O
Mer-	O
/	O
Mex-	O
cells	O
unable	O
to	O
remove	O
O6	O
MeG	O
are	O
very	O
sensitive	O
to	O
killing	O
by	O
MNNG	O
.	O

It	O
has	O
been	O
proposed	O
that	O
repeated	O
futile	O
mismatch	O
correction	O
of	O
O6	O
MeG	O
-	O
containing	O
bp	O
is	O
responsible	O
for	O
the	O
genotoxicity	O
of	O
the	O
O6	O
MeG	O
lesion	O
and	O
that	O
loss	O
of	O
mismatch	O
repair	O
activity	O
results	O
in	O
cellular	O
tolerance	O
to	O
O6	O
MeG	O
,	O
but	O
the	O
hypothesis	O
has	O
not	O
been	O
proved	O
.	O

We	O
used	O
yeast	O
as	O
a	O
model	O
to	O
test	O
this	O
hypothesis	O
and	O
found	O
that	O
chromosome	O
deletion	O
of	O
any	O
known	O
nuclear	O
mitotic	O
mismatch	O
repair	O
genes	O
,	O
including	O
MLH1	B
,	O
MSH2	B
,	O
MSH3	B
,	O
MSH6	B
,	O
and	O
PMS1	B
,	O
did	O
not	O
rescue	O
mgt1delta	O
O6	O
MeG	O
DNA	O
repair	O
methyltransferase	O
-	O
deficient	O
cells	O
from	O
killing	O
by	O
MNNG	O
.	O

A	O
large	O
number	O
of	O
mgt1delta	O
,	O
MNNG	O
-	O
tolerant	O
revertants	O
were	O
isolated	O
,	O
among	O
which	O
one	O
cell	O
line	O
,	O
XS-14	O
,	O
has	O
been	O
found	O
to	O
carry	O
a	O
mutated	O
allele	O
of	O
the	O
MSH5	B
gene	O
.	O

The	O
mutation	O
also	O
affected	O
spore	O
survival	O
but	O
did	O
not	O
increase	O
the	O
spontaneous	O
mutation	O
rate	O
.	O

We	O
further	O
demonstrated	O
that	O
a	O
mutated	O
form	O
of	O
the	O
MSH5	B
gene	O
,	O
msh5	B
-	I
14	I
,	O
not	O
the	O
msh5delta	O
-	O
null	O
mutation	O
,	O
is	O
responsible	O
for	O
the	O
cellular	O
tolerance	O
to	O
MNNG	O
in	O
XS-14	O
cells	O
.	O

This	O
observation	O
offers	O
an	O
alternative	O
model	O
that	O
may	O
reconcile	O
seemingly	O
contradictory	O
observations	O
of	O
yeast	O
and	O
mammalian	O
cells	O
.	O

To	O
learn	O
more	O
about	O
the	O
variety	O
of	O
Ty	O
elements	O
capable	O
of	O
activating	O
gene	O
expression	O
,	O
we	O
characterized	O
206	O
spontaneous	O
Ty	O
transpositions	O
that	O
activate	O
the	O
promoterless	O
gene	O
his3	B
delta	O
4	O
.	O

Most	O
of	O
the	O
Ty	O
elements	O
appear	O
to	O
be	O
full	O
-	O
length	O
,	O
although	O
a	O
few	O
deleted	O
elements	O
were	O
recovered	O
.	O

Over	O
95	O
%	O
of	O
the	O
insertions	O
belong	O
to	O
the	O
Ty1	O
family	O
,	O
and	O
the	O
rest	O
are	O
Ty2	O
elements	O
.	O

The	O
excessive	O
number	O
of	O
Ty1	O
transpositions	O
was	O
unexpected	O
because	O
there	O
are	O
only	O
2-fold	O
more	O
Ty1	O
than	O
Ty2	O
elements	O
in	O
the	O
yeast	O
strains	O
used	O
in	O
the	O
selection	O
.	O

However	O
,	O
there	O
is	O
20-fold	O
more	O
Ty1	O
than	O
Ty2	O
RNA	O
present	O
in	O
these	O
yeast	O
strains	O
.	O

This	O
difference	O
in	O
RNA	O
level	O
explains	O
the	O
greater	O
number	O
of	O
Ty1	O
verses	O
Ty2	O
transpositions	O
at	O
his3	B
delta	O
4	O
,	O
because	O
Ty	O
elements	O
transpose	O
through	O
an	O
RNA	O
intermediate	O
.	O

A	O
similar	O
association	O
between	O
the	O
Ty	O
transcript	O
level	O
and	O
transpositional	O
activation	O
of	O
his3	B
delta	O
4	O
is	O
obtained	O
in	O
cells	O
expressing	O
GAL1-promoted	O
Ty2-H556	O
or	O
Ty2	O
-	O
917	O
elements	O
,	O
but	O
only	O
if	O
the	O
element	O
does	O
not	O
contain	O
a	O
marker	O
.	O

Genetically	O
marked	O
Ty2-H556NEO	O
and	O
-917NEO	O
elements	O
transpose	O
into	O
and	O
activate	O
his3	B
delta	O
4	O
with	O
the	O
same	O
efficiency	O
as	O
the	O
previously	O
characterized	O
Ty1-H3NEO	O
element	O
,	O
but	O
are	O
underrepresented	O
relative	O
to	O
the	O
levels	O
of	O
TyNEO	O
transcript	O
.	O

We	O
also	O
found	O
that	O
chromosomal	O
Ty	O
transcripts	O
are	O
even	O
more	O
abundant	O
than	O
previously	O
estimated	O
and	O
comprise	O
about	O
1	O
%	O
of	O
total	O
cellular	O
RNA	O
.	O

When	O
yeast	O
from	O
the	O
early	O
stages	O
of	O
meiosis	O
are	O
transferred	O
from	O
sporulation	O
to	O
growth	O
medium	O
,	O
they	O
can	O
reenter	O
the	O
mitotic	O
cell	O
cycle	O
directly	O
.	O

In	O
contrast	O
,	O
cells	O
from	O
later	O
stages	O
of	O
meiosis	O
(	O
after	O
the	O
initiation	O
of	O
the	O
first	O
nuclear	O
division	O
)	O
will	O
complete	O
meiosis	O
and	O
sporulation	O
despite	O
the	O
shift	O
to	O
growth	O
medium	O
,	O
a	O
phenomenon	O
known	O
as	O
""""	O
commitment	O
to	O
meiosis	O
.	O
""""	O

This	O
study	O
reports	O
the	O
surprising	O
finding	O
that	O
when	O
the	O
normal	O
progression	O
of	O
meiosis	O
is	O
arrested	O
,	O
cells	O
from	O
later	O
stages	O
of	O
meiosis	O
can	O
return	O
to	O
growth	O
.	O

Cells	O
were	O
arrested	O
after	O
the	O
first	O
or	O
second	O
meiotic	O
division	O
by	O
three	O
independent	O
means	O
:	O
the	O
spo14	B
mutation	O
,	O
the	O
spo3	B
-	I
1	I
mutation	O
,	O
and	O
a	O
high	O
-	O
temperature	O
arrest	O
of	O
wild	O
-	O
type	O
cells	O
.	O

In	O
every	O
case	O
,	O
the	O
arrested	O
cells	O
were	O
able	O
to	O
form	O
buds	O
after	O
transfer	O
to	O
growth	O
medium	O
.	O

These	O
cells	O
,	O
however	O
,	O
experienced	O
a	O
delay	O
upon	O
return	O
to	O
growth	O
relative	O
to	O
uncommitted	O
cells	O
.	O

We	O
propose	O
that	O
the	O
commitment	O
phenomenon	O
results	O
from	O
a	O
transient	O
delay	O
of	O
mitotic	O
growth	O
,	O
which	O
occurs	O
specifically	O
during	O
meiosis	O
,	O
and	O
that	O
commitment	O
does	O
not	O
involve	O
an	O
irreversible	O
inhibition	O
of	O
mitosis	O
as	O
previously	O
thought	O
.	O

The	O
FET3	B
gene	O
product	O
of	O
Saccharomyces	O
cerevisiae	O
is	O
an	O
essential	O
component	O
of	O
the	O
high	O
affinity	O
iron	O
transport	O
system	O
.	O

Based	O
on	O
FET3	B
sequence	O
homology	O
to	O
the	O
multicopper	O
oxidase	O
family	O
and	O
iron	O
oxidation	O
studies	O
in	O
spheroplasts	O
(	O
De	O
Silva	O
,	O
D.	O
M.	O
,	O
Askwith	O
,	O
C.	O
C.	O
,	O
Eide	O
,	O
D.	O
,	O
and	O
Kaplan	O
,	O
J.	O
(	O
1995	O
)	O
J.	O
Biol	O
.	O

Chem	O
.	O
270	O
,	O
1098	O
-	O
1101	O
)	O
,	O
it	O
was	O
hypothesized	O
that	O
the	O
Fet3	B
protein	O
(	O
Fet3p	O
)	O
was	O
a	O
cell	O
surface	O
ferroxidase	O
.	O

To	O
further	O
characterize	O
the	O
protein	O
,	O
we	O
have	O
isolated	O
Fet3p	O
from	O
yeast	O
membranes	O
and	O
purified	O
the	O
protein	O
to	O
apparent	O
homogeneity	O
.	O

Consistent	O
with	O
its	O
localization	O
at	O
the	O
plasma	O
membrane	O
,	O
Fet3p	O
is	O
a	O
glycosylated	O
protein	O
.	O

SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
analysis	O
showed	O
that	O
the	O
protein	O
was	O
present	O
in	O
two	O
differentially	O
glycosylated	O
forms	O
of	O
approximately	O
120	O
and	O
100	O
kDa	O
.	O

Purified	O
Fet3p	O
is	O
a	O
copper	O
-	O
containing	O
protein	O
that	O
is	O
able	O
to	O
catalyze	O
the	O
oxidation	O
of	O
a	O
variety	O
of	O
organic	O
compounds	O
in	O
addition	O
to	O
ferrous	O
iron	O
.	O

Azide	O
and	O
metal	O
chelators	O
strongly	O
inhibited	O
enzyme	O
activity	O
.	O

Iron	O
appeared	O
to	O
be	O
the	O
best	O
substrate	O
for	O
the	O
enzyme	O
,	O
and	O
the	O
apparent	O
Km	O
for	O
ferrous	O
oxidation	O
was	O
2	O
microM.	O
Interestingly	O
,	O
Fet3p	O
was	O
able	O
to	O
effectively	O
catalyze	O
the	O
incorporation	O
of	O
iron	O
onto	O
apotransferrin	O
.	O

We	O
conclude	O
that	O
Fet3p	O
is	O
a	O
ferro	O
-	O
O2-oxidoreductase	O
in	O
yeast	O
,	O
homologous	O
to	O
the	O
human	O
plasma	O
protein	O
ceruloplasmin	O
.	O

Using	O
the	O
gel	O
shift	O
assay	O
system	O
,	O
we	O
have	O
measured	O
the	O
apparent	O
affinity	O
constant	O
for	O
the	O
interaction	O
of	O
two	O
different	O
DNAs	O
with	O
MAP	O
proteins	O
found	O
in	O
both	O
total	O
calf	O
brain	O
microtubules	O
and	O
heat	O
stable	O
brain	O
preparations	O
.	O

Both	O
DNAs	O
studied	O
contained	O
centromere	O
/	O
kinetochore	O
sequences-	O
one	O
was	O
enriched	O
in	O
the	O
calf	O
satellite	O
DNA	O
;	O
the	O
other	O
was	O
a	O
large	O
restriction	O
fragment	O
containing	O
the	O
yeast	O
CEN11	B
DNA	O
sequence	O
.	O

Complexes	O
formed	O
using	O
both	O
DNAs	O
had	O
similar	O
Kapp	O
values	O
in	O
the	O
range	O
of	O
2.1	O
x	O
10	O
(	O
7	O
)	O
M-1	O
to	O
2.0	O
x	O
10	O
(	O
8	O
)	O
M-1	O
.	O

CEN11	B
DNA	O
-	O
MTP	O
complexes	O
had	O
by	O
far	O
the	O
highest	O
Kapp	O
value	O
of	O
2.0	O
x	O
10	O
(	O
8	O
)	O
M-1	O
.	O

The	O
CEN11	B
DNA	O
sequence	O
is	O
where	O
the	O
yeast	O
kinetochore	O
of	O
chromosome	O
11	O
is	O
formed	O
and	O
where	O
the	O
single	O
yeast	O
microtubule	O
is	O
bound	O
in	O
vivo	O
.	O

The	O
CEN11	B
conserved	O
region	O
II	O
known	O
binding	O
sites-	O
(	O
dA	O
/	O
dT	O
)	O
n	O
runs-	O
for	O
mammalian	O
MAP2	B
protein	O
,	O
are	O
in	O
good	O
agreement	O
with	O
this	O
higher	O
Kapp	O
value	O
.	O

The	O
effects	O
of	O
the	O
classical	O
tubulin	O
binding	O
drugs	O
colchicine	O
,	O
podophyllotoxin	O
and	O
vinblastine	O
on	O
the	O
DNA	O
-	O
MAP	O
protein	O
complex	O
stability	O
were	O
investigated	O
by	O
determining	O
the	O
drug	O
concentrations	O
where	O
the	O
complexes	O
were	O
destabilized	O
.	O

Only	O
the	O
complexes	O
formed	O
from	O
total	O
microtubule	O
protein	O
(	O
tubulin	O
containing	O
)	O
were	O
destabilized	O
over	O
a	O
wide	O
drug	O
concentration	O
range	O
.	O

Heat	O
stable	O
brain	O
protein	O
complexes	O
(	O
no	O
tubulin	O
)	O
were	O
largely	O
unaffected	O
.	O

Furthermore	O
,	O
it	O
took	O
10	O
-	O
100	O
fold	O
higher	O
drug	O
concentrations	O
to	O
disrupt	O
the	O
CEN11	B
DNA	O
complexes	O
compared	O
to	O
the	O
calf	O
thymus	O
satellite	O
DNA	O
enriched	O
complexes	O
.	O

These	O
data	O
support	O
our	O
previous	O
results	O
suggesting	O
that	O
there	O
is	O
a	O
DNA	O
sequence	O
dependent	O
interaction	O
with	O
MAP	O
proteins	O
that	O
appears	O
to	O
be	O
conserved	O
in	O
evolution	O
(	O
Marx	O
et	O
.	O

al.	O
,	O
Biochim	O
.	O

Biophys	O
.	O

Acta	O
.	O

783	O
,	O
383	O
-	O
392	O
,	O
1984	O
;	O
Marx	O
and	O
Denial	O
,	O
Molecular	O
Basis	O
of	O
Cancer	O
172B	O
,	O
65	O
-	O
75	O
1985	O
)	O
.	O

In	O
addition	O
,	O
these	O
results	O
imply	O
that	O
the	O
classical	O
tubulin	O
binding	O
drugs	O
may	O
exert	O
their	O
biological	O
effects	O
in	O
cells	O
at	O
least	O
in	O
part	O
by	O
disrupting	O
DNA	O
-	O
Protein	O
complexes	O
of	O
the	O
type	O
we	O
have	O
studied	O
here	O
.	O

Recent	O
studies	O
have	O
demonstrated	O
that	O
cells	O
have	O
evolved	O
elaborate	O
mechanisms	O
to	O
rid	O
themselves	O
of	O
aberrant	O
proteins	O
and	O
transcripts	O
.	O

The	O
nonsense	O
-	O
mediated	O
mRNA	O
decay	O
pathway	O
(	O
NMD	O
)	O
is	O
an	O
example	O
of	O
a	O
pathway	O
that	O
eliminates	O
aberrant	O
mRNAs	O
.	O

In	O
yeast	O
,	O
a	O
transcript	O
is	O
recognized	O
as	O
aberrant	O
and	O
is	O
rapidly	O
degraded	O
if	O
a	O
specific	O
sequence	O
,	O
called	O
the	O
DSE	O
,	O
is	O
present	O
3	O
'	O
of	O
a	O
premature	O
termination	O
codon	O
.	O

Results	O
presented	O
here	O
show	O
that	O
strains	O
harboring	O
the	O
mof2	B
-	I
1	I
,	O
mof4	B
-	I
1	I
,	O
mof5	B
-	I
1	I
,	O
and	O
mof8	B
-	I
1	I
alleles	O
,	O
previously	O
demonstrated	O
to	O
increase	O
the	O
efficiency	O
of	O
programmed	O
-1	O
ribosomal	O
frameshifting	O
,	O
decrease	O
the	O
activity	O
of	O
the	O
NMD	O
pathway	O
.	O

The	O
effect	O
of	O
the	O
mof2	B
-	I
1	I
allele	O
on	O
NMD	O
was	O
characterized	O
in	O
more	O
detail	O
.	O

Previous	O
results	O
demonstrated	O
that	O
the	O
wild	O
-	O
type	O
MOF2	B
gene	O
is	O
identical	O
to	O
the	O
SUI1	B
gene	O
.	O

Studies	O
on	O
the	O
mof2	B
-	I
1	I
allele	O
of	O
the	O
SUI1	B
gene	O
indicate	O
that	O
in	O
addition	O
to	O
its	O
role	O
in	O
recognition	O
of	O
the	O
AUG	O
codon	O
during	O
translation	O
initiation	O
and	O
maintenance	O
of	O
the	O
appropriate	O
reading	O
frame	O
during	O
translation	O
elongation	O
,	O
the	O
Mof2	B
protein	O
plays	O
a	O
role	O
in	O
the	O
NMD	O
pathway	O
.	O

The	O
Mof2p	O
/	O
Sui1	B
p	O
is	O
conserved	O
throughout	O
nature	O
and	O
the	O
human	O
homolog	O
of	O
the	O
Mof2p	O
/	O
Sui1p	O
functions	O
in	O
yeast	O
cells	O
to	O
activate	O
NMD	O
.	O

These	O
results	O
suggest	O
that	O
factors	O
involved	O
in	O
NMD	O
are	O
general	O
modulators	O
that	O
act	O
in	O
several	O
aspects	O
of	O
translation	O
and	O
mRNA	O
turnover	O
.	O

The	O
TOP3	B
gene	O
of	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
was	O
postulated	O
to	O
encode	O
a	O
DNA	O
topoisomerase	O
,	O
based	O
on	O
its	O
sequence	O
homology	O
to	O
Escherichia	O
coli	O
DNA	O
topoisomerase	O
I	O
and	O
the	O
suppression	O
of	O
the	O
poor	O
growth	O
phenotype	O
of	O
top3	B
mutants	O
by	O
the	O
expression	O
of	O
the	O
E.	O
coli	O
enzyme	O
(	O
Wallis	O
,	O
J.W.	O
,	O
Chrebet	O
,	O
G.	O
,	O
Brodsky	O
,	O
G.	O
,	O
Golfe	O
,	O
M.	O
,	O
and	O
Rothstein	O
,	O
R.	O
(	O
1989	O
)	O
Cell	O
58	O
,	O
409	O
-	O
419	O
)	O
.	O

We	O
have	O
purified	O
the	O
yeast	O
TOP3	B
gene	O
product	O
to	O
near	O
homogeneity	O
as	O
a	O
74-kDA	O
protein	O
from	O
yeast	O
cells	O
lacking	O
DNA	O
topoisomerase	O
I	O
and	O
overexpressing	O
a	O
plasmid	O
-	O
borne	O
TOP3	B
gene	O
linked	O
to	O
a	O
phosphate	O
-	O
regulated	O
yeast	O
PHO5	B
gene	O
promoter	O
.	O

The	O
purified	O
protein	O
possesses	O
a	O
distinct	O
DNA	O
topoisomerase	O
activity	O
:	O
similar	O
to	O
E.	O
coli	O
DNA	O
topoisomerases	O
I	O
and	O
III	O
,	O
it	O
partially	O
relaxes	O
negatively	O
but	O
not	O
positively	O
supercoiled	O
DNA	O
.	O

Several	O
experiments	O
,	O
including	O
the	O
use	O
of	O
a	O
negatively	O
supercoiled	O
heteroduplex	O
DNA	O
containing	O
a	O
29-nucleotide	O
single	O
-	O
stranded	O
loop	O
,	O
indicate	O
that	O
the	O
activity	O
has	O
a	O
strong	O
preference	O
for	O
single	O
-	O
stranded	O
DNA	O
.	O

A	O
protein	O
-	O
DNA	O
covalent	O
complex	O
in	O
which	O
the	O
74-kDa	O
protein	O
is	O
linked	O
to	O
a	O
5	O
'	O
DNA	O
phosphoryl	O
group	O
has	O
been	O
identified	O
,	O
and	O
the	O
nucleotide	O
sequences	O
of	O
30	O
sites	O
of	O
DNA	O
-	O
protein	O
covalent	O
complex	O
formation	O
have	O
been	O
determined	O
.	O

These	O
sequences	O
differ	O
from	O
those	O
recognized	O
by	O
E.	O
coli	O
DNA	O
topoisomerase	O
I	O
but	O
resemble	O
those	O
recognized	O
by	O
E.	O
coli	O
DNA	O
topoisomerase	O
III	O
.	O

Based	O
on	O
these	O
results	O
,	O
the	O
yeast	O
TOP3	B
gene	O
product	O
can	O
formally	O
be	O
termed	O
S.	O
cerevisiae	O
DNA	O
topoisomerase	O
III	O
.	O

Analysis	O
of	O
supercoiling	O
of	O
intracellular	O
yeast	O
plasmids	O
in	O
various	O
DNA	O
topoisomerase	O
mutants	O
indicates	O
that	O
yeast	O
DNA	O
topoisomerase	O
III	O
has	O
at	O
most	O
a	O
weak	O
activity	O
in	O
relaxing	O
negatively	O
supercoiled	O
double	O
-	O
stranded	O
DNA	O
in	O
vivo	O
,	O
in	O
accordance	O
with	O
the	O
characteristics	O
of	O
the	O
purified	O
enzyme	O
.	O

We	O
have	O
previously	O
reported	O
the	O
identification	O
of	O
a	O
G4-DNA	O
-	O
dependent	O
nuclease	O
from	O
S.	O
cerevisiae	O
that	O
recognizes	O
a	O
tetrastranded	O
G4-DNA	O
structure	O
and	O
cuts	O
in	O
a	O
single	O
-	O
stranded	O
region	O
5	O
'	O
to	O
the	O
G4	O
structure	O
.	O

We	O
purify	O
this	O
activity	O
to	O
homogeneity	O
and	O
show	O
it	O
to	O
be	O
the	O
product	O
of	O
the	O
S.	O
cerevisiae	O
KEM1	B
gene	O
,	O
which	O
is	O
also	O
known	O
as	O
SEP1	B
,	O
DST2	B
,	O
XRN1	B
,	O
and	O
RAR5	B
.	O

Since	O
a	O
homozygous	O
deletion	O
of	O
the	O
KEM1	B
gene	O
blocks	O
meiotic	O
cells	O
at	O
the	O
4N	O
stage	O
,	O
the	O
finding	O
of	O
these	O
G4-dependent	O
DNA	O
binding	O
and	O
cleavage	O
activities	O
for	O
the	O
KEM1	B
gene	O
product	O
supports	O
the	O
hypothesis	O
that	O
G4-DNA	O
may	O
play	O
a	O
role	O
in	O
meiosis	O
.	O

In	O
Saccharomyces	O
cerevisiae	O
,	O
phosphorylation	O
of	O
the	O
alpha	O
subunit	O
of	O
translation	O
initiation	O
factor	O
2	O
(	O
eIF-2	O
)	O
by	O
protein	O
kinase	O
GCN2	B
stimulates	O
translation	O
of	O
GCN4	B
mRNA	O
.	O

In	O
mammalian	O
cells	O
,	O
phosphorylation	O
of	O
eIF-2	O
alpha	O
inhibits	O
the	O
activity	O
of	O
eIF-2B	O
,	O
the	O
GDP	O
-	O
GTP	O
exchange	O
factor	O
for	O
eIF-2	O
.	O

We	O
present	O
biochemical	O
evidence	O
that	O
five	O
translational	O
regulators	O
of	O
GCN4	B
encoded	O
by	O
GCD1	B
,	O
GCD2	B
,	O
GCD6	B
,	O
GCD7	B
,	O
and	O
GCN3	B
are	O
components	O
of	O
a	O
protein	O
complex	O
that	O
stably	O
interacts	O
with	O
eIF-2	O
and	O
represents	O
the	O
yeast	O
equivalent	O
of	O
eIF-2B	O
.	O

In	O
vitro	O
,	O
this	O
complex	O
catalyzes	O
guanine	O
nucleotide	O
exchange	O
on	O
eIF-2	O
and	O
overcomes	O
the	O
inhibitory	O
effect	O
of	O
GDP	O
on	O
formation	O
of	O
eIF-2.GTP.Met	O
-	O
initiator	O
tRNA	O
(	O
Met	O
)	O
ternary	O
complexes	O
.	O

This	O
finding	O
suggests	O
that	O
mutations	O
in	O
GCD	O
-	O
encoded	O
subunits	O
of	O
the	O
complex	O
derepress	O
GCN4	B
translation	O
because	O
they	O
mimic	O
eIF-2	O
alpha	O
phosphorylation	O
in	O
decreasing	O
eIF-2B	O
activity	O
.	O

Our	O
results	O
indicate	O
that	O
translational	O
control	O
of	O
GCN4	B
involves	O
a	O
reduction	O
in	O
eIF-2B	O
function	O
,	O
a	O
mechanism	O
used	O
in	O
mammalian	O
cells	O
to	O
regulate	O
total	O
protein	O
synthesis	O
in	O
response	O
to	O
stress	O
.	O

Type	O
I	O
congenital	O
disorders	O
of	O
glycosylation	O
(	O
CDG	O
I	O
)	O
are	O
diseases	O
presenting	O
multisystemic	O
lesions	O
including	O
central	O
and	O
peripheral	O
nervous	O
system	O
deficits	O
.	O

The	O
disease	O
is	O
characterized	O
by	O
under	O
-	O
glycosylated	O
serum	O
glycoproteins	O
and	O
is	O
caused	O
by	O
mutations	O
in	O
genes	O
encoding	O
proteins	O
involved	O
in	O
the	O
stepwise	O
assembly	O
of	O
dolichol	O
-	O
oligosaccharide	O
used	O
for	O
protein	O
N	O
-	O
glycosylation	O
.	O

We	O
report	O
that	O
fibroblasts	O
from	O
a	O
type	O
I	O
CDG	O
patient	O
,	O
born	O
of	O
consanguineous	O
parents	O
,	O
are	O
deficient	O
in	O
their	O
capacity	O
to	O
add	O
the	O
eighth	O
mannose	O
residue	O
onto	O
the	O
lipid	O
-	O
linked	O
oligosaccharide	O
precursor	O
.	O

We	O
have	O
characterized	O
cDNA	O
corresponding	O
to	O
the	O
human	O
ortholog	O
of	O
the	O
yeast	O
gene	O
ALG12	B
that	O
encodes	O
the	O
dolichyl	O
-	O
P	O
-	O
Man	O
:	O
Man	O
(	O
7	O
)	O
GlcNAc	O
(	O
2	O
)	O
-PP	O
-	O
dolichyl	O
alpha6-mannosyltransferase	O
that	O
is	O
thought	O
to	O
accomplish	O
this	O
reaction	O
,	O
and	O
we	O
show	O
that	O
the	O
patient	O
is	O
homozygous	O
for	O
a	O
point	O
mutation	O
(	O
T571	O
G	O
)	O
that	O
causes	O
an	O
amino	O
acid	O
substitution	O
(	O
F142V	O
)	O
in	O
a	O
conserved	O
region	O
of	O
the	O
protein	O
.	O

As	O
the	O
pathological	O
phenotype	O
of	O
the	O
fibroblasts	O
of	O
the	O
patient	O
was	O
largely	O
normalized	O
upon	O
transduction	O
with	O
the	O
wild	O
type	O
gene	O
,	O
we	O
demonstrate	O
that	O
the	O
F142V	O
substitution	O
is	O
the	O
underlying	O
cause	O
of	O
this	O
new	O
CDG	O
,	O
which	O
we	O
suggest	O
be	O
called	O
CDG	O
Ig	O
.	O

Finally	O
,	O
we	O
show	O
that	O
the	O
fibroblasts	O
of	O
the	O
patient	O
are	O
capable	O
of	O
the	O
direct	O
transfer	O
of	O
Man	O
(	O
7	O
)	O
GlcNAc	O
(	O
2	O
)	O
from	O
dolichol	O
onto	O
protein	O
and	O
that	O
this	O
N	O
-	O
linked	O
structure	O
can	O
be	O
glucosylated	O
by	O
UDP	O
-	O
glucose	O
:	O
glycoprotein	O
glucosyltransferase	O
in	O
the	O
endoplasmic	O
reticulum	O
.	O

Examination	O
of	O
the	O
control	O
of	O
cell	O
type	O
in	O
yeast	O
at	O
the	O
molecular	O
level	O
and	O
understanding	O
of	O
the	O
biochemical	O
basis	O
of	O
the	O
cell	O
-	O
cell	O
interactions	O
involved	O
in	O
the	O
mating	O
process	O
are	O
clearly	O
entering	O
an	O
extremely	O
productive	O
and	O
exciting	O
period	O
.	O

The	O
tools	O
and	O
opportunities	O
are	O
now	O
available	O
to	O
answer	O
fundamental	O
questions	O
with	O
regard	O
to	O
the	O
mechanism	O
of	O
differential	O
gene	O
expression	O
in	O
eukaryotic	O
cells	O
by	O
using	O
cloned	O
a	O
-	O
specific	O
,	O
alpha	O
-	O
specific	O
,	O
and	O
haploid	O
-	O
specific	O
genes	O
as	O
the	O
probes	O
.	O

Basic	O
questions	O
concerning	O
eukaryotic	O
chromosome	O
structure	O
and	O
organization	O
can	O
be	O
addressed	O
by	O
elucidating	O
the	O
properties	O
of	O
the	O
SIR	O
/	O
MAR	O
regulators	O
and	O
their	O
mode	O
of	O
action	O
.	O

Furthermore	O
,	O
the	O
availability	O
both	O
of	O
cloned	O
MAT	B
,	O
HML	B
,	O
and	O
HMR	B
regions	O
and	O
of	O
the	O
HO	B
gene	O
will	O
provide	O
the	O
material	O
for	O
unravelling	O
the	O
enzymology	O
of	O
the	O
DNA	O
transposition	O
that	O
occurs	O
during	O
mating	O
type	O
interconversion	O
.	O

The	O
isolation	O
of	O
the	O
structural	O
genes	O
for	O
the	O
pheromones	O
and	O
mutations	O
that	O
block	O
pheromone	O
production	O
will	O
provide	O
useful	O
information	O
on	O
how	O
extracellular	O
hormones	O
are	O
synthesized	O
,	O
processed	O
,	O
and	O
secreted	O
by	O
eukaryotic	O
cells	O
.	O

Moreover	O
,	O
the	O
apparent	O
mode	O
of	O
action	O
of	O
the	O
phermonones	O
through	O
cyclic	O
AMP	O
as	O
an	O
intracellular	O
""""	O
second	O
messenger	O
,	O
""""	O
and	O
the	O
genetic	O
and	O
biochemical	O
tractability	O
of	O
yeast	O
cells	O
,	O
may	O
allow	O
tracing	O
of	O
the	O
entire	O
pathway	O
of	O
hormonal	O
regulation	O
of	O
a	O
eukaryotic	O
cell	O
division	O
cycle	O
.	O

These	O
and	O
other	O
studies	O
of	O
the	O
developmental	O
biology	O
of	O
yeast	O
cells	O
will	O
provide	O
more	O
important	O
insights	O
into	O
fundamental	O
aspects	O
of	O
the	O
genetic	O
control	O
of	O
developmental	O
processes	O
in	O
eukaryotic	O
cells	O
.	O

The	O
KRE1	B
gene	O
of	O
Saccharomyces	O
cerevisiae	O
,	O
sacKRE1	O
,	O
appears	O
to	O
be	O
involved	O
in	O
the	O
synthesis	O
of	O
cell	O
wall	O
beta	O
-	O
glucan	O
.	O

S.	O
cerevisiae	O
strains	O
with	O
mutations	O
in	O
the	O
KRE1	B
gene	O
produce	O
a	O
structurally	O
altered	O
cell	O
wall	O
(	O
1	O
-	O
---6	O
)	O
-beta	O
-	O
glucan	O
,	O
which	O
results	O
in	O
resistance	O
to	O
K1	O
killer	O
toxin	O
.	O

We	O
isolated	O
the	O
canKRE1	O
gene	O
from	O
Candida	O
albicans	O
by	O
its	O
ability	O
to	O
complement	O
a	O
kre1	B
mutation	O
in	O
S.	O
cerevisiae	O
and	O
confer	O
sensitivity	O
to	O
killer	O
toxin	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
the	O
predicted	O
protein	O
encoded	O
by	O
canKRE1	O
shares	O
an	O
overall	O
structural	O
similarity	O
with	O
that	O
encoded	O
by	O
sacKRE1	O
.	O

The	O
canKRE1	O
protein	O
is	O
composed	O
of	O
an	O
N	O
-	O
terminal	O
signal	O
sequence	O
,	O
a	O
central	O
domain	O
of	O
46	O
%	O
identity	O
with	O
the	O
sacKRE1	O
protein	O
,	O
and	O
a	O
C	O
-	O
terminal	O
hydrophobic	O
tract	O
.	O

These	O
structural	O
and	O
functional	O
similarities	O
imply	O
that	O
the	O
canKRE1	O
gene	O
carries	O
out	O
a	O
function	O
in	O
C.	O
albicans	O
cell	O
wall	O
assembly	O
similar	O
to	O
that	O
observed	O
for	O
sacKRE1	O
in	O
S.	O
cerevisiae	O
.	O

From	O
the	O
amino	O
acid	O
sequence	O
of	O
yeast	O
cytochrome	O
c	O
oxidase	O
subunit	O
VIII	O
published	O
previously	O
(	O
Power	O
,	O
S.	O
D.	O
,	O
Lochrie	O
,	O
M.A.	O
,	O
Patterson	O
,	O
T.E.	O
,	O
and	O
Poyton	O
,	O
R.C.	O
(	O
1984	O
)	O
J.	O
Biol	O
.	O

Chem	O
.	O
259	O
,	O
6571	O
-	O
6574	O
)	O
,	O
we	O
have	O
synthesized	O
a	O
pair	O
of	O
oligonucleotide	O
probes	O
and	O
used	O
them	O
to	O
identify	O
COX8	B
,	O
its	O
structural	O
gene	O
.	O

By	O
genomic	O
Southern	O
blot	O
analysis	O
and	O
disruption	O
of	O
the	O
COX8	B
chromosomal	O
locus	O
,	O
we	O
have	O
shown	O
that	O
this	O
gene	O
is	O
present	O
in	O
one	O
copy	O
per	O
haploid	O
genome	O
and	O
that	O
its	O
product	O
,	O
subunit	O
VIII	O
,	O
is	O
essential	O
for	O
maximal	O
levels	O
of	O
cellular	O
respiration	O
and	O
cytochrome	O
c	O
oxidase	O
activity	O
.	O

Alignment	O
of	O
the	O
amino	O
acid	O
sequence	O
predicted	O
from	O
the	O
DNA	O
sequence	O
of	O
COX8	B
with	O
the	O
determined	O
amino	O
acid	O
sequence	O
of	O
subunit	O
VIII	O
indicates	O
that	O
mature	O
subunit	O
VIII	O
is	O
derived	O
from	O
a	O
larger	O
precursor	O
that	O
extends	O
from	O
both	O
the	O
NH2	O
and	O
COOH	O
termini	O
of	O
the	O
mature	O
polypeptide	O
.	O

Thus	O
,	O
like	O
many	O
other	O
nuclear	O
coded	O
mitochondrial	O
proteins	O
,	O
subunit	O
VIII	O
is	O
derived	O
from	O
a	O
precursor	O
which	O
carries	O
a	O
leader	O
peptide	O
.	O

In	O
addition	O
,	O
this	O
precursor	O
,	O
like	O
that	O
for	O
yeast	O
cytochrome	O
c	O
oxidase	O
subunit	O
VIIa	O
,	O
appears	O
to	O
carry	O
a	O
four	O
-	O
amino	O
acid	O
""""	O
trailer	O
peptide	O
""""	O
at	O
its	O
COOH	O
terminus	O
.	O

To	O
uncover	O
the	O
functional	O
circuitry	O
both	O
within	O
the	O
mitochondrial	O
genome	O
and	O
between	O
the	O
mitochondrial	O
and	O
the	O
nuclear	O
genome	O
,	O
we	O
have	O
developed	O
a	O
general	O
method	O
for	O
selecting	O
and	O
characterizing	O
genetically	O
suppressor	O
mutations	O
that	O
restore	O
the	O
respiratory	O
capacity	O
of	O
mit-	O
mitochondrial	O
mutants	O
.	O

Several	O
hundreds	O
of	O
pseudo	O
-	O
wild	O
type	O
revertants	O
due	O
to	O
a	O
second	O
unlinked	O
mutation	O
which	O
suppresses	O
a	O
target	O
mit-	O
mutation	O
were	O
isolated	O
.	O

The	O
suppressor	O
mutations	O
were	O
found	O
located	O
either	O
in	O
the	O
nuclear	O
(	O
abbreviated	O
NAM	O
for	O
'	O
nuclear	O
accommodation	O
of	O
mitochondria	O
'	O
)	O
or	O
in	O
the	O
mitochondrial	O
genome	O
(	O
abbreviated	O
MIM	O
for	O
'	O
mitochondrial	O
-	O
mitochondrial	O
interaction	O
'	O
)	O
.	O

The	O
specificity	O
of	O
action	O
of	O
various	O
suppressors	O
upon	O
some	O
250	O
different	O
mit-	O
mutations	O
located	O
in	O
several	O
genes	O
was	O
tested	O
.	O

According	O
to	O
this	O
specificity	O
of	O
action	O
,	O
suppressors	O
were	O
subdivided	O
into	O
two	O
major	O
classes	O
:	O
allele	O
specific	O
or	O
gene	O
specific	O
suppressors	O
.	O

Because	O
the	O
cob	B
-	O
box	O
mitochondrial	O
gene	O
has	O
a	O
mosaic	O
organization	O
,	O
we	O
were	O
able	O
to	O
find	O
a	O
novel	O
third	O
class	O
of	O
extragenic	O
suppressors	O
specific	O
for	O
mit-	O
mutations	O
within	O
the	O
introns	O
of	O
this	O
gene	O
.	O

Four	O
examples	O
of	O
suppressors	O
showing	O
various	O
specificities	O
of	O
action	O
illustrate	O
our	O
approach	O
.	O

(	O
1	O
)	O
a	O
nuclear	O
gene	O
controlling	O
specific	O
alleles	O
of	O
different	O
mitochondrial	O
genes	O
;	O
(	O
2	O
)	O
a	O
nuclear	O
gene	O
controlling	O
selectively	O
one	O
intron	O
of	O
a	O
split	O
mitochondrial	O
gene	O
;	O
(	O
3	O
)	O
a	O
mitochondrial	O
gene	O
controlling	O
specific	O
alleles	O
of	O
different	O
mitochondrial	O
genes	O
;	O
(	O
4	O
)	O
a	O
region	O
in	O
one	O
complex	O
mitochondrial	O
gene	O
which	O
controls	O
selectively	O
one	O
intron	O
of	O
another	O
split	O
mitochondrial	O
gene	O
.	O

Different	O
mechanisms	O
of	O
suppression	O
are	O
discussed	O
stressing	O
the	O
alleviation	O
of	O
splicing	O
deficiencies	O
of	O
intron	O
mutations	O
.	O

Carboxypeptidase	O
Y	B
(	O
CPY	O
;	O
EC	O
3.4.16.1	O
)	O
is	O
the	O
yeast	O
vacuolar	O
protease	O
.	O

To	O
have	O
CPY	O
secreted	O
and	O
to	O
increase	O
its	O
secretion	O
level	O
,	O
we	O
tried	O
to	O
express	O
the	O
prepro	O
-	O
CPY	O
gene	O
under	O
the	O
control	O
of	O
the	O
inducible	O
GAL10	O
promoter	O
or	O
constitutive	O
ENO1	O
promoter	O
on	O
a	O
multicopy	O
plasmid	O
.	O

In	O
the	O
strains	O
KK4	O
,	O
PEP4	B
,	O
and	O
A2	O
-	O
1	O
-	O
1A	O
,	O
carrying	O
the	O
CPY	O
expression	O
plasmid	O
,	O
active	O
CPY	O
was	O
not	O
detected	O
in	O
the	O
culture	O
broth	O
although	O
the	O
CPY	O
activity	O
was	O
greatly	O
increased	O
inside	O
the	O
cells	O
.	O

In	O
contrast	O
,	O
when	O
we	O
used	O
a	O
strain	O
that	O
contained	O
the	O
ssl1	B
(	O
super	O
-	O
secretion	O
of	O
lysozyme	O
)	O
mutation	O
,	O
a	O
large	O
amount	O
of	O
active	O
CPY	O
(	O
about	O
10	O
-	O
50	O
mg	O
/	O
liter	O
)	O
was	O
detected	O
in	O
the	O
culture	O
broth	O
.	O

The	O
ssl1	B
mutants	O
secreted	O
active	O
CPY	O
when	O
the	O
CPY	O
level	O
was	O
increased	O
by	O
expressing	O
it	O
under	O
the	O
control	O
of	O
a	O
strong	O
promoter	O
on	O
a	O
multicopy	O
plasmid	O
,	O
while	O
the	O
endogenous	O
expression	O
of	O
chromosomal	O
CPY	O
gene	O
in	O
the	O
same	O
ssl1	B
mutant	O
caused	O
a	O
deficiency	O
in	O
the	O
processing	O
of	O
pro	O
-	O
CPY	O
to	O
mature	O
CPY	O
.	O

An	O
autonomously	O
replicating	O
element	O
(	O
ars189	O
)	O
has	O
been	O
isolated	O
from	O
the	O
maxicircle	O
DNA	O
of	O
an	O
insect	O
trypanosomatid	O
Crithidia	O
fasciculata	O
.	O

This	O
189-bp	O
fragment	O
contains	O
two	O
copies	O
of	O
the	O
yeast	O
consensus	O
ARS	O
sequence	O
of	O
(	O
A	O
/	O
T	O
)	O
TTTATPuTTT	O
(	O
T	O
/	O
A	O
)	O
,	O
has	O
an	O
A	O
+	O
T	O
composition	O
of	O
79.4	O
%	O
,	O
and	O
shows	O
a	O
large	O
asymmetry	O
in	O
the	O
distribution	O
of	O
adenine	O
and	O
thymine	O
residues	O
between	O
the	O
two	O
strands	O
.	O

The	O
complementary	O
strands	O
of	O
ars189	O
have	O
been	O
cloned	O
into	O
an	O
M13	O
vector	O
containing	O
the	O
URA3	B
gene	O
of	O
Saccharomyces	O
cerevisiae	O
.	O

When	O
these	O
circular	O
single	O
-	O
stranded	O
(	O
ss	O
)	O
DNAs	O
were	O
used	O
to	O
transform	O
yeast	O
spheroplasts	O
,	O
the	O
M13	O
chimeric	O
DNA	O
carrying	O
the	O
strand	O
of	O
ars189	O
rich	O
in	O
adenine	O
generated	O
approximately	O
four	O
times	O
more	O
yeast	O
Ura	O
+	O
transformants	O
than	O
the	O
construct	O
containing	O
the	O
thymine	O
-	O
rich	O
strand	O
.	O

In	O
contrast	O
,	O
both	O
strands	O
of	O
yeast	O
ARS1	B
cloned	O
into	O
an	O
M13	O
vector	O
transformed	O
yeast	O
at	O
an	O
equivalent	O
level	O
.	O

The	O
conversion	O
of	O
ARS	O
-	O
containing	O
ss	O
DNAs	O
to	O
duplex	O
forms	O
in	O
vivo	O
and	O
their	O
subsequent	O
autonomous	O
replication	O
have	O
been	O
verified	O
by	O
Southern	O
hybridization	O
analysis	O
of	O
extracts	O
from	O
yeast	O
transformants	O
.	O

A	O
gene	O
of	O
the	O
soluble	O
fumarate	O
reductase	O
(	O
FRDS	B
)	O
that	O
binds	O
FAD	O
non	O
-	O
covalently	O
was	O
cloned	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
using	O
degenerate	O
oligonucleotides	O
designed	O
from	O
partial	O
amino	O
acid	O
sequences	O
of	O
highly	O
purified	O
enzyme	O
.	O

The	O
nucleotide	O
sequence	O
of	O
a	O
0.99-kb	O
amplified	O
product	O
was	O
found	O
to	O
be	O
nearly	O
identical	O
to	O
a	O
partial	O
sequence	O
of	O
an	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
previously	O
reported	O
(	O
EMBL	O
database	O
accession	O
number	O
S-30830	O
)	O
.	O

According	O
to	O
the	O
sequence	O
in	O
the	O
EMBL	O
database	O
,	O
we	O
cloned	O
1.7-kb	O
fragment	O
containing	O
entire	O
sequence	O
of	O
this	O
ORF	O
by	O
PCR	O
and	O
found	O
that	O
this	O
fragment	O
contained	O
a	O
perfect	O
match	O
to	O
the	O
0.99-kb	O
sequence	O
amplified	O
with	O
the	O
degenerate	O
primers	O
.	O

From	O
these	O
results	O
,	O
we	O
concluded	O
that	O
this	O
ORF	O
is	O
the	O
FRDS	B
gene	O
.	O

The	O
amino	O
acid	O
sequences	O
of	O
the	O
regions	O
involved	O
in	O
the	O
non	O
-	O
covalent	O
binding	O
of	O
FAD	O
and	O
the	O
active	O
site	O
,	O
which	O
are	O
conserved	O
among	O
the	O
flavoprotein	O
subunits	O
of	O
membrane	O
-	O
bound	O
fumarate	O
reductase	O
and	O
succinate	O
dehydrogenase	O
,	O
were	O
found	O
in	O
FRDS	B
.	O

However	O
,	O
unlike	O
the	O
membrane	O
-	O
bound	O
enzymes	O
,	O
FRDS	B
did	O
not	O
contain	O
the	O
histidine	O
residue	O
that	O
covalently	O
binds	O
the	O
isoalloxazine	O
ring	O
of	O
FAD	O
at	O
or	O
near	O
the	O
corresponding	O
position	O
.	O

FRDS	B
showed	O
high	O
homology	O
to	O
the	O
product	O
of	O
S.	O
cerevisiae	O
OSM1	B
gene	O
which	O
was	O
reported	O
to	O
be	O
required	O
for	O
growth	O
in	O
hypertonic	O
media	O
.	O

Previous	O
work	O
has	O
shown	O
that	O
when	O
yeast	O
mitochondria	O
are	O
incubated	O
in	O
the	O
presence	O
of	O
the	O
presequence	O
peptide	O
pL4	O
(	O
1	O
-	O
22	O
)	O
,	O
the	O
peptide	O
is	O
imported	O
and	O
accumulates	O
within	O
the	O
mitochondrial	O
membranes	O
,	O
presumably	O
at	O
the	O
import	O
sites	O
.	O

If	O
the	O
extramitochondrial	O
concentration	O
of	O
peptide	O
is	O
sufficiently	O
high	O
,	O
enough	O
peptide	O
accumulates	O
within	O
the	O
import	O
sites	O
to	O
prevent	O
the	O
uptake	O
of	O
authentic	O
precursor	O
proteins	O
.	O

We	O
have	O
used	O
chemical	O
cross	O
-	O
linking	O
to	O
probe	O
the	O
interaction	O
of	O
this	O
peptide	O
with	O
yeast	O
mitochondrial	O
proteins	O
.	O

We	O
found	O
that	O
radiolabeled	O
pL4	O
(	O
1	O
-	O
22	O
)	O
could	O
be	O
reproducibly	O
cross	O
-	O
linked	O
to	O
a	O
number	O
of	O
polypeptides	O
.	O

Interestingly	O
,	O
nearly	O
all	O
were	O
membrane	O
proteins	O
.	O

Several	O
of	O
the	O
cross	O
-	O
linked	O
proteins	O
were	O
located	O
in	O
the	O
outer	O
membrane	O
,	O
while	O
others	O
were	O
located	O
in	O
the	O
inner	O
membrane	O
.	O

The	O
interaction	O
between	O
the	O
peptide	O
and	O
many	O
of	O
the	O
cross	O
-	O
linked	O
products	O
was	O
shown	O
to	O
be	O
specific	O
by	O
two	O
independent	O
criteria	O
.	O

First	O
,	O
an	O
excess	O
of	O
unlabeled	O
peptide	O
acted	O
as	O
a	O
competitor	O
in	O
the	O
cross	O
-	O
linking	O
reaction	O
,	O
and	O
,	O
second	O
,	O
treatment	O
of	O
the	O
peptide	O
with	O
the	O
alkylating	O
agent	O
N	O
-	O
ethylmaleimide	O
dramatically	O
reduced	O
its	O
ability	O
to	O
form	O
cross	O
-	O
links	O
.	O

Two	O
of	O
the	O
cross	O
-	O
linked	O
species	O
corresponded	O
to	O
the	O
outer	O
membrane	O
proteins	O
,	O
Mas70p	O
and	O
ISP42	B
.	O

Significantly	O
,	O
both	O
of	O
these	O
proteins	O
have	O
previously	O
been	O
shown	O
to	O
play	O
critical	O
roles	O
in	O
mitochondrial	O
protein	O
import	O
.	O

While	O
the	O
role	O
of	O
the	O
other	O
cross	O
-	O
linked	O
proteins	O
in	O
the	O
import	O
process	O
remains	O
to	O
be	O
determined	O
,	O
the	O
results	O
of	O
this	O
study	O
demonstrate	O
that	O
our	O
experimental	O
approach	O
may	O
be	O
useful	O
in	O
identifying	O
components	O
of	O
the	O
import	O
machinery	O
as	O
well	O
as	O
proteins	O
that	O
interact	O
with	O
mitochondrial	O
presequences	O
.	O

Ubiquitin	O
-	O
mediated	O
proteolysis	O
of	O
securin	O
and	O
mitotic	O
cyclins	O
is	O
essential	O
for	O
exit	O
from	O
mitosis	O
.	O

The	O
final	O
step	O
in	O
ubiquitination	O
of	O
these	O
and	O
other	O
proteins	O
is	O
catalysed	O
by	O
the	O
anaphase	O
-	O
promoting	O
complex	O
(	O
APC	O
)	O
,	O
a	O
multi	O
-	O
subunit	O
ubiquitin	O
-	O
protein	O
ligase	O
(	O
E3	O
)	O
.	O

Little	O
is	O
known	O
about	O
the	O
molecular	O
reaction	O
resulting	O
in	O
APC	O
-	O
dependent	O
substrate	O
ubiquitination	O
or	O
the	O
role	O
of	O
individual	O
APC	O
subunits	O
in	O
the	O
reaction	O
.	O

Using	O
a	O
well	O
-	O
defined	O
in	O
vitro	O
system	O
,	O
we	O
show	O
that	O
highly	O
purified	O
APC	O
from	O
Saccharomyces	O
cerevisiae	O
ubiquitinates	O
a	O
model	O
cyclin	O
substrate	O
in	O
a	O
processive	O
manner	O
.	O

Analysis	O
of	O
mutant	O
APC	O
lacking	O
the	O
Doc1	B
/	O
Apc10	B
subunit	O
(	O
APC	O
(	O
doc1	B
Delta	O
)	O
)	O
indicates	O
that	O
Doc1	B
is	O
required	O
for	O
processivity	O
.	O

The	O
specific	O
molecular	O
defect	O
in	O
APC	O
(	O
doc1	B
Delta	O
)	O
is	O
identified	O
by	O
a	O
large	O
increase	O
in	O
apparent	O
K	O
(	O
M	O
)	O
for	O
the	O
cyclin	O
substrate	O
relative	O
to	O
the	O
wild	O
-	O
type	O
enzyme	O
.	O

This	O
suggests	O
that	O
Doc1	B
stimulates	O
processivity	O
by	O
limiting	O
substrate	O
dissociation	O
.	O

Addition	O
of	O
recombinant	O
Doc1	B
to	O
APC	O
(	O
doc1	B
Delta	O
)	O
fully	O
restores	O
enzyme	O
function	O
.	O

Doc1-related	B
domains	O
are	O
found	O
in	O
mechanistically	O
distinct	O
ubiquitin	O
-	O
ligase	O
enzymes	O
and	O
may	O
generally	O
stimulate	O
ubiquitination	O
by	O
contributing	O
to	O
substrate	O
-	O
enzyme	O
affinity	O
.	O

The	O
Saccharomyces	O
cerevisiae	O
hyperrecombination	O
mutation	O
hpr1Delta	O
results	O
in	O
instability	O
of	O
sequences	O
between	O
direct	O
repeats	O
that	O
is	O
dependent	O
on	O
transcription	O
of	O
the	O
repeat	O
.	O

Here	O
it	O
is	O
shown	O
that	O
the	O
HPR1	B
gene	O
also	O
functions	O
in	O
plasmid	O
stability	O
in	O
the	O
presence	O
of	O
destabilizing	O
transcription	O
elongation	O
.	O

In	O
the	O
hpr1Delta	O
mutant	O
,	O
plasmid	O
instability	O
results	O
from	O
unchecked	O
transcription	O
elongation	O
,	O
which	O
can	O
be	O
suppressed	O
by	O
a	O
strong	O
transcription	O
terminator	O
.	O

The	O
plasmid	O
system	O
has	O
been	O
used	O
to	O
examine	O
in	O
vivo	O
aspects	O
of	O
transcription	O
in	O
the	O
absence	O
of	O
Hpr1p	O
.	O

Nuclear	O
run	O
-	O
on	O
studies	O
suggest	O
that	O
there	O
is	O
an	O
increased	O
RNA	O
polymerase	O
II	O
density	O
in	O
the	O
hpr1Delta	O
mutant	O
strain	O
,	O
but	O
this	O
is	O
not	O
accompanied	O
by	O
an	O
increase	O
in	O
accumulation	O
of	O
cytoplasmic	O
mRNA	O
.	O

Suppression	O
of	O
plasmid	O
instability	O
in	O
hpr1Delta	O
can	O
also	O
be	O
achieved	O
by	O
high	O
-	O
copy	O
expression	O
of	O
the	O
RNA	O
splicing	O
factor	O
SUB2	B
,	O
which	O
has	O
recently	O
been	O
proposed	O
to	O
function	O
in	O
mRNA	O
export	O
,	O
in	O
addition	O
to	O
its	O
role	O
in	O
pre	O
-	O
mRNA	O
splicing	O
.	O

High	O
-	O
copy	O
-	O
number	O
SUB2	B
expression	O
is	O
accompanied	O
by	O
an	O
increase	O
in	O
message	O
accumulation	O
from	O
the	O
plasmid	O
,	O
suggesting	O
that	O
the	O
mechanism	O
of	O
suppression	O
by	O
Sub2p	O
involves	O
the	O
formation	O
of	O
mature	O
mRNA	O
.	O

Models	O
for	O
the	O
role	O
of	O
Hpr1p	O
in	O
mature	O
mRNA	O
formation	O
and	O
the	O
cause	O
of	O
plasmid	O
instability	O
in	O
the	O
absence	O
of	O
the	O
Hpr1	B
protein	O
are	O
discussed	O
.	O

At	O
least	O
six	O
DNA	O
helicases	O
have	O
been	O
identified	O
during	O
fractionation	O
of	O
extracts	O
from	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

Three	O
of	O
those	O
,	O
DNA	O
helicases	O
B	O
,	O
C	O
,	O
and	O
D	O
,	O
have	O
been	O
further	O
purified	O
and	O
characterized	O
.	O

DNA	O
helicases	O
B	O
and	O
C	O
co	O
-	O
purified	O
with	O
DNA	O
polymerase	O
delta	O
through	O
several	O
chromatographic	O
steps	O
,	O
but	O
were	O
separated	O
from	O
the	O
polymerase	O
by	O
hydrophobic	O
chromatography	O
.	O

DNA	O
helicase	O
D	O
co	O
-	O
purified	O
with	O
Replication	O
Factor	O
C	O
over	O
seven	O
chromatographic	O
steps	O
,	O
and	O
was	O
only	O
separated	O
from	O
it	O
by	O
glycerol	O
gradient	O
centrifugation	O
in	O
the	O
presence	O
of	O
0.2	O
M	O
NaCl	O
.	O

All	O
three	O
helicases	O
are	O
DNA	O
dependent	O
ATPases	O
with	O
Km	O
values	O
for	O
ATP	O
of	O
190	O
microM	O
,	O
325	O
microM	O
,	O
and	O
60	O
microM	O
for	O
DNA	O
helicases	O
B	O
,	O
C	O
,	O
and	O
D	O
,	O
respectively	O
.	O

Their	O
DNA	O
helicase	O
activities	O
are	O
comparable	O
.	O

They	O
are	O
5'-3	O
'	O
helicases	O
and	O
have	O
pH	O
optima	O
of	O
6.5	O
-	O
7	O
and	O
Mg2	O
+	O
optima	O
of	O
1	O
-	O
2	O
mM.	O
However	O
,	O
they	O
differ	O
in	O
the	O
nucleotide	O
requirement	O
for	O
helicase	O
action	O
.	O

Whereas	O
all	O
three	O
helicases	O
preferred	O
ATP	O
,	O
dATP	O
,	O
UTP	O
,	O
CTP	O
,	O
and	O
dCTP	O
as	O
cofactors	O
,	O
DNA	O
helicase	O
C	O
also	O
used	O
GTP	O
,	O
but	O
not	O
dTTP	O
.	O

On	O
the	O
other	O
hand	O
,	O
DNA	O
helicase	O
D	O
used	O
dTTP	O
,	O
but	O
not	O
GTP	O
,	O
and	O
DNA	O
helicase	O
B	O
used	O
neither	O
nucleotide	O
as	O
cofactor	O
.	O

These	O
studies	O
allowed	O
us	O
to	O
conclude	O
that	O
DNA	O
helicases	O
B	O
,	O
C	O
,	O
and	O
D	O
are	O
not	O
only	O
distinct	O
enzymes	O
,	O
but	O
also	O
different	O
from	O
two	O
previously	O
identified	O
yeast	O
DNA	O
helicases	O
,	O
the	O
RAD3	B
protein	O
and	O
ATPase	O
III	O
.	O

Import	O
of	O
preproteins	O
into	O
mitochondria	O
requires	O
transport	O
machineries	O
in	O
both	O
mitochondrial	O
membranes	O
that	O
have	O
been	O
characterized	O
in	O
Saccharomyces	O
cerevisiae	O
and	O
Neurospora	O
crassa	O
.	O

By	O
cDNA	O
analysis	O
,	O
we	O
identified	O
a	O
human	O
protein	O
of	O
16	O
kDa	O
with	O
significant	O
overall	O
homology	O
to	O
the	O
fungal	O
mitochondrial	O
import	O
receptor	O
Mom19	B
,	O
including	O
the	O
three	O
typical	O
characteristics	O
:	O
a	O
hydrophobic	O
N	O
-	O
terminal	O
segment	O
,	O
a	O
tetratrico	O
peptide	O
motif	O
in	O
the	O
middle	O
and	O
a	O
negatively	O
charged	O
C	O
-	O
terminus	O
.	O

The	O
human	O
Mom19	B
homolog	O
is	O
expressed	O
in	O
all	O
tissues	O
analyzed	O
.	O

When	O
synthesized	O
in	O
vitro	O
,	O
the	O
human	O
Mom19	B
homolog	O
is	O
targeted	O
to	O
isolated	O
yeast	O
mitochondria	O
and	O
specifically	O
associates	O
with	O
the	O
outer	O
membrane	O
receptor	O
complex	O
,	O
suggesting	O
that	O
indeed	O
a	O
mitochondrial	O
import	O
receptor	O
was	O
identified	O
.	O

The	O
first	O
protein	O
that	O
binds	O
to	O
all	O
newly	O
synthesized	O
RNA	O
polymerase	O
III	O
transcripts	O
is	O
a	O
highly	O
conserved	O
phosphoprotein	O
known	O
as	O
the	O
La	O
autoantigen	O
.	O

Although	O
binding	O
by	O
the	O
yeast	O
La	O
protein	O
Lhp1p	O
to	O
pre	O
-	O
tRNAs	O
is	O
required	O
for	O
the	O
normal	O
pathway	O
of	O
tRNA	O
maturation	O
,	O
the	O
role	O
of	O
the	O
La	O
protein	O
in	O
the	O
biogenesis	O
of	O
other	O
polymerase	O
III	O
transcripts	O
has	O
been	O
unclear	O
.	O

We	O
identified	O
a	O
mutation	O
in	O
a	O
novel	O
component	O
of	O
the	O
U6	O
snRNP	O
that	O
causes	O
yeast	O
cells	O
to	O
require	O
Lhp1p	O
for	O
growth	O
.	O

This	O
protein	O
,	O
Lsm8p	O
,	O
is	O
a	O
member	O
of	O
a	O
family	O
of	O
proteins	O
,	O
known	O
as	O
Sm	O
-	O
like	O
proteins	O
,	O
that	O
shares	O
two	O
conserved	O
motifs	O
with	O
the	O
core	O
Sm	O
proteins	O
of	O
the	O
U1	O
,	O
U2	O
,	O
U4	O
and	O
U5	O
snRNPs	O
.	O

The	O
lsm8	B
-	I
1	I
cells	O
have	O
drastically	O
reduced	O
levels	O
of	O
the	O
mature	O
U6	O
snRNP	O
,	O
consistent	O
with	O
a	O
defect	O
in	O
U6	O
snRNP	O
assembly	O
.	O

In	O
these	O
cells	O
,	O
Lhp1p	O
stabilizes	O
newly	O
synthesized	O
U6	O
RNA	O
,	O
thus	O
facilitating	O
assembly	O
of	O
the	O
RNA	O
into	O
the	O
U6	O
snRNP	O
.	O

These	O
results	O
provide	O
evidence	O
that	O
Lhp1p	O
is	O
a	O
molecular	O
chaperone	O
for	O
polymerase	O
III	O
-	O
transcribed	O
RNAs	O
and	O
implicate	O
Lsm8p	O
as	O
a	O
key	O
component	O
in	O
the	O
very	O
early	O
steps	O
of	O
U6	O
snRNP	O
assembly	O
.	O

The	O
amino	O
-	O
terminal	O
propeptide	O
of	O
carboxypeptidase	O
Y	O
(	O
CPY	O
)	O
is	O
necessary	O
and	O
sufficient	O
for	O
targeting	O
this	O
glycoprotein	O
to	O
the	O
vacuole	O
of	O
Saccharomyces	O
cerevisiae	O
.	O

A	O
16	O
amino	O
acid	O
stretch	O
of	O
the	O
propeptide	O
was	O
subjected	O
to	O
region	O
-	O
directed	O
mutagenesis	O
using	O
randomized	O
oligonucleotides	O
.	O

Mutations	O
altering	O
any	O
of	O
four	O
contiguous	O
amino	O
acids	O
,	O
Gln	O
-	O
Arg	O
-	O
Pro	O
-	O
Leu	O
,	O
resulted	O
in	O
secretion	O
of	O
the	O
encoded	O
CPY	O
precursor	O
(	O
proCPY	O
)	O
,	O
demonstrating	O
that	O
these	O
residues	O
form	O
the	O
core	O
of	O
the	O
vacuolar	O
targeting	O
signal	O
.	O

Cells	O
that	O
simultaneously	O
synthesize	O
both	O
wild	O
-	O
type	O
and	O
sorting	O
-	O
defective	O
forms	O
of	O
proCPY	O
efficiently	O
sort	O
and	O
deliver	O
only	O
the	O
wild	O
-	O
type	O
molecule	O
to	O
the	O
vacuole	O
.	O

These	O
results	O
indicate	O
that	O
the	O
PRC1	B
missorting	O
mutations	O
are	O
cis	O
-	O
dominant	O
,	O
implying	O
that	O
the	O
mutant	O
forms	O
of	O
proCPY	O
are	O
secreted	O
as	O
a	O
consequence	O
of	O
failing	O
to	O
interact	O
with	O
the	O
sorting	O
apparatus	O
,	O
rather	O
than	O
a	O
general	O
poisoning	O
of	O
the	O
vacuolar	O
protein	O
targeting	O
system	O
.	O

In	O
wild	O
-	O
type	O
cells	O
,	O
the	O
3	O
'	O
poly	O
(	O
A	O
)	O
structure	O
is	O
necessary	O
for	O
translation	O
of	O
mRNA	O
and	O
for	O
mRNA	O
stability	O
.	O

The	O
superkiller	O
2	O
(	O
ski2	B
)	O
,	O
ski3	B
,	O
ski6	B
,	O
ski7	B
,	O
and	O
ski8	B
mutations	O
enhance	O
the	O
expression	O
of	O
the	O
poly	O
(	O
A	O
)	O
(	O
-	O
)	O
mRNAs	O
of	O
yeast	O
RNA	O
viruses	O
.	O

Ski2p	O
is	O
a	O
DEVH	O
-	O
box	O
RNA	O
helicase	O
and	O
Slh1p	O
resembles	O
Ski2p	O
.	O

Both	O
repress	O
L	O
-	O
A	O
double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
)	O
virus	O
copy	O
number	O
,	O
further	O
suggesting	O
that	O
their	O
functions	O
may	O
overlap	O
.	O

We	O
find	O
that	O
slh1Delta	O
ski2Delta	O
double	O
mutants	O
are	O
healthy	O
(	O
in	O
the	O
absence	O
of	O
viruses	O
)	O
and	O
show	O
normal	O
rates	O
of	O
turnover	O
of	O
several	O
cellular	O
mRNAs	O
.	O

The	O
slh1Delta	O
ski2Delta	O
strains	O
translate	O
electroporated	O
nonpoly	O
(	O
A	O
)	O
mRNA	O
with	O
the	O
same	O
kinetics	O
as	O
polyA	O
(	O
+	O
)	O
mRNA	O
.	O

Thus	O
,	O
the	O
translation	O
apparatus	O
is	O
inherently	O
capable	O
of	O
efficiently	O
using	O
nonpoly	O
(	O
A	O
)	O
mRNA	O
even	O
in	O
the	O
presence	O
of	O
normal	O
amounts	O
of	O
competing	O
poly	O
(	O
A	O
)	O
(	O
+	O
)	O
mRNA	O
,	O
but	O
is	O
normally	O
prevented	O
from	O
doing	O
so	O
by	O
the	O
combined	O
action	O
of	O
the	O
nonessential	O
proteins	O
Ski2p	O
and	O
Slh1p	O
.	O

The	O
frequency	O
of	O
the	O
YEp13	O
,	O
pEF91	O
,	O
YEp13	O
+	O
HBs	O
,	O
pNMVG3954	O
plasmids	O
'	O
elimination	O
in	O
a	O
series	O
of	O
isogenic	O
strains	O
n.	O
2n	O
and	O
3n	O
was	O
studied	O
.	O

Plasmid	O
stability	O
and	O
the	O
level	O
of	O
expression	O
of	O
the	O
gene	O
of	O
hepatitis	O
B	O
surface	O
antigen	O
(	O
HBsAg	O
)	O
increased	O
in	O
polyploid	O
transformants	O
as	O
a	O
result	O
of	O
increase	O
in	O
plasmid	O
copy	O
number	O
.	O

Heterozygotes	O
MATa	O
/	O
MAT	B
differed	O
from	O
the	O
homozygotes	O
in	O
higher	O
stability	O
of	O
YEp13	O
,	O
pEF91	O
,	O
and	O
YEp13	O
+	O
HBs	O
plasmids	O
having	O
the	O
same	O
quantity	O
of	O
the	O
HBsAg	O
antigen	O
.	O

The	O
appearance	O
of	O
negative	O
properties	O
--	O
destabilization	O
of	O
episomal	O
plasmids	O
or	O
decrease	O
in	O
synthesis	O
of	O
heterologous	O
protein	O
have	O
been	O
discovered	O
in	O
certain	O
diploid	O
cell	O
.	O

These	O
results	O
point	O
to	O
limitations	O
in	O
constructing	O
a	O
polyploid	O
producer	O
on	O
the	O
basis	O
of	O
the	O
similar	O
type	O
of	O
genome	O
.	O

The	O
mesl-	O
mutants	O
of	O
Saccharomyces	O
cerevisiae	O
cease	O
division	O
and	O
accumulate	O
in	O
the	O
G1	O
interval	O
of	O
the	O
cell	O
cycle	O
when	O
deprived	O
of	O
methionine	O
or	O
shifted	O
from	O
23	O
to	O
36	O
degrees	O
C	O
in	O
the	O
presence	O
of	O
methionine	O
.	O

Synchronous	O
cell	O
cycle	O
arrest	O
results	O
from	O
a	O
deficiency	O
of	O
charged	O
methionyl	O
-	O
transfer	O
ribonucleic	O
acid	O
(	O
methionyl	O
-	O
tRNAMet	O
)	O
as	O
shown	O
by	O
direct	O
measurement	O
of	O
the	O
in	O
vivo	O
pools	O
of	O
methionine	O
,	O
S	O
-	O
adenosylmethionine	O
,	O
and	O
methionyl	O
-	O
tRNAMet	O
.	O

The	O
deficiency	O
of	O
methionyl	O
-	O
tRNAMet	O
in	O
these	O
cells	O
is	O
the	O
consequence	O
of	O
a	O
lesion	O
in	O
a	O
single	O
gene	O
,	O
mes1	B
.	O

mes1	B
appears	O
to	O
be	O
the	O
structural	O
gene	O
for	O
the	O
methionyl	O
-	O
tRNA	O
synthetase	O
because	O
some	O
revertants	O
of	O
this	O
mutation	O
exhibited	O
a	O
thermolabile	O
methionyl	O
-	O
tRNA	O
synthetase	O
in	O
vitro	O
.	O

A	O
sufficient	O
hypothesis	O
to	O
explain	O
these	O
and	O
previous	O
results	O
is	O
that	O
the	O
control	O
of	O
cell	O
division	O
by	O
S.	O
cerevisiae	O
in	O
response	O
to	O
nutrient	O
limitation	O
is	O
mediated	O
through	O
aminoacyl	O
-	O
tRNA	O
or	O
subsequent	O
steps	O
in	O
protein	O
biosynthesis	O
.	O

A	O
cDNA	O
encoding	O
the	O
proliferating	O
cell	O
nuclear	O
antigen	O
(	O
PCNA	B
)	O
from	O
Brassica	O
napus	O
(	O
oilseed	O
rape	O
)	O
was	O
shown	O
to	O
complement	O
the	O
lethal	O
deletion	O
mutation	O
in	O
the	O
PCNA	B
gene	O
(	O
delta	O
POL30	B
)	O
of	O
Saccharomyces	O
cerevisiae	O
.	O

We	O
provide	O
unequivocal	O
evidence	O
that	O
the	O
B.	O
napus	O
PCNA	B
can	O
perform	O
all	O
the	O
essential	O
functions	O
of	O
the	O
yeast	O
PCNA	B
in	O
DNA	O
replication	O
,	O
although	O
some	O
species	O
-	O
specific	O
differences	O
may	O
exist	O
.	O

In	O
addition	O
,	O
the	O
B.	O
napus	O
PCNA	B
expressed	O
as	O
a	O
fusion	O
polypeptide	O
with	O
glutathione	O
S	O
-	O
transferase	O
(	O
GST	O
)	O
was	O
shown	O
to	O
stimulate	O
the	O
activity	O
and	O
processivity	O
of	O
two	O
delta	O
-	O
like	O
DNA	O
polymerases	O
from	O
wheat	O
in	O
vitro	O
.	O

These	O
experiments	O
provide	O
direct	O
biochemical	O
evidence	O
that	O
the	O
B.	O
napus	O
PCNA	B
may	O
function	O
as	O
an	O
auxiliary	O
factor	O
in	O
plant	O
cell	O
DNA	O
replication	O
.	O

Recently	O
a	O
new	O
family	O
of	O
membrane	O
proteins	O
comprising	O
the	O
bovine	O
lens	O
fibre	O
major	O
intrinsic	O
protein	O
,	O
soybean	O
nodulin-26	O
protein	O
and	O
the	O
Escherichia	O
coli	O
glycerol	O
facilitator	O
has	O
been	O
described	O
[	O
M.E.	O
Baker	O
and	O
M.H.	O
Saier	O
,	O
Jr	O
(	O
1990	O
)	O
Cell	O
,	O
60	O
,	O
185	O
-	O
186	O
]	O
.	O

These	O
proteins	O
have	O
six	O
putative	O
membrane	O
spanning	O
domains	O
and	O
one	O
(	O
probably	O
intracellular	O
)	O
intermembrane	O
fragment	O
is	O
particularly	O
well	O
conserved	O
.	O

We	O
have	O
identified	O
a	O
new	O
member	O
of	O
this	O
family	O
in	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

It	O
also	O
possesses	O
the	O
six	O
transmembrane	O
domains	O
and	O
the	O
highly	O
conserved	O
intermembrane	O
sequence	O
.	O

In	O
contrast	O
to	O
the	O
other	O
three	O
proteins	O
which	O
are	O
all	O
approximately	O
280	O
amino	O
acids	O
long	O
,	O
the	O
yeast	O
protein	O
has	O
an	O
N	O
-	O
terminal	O
extension	O
of	O
approximately	O
250	O
amino	O
acids	O
,	O
which	O
contains	O
a	O
string	O
of	O
17	O
asparagine	O
residues	O
and	O
a	O
C	O
-	O
terminal	O
extension	O
of	O
approximately	O
150	O
amino	O
acids	O
.	O

The	O
gene	O
,	O
which	O
we	O
called	O
FPS1	B
(	O
for	O
fdp1	B
suppressor	O
)	O
,	O
suppresses	O
in	O
single	O
copy	O
the	O
growth	O
defect	O
on	O
fermentable	O
sugars	O
of	O
the	O
yeast	O
fdp1	B
mutant	O
but	O
it	O
is	O
not	O
allelic	O
to	O
FDP1	B
.	O

The	O
deficiency	O
of	O
the	O
fdp1	B
mutant	O
in	O
glucose	O
-	O
induced	O
RAS	O
-	O
mediated	O
cAMP	O
signalling	O
and	O
in	O
rapid	O
glucose	O
-	O
induced	O
changes	O
in	O
the	O
activity	O
of	O
certain	O
enzymes	O
was	O
not	O
restored	O
.	O

Deletion	O
of	O
FPS1	B
does	O
not	O
cause	O
any	O
of	O
the	O
phenotypic	O
deficiencies	O
of	O
the	O
fdp1	B
mutant	O
.	O

Identification	O
of	O
a	O
Wnt	B
-	O
responsive	O
signal	O
transduction	O
pathway	O
in	O
primary	O
endothelial	O
cells	O
.	O

The	O
beta	B
-	I
catenin	I
signal	O
transduction	O
pathway	O
,	O
which	O
can	O
be	O
activated	O
by	O
secreted	O
Wnt	B
proteins	O
,	O
plays	O
a	O
key	O
role	O
in	O
normal	O
embryonic	O
development	O
and	O
in	O
malignant	O
transformation	O
of	O
the	O
mammary	O
gland	O
and	O
colon	O
.	O

Here	O
we	O
demonstrate	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
Wnt	B
and	O
beta	B
-	I
catenin	I
signaling	O
also	O
function	O
in	O
cells	O
of	O
the	O
vasculature	O
.	O

RT	O
-	O
PCR	O
analysis	O
showed	O
that	O
primary	O
endothelial	O
and	O
smooth	O
muscle	O
cell	O
cultures	O
,	O
of	O
both	O
mouse	O
and	O
human	O
origin	O
,	O
express	O
members	O
of	O
the	O
Wnt	B
and	O
Wnt	B
receptor	O
(	O
Frizzled	O
)	O
gene	O
families	O
.	O

Transfection	O
of	O
an	O
expression	O
vector	O
for	O
Wnt-1	B
into	O
primary	O
endothelial	O
cells	O
increased	O
both	O
the	O
free	O
pool	O
of	O
beta	B
-	I
catenin	I
and	O
the	O
transcription	O
from	O
a	O
Lef	O
/	O
tcf	O
-	O
dependent	O
reporter	O
gene	O
construct	O
.	O

Expression	O
of	O
Wnt-1	B
,	O
but	O
not	O
Wnt-5a	B
,	O
also	O
stimulated	O
proliferation	O
of	O
primary	O
endothelial	O
cell	O
cultures	O
.	O

These	O
data	O
show	O
that	O
Wnt	B
and	O
Frizzled	O
proteins	O
can	O
regulate	O
signal	O
transduction	O
,	O
via	O
beta	B
-	I
catenin	I
,	O
in	O
endothelial	O
cells	O
.	O

These	O
findings	O
suggest	O
that	O
Wnt	B
signaling	O
may	O
feature	O
in	O
normal	O
differentiation	O
of	O
the	O
vasculature	O
as	O
well	O
as	O
in	O
pathological	O
settings	O
where	O
endothelial	O
and	O
smooth	O
muscle	O
proliferation	O
is	O
disturbed	O
.	O

The	O
VacA	O
toxin	O
of	O
Helicobacter	O
pylori	O
identifies	O
a	O
new	O
intermediate	O
filament	O
-	O
interacting	O
protein	O
.	O

The	O
VacA	O
toxin	O
produced	O
by	O
Helicobacter	O
pylori	O
acts	O
inside	O
cells	O
and	O
induces	O
the	O
formation	O
of	O
vacuoles	O
arising	O
from	O
late	O
endosomal	O
/	O
lysosomal	O
compartments	O
.	O

Using	O
VacA	O
as	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screening	O
of	O
a	O
HeLa	O
cell	O
library	O
,	O
we	O
have	O
identified	O
a	O
novel	O
protein	O
of	O
54	O
kDa	O
(	O
VIP54	B
)	O
,	O
which	O
interacts	O
specifically	O
with	O
VacA	O
,	O
as	O
indicated	O
by	O
co	O
-	O
immunoprecipitation	O
and	O
binding	O
experiments	O
.	O

VIP54	B
is	O
expressed	O
in	O
cultured	O
cells	O
and	O
many	O
tissues	O
,	O
with	O
higher	O
expression	O
in	O
the	O
brain	O
,	O
muscle	O
,	O
kidney	O
and	O
liver	O
.	O

Confocal	O
immunofluorescence	O
microscopy	O
with	O
anti	O
-	O
VIP54	B
affinity-	O
purified	O
antibodies	O
shows	O
a	O
fibrous	O
pattern	O
typical	O
of	O
intermediate	O
filaments	O
.	O

Double	O
label	O
immunofluorescence	O
performed	O
on	O
various	O
cell	O
lines	O
with	O
antibodies	O
specific	O
to	O
different	O
intermediate	O
filament	O
proteins	O
revealed	O
that	O
VIP54	B
largely	O
co	O
-	O
distributes	O
with	O
vimentin	B
.	O

In	O
contrast	O
to	O
known	O
intermediate	O
filament	O
proteins	O
,	O
VIP54	B
is	O
predicted	O
to	O
contain	O
approximately	O
50	O
%	O
of	O
helical	O
segments	O
,	O
but	O
no	O
extended	O
coiled	O
-	O
coil	O
regions	O
.	O

The	O
possible	O
involvement	O
of	O
this	O
novel	O
protein	O
in	O
interactions	O
between	O
intermediate	O
filaments	O
and	O
late	O
endosomal	O
compartments	O
is	O
discussed	O
.	O

Identification	O
and	O
characterization	O
of	O
a	O
new	O
human	O
ETS	O
-	O
family	O
transcription	O
factor	O
,	O
TEL2	B
,	O
that	O
is	O
expressed	O
in	O
hematopoietic	O
tissues	O
and	O
can	O
associate	O
with	O
TEL1	B
/	O
ETV6	B
.	O

The	O
ETS	O
family	O
of	O
proteins	O
is	O
a	O
large	O
group	O
of	O
transcription	O
factors	O
implicated	O
in	O
many	O
aspects	O
of	O
normal	O
hematopoietic	O
development	O
,	O
as	O
well	O
as	O
oncogenesis	O
.	O

For	O
example	O
,	O
the	O
TEL1	B
/	O
ETV6	B
(	O
TEL1	B
)	O
gene	O
is	O
required	O
for	O
normal	O
yolk	O
sac	O
angiogenesis	O
,	O
adult	O
bone	O
marrow	O
hematopoiesis	O
,	O
and	O
is	O
rearranged	O
or	O
deleted	O
in	O
numerous	O
leukemias	O
.	O

This	O
report	O
describes	O
the	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
ETS	O
gene	O
that	O
is	O
highly	O
related	O
to	O
TEL1	B
and	O
is	O
therefore	O
called	O
TEL2	B
.	O

The	O
TEL2	B
gene	O
consists	O
of	O
8	O
exons	O
spanning	O
approximately	O
21	O
kilobases	O
(	O
kb	O
)	O
in	O
human	O
chromosome	O
6p21	O
.	O

Unlike	O
the	O
ubiquitously	O
expressed	O
TEL1	B
gene	O
,	O
however	O
,	O
TEL2	B
appears	O
to	O
be	O
expressed	O
predominantly	O
in	O
hematopoietic	O
tissues	O
.	O

Antibodies	O
raised	O
against	O
the	O
C	O
-	O
terminus	O
of	O
the	O
TEL2	B
protein	O
were	O
used	O
to	O
show	O
that	O
TEL2	B
localizes	O
to	O
the	O
nucleus	O
.	O

All	O
ETS	O
proteins	O
can	O
bind	O
DNA	O
via	O
the	O
highly	O
conserved	O
ETS	O
domain	O
,	O
which	O
recognizes	O
a	O
purine	O
-	O
rich	O
DNA	O
sequence	O
with	O
a	O
GGAA	O
core	O
motif	O
.	O

DNA	O
binding	O
assays	O
show	O
that	O
TEL2	B
can	O
bind	O
the	O
same	O
consensus	O
DNA	O
binding	O
sequence	O
recognized	O
by	O
TEL1	B
/	O
ETV6	B
.	O

Additionally	O
,	O
the	O
TEL2	B
protein	O
is	O
capable	O
of	O
associating	O
with	O
itself	O
and	O
with	O
TEL1	B
in	O
doubly	O
transfected	O
Hela	O
cells	O
,	O
and	O
this	O
interaction	O
is	O
mediated	O
through	O
the	O
pointed	O
(	O
PNT	O
)	O
domain	O
of	O
TEL1	B
.	O

The	O
striking	O
similarities	O
of	O
TEL2	B
to	O
the	O
oncogenic	O
TEL1	B
,	O
its	O
expression	O
in	O
hematopoietic	O
tissues	O
,	O
and	O
its	O
ability	O
to	O
associate	O
with	O
TEL1	B
suggest	O
that	O
TEL2	B
may	O
be	O
an	O
important	O
hematopoietic	O
regulatory	O
protein	O
.	O

The	O
SCA8	O
transcript	O
is	O
an	O
antisense	O
RNA	O
to	O
a	O
brain	O
-	O
specific	O
transcript	O
encoding	O
a	O
novel	O
actin	O
-	O
binding	O
protein	O
(	O
KLHL1	B
)	O
.	O

Spinocerebellar	O
ataxia	O
type	O
8	O
(	O
SCA8	O
)	O
is	O
a	O
neurodegenerative	O
disorder	O
caused	O
by	O
the	O
expansion	O
of	O
a	O
CTG	O
trinucleotide	O
repeat	O
that	O
is	O
transcribed	O
as	O
part	O
of	O
an	O
untranslated	O
RNA	O
.	O

As	O
a	O
step	O
towards	O
understanding	O
the	O
molecular	O
pathology	O
of	O
SCA8	O
,	O
we	O
have	O
defined	O
the	O
genomic	O
organization	O
of	O
the	O
SCA8	O
RNA	O
transcripts	O
and	O
assembled	O
a	O
166	O
kb	O
segment	O
of	O
genomic	O
sequence	O
containing	O
the	O
repeat	O
.	O

The	O
most	O
striking	O
feature	O
of	O
the	O
SCA8	O
transcripts	O
is	O
that	O
the	O
most	O
5	O
'	O
exon	O
is	O
transcribed	O
through	O
the	O
first	O
exon	O
of	O
another	O
gene	O
that	O
is	O
transcribed	O
in	O
the	O
opposite	O
orientation	O
.	O

This	O
gene	O
arrangement	O
suggests	O
that	O
the	O
SCA8	O
transcript	O
is	O
an	O
endogenous	O
antisense	O
RNA	O
that	O
overlaps	O
the	O
transcription	O
and	O
translation	O
start	O
sites	O
as	O
well	O
as	O
the	O
first	O
splice	O
donor	O
sequence	O
of	O
the	O
sense	O
gene	O
.	O

The	O
sense	O
transcript	O
encodes	O
a	O
748	O
amino	O
acid	O
protein	O
with	O
a	O
predicted	O
domain	O
structure	O
typical	O
of	O
a	O
family	O
of	O
actin	O
-	O
organizing	O
proteins	O
related	O
to	O
the	O
Drosophila	O
Kelch	O
gene	O
,	O
and	O
so	O
has	O
been	O
given	O
the	O
name	O
Kelch	B
-	I
like	I
1	I
(	O
KLHL1	B
)	O
.	O

We	O
have	O
identified	O
the	O
full	O
-	O
length	O
cDNA	O
sequence	O
for	O
both	O
the	O
human	O
and	O
mouse	O
KLHLI	B
genes	O
,	O
and	O
have	O
elucidated	O
the	O
general	O
genomic	O
organization	O
of	O
the	O
human	O
gene	O
.	O

The	O
predicted	O
open	O
reading	O
frame	O
and	O
promoter	O
region	O
are	O
highly	O
conserved	O
,	O
and	O
both	O
genes	O
are	O
primarily	O
expressed	O
in	O
specific	O
brain	O
tissues	O
,	O
including	O
the	O
cerebellum	O
,	O
the	O
tissue	O
most	O
affected	O
by	O
SCA8	O
.	O

Transfection	O
studies	O
with	O
epitope	O
-	O
tagged	O
KLHL1	B
demonstrate	O
that	O
the	O
protein	O
localizes	O
to	O
the	O
cytoplasm	O
,	O
suggesting	O
that	O
it	O
may	O
play	O
a	O
role	O
in	O
organizing	O
the	O
actin	O
cytoskeleton	O
of	O
the	O
brain	O
cells	O
in	O
which	O
it	O
is	O
expressed	O
.	O

Identification	O
of	O
cDNAs	O
encoding	O
two	O
novel	O
nuclear	O
proteins	O
,	O
IMUP-1	B
and	O
IMUP-2	B
,	O
upregulated	O
in	O
SV40-immortalized	O
human	O
fibroblasts	O
.	O

Using	O
a	O
model	O
system	O
of	O
young	O
,	O
senescent	O
and	O
SV40-immortalized	O
WI-38	O
fibroblasts	O
,	O
we	O
identified	O
two	O
mRNAs	O
upregulated	O
in	O
immortalized	O
cells	O
(	O
imup-1	B
,	O
immortalization	B
-	I
upregulated	I
protein	I
1	I
,	O
and	O
imup-2	B
)	O
.	O

Compared	O
to	O
normal	O
tissues	O
,	O
both	O
genes	O
were	O
more	O
frequently	O
expressed	O
in	O
cancer	O
cells	O
.	O

The	O
open	O
reading	O
frame	O
of	O
imup-1	B
spans	O
321bp	O
,	O
coding	O
for	O
a	O
10.9	O
kDa	O
protein	O
of	O
106	O
amino	O
acids	O
,	O
while	O
an	O
insertion	O
of	O
59bp	O
in	O
the	O
otherwise	O
identical	O
mRNA	O
of	O
imup-2	B
leads	O
to	O
a	O
frameshift	O
,	O
resulting	O
in	O
an	O
8.5	O
kDa	O
protein	O
of	O
85	O
amino	O
acids	O
.	O

Database	O
searches	O
identified	O
these	O
genes	O
on	O
chromosome	O
19	O
,	O
which	O
could	O
account	O
for	O
the	O
cloned	O
imup-1	B
and	O
imup-2	B
transcripts	O
by	O
alternative	O
splicing	O
.	O

Southern	O
blot	O
analysis	O
of	O
digested	O
genomic	O
DNA	O
confirmed	O
that	O
both	O
transcripts	O
are	O
derived	O
from	O
a	O
single	O
locus	O
.	O

The	O
expressed	O
proteins	O
IMUP-1	B
and	O
IMUP-2	B
share	O
46	O
identical	O
N	O
-	O
terminal	O
amino	O
acids	O
,	O
whereas	O
the	O
C	O
-	O
termini	O
are	O
unrelated	O
.	O

Green	O
fluorescent	O
protein	O
-	O
fusions	O
of	O
both	O
IMUP-1	B
and	O
IMUP-2	B
accumulated	O
in	O
the	O
nucleus	O
of	O
HeLa	O
cells	O
.	O

The	O
C	O
-	O
terminus	O
of	O
IMUP-1	B
contains	O
a	O
bipartite	O
nuclear	O
localization	O
signal	O
,	O
the	O
deletion	O
of	O
which	O
impaired	O
nuclear	O
translocation	O
.	O

In	O
-	O
vitro	O
translated	O
proteins	O
bound	O
to	O
poly	O
(	O
rG	O
)	O
,	O
but	O
did	O
not	O
interact	O
with	O
single	O
-	O
stranded	O
DNA	O
or	O
double	O
-	O
stranded	O
DNA	O
.	O

The	O
nuclear	O
localization	O
of	O
IMUP-1	B
and	O
IMUP-2	B
as	O
well	O
as	O
the	O
upregulation	O
of	O
both	O
underlying	O
mRNAs	O
in	O
immortalized	O
cells	O
suggest	O
a	O
function	O
in	O
immortalization	O
.	O

Identification	O
of	O
a	O
novel	O
thioredoxin	B
-	O
related	O
transmembrane	O
protein	O
.	O

We	O
recently	O
identified	O
a	O
series	O
of	O
transforming	O
growth	O
factor	O
-	O
beta	O
-	O
responsive	O
genes	O
in	O
A549	O
human	O
adenocarcinoma	O
cell	O
line	O
by	O
a	O
gene	O
trap	O
screening	O
method	O
.	O

Here	O
we	O
report	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
one	O
of	O
these	O
genes	O
,	O
designated	O
TMX	B
,	O
that	O
encodes	O
a	O
novel	O
protein	O
of	O
280	O
amino	O
acid	O
residues	O
.	O

The	O
TMX	B
protein	O
possesses	O
an	O
N	O
-	O
terminal	O
signal	O
peptide	O
followed	O
by	O
one	O
thioredoxin	B
(	O
Trx	B
)	O
-like	O
domain	O
with	O
a	O
unique	O
active	O
site	O
sequence	O
,	O
Cys	O
-	O
Pro	O
-	O
Ala	O
-	O
Cys	O
,	O
and	O
a	O
potential	O
transmembrane	O
domain	O
.	O

There	O
are	O
putative	O
TMX	B
homologs	O
with	O
identical	O
active	O
site	O
sequences	O
in	O
the	O
Caenorhabditis	O
elegans	O
and	O
Drosophila	O
genomes	O
.	O

Using	O
recombinant	O
proteins	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
we	O
demonstrated	O
the	O
activity	O
of	O
the	O
Trx	B
domain	O
of	O
TMX	B
to	O
cleave	O
the	O
interchain	O
disulfide	O
bridges	O
in	O
insulin	B
in	O
vitro	O
.	O

The	O
TMX	B
transcript	O
is	O
widely	O
expressed	O
in	O
normal	O
human	O
tissues	O
,	O
and	O
subcellular	O
fractionation	O
and	O
immunostaining	O
for	O
an	O
epitope	O
-	O
tagged	O
TMX	B
protein	O
suggest	O
that	O
TMX	B
is	O
predominantly	O
localized	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
.	O

When	O
TMX	B
was	O
expressed	O
in	O
HEK293	O
cells	O
,	O
it	O
significantly	O
suppressed	O
the	O
apoptosis	O
induced	O
by	O
brefeldin	O
A	O
,	O
an	O
inhibitor	O
of	O
ER	O
-	O
Golgi	O
transport	O
.	O

This	O
activity	O
was	O
abolished	O
when	O
two	O
Cys	O
residues	O
in	O
the	O
active	O
site	O
sequence	O
were	O
mutated	O
to	O
Ser	O
,	O
suggesting	O
that	O
the	O
Trx	B
-	O
like	O
activity	O
of	O
TMX	B
may	O
help	O
relieve	O
ER	O
stress	O
caused	O
by	O
brefeldin	O
A.	O

A	O
new	O
spectrin	B
,	I
beta	I
IV	I
,	O
has	O
a	O
major	O
truncated	O
isoform	O
that	O
associates	O
with	O
promyelocytic	B
leukemia	I
protein	I
nuclear	O
bodies	O
and	O
the	O
nuclear	O
matrix	O
.	O

We	O
isolated	O
cDNAs	O
that	O
encode	O
a	O
77-kDa	O
peptide	O
similar	O
to	O
repeats	O
10	O
-	O
16	O
of	O
beta	O
-	O
spectrins	O
.	O

Its	O
gene	O
localizes	O
to	O
human	O
chromosome	O
19q13.13-q13.2	O
and	O
mouse	O
chromosome	O
7	O
,	O
at	O
7.5	O
centimorgans	O
.	O

A	O
289-kDa	O
isoform	O
,	O
similar	O
to	O
full	O
-	O
length	O
beta	O
-	O
spectrins	O
,	O
was	O
partially	O
assembled	O
from	O
sequences	O
in	O
the	O
human	O
genomic	O
DNA	O
data	O
base	O
and	O
completely	O
cloned	O
and	O
sequenced	O
.	O

RNA	O
transcripts	O
are	O
seen	O
predominantly	O
in	O
the	O
brain	O
,	O
and	O
Western	O
analysis	O
shows	O
a	O
major	O
peptide	O
that	O
migrates	O
as	O
a	O
72-kDa	O
band	O
.	O

This	O
new	O
gene	O
,	O
spectrin	B
betaIV	I
,	O
thus	O
encodes	O
a	O
full	O
-	O
length	O
minor	O
isoform	O
(	O
SpbetaIVSigma1	B
)	O
and	O
a	O
truncated	O
major	O
isoform	O
(	O
SpbetaIVSigma5	B
)	O
.	O

Immunostaining	O
of	O
cells	O
shows	O
a	O
micropunctate	O
pattern	O
in	O
the	O
cytoplasm	O
and	O
nucleus	O
.	O

In	O
mesenchymal	O
stem	O
cells	O
,	O
the	O
staining	O
concentrates	O
at	O
nuclear	O
dots	O
that	O
stain	O
positively	O
for	O
the	O
promyelocytic	B
leukemia	I
protein	I
(	O
PML	B
)	O
.	O

Expression	O
of	O
SpbetaIVSigma5	B
fused	O
to	O
green	O
fluorescence	O
protein	O
in	O
cells	O
produces	O
nuclear	O
dots	O
that	O
include	O
all	O
PML	B
bodies	O
,	O
which	O
double	O
in	O
number	O
in	O
transfected	O
cells	O
.	O

Deletion	O
analysis	O
shows	O
that	O
partial	O
repeats	O
10	O
and	O
16	O
of	O
SpbetaIVSigma5	B
are	O
necessary	O
for	O
nuclear	O
dot	O
formation	O
.	O

Immunostaining	O
of	O
whole	O
-	O
mount	O
nuclear	O
matrices	O
reveals	O
diffuse	O
positivity	O
with	O
accentuation	O
at	O
PML	B
bodies	O
.	O

Spectrin	B
betaIV	I
is	O
the	O
first	O
beta	O
-	O
spectrin	O
associated	O
with	O
a	O
subnuclear	O
structure	O
and	O
may	O
be	O
part	O
of	O
a	O
nuclear	O
scaffold	O
to	O
which	O
gene	O
regulatory	O
machinery	O
binds	O
.	O

Identification	O
and	O
characterization	O
of	O
a	O
human	O
mitochondrial	O
homologue	O
of	O
the	O
bacterial	O
co	O
-	O
chaperone	O
GrpE.	B
We	O
have	O
identified	O
a	O
novel	O
human	O
cDNA	O
with	O
a	O
predicted	O
protein	O
sequence	O
that	O
has	O
28	O
%	O
amino	O
acid	O
identity	O
with	O
the	O
E.	O
coli	O
Hsp70	O
co	O
-	O
chaperone	O
GrpE	B
and	O
designated	O
it	O
HMGE	B
.	O

Even	O
with	O
this	O
low	O
level	O
of	O
amino	O
acid	O
identity	O
the	O
human	O
sequence	O
could	O
be	O
efficiently	O
modelled	O
on	O
the	O
X	O
-	O
ray	O
structure	O
of	O
the	O
E.	O
coli	O
protein	O
,	O
suggesting	O
that	O
there	O
may	O
be	O
significant	O
functional	O
conservation	O
.	O

Indeed	O
,	O
HMGE	B
expressed	O
in	O
E.	O
coli	O
as	O
a	O
GST	O
fusion	O
protein	O
co	O
-	O
purified	O
with	O
the	O
E.	O
coli	O
Hsp70	O
protein	O
DnaK	O
in	O
the	O
absence	O
of	O
ATP	O
.	O

DnaK	O
could	O
be	O
released	O
from	O
the	O
GST	O
-	O
HMGE	B
with	O
a	O
Mg	O
-	O
ATP	O
wash	O
.	O

Subcellular	O
fractionation	O
and	O
immunocytochemistry	O
studies	O
using	O
antisera	O
raized	O
against	O
HMGE	B
show	O
that	O
it	O
is	O
a	O
mitochondrial	O
protein	O
.	O

In	O
contrast	O
to	O
studies	O
of	O
rat	O
GrpE	B
,	O
however	O
,	O
HMGE	B
also	O
appears	O
to	O
bind	O
the	O
constitutive	O
cytosolic	O
Hsp70	O
,	O
Hsc70	B
,	O
in	O
addition	O
to	O
mitochondrial	O
Hsp70	O
,	O
Mt	B
-	I
Hsp70	I
.	O

We	O
have	O
previously	O
shown	O
that	O
Hsc70	B
nucleotide	O
-	O
exchange	O
is	O
rate	O
limiting	O
in	O
the	O
presence	O
of	O
the	O
DnaJ	O
-	O
protein	O
,	O
HSJ1b	B
.	O

However	O
,	O
HMGE	B
was	O
found	O
to	O
inhibit	O
the	O
HSJ1b	B
-	O
enhanced	O
Hsc70	B
ATPase	O
activity	O
and	O
may	O
mediate	O
this	O
inhibition	O
by	O
binding	O
the	O
DnaJ	O
-	O
protein	O
,	O
HSJ1b	B
.	O

This	O
is	O
the	O
first	O
description	O
of	O
a	O
direct	O
interaction	O
between	O
a	O
DnaJ	O
protein	O
and	O
GrpE	B
-	O
like	O
protein	O
.	O

These	O
studies	O
suggest	O
that	O
the	O
structure	O
of	O
GrpE	B
has	O
been	O
conserved	O
throughout	O
evolution	O
and	O
that	O
the	O
conserved	O
structure	O
can	O
interact	O
with	O
several	O
forms	O
of	O
Hsp70	O
,	O
but	O
that	O
HMGE	B
can	O
not	O
form	O
part	O
of	O
the	O
reaction	O
cycle	O
for	O
cytosolic	O
Hsc70	B
.	O

Paip1	B
interacts	O
with	O
poly	B
(	I
A	I
)	I
binding	I
protein	I
through	O
two	O
independent	O
binding	O
motifs	O
.	O

The	O
3	O
'	O
poly	O
(	O
A	O
)	O
tail	O
of	O
eukaryotic	O
mRNAs	O
plays	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
translation	O
.	O

The	O
poly	B
(	I
A	I
)	I
binding	I
protein	I
(	O
PABP	B
)	O
interacts	O
with	O
eukaryotic	B
initiation	I
factor	I
4	I
G	I
(	O
eIF4	B
G	I
)	O
,	O
a	O
component	O
of	O
the	O
eIF4F	B
complex	O
,	O
which	O
binds	O
to	O
the	O
5	O
'	O
cap	O
structure	O
.	O

The	O
PABP	B
-	O
eIF4	B
G	I
interaction	O
brings	O
about	O
the	O
circularization	O
of	O
the	O
mRNA	O
by	O
joining	O
its	O
5	O
'	O
and	O
3	O
'	O
termini	O
,	O
thereby	O
stimulating	O
mRNA	O
translation	O
.	O

The	O
activity	O
of	O
PABP	B
is	O
regulated	O
by	O
two	O
interacting	O
proteins	O
,	O
Paip1	B
and	O
Paip2	B
.	O

To	O
study	O
the	O
mechanism	O
of	O
the	O
Paip1-PABP	B
interaction	O
,	O
far	O
-	O
Western	O
,	O
glutathione	O
S	O
-	O
transferase	O
pull	O
-	O
down	O
,	O
and	O
surface	O
plasmon	O
resonance	O
experiments	O
were	O
performed	O
.	O

Paip1	B
contains	O
two	O
binding	O
sites	O
for	O
PABP	B
,	O
PAM1	O
and	O
PAM2	O
(	O
for	O
PABP	B
-	O
interacting	O
motifs	O
1	O
and	O
2	O
)	O
.	O

PAM2	O
consists	O
of	O
a	O
15-amino	O
-	O
acid	O
stretch	O
residing	O
in	O
the	O
N	O
terminus	O
,	O
and	O
PAM1	O
encompasses	O
a	O
larger	O
C	O
-	O
terminal	O
acidic	O
-	O
amino	O
-	O
acid	O
-	O
rich	O
region	O
.	O

PABP	B
also	O
contains	O
two	O
Paip1	B
binding	O
sites	O
,	O
one	O
located	O
in	O
RNA	O
recognition	O
motifs	O
1	O
and	O
2	O
and	O
the	O
other	O
located	O
in	O
the	O
C	O
-	O
terminal	O
domain	O
.	O

Paip1	B
binds	O
to	O
PABP	B
with	O
a	O
1:1	O
stoichiometry	O
and	O
an	O
apparent	O
K	O
(	O
d	O
)	O
of	O
1.9	O
nM.	O

Poly	B
(	I
ADP	I
-	I
ribose	I
)	I
polymerase-1	I
cleavage	O
during	O
apoptosis	O
:	O
an	O
update	O
.	O

Poly	O
(	O
ADP	O
-	O
ribosylation	O
)	O
is	O
a	O
post	O
-	O
translational	O
modification	O
of	O
proteins	O
playing	O
a	O
crucial	O
role	O
in	O
many	O
processes	O
,	O
including	O
DNA	O
repair	O
and	O
cell	O
death	O
.	O

The	O
best	O
known	O
poly	O
(	O
ADP	O
-	O
ribosylating	O
)	O
enzyme	O
,	O
PARP-1	B
,	O
is	O
a	O
DNA	O
nick	O
sensor	O
and	O
uses	O
betaNAD	O
(	O
+	O
)	O
to	O
form	O
polymers	O
of	O
ADP	O
-	O
ribose	O
which	O
are	O
further	O
bound	O
to	O
nuclear	O
protein	O
acceptors	O
.	O

To	O
strictly	O
regulate	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
turnover	O
,	O
its	O
degradation	O
is	O
assured	O
by	O
the	O
enzyme	O
poly	B
(	I
ADP	I
-	I
ribose	I
)	I
glycohydrolase	I
(	O
PARG	B
)	O
.	O

During	O
apoptosis	O
,	O
PARP-1	B
plays	O
two	O
opposite	O
roles	O
:	O
its	O
stimulation	O
leads	O
to	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
synthesis	O
,	O
whereas	O
caspases	O
cause	O
PARP-1	B
cleavage	O
and	O
inactivation	O
.	O

PARP-1	B
proteolysis	O
produces	O
an	O
89	O
kDa	O
C	O
-	O
terminal	O
fragment	O
,	O
with	O
a	O
reduced	O
catalytic	O
activity	O
,	O
and	O
a	O
24	O
kDa	O
N	O
-	O
terminal	O
peptide	O
,	O
which	O
retains	O
the	O
DNA	O
binding	O
domains	O
.	O

The	O
fate	O
and	O
the	O
possible	O
role	O
of	O
these	O
fragments	O
during	O
apoptosis	O
will	O
be	O
discussed	O
.	O

Inhibition	O
of	O
poly	B
(	I
ADP	I
-	I
ribose	I
)	I
polymerase	I
activation	O
attenuates	O
beta	O
-	O
lapachone	O
-	O
induced	O
necrotic	O
cell	O
death	O
in	O
human	O
osteosarcoma	O
cells	O
.	O

beta	O
-	O
Lapachone	O
,	O
a	O
novel	O
anticancer	O
drug	O
,	O
induces	O
various	O
human	O
carcinoma	O
cells	O
to	O
undergo	O
apoptotic	O
cell	O
death	O
.	O

However	O
,	O
we	O
report	O
here	O
that	O
,	O
in	O
human	O
osteocarcinoma	O
(	O
U2-OS	O
)	O
cells	O
,	O
beta	O
-	O
lapachone	O
induces	O
necrosis	O
rather	O
than	O
apoptosis	O
.	O

beta	O
-	O
Lapachone	O
-	O
induced	O
necrotic	O
cell	O
death	O
in	O
U2-OS	O
cells	O
was	O
characterized	O
by	O
propidium	O
iodide	O
uptake	O
,	O
cytochrome	B
c	I
release	O
,	O
a	O
decreased	O
mitochondrial	O
membrane	O
potential	O
,	O
and	O
ATP	O
depletion	O
.	O

The	O
mitochondrial	O
potential	O
transition	O
(	O
MPT	O
)	O
,	O
including	O
the	O
reduction	O
of	O
the	O
mitochondrial	O
transmembrane	O
potential	O
and	O
the	O
release	O
of	O
mitochondrial	O
cytochrome	B
c	I
,	O
occurred	O
in	O
beta	O
-	O
lapachone	O
-	O
treated	O
cells	O
;	O
cotreatment	O
of	O
these	O
cells	O
with	O
cyclosporin	O
A	O
,	O
an	O
inhibitor	O
of	O
MPT	O
pore	O
,	O
failed	O
to	O
prevent	O
necrotic	O
cell	O
death	O
.	O

This	O
indicates	O
that	O
the	O
MPT	O
transition	O
does	O
not	O
play	O
a	O
crucial	O
role	O
in	O
this	O
process	O
.	O

Furthermore	O
,	O
beta	O
-	O
lapachone	O
-	O
induced	O
necrosis	O
was	O
independent	O
of	O
oxidative	O
stress	O
and	O
caspase	O
activation	O
.	O

However	O
,	O
excessive	O
poly	B
(	I
ADP	I
-	I
ribose	I
)	I
polymerase	I
(	O
PARP	B
)	O
activation	O
and	O
subsequent	O
depletion	O
of	O
intracellular	O
NAD	O
(	O
+	O
)	O
and	O
ATP	O
were	O
seen	O
in	O
beta	O
-	O
lapachone	O
-	O
treated	O
U2-OS	O
cells	O
.	O

Cotreatment	O
with	O
a	O
PARP	B
inhibitor	O
,	O
3-aminobenzamide	O
,	O
decreased	O
beta	O
-	O
lapachone	O
-	O
induced	O
PARP	B
activation	O
and	O
provided	O
significant	O
protection	O
from	O
necrosis	O
by	O
preventing	O
depletion	O
of	O
intracellular	O
NAD	O
(	O
+	O
)	O
and	O
ATP	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
PARP	B
plays	O
an	O
important	O
role	O
in	O
the	O
signaling	O
pathway	O
for	O
beta	O
-	O
lapachone	O
-	O
induced	O
necrosis	O
in	O
U2-OS	O
cells	O
.	O

Nociceptive	O
sensitization	O
by	O
the	O
secretory	O
protein	O
Bv8	O
.	O

1	O
The	O
small	O
protein	O
Bv8	O
,	O
isolated	O
from	O
amphibian	O
skin	O
,	O
belongs	O
to	O
a	O
novel	O
family	O
of	O
secretory	O
proteins	O
(	O
Bv8-Prokineticin	O
family	O
,	O
SWISS	O
-	O
PROT	O
:	O
Q9PW66	O
)	O
whose	O
orthologues	O
have	O
been	O
conserved	O
throughout	O
evolution	O
,	O
from	O
invertebrates	O
to	O
humans	O
.	O

2	O
When	O
injected	O
intravenously	O
or	O
subcutaneously	O
(	O
from	O
0.06	O
to	O
500	O
pmol	O
kg	O
(	O
-1	O
)	O
)	O
or	O
intrathecally	O
(	O
from	O
6	O
fmol	O
to	O
250	O
pmol	O
)	O
in	O
rats	O
,	O
Bv8	O
produced	O
an	O
intense	O
systemic	O
nociceptive	O
sensitization	O
to	O
mechanical	O
and	O
thermal	O
stimuli	O
applied	O
to	O
the	O
tail	O
and	O
paws	O
.	O

3	O
Topically	O
delivered	O
into	O
one	O
rat	O
paw	O
,	O
50	O
fmol	O
of	O
Bv8	O
decreased	O
by	O
50	O
%	O
the	O
nociceptive	O
threshold	O
to	O
pressure	O
in	O
the	O
injected	O
paw	O
without	O
affecting	O
the	O
threshold	O
in	O
the	O
contralateral	O
paw	O
.	O

4	O
The	O
two	O
G	O
-	O
protein	O
coupled	O
prokineticin	O
receptors	O
,	O
PK	B
-	I
R1	I
and	O
PK	B
-	I
R2	I
,	O
were	O
expressed	O
in	O
rat	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
)	O
and	O
in	O
dorsal	O
quadrants	O
of	O
spinal	O
cord	O
(	O
DSC	O
)	O
and	O
bound	O
Bv8	O
and	O
the	O
mammalian	O
orthologue	O
,	O
EG	B
-	I
VEGF	I
,	O
with	O
high	O
affinity	O
.	O

In	O
DSC	O
,	O
PK	B
-	I
R1	I
was	O
more	O
abundant	O
than	O
PK	B
-	I
R2	I
,	O
whereas	O
both	O
receptors	O
were	O
equally	O
expressed	O
in	O
DRG	O
.	O

IC	O
(	O
50	O
)	O
of	O
Bv8	O
and	O
EG	B
-	I
VEGF	I
to	O
inhibit	O
[	O
(	O
125	O
)	O
I	O
]	O
-Bv8	O
binding	O
to	O
rat	O
DRG	O
and	O
DSC	O
were	O
4.1+	O
/	O
-0.4	O
nM	O
Bv8	O
and	O
76.4+	O
/	O
-7.6	O
nM	O
EG	B
-	I
VEGF	I
,	O
in	O
DRG	O
;	O
7.3+	O
/	O
-0.9	O
nM	O
Bv8	O
and	O
330+	O
/	O
-41	O
nM	O
EG	B
-	I
VEGF	I
,	O
in	O
DSC	O
.	O

5	O
In	O
the	O
small	O
diameter	O
neurons	O
(	O
<	O
30	O
microm	O
)	O
of	O
rat	O
DRG	O
cultures	O
,	O
Bv8	O
concentrations	O
,	O
ranging	O
from	O
0.2	O
to	O
10	O
nM	O
,	O
raised	O
[	O
Ca	O
(	O
2+	O
)	O
]	O
(	O
i	O
)	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

6	O
These	O
data	O
suggest	O
that	O
Bv8	O
,	O
through	O
binding	O
to	O
PK	O
receptors	O
of	O
DSC	O
and	O
primary	O
sensitive	O
neurons	O
,	O
results	O
in	O
intense	O
sensitization	O
of	O
peripheral	O
nociceptors	O
to	O
thermal	O
and	O
mechanical	O
stimuli	O
.	O

US11	O
of	O
herpes	O
simplex	O
virus	O
type	O
1	O
interacts	O
with	O
HIPK2	B
and	O
antagonizes	O
HIPK2-induced	B
cell	O
growth	O
arrest	O
.	O

Homeodomain	B
-	I
interacting	I
protein	I
kinase	I
2	I
(	O
HIPK2	B
)	O
is	O
a	O
nuclear	O
serine	O
/	O
threonine	O
kinase	O
of	O
the	O
subfamily	O
of	O
dual	O
-	O
specificity	O
Yak1-related	O
kinase	O
proteins	O
.	O

HIPK2	B
was	O
first	O
described	O
as	O
a	O
homeodomain	O
-	O
interacting	O
protein	O
kinase	O
acting	O
as	O
a	O
corepressor	O
for	O
homeodomain	O
transcription	O
factors	O
.	O

More	O
recently	O
,	O
it	O
was	O
reported	O
that	O
HIPK2	B
plays	O
a	O
role	O
in	O
p53-mediated	B
cellular	O
apoptosis	O
and	O
could	O
also	O
participate	O
in	O
the	O
regulation	O
of	O
the	O
cell	O
cycle	O
.	O

US11	O
protein	O
of	O
herpes	O
simplex	O
virus	O
type	O
1	O
is	O
a	O
multifunctional	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
several	O
processes	O
related	O
to	O
the	O
survival	O
of	O
cells	O
submitted	O
to	O
environmental	O
stresses	O
by	O
mechanisms	O
that	O
are	O
not	O
fully	O
elucidated	O
.	O

In	O
an	O
attempt	O
to	O
better	O
understand	O
the	O
multiple	O
functions	O
of	O
US11	O
,	O
we	O
identified	O
cellular	O
binding	O
partners	O
of	O
this	O
protein	O
by	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

We	O
report	O
that	O
US11	O
interacts	O
with	O
HIPK2	B
through	O
the	O
PEST	O
domain	O
of	O
HIPK2	B
and	O
that	O
this	O
interaction	O
occurs	O
also	O
in	O
human	O
cells	O
.	O

This	O
interaction	O
modifies	O
the	O
subcellular	O
distribution	O
of	O
HIPK2	B
and	O
protects	O
the	O
cell	O
against	O
the	O
HIPK2-induced	B
cell	O
growth	O
arrest	O
.	O

Physical	O
and	O
functional	O
interactions	O
between	O
Daxx	B
and	O
TSG101	B
.	O

Daxx	B
has	O
been	O
reported	O
to	O
mediate	O
the	O
Fas	B
/	O
JNK	B
-	O
dependent	O
signals	O
in	O
the	O
cytoplasm	O
.	O

However	O
,	O
several	O
evidences	O
have	O
suggested	O
that	O
Daxx	B
is	O
located	O
mainly	O
in	O
the	O
nucleus	O
and	O
functions	O
as	O
a	O
transcriptional	O
regulator	O
.	O

Recently	O
,	O
we	O
identified	O
DMAP1	B
,	O
a	O
TSG101-interacting	B
protein	O
as	O
a	O
Daxx	B
binding	O
partner	O
by	O
yeast	O
two	O
-	O
hybrid	O
screening	O
.	O

TSG101	B
has	O
been	O
shown	O
to	O
act	O
as	O
transcriptional	O
co	O
-	O
repressor	O
of	O
nuclear	O
hormone	O
receptors	O
.	O

Here	O
we	O
examined	O
whether	O
TSG101also	O
interacts	O
with	O
Daxx	B
directly	O
.	O

The	O
association	O
of	O
Daxx	B
and	O
TSG101	B
was	O
confirmed	O
using	O
co	O
-	O
expressed	O
tagged	O
proteins	O
.	O

The	O
interaction	O
regions	O
in	O
both	O
proteins	O
were	O
also	O
mapped	O
,	O
and	O
the	O
cellular	O
localization	O
of	O
the	O
interaction	O
was	O
examined	O
.	O

TSG101	B
formed	O
a	O
complex	O
with	O
Daxx	B
through	O
its	O
coiled	O
-	O
coil	O
domain	O
and	O
co	O
-	O
localized	O
in	O
the	O
nucleus	O
.	O

Furthermore	O
,	O
TSG101	B
enhanced	O
Daxx	B
-	O
mediated	O
repression	O
of	O
glucocorticoid	B
receptor	I
transcriptional	O
activity	O
.	O

These	O
results	O
provide	O
the	O
novel	O
molecular	O
interactions	O
between	O
Daxx	B
and	O
TSG101	B
,	O
which	O
establish	O
an	O
efficient	O
repressive	O
transcription	O
complex	O
in	O
the	O
nucleus	O
.	O

Statherin	B
:	O
a	O
major	O
boundary	O
lubricant	O
of	O
human	O
saliva	O
.	O

The	O
lubricating	O
properties	O
of	O
human	O
submandibular	O
-	O
sublingual	O
salivary	O
fractions	O
were	O
examined	O
using	O
a	O
servohydraulic	O
model	O
of	O
mandibular	O
movement	O
.	O

Fractions	O
containing	O
statherin	B
exhibited	O
a	O
strong	O
tendency	O
to	O
boundary	O
lubrication	O
.	O

The	O
lubricity	O
of	O
purified	O
statherin	B
was	O
confirmed	O
and	O
compared	O
to	O
the	O
amphipathic	O
molecules	O
gramacidin	O
S	O
and	O
sodium	O
dodecyl	O
sulfate	O
.	O

Contact	O
angle	O
measurements	O
of	O
statherin	B
paralleled	O
the	O
other	O
amphipathic	O
molecules	O
.	O

The	O
helical	O
content	O
of	O
statherin	B
increased	O
in	O
trifluoroethanol	O
indicating	O
the	O
presence	O
of	O
amphipathic	O
helical	O
regions	O
.	O

CD	O
studies	O
and	O
hydrophobic	O
moment	O
calculations	O
indicated	O
that	O
statherin	B
adopts	O
an	O
amphipathic	O
helical	O
conformation	O
at	O
the	O
N	O
-	O
terminus	O
.	O

An	O
energy	O
-	O
minimized	O
model	O
of	O
the	O
polar	O
N	O
-	O
terminal	O
residues	O
1	O
-	O
15	O
suggested	O
that	O
this	O
domain	O
could	O
be	O
positioned	O
in	O
space	O
to	O
interact	O
with	O
a	O
hydroxyapatite	O
substrate	O
.	O

These	O
data	O
imply	O
that	O
under	O
appropriate	O
conditions	O
statherin	B
may	O
display	O
an	O
amphipathic	O
nature	O
which	O
enables	O
it	O
to	O
function	O
as	O
a	O
boundary	O
lubricant	O
on	O
enamel	O
.	O

A	O
novel	O
IL-1	B
receptor	O
,	O
cloned	O
from	O
B	O
cells	O
by	O
mammalian	O
expression	O
,	O
is	O
expressed	O
in	O
many	O
cell	O
types	O
.	O

cDNA	O
clones	O
corresponding	O
to	O
an	O
Mr	O
approximately	O
80,000	O
receptor	O
(	B
type	I
I	I
receptor	I
)	I
for	I
interleukin-1	I
(	I
IL-1	I
)	I
have	O
been	O
isolated	O
previously	O
by	O
mammalian	O
expression	O
.	O

Here	O
,	O
we	O
report	O
the	O
use	O
of	O
an	O
improved	O
expression	O
cloning	O
method	O
to	O
isolate	O
human	O
and	O
murine	O
cDNA	O
clones	O
encoding	O
a	B
second	I
type	I
(	I
Mr	I
approximately	I
60,000	I
)	I
of	I
IL-1	I
receptor	I
(	I
type	I
II	I
receptor	I
)	I
.	O

The	O
mature	O
type	B
II	I
IL-1	I
receptor	I
consists	O
of	O
(	O
i	O
)	O
a	O
ligand	O
binding	O
portion	O
comprised	O
of	O
three	O
immunoglobulin	O
-	O
like	O
domains	O
;	O
(	O
ii	O
)	O
a	O
single	O
transmembrane	O
region	O
;	O
and	O
(	O
iii	O
)	O
a	O
short	O
cytoplasmic	O
domain	O
of	O
29	O
amino	O
acids	O
.	O

This	O
last	O
contrasts	O
with	O
the	O
approximately	O
215	O
amino	O
acid	O
cytoplasmic	O
domain	O
of	O
the	O
type	O
I	O
receptor	O
,	O
and	O
suggests	O
that	O
the	O
two	O
IL-1	B
receptors	O
may	O
interact	O
with	O
different	O
signal	O
transduction	O
pathways	O
.	O

The	O
type	O
II	O
receptor	O
is	O
expressed	O
in	O
a	O
number	O
of	O
different	O
tissues	O
,	O
including	O
both	O
B	O
and	O
T	O
lymphocytes	O
,	O
and	O
can	O
be	O
induced	O
in	O
several	O
cell	O
types	O
by	O
treatment	O
with	O
phorbol	O
ester	O
.	O

Both	O
IL-1	B
receptors	O
appear	O
to	O
be	O
well	O
conserved	O
in	O
evolution	O
,	O
and	O
map	O
to	O
the	O
same	O
chromosomal	O
location	O
.	O

Like	O
the	O
type	O
I	O
receptor	O
,	O
the	O
human	O
type	B
II	I
IL-1	I
receptor	I
can	O
bind	O
all	O
three	O
forms	O
of	O
IL-1	B
(	O
IL-1	B
alpha	I
,	O
IL-1	B
beta	I
and	O
IL-1ra	B
)	O
.	O

Vaccinia	O
virus	O
contains	O
an	O
open	O
reading	O
frame	O
bearing	O
strong	O
resemblance	O
to	O
the	O
type	B
II	I
IL-1	I
receptor	I
.	O

A	O
1.1-Mb	O
transcript	O
map	O
of	O
the	O
hereditary	O
hemochromatosis	O
locus	O
.	O

In	O
the	O
process	O
of	O
positionally	O
cloning	O
a	O
candidate	O
gene	O
responsible	O
for	O
hereditary	O
hemochromatosis	O
(	O
HH	O
)	O
,	O
we	O
constructed	O
a	O
1.1-Mb	O
transcript	O
map	O
of	O
the	O
region	O
of	O
human	O
chromosome	O
6p	O
that	O
lies	O
4.5	O
Mb	O
telomeric	O
to	O
HLA	B
-	I
A.	I
A	O
combination	O
of	O
three	O
gene	O
-	O
finding	O
techniques	O
,	O
direct	O
cDNA	O
selection	O
,	O
exon	O
trapping	O
,	O
and	O
sample	O
sequencing	O
,	O
were	O
used	O
initially	O
for	O
a	O
saturation	O
screening	O
of	O
the	O
1.1-Mb	O
region	O
for	O
expressed	O
sequence	O
fragments	O
.	O

As	O
genetic	O
analysis	O
further	O
narrowed	O
the	O
HH	O
candidate	O
locus	O
,	O
we	O
sequenced	O
completely	O
0.25	O
Mb	O
of	O
genomic	O
DNA	O
as	O
a	O
final	O
measure	O
to	O
identify	O
all	O
genes	O
.	O

Besides	O
the	O
novel	O
MHC	O
class	O
1-like	O
HH	O
candidate	O
gene	O
HLA	B
-	I
H	I
,	O
we	O
identified	O
a	O
family	O
of	O
five	O
butyrophilin	O
-	O
related	O
sequences	O
,	O
two	O
genes	O
with	O
structural	O
similarity	O
to	O
a	O
type	O
1	O
sodium	O
phosphate	O
transporter	O
,	O
12	O
novel	O
histone	O
genes	O
,	O
and	O
a	O
gene	O
we	O
named	O
RoRet	B
based	O
on	O
its	O
strong	O
similarity	O
to	O
the	O
52-kD	O
Ro	O
/	O
SSA	B
lupus	O
and	O
Sjogren	O
's	O
syndrome	O
auto	O
-	O
antigen	O
and	O
the	O
RET	B
finger	I
protein	I
.	O

Several	O
members	O
of	O
the	O
butyrophilin	O
family	O
and	O
the	O
RoRet	B
gene	O
share	O
an	O
exon	O
of	O
common	O
evolutionary	O
origin	O
called	O
B30	O
-	O
2	O
.	O

The	O
B30	O
-	O
2	O
exon	O
was	O
originally	O
isolated	O
from	O
the	O
HLA	O
class	O
1	O
region	O
,	O
yet	O
has	O
apparently	O
""""	O
shuffled	O
""""	O
into	O
several	O
genes	O
along	O
the	O
chromosome	O
telomeric	O
to	O
the	O
MHC	O
.	O

The	O
conservation	O
of	O
the	O
B30	O
-	O
2	O
exon	O
in	O
several	O
novel	O
genes	O
and	O
the	O
previously	O
described	O
amino	O
acid	O
homology	O
of	O
HLA	B
-	I
H	I
to	O
MHC	O
class	O
1	O
molecules	O
provide	O
further	O
support	O
that	O
this	O
gene	O
-	O
rich	O
region	O
of	O
6p21.3	O
is	O
related	O
to	O
the	O
MHC	O
.	O

Finally	O
,	O
we	O
performed	O
an	O
analysis	O
of	O
the	O
four	O
approaches	O
for	O
gene	O
finding	O
and	O
conclude	O
that	O
direct	O
selection	O
provides	O
the	O
most	O
effective	O
probes	O
for	O
cDNA	O
screening	O
,	O
and	O
that	O
as	O
much	O
as	O
30	O
%	O
of	O
ESTs	O
in	O
this	O
1.1-Mb	O
region	O
may	O
be	O
derived	O
from	O
noncoding	O
genomic	O
DNA	O
.	O

Mutations	O
in	O
PROP1	B
cause	O
familial	O
combined	O
pituitary	O
hormone	O
deficiency	O
.	O

Combined	O
pituitary	O
hormone	O
deficiency	O
(	O
CPHD	O
)	O
in	O
man	O
denotes	O
impaired	O
production	O
of	O
growth	B
hormone	I
(	O
GH	B
)	O
and	O
one	O
or	O
more	O
of	O
the	O
other	O
five	O
anterior	O
pituitary	O
hormones	O
.	O

Mutations	O
of	O
the	O
pituitary	O
transcription	O
factor	O
gene	O
POU1F1	B
(	O
the	O
human	B
homologue	I
of	I
mouse	I
Pit1	I
)	O
are	O
responsible	O
for	O
deficiencies	O
of	O
GH	B
,	O
prolactin	B
and	O
thyroid	O
stimulating	O
hormone	O
(	O
TSH	O
)	O
in	O
Snell	O
and	O
Jackson	O
dwarf	O
mice	O
and	O
in	O
man	O
,	O
while	O
the	O
production	O
of	O
adrenocorticotrophic	O
hormone	O
(	O
ACTH	O
)	O
,	O
luteinizing	O
hormone	O
(	O
LH	O
)	O
and	O
follicle	O
stimulating	O
hormone	O
(	O
FSH	O
)	O
is	O
preserved	O
.	O

The	O
Ames	O
dwarf	O
(	O
df	O
)	O
mouse	O
displays	O
a	O
similar	O
phenotype	O
,	O
and	O
appears	O
to	O
be	O
epistatic	O
to	O
Snell	O
and	O
Jackson	O
dwarfism	O
.	O

We	O
have	O
recently	O
positionally	O
cloned	O
the	O
putative	O
Ames	O
dwarf	O
gene	O
Prop1	B
,	O
which	O
encodes	O
a	O
paired	O
-	O
like	O
homeodomain	O
protein	O
that	O
is	O
expressed	O
specifically	O
in	O
embryonic	O
pituitary	O
and	O
is	O
necessary	O
for	O
Pit1	B
expression	O
.	O

In	O
this	O
report	O
,	O
we	O
have	O
identified	O
four	O
CPHD	O
families	O
with	O
homozygosity	O
or	O
compound	O
heterozygosity	O
for	O
inactivating	O
mutations	O
of	O
PROP1	B
.	O

These	O
mutations	O
in	O
the	O
human	O
PROP1	B
gene	O
result	O
in	O
a	O
gene	O
product	O
with	O
reduced	O
DNA	O
-	O
binding	O
and	O
transcriptional	O
activation	O
ability	O
in	O
comparison	O
to	O
the	O
product	O
of	O
the	O
murine	O
df	O
mutation	O
.	O

In	O
contrast	O
to	O
individuals	O
with	O
POU1F1	B
mutations	O
,	O
those	O
with	O
PROP1	B
mutations	O
can	O
not	O
produce	O
LH	O
and	O
FSH	O
at	O
a	O
sufficient	O
level	O
and	O
do	O
not	O
enter	O
puberty	O
spontaneously	O
.	O

Our	O
results	O
identify	O
a	O
major	O
cause	O
of	O
CPHD	O
in	O
humans	O
and	O
suggest	O
a	O
direct	O
or	O
indirect	O
role	O
for	O
PROP1	B
in	O
the	O
ontogenesis	O
of	O
pituitary	O
gonadotropes	O
,	O
as	O
well	O
as	O
somatotropes	O
,	O
lactotropes	O
and	O
caudomedial	O
thyrotropes	O
.	O

Discovery	O
of	O
three	O
novel	O
G	O
-	O
protein	O
-	O
coupled	O
receptor	O
genes	O
.	O

We	O
report	O
here	O
the	O
molecular	O
cloning	O
,	O
tissue	O
distribution	O
,	O
and	O
chromosomal	O
localization	O
of	O
novel	O
genes	O
encoding	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
(	O
GPCRs	O
)	O
.	O

A	O
search	O
of	O
a	O
mouse	O
database	O
of	O
expressed	O
sequence	O
tags	O
revealed	O
an	O
EST	O
partially	O
encoding	O
a	O
GPCR	O
,	O
which	O
was	O
used	O
to	O
screen	O
a	O
mouse	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
.	O

The	O
resultant	O
clone	O
,	O
GPR27	B
,	O
contained	O
an	O
intronless	O
ORF	O
,	O
encoding	O
a	O
receptor	O
of	O
379	O
amino	O
acids	O
.	O

In	O
an	O
alternate	O
strategy	O
,	O
human	O
genomic	O
DNA	O
was	O
subjected	O
to	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
,	O
using	O
degenerate	O
oligonucleotides	O
based	O
on	O
GPR1	B
.	O

Two	O
PCR	O
products	O
partially	O
encoding	O
GPCRs	O
were	O
isolated	O
and	O
used	O
to	O
screen	O
a	O
genomic	O
library	O
to	O
obtain	O
the	O
translational	O
ORF	O
.	O

One	O
of	O
the	O
resultant	O
clones	O
,	O
GPR30	B
,	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
375	O
amino	O
acids	O
.	O

The	O
other	O
clone	O
,	O
GPR35	B
,	O
also	O
contained	O
an	O
intronless	O
ORF	O
encoding	O
a	O
receptor	O
of	O
309	O
amino	O
acids	O
.	O

Transcripts	O
corresponding	O
to	O
GPR27	B
and	O
GPR30	B
were	O
detected	O
in	O
several	O
areas	O
of	O
human	O
and	O
rat	O
CNS	O
,	O
While	O
GPR35	B
expression	O
was	O
detected	O
only	O
in	O
the	O
rat	O
intestine	O
.	O

Through	O
fluorescence	O
in	O
situ	O
hybridization	O
analysis	O
the	O
gene	O
encoding	O
GPR30	B
was	O
localized	O
to	O
chromosome	O
7p22	O
and	O
GPR35	B
to	O
chromosome	O
2q37.3	O
.	O

New	O
eukaryotic	O
semaphorins	O
with	O
close	O
homology	O
to	O
semaphorins	O
of	O
DNA	O
viruses	O
.	O

Semaphorins	O
were	O
initially	O
described	O
as	O
a	O
family	O
of	O
repulsive	O
guidance	O
molecules	O
in	O
embryonal	O
development	O
.	O

Their	O
basic	O
structure	O
consists	O
of	O
an	O
N	O
-	O
terminal	O
signal	O
sequence	O
,	O
the	O
defining	O
semaphorin	O
domain	O
ofapproximately	O
500	O
amino	O
acids	O
,	O
an	O
Ig	O
-	O
like	O
domain	O
,	O
and	O
a	O
variable	O
carboxy	O
-	O
terminus	O
.	O

We	O
recently	O
described	O
a	O
viral	O
semaphorin	O
homologue	O
encoded	O
by	O
the	O
alcelaphine	O
herpesvirus	O
type	O
1	O
.	O

Less	O
conserved	O
,	O
truncated	O
homologues	O
were	O
also	O
identified	O
in	O
poxviruses	O
.	O

Here	O
we	O
describe	O
new	O
human	O
and	O
murine	O
semaphorin	O
homologues	O
.	O

The	O
respective	O
genes	O
were	O
cloned	O
and	O
sequenced	O
,	O
and	O
they	O
were	O
termed	O
H	B
-	I
Sema	I
-	I
L	I
and	O
M	O
-	O
Sema	O
-	O
L	O
(	O
HGMW	O
-	O
approved	O
symbols	O
SEMAL	B
and	O
Semal	B
,	O
respectively	O
)	O
.	O

A	O
multiply	O
spliced	O
mRNA	O
of	O
3.2	O
kb	O
is	O
expressed	O
in	O
human	O
placenta	O
,	O
spleen	O
,	O
thymus	O
,	O
and	O
gonadal	O
tissue	O
.	O

H	B
-	I
Sema	I
-	I
L	I
maps	O
to	O
chromosome	O
15q22.3-q23	O
and	O
M	O
-	O
Sema	O
-	O
L	O
to	O
the	O
homologous	O
locus	O
9A3.3-B	O
in	O
the	O
mouse	O
genome	O
.	O

The	O
expression	O
patterns	O
and	O
the	O
presence	O
of	O
related	O
genes	O
in	O
large	O
DNA	O
viruses	O
suggest	O
that	O
this	O
new	O
semaphorin	O
has	O
a	O
relevant	O
function	O
in	O
the	O
immune	O
system	O
.	O

We	O
describe	O
an	O
experimental	O
approach	O
to	O
the	O
use	O
of	O
genetics	O
to	O
study	O
muscle	O
contraction	O
in	O
Drosophila	O
melanogaster	O
.	O

Mutations	O
induced	O
by	O
in	O
vitro	O
mutagenesis	O
are	O
inserted	O
into	O
the	O
genome	O
of	O
flies	O
using	O
P	B
-	I
element	I
mediated	O
transformation	O
,	O
permitting	O
the	O
effects	O
of	O
the	O
mutant	O
genes	O
to	O
be	O
studied	O
in	O
vivo	O
in	O
the	O
indirect	O
flight	O
muscles	O
(	O
IFMs	O
)	O
.	O

Details	O
of	O
how	O
mechanical	O
experiments	O
can	O
be	O
performed	O
on	O
skinned	O
IFMs	O
,	O
despite	O
their	O
small	O
size	O
,	O
are	O
provided	O
.	O

The	O
effects	O
of	O
two	O
in	O
vitro	O
actin	B
mutations	O
,	O
G368E	O
and	O
E316	O
K	O
,	O
are	O
described	O
.	O

The	O
problems	O
of	O
performing	O
biochemical	O
and	O
biophysical	O
experiments	O
on	O
the	O
IFMs	O
and	O
their	O
myofibrillar	O
proteins	O
are	O
described	O
,	O
together	O
with	O
indications	O
as	O
to	O
how	O
these	O
may	O
be	O
overcome	O
.	O

The	O
genetic	O
structure	O
of	O
a	O
segregation	B
distorter	I
chromosome	O
(	O
a	O
derivative	O
of	O
SD-36	B
)	O
has	O
been	O
analyzed	O
in	O
a	O
system	O
in	O
which	O
recombination	O
in	O
the	O
second	O
chromosome	O
is	O
blocked	O
by	O
inversions	O
except	O
for	O
the	O
critical	O
region	O
around	O
the	O
centromeric	O
heterochromatin	O
.	O

The	O
results	O
confirm	O
the	O
map	O
order	O
and	O
characteristics	O
of	O
four	O
loci	O
known	O
to	O
be	O
involved	O
in	O
segregation	O
distortion	O
,	O
namely	O
Sd	B
,	O
E	B
(	I
SD	I
)	I
,	O
Rspins	O
,	O
M	B
(	I
SD	I
)	I
.	O

However	O
,	O
SD-36	B
carries	O
a	O
fifth	O
major	O
locus	O
involved	O
in	O
distortion	O
.	O

This	O
locus	O
is	O
near	O
pr	O
in	O
2L	O
and	O
has	O
the	O
effect	O
of	O
enhancing	O
the	O
degree	O
of	O
distortion	O
.	O

In	O
addition	O
,	O
reciprocal	O
recombinant	O
products	O
from	O
SD-36	B
are	O
recovered	O
unequally	O
.	O

All	O
recombinants	O
carrying	O
the	O
pr	O
region	O
from	O
SD-36	B
seem	O
also	O
to	O
carry	O
Sd	B
,	O
although	O
Sd	B
has	O
previously	O
been	O
mapped	O
1.6	O
units	O
to	O
the	O
left	O
of	O
pr	O
.	O

Both	O
the	O
enhancement	O
of	O
distortion	O
and	O
the	O
unequal	O
recovery	O
of	O
reciprocal	O
products	O
can	O
be	O
explained	O
if	O
it	O
is	O
assumed	O
that	O
the	O
new	O
locus	O
near	O
pr	O
in	O
SD-36	B
is	O
actually	O
a	O
duplication	O
of	O
Sd	B
.	O

Cellularization	O
of	O
the	O
Drosophila	O
embryo	O
requires	O
the	O
establishment	O
of	O
a	O
hexagonal	O
network	O
of	O
actin	O
and	O
myosin	O
filaments	O
that	O
are	O
interconnected	O
around	O
the	O
nuclei	O
in	O
the	O
cortex	O
of	O
the	O
syncytial	O
blastoderm	O
.	O

This	O
cytoskeletal	O
network	O
provides	O
the	O
framework	O
and	O
possibly	O
the	O
contractile	O
force	O
for	O
the	O
membrane	O
invaginations	O
that	O
synchronously	O
subdivide	O
the	O
syncytial	O
embryo	O
into	O
individual	O
cells	O
.	O

Zygotic	O
expression	O
of	O
the	O
nullo	B
locus	O
is	O
essential	O
for	O
the	O
preservation	O
of	O
an	O
intact	O
actin	O
-	O
myosin	O
network	O
.	O

Embryos	O
deleted	O
for	O
the	O
nullo	B
locus	O
have	O
a	O
disrupted	O
network	O
,	O
resulting	O
in	O
the	O
formation	O
of	O
many	O
multinucleate	O
cells	O
.	O

We	O
show	O
that	O
nullo	B
is	O
not	O
required	O
for	O
the	O
initial	O
formation	O
of	O
the	O
actin	O
-	O
myosin	O
network	O
,	O
but	O
is	O
necessary	O
for	O
the	O
maintenance	O
of	O
its	O
hexagonal	O
shape	O
during	O
cellularization	O
.	O

The	O
phenotype	O
of	O
embryonic	O
mosaics	O
is	O
nonautonomous	O
,	O
indicating	O
that	O
nullo	B
does	O
not	O
have	O
to	O
be	O
expressed	O
in	O
every	O
nucleus	O
for	O
proper	O
cellularization	O
.	O

Examination	O
of	O
nullo	B
mutant	O
clones	O
in	O
adults	O
reveals	O
that	O
nullo	B
activity	O
is	O
not	O
required	O
for	O
cell	O
division	O
in	O
imaginal	O
discs	O
.	O

Furthermore	O
,	O
germline	O
clone	O
experiments	O
suggest	O
that	O
maternal	O
expression	O
of	O
the	O
nullo	B
locus	O
is	O
not	O
essential	O
for	O
either	O
germline	O
proliferation	O
or	O
the	O
cellularization	O
of	O
progeny	O
.	O

We	O
propose	O
a	O
model	O
in	O
which	O
nullo	B
functions	O
specifically	O
at	O
cellularization	O
to	O
stabilize	O
the	O
actin	O
-	O
myosin	O
network	O
during	O
contraction	O
.	O

The	O
nucleotide	O
sequence	O
of	O
a	O
segment	O
of	O
the	O
mtDNA	B
molecule	O
of	O
Drosophila	O
yakuba	O
has	O
been	O
determined	O
,	O
within	O
which	O
have	O
been	O
identified	O
the	O
3	O
'	O
end	O
of	O
the	O
large	O
rRNA	O
gene	O
and	O
the	O
entire	O
genes	O
for	O
tRNAleuCUN	O
,	O
URF1	O
,	O
tRNAserUCN	O
,	O
cytochrome	O
b	O
,	O
URF6	O
,	O
tRNApro	O
,	O
tRNAthr	O
,	O
URF4L	O
,	O
URF4	O
,	O
tRNAhis	O
and	O
URF5	O
.	O

The	O
genes	O
are	O
arranged	O
in	O
the	O
order	O
given	O
,	O
with	O
the	O
large	O
rRNA	O
gene	O
being	O
closest	O
to	O
the	O
A+T	O
-	O
rich	O
region	O
which	O
contains	O
the	O
origin	O
of	O
replication	O
.	O

Transcription	O
of	O
all	O
of	O
these	O
genes	O
except	O
those	O
for	O
cytochrome	O
b	O
,	O
URF6	O
,	O
tRNAserUCN	O
and	O
tRNAthr	O
proceeds	O
in	O
the	O
same	O
direction	O
as	O
replication	O
.	O

Differences	O
occur	O
in	O
the	O
relative	O
arrangement	O
and	O
in	O
the	O
direction	O
of	O
transcription	O
of	O
these	O
twelve	O
genes	O
between	O
D.	O
yakuba	O
and	O
mammalian	O
mtDNA	B
molecules	O
.	O

Internal	O
AGA	O
codons	O
occur	O
in	O
all	O
of	O
the	O
polypeptide	O
genes	O
except	O
URF6	O
.	O

Comparisons	O
of	O
the	O
positions	O
of	O
these	O
AGA	O
codons	O
to	O
codons	O
in	O
corresponding	O
mouse	O
genes	O
is	O
consistent	O
with	O
the	O
view	O
that	O
in	O
the	O
D.	O
yakuba	O
mitochondrial	O
genetic	O
code	O
AGA	O
specifies	O
serine	O
.	O

Genes	O
equivalent	O
to	O
all	O
of	O
the	O
polypeptide	O
,	O
tRNA	O
and	O
rRNA	O
genes	O
found	O
in	O
mammalian	O
mtDNA	B
have	O
now	O
been	O
identified	O
in	O
D.	O
yakuba	O
mtDNA	B
.	O

Arthropods	B
exhibit	O
great	O
diversity	O
in	O
the	O
position	O
,	O
number	O
,	O
morphology	O
,	O
and	O
function	O
of	O
their	O
limbs	O
.	O

The	O
evolutionary	O
relations	O
among	O
limb	O
types	O
and	O
among	O
the	O
arthropod	O
groups	O
that	O
bear	O
them	O
(	O
insects	O
,	O
crustaceans	O
,	O
myriapods	O
,	O
and	O
chelicerates	O
)	O
are	O
controversial	O
.	O

Here	O
,	O
the	O
use	O
of	O
molecular	O
probes	O
,	O
including	O
an	O
antibody	O
to	O
proteins	O
encoded	O
by	O
arthropod	O
and	O
vertebrate	O
Distal	B
-	I
less	I
(	O
Dll	B
and	O
Dlx	O
)	O
genes	O
,	O
provided	O
evidence	O
that	O
common	O
genetic	O
mechanisms	O
underlie	O
the	O
development	O
of	O
all	O
arthropod	O
limbs	O
and	O
their	O
branches	O
and	O
that	O
all	O
arthropods	O
derive	O
from	O
a	O
common	O
ancestor	O
.	O

However	O
,	O
differences	O
between	O
crustacean	O
and	O
insect	O
body	O
plans	O
were	O
found	O
to	O
correlate	O
with	O
differences	O
in	O
the	O
deployment	O
of	O
particular	O
homeotic	O
genes	O
and	O
in	O
the	O
ways	O
that	O
these	O
genes	O
regulate	O
limb	O
development	O
.	O

Dorsal	B
-	O
ventral	O
patterning	O
within	O
the	O
ectoderm	O
of	O
the	O
Drosophila	O
embryo	O
requires	O
seven	O
zygotic	O
genes	O
,	O
including	O
short	B
gastrulation	I
(	O
sog	B
)	O
.	O

Here	O
we	O
demonstrate	O
that	O
sog	B
,	O
which	O
is	O
expressed	O
in	O
the	O
ventrolateral	O
region	O
of	O
the	O
embryo	O
that	O
gives	O
rise	O
to	O
the	O
nerve	O
cord	O
,	O
is	O
functionally	O
homologous	O
to	O
the	O
chordin	B
gene	O
of	O
Xenopus	O
,	O
which	O
is	O
expressed	O
in	O
the	O
dorsal	B
blastopore	O
lip	O
of	O
the	O
embryo	O
and	O
in	O
dorsal	B
mesoderm	O
,	O
in	O
particular	O
the	O
notochord	O
.	O

We	O
show	O
by	O
injections	O
of	O
messenger	O
RNA	O
that	O
both	O
sog	B
and	O
chordin	B
can	O
promote	O
ventral	O
development	O
in	O
Drosophila	O
,	O
and	O
that	O
sog	B
,	O
like	O
chordin	B
,	O
can	O
promote	O
dorsal	B
development	O
in	O
Xenopus	O
.	O

In	O
Drosophila	O
,	O
sog	B
antagonizes	O
the	O
dorsalizing	O
effects	O
of	O
decapentaplegic	B
(	O
dpp	B
)	O
,	O
a	O
member	O
of	O
the	O
transforming	O
growth	O
factor	O
-	O
beta	O
family	O
.	O

One	O
of	O
the	O
dpp	B
homologues	O
in	O
vertebrates	O
,	O
bmp-4	O
,	O
is	O
expressed	O
ventrally	O
in	O
Xenopus	O
and	O
promotes	O
ventral	O
development	O
.	O

We	O
show	O
that	O
dpp	B
can	O
promote	O
ventral	O
fates	O
in	O
Xenopus	O
,	O
and	O
that	O
injection	O
of	O
sog	B
mRNA	O
counteracts	O
the	O
ventralizing	O
effects	O
of	O
dpp	B
.	O

These	O
results	O
suggest	O
the	O
molecular	O
conservation	O
of	O
dorsoventral	O
patterning	O
mechanisms	O
during	O
evolution	O
.	O

The	O
three	O
yolk	O
proteins	O
(	O
YP1	B
,	O
YP2	B
and	O
YP3	B
)	O
of	O
Drosophila	O
melanogaster	O
are	O
synthesized	O
in	O
two	O
tissues	O
of	O
the	O
adult	O
female	O
,	O
the	O
fat	O
body	O
and	O
ovarian	O
follicle	O
cells	O
.	O

The	O
YPs	O
are	O
selectively	O
accumulated	O
in	O
the	O
oocyte	O
to	O
provide	O
nutrients	O
for	O
embryogenesis	O
.	O

We	O
describe	O
a	O
female	O
-	O
sterile	O
mutant	O
,	O
fs	O
(	O
1	O
)	O
A1526	O
,	O
which	O
lacks	O
YP3	B
in	O
the	O
haemolymph	O
.	O

The	O
female	O
sterility	O
mutation	O
mapped	O
some	O
distance	O
away	O
from	O
the	O
yp3	B
gene	O
on	O
the	O
X	B
chromosome	O
and	O
we	O
were	O
able	O
to	O
separate	O
the	O
YP3	B
defect	O
from	O
the	O
female	O
sterility	O
by	O
recombination	O
,	O
thus	O
producing	O
a	O
fertile	O
line	O
of	O
flies	O
having	O
no	O
YP3	B
in	O
the	O
eggs	O
.	O

This	O
shows	O
that	O
YP3	B
is	O
not	O
essential	O
for	O
embryogenesis	O
.	O

The	O
mutant	O
line	O
is	O
to	O
be	O
known	O
as	O
YP3s1	O
.	O

Investigation	O
of	O
yp3	B
transcription	O
in	O
the	O
mutant	O
females	O
revealed	O
that	O
the	O
gene	O
is	O
transcribed	O
but	O
yp3s1	O
mRNA	O
levels	O
are	O
reduced	O
relative	O
to	O
wild	O
type	O
.	O

Transcription	O
of	O
the	O
mutant	O
yp3	B
gene	O
can	O
be	O
induced	O
in	O
males	O
by	O
ecdysone	O
.	O

Investigation	O
of	O
the	O
yolk	O
proteins	O
in	O
YP3s1	O
females	O
suggested	O
that	O
the	O
YP3s1	O
polypeptide	O
is	O
synthesized	O
in	O
the	O
fat	O
body	O
but	O
not	O
secreted	O
.	O

The	O
mutant	O
YP3	B
protein	O
shows	O
an	O
increase	O
in	O
apparent	O
molecular	O
weight	O
of	O
approximately	O
1	O
kDa	O
.	O

The	O
mutant	O
yp3	B
gene	O
was	O
cloned	O
and	O
the	O
DNA	O
sequence	O
determined	O
.	O

The	O
sequence	O
differences	O
between	O
the	O
mutant	O
and	O
wild	O
-	O
type	O
genes	O
include	O
an	O
amino	O
acid	O
substitution	O
in	O
the	O
leader	O
sequence	O
.	O

We	O
suggest	O
that	O
this	O
may	O
be	O
responsible	O
for	O
the	O
failure	O
of	O
YP3	B
secretion	O
in	O
the	O
mutant	O
YP3s1	O
,	O
and	O
speculate	O
on	O
the	O
cause	O
of	O
the	O
reduction	O
seen	O
in	O
the	O
steady	O
-	O
state	O
level	O
of	O
yp3	B
mRNA	O
.	O

We	O
have	O
examined	O
the	O
RNA	O
expression	O
pattern	O
for	O
the	O
Drosophila	O
calmodulin	B
gene	O
during	O
embryogenesis	O
by	O
in	O
situ	O
hybridization	O
to	O
transcripts	O
in	O
whole	O
embryos	O
.	O

Our	O
results	O
indicate	O
that	O
maternally	O
derived	O
calmodulin	B
mRNA	O
is	O
homogeneously	O
distributed	O
throughout	O
the	O
early	O
embryo	O
,	O
but	O
that	O
these	O
maternal	O
transcripts	O
are	O
lost	O
by	O
maximal	O
germ	O
band	O
extension	O
.	O

Zygotic	O
transcription	O
of	O
the	O
gene	O
in	O
mid-	O
to	O
late	O
-	O
stage	O
embryos	O
is	O
restricted	O
to	O
neural	O
cell	O
precursors	O
and	O
their	O
progeny	O
in	O
both	O
the	O
central	O
and	O
peripheral	O
nervous	O
systems	O
.	O

Thus	O
,	O
activation	O
of	O
calmodulin	B
transcription	O
during	O
embryonic	O
development	O
appears	O
to	O
mark	O
a	O
commitment	O
to	O
a	O
neural	O
fate	O
.	O

Northern	O
blot	O
analysis	O
revealed	O
that	O
the	O
two	O
transcripts	O
from	O
the	O
calmodulin	B
gene	O
are	O
differentially	O
expressed	O
during	O
embryogenesis	O
.	O

Comparison	O
of	O
Northern	O
blot	O
and	O
in	O
situ	O
hybridization	O
data	O
indicates	O
that	O
the	O
longer	O
calmodulin	B
mRNA	O
is	O
a	O
nervous	O
tissue	O
-	O
specific	O
transcript	O
.	O

This	O
suggests	O
that	O
neural	O
-	O
specific	O
regulation	O
of	O
polyadenylation	O
site	O
usage	O
occurs	O
.	O

We	O
have	O
also	O
examined	O
calmodulin	B
expression	O
in	O
embryos	O
homozygous	O
for	O
mutations	O
in	O
four	O
loci	O
which	O
are	O
known	O
to	O
affect	O
nervous	O
system	O
development	O
:	O
numb	B
,	O
the	O
achaete	B
-	I
scute	I
complex	I
,	O
daughterless	B
,	O
and	O
mastermind	B
.	O

The	O
calmodulin	B
transcription	O
pattern	O
is	O
altered	O
in	O
embryos	O
mutant	O
for	O
each	O
of	O
these	O
loci	O
,	O
suggesting	O
that	O
regulation	O
by	O
these	O
genes	O
,	O
either	O
directly	O
or	O
indirectly	O
,	O
is	O
taking	O
place	O
.	O

A	B
goal	O
of	O
modern	O
biology	O
is	O
to	O
identify	O
the	O
physical	O
interactions	O
that	O
define	O
'	O
functional	O
modules	O
'	O
of	O
proteins	O
that	O
govern	O
biological	O
processes	O
.	O

One	O
essential	O
regulatory	O
process	O
is	O
the	O
maintenance	O
of	O
master	O
regulatory	O
genes	O
,	O
such	O
as	O
homeotic	O
genes	O
,	O
in	O
an	O
appropriate	O
'	O
on	O
'	O
or	O
'	O
off	O
'	O
state	O
for	O
the	O
lifetime	O
of	O
an	O
organism	O
.	O

The	O
Polycomb	B
group	O
(	O
PcG	O
)	O
of	O
genes	O
maintain	O
a	B
repressed	O
transcriptional	O
state	O
,	O
and	O
PcG	O
proteins	O
form	O
large	O
multiprotein	O
complexes	O
,	O
but	O
these	O
complexes	O
have	O
not	O
been	O
described	O
owing	O
to	O
inherent	O
difficulties	O
in	O
purification	O
.	O

We	O
previously	O
fractionated	O
a	B
major	O
PcG	O
complex	O
,	O
PRC1	O
,	O
to	O
20	O
-	O
50	O
%	O
homogeneity	O
from	O
Drosophila	O
embryos	O
.	O

Here	O
,	O
we	O
identify	O
30	O
proteins	O
in	O
these	O
preparations	O
,	O
then	O
further	O
fractionate	O
the	O
preparation	O
and	O
use	O
western	O
analyses	O
to	O
validate	O
unanticipated	O
connections	O
.	O

We	O
show	O
that	O
the	O
known	O
PcG	O
proteins	O
Polycomb	B
,	O
Posterior	B
sex	I
combs	I
,	O
Polyhomeotic	B
and	O
dRING1	B
exist	O
in	O
robust	O
association	O
with	O
the	O
sequence	O
-	O
specific	O
DNA	O
-	O
binding	O
factor	O
Zeste	B
and	O
with	O
numerous	O
TBP	B
(	O
TATA	O
-	O
binding	O
-	O
protein	O
)	O
-associated	O
factors	O
that	O
are	O
components	O
of	O
general	O
transcription	O
factor	O
TFIID	B
(	O
dTAFIIs	O
)	O
.	O

Thus	O
,	O
in	O
fly	O
embryos	O
,	O
there	O
is	O
a	B
direct	O
physical	O
connection	O
between	O
proteins	O
that	O
bind	O
to	O
specific	O
regulatory	O
sequences	O
,	O
PcG	O
proteins	O
,	O
and	O
proteins	O
of	O
the	O
general	O
transcription	O
machinery	O
.	O

We	O
have	O
developed	O
an	O
in	O
vitro	O
reaction	O
system	O
for	O
Drosophila	O
P	B
element	I
transposition	O
.	O

Transposition	O
products	O
were	O
recovered	O
by	O
selection	O
in	O
E.	O
coli	O
,	O
and	O
contained	O
simple	O
P	B
element	I
insertions	O
flanked	O
by	O
8	O
bp	O
target	O
site	O
duplications	O
as	O
observed	O
in	O
vivo	O
.	O

Transposition	O
required	O
Mg+2	O
and	O
partially	O
purified	O
P	B
element	I
transposase	I
.	O

Unlike	O
other	O
DNA	O
rearrangement	O
reactions	O
,	O
P	B
element	I
transposition	O
in	O
vitro	O
used	O
GTP	O
as	O
a	O
cofactor	O
;	O
deoxyGTP	O
,	O
dideoxyGTP	O
,	O
or	O
the	O
nonhydrolyzable	O
GTP	O
analogs	O
GMP	O
-	O
PNP	O
or	O
GMP	O
-	O
PCP	O
were	O
also	O
used	O
.	O

Transposon	O
DNA	O
molecules	O
cleaved	O
at	O
the	O
P	B
element	I
termini	O
were	O
able	O
to	O
transpose	O
,	O
but	O
those	O
lacking	O
3'-hydroxyl	O
groups	O
were	O
inactive	O
.	O

These	O
biochemical	O
data	O
are	O
consistent	O
with	O
genetic	O
data	O
suggesting	O
that	O
P	B
element	I
transposition	O
occurs	O
via	O
a	O
""""	O
cut	O
-	O
and	O
-	O
paste	O
""""	O
mechanism	O
.	O

The	O
extracellular	O
signal	O
-	O
regulated	O
kinases	O
(	O
ERKs	O
)	O
comprise	O
a	O
class	O
of	O
protein	O
-	O
serine	O
/	O
threonine	O
kinases	O
that	O
are	O
activated	O
in	O
response	O
to	O
a	O
wide	O
variety	O
of	O
extracellular	O
signals	O
transduced	O
via	O
receptor	O
tyrosine	O
kinases	O
.	O

Activation	O
of	O
the	O
ERKs	O
requires	O
both	O
threonine	O
and	O
tyrosine	O
phosphorylation	O
suggestive	O
of	O
a	O
key	O
role	O
in	O
mediating	O
intracellular	O
events	O
in	O
response	O
to	O
extracellular	O
cues	O
.	O

To	O
critically	O
assess	O
the	O
role	O
of	O
ERKs	O
in	O
intracellular	O
signaling	O
,	O
a	O
genetically	O
tractable	O
receptor	O
tyrosine	O
kinase	O
system	O
would	O
be	O
invaluable	O
.	O

In	O
this	O
paper	O
we	O
report	O
the	O
identification	O
of	O
a	O
Drosophila	O
homolog	O
of	O
ERK1	B
and	O
-2	O
,	O
designated	O
DmERK	B
-	I
A.	I
DmERK	B
-	I
A	I
is	O
80	O
%	O
identical	O
to	O
rat	O
ERK1	B
and	O
-2	O
and	O
is	O
rapidly	O
phosphorylated	O
on	O
tyrosine	O
in	O
response	O
to	O
an	O
extracellular	O
signal	O
activating	O
a	O
receptor	O
tyrosine	O
kinase	O
.	O

Biochemical	O
and	O
histological	O
studies	O
reveal	O
its	O
expression	O
in	O
the	O
eye	O
imaginal	O
disc	O
.	O

These	O
studies	O
provide	O
a	O
first	O
step	O
in	O
a	O
genetic	O
analysis	O
of	O
ERK	B
function	O
.	O

We	O
have	O
expressed	O
two	O
antifreeze	O
protein	O
genes	O
from	O
the	O
Atlantic	O
wolffish	O
,	O
Anarhichas	O
lupus	O
,	O
in	O
Drosophila	O
melanogaster	O
by	O
placing	O
them	O
under	O
the	O
divergent	O
transcriptional	O
control	O
of	O
the	O
host	O
yolk	O
polypeptide	O
(	O
1	O
and	O
2	O
)	O
gene	O
promoters	O
.	O

Both	O
genes	O
were	O
joined	O
to	O
the	O
central	O
promoter	O
region	O
by	O
fusion	O
within	O
the	O
DNA	O
encoding	O
the	O
signal	O
polypeptides	O
.	O

The	O
chimeric	O
genes	O
were	O
introduced	O
into	O
flightless	O
mutant	O
Drosophila	O
through	O
P	B
-	I
element	I
transformation	O
.	O

Transformed	O
adult	O
females	O
from	O
individual	O
lines	O
accumulated	O
1.5	O
-	O
5	O
mg	O
/	O
ml	O
of	O
antifreeze	O
protein	O
in	O
their	O
hemolymph	O
.	O

The	O
protein	O
was	O
purified	O
to	O
homogeneity	O
from	O
hemolymph	O
following	O
thermal	O
denaturation	O
,	O
step	O
elution	O
from	O
SP	O
-	O
Sephadex	O
,	O
and	O
reverse	O
-	O
phase	O
HPLC	O
.	O

It	O
was	O
recovered	O
in	O
high	O
yield	O
and	O
retained	O
full	O
biological	O
activity	O
even	O
though	O
one	O
of	O
the	O
two	O
gene	O
fusions	O
gave	O
rise	O
to	O
a	O
seven	O
amino	O
acid	O
N	O
-	O
terminal	O
extension	O
on	O
its	O
antifreeze	O
protein	O
product	O
.	O

cDNA	O
clones	O
encoding	O
the	O
BALB	O
/	O
c	O
murine	O
erythrocyte	O
band	O
7	O
integral	O
membrane	O
protein	O
(	O
also	O
termed	O
protein	B
7.2b	I
,	O
or	O
'	O
stomatin	B
'	O
)	O
were	O
isolated	O
by	O
the	O
screening	O
of	O
a	O
corresponding	O
bone	O
-	O
marrow	O
lambda	O
gt11	O
cDNA	O
library	O
with	O
a	O
human	O
cDNA	O
probe	O
,	O
and	O
by	O
5'-RACE	O
PCR	O
cloning	O
.	O

Comparison	O
of	O
the	O
murine	O
,	O
human	O
and	O
Caenorhabditis	O
elegans	O
protein	B
7.2b	I
amino	O
acid	O
(	O
aa	O
)	O
sequences	O
revealed	O
overall	O
identities	O
of	O
88	O
%	O
(	O
human	O
)	O
and	O
61	O
%	O
(	O
C.	O
elegans	O
)	O
,	O
with	O
the	O
N	O
-	O
terminal	O
domains	O
showing	O
only	O
little	O
similarity	O
.	O

The	O
7.2b	O
protein	O
sequences	O
of	O
the	O
two	O
mouse	O
strains	O
,	O
BALB	O
/	O
c	O
and	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
,	O
showed	O
six	O
rather	O
conservative	O
aa	O
substitutions	O
,	O
three	O
of	O
them	O
in	O
the	O
hydrophobic	O
domain	O
.	O

The	O
BALB	O
/	O
c	O
murine	O
mRNA	O
,	O
about	O
3.5	O
kb	O
in	O
size	O
,	O
is	O
widely	O
expressed	O
in	O
various	O
tissues	O
,	O
most	O
notably	O
in	O
spleen	O
,	O
lung	O
and	O
testis	O
.	O

Using	O
a	O
transgenic	O
mouse	O
derived	O
GnRH	B
expressing	O
neuronal	O
cell	O
line	O
,	O
GT1	O
-	O
3	O
,	O
we	O
studied	O
the	O
effects	O
of	O
activation	O
of	O
cAMP	O
,	O
Ca2	O
+	O
and	O
protein	O
kinase	O
C	O
pathways	O
by	O
forskolin	O
,	O
ionomycin	O
and	O
the	O
phorbol	O
ester	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
,	O
respectively	O
,	O
upon	O
gonadotropin	O
-	O
releasing	O
hormone	O
(	O
GnRH	B
)	O
secretion	O
,	O
cellular	O
peptide	O
content	O
,	O
mRNA	O
and	O
RNA	O
primary	O
transcript	O
levels	O
.	O

Forskolin	O
,	O
ionomycin	O
and	O
phorbol	O
ester	O
all	O
caused	O
an	O
increase	O
in	O
GnRH	B
secretion	O
in	O
GT1	O
-	O
3	O
cells	O
in	O
a	O
time	O
and	O
dose	O
-	O
dependent	O
manner	O
during	O
a	O
short	O
-	O
term	O
(	O
1	O
h	O
)	O
static	O
incubation	O
.	O

Prolonged	O
treatment	O
with	O
forskolin	O
(	O
10	O
microM	O
)	O
,	O
ionomycin	O
(	O
1	O
microM	O
)	O
and	O
PMA	O
(	O
10	O
nM	O
)	O
for	O
12	O
or	O
24	O
h	O
resulted	O
in	O
significant	O
decreases	O
in	O
GnRH	B
mRNA	O
levels	O
.	O

Time	O
-	O
course	O
studies	O
showed	O
that	O
the	O
increases	O
in	O
GnRH	B
secretion	O
stimulated	O
by	O
forskolin	O
,	O
ionomycin	O
and	O
PMA	O
were	O
gradually	O
attenuated	O
over	O
time	O
in	O
parallel	O
with	O
the	O
decreases	O
in	O
mRNA	O
expression	O
.	O

In	O
contrast	O
,	O
there	O
were	O
only	O
small	O
and	O
variable	O
changes	O
in	O
the	O
GnRH	B
cellular	O
content	O
.	O

Studies	O
using	O
a	O
GnRH	B
antagonist	O
(	O
100	O
microM	O
)	O
suggested	O
that	O
the	O
released	O
GnRH	B
has	O
a	O
negative	O
feedback	O
effect	O
on	O
its	O
own	O
secretion	O
.	O

However	O
,	O
co	O
-	O
incubation	O
with	O
the	O
GnRH	B
antagonist	O
did	O
not	O
alter	O
the	O
inhibitory	O
effects	O
on	O
GnRH	B
mRNA	O
levels	O
by	O
the	O
secretagogues	O
.	O

Further	O
studies	O
on	O
the	O
transcriptional	O
effects	O
of	O
forskolin	O
,	O
ionomycin	O
and	O
PMA	O
on	O
GnRH	B
gene	O
expression	O
in	O
GT1	O
-	O
3	O
cells	O
revealed	O
that	O
all	O
three	O
secretagogues	O
suppressed	O
GnRH	B
RNA	O
primary	O
transcript	O
levels	O
,	O
with	O
forskolin	O
having	O
a	O
slower	O
time	O
course	O
of	O
action	O
.	O

Thus	O
,	O
the	O
inhibition	O
of	O
cytoplasmic	O
GnRH	B
mRNA	O
,	O
and	O
presumably	O
its	O
synthesis	O
,	O
after	O
12	O
-	O
24	O
h	O
of	O
secretagogue	O
treatment	O
may	O
be	O
due	O
at	O
least	O
in	O
part	O
to	O
a	O
suppression	O
of	O
GnRH	B
gene	O
transcription.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	O
primary	O
structures	O
of	O
interferon	O
(	O
IFN	O
)	O
-induced	O
guanylate	O
-	O
binding	O
proteins	O
(	O
GBPs	O
)	O
were	O
deduced	O
from	O
cloned	O
human	O
and	O
murine	O
cDNAs	O
.	O

These	O
proteins	O
contained	O
only	O
two	O
of	O
the	O
three	O
sequence	O
motifs	O
typically	O
found	O
in	O
GTP	O
/	O
GDP	O
-	O
binding	O
proteins	O
.	O

The	O
N	O
(	O
T	O
)	O
KXD	O
motif	O
,	O
which	O
is	O
believed	O
to	O
confer	O
guanine	O
specificity	O
in	O
other	O
nucleotide	O
-	O
binding	O
proteins	O
,	O
was	O
absent	O
.	O

Nevertheless	O
,	O
the	O
IFN	O
-	O
induced	O
GBPs	O
exhibited	O
a	O
high	O
degree	O
of	O
selectivity	O
for	O
binding	O
to	O
agarose	O
-	O
immobilized	O
guanine	O
nucleotides	O
.	O

An	O
interesting	O
feature	O
of	O
IFN	O
-	O
induced	O
GBPs	O
is	O
that	O
they	O
strongly	O
bound	O
to	O
GMP	O
agarose	O
in	O
addition	O
to	O
GDP	O
and	O
GTP	O
agaroses	O
but	O
failed	O
to	O
bind	O
to	O
ATP	O
agarose	O
and	O
all	O
other	O
nucleotide	O
agaroses	O
tested	O
.	O

Both	O
GTP	O
and	O
GMP	O
,	O
but	O
not	O
ATP	O
,	O
competed	O
for	O
binding	O
of	O
murine	O
GBP-1	B
to	O
agarose	O
-	O
immobilized	O
GMP	O
.	O

The	O
IFN	O
-	O
induced	O
GBPs	O
thus	O
define	O
a	O
distinct	O
novel	O
family	O
of	O
proteins	O
with	O
GTP	O
-	O
binding	O
activity	O
.	O

We	O
further	O
demonstrate	O
that	O
human	O
and	O
murine	O
cells	O
contain	O
at	O
least	O
two	O
genes	O
encoding	O
IFN	O
-	O
induced	O
GBPs	O
.	O

The	O
cloned	O
murine	O
cDNA	O
codes	O
for	O
GBP-1	B
,	O
an	O
IFN	O
-	O
induced	O
protein	O
previously	O
shown	O
to	O
be	O
absent	O
from	O
mice	O
of	O
Gbp-1b	O
genotype	O
.	O

Dominant	B
megacolon	I
(	O
Dom	B
)	O
is	O
one	O
of	O
four	O
mutations	O
in	O
the	O
mouse	O
that	O
can	O
produce	O
a	O
phenotype	O
similar	O
to	O
Hirschsprung	O
disease	O
in	O
human	O
.	O

The	O
Dom	B
gene	O
product	O
is	O
not	O
known	O
,	O
and	O
no	O
candidate	O
region	O
has	O
been	O
defined	O
for	O
a	O
possible	O
human	O
homolog	O
.	O

In	O
this	O
publication	O
we	O
report	O
mapping	O
the	O
Dom	B
locus	O
with	O
high	O
definition	O
,	O
using	O
several	O
intra	O
-	O
and	O
interspecific	O
crosses	O
and	O
a	O
set	O
of	O
16	O
Chr	O
15-specific	O
microsatellites	O
flanking	O
this	O
locus	O
.	O

Zp1	B
encodes	O
one	O
of	O
the	O
three	O
major	O
glycoproteins	O
of	O
the	O
zona	O
pellucida	O
,	O
an	O
extracellular	O
matrix	O
that	O
surrounds	O
growing	O
oocytes	O
,	O
ovulated	O
eggs	O
,	O
and	O
preimplantation	O
embryos	O
.	O

The	O
mouse	O
gene	O
is	O
composed	O
of	O
12	O
exons	O
ranging	O
in	O
size	O
from	O
82	O
to	O
364	O
base	O
pairs	O
and	O
spans	O
6.5	O
kilobase	O
pairs	O
on	O
chromosome	O
19	O
(	O
2.13	O
+	O
/-	O

1.5	O
centimorgans	O
distal	O
to	O
D19Bir1	B
)	O
.	O

The	O
Zp1	B
exon	O
map	O
is	O
similar	O
to	O
ZPB	O
,	O
a	O
human	O
orthologue	O
,	O
and	O
an	O
E	O
-	O
box	O
(	O
CANNTG	O
)	O
,	O
implicated	O
in	O
oocyte	O
-	O
specific	O
gene	O
expression	O
of	O
mouse	O
Zp2	O
and	O
Zp3	O
,	O
is	O
similarly	O
located	O
upstream	O
of	O
the	O
transcription	O
start	O
site	O
.	O

The	O
single	O
copy	O
Zp1	B
gene	O
encodes	O
a	O
623-amino	O
acid	O
protein	O
,	O
the	O
carboxyl	O
-	O
terminal	O
half	O
of	O
which	O
is	O
significantly	O
similar	O
to	O
a	O
corresponding	O
region	O
of	O
mouse	O
ZP2	O
.	O

The	O
conservation	O
of	O
this	O
same	O
region	O
in	O
a	O
fish	O
egg	O
envelope	O
protein	O
suggests	O
that	O
not	O
only	O
has	O
this	O
protein	O
domain	O
been	O
duplicated	O
in	O
mammals	O
but	O
that	O
it	O
has	O
been	O
conserved	O
and	O
used	O
as	O
an	O
egg	O
envelope	O
protein	O
in	O
species	O
that	O
diverged	O
650	O
million	O
years	O
ago	O
.	O

Glycogen	O
storage	O
disease	O
type	O
1a	O
(	O
GSD-1a	O
)	O
,	O
characterized	O
by	O
hypoglycemia	O
,	O
liver	O
and	O
kidney	O
enlargement	O
,	O
growth	O
retardation	O
,	O
hyperlipidemia	O
,	O
and	O
hyperuricemia	O
,	O
is	O
caused	O
by	O
a	O
deficiency	O
in	O
glucose-6-phosphatase	O
(	O
G6Pase	B
)	O
,	O
a	O
key	O
enzyme	O
in	O
glucose	O
homeostasis	O
.	O

To	O
evaluate	O
the	O
feasibility	O
of	O
gene	O
replacement	O
therapy	O
for	O
GSD-1a	O
,	O
we	O
have	O
infused	O
adenoviral	O
vector	O
containing	O
the	O
murine	O
G6Pase	B
gene	O
(	O
Ad	O
-	O
mG6Pase	O
)	O
into	O
G6Pase	B
-	O
deficient	O
(	O
G6Pase	B
(	I
-	I
/	I
-	I
)	I
)	O
mice	O
that	O
manifest	O
symptoms	O
characteristic	O
of	O
human	O
GSD-1a	O
.	O

Whereas	O
<	O
15	O
%	O
of	O
G6Pase	B
(	I
-	I
/	I
-	I
)	I
mice	O
under	O
glucose	O
therapy	O
survived	O
weaning	O
,	O
a	O
100	O
%	O
survival	O
rate	O
was	O
achieved	O
when	O
G6Pase	B
(	I
-	I
/	I
-	I
)	I
mice	O
were	O
infused	O
with	O
Ad	O
-	O
mG6Pase	O
,	O
90	O
%	O
of	O
which	O
lived	O
to	O
3	O
months	O
of	O
age	O
.	O

Hepatic	O
G6Pase	B
activity	O
in	O
Ad	O
-	O
mG6Pase	O
-	O
infused	O
mice	O
was	O
restored	O
to	O
19	O
%	O
of	O
that	O
in	O
G6Pase	B
(	I
+	I
/	I
+	I
)	I
mice	O
at	O
7	O
-	O
14	O
days	O
post	O
-	O
infusion	O
;	O
the	O
activity	O
persisted	O
for	O
at	O
least	O
70	O
days	O
.	O

Ad	O
-	O
mG6Pase	O
infusion	O
also	O
greatly	O
improved	O
growth	O
of	O
G6Pase	B
(	I
-	I
/	I
-	I
)	I
mice	O
and	O
normalized	O
plasma	O
glucose	O
,	O
cholesterol	O
,	O
triglyceride	O
,	O
and	O
uric	O
acid	O
profiles	O
.	O

Furthermore	O
,	O
liver	O
and	O
kidney	O
enlargement	O
was	O
less	O
pronounced	O
with	O
near	O
-	O
normal	O
levels	O
of	O
glycogen	O
depositions	O
in	O
both	O
organs	O
.	O

Our	O
data	O
demonstrate	O
that	O
a	O
single	O
administration	O
of	O
a	O
recombinant	O
adenoviral	O
vector	O
can	O
alleviate	O
the	O
pathological	O
manifestations	O
of	O
GSD-1a	O
in	O
mice	O
,	O
suggesting	O
that	O
this	O
disorder	O
in	O
humans	O
can	O
potentially	O
be	O
corrected	O
by	O
gene	O
therapy	O
.	O

The	O
role	O
of	O
metallothionein	O
with	O
regard	O
to	O
cadmium	O
toxicity	O
in	O
vitro	O
was	O
investigated	O
using	O
preimplantation	O
mouse	O
blastocysts	O
derived	O
from	O
a	O
transgenic	O
strain	O
that	O
constitutively	O
overexpresses	O
metallothionein	O
-	O
I	O
transgenes	O
(	O
MT	B
-	I
I	I
*	O
)	O
.	O

Northern	O
blot	O
and	O
in	O
situ	O
hybridization	O
revealed	O
high	O
levels	O
of	O
MT	B
-	I
I	I
mRNA	O
in	O
transgenic	O
blastocysts	O
when	O
compared	O
with	O
control	O
blastocysts	O
,	O
and	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
-	O
amplified	O
MT	B
-	I
I	I
mRNA	O
was	O
almost	O
exclusively	O
MT	B
-	I
I*.	I
Moreover	O
,	O
pulse	O
-	O
labeling	O
experiments	O
showed	O
that	O
the	O
relative	O
rate	O
of	O
synthesis	O
of	O
MT	O
was	O
9-fold	O
higher	O
in	O
transgenic	O
blastocysts	O
.	O

Cadmium	O
(	O
Cd2	O
+	O
)	O
toxicity	O
was	O
assessed	O
after	O
incubating	O
blastocysts	O
for	O
4	O
hr	O
in	O
Whitten	O
's	O
medium	O
containing	O
50	O
microM	O
Cd2	O
+	O
.	O

Embryos	O
that	O
displayed	O
abnormal	O
morphology	O
were	O
judged	O
""""	O
sensitive	O
""""	O
.	O

Transgenic	O
blastocysts	O
were	O
more	O
resistant	O
to	O
cadmium	O
-	O
induced	O
morphological	O
changes	O
than	O
were	O
control	O
blastocysts	O
.	O
""""	O

Sensitive	O
""""	O
and	O
""""	O
resistant	O
""""	O
blastocysts	O
were	O
individually	O
genotyped	O
by	O
polymerase	O
chain	O
reaction	O
,	O
or	O
they	O
were	O
transferred	O
to	O
foster	O
mothers	O
,	O
and	O
embryonic	O
development	O
to	O
midterm	O
was	O
monitored	O
.	O

Of	O
the	O
blastocysts	O
derived	O
from	O
mating	O
heterozygous	O
transgenic	O
males	O
with	O
control	O
females	O
,	O
56	O
%	O
were	O
transgenic	O
before	O
incubation	O
with	O
Cd2	O
+	O
,	O
whereas	O
95	O
%	O
of	O
the	O
blastocysts	O
that	O
retained	O
normal	O
morphology	O
after	O
incubation	O
were	O
transgenic	O
.	O

Moreover	O
,	O
after	O
Cd2	O
+	O
exposure	O
,	O
transgenic	O
blastocysts	O
with	O
normal	O
morphology	O
were	O
nine	O
times	O
more	O
likely	O
to	O
develop	O
to	O
midterm	O
than	O
were	O
control	O
blastocysts	O
with	O
normal	O
morphology	O
.	O

Blastocysts	O
with	O
abnormal	O
morphology	O
failed	O
to	O
develop	O
to	O
midterm	O
.	O

These	O
studies	O
indicate	O
that	O
MT	O
plays	O
a	O
central	O
role	O
in	O
protection	O
from	O
Cd2	O
+	O
toxicity	O
within	O
the	O
physiological	O
context	O
of	O
the	O
developing	O
mouse	O
embryo	O
.	O

Breast	O
cancer	O
is	O
the	O
most	O
frequent	O
tumor	O
type	O
among	O
women	O
in	O
the	O
United	O
States	O
and	O
in	O
individuals	O
with	O
Li	O
-	O
Fraumeni	O
syndrome	O
.	O

The	O
p53	B
tumor	O
suppressor	O
gene	O
is	O
altered	O
in	O
a	O
large	O
proportion	O
of	O
both	O
spontaneous	O
breast	O
malignancies	O
and	O
Li	O
-	O
Fraumeni	O
breast	O
cancers	O
.	O

This	O
suggests	O
that	O
loss	O
of	O
p53	B
can	O
accelerate	O
breast	O
tumorigenesis	O
,	O
yet	O
p53-deficient	B
mice	O
rarely	O
develop	O
mammary	O
tumors	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
p53	B
loss	O
on	O
mammary	O
tumor	O
formation	O
,	O
the	O
p53	B
(	I
null	I
)	I
allele	O
was	O
back	O
-	O
crossed	O
onto	O
the	O
BALB	O
/	O
c	O
genetic	O
background	O
.	O

Median	O
survival	O
was	O
15.4	O
weeks	O
for	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
-	I
/	I
-	I
)	I
mice	O
compared	O
to	O
54	O
weeks	O
for	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
+	I
/	I
-	I
)	I
mice	O
.	O

Sarcomas	O
and	O
lymphomas	O
were	O
the	O
most	O
frequent	O
tumor	O
types	O
in	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
-	I
/	I
-	I
)	I
mice	O
,	O
whereas	O
55	O
%	O
of	O
the	O
female	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
+	I
/	I
-	I
)	I
mice	O
developed	O
mammary	O
carcinomas	O
.	O

The	O
mammary	O
tumors	O
were	O
highly	O
aneuploid	O
,	O
frequently	O
lost	O
the	O
remaining	O
wild	O
-	O
type	O
p53	B
allele	O
,	O
but	O
rarely	O
lost	O
BRCA1	O
.	O

Although	O
mammary	O
tumors	O
were	O
rarely	O
detected	O
in	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
-	I
/	I
-	I
)	I
female	O
mice	O
,	O
when	O
glands	O
from	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
-	I
/	I
-	I
)	I
mice	O
were	O
transplanted	O
into	O
wild	O
-	O
type	O
BALB	O
/	O
c	O
hosts	O
,	O
75	O
%	O
developed	O
mammary	O
tumors	O
.	O

The	O
high	O
rate	O
of	O
mammary	O
tumor	O
development	O
in	O
the	O
BALB	O
/	O
c	O
background	O
,	O
but	O
not	O
C57Bl	O
/	O
6	O
or	O
129	O
/	O
Sv	O
,	O
suggests	O
a	O
genetic	O
predisposition	O
toward	O
mammary	O
tumorigenesis	O
.	O

Therefore	O
,	O
the	O
BALB	O
/	O
c	O
-	O
p53	B
(	I
+	I
/	I
-	I
)	I
mice	O
provide	O
a	O
unique	O
model	O
for	O
the	O
study	O
of	O
breast	O
cancer	O
in	O
Li	O
-	O
Fraumeni	O
syndrome	O
.	O

These	O
results	O
demonstrate	O
the	O
critical	O
role	O
that	O
the	O
p53	B
tumor	O
suppressor	O
gene	O
plays	O
in	O
preventing	O
tumorigenesis	O
in	O
the	O
mammary	O
gland	O
.	O

Nonobese	O
diabetic	O
(	O
NOD	O
)	O
mice	O
spontaneously	O
develop	O
diabetes	O
as	O
a	O
consequence	O
of	O
an	O
autoimmune	O
process	O
that	O
can	O
be	O
inhibited	O
by	O
immunotherapy	O
with	O
the	O
60-kDa	O
heat	O
shock	O
protein	O
(	O
hsp60	B
)	O
,	O
with	O
its	O
mycobacterial	O
counterpart	O
65-kDa	O
(	O
hsp65	O
)	O
,	O
or	O
with	O
other	O
Ags	O
such	O
as	O
insulin	O
and	O
glutamic	O
acid	O
decarboxylase	O
(	O
GAD	O
)	O
.	O

Microbial	O
infection	O
and	O
innate	O
signaling	O
via	O
LPS	O
or	O
CpG	O
motifs	O
can	O
also	O
inhibit	O
the	O
spontaneous	O
diabetogenic	O
process	O
.	O

In	O
addition	O
to	O
the	O
spontaneous	O
disease	O
,	O
however	O
,	O
NOD	O
mice	O
can	O
develop	O
a	O
more	O
robust	O
cyclophosphamide	O
-	O
accelerated	O
diabetes	O
(	O
CAD	O
)	O
.	O

In	O
this	O
work	O
,	O
we	O
studied	O
the	O
effect	O
on	O
CAD	O
of	O
DNA	O
vaccination	O
with	O
constructs	O
encoding	O
the	O
Ags	O
human	O
hsp60	B
(	O
phsp60	O
)	O
or	O
mycobacterial	O
hsp65	O
(	O
phsp65	O
)	O
.	O

Vaccination	O
with	O
phsp60	O
protected	O
NOD	O
mice	O
from	O
CAD	O
.	O

In	O
contrast	O
,	O
vaccination	O
with	O
phsp65	O
,	O
with	O
an	O
empty	O
vector	O
,	O
or	O
with	O
a	O
CpG	O
-	O
positive	O
oligonucleotide	O
was	O
not	O
effective	O
,	O
suggesting	O
that	O
the	O
efficacy	O
of	O
the	O
phsp60	O
construct	O
might	O
be	O
based	O
on	O
regulatory	O
hsp60	B
epitopes	O
not	O
shared	O
with	O
its	O
mycobacterial	O
counterpart	O
,	O
hsp65	O
.	O

Vaccination	O
with	O
phsp60	O
modulated	O
the	O
T	O
cell	O
responses	O
to	O
hsp60	B
and	O
also	O
to	O
the	O
GAD	O
and	O
insulin	O
autoantigens	O
;	O
T	O
cell	O
proliferative	O
responses	O
were	O
significantly	O
reduced	O
,	O
and	O
the	O
pattern	O
of	O
cytokine	O
secretion	O
to	O
hsp60	B
,	O
GAD	O
,	O
and	O
insulin	O
showed	O
an	O
increase	O
in	O
IL-10	B
and	O
IL-5	B
secretion	O
and	O
a	O
decrease	O
in	O
IFN	B
-	I
gamma	I
secretion	O
,	O
compatible	O
with	O
a	O
shift	O
from	O
a	O
Th1-like	O
toward	O
a	O
Th2-like	O
autoimmune	O
response	O
.	O

Our	O
results	O
extend	O
the	O
role	O
of	O
specific	O
hsp60	B
immunomodulation	O
in	O
the	O
control	O
of	O
beta	O
cell	O
autoimmunity	O
and	O
demonstrate	O
that	O
immunoregulatory	O
networks	O
activated	O
by	O
specific	O
phsp60	O
vaccination	O
can	O
spread	O
to	O
other	O
Ags	O
targeted	O
during	O
the	O
progression	O
of	O
diabetes	O
,	O
like	O
insulin	O
and	O
GAD	O
.	O

Age	O
-	O
related	O
changes	O
in	O
T	O
cell	O
subsets	O
were	O
examined	O
in	O
intestinal	O
intraepithelial	O
lymphocytes	O
(	O
i	O
-	O
IEL	O
)	O
,	O
which	O
contain	O
unique	O
T	O
cells	O
differentiating	O
extrathymically	O
.	O

In	O
2-month	O
-	O
old	O
mice	O
bred	O
under	O
conventional	O
condition	O
,	O
i	O
-	O
IEL	O
consisted	O
of	O
a	O
large	O
number	O
of	O
CD4-CD8	O
alpha	O
/	O
alpha+	O
cells	O
bearing	O
either	O
T	O
cell	O
receptor	O
(	O
TcR	O
)	O
alpha	O
/	O
beta	O
or	O
TcR	O
gamma	O
/	O
delta	O
and	O
only	O
a	O
few	O
CD4+CD8	O
alpha-	O
cells	O
.	O

In	O
aged	O
mice	O
(	O
6	O
months	O
old	O
and	O
24	O
months	O
old	O
)	O
,	O
unique	O
CD4+CD8	O
alpha	O
/	O
alpha+	O
i	O
-	O
IEL	O
bearing	O
TcR	B
alpha	I
/	O
beta	O
increased	O
in	O
number	O
and	O
conversely	O
the	O
proportion	O
of	O
TcR	O
gamma	O
/	O
delta+	O
i	O
-	O
IEL	O
was	O
decreased	O
.	O

Such	O
an	O
increase	O
in	O
number	O
of	O
CD4+CD8	O
alpha	O
/	O
alpha+	O
cells	O
was	O
detected	O
in	O
i	O
-	O
IEL	O
from	O
aged	O
(	O
14-months	O
old	O
)	O
nude	O
mice	O
,	O
but	O
not	O
in	O
aged	O
(	O
14	O
months	O
old	O
)	O
germ	O
-	O
free	O
mice	O
,	O
suggesting	O
that	O
a	O
significant	O
fraction	O
of	O
TcR	B
alpha	I
/	O
beta	O
T	O
cells	O
such	O
as	O
CD4+CD8	O
alpha+	O
i	O
-	O
IEL	O
can	O
develop	O
along	O
an	O
extrathymic	O
pathway	O
under	O
the	O
influence	O
of	O
intestinal	O
microflora	O
with	O
age	O
.	O

BACKGROUND	O
:	O
Tumor	B
necrosis	I
factor	I
-	I
alpha	I
(	O
TNF	B
-	I
alpha	I
)	O
is	O
chronically	O
elevated	O
in	O
the	O
adipose	O
tissue	O
from	O
obese	O
humans	O
and	O
mice	O
.	O

This	O
increase	O
in	O
TNF	B
-	I
alpha	I
contributes	O
to	O
the	O
insulin	O
resistance	O
,	O
elevated	O
plasminogen	O
activator	O
inhibitor-1	O
(	O
PAI-1	B
)	O
levels	O
,	O
and	O
cardiovascular	O
complications	O
associated	O
with	O
obesity	O
and	O
noninsulin	O
-	O
dependent	O
diabetes	O
(	O
NIDDM	O
)	O
.	O

PAI-1	B
gene	O
expression	O
in	O
adipose	O
tissue	O
is	O
also	O
stimulated	O
by	O
transforming	O
growth	O
factor	O
-	O
beta	O
(	O
TGF	O
-	O
beta	O
)	O
.	O

Experiments	O
were	O
performed	O
to	O
determine	O
whether	O
TGF	O
-	O
beta	O
is	O
regulated	O
by	O
TNF	B
-	I
alpha	I
and	O
elevated	O
in	O
obesity	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
The	O
concentration	O
of	O
TGF	O
-	O
beta	O
and	O
PAI-1	B
mRNA	O
in	O
murine	O
adipose	O
tissue	O
and	O
cultured	O
3T3-L1	O
adipocytes	O
was	O
determined	O
by	O
quantitative	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
,	O
and	O
the	O
cellular	O
localization	O
of	O
these	O
molecules	O
was	O
evaluated	O
using	O
in	O
situ	O
hybridization	O
and	O
cell	O
fractionation	O
.	O

Total	O
TGF	O
-	O
beta	O
protein	O
was	O
determined	O
by	O
employing	O
an	O
ELISA	O
assay	O
.	O

RESULTS	O
:	O
TGF	O
-	O
beta	O
mRNA	O
and	O
protein	O
were	O
increased	O
in	O
the	O
adipose	O
tissue	O
from	O
two	O
different	O
strains	O
of	O
genetically	O
obese	O
mice	O
(	O
i.e.	O
,	O
ob	O
/	O
ob	O
and	O
db	O
/	O
db	O
)	O
,	O
compared	O
with	O
their	O
lean	O
counterparts	O
.	O

This	O
increase	O
in	O
TGF	O
-	O
beta	O
may	O
result	O
from	O
TNF	B
-	I
alpha	I
since	O
TNF	B
-	I
alpha	I
increased	O
TGF	O
-	O
beta	O
mRNA	O
expression	O
in	O
the	O
adipose	O
tissue	O
of	O
lean	O
mice	O
and	O
stimulated	O
TGF	O
-	O
beta	O
production	O
by	O
cultured	O
adipocytes	O
.	O

Administration	O
of	O
TGF	O
-	O
beta	O
increased	O
PAI-1	B
antigen	O
in	O
the	O
plasma	O
and	O
PAI-1	B
mRNA	O
in	O
the	O
adipocytes	O
of	O
lean	O
mice	O
,	O
and	O
enhanced	O
the	O
rate	O
of	O
PAI-1	B
synthesis	O
by	O
adipocytes	O
in	O
vitro	O
.	O

CONCLUSIONS	O
:	O
TNF	B
-	I
alpha	I
contributes	O
to	O
the	O
elevated	O
TGF	O
-	O
beta	O
expression	O
demonstrated	O
in	O
the	O
adipose	O
tissue	O
of	O
obese	O
mice	O
.	O

A	O
potential	O
role	O
for	O
TGF	O
-	O
beta	O
in	O
the	O
increased	O
PAI-1	B
and	O
vascular	O
pathologies	O
associated	O
with	O
obesity	O
/	O
NIDDM	O
is	O
suggested	O
.	O

These	O
studies	O
examined	O
the	O
importance	O
of	O
phospholipase	O
Cbeta	O
(	O
PLCbeta	O
)	O
in	O
the	O
calcium	O
responses	O
of	O
pituitary	O
cells	O
using	O
PLCbeta3	O
knockout	O
mice	O
.	O

Pituitary	O
tissue	O
from	O
wild	O
-	O
type	O
mice	O
contained	O
PLCbeta1	O
and	O
PLCbeta3	O
but	O
not	O
PLCbeta2	O
or	O
PLCbeta4	O
.	O

Both	O
Galphaq	B
/	O
11	O
and	O
Gbetagamma	O
can	O
activate	O
PLCbeta3	O
,	O
whereas	O
only	O
Galphaq	B
/	O
11	O
activates	O
PLCss1	O
effectively	O
.	O

In	O
knockout	O
mice	O
,	O
PLCbeta3	O
was	O
absent	O
,	O
PLCbeta1	O
was	O
not	O
up	O
-	O
regulated	O
,	O
and	O
PLCbeta2	O
and	O
PLCbeta4	O
were	O
not	O
expressed	O
.	O

Since	O
somatostatin	B
inhibited	O
influx	O
of	O
extracellular	O
calcium	O
in	O
pituitary	O
cells	O
from	O
wild	O
-	O
type	O
and	O
PLCbeta3	O
knockout	O
mice	O
,	O
the	O
somatostatin	B
signal	O
pathway	O
was	O
intact	O
.	O

However	O
,	O
somatostatin	B
failed	O
to	O
increase	O
intracellular	O
calcium	O
in	O
pituitary	O
cells	O
from	O
either	O
wild	O
-	O
type	O
or	O
knockout	O
mice	O
under	O
a	O
variety	O
of	O
conditions	O
,	O
indicating	O
that	O
it	O
did	O
not	O
stimulate	O
PLCbeta3	O
.	O

In	O
contrast	O
,	O
somatostatin	B
increased	O
intracellular	O
calcium	O
in	O
aortic	O
smooth	O
muscle	O
cells	O
from	O
wild	O
-	O
type	O
mice	O
,	O
although	O
it	O
evoked	O
no	O
calcium	O
response	O
in	O
cells	O
from	O
PLCbeta3	O
knockout	O
animals	O
These	O
results	O
show	O
that	O
somatostatin	B
,	O
like	O
other	O
Gi	O
/	O
Go	O
-	O
linked	O
hormones	O
,	O
can	O
stimulate	O
a	O
calcium	O
transient	O
by	O
activating	O
PLCbeta3	O
through	O
Gbetagamma	O
,	O
but	O
this	O
response	O
does	O
not	O
normally	O
occur	O
in	O
pituitary	O
cells	O
.	O

The	O
densities	O
of	O
Gi	O
and	O
Go	O
,	O
as	O
well	O
as	O
the	O
relative	O
concentrations	O
of	O
PLCbeta1	O
and	O
PLCbeta3	O
,	O
were	O
similar	O
in	O
cells	O
that	O
responded	O
to	O
somatostatin	B
with	O
an	O
increase	O
in	O
calcium	O
and	O
pituitary	O
cells	O
.	O

Calcium	O
responses	O
to	O
1	O
nM	O
and	O
1	O
microM	O
TRH	B
and	O
GnRH	B
were	O
identical	O
in	O
pituitary	O
cells	O
from	O
wild	O
-	O
type	O
and	O
PLCbeta3	O
knockout	O
mice	O
,	O
as	O
were	O
responses	O
to	O
other	O
Gq	B
-	O
linked	O
agonists	O
.	O

These	O
results	O
show	O
that	O
in	O
pituitary	O
cells	O
,	O
PLCbeta1	O
is	O
sufficient	O
to	O
transmit	O
signals	O
from	O
Gq	B
-	O
coupled	O
hormones	O
,	O
whereas	O
PLCbeta3	O
is	O
required	O
for	O
the	O
calcium	O
-	O
mobilizing	O
actions	O
of	O
somatostatin	B
observed	O
in	O
smooth	O
muscle	O
cells	O
.	O

Mitochondrial	O
uncoupling	O
proteins	O
have	O
been	O
implicated	O
in	O
the	O
maintenance	O
of	O
metabolic	O
rate	O
and	O
adaptational	O
thermoregulation	O
.	O

We	O
recently	O
reported	O
the	O
identification	O
of	O
a	O
brain	O
-	O
specific	O
mitochondrial	O
uncoupling	O
protein	O
homologue	O
,	O
UCP4	O
.	O

Here	O
we	O
characterized	O
another	O
newly	O
described	O
member	O
of	O
the	O
uncoupling	O
protein	O
family	O
,	O
termed	O
UCP5	B
(	O
also	O
called	O
BMCP1	B
)	O
.	O

UCP5	B
transcripts	O
are	O
present	O
in	O
multiple	O
human	O
and	O
mouse	O
tissues	O
,	O
with	O
an	O
especially	O
high	O
abundance	O
in	O
the	O
brain	O
and	O
testis	O
.	O

Expression	O
of	O
UCP5	B
in	O
mammalian	O
cells	O
reduces	O
the	O
mitochondrial	O
membrane	O
potential	O
.	O

Multiple	O
isoforms	O
of	O
UCP5	B
were	O
identified	O
and	O
exhibited	O
tissue	O
-	O
specific	O
distribution	O
and	O
different	O
potency	O
in	O
reduction	O
of	O
membrane	O
potential	O
.	O

Furthermore	O
,	O
the	O
mRNA	O
abundance	O
of	O
both	O
UCP4	O
and	O
UCP5	B
is	O
modulated	O
by	O
nutritional	O
status	O
or	O
temperature	O
in	O
a	O
tissue	O
-	O
specific	O
manner	O
in	O
mice	O
.	O

Brain	O
UCP4	O
and	O
UCP5	B
mRNA	O
transcripts	O
rose	O
by	O
1.5-	O
and	O
1.7-fold	O
,	O
respectively	O
,	O
and	O
liver	O
UCP5	B
expression	O
increased	O
by	O
1.8-fold	O
in	O
response	O
to	O
acute	O
cold	O
exposure	O
.	O

A	O
high	O
-	O
fat	O
diet	O
increased	O
UCP5	B
mRNA	O
in	O
liver	O
by	O
1.6-fold	O
selectively	O
in	O
the	O
obesity	O
-	O
resistant	O
A	O
/	O
J	O
but	O
not	O
in	O
the	O
obesity	O
-	O
prone	O
C57BL	O
/	O
6J	O
mouse	O
strain	O
.	O

Liver	O
UCP5	B
expression	O
decreased	O
significantly	O
with	O
a	O
24	O
h	O
fast	O
and	O
was	O
restored	O
to	O
the	O
normal	O
level	O
after	O
refeeding	O
.	O

In	O
contrast	O
,	O
brain	O
transcripts	O
for	O
both	O
genes	O
were	O
not	O
significantly	O
altered	O
by	O
fasting	O
or	O
high	O
-	O
fat	O
diet	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
the	O
notion	O
that	O
UCP4	O
and	O
UCP5	B
may	O
be	O
involved	O
in	O
tissue	O
-	O
specific	O
thermoregulation	O
and	O
metabolic	O
changes	O
associated	O
with	O
nutritional	O
status	O
.	O

In	O
this	O
study	O
we	O
investigate	O
the	O
roles	O
of	O
the	O
organizer	O
factors	O
chordin	B
and	O
noggin	B
,	O
which	O
are	O
dedicated	O
antagonists	O
of	O
the	O
bone	O
morphogenetic	O
proteins	O
(	O
BMPs	O
)	O
,	O
in	O
formation	O
of	O
the	O
mammalian	O
head	O
.	O

The	O
mouse	O
chordin	B
and	O
noggin	B
genes	O
(	O
Chrd	B
and	O
Nog	B
)	O
are	O
expressed	O
in	O
the	O
organizer	O
(	O
the	O
node	O
)	O
and	O
its	O
mesendodermal	O
derivatives	O
,	O
including	O
the	O
prechordal	O
plate	O
,	O
an	O
organizing	O
center	O
for	O
rostral	O
development	O
.	O

They	O
are	O
also	O
expressed	O
at	O
lower	O
levels	O
in	O
and	O
around	O
the	O
anterior	O
neural	O
ridge	O
,	O
another	O
rostral	O
organizing	O
center	O
.	O

To	O
elucidate	O
roles	O
of	O
Chrd	B
and	O
Nog	B
that	O
are	O
masked	O
by	O
the	O
severe	O
phenotype	O
and	O
early	O
lethality	O
of	O
the	O
double	O
null	O
,	O
we	O
have	O
characterized	O
embryos	O
of	O
the	O
genotype	O
Chrd	B
(	I
-	I
/	I
-	I
)	I
;Nog	O
(	B
+	I
/	I
-	I
)	I
.	O

These	O
animals	O
display	O
partially	O
penetrant	O
neonatal	O
lethality	O
,	O
with	O
defects	O
restricted	O
to	O
the	O
head	O
.	O

The	O
variable	O
phenotypes	O
include	O
cyclopia	O
,	O
holoprosencephaly	O
,	O
and	O
rostral	O
truncations	O
of	O
the	O
brain	O
and	O
craniofacial	O
skeleton	O
.	O

In	O
situ	O
hybridization	O
reveals	O
a	O
loss	O
of	O
SHH	B
expression	O
and	O
signaling	O
by	O
the	O
prechordal	O
plate	O
,	O
and	O
a	O
decrease	O
in	O
FGF8	B
expression	O
and	O
signaling	O
by	O
the	O
anterior	O
neural	O
ridge	O
at	O
the	O
five	O
-	O
somite	O
stage	O
.	O

Defective	O
Chrd	B
(	I
-	I
/	I
-	I
)	I
;Nog	O
(	B
+	I
/	I
-	I
)	I
embryos	O
exhibit	O
reduced	O
cell	O
proliferation	O
in	O
the	O
rostral	O
neuroepithelium	O
at	O
10	O
somites	O
,	O
followed	O
by	O
increased	O
cell	O
death	O
1	O
day	O
later	O
.	O

Because	O
these	O
phenotypes	O
result	O
from	O
reduced	O
levels	O
of	O
BMP	O
antagonists	O
,	O
we	O
hypothesized	O
that	O
they	O
are	O
due	O
to	O
increased	O
BMP	O
activity	O
.	O

Ectopic	O
application	O
of	O
BMP2	B
to	O
wild	O
-	O
type	O
cephalic	O
explants	O
results	O
in	O
decreased	O
FGF8	B
and	O
SHH	B
expression	O
in	O
rostral	O
tissue	O
,	O
suggesting	O
that	O
the	O
decreased	O
expression	O
of	O
FGF8	B
and	O
SHH	B
observed	O
in	O
vivo	O
is	O
due	O
to	O
ectopic	O
BMP	O
activity	O
.	O

Cephalic	O
explants	O
isolated	O
from	O
Chrd;Nog	B
double	O
mutant	O
embryos	O
show	O
an	O
increased	O
sensitivity	O
to	O
ectopic	O
BMP	O
protein	O
,	O
further	O
supporting	O
the	O
hypothesis	O
that	O
these	O
mutants	O
are	O
deficient	O
in	O
BMP	O
antagonism	O
.	O

These	O
results	O
indicate	O
that	O
the	O
BMP	O
antagonists	O
chordin	B
and	O
noggin	B
promote	O
the	O
inductive	O
and	O
trophic	O
activities	O
of	O
rostral	O
organizing	O
centers	O
in	O
early	O
development	O
of	O
the	O
mammalian	O
head	O
.	O

Cyclic	O
AMP	O
is	O
hydrolyzed	O
by	O
members	O
of	O
at	O
least	O
eight	O
classes	O
of	O
cyclic	O
nucleotide	O
phosphodiesterases	O
(	O
PDEs	O
)	O
.	O

Although	O
it	O
has	O
been	O
reported	O
that	O
cyclic	O
AMP	O
PDE	O
activity	O
in	O
mammalian	O
tissues	O
can	O
be	O
inhibited	O
by	O
benzodiazepines	O
,	O
it	O
has	O
not	O
been	O
conclusively	O
demonstrated	O
that	O
members	O
of	O
the	O
class	O
of	O
cyclic	O
AMP	O
-	O
specific	O
,	O
rolipram	O
-	O
inhibitable	O
PDEs	O
(	O
PDE4s	O
)	O
are	O
targets	O
for	O
these	O
drugs	O
.	O

Moreover	O
,	O
no	O
PDE4s	O
expressed	O
in	O
mice	O
have	O
been	O
characterized	O
.	O

To	O
address	O
these	O
issues	O
,	O
we	O
isolated	O
two	O
cDNAs	O
representing	O
homologues	O
of	O
PDE4A1	O
and	O
PDE4B3	O
from	O
a	O
mouse	O
brain	O
library	O
.	O

After	O
transient	O
transfection	O
in	O
human	O
embryonic	O
kidney	O
(	O
HEK	O
)	O
293	O
cells	O
,	O
the	O
mouse	O
PDEs	O
hydrolyzed	O
cyclic	O
AMP	O
with	O
a	O
low	O
K	O
(	O
m	O
)	O
and	O
were	O
inhibited	O
by	O
rolipram	O
;	O
both	O
are	O
properties	O
typical	O
of	O
other	O
mammalian	O
PDE4	O
enzymes	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
diazepam	O
inhibited	O
cyclic	O
AMP	O
hydrolysis	O
by	O
the	O
mouse	O
PDE4	O
subtypes	O
.	O

Interestingly	O
,	O
PDE4B	B
was	O
significantly	O
more	O
sensitive	O
to	O
inhibition	O
by	O
both	O
rolipram	O
and	O
diazepam	O
than	O
the	O
PDE4A	B
subtype	O
.	O

This	O
is	O
the	O
first	O
demonstration	O
that	O
recombinantly	O
expressed	O
PDE4s	O
are	O
inhibited	O
by	O
diazepam	O
,	O
and	O
should	O
facilitate	O
future	O
studies	O
with	O
mouse	O
models	O
of	O
depression	O
and	O
anxiety	O
.	O

The	O
renin	O
-	O
angiotensin	O
system	O
is	O
normally	O
subject	O
to	O
servo	O
control	O
mechanisms	O
that	O
suppress	O
plasma	O
renin	O
levels	O
in	O
response	O
to	O
increased	O
blood	O
pressure	O
and	O
increase	O
plasma	O
renin	O
levels	O
when	O
blood	O
pressure	O
falls	O
.	O

In	O
most	O
species	O
,	O
renin	O
is	O
rate	O
limiting	O
,	O
and	O
angiotensinogen	B
circulates	O
at	O
a	O
concentration	O
close	O
to	O
the	O
Km	O
,	O
so	O
varying	O
the	O
concentration	O
of	O
either	O
can	O
affect	O
the	O
rate	O
of	O
angiotensin	O
formation	O
.	O

However	O
,	O
only	O
the	O
plasma	O
renin	O
level	O
responds	O
to	O
changes	O
in	O
blood	O
pressure	O
and	O
sodium	O
balance	O
to	O
maintain	O
blood	O
pressure	O
homeostasis	O
.	O

Therefore	O
,	O
the	O
high	O
plasma	O
human	O
renin	O
levels	O
and	O
the	O
hypertension	O
of	O
mice	O
and	O
rats	O
containing	O
both	O
human	O
renin	O
and	O
angiotensinogen	B
transgenes	O
indicate	O
inappropriate	O
regulation	O
of	O
renin	O
and	O
blood	O
pressure	O
.	O

These	O
anomalies	O
led	O
us	O
to	O
develop	O
new	O
lines	O
of	O
transgenic	O
mice	O
with	O
a	O
longer	O
human	O
renin	O
gene	O
fragment	O
(	O
45	O
kb	O
)	O
than	O
earlier	O
lines	O
(	O
13	O
to	O
15	O
kb	O
)	O
.	O

Unlike	O
their	O
predecessors	O
,	O
the	O
45-kb	O
hREN	O
mice	O
secrete	O
human	O
renin	O
only	O
from	O
the	O
kidneys	O
,	O
and	O
both	O
the	O
human	O
and	O
mouse	O
renins	O
respond	O
appropriately	O
to	O
physiological	O
stimuli	O
.	O

To	O
determine	O
whether	O
blood	O
pressure	O
is	O
also	O
regulated	O
appropriately	O
,	O
we	O
crossed	O
these	O
new	O
45-kb	O
hREN	O
mice	O
with	O
mice	O
containing	O
the	O
human	O
angiotensinogen	B
gene	O
.	O

All	O
doubly	O
transgenic	O
mice	O
were	O
normotensive	O
like	O
their	O
singly	O
transgenic	O
and	O
nontransgenic	O
littermates	O
.	O

Moreover	O
,	O
among	O
doubly	O
transgenic	O
mice	O
,	O
both	O
human	O
and	O
mouse	O
plasma	O
renin	O
concentrations	O
were	O
suppressed	O
relative	O
to	O
the	O
singly	O
transgenic	O
45-kb	O
hREN	O
mice	O
.	O

These	O
findings	O
demonstrate	O
the	O
importance	O
of	O
appropriate	O
cell	O
and	O
tissue	O
specificity	O
of	O
gene	O
expression	O
in	O
constructing	O
transgenic	O
models	O
and	O
affirm	O
the	O
pivotal	O
role	O
played	O
by	O
renal	O
renin	O
secretion	O
in	O
blood	O
pressure	O
control	O
.	O

Endoglin	B
is	O
an	O
integral	O
membrane	O
glycoprotein	O
predominantly	O
expressed	O
on	O
human	O
endothelial	O
cells	O
and	O
recently	O
shown	O
to	O
bind	O
transforming	O
growth	O
factor	O
-	O
beta	O
1	O
(	O
TGF	O
beta	O
1	O
)	O
with	O
high	O
affinity	O
.	O

We	O
now	O
report	O
the	O
cloning	O
and	O
sequencing	O
of	O
a	O
full	O
-	O
length	O
murine	O
endoglin	B
complementary	O
DNA	O
of	O
2902	O
base	O
pairs	O
which	O
hybridizes	O
specifically	O
with	O
a	O
single	O
messenger	O
RNA	O
(	O
mRNA	O
)	O
species	O
.	O

The	O
polypeptide	O
of	O
653	O
amino	O
acids	O
has	O
an	O
overall	O
identity	O
of	O
72	O
%	O
with	O
human	O
and	O
porcine	O
endoglin	B
.	O

The	O
transmembrane	O
and	O
cytoplasmic	O
domains	O
of	O
all	O
three	O
proteins	O
differ	O
by	O
two	O
to	O
four	O
amino	O
acids	O
and	O
are	O
70	O
%	O
identical	O
to	O
the	O
corresponding	O
regions	O
of	O
the	O
TGF	O
beta	O
binding	O
protein	O
,	O
betaglycan	B
.	O

Relative	O
levels	O
of	O
murine	O
endoglin	B
mRNA	O
were	O
estimated	O
by	O
polymerase	O
chain	O
reaction	O
and	O
found	O
to	O
be	O
high	O
in	O
ovary	O
and	O
uterus	O
,	O
intermediate	O
in	O
heart	O
and	O
muscle	O
,	O
and	O
low	O
in	O
placenta	O
and	O
spleen	O
.	O

In	O
situ	O
hybridization	O
and	O
immunofluorescence	O
confirmed	O
that	O
murine	O
endoglin	B
,	O
like	O
its	O
human	O
counterpart	O
,	O
is	O
present	O
in	O
blood	O
vessels	O
and	O
capillaries	O
in	O
all	O
tissues	O
examined	O
.	O

In	O
addition	O
,	O
the	O
stromal	O
cells	O
in	O
the	O
connective	O
tissue	O
of	O
intestine	O
,	O
stomach	O
,	O
heart	O
,	O
muscle	O
,	O
uterus	O
,	O
ovary	O
,	O
and	O
testis	O
were	O
strongly	O
and	O
specifically	O
reactive	O
with	O
complementary	O
RNA	O
probes	O
and	O
with	O
a	O
polyclonal	O
antibody	O
to	O
endoglin	B
;	O
epithelial	O
cell	O
layers	O
were	O
distinctly	O
unreactive	O
.	O

This	O
distribution	O
is	O
similar	O
to	O
that	O
of	O
extracellular	O
TGF	O
beta	O
1	O
,	O
particularly	O
in	O
heart	O
and	O
uterus	O
,	O
and	O
suggests	O
that	O
endoglin	B
on	O
stromal	O
fibroblast	O
-	O
like	O
cells	O
might	O
be	O
regulating	O
access	O
of	O
TGF	O
beta	O
1	O
to	O
the	O
signaling	O
receptor	O
complex	O
.	O

NCTC-2071	O
fibroblasts	O
in	O
culture	O
were	O
shown	O
to	O
express	O
high	O
levels	O
of	O
endoglin	B
mRNA	O
by	O
polymerase	O
chain	O
reaction	O
.	O

After	O
chemical	O
cross	O
-	O
linking	O
with	O
[	O
125I	O
]	O
TGF	O
beta	O
1	O
and	O
immunoprecipitation	O
with	O
the	O
polyclonal	O
antihuman	O
endoglin	B
serum	O
,	O
a	O
radiolabeled	O
band	O
of	O
mol	O
wt	O
180,000	O
corresponding	O
to	O
dimeric	O
endoglin	B
was	O
observed	O
under	O
nonreducing	O
conditions	O
,	O
whereas	O
a	O
single	O
band	O
of	O
mol	O
wt	O
90,000	O
was	O
seen	O
under	O
reducing	O
conditions	O
.	O

Thus	O
murine	O
fibroblast	O
endoglin	B
is	O
capable	O
of	O
binding	O
TGF	O
beta	O
1	O
.	O

Future	O
studies	O
should	O
establish	O
the	O
specialized	O
role	O
of	O
endoglin	B
in	O
the	O
TGF	O
beta	O
receptor	O
complex	O
of	O
endothelial	O
and	O
stromal	O
cells	O
.	O

The	O
BCL-2	B
family	O
has	O
various	O
pairs	O
of	O
antagonist	O
and	O
agonist	O
proteins	O
that	O
regulate	O
apoptosis	O
.	O

Whether	O
their	O
function	O
is	O
interdependent	O
is	O
uncertain	O
.	O

Using	O
a	O
genetic	O
approach	O
to	O
address	O
this	O
question	O
,	O
we	O
utilized	O
gain-	O
and	O
loss	O
-	O
of	O
-	O
function	O
models	O
of	O
Bcl-2	B
and	O
Bax	B
and	O
found	O
that	O
apoptosis	O
and	O
thymic	O
hypoplasia	O
characteristic	O
of	O
Bcl-2-deficient	B
mice	O
are	O
largely	O
absent	O
in	O
mice	O
also	O
deficient	O
in	O
Bax	B
.	O

A	O
single	O
copy	O
of	O
Bax	B
promoted	O
apoptosis	O
in	O
the	O
absence	O
of	O
Bcl-2	B
.	O

In	O
contrast	O
,	O
overexpression	O
of	O
Bcl-2	B
still	O
repressed	O
apoptosis	O
in	O
the	O
absence	O
of	O
Bax	B
.	O

While	O
an	O
in	O
vivo	O
competition	O
exists	O
between	O
Bax	B
and	O
Bcl-2	B
,	O
each	O
is	O
able	O
to	O
regulate	O
apoptosis	O
independently	O
.	O

Major	O
histocompatibility	O
complex	O
class	O
II	O
positive	O
cells	O
,	O
namely	O
dendritic	O
cells	O
,	O
monocytes	O
/	O
macrophages	O
,	O
and	O
B	O
cells	O
,	O
are	O
categorized	O
as	O
antigen	O
-	O
presenting	O
cells	O
.	O

Dendritic	O
cells	O
,	O
so	O
-	O
called	O
professional	O
antigen	O
-	O
presenting	O
cells	O
,	O
use	O
distinct	O
sets	O
of	O
surface	O
receptors	O
before	O
and	O
after	O
maturation	O
:	O
those	O
to	O
capture	O
antigens	O
and	O
those	O
to	O
interact	O
with	O
T	O
cells	O
,	O
respectively	O
.	O

But	O
there	O
remain	O
many	O
surface	O
molecules	O
whose	O
functions	O
are	O
still	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
isolated	O
dendritic	B
cell	I
immunoreceptor	I
from	O
mouse	O
bone	O
-	O
marrow	O
-	O
derived	O
mature	O
dendritic	O
cells	O
.	O

Dendritic	B
cell	I
immunoreceptor	I
is	O
a	O
recently	O
reported	O
C	O
-	O
type	O
lectin	O
receptor	O
characteristic	O
with	O
cytoplasmic	O
immunoreceptor	O
tyrosine	O
-	O
based	O
inhibitory	O
motif	O
.	O

Expression	O
of	O
mouse	O
dendritic	B
cell	I
immunoreceptor	I
mRNA	O
was	O
observed	O
specifically	O
in	O
spleen	O
and	O
lymph	O
node	O
,	O
slightly	O
increased	O
with	O
dendritic	O
cell	O
maturation	O
during	O
in	O
vitro	O
culture	O
of	O
bone	O
marrow	O
cells	O
,	O
and	O
was	O
not	O
detected	O
in	O
cultured	O
natural	O
killer	O
cells	O
.	O

Surface	O
expression	O
of	O
mouse	O
dendritic	B
cell	I
immunoreceptor	I
protein	O
was	O
observed	O
in	O
splenic	O
antigen	O
-	O
presenting	O
cells	O
including	O
B	O
cells	O
,	O
monocytes	O
/	O
macrophages	O
,	O
and	O
dendritic	O
cells	O
,	O
but	O
not	O
in	O
T	O
cells	O
.	O

To	O
reveal	O
the	O
downregulating	O
capacity	O
of	O
dendritic	B
cell	I
immunoreceptor	I
in	O
antigen	O
-	O
presenting	O
cells	O
,	O
the	O
change	O
of	O
B	O
-	O
cell	O
-	O
receptor	O
-	O
mediated	O
signals	O
after	O
coligation	O
with	O
a	O
chimeric	O
Fcgamma	O
receptor	O
IIB	O
containing	O
the	O
cytoplasmic	O
portion	O
of	O
mouse	O
dendritic	B
cell	I
immunoreceptor	I
was	O
examined	O
.	O

As	O
a	O
result	O
,	O
we	O
detected	O
two	O
distinct	O
inhibitory	O
effects	O
of	O
cytoplasmic	O
dendritic	B
cell	I
immunoreceptor	I
minus	O
sign	O
inhibition	O
of	O
B	O
-	O
cell	O
-	O
receptor	O
-	O
mediated	O
Ca2	O
+	O
mobilization	O
and	O
protein	O
tyrosine	O
phosphorylation	O
minus	O
sign	O
and	O
both	O
of	O
these	O
effects	O
required	O
the	O
tyrosine	O
residue	O
inside	O
the	O
immunoreceptor	O
tyrosine	O
-	O
based	O
inhibitory	O
motif	O
.	O

This	O
report	O
presents	O
immunoreceptor	O
tyrosine	O
-	O
based	O
inhibitory	O
motif	O
-	O
dependent	O
negative	O
regulatory	O
function	O
of	O
dendritic	O
cell	O
immunoreceptors	O
.	O

In	O
conclusion	O
,	O
mouse	O
dendritic	B
cell	I
immunoreceptor	I
expressed	O
on	O
antigen	O
-	O
presenting	O
cells	O
can	O
exert	O
two	O
distinct	O
inhibitory	O
signals	O
depending	O
on	O
its	O
immunoreceptor	O
tyrosine	O
-	O
based	O
inhibitory	O
motif	O
tyrosine	O
residue	O
.	O

We	O
have	O
used	O
a	O
quantitative	O
RT	O
-	O
PCR	O
approach	O
to	O
determine	O
the	O
levels	O
of	O
Brn3a	B
and	O
Brn3b	B
POU	O
domain	O
transcription	O
factor	O
mRNAs	O
in	O
the	O
developing	O
mouse	O
trigeminal	O
ganglion	O
from	O
E10	O
to	O
E18	O
.	O

Using	O
low	O
density	O
neuronal	O
cultures	O
,	O
we	O
have	O
shown	O
that	O
NT-3	B
can	O
regulate	O
the	O
expression	O
of	O
Brn3a	B
mRNA	O
in	O
trigeminal	O
neurons	O
during	O
the	O
periods	O
that	O
they	O
are	O
differentiating	O
and	O
innervating	O
their	O
peripheral	O
and	O
central	O
targets	O
.	O

In	O
contrast	O
to	O
Brn3a	B
,	O
Brn3b	B
mRNA	O
is	O
expressed	O
at	O
extremely	O
low	O
levels	O
in	O
the	O
early	O
trigeminal	O
ganglion	O
.	O

Trigeminal	O
neurons	O
from	O
early	O
ganglia	O
express	O
low	O
levels	O
of	O
Brn3b	B
mRNA	O
in	O
culture	O
and	O
do	O
not	O
up	O
-	O
regulate	O
Brn3b	B
mRNA	O
in	O
response	O
to	O
a	O
number	O
of	O
growth	O
factors	O
and	O
experimental	O
conditions	O
.	O

However	O
,	O
at	O
later	O
ages	O
,	O
when	O
in	O
vivo	O
levels	O
of	O
Brn3b	B
mRNA	O
are	O
high	O
,	O
FGF2	B
,	O
TGFbeta1	O
and	O
retinoic	O
acid	O
all	O
up	O
-	O
regulate	O
Brn3b	B
mRNA	O
expression	O
in	O
cultured	O
trigeminal	O
neurons	O
.	O

Since	O
NT-3	B
regulates	O
the	O
developmental	O
expression	O
of	O
Brn3a	B
,	O
Brn3a	B
may	O
mediate	O
some	O
of	O
the	O
effects	O
that	O
NT-3	B
exerts	O
on	O
sensory	O
neurons	O
and	O
their	O
progenitors	O
.	O

Similarly	O
,	O
Brn3b	B
may	O
mediate	O
some	O
of	O
the	O
effects	O
that	O
FGF2	B
,	O
TGFbeta1	O
and	O
retinoic	O
acid	O
have	O
on	O
neurons	O
.	O

In	O
this	O
study	O
we	O
have	O
examined	O
the	O
expression	O
of	O
murine	O
Hox	O
homeobox	O
containing	O
genes	O
by	O
in	O
situ	O
hybridisation	O
in	O
the	O
branchial	O
region	O
of	O
the	O
head	O
.	O

Genes	O
from	O
the	O
Hox	O
complexes	O
display	O
segmentally	O
restricted	O
domains	O
of	O
expression	O
in	O
the	O
developing	O
hindbrain	O
,	O
which	O
are	O
correlated	O
with	O
similar	O
restricted	O
domains	O
in	O
the	O
neural	O
crest	O
and	O
surface	O
ectoderm	O
of	O
the	O
branchial	O
arches	O
.	O

Comparison	O
of	O
related	O
genes	O
from	O
the	O
different	O
clusters	O
shows	O
that	O
subfamily	O
members	O
are	O
expressed	O
in	O
identical	O
rhombomeres	O
and	O
branchial	O
arches	O
.	O

These	O
patterns	O
suggest	O
a	O
combinatorial	O
system	O
for	O
specifying	O
regional	O
variation	O
in	O
the	O
head	O
,	O
which	O
we	O
refer	O
to	O
as	O
a	O
Hox	O
code	O
.	O

The	O
Hox	O
genes	O
also	O
display	O
dynamic	O
dorso	O
-	O
ventral	O
(	O
D	O
-	O
V	O
)	O
restrictions	O
in	O
the	O
developing	O
neural	O
tube	O
which	O
mirror	O
the	O
timing	O
and	O
spatial	O
distributions	O
of	O
the	O
birth	O
of	O
major	O
classes	O
of	O
neurons	O
in	O
the	O
CNS	O
.	O

Genes	O
in	O
the	O
Hox-2	O
cluster	O
all	O
have	O
a	O
similar	O
D	O
-	O
V	O
distribution	O
that	O
differs	O
from	O
that	O
of	O
genes	O
from	O
the	O
other	O
Hox	O
clusters	O
,	O
and	O
suggests	O
that	O
members	O
of	O
a	O
subfamily	O
may	O
be	O
used	O
to	O
specify	O
positional	O
values	O
to	O
different	O
subsets	O
of	O
cells	O
at	O
the	O
same	O
axial	O
level	O
.	O

These	O
results	O
are	O
discussed	O
in	O
terms	O
of	O
a	O
system	O
for	O
patterning	O
the	O
branchial	O
regions	O
of	O
the	O
vertebrate	O
head	O
,	O
and	O
evolution	O
of	O
head	O
structures	O
.	O

We	O
have	O
also	O
examined	O
aspects	O
of	O
the	O
transcriptional	O
regulation	O
of	O
Hox-2	O
genes	O
in	O
transgenic	O
mice	O
using	O
a	O
lacZ	O
reporter	O
gene	O
.	O

We	O
have	O
been	O
able	O
to	O
reconstruct	O
the	O
major	O
pattern	O
of	O
the	O
Hox-2.6	O
gene	O
on	O
the	O
basis	O
of	O
identical	O
expression	O
of	O
the	O
transgene	O
and	O
the	O
endogenous	O
gene	O
with	O
respect	O
to	O
timing	O
,	O
spatial	O
restrictions	O
and	O
tissue	O
-	O
specific	O
distributions	O
.	O

Deletion	O
analysis	O
has	O
enabled	O
us	O
to	O
identify	O
three	O
regions	O
involved	O
in	O
generating	O
this	O
pattern	O
.	O

Two	O
of	O
these	O
regions	O
have	O
the	O
properties	O
of	O
enhancers	O
which	O
are	O
capable	O
of	O
imposing	O
spatially	O
-	O
restricted	O
domains	O
of	O
expression	O
on	O
heterologous	O
promoters	O
.	O

We	O
have	O
generated	O
similar	O
Hox	O
-	O
lacZ	O
fusions	O
that	O
reconstruct	O
the	O
highly	O
restricted	O
patterns	O
of	O
the	O
Hox-2.1	B
and	O
Hox-2.8	B
genes	O
in	O
the	O
developing	O
nervous	O
system	O
,	O
supporting	O
our	O
in	O
situ	O
analysis	O
and	O
the	O
idea	O
of	O
a	O
Hox	O
code	O
.	O

These	O
transgenic	O
experiments	O
are	O
a	O
useful	O
step	O
in	O
examining	O
regulation	O
in	O
the	O
Hox	O
cascade	O
.	O

Tottering	B
mice	O
inherit	O
a	O
recessive	O
mutation	O
of	O
the	O
calcium	O
channel	O
alpha1A	B
subunit	O
that	O
causes	O
ataxia	O
,	O
polyspike	O
discharges	O
,	O
and	O
intermittent	O
dystonic	O
episodes	O
.	O

The	O
calcium	O
channel	O
alpha1A	B
subunit	O
gene	O
encodes	O
the	O
pore	O
-	O
forming	O
protein	O
of	O
P	O
/	O
Q	O
-	O
type	O
voltage	O
-	O
dependent	O
calcium	O
channels	O
and	O
is	O
predominantly	O
expressed	O
in	O
cerebellar	O
granule	O
and	O
Purkinje	O
neurons	O
with	O
moderate	O
expression	O
in	O
hippocampus	O
and	O
inferior	O
colliculus	O
.	O

Because	O
calcium	O
misregulation	O
likely	O
underlies	O
the	O
tottering	B
mouse	O
phenotype	O
,	O
calcium	O
channel	O
blockers	O
were	O
tested	O
for	O
their	O
ability	O
to	O
block	O
the	O
motor	O
episodes	O
.	O

Pharmacologic	O
agents	O
that	O
specifically	O
block	O
L	O
-	O
type	O
voltage	O
-	O
dependent	O
calcium	O
channels	O
,	O
but	O
not	O
P	O
/	O
Q	O
-	O
type	O
calcium	O
channels	O
,	O
prevented	O
the	O
inducible	O
dystonia	O
of	O
tottering	B
mutant	O
mice	O
.	O

Specifically	O
,	O
the	O
dihydropyridines	O
nimodipine	O
,	O
nifedipine	O
,	O
and	O
nitrendipine	O
,	O
the	O
benzothiazepine	O
diltiazem	O
,	O
and	O
the	O
phenylalkylamine	O
verapamil	O
all	O
prevented	O
restraint	O
-	O
induced	O
tottering	B
mouse	O
motor	O
episodes	O
.	O

Conversely	O
,	O
the	O
L	O
-	O
type	O
calcium	O
channel	O
agonist	O
Bay	O
K8644	O
induced	O
stereotypic	O
tottering	B
mouse	O
dystonic	O
at	O
concentrations	O
significantly	O
below	O
those	O
required	O
to	O
induce	O
seizures	O
in	O
control	O
mice	O
.	O

In	O
situ	O
hybridization	O
demonstrated	O
that	O
L	O
-	O
type	O
calcium	O
channel	O
alpha1C	O
subunit	O
mRNA	O
expression	O
was	O
up	O
-	O
regulated	O
in	O
the	O
Purkinje	O
cells	O
of	O
tottering	B
mice	O
.	O

Radioligand	O
binding	O
with	O
[	O
3H	O
]	O
nitrendipine	O
also	O
revealed	O
a	O
significant	O
increase	O
in	O
the	O
density	O
of	O
L	O
-	O
type	O
calcium	O
channels	O
in	O
tottering	B
mouse	O
cerebellum	O
.	O

These	O
data	O
suggest	O
that	O
although	O
a	O
P	O
/	O
Q	O
-	O
type	O
calcium	O
channel	O
mutation	O
is	O
the	O
primary	O
defect	O
in	O
tottering	B
mice	O
,	O
L	O
-	O
type	O
calcium	O
channels	O
may	O
contribute	O
to	O
the	O
generation	O
of	O
the	O
intermittent	O
dystonia	O
observed	O
in	O
these	O
mice	O
.	O

The	O
susceptibility	O
of	O
L	O
-	O
type	O
calcium	O
channels	O
to	O
voltage	O
-	O
dependent	O
facilitation	O
may	O
promote	O
this	O
abnormal	O
motor	O
phenotype	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
shows	O
that	O
fission	O
yeast	O
centromeres	O
and	O
telomeres	O
make	O
up	O
specific	O
spatial	O
arrangements	O
in	O
the	O
nucleus	O
.	O

Their	O
positioning	O
and	O
clustering	O
are	O
cell	O
cycle	O
regulated	O
.	O

In	O
G2	O
,	O
centromeres	O
cluster	O
adjacent	O
to	O
the	O
spindle	O
pole	O
body	O
(	O
SPB	O
)	O
,	O
while	O
in	O
mitosis	O
,	O
their	O
association	O
with	O
each	O
other	O
and	O
with	O
the	O
SPB	O
is	O
disrupted	O
.	O

Similarly	O
,	O
telomeres	O
cluster	O
at	O
the	O
nuclear	O
periphery	O
in	O
G2	O
and	O
their	O
associations	O
are	O
disrupted	O
in	O
mitosis	O
.	O

Mitotic	O
centromeres	O
interact	O
with	O
the	O
spindle	O
.	O

They	O
remain	O
undivided	O
until	O
the	O
spindle	O
reaches	O
a	O
critical	O
length	O
,	O
then	O
separate	O
and	O
move	O
towards	O
the	O
poles	O
.	O

This	O
demonstrated	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
anaphase	O
A	O
occurs	O
in	O
fission	O
yeast	O
.	O

The	O
mode	O
of	O
anaphase	O
A	O
and	O
B	O
is	O
similar	O
to	O
that	O
of	O
higher	O
eukaryotes	O
.	O

In	O
nda3	O
and	O
cut7	O
mutants	O
defective	O
in	O
tubulin	O
of	O
a	O
kinesin	O
-	O
related	O
motor	O
,	O
cells	O
are	O
blocked	O
in	O
early	O
stages	O
of	O
mitosis	O
due	O
to	O
the	O
absence	O
of	O
the	O
spindle	O
,	O
and	O
centromeres	O
dissociate	O
but	O
remain	O
close	O
to	O
the	O
SPB	O
,	O
whereas	O
in	O
a	O
metaphase	O
-	O
arrested	O
nuc2	B
mutant	O
,	O
they	O
reside	O
at	O
the	O
middle	O
of	O
the	O
spindle	O
.	O

FISH	O
is	O
therefore	O
a	O
powerful	O
tool	O
for	O
analyzing	O
mitotic	O
chromosome	O
movement	O
and	O
disjunction	O
using	O
various	O
mutants	O
.	O

Surprisingly	O
,	O
in	O
top2	B
defective	O
in	O
DNA	O
topoisomerase	O
II	O
,	O
while	O
most	O
chromatid	O
DNAs	O
remain	O
undivided	O
,	O
sister	O
centromeres	O
are	O
separated	O
.	O

Significance	O
of	O
this	O
finding	O
is	O
discussed	O
.	O

In	O
contrast	O
,	O
most	O
chromatid	O
DNAs	O
are	O
separated	O
but	O
telomeric	O
DNAs	O
are	O
not	O
in	O
cut1	O
mutant	O
.	O

In	O
cut1	O
,	O
the	O
dependence	O
of	O
SPB	O
duplication	O
on	O
the	O
completion	O
of	O
mitosis	O
is	O
abolished	O
.	O

In	O
crm1	B
mutant	O
cells	O
defective	O
in	O
higher	O
-	O
order	O
chromosome	O
organization	O
,	O
the	O
interphase	O
arrangements	O
of	O
centromeres	O
and	O
telomeres	O
are	O
disrupted	O
.	O

We	O
have	O
continued	O
our	O
studies	O
on	O
the	O
import	O
pathway	O
of	O
the	O
precursor	O
to	O
yeast	O
cytochrome	O
c	O
oxidase	O
subunit	O
Va	O
(	O
pVa	O
)	O
,	O
a	O
mitochondrial	O
inner	O
membrane	O
protein	O
.	O

Previous	O
work	O
on	O
this	O
precursor	O
demonstrated	O
that	O
import	O
of	O
pVa	O
is	O
unusually	O
efficient	O
,	O
and	O
that	O
inner	O
membrane	O
localization	O
is	O
directed	O
by	O
a	O
membrane	O
-	O
spanning	O
domain	O
in	O
the	O
COOH	O
-	O
terminal	O
third	O
of	O
the	O
protein	O
.	O

Here	O
we	O
report	O
the	O
results	O
of	O
studies	O
aimed	O
at	O
analyzing	O
the	O
intramitochondrial	O
sorting	O
of	O
pVa	O
,	O
as	O
well	O
as	O
the	O
role	O
played	O
by	O
ancillary	O
factors	O
in	O
import	O
and	O
localization	O
of	O
the	O
precursor	O
.	O

We	O
found	O
that	O
pVa	O
was	O
efficiently	O
imported	O
and	O
correctly	O
sorted	O
in	O
mitochondria	O
prepared	O
from	O
yeast	O
strains	O
defective	O
in	O
the	O
function	O
of	O
either	O
mitochondrial	O
heat	O
shock	O
protein	O
(	O
hsp	O
)	O
60	O
or	O
hsp70	B
.	O

Under	O
identical	O
conditions	O
the	O
import	O
and	O
sorting	O
of	O
another	O
mitochondrial	O
protein	O
,	O
the	O
precursor	O
to	O
the	O
beta	O
subunit	O
of	O
the	O
F1	O
ATPase	O
,	O
was	O
completely	O
defective	O
.	O

Consistent	O
with	O
previous	O
results	O
demonstrating	O
that	O
the	O
subunit	O
Va	O
precursor	O
is	O
loosely	O
folded	O
,	O
we	O
found	O
that	O
pVa	O
could	O
be	O
efficiently	O
imported	O
into	O
mitochondria	O
after	O
translation	O
in	O
wheat	O
germ	O
extracts	O
.	O

This	O
results	O
suggests	O
that	O
normal	O
levels	O
of	O
extramitochondrial	O
hsp70	B
are	O
also	O
not	O
required	O
for	O
import	O
of	O
the	O
protein	O
.	O

The	O
results	O
of	O
this	O
study	O
enhance	O
our	O
understanding	O
of	O
the	O
mechanism	O
by	O
which	O
pVa	O
is	O
routed	O
to	O
the	O
mitochondrial	O
inner	O
membrane	O
.	O

They	O
suggest	O
that	O
while	O
the	O
NH2	O
terminus	O
of	O
pVa	O
is	O
exposed	O
to	O
the	O
matrix	O
and	O
processed	O
by	O
the	O
matrix	O
metalloprotease	O
,	O
the	O
protein	O
remains	O
anchored	O
to	O
the	O
inner	O
membrane	O
before	O
being	O
assembled	O
into	O
a	O
functional	O
holoenzyme	O
complex	O
.	O

ENP1	B
is	O
an	O
essential	O
Saccharomyces	O
cerevisiae	O
gene	O
encoding	O
a	O
483	O
amino	O
acid	O
polypeptide	O
.	O

Enp1	B
protein	O
is	O
localized	O
in	O
the	O
nucleus	O
and	O
concentrated	O
in	O
the	O
nucleolus	O
.	O

An	O
enp1	B
-	I
1	I
temperature	O
-	O
sensitive	O
mutant	O
inhibited	O
35S	O
pre	O
-	O
rRNA	O
early	O
processing	O
at	O
sites	O
A	O
(	O
0	O
)	O
,	O
A	O
(	O
1	O
)	O
and	O
A	O
(	O
2	O
)	O
as	O
shown	O
by	O
northern	O
analysis	O
of	O
steady	O
state	O
levels	O
of	O
rRNA	O
precursors	O
.	O

Pulse	O
-	O
chase	O
analysis	O
further	O
revealed	O
that	O
the	O
enp1	B
-	I
1	I
strain	O
was	O
defective	O
in	O
the	O
synthesis	O
of	O
20S	O
pre	O
-	O
rRNA	O
and	O
hence	O
18S	O
rRNA	O
,	O
which	O
led	O
to	O
reduced	O
formation	O
of	O
40S	O
ribosomal	O
subunits	O
.	O

Co	O
-	O
precipitation	O
analysis	O
revealed	O
that	O
Enp1	B
was	O
associated	O
with	O
Nop1	B
protein	O
,	O
as	O
well	O
as	O
with	O
U3	O
and	O
U14	O
RNAs	O
,	O
two	O
snoRNAs	O
implicated	O
in	O
early	O
pre	O
-	O
rRNA	O
processing	O
steps	O
.	O

These	O
results	O
suggest	O
a	O
direct	O
role	O
for	O
Enp1	B
in	O
the	O
early	O
steps	O
of	O
rRNA	O
processing	O
.	O

The	O
PUT1	B
gene	O
of	O
Saccharomyces	O
cerevisiae	O
,	O
believed	O
to	O
encode	O
proline	O
oxidase	O
,	O
has	O
been	O
completely	O
sequenced	O
and	O
contains	O
an	O
open	O
reading	O
frame	O
capable	O
of	O
encoding	O
a	O
polypeptide	O
of	O
476	O
amino	O
acids	O
in	O
length	O
.	O

The	O
amino	O
terminus	O
of	O
the	O
protein	O
deduced	O
from	O
the	O
DNA	O
sequence	O
has	O
a	O
characteristic	O
mitochondrial	O
import	O
signal	O
;	O
two	O
PUT1-lacZ	B
gene	O
fusions	O
were	O
constructed	O
that	O
produced	O
mitochondrially	O
localized	O
beta	O
-	O
galactosidase	O
in	O
vivo	O
.	O

The	O
transcription	O
initiation	O
and	O
termination	O
sites	O
of	O
the	O
PUT1	B
mRNA	O
were	O
determined	O
.	O

By	O
using	O
a	O
PUT1-lacZ	B
gene	O
fusion	O
that	O
makes	O
a	O
cytoplasmic	O
beta	O
-	O
galactosidase	O
,	O
the	O
regulation	O
of	O
the	O
PUT1	B
gene	O
was	O
studied	O
.	O

PUT1	B
is	O
inducible	O
by	O
proline	O
,	O
responds	O
only	O
slightly	O
to	O
carbon	O
catabolite	O
repression	O
,	O
and	O
is	O
not	O
regulated	O
by	O
the	O
cytochrome	O
activator	O
proteins	O
HAP1	B
and	O
HAP2	B
.	O

The	O
PUT1	B
gene	O
is	O
under	O
oxygen	O
regulation	O
;	O
expression	O
in	O
anaerobically	O
grown	O
cells	O
is	O
10-fold	O
lower	O
than	O
in	O
aerobically	O
grown	O
cells	O
.	O

Oxygen	O
regulation	O
is	O
abolished	O
when	O
cells	O
are	O
respiratory	O
deficient	O
.	O

PUT1	B
expression	O
in	O
a	O
[	O
rho-	O
]	O
strain	O
grown	O
either	O
aerobically	O
or	O
anaerobically	O
is	O
as	O
high	O
as	O
that	O
seen	O
in	O
a	O
[	O
rho+	O
]	O
strain	O
grown	O
aerobically	O
.	O

Studies	O
on	O
PUT1	B
promoter	O
deletions	O
define	O
a	O
region	O
between	O
positions	O
-458	O
and	O
-293	O
from	O
the	O
translation	O
initiation	O
site	O
that	O
is	O
important	O
for	O
full	O
expression	O
of	O
the	O
PUT1	B
gene	O
and	O
required	O
for	O
oxygen	O
regulation	O
.	O

The	O
cycl-362	O
allele	O
contains	O
a	O
point	O
mutation	O
that	O
generates	O
an	O
aberrant	O
AUG	O
codon	O
upstream	O
of	O
the	O
normal	O
CYC1	B
translation	O
initiation	O
codon	O
.	O

Mutants	O
containing	O
this	O
allele	O
express	O
only	O
about	O
2	O
%	O
of	O
normal	O
iso-1-cytochrome	O
c	O
,	O
presumably	O
due	O
to	O
translation	O
initiation	O
at	O
the	O
upstream	O
AUG	O
,	O
termination	O
at	O
a	O
UAA	O
sequence	O
six	O
codons	O
downstream	O
,	O
and	O
failure	O
to	O
reinitiate	O
at	O
the	O
normal	O
AUG	O
codon	O
two	O
nucleotides	O
later	O
.	O

Both	O
intragenic	O
and	O
extragenic	O
revertants	O
of	O
cycl-362	O
,	O
expressing	O
elevated	O
levels	O
of	O
iso-1-cytochrome	O
c	O
,	O
have	O
been	O
isolated	O
simply	O
by	O
selecting	O
for	O
growth	O
on	O
lactate	O
medium	O
.	O

Here	O
we	O
describe	O
an	O
improved	O
method	O
for	O
isolating	O
and	O
readily	O
distinguishing	O
cis-	O
from	O
trans	O
-	O
acting	O
suppressors	O
of	O
the	O
upstream	O
AUG	O
.	O

Eight	O
different	O
genes	O
,	O
designated	O
sua1-sua8	B
,	O
are	O
represented	O
in	O
our	O
current	O
collection	O
of	O
extragenic	O
suppressors	O
;	O
all	O
are	O
recessive	O
and	O
enhance	O
iso-1-cytochrome	O
c	O
levels	O
to	O
10	O
-	O
60	O
%	O
of	O
normal	O
.	O

None	O
of	O
the	O
sua	O
genes	O
is	O
allelic	O
to	O
SUI2	B
or	O
sui3	B
,	O
which	O
encode	O
eIF-2	O
alpha	O
and	O
eIF-2	O
beta	O
,	O
respectively	O
,	O
or	O
to	O
SUI1	B
.	O

Many	O
of	O
the	O
suppressors	O
exhibit	O
pleiotropic	O
phenotypes	O
,	O
including	O
slow	O
growth	O
,	O
cold	O
(	O
16	O
degrees	O
C	O
)	O
and	O
heat	O
(	O
37	O
degrees	O
C	O
)	O
sensitivity	O
.	O

These	O
phenotypes	O
have	O
been	O
exploited	O
to	O
clone	O
the	O
SUA5	B
,	O
SUA7	B
and	O
SUA8	B
genes	O
,	O
which	O
are	O
presently	O
being	O
characterized	O
.	O

The	O
structure	O
of	O
cyc1	B
-	I
362	I
and	O
the	O
number	O
of	O
sua	O
genes	O
already	O
uncovered	O
suggest	O
that	O
the	O
SUA	O
genes	O
are	O
likely	O
to	O
encode	O
factors	O
affecting	O
several	O
different	O
cellular	O
processes	O
,	O
including	O
translation	O
initiation	O
,	O
mRNA	O
stability	O
and	O
possibly	O
transcription	O
start	O
site	O
selection	O
.	O

The	O
yeast	O
Saccharomyces	O
cerevisiae	O
has	O
a	O
genetic	O
program	O
for	O
selecting	O
and	O
assembling	O
a	O
bud	O
site	O
on	O
the	O
cell	O
cortex	O
.	O

Yeast	O
cells	O
confine	O
their	O
growth	O
to	O
the	O
emerging	O
bud	O
,	O
a	O
process	O
directed	O
by	O
cortical	O
patches	O
of	O
actin	O
filaments	O
within	O
the	O
bud	O
.	O

We	O
have	O
investigated	O
how	O
cells	O
regulate	O
budding	O
in	O
response	O
to	O
osmotic	O
stress	O
,	O
focusing	O
on	O
the	O
role	O
of	O
the	O
high	O
osmolarity	O
glycerol	O
response	O
(	O
HOG	O
)	O
pathway	O
in	O
mediating	O
this	O
regulation	O
.	O

An	O
increase	O
in	O
external	O
osmolarity	O
induces	O
a	O
growth	O
arrest	O
in	O
which	O
actin	O
filaments	O
are	O
lost	O
from	O
the	O
bud	O
.	O

This	O
is	O
followed	O
by	O
a	O
recovery	O
phase	O
in	O
which	O
actin	O
filaments	O
return	O
to	O
their	O
original	O
locations	O
and	O
growth	O
of	O
the	O
original	O
bud	O
resumes	O
.	O

After	O
recovery	O
from	O
osmotic	O
stress	O
,	O
haploid	O
cells	O
retain	O
an	O
axial	O
pattern	O
of	O
bud	O
site	O
selection	O
while	O
diploids	O
change	O
their	O
bipolar	O
budding	O
pattern	O
to	O
an	O
increased	O
bias	O
for	O
forming	O
a	O
bud	O
on	O
the	O
opposite	O
side	O
of	O
the	O
cell	O
from	O
the	O
previous	O
bud	O
site	O
.	O

Mutants	O
lacking	O
the	O
mitogen	O
-	O
activated	O
protein	O
(	O
MAP	O
)	O
kinase	O
encoded	O
by	O
HOG1	B
or	O
the	O
MAP	O
kinase	O
kinase	O
encoded	O
by	O
PBS2	B
(	O
previously	O
HOG4	B
)	O
show	O
a	O
similar	O
growth	O
arrest	O
after	O
osmotic	O
stress	O
.	O

However	O
,	O
in	O
the	O
recovery	O
phase	O
,	O
the	O
mutant	O
cells	O
(	O
a	O
)	O
do	O
not	O
restart	O
growth	O
of	O
the	O
original	O
bud	O
but	O
rather	O
start	O
a	O
new	O
bud	O
,	O
(	O
b	O
)	O
fail	O
to	O
restore	O
actin	O
filaments	O
to	O
the	O
original	O
bud	O
but	O
move	O
them	O
to	O
the	O
new	O
one	O
,	O
and	O
(	O
c	O
)	O
show	O
a	O
more	O
random	O
budding	O
pattern	O
.	O

These	O
defects	O
are	O
elicited	O
by	O
an	O
increase	O
in	O
osmolarity	O
and	O
not	O
by	O
other	O
environmental	O
stresses	O
(	O
e.g.	O
,	O
heat	O
shock	O
or	O
change	O
in	O
carbon	O
source	O
)	O
that	O
also	O
cause	O
a	O
temporary	O
growth	O
arrest	O
and	O
shift	O
in	O
actin	O
distribution	O
.	O

Thus	O
,	O
the	O
HOG	O
pathway	O
is	O
required	O
for	O
repositioning	O
of	O
the	O
actin	O
cytoskeleton	O
and	O
the	O
normal	O
spatial	O
patterns	O
of	O
cell	O
growth	O
after	O
recovery	O
from	O
osmotic	O
stress	O
.	O

A	O
cDNA	O
clone	O
encoding	O
Arabidopsis	O
thaliana	O
galactokinase	O
was	O
fortuitously	O
isolated	O
during	O
the	O
course	O
of	O
a	O
screen	O
for	O
plant	O
homologues	O
of	O
a	O
Saccharomyces	O
cerevisiae	O
peroxisome	O
assembly	O
gene	O
,	O
PAS9	B
.	O

Clones	O
were	O
sought	O
which	O
restored	O
the	O
ability	O
of	O
pas9	B
cells	O
to	O
grow	O
on	O
oleate	O
as	O
a	O
sole	O
carbon	O
source	O
,	O
as	O
oleate	O
metabolism	O
requires	O
peroxisomal	O
beta	O
-	O
oxidation	O
and	O
therefore	O
functional	O
peroxisomes	O
.	O

Subsequent	O
experiments	O
showed	O
that	O
high	O
level	O
expression	O
of	O
the	O
galactokinase	O
cDNA	O
did	O
not	O
complement	O
the	O
peroxisomal	O
assembly	O
defect	O
,	O
but	O
instead	O
permitted	O
the	O
cells	O
to	O
grow	O
on	O
agar	O
plates	O
in	O
the	O
absence	O
of	O
an	O
external	O
carbon	O
source	O
.	O

Agar	O
plates	O
were	O
shown	O
to	O
contain	O
a	O
small	O
amount	O
of	O
galactose	O
released	O
from	O
the	O
agar	O
as	O
a	O
result	O
of	O
autoclaving	O
.	O

The	O
galactokinase	O
clone	O
was	O
shown	O
to	O
be	O
functional	O
,	O
as	O
it	O
could	O
complement	O
a	O
S.	O
cerevisiae	O
galactokinase	O
mutant	O
.	O

Galactokinase	O
is	O
a	O
single	O
copy	O
gene	O
in	O
Arabidopsis	O
,	O
which	O
has	O
been	O
designated	O
AGK1	O
,	O
and	O
is	O
expressed	O
in	O
all	O
the	O
major	O
organs	O
of	O
the	O
plant	O
.	O

Human	O
cystathionine	O
beta	O
-	O
synthase	O
(	O
CBS	O
;	O
EC	O
4.2.1.22	O
)	O
deficiency	O
results	O
in	O
a	O
recessive	O
genetic	O
disorder	O
whose	O
clinical	O
and	O
biochemical	O
manifestations	O
vary	O
greatly	O
among	O
affected	O
individuals	O
.	O

In	O
an	O
effort	O
to	O
identify	O
and	O
analyze	O
mutations	O
in	O
the	O
human	O
CBS	O
gene	O
,	O
we	O
have	O
developed	O
a	O
yeast	O
expression	O
system	O
for	O
human	O
CBS	O
.	O

We	O
have	O
cloned	O
and	O
sequenced	O
a	O
human	O
cDNA	O
that	O
codes	O
for	O
CBS	O
and	O
have	O
expressed	O
the	O
human	O
CBS	O
protein	O
in	O
yeast	O
cells	O
lacking	O
endogenous	O
CBS	O
.	O

The	O
human	O
enzyme	O
produced	O
in	O
yeast	O
is	O
functional	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

We	O
have	O
also	O
cloned	O
and	O
sequenced	O
the	O
yeast	O
gene	O
,	O
CYS4	B
,	O
that	O
codes	O
for	O
CBS	O
.	O

The	O
predicted	O
human	O
and	O
yeast	O
CBS	O
proteins	O
are	O
38	O
%	O
identical	O
and	O
72	O
%	O
similar	O
to	O
each	O
other	O
,	O
as	O
well	O
as	O
sharing	O
significant	O
similarity	O
with	O
bacterial	O
cysteine	O
synthase	O
.	O

These	O
results	O
demonstrate	O
the	O
evolutionary	O
conservation	O
of	O
CBS	O
and	O
establish	O
the	O
utility	O
of	O
a	O
yeast	O
expression	O
system	O
for	O
studying	O
human	O
CBS	O
.	O

It	O
is	O
thought	O
that	O
DNA	O
replication	O
and	O
mitosis	O
in	O
yeast	O
are	O
triggered	O
by	O
oscillations	O
in	O
the	O
level	O
of	O
G1-specific	O
(	O
CLN1	B
and	O
CLN2	B
)	O
and	O
G2-specific	O
(	O
CLB1-CLB4	B
)	O
cyclins	O
,	O
which	O
determine	O
the	O
substrate	O
specificity	O
of	O
the	O
CDC28	B
protein	O
kinase	O
.	O

It	O
is	O
not	O
understood	O
how	O
the	O
time	O
and	O
order	O
of	O
appearance	O
of	O
different	O
cyclin	O
types	O
are	O
determined	O
.	O

We	O
show	O
here	O
that	O
CLB2	B
proteolysis	O
,	O
which	O
is	O
important	O
for	O
transition	O
from	O
mitosis	O
to	O
G1	O
,	O
is	O
not	O
confined	O
to	O
a	O
narrow	O
window	O
at	O
the	O
end	O
of	O
mitosis	O
as	O
previously	O
thought	O
but	O
continues	O
until	O
reactivation	O
of	O
CDC28	B
by	O
CLN	O
cyclins	O
toward	O
the	O
end	O
of	O
the	O
subsequent	O
G1	O
period	O
.	O

Thus	O
,	O
cell	O
cycle	O
-	O
regulated	O
proteolysis	O
prevents	O
accumulation	O
of	O
G2-specific	O
CLB	O
cyclins	O
during	O
G1	O
and	O
thereby	O
ensures	O
that	O
the	O
CLN	O
-	O
associated	O
forms	O
of	O
the	O
CDC28	B
kinase	O
are	O
activated	O
without	O
interference	O
from	O
CLB	O
cyclins	O
.	O

Accumulation	O
of	O
CLN	O
cyclins	O
leads	O
to	O
inactivation	O
of	O
CLB	O
cyclin	O
proteolysis	O
,	O
which	O
is	O
a	O
precondition	O
for	O
subsequent	O
activation	O
of	O
G2-specific	O
B	O
-	O
type	O
cyclins	O
.	O

The	O
RES1	B
-	I
1	I
mutation	O
was	O
isolated	O
on	O
the	O
basis	O
of	O
its	O
ability	O
to	O
allow	O
MATa	O
/	O
MAT	B
alpha	O
diploid	O
Saccharomyces	O
cerevisiae	O
cells	O
to	O
express	O
a	O
late	O
sporulation	O
-	O
regulated	O
gene	O
,	O
SPR3	B
,	O
in	O
the	O
presence	O
of	O
excess	O
copies	O
of	O
RME1	B
.	O

RME1	B
is	O
a	O
repressor	O
of	O
meiosis	O
that	O
is	O
normally	O
expressed	O
in	O
cells	O
that	O
lack	O
the	O
a1	B
/	O
alpha	O
2	O
repressor	O
encoded	O
by	O
MAT	B
.	O

The	O
RES1	B
-	I
1	I
mutation	O
also	O
supports	O
sporulation	O
in	O
mat	B
-	O
insufficient	O
diploids	O
.	O

This	O
phenotype	O
does	O
not	O
result	O
from	O
a	O
failure	O
to	O
express	O
RME1	B
and	O
is	O
not	O
due	O
to	O
activation	O
of	O
the	O
silent	O
copies	O
of	O
mating	O
type	O
information	O
.	O

RES1	B
-	I
1	I
activates	O
sporulation	O
by	O
allowing	O
IME1	B
accumulation	O
in	O
all	O
cell	O
types	O
,	O
irrespective	O
of	O
the	O
presence	O
of	O
the	O
MAT	B
products	O
.	O

IME1	B
is	O
still	O
responsive	O
to	O
RME1	B
in	O
RES1	B
-	I
1	I
cells	O
,	O
since	O
double	O
mutants	O
(	O
rme1	B
RES1	B
-	I
1	I
)	O
that	O
are	O
deficient	O
at	O
MAT	B
can	O
sporulate	O
better	O
than	O
either	O
single	O
mutant	O
.	O

RES1	B
-	I
1	I
is	O
not	O
an	O
allele	O
of	O
IME1	B
.	O

